network pathfinder {
}
variable Fault {
  type discrete [ 76 ] { AIDS_early, AILD, ALIP, Cat_scratch_disease, Dermatopathic_laden, Florid_follic_hyperp, GLH_hyaline_vascular, GLH_plasma_cell, Granulomatous_laden, Histiocytosis_x, Infectious_mono, Leprosy_lepromatous, Lymphangiographic, Mantle_zone_hyperpla, Necrotizing_Kikuchi, Necrotiz_non_Kikuchi, Rheumatoid_arthritis, Sarcoidosis, SHML, Sinus_histiocytosis, Syphilis, Toxoplasmosis, Tuberculosis, Viral_NOS, Whipple_s_disease, L_H_nodular_HD, L_H_diffuse_HD, Nodular_sclerosis_HD, Cellular_phase_NSHD, Syncytial_NSHD, Mixed_cellularity_HD, Interfollicular_HD, Diffuse_fibrosis_HD, Reticular_type_HD, Small_cleaved_fol, Mixed_fol, Large_cell_fol, Small_noncleaved_fol, Small_lymphocytic, Plasmacytoid_lyctic, Mantle_zone_lymphoma, Small_cleaved_dif, Mixed_FCC_dif, Large_cell_dif, B_immunoblastic, T_immunob_mixed, AILD_like_T_cell_lym, Japanese_ATL, Lymphoblastic, Small_noncleaved_dif, True_histiocytic, Ki_1_LC_anaplas_T, Multiple_myeloma, Mycosis_fungoides, AML, Hairy_cell_leukemia, Carcinoma, Melanoma, EM_plasmacytoma, Kaposi_s_sarcoma, Mast_cell_disease, AIDS_involutionary, T_immunob_large, Monocytoid_B_cell, Nasopharyngeal_CA, Seminoma, SLE, Mycobact_histiocytos, Mast_cell_hyperplas, LGV, Histoplasmosis, Coccidioidomycosis, CMV, Brucellosis, Ki_1_LC_anaplas_B, Intermed_lymphocytic };
}
variable ACID {
  type discrete [ 2 ] { Negative, Positive };
}
variable F_CSA {
  type discrete [ 3 ] { No_follicles, Absent, Present };
}
variable F_ISL {
  type discrete [ 3 ] { No_follicles, Absent, Present };
}
variable F_POL {
  type discrete [ 3 ] { No_follicles, Absent, Present };
}
variable F_RPBV {
  type discrete [ 4 ] { No_follicles, None, One, More_than_one };
}
variable BH_LANG {
  type discrete [ 4 ] { Absent, Slight, Moderate, Marked };
}
variable BH_FOAM {
  type discrete [ 5 ] { Absent, Rare, Focal, Multifocal, Extensive };
}
variable BH_NOS {
  type discrete [ 3 ] { Absent_to_slight_LT_5pc, Moderate_5_to_50pc, Marked_GT_50pc };
}
variable BH_SS {
  type discrete [ 5 ] { Absent, Rare, Focal_SS_pattern, MultiFocal_SS_pattern, Extensive_SS_pattern };
}
variable CA {
  type discrete [ 2 ] { Absent, Present };
}
variable SR {
  type discrete [ 5 ] { Absent_0, Rare_1_to_3, Present_4_to_15, Many_16_to_50, Striking_GT_50 };
}
variable DVS {
  type discrete [ 2 ] { Absent, Present };
}
variable EMPERI {
  type discrete [ 3 ] { Absent_0, Present1_to_2, Prominent_GT_2 };
}
variable MA_EOSIN {
  type discrete [ 2 ] { Absent, Present };
}
variable EMM {
  type discrete [ 2 ] { Absent, Present };
}
variable EOSIN {
  type discrete [ 3 ] { Absent, Present, Prominent };
}
variable EHC {
  type discrete [ 3 ] { Absent_0pc, Present_LT_5pc, Prominent_GT_5pc };
}
variable EHC_ENC {
  type discrete [ 4 ] { No_epithelial_clusters_No_follicles, Absent_no, Some, Many };
}
variable EH_NC {
  type discrete [ 3 ] { Absent_0pc, Present_LT_5pc, Prominent_GT_5pc };
}
variable ECCC {
  type discrete [ 4 ] { Absent_0pc, Rare_1_to_10pc, Present_11_to_50pc, Many_51_to_70pc };
}
variable FCB {
  type discrete [ 3 ] { Absent, Present, Prominent };
}
variable FCB_NOD {
  type discrete [ 3 ] { No_collagenous_bands, Absent, Present };
}
variable FIBROS {
  type discrete [ 2 ] { Absent, Present };
}
variable FITE {
  type discrete [ 2 ] { Negative, Positive };
}
variable FBODY {
  type discrete [ 3 ] { Absent_0, Present_1_to_5, Prominent_GT_5 };
}
variable GENE_TC {
  type discrete [ 2 ] { Absent, Present };
}
variable HAIRY {
  type discrete [ 2 ] { Absent, Present };
}
variable HTLV_I {
  type discrete [ 2 ] { Negative, Positive };
}
variable HIV {
  type discrete [ 2 ] { Negative, Positive };
}
variable INTFOL {
  type discrete [ 3 ] { No_expansion, Mild_moderate_expansion, Unif_mrkd_expan_No_follicles };
}
variable ICLC {
  type discrete [ 2 ] { Absent, Present };
}
variable KARYO {
  type discrete [ 3 ] { Absent, Present, Prominent };
}
variable L_and_H {
  type discrete [ 5 ] { Absent_0, Rare_1_to_5, Few_6_to_25, Many_26_to_100, Striking_GT_100 };
}
variable LH_NOD {
  type discrete [ 2 ] { Absent, Present };
}
variable LACUN {
  type discrete [ 6 ] { Absent_0, Rare_1_to_5, Few_6_to_25, Many_26_to_100, Striking_GT_100, Sheets_GT_50pc_of_section };
}
variable LANG {
  type discrete [ 3 ] { Absent_0, Present_1_to_5, Prominent_GT_5 };
}
variable LEUK {
  type discrete [ 2 ] { Absent, Present };
}
variable LLC_CY {
  type discrete [ 4 ] { No_LLCs, Scanty, Moderate_abundant_clear, Moderate_abundant_deep };
}
variable LLC_NS {
  type discrete [ 6 ] { No_LLCs, Multilobated_some, Cerebriform_Mulberry_some, Convoluted_some, Irregular_most, Round_slightly_Irregular_most };
}
variable LLC {
  type discrete [ 5 ] { Absent_0pc, Sparse_LT_10pc, Moderate_11_to_50pc, Numerous_51_to_90pc, Striking_GT_90pc };
}
variable F_POPU {
  type discrete [ 5 ] { No_follicles, GT_80pc_6_to_12u, GT_50pc_13_to_20u_with_nucleoli, GT_50pc_GT_20u_with_nucleoli, Other };
}
variable MAST {
  type discrete [ 3 ] { Absent_0, Present_1_to_50, Prominent_GT_50 };
}
variable MLC {
  type discrete [ 5 ] { Absent_0pc, Sparse_LT_10pc, Moderate_11_to_50pc, Numerous_51_to_90pc, Striking_GT_90pc };
}
variable MELANOMA {
  type discrete [ 2 ] { Absent, Present };
}
variable MF10HP {
  type discrete [ 4 ] { 0_to_5, 6_to_15, 16_to_50, GT_50 };
}
variable MLC_CY {
  type discrete [ 4 ] { No_MLCs, Scanty, Moderate_abundant_clear, Moderate_abundant_deep };
}
variable MLC_NS {
  type discrete [ 5 ] { No_MLCs, Cerebriform_some, Convoluted_some, Irregular_most, Round_slightly_Irregular_most };
}
variable MLC_NI {
  type discrete [ 5 ] { No_MLCs, Absent_to_rare, Large_central, Peripheral, Other };
}
variable MCC {
  type discrete [ 4 ] { Absent_0pc, Present_LT_5pc, Prominent_5_to_50pc, Confluence_GT_50pc };
}
variable MONO {
  type discrete [ 4 ] { Absent_0, Rare_1_to_2, Present_3_to_20, Many_GT_20 };
}
variable MOT_HIST {
  type discrete [ 4 ] { Absent, Focal_nonextensive, MultiFocal_nonextensive, Extensive };
}
variable MOT_LLC {
  type discrete [ 4 ] { No_mottling, Focal_nonextensive, MultiFocal_nonextensive, Extensive };
}
variable MUMMY {
  type discrete [ 4 ] { Absent_0, Rare_1_to_2, Present_3_to_20, Many_GT_20 };
}
variable NECR {
  type discrete [ 4 ] { Absent, Focal_nonextensive, MultiFocal_nonextensive, Extensive };
}
variable MA_NEUT {
  type discrete [ 2 ] { Absent, Present };
}
variable NEUTRO {
  type discrete [ 3 ] { Absent, Present, Prominent };
}
variable PAS {
  type discrete [ 2 ] { No, Yes };
}
variable PI {
  type discrete [ 3 ] { Absent, Present, Prominent };
}
variable PLASMA {
  type discrete [ 6 ] { Absent_0pc, Few_LT_5pc, Moderate_6_to_20pc, Marked_21_to_50pc, Striking_51_to_90pc, Sheets_GT_90pc };
}
variable PC_TP {
  type discrete [ 6 ] { No_plasma_cells, Mature, Immature, Blastic, Pleomorphic, Mixed };
}
variable PLEO {
  type discrete [ 5 ] { Absent_0, Rare_1_to_5, Few_6_to_25, Many_26_to_100, Striking_GT_100 };
}
variable PFP {
  type discrete [ 2 ] { Absent, Present };
}
variable PTGC_NOD {
  type discrete [ 2 ] { Absent, Present };
}
variable RD_BOD {
  type discrete [ 2 ] { Absent, Present };
}
variable SARCOMA {
  type discrete [ 2 ] { Absent, Present };
}
variable SCHAUM {
  type discrete [ 2 ] { Absent, Present };
}
variable S_RING {
  type discrete [ 2 ] { Absent, Present };
}
variable SLC_CY {
  type discrete [ 4 ] { No_SLCs, Scanty, Moderate_abundant_clear, Moderate_abundant_deep };
}
variable SLC_NS {
  type discrete [ 5 ] { No_SLCs, Cerebriform_some, Convoluted_some, Moderate_mark_Irregular_most, Round_slightly_Irregular_most };
}
variable SLC {
  type discrete [ 5 ] { Absent_0pc, Sparse_1_to_10pc, Moderate_11_to_50pc, Numerous_51_to_90pc, Striking_GT_90pc };
}
variable SINUSES {
  type discrete [ 4 ] { Distended, Patent, Part_greatly_obliterated, Completely_obliterated };
}
variable VASC_C {
  type discrete [ 2 ] { Absent, Present };
}
variable VASC_NS {
  type discrete [ 5 ] { Absent, Slight, Moderate, Marked, Pronounced };
}
variable VASC_S {
  type discrete [ 2 ] { Absent, Present };
}
variable F_HEM {
  type discrete [ 3 ] { No_follicles, Absent, Present };
}
variable TAB {
  type discrete [ 2 ] { Absent, Present };
}
variable CT {
  type discrete [ 4 ] { Absent, Slight_LT_10, Moderate_10_to_20, Marked_GT_20 };
}
variable GENE_IG {
  type discrete [ 2 ] { Absent, Present };
}
variable HIV_ST {
  type discrete [ 3 ] { Negative, Positive_Asymptomatic, Positive_Symptomatic };
}
variable MLC_LLC {
  type discrete [ 2 ] { No, Yes };
}
variable LLC_NI {
  type discrete [ 5 ] { No_LLCs, Absent_to_rare, Large_central, Peripheral, Other };
}
variable SLC_CS {
  type discrete [ 5 ] { No_SLCs, Clumped, Vesicular, Fine_and_delicate, Plasmacytoid };
}
variable LLC_ID {
  type discrete [ 4 ] { No_LLCs, Other, Large_cleaved, Large_noncleaved };
}
variable FOLLICLE {
  type discrete [ 5 ] { Absent_0pc, 1_to_25pc, 25_to_75pc, 75_to_90pc, GT_90pc };
}
variable F_DEN {
  type discrete [ 5 ] { No_follicles, Back_to_back, Closely_packed, Separated, Far_apart };
}
variable F_SS {
  type discrete [ 5 ] { No_follicles, Absent_0, Slight_1_to_15, Moderate_16_to_30, Marked_GT_30 };
}
variable F_MZSTAT {
  type discrete [ 5 ] { No_follicles_no_mantle_zones, Mantle_zones_absent_in_most_follicles, Most_incompletely_surround_follicles, Most_completely_surround_fol_not_thick, Most_thick_GT_10_lymphocytes };
}
variable F_MZCM {
  type discrete [ 3 ] { No_follicles_no_mantle_zones, Absent, Present };
}
variable F_DEF {
  type discrete [ 4 ] { No_follicles, Almost_all_well_defined, Both_well_and_poor_defined, Almost_all_poor_defined };
}
variable F_MITO {
  type discrete [ 4 ] { No_follicles, 0_to_20, 21_to_50, GT_50 };
}
variable F_MZ {
  type discrete [ 3 ] { No_follicles, Absent, Present };
}
variable F_CIO {
  type discrete [ 4 ] { No_follicles, Most_similar, Some_similar, None_similar };
}
variable LLC_KL {
  type discrete [ 4 ] { No_LLCs, Neither_positive, Monoclonal, Polyclonal };
}
variable PLAS_KL {
  type discrete [ 4 ] { No_plasma_cells, Polyclonal, Monoclonal, Neither_positive };
}
variable FCC_KL {
  type discrete [ 4 ] { No_follicles, Polyclonal, Monoclonal, Neither_positive };
}
variable MZL_KL {
  type discrete [ 4 ] { No_mantle_zones, Polyclonal, Monoclonal, Neither_positive };
}
variable SR_LEU {
  type discrete [ 5 ] { No_classic_SRs, Both_NEG, Leu_M1_POS_CLA_NEG, Leu_M1_NEG_CLA_POS, Both_POS };
}
variable LAC_LEU {
  type discrete [ 5 ] { No_Lacunar_SRs, Both_NEG, Leu_M1_POS_CLA_NEG, Leu_M1_NEG_CLA_POS, Both_POS };
}
variable PLEO_LEU {
  type discrete [ 5 ] { No_pleomorphic_SRs, Both_NEG, Leu_M1_POS_CLA_NEG, Leu_M1_NEG_CLA_POS, Both_POS };
}
variable MONO_LEU {
  type discrete [ 5 ] { No_mononuclear_SRs, Both_NEG, Leu_M1_POS_CLA_NEG, Leu_M1_NEG_CLA_POS, Both_POS };
}
variable LH_LEU {
  type discrete [ 5 ] { No_L_H_SRs, Both_NEG, Leu_M1_POS_CLA_NEG, Leu_M1_NEG_CLA_POS, Both_POS };
}
variable CA_KER {
  type discrete [ 2 ] { Negative, Positive };
}
variable MLC_LEU9 {
  type discrete [ 3 ] { No_MLCs, Negative, Positive };
}
variable MLC_TDT {
  type discrete [ 3 ] { No_MLCs, Negative, Positive };
}
variable CA_CHROM {
  type discrete [ 2 ] { Negative, Positive };
}
variable UCHL_1 {
  type discrete [ 2 ] { Negative, Positive };
}
variable KI_AB {
  type discrete [ 2 ] { Negative, Positive };
}
variable L_26 {
  type discrete [ 2 ] { Negative, Positive };
}
variable BER_H2 {
  type discrete [ 2 ] { Negative, Positive };
}
variable SEMINOMA {
  type discrete [ 2 ] { Absent, Present };
}
variable AGE {
  type discrete [ 4 ] { 0_to_20, 21_to_30, 31_to_70, GT_70 };
}
variable LYMPHADE {
  type discrete [ 2 ] { Localized_stage_1_or_2, Generalized_stage_3_or_4 };
}
variable MED_MASS {
  type discrete [ 2 ] { Absent, Present };
}
variable HMB45 {
  type discrete [ 2 ] { Negative, Positive };
}
variable MLC_LYZ {
  type discrete [ 3 ] { No_MLCs, Negative, Positive };
}
variable MLC_I {
  type discrete [ 2 ] { Absent_no, Present_yes };
}
variable LLC_I {
  type discrete [ 2 ] { Absent_no, Present_yes };
}
variable LIPID {
  type discrete [ 2 ] { Absent_to_few, Prominent };
}
variable HX_LA {
  type discrete [ 2 ] { Absent, Present };
}
variable HEMATOX {
  type discrete [ 2 ] { Absent, Present };
}
variable CMV {
  type discrete [ 2 ] { Absent, Present };
}
variable BRUCELLA {
  type discrete [ 2 ] { No, Yes };
}
variable COCCIDIA {
  type discrete [ 2 ] { Absent, Present };
}
variable HISTOPLA {
  type discrete [ 2 ] { Absent, Present };
}
variable LGV {
  type discrete [ 2 ] { No, Yes };
}
variable VDRL {
  type discrete [ 2 ] { No, Yes };
}
variable PLASCY_T {
  type discrete [ 3 ] { Absent, Present, Prominent };
}
variable TB {
  type discrete [ 3 ] { Absent, Present, Prominent };
}
variable MELANIN {
  type discrete [ 3 ] { Absent_to_normal, Present, Prominent };
}
variable MC_SL_NS {
  type discrete [ 5 ] { No_follicles_no_mantle_zones, Round, Slightly_irregular, Moderately_irregular, Markedly_irregular };
}
variable FMZ_FUS {
  type discrete [ 4 ] { No_thick_mantle_zones, No_nodules_no_fusion, Nodules_but_no_fusion, Fusion_with_or_without_nodules };
}
variable BH_NOS_L {
  type discrete [ 4 ] { No_NOS_benign_histiocytes, Mainly_interfollicular, Mainly_sinusoidal, Both_interfollicular_and_sinusoidal };
}
variable SLC_NI {
  type discrete [ 5 ] { No_SLCs, None_identifiable, one_or_more_peripheral_small, one_central_medium_to_large, Other };
}
variable HYALIN {
  type discrete [ 3 ] { Absent, Present, Prominent };
}
probability ( Fault ) {
  table  20.00,   1.50,   5.00,   5.00,  25.00,  25.00,   5.00,   5.00,  15.00,   4.00,   2.00,   2.00,   5.00,  12.50,   8.00,  12.80,   2.00,   2.00,   3.00,  20.00,   2.00,   5.00,   4.00,  15.00,   0.50,  15.00,   2.50,  90.00,   8.00,   8.00,  70.00,   5.00,   3.00,   3.00, 110.00,  55.00,  20.00,   5.00,  40.00,   8.00,  10.00,   5.00,   6.00, 110.00,  20.00,  20.00,  12.00,   2.00,  10.00,  80.00,   1.00,  15.00,   2.00,   3.00,   5.00,   0.10,  20.00,   8.00,   5.00,   8.00,   2.00,  20.00,  25.00,  20.00,   5.00,   2.00,   2.00,   2.00,   2.00,   2.00,   2.00,   2.00,   5.00,   0.25,   4.00,   8.00;
}
probability ( ACID | TB ) {
  (Absent) 1.0, 0.0;
  (Present) 0.1, 0.9;
  (Prominent) 0.0, 1.0;
}
probability ( F_CSA | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.0, 0.9, 0.1;
  (AILD, 1_to_25pc) 0.0, 0.3, 0.7;
  (ALIP, 1_to_25pc) 0.0, 0.9, 0.1;
  (Cat_scratch_disease, 1_to_25pc) 0.0, 0.9, 0.1;
  (Dermatopathic_laden, 1_to_25pc) 0.0, 0.9, 0.1;
  (Florid_follic_hyperp, 1_to_25pc) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, 1_to_25pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, 1_to_25pc) 0.0, 0.9, 0.1;
  (Granulomatous_laden, 1_to_25pc) 0.0, 0.9, 0.1;
  (Histiocytosis_x, 1_to_25pc) 0.0, 0.9, 0.1;
  (Infectious_mono, 1_to_25pc) 0.0, 0.9, 0.1;
  (Leprosy_lepromatous, 1_to_25pc) 0.0, 0.9, 0.1;
  (Lymphangiographic, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.0, 0.2, 0.8;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, 1_to_25pc) 0.0, 0.9, 0.1;
  (Sarcoidosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (SHML, 1_to_25pc) 0.0, 0.9, 0.1;
  (Sinus_histiocytosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (Syphilis, 1_to_25pc) 0.0, 0.9, 0.1;
  (Toxoplasmosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (Tuberculosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (Viral_NOS, 1_to_25pc) 0.0, 0.9, 0.1;
  (Whipple_s_disease, 1_to_25pc) 0.0, 0.9, 0.1;
  (L_H_nodular_HD, 1_to_25pc) 0.0, 0.9, 0.1;
  (L_H_diffuse_HD, 1_to_25pc) 0.0, 0.9, 0.1;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.0, 0.9, 0.1;
  (Cellular_phase_NSHD, 1_to_25pc) 0.0, 0.9, 0.1;
  (Syncytial_NSHD, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mixed_cellularity_HD, 1_to_25pc) 0.0, 0.9, 0.1;
  (Interfollicular_HD, 1_to_25pc) 0.0, 0.9, 0.1;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.0, 0.9, 0.1;
  (Reticular_type_HD, 1_to_25pc) 0.0, 0.9, 0.1;
  (Small_cleaved_fol, 1_to_25pc) 0.000, 0.999, 0.001;
  (Mixed_fol, 1_to_25pc) 0.000, 0.999, 0.001;
  (Large_cell_fol, 1_to_25pc) 0.000, 0.999, 0.001;
  (Small_noncleaved_fol, 1_to_25pc) 0.000, 0.999, 0.001;
  (Small_lymphocytic, 1_to_25pc) 0.0, 0.9, 0.1;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.0, 0.1, 0.9;
  (Small_cleaved_dif, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mixed_FCC_dif, 1_to_25pc) 0.0, 0.9, 0.1;
  (Large_cell_dif, 1_to_25pc) 0.0, 0.9, 0.1;
  (B_immunoblastic, 1_to_25pc) 0.0, 0.9, 0.1;
  (T_immunob_mixed, 1_to_25pc) 0.0, 0.9, 0.1;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.0, 0.3, 0.7;
  (Japanese_ATL, 1_to_25pc) 0.0, 0.9, 0.1;
  (Lymphoblastic, 1_to_25pc) 0.0, 0.9, 0.1;
  (Small_noncleaved_dif, 1_to_25pc) 0.0, 0.9, 0.1;
  (True_histiocytic, 1_to_25pc) 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.0, 0.9, 0.1;
  (Multiple_myeloma, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mycosis_fungoides, 1_to_25pc) 0.0, 0.9, 0.1;
  (AML, 1_to_25pc) 0.0, 0.9, 0.1;
  (Hairy_cell_leukemia, 1_to_25pc) 0.0, 0.9, 0.1;
  (Carcinoma, 1_to_25pc) 0.0, 0.9, 0.1;
  (Melanoma, 1_to_25pc) 0.0, 0.9, 0.1;
  (EM_plasmacytoma, 1_to_25pc) 0.0, 0.9, 0.1;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.0, 0.8, 0.2;
  (Mast_cell_disease, 1_to_25pc) 0.0, 0.9, 0.1;
  (AIDS_involutionary, 1_to_25pc) 0.0, 0.1, 0.9;
  (T_immunob_large, 1_to_25pc) 0.0, 0.9, 0.1;
  (Monocytoid_B_cell, 1_to_25pc) 0.0, 0.9, 0.1;
  (Nasopharyngeal_CA, 1_to_25pc) 0.0, 0.9, 0.1;
  (Seminoma, 1_to_25pc) 0.0, 0.9, 0.1;
  (SLE, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mycobact_histiocytos, 1_to_25pc) 0.0, 0.8, 0.2;
  (Mast_cell_hyperplas, 1_to_25pc) 0.0, 0.9, 0.1;
  (LGV, 1_to_25pc) 0.0, 0.9, 0.1;
  (Histoplasmosis, 1_to_25pc) 0.0, 0.8, 0.2;
  (Coccidioidomycosis, 1_to_25pc) 0.0, 0.8, 0.2;
  (CMV, 1_to_25pc) 0.0, 0.8, 0.2;
  (Brucellosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.0, 0.9, 0.1;
  (Intermed_lymphocytic, 1_to_25pc) 0.0, 0.1, 0.9;
  (AIDS_early, 25_to_75pc) 0.0, 0.9, 0.1;
  (AILD, 25_to_75pc) 0.0, 0.3, 0.7;
  (ALIP, 25_to_75pc) 0.0, 0.9, 0.1;
  (Cat_scratch_disease, 25_to_75pc) 0.0, 0.9, 0.1;
  (Dermatopathic_laden, 25_to_75pc) 0.0, 0.9, 0.1;
  (Florid_follic_hyperp, 25_to_75pc) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, 25_to_75pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, 25_to_75pc) 0.0, 0.9, 0.1;
  (Granulomatous_laden, 25_to_75pc) 0.0, 0.9, 0.1;
  (Histiocytosis_x, 25_to_75pc) 0.0, 0.9, 0.1;
  (Infectious_mono, 25_to_75pc) 0.0, 0.9, 0.1;
  (Leprosy_lepromatous, 25_to_75pc) 0.0, 0.9, 0.1;
  (Lymphangiographic, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.0, 0.2, 0.8;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, 25_to_75pc) 0.0, 0.9, 0.1;
  (Sarcoidosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (SHML, 25_to_75pc) 0.0, 0.9, 0.1;
  (Sinus_histiocytosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (Syphilis, 25_to_75pc) 0.0, 0.9, 0.1;
  (Toxoplasmosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (Tuberculosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (Viral_NOS, 25_to_75pc) 0.0, 0.9, 0.1;
  (Whipple_s_disease, 25_to_75pc) 0.0, 0.9, 0.1;
  (L_H_nodular_HD, 25_to_75pc) 0.0, 0.9, 0.1;
  (L_H_diffuse_HD, 25_to_75pc) 0.0, 0.9, 0.1;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.0, 0.9, 0.1;
  (Cellular_phase_NSHD, 25_to_75pc) 0.0, 0.9, 0.1;
  (Syncytial_NSHD, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mixed_cellularity_HD, 25_to_75pc) 0.0, 0.9, 0.1;
  (Interfollicular_HD, 25_to_75pc) 0.0, 0.9, 0.1;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.0, 0.9, 0.1;
  (Reticular_type_HD, 25_to_75pc) 0.0, 0.9, 0.1;
  (Small_cleaved_fol, 25_to_75pc) 0.000, 0.999, 0.001;
  (Mixed_fol, 25_to_75pc) 0.000, 0.999, 0.001;
  (Large_cell_fol, 25_to_75pc) 0.000, 0.999, 0.001;
  (Small_noncleaved_fol, 25_to_75pc) 0.000, 0.999, 0.001;
  (Small_lymphocytic, 25_to_75pc) 0.0, 0.9, 0.1;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.0, 0.1, 0.9;
  (Small_cleaved_dif, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mixed_FCC_dif, 25_to_75pc) 0.0, 0.9, 0.1;
  (Large_cell_dif, 25_to_75pc) 0.0, 0.9, 0.1;
  (B_immunoblastic, 25_to_75pc) 0.0, 0.9, 0.1;
  (T_immunob_mixed, 25_to_75pc) 0.0, 0.9, 0.1;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.0, 0.3, 0.7;
  (Japanese_ATL, 25_to_75pc) 0.0, 0.9, 0.1;
  (Lymphoblastic, 25_to_75pc) 0.0, 0.9, 0.1;
  (Small_noncleaved_dif, 25_to_75pc) 0.0, 0.9, 0.1;
  (True_histiocytic, 25_to_75pc) 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.0, 0.9, 0.1;
  (Multiple_myeloma, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mycosis_fungoides, 25_to_75pc) 0.0, 0.9, 0.1;
  (AML, 25_to_75pc) 0.0, 0.9, 0.1;
  (Hairy_cell_leukemia, 25_to_75pc) 0.0, 0.9, 0.1;
  (Carcinoma, 25_to_75pc) 0.0, 0.9, 0.1;
  (Melanoma, 25_to_75pc) 0.0, 0.9, 0.1;
  (EM_plasmacytoma, 25_to_75pc) 0.0, 0.9, 0.1;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.0, 0.8, 0.2;
  (Mast_cell_disease, 25_to_75pc) 0.0, 0.9, 0.1;
  (AIDS_involutionary, 25_to_75pc) 0.0, 0.1, 0.9;
  (T_immunob_large, 25_to_75pc) 0.0, 0.9, 0.1;
  (Monocytoid_B_cell, 25_to_75pc) 0.0, 0.9, 0.1;
  (Nasopharyngeal_CA, 25_to_75pc) 0.0, 0.9, 0.1;
  (Seminoma, 25_to_75pc) 0.0, 0.9, 0.1;
  (SLE, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mycobact_histiocytos, 25_to_75pc) 0.0, 0.8, 0.2;
  (Mast_cell_hyperplas, 25_to_75pc) 0.0, 0.9, 0.1;
  (LGV, 25_to_75pc) 0.0, 0.9, 0.1;
  (Histoplasmosis, 25_to_75pc) 0.0, 0.8, 0.2;
  (Coccidioidomycosis, 25_to_75pc) 0.0, 0.8, 0.2;
  (CMV, 25_to_75pc) 0.0, 0.8, 0.2;
  (Brucellosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.0, 0.9, 0.1;
  (Intermed_lymphocytic, 25_to_75pc) 0.0, 0.1, 0.9;
  (AIDS_early, 75_to_90pc) 0.0, 0.9, 0.1;
  (AILD, 75_to_90pc) 0.0, 0.3, 0.7;
  (ALIP, 75_to_90pc) 0.0, 0.9, 0.1;
  (Cat_scratch_disease, 75_to_90pc) 0.0, 0.9, 0.1;
  (Dermatopathic_laden, 75_to_90pc) 0.0, 0.9, 0.1;
  (Florid_follic_hyperp, 75_to_90pc) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, 75_to_90pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, 75_to_90pc) 0.0, 0.9, 0.1;
  (Granulomatous_laden, 75_to_90pc) 0.0, 0.9, 0.1;
  (Histiocytosis_x, 75_to_90pc) 0.0, 0.9, 0.1;
  (Infectious_mono, 75_to_90pc) 0.0, 0.9, 0.1;
  (Leprosy_lepromatous, 75_to_90pc) 0.0, 0.9, 0.1;
  (Lymphangiographic, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.0, 0.2, 0.8;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, 75_to_90pc) 0.0, 0.9, 0.1;
  (Sarcoidosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (SHML, 75_to_90pc) 0.0, 0.9, 0.1;
  (Sinus_histiocytosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (Syphilis, 75_to_90pc) 0.0, 0.9, 0.1;
  (Toxoplasmosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (Tuberculosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (Viral_NOS, 75_to_90pc) 0.0, 0.9, 0.1;
  (Whipple_s_disease, 75_to_90pc) 0.0, 0.9, 0.1;
  (L_H_nodular_HD, 75_to_90pc) 0.0, 0.9, 0.1;
  (L_H_diffuse_HD, 75_to_90pc) 0.0, 0.9, 0.1;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.0, 0.9, 0.1;
  (Cellular_phase_NSHD, 75_to_90pc) 0.0, 0.9, 0.1;
  (Syncytial_NSHD, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mixed_cellularity_HD, 75_to_90pc) 0.0, 0.9, 0.1;
  (Interfollicular_HD, 75_to_90pc) 0.0, 0.9, 0.1;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.0, 0.9, 0.1;
  (Reticular_type_HD, 75_to_90pc) 0.0, 0.9, 0.1;
  (Small_cleaved_fol, 75_to_90pc) 0.000, 0.999, 0.001;
  (Mixed_fol, 75_to_90pc) 0.000, 0.999, 0.001;
  (Large_cell_fol, 75_to_90pc) 0.000, 0.999, 0.001;
  (Small_noncleaved_fol, 75_to_90pc) 0.000, 0.999, 0.001;
  (Small_lymphocytic, 75_to_90pc) 0.0, 0.9, 0.1;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.0, 0.1, 0.9;
  (Small_cleaved_dif, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mixed_FCC_dif, 75_to_90pc) 0.0, 0.9, 0.1;
  (Large_cell_dif, 75_to_90pc) 0.0, 0.9, 0.1;
  (B_immunoblastic, 75_to_90pc) 0.0, 0.9, 0.1;
  (T_immunob_mixed, 75_to_90pc) 0.0, 0.9, 0.1;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.0, 0.3, 0.7;
  (Japanese_ATL, 75_to_90pc) 0.0, 0.9, 0.1;
  (Lymphoblastic, 75_to_90pc) 0.0, 0.9, 0.1;
  (Small_noncleaved_dif, 75_to_90pc) 0.0, 0.9, 0.1;
  (True_histiocytic, 75_to_90pc) 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.0, 0.9, 0.1;
  (Multiple_myeloma, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mycosis_fungoides, 75_to_90pc) 0.0, 0.9, 0.1;
  (AML, 75_to_90pc) 0.0, 0.9, 0.1;
  (Hairy_cell_leukemia, 75_to_90pc) 0.0, 0.9, 0.1;
  (Carcinoma, 75_to_90pc) 0.0, 0.9, 0.1;
  (Melanoma, 75_to_90pc) 0.0, 0.9, 0.1;
  (EM_plasmacytoma, 75_to_90pc) 0.0, 0.9, 0.1;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.0, 0.8, 0.2;
  (Mast_cell_disease, 75_to_90pc) 0.0, 0.9, 0.1;
  (AIDS_involutionary, 75_to_90pc) 0.0, 0.1, 0.9;
  (T_immunob_large, 75_to_90pc) 0.0, 0.9, 0.1;
  (Monocytoid_B_cell, 75_to_90pc) 0.0, 0.9, 0.1;
  (Nasopharyngeal_CA, 75_to_90pc) 0.0, 0.9, 0.1;
  (Seminoma, 75_to_90pc) 0.0, 0.9, 0.1;
  (SLE, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mycobact_histiocytos, 75_to_90pc) 0.0, 0.8, 0.2;
  (Mast_cell_hyperplas, 75_to_90pc) 0.0, 0.9, 0.1;
  (LGV, 75_to_90pc) 0.0, 0.9, 0.1;
  (Histoplasmosis, 75_to_90pc) 0.0, 0.8, 0.2;
  (Coccidioidomycosis, 75_to_90pc) 0.0, 0.8, 0.2;
  (CMV, 75_to_90pc) 0.0, 0.8, 0.2;
  (Brucellosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.0, 0.9, 0.1;
  (Intermed_lymphocytic, 75_to_90pc) 0.0, 0.1, 0.9;
  (AIDS_early, GT_90pc) 0.0, 0.9, 0.1;
  (AILD, GT_90pc) 0.0, 0.3, 0.7;
  (ALIP, GT_90pc) 0.0, 0.9, 0.1;
  (Cat_scratch_disease, GT_90pc) 0.0, 0.9, 0.1;
  (Dermatopathic_laden, GT_90pc) 0.0, 0.9, 0.1;
  (Florid_follic_hyperp, GT_90pc) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, GT_90pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, GT_90pc) 0.0, 0.9, 0.1;
  (Granulomatous_laden, GT_90pc) 0.0, 0.9, 0.1;
  (Histiocytosis_x, GT_90pc) 0.0, 0.9, 0.1;
  (Infectious_mono, GT_90pc) 0.0, 0.9, 0.1;
  (Leprosy_lepromatous, GT_90pc) 0.0, 0.9, 0.1;
  (Lymphangiographic, GT_90pc) 0.0, 0.9, 0.1;
  (Mantle_zone_hyperpla, GT_90pc) 0.0, 0.2, 0.8;
  (Necrotizing_Kikuchi, GT_90pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, GT_90pc) 0.0, 0.9, 0.1;
  (Sarcoidosis, GT_90pc) 0.0, 0.9, 0.1;
  (SHML, GT_90pc) 0.0, 0.9, 0.1;
  (Sinus_histiocytosis, GT_90pc) 0.0, 0.9, 0.1;
  (Syphilis, GT_90pc) 0.0, 0.9, 0.1;
  (Toxoplasmosis, GT_90pc) 0.0, 0.9, 0.1;
  (Tuberculosis, GT_90pc) 0.0, 0.9, 0.1;
  (Viral_NOS, GT_90pc) 0.0, 0.9, 0.1;
  (Whipple_s_disease, GT_90pc) 0.0, 0.9, 0.1;
  (L_H_nodular_HD, GT_90pc) 0.0, 0.9, 0.1;
  (L_H_diffuse_HD, GT_90pc) 0.0, 0.9, 0.1;
  (Nodular_sclerosis_HD, GT_90pc) 0.0, 0.9, 0.1;
  (Cellular_phase_NSHD, GT_90pc) 0.0, 0.9, 0.1;
  (Syncytial_NSHD, GT_90pc) 0.0, 0.9, 0.1;
  (Mixed_cellularity_HD, GT_90pc) 0.0, 0.9, 0.1;
  (Interfollicular_HD, GT_90pc) 0.0, 0.9, 0.1;
  (Diffuse_fibrosis_HD, GT_90pc) 0.0, 0.9, 0.1;
  (Reticular_type_HD, GT_90pc) 0.0, 0.9, 0.1;
  (Small_cleaved_fol, GT_90pc) 0.000, 0.999, 0.001;
  (Mixed_fol, GT_90pc) 0.000, 0.999, 0.001;
  (Large_cell_fol, GT_90pc) 0.000, 0.999, 0.001;
  (Small_noncleaved_fol, GT_90pc) 0.000, 0.999, 0.001;
  (Small_lymphocytic, GT_90pc) 0.0, 0.9, 0.1;
  (Plasmacytoid_lyctic, GT_90pc) 0.0, 0.9, 0.1;
  (Mantle_zone_lymphoma, GT_90pc) 0.0, 0.1, 0.9;
  (Small_cleaved_dif, GT_90pc) 0.0, 0.9, 0.1;
  (Mixed_FCC_dif, GT_90pc) 0.0, 0.9, 0.1;
  (Large_cell_dif, GT_90pc) 0.0, 0.9, 0.1;
  (B_immunoblastic, GT_90pc) 0.0, 0.9, 0.1;
  (T_immunob_mixed, GT_90pc) 0.0, 0.9, 0.1;
  (AILD_like_T_cell_lym, GT_90pc) 0.0, 0.3, 0.7;
  (Japanese_ATL, GT_90pc) 0.0, 0.9, 0.1;
  (Lymphoblastic, GT_90pc) 0.0, 0.9, 0.1;
  (Small_noncleaved_dif, GT_90pc) 0.0, 0.9, 0.1;
  (True_histiocytic, GT_90pc) 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.0, 0.9, 0.1;
  (Multiple_myeloma, GT_90pc) 0.0, 0.9, 0.1;
  (Mycosis_fungoides, GT_90pc) 0.0, 0.9, 0.1;
  (AML, GT_90pc) 0.0, 0.9, 0.1;
  (Hairy_cell_leukemia, GT_90pc) 0.0, 0.9, 0.1;
  (Carcinoma, GT_90pc) 0.0, 0.9, 0.1;
  (Melanoma, GT_90pc) 0.0, 0.9, 0.1;
  (EM_plasmacytoma, GT_90pc) 0.0, 0.9, 0.1;
  (Kaposi_s_sarcoma, GT_90pc) 0.0, 0.8, 0.2;
  (Mast_cell_disease, GT_90pc) 0.0, 0.9, 0.1;
  (AIDS_involutionary, GT_90pc) 0.0, 0.1, 0.9;
  (T_immunob_large, GT_90pc) 0.0, 0.9, 0.1;
  (Monocytoid_B_cell, GT_90pc) 0.0, 0.9, 0.1;
  (Nasopharyngeal_CA, GT_90pc) 0.0, 0.9, 0.1;
  (Seminoma, GT_90pc) 0.0, 0.9, 0.1;
  (SLE, GT_90pc) 0.0, 0.9, 0.1;
  (Mycobact_histiocytos, GT_90pc) 0.0, 0.8, 0.2;
  (Mast_cell_hyperplas, GT_90pc) 0.0, 0.9, 0.1;
  (LGV, GT_90pc) 0.0, 0.9, 0.1;
  (Histoplasmosis, GT_90pc) 0.0, 0.8, 0.2;
  (Coccidioidomycosis, GT_90pc) 0.0, 0.8, 0.2;
  (CMV, GT_90pc) 0.0, 0.8, 0.2;
  (Brucellosis, GT_90pc) 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.0, 0.9, 0.1;
  (Intermed_lymphocytic, GT_90pc) 0.0, 0.1, 0.9;
}
probability ( F_ISL | Fault, F_HEM ) {
  (AIDS_early, No_follicles) 1.0, 0.0, 0.0;
  (AILD, No_follicles) 1.0, 0.0, 0.0;
  (ALIP, No_follicles) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, No_follicles) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, No_follicles) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_follicles) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_follicles) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, No_follicles) 1.0, 0.0, 0.0;
  (Granulomatous_laden, No_follicles) 1.0, 0.0, 0.0;
  (Histiocytosis_x, No_follicles) 1.0, 0.0, 0.0;
  (Infectious_mono, No_follicles) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_follicles) 1.0, 0.0, 0.0;
  (Lymphangiographic, No_follicles) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_follicles) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_follicles) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_follicles) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_follicles) 1.0, 0.0, 0.0;
  (Sarcoidosis, No_follicles) 1.0, 0.0, 0.0;
  (SHML, No_follicles) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_follicles) 1.0, 0.0, 0.0;
  (Syphilis, No_follicles) 1.0, 0.0, 0.0;
  (Toxoplasmosis, No_follicles) 1.0, 0.0, 0.0;
  (Tuberculosis, No_follicles) 1.0, 0.0, 0.0;
  (Viral_NOS, No_follicles) 1.0, 0.0, 0.0;
  (Whipple_s_disease, No_follicles) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, No_follicles) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_follicles) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_follicles) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_follicles) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, No_follicles) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_follicles) 1.0, 0.0, 0.0;
  (Interfollicular_HD, No_follicles) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_follicles) 1.0, 0.0, 0.0;
  (Reticular_type_HD, No_follicles) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, No_follicles) 1.0, 0.0, 0.0;
  (Mixed_fol, No_follicles) 1.0, 0.0, 0.0;
  (Large_cell_fol, No_follicles) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_follicles) 1.0, 0.0, 0.0;
  (Small_lymphocytic, No_follicles) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_follicles) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_follicles) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, No_follicles) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_follicles) 1.0, 0.0, 0.0;
  (Large_cell_dif, No_follicles) 1.0, 0.0, 0.0;
  (B_immunoblastic, No_follicles) 1.0, 0.0, 0.0;
  (T_immunob_mixed, No_follicles) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_follicles) 1.0, 0.0, 0.0;
  (Japanese_ATL, No_follicles) 1.0, 0.0, 0.0;
  (Lymphoblastic, No_follicles) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_follicles) 1.0, 0.0, 0.0;
  (True_histiocytic, No_follicles) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_follicles) 1.0, 0.0, 0.0;
  (Multiple_myeloma, No_follicles) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, No_follicles) 1.0, 0.0, 0.0;
  (AML, No_follicles) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_follicles) 1.0, 0.0, 0.0;
  (Carcinoma, No_follicles) 1.0, 0.0, 0.0;
  (Melanoma, No_follicles) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, No_follicles) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_follicles) 1.0, 0.0, 0.0;
  (Mast_cell_disease, No_follicles) 1.0, 0.0, 0.0;
  (AIDS_involutionary, No_follicles) 1.0, 0.0, 0.0;
  (T_immunob_large, No_follicles) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_follicles) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_follicles) 1.0, 0.0, 0.0;
  (Seminoma, No_follicles) 1.0, 0.0, 0.0;
  (SLE, No_follicles) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_follicles) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_follicles) 1.0, 0.0, 0.0;
  (LGV, No_follicles) 1.0, 0.0, 0.0;
  (Histoplasmosis, No_follicles) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, No_follicles) 1.0, 0.0, 0.0;
  (CMV, No_follicles) 1.0, 0.0, 0.0;
  (Brucellosis, No_follicles) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_follicles) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_follicles) 1.0, 0.0, 0.0;
  (AIDS_early, Absent) 0.0, 0.8, 0.2;
  (AILD, Absent) 0.00, 0.99, 0.01;
  (ALIP, Absent) 0.00, 0.99, 0.01;
  (Cat_scratch_disease, Absent) 0.00, 0.99, 0.01;
  (Dermatopathic_laden, Absent) 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, Absent) 0.00, 0.95, 0.05;
  (GLH_hyaline_vascular, Absent) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, Absent) 0.00, 0.99, 0.01;
  (Granulomatous_laden, Absent) 0.00, 0.99, 0.01;
  (Histiocytosis_x, Absent) 0.00, 0.99, 0.01;
  (Infectious_mono, Absent) 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, Absent) 0.00, 0.99, 0.01;
  (Lymphangiographic, Absent) 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, Absent) 0.00, 0.99, 0.01;
  (Necrotizing_Kikuchi, Absent) 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, Absent) 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, Absent) 0.00, 0.99, 0.01;
  (Sarcoidosis, Absent) 0.00, 0.99, 0.01;
  (SHML, Absent) 0.00, 0.99, 0.01;
  (Sinus_histiocytosis, Absent) 0.00, 0.99, 0.01;
  (Syphilis, Absent) 0.00, 0.99, 0.01;
  (Toxoplasmosis, Absent) 0.00, 0.99, 0.01;
  (Tuberculosis, Absent) 0.00, 0.99, 0.01;
  (Viral_NOS, Absent) 0.00, 0.99, 0.01;
  (Whipple_s_disease, Absent) 0.00, 0.99, 0.01;
  (L_H_nodular_HD, Absent) 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, Absent) 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, Absent) 0.00, 0.99, 0.01;
  (Cellular_phase_NSHD, Absent) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, Absent) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, Absent) 0.00, 0.99, 0.01;
  (Interfollicular_HD, Absent) 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, Absent) 0.00, 0.99, 0.01;
  (Reticular_type_HD, Absent) 0.00, 0.99, 0.01;
  (Small_cleaved_fol, Absent) 0.00, 0.99, 0.01;
  (Mixed_fol, Absent) 0.00, 0.99, 0.01;
  (Large_cell_fol, Absent) 0.00, 0.99, 0.01;
  (Small_noncleaved_fol, Absent) 0.00, 0.99, 0.01;
  (Small_lymphocytic, Absent) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, Absent) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, Absent) 0.00, 0.99, 0.01;
  (Small_cleaved_dif, Absent) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, Absent) 0.00, 0.99, 0.01;
  (Large_cell_dif, Absent) 0.00, 0.99, 0.01;
  (B_immunoblastic, Absent) 0.00, 0.99, 0.01;
  (T_immunob_mixed, Absent) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, Absent) 0.00, 0.99, 0.01;
  (Japanese_ATL, Absent) 0.00, 0.99, 0.01;
  (Lymphoblastic, Absent) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, Absent) 0.00, 0.99, 0.01;
  (True_histiocytic, Absent) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, Absent) 0.00, 0.99, 0.01;
  (Multiple_myeloma, Absent) 0.00, 0.99, 0.01;
  (Mycosis_fungoides, Absent) 0.00, 0.99, 0.01;
  (AML, Absent) 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, Absent) 0.00, 0.99, 0.01;
  (Carcinoma, Absent) 0.00, 0.99, 0.01;
  (Melanoma, Absent) 0.00, 0.99, 0.01;
  (EM_plasmacytoma, Absent) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, Absent) 0.00, 0.99, 0.01;
  (Mast_cell_disease, Absent) 0.00, 0.99, 0.01;
  (AIDS_involutionary, Absent) 0.0, 0.9, 0.1;
  (T_immunob_large, Absent) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, Absent) 0.00, 0.99, 0.01;
  (Nasopharyngeal_CA, Absent) 0.00, 0.99, 0.01;
  (Seminoma, Absent) 0.00, 0.99, 0.01;
  (SLE, Absent) 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, Absent) 0.00, 0.95, 0.05;
  (Mast_cell_hyperplas, Absent) 0.00, 0.99, 0.01;
  (LGV, Absent) 0.00, 0.99, 0.01;
  (Histoplasmosis, Absent) 0.00, 0.95, 0.05;
  (Coccidioidomycosis, Absent) 0.00, 0.95, 0.05;
  (CMV, Absent) 0.00, 0.95, 0.05;
  (Brucellosis, Absent) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, Absent) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, Absent) 0.00, 0.99, 0.01;
  (AIDS_early, Present) 0.0, 0.7, 0.3;
  (AILD, Present) 0.00, 0.99, 0.01;
  (ALIP, Present) 0.00, 0.99, 0.01;
  (Cat_scratch_disease, Present) 0.00, 0.99, 0.01;
  (Dermatopathic_laden, Present) 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, Present) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, Present) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, Present) 0.00, 0.99, 0.01;
  (Granulomatous_laden, Present) 0.00, 0.99, 0.01;
  (Histiocytosis_x, Present) 0.00, 0.99, 0.01;
  (Infectious_mono, Present) 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, Present) 0.00, 0.99, 0.01;
  (Lymphangiographic, Present) 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, Present) 0.00, 0.99, 0.01;
  (Necrotizing_Kikuchi, Present) 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, Present) 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, Present) 0.00, 0.99, 0.01;
  (Sarcoidosis, Present) 0.00, 0.99, 0.01;
  (SHML, Present) 0.00, 0.99, 0.01;
  (Sinus_histiocytosis, Present) 0.00, 0.99, 0.01;
  (Syphilis, Present) 0.00, 0.99, 0.01;
  (Toxoplasmosis, Present) 0.00, 0.99, 0.01;
  (Tuberculosis, Present) 0.00, 0.99, 0.01;
  (Viral_NOS, Present) 0.00, 0.99, 0.01;
  (Whipple_s_disease, Present) 0.00, 0.99, 0.01;
  (L_H_nodular_HD, Present) 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, Present) 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, Present) 0.00, 0.99, 0.01;
  (Cellular_phase_NSHD, Present) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, Present) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, Present) 0.00, 0.99, 0.01;
  (Interfollicular_HD, Present) 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, Present) 0.00, 0.99, 0.01;
  (Reticular_type_HD, Present) 0.00, 0.99, 0.01;
  (Small_cleaved_fol, Present) 0.00, 0.99, 0.01;
  (Mixed_fol, Present) 0.00, 0.99, 0.01;
  (Large_cell_fol, Present) 0.00, 0.99, 0.01;
  (Small_noncleaved_fol, Present) 0.00, 0.99, 0.01;
  (Small_lymphocytic, Present) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, Present) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, Present) 0.00, 0.99, 0.01;
  (Small_cleaved_dif, Present) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, Present) 0.00, 0.99, 0.01;
  (Large_cell_dif, Present) 0.00, 0.99, 0.01;
  (B_immunoblastic, Present) 0.00, 0.99, 0.01;
  (T_immunob_mixed, Present) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, Present) 0.00, 0.99, 0.01;
  (Japanese_ATL, Present) 0.00, 0.99, 0.01;
  (Lymphoblastic, Present) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, Present) 0.00, 0.99, 0.01;
  (True_histiocytic, Present) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, Present) 0.00, 0.99, 0.01;
  (Multiple_myeloma, Present) 0.00, 0.99, 0.01;
  (Mycosis_fungoides, Present) 0.00, 0.99, 0.01;
  (AML, Present) 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, Present) 0.00, 0.99, 0.01;
  (Carcinoma, Present) 0.00, 0.99, 0.01;
  (Melanoma, Present) 0.00, 0.99, 0.01;
  (EM_plasmacytoma, Present) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, Present) 0.00, 0.99, 0.01;
  (Mast_cell_disease, Present) 0.00, 0.99, 0.01;
  (AIDS_involutionary, Present) 0.00, 0.85, 0.15;
  (T_immunob_large, Present) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, Present) 0.00, 0.99, 0.01;
  (Nasopharyngeal_CA, Present) 0.00, 0.99, 0.01;
  (Seminoma, Present) 0.00, 0.99, 0.01;
  (SLE, Present) 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, Present) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, Present) 0.00, 0.99, 0.01;
  (LGV, Present) 0.00, 0.99, 0.01;
  (Histoplasmosis, Present) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, Present) 0.0, 0.9, 0.1;
  (CMV, Present) 0.0, 0.9, 0.1;
  (Brucellosis, Present) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, Present) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, Present) 0.00, 0.99, 0.01;
}
probability ( F_POL | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.00, 0.05, 0.95;
  (AILD, 1_to_25pc) 0.00, 0.99, 0.01;
  (ALIP, 1_to_25pc) 0.00, 0.98, 0.02;
  (Cat_scratch_disease, 1_to_25pc) 0.0, 0.9, 0.1;
  (Dermatopathic_laden, 1_to_25pc) 0.00, 0.95, 0.05;
  (Florid_follic_hyperp, 1_to_25pc) 0.0, 0.8, 0.2;
  (GLH_hyaline_vascular, 1_to_25pc) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, 1_to_25pc) 0.0, 0.8, 0.2;
  (Granulomatous_laden, 1_to_25pc) 0.00, 0.95, 0.05;
  (Histiocytosis_x, 1_to_25pc) 0.00, 0.98, 0.02;
  (Infectious_mono, 1_to_25pc) 0.0, 0.9, 0.1;
  (Leprosy_lepromatous, 1_to_25pc) 0.00, 0.98, 0.02;
  (Lymphangiographic, 1_to_25pc) 0.00, 0.98, 0.02;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.00, 0.98, 0.02;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, 1_to_25pc) 0.0, 0.8, 0.2;
  (Sarcoidosis, 1_to_25pc) 0.00, 0.98, 0.02;
  (SHML, 1_to_25pc) 0.00, 0.98, 0.02;
  (Sinus_histiocytosis, 1_to_25pc) 0.00, 0.98, 0.02;
  (Syphilis, 1_to_25pc) 0.00, 0.95, 0.05;
  (Toxoplasmosis, 1_to_25pc) 0.00, 0.95, 0.05;
  (Tuberculosis, 1_to_25pc) 0.00, 0.98, 0.02;
  (Viral_NOS, 1_to_25pc) 0.0, 0.9, 0.1;
  (Whipple_s_disease, 1_to_25pc) 0.00, 0.98, 0.02;
  (L_H_nodular_HD, 1_to_25pc) 0.00, 0.98, 0.02;
  (L_H_diffuse_HD, 1_to_25pc) 0.00, 0.98, 0.02;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.00, 0.98, 0.02;
  (Cellular_phase_NSHD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Interfollicular_HD, 1_to_25pc) 0.00, 0.98, 0.02;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.00, 0.98, 0.02;
  (Reticular_type_HD, 1_to_25pc) 0.00, 0.98, 0.02;
  (Small_cleaved_fol, 1_to_25pc) 0.0, 1.0, 0.0;
  (Mixed_fol, 1_to_25pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, 1_to_25pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, 1_to_25pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.00, 0.98, 0.02;
  (Small_cleaved_dif, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, 1_to_25pc) 0.00, 0.99, 0.01;
  (Large_cell_dif, 1_to_25pc) 0.00, 0.99, 0.01;
  (B_immunoblastic, 1_to_25pc) 0.00, 0.99, 0.01;
  (T_immunob_mixed, 1_to_25pc) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.00, 0.99, 0.01;
  (Japanese_ATL, 1_to_25pc) 0.00, 0.99, 0.01;
  (Lymphoblastic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, 1_to_25pc) 0.00, 0.99, 0.01;
  (True_histiocytic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.00, 0.99, 0.01;
  (Multiple_myeloma, 1_to_25pc) 0.00, 0.98, 0.02;
  (Mycosis_fungoides, 1_to_25pc) 0.00, 0.98, 0.02;
  (AML, 1_to_25pc) 0.00, 0.98, 0.02;
  (Hairy_cell_leukemia, 1_to_25pc) 0.00, 0.98, 0.02;
  (Carcinoma, 1_to_25pc) 0.00, 0.98, 0.02;
  (Melanoma, 1_to_25pc) 0.00, 0.98, 0.02;
  (EM_plasmacytoma, 1_to_25pc) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.0, 0.8, 0.2;
  (Mast_cell_disease, 1_to_25pc) 0.00, 0.99, 0.01;
  (AIDS_involutionary, 1_to_25pc) 0.0, 0.9, 0.1;
  (T_immunob_large, 1_to_25pc) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, 1_to_25pc) 0.0, 0.9, 0.1;
  (Nasopharyngeal_CA, 1_to_25pc) 0.00, 0.98, 0.02;
  (Seminoma, 1_to_25pc) 0.00, 0.98, 0.02;
  (SLE, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mycobact_histiocytos, 1_to_25pc) 0.00, 0.95, 0.05;
  (Mast_cell_hyperplas, 1_to_25pc) 0.00, 0.95, 0.05;
  (LGV, 1_to_25pc) 0.00, 0.95, 0.05;
  (Histoplasmosis, 1_to_25pc) 0.00, 0.95, 0.05;
  (Coccidioidomycosis, 1_to_25pc) 0.00, 0.95, 0.05;
  (CMV, 1_to_25pc) 0.00, 0.95, 0.05;
  (Brucellosis, 1_to_25pc) 0.00, 0.95, 0.05;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, 1_to_25pc) 0.00, 0.98, 0.02;
  (AIDS_early, 25_to_75pc) 0.00, 0.05, 0.95;
  (AILD, 25_to_75pc) 0.00, 0.99, 0.01;
  (ALIP, 25_to_75pc) 0.00, 0.98, 0.02;
  (Cat_scratch_disease, 25_to_75pc) 0.0, 0.9, 0.1;
  (Dermatopathic_laden, 25_to_75pc) 0.00, 0.95, 0.05;
  (Florid_follic_hyperp, 25_to_75pc) 0.0, 0.8, 0.2;
  (GLH_hyaline_vascular, 25_to_75pc) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, 25_to_75pc) 0.0, 0.8, 0.2;
  (Granulomatous_laden, 25_to_75pc) 0.00, 0.95, 0.05;
  (Histiocytosis_x, 25_to_75pc) 0.00, 0.98, 0.02;
  (Infectious_mono, 25_to_75pc) 0.0, 0.9, 0.1;
  (Leprosy_lepromatous, 25_to_75pc) 0.00, 0.98, 0.02;
  (Lymphangiographic, 25_to_75pc) 0.00, 0.98, 0.02;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.00, 0.98, 0.02;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, 25_to_75pc) 0.0, 0.8, 0.2;
  (Sarcoidosis, 25_to_75pc) 0.00, 0.98, 0.02;
  (SHML, 25_to_75pc) 0.00, 0.98, 0.02;
  (Sinus_histiocytosis, 25_to_75pc) 0.00, 0.98, 0.02;
  (Syphilis, 25_to_75pc) 0.00, 0.95, 0.05;
  (Toxoplasmosis, 25_to_75pc) 0.00, 0.95, 0.05;
  (Tuberculosis, 25_to_75pc) 0.00, 0.98, 0.02;
  (Viral_NOS, 25_to_75pc) 0.0, 0.9, 0.1;
  (Whipple_s_disease, 25_to_75pc) 0.00, 0.98, 0.02;
  (L_H_nodular_HD, 25_to_75pc) 0.00, 0.98, 0.02;
  (L_H_diffuse_HD, 25_to_75pc) 0.00, 0.98, 0.02;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.00, 0.98, 0.02;
  (Cellular_phase_NSHD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Interfollicular_HD, 25_to_75pc) 0.00, 0.98, 0.02;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.00, 0.98, 0.02;
  (Reticular_type_HD, 25_to_75pc) 0.00, 0.98, 0.02;
  (Small_cleaved_fol, 25_to_75pc) 0.0, 1.0, 0.0;
  (Mixed_fol, 25_to_75pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, 25_to_75pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, 25_to_75pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.00, 0.98, 0.02;
  (Small_cleaved_dif, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, 25_to_75pc) 0.00, 0.99, 0.01;
  (Large_cell_dif, 25_to_75pc) 0.00, 0.99, 0.01;
  (B_immunoblastic, 25_to_75pc) 0.00, 0.99, 0.01;
  (T_immunob_mixed, 25_to_75pc) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.00, 0.99, 0.01;
  (Japanese_ATL, 25_to_75pc) 0.00, 0.99, 0.01;
  (Lymphoblastic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, 25_to_75pc) 0.00, 0.99, 0.01;
  (True_histiocytic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.00, 0.99, 0.01;
  (Multiple_myeloma, 25_to_75pc) 0.00, 0.98, 0.02;
  (Mycosis_fungoides, 25_to_75pc) 0.00, 0.98, 0.02;
  (AML, 25_to_75pc) 0.00, 0.98, 0.02;
  (Hairy_cell_leukemia, 25_to_75pc) 0.00, 0.98, 0.02;
  (Carcinoma, 25_to_75pc) 0.00, 0.98, 0.02;
  (Melanoma, 25_to_75pc) 0.00, 0.98, 0.02;
  (EM_plasmacytoma, 25_to_75pc) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.0, 0.8, 0.2;
  (Mast_cell_disease, 25_to_75pc) 0.00, 0.99, 0.01;
  (AIDS_involutionary, 25_to_75pc) 0.0, 0.9, 0.1;
  (T_immunob_large, 25_to_75pc) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, 25_to_75pc) 0.0, 0.9, 0.1;
  (Nasopharyngeal_CA, 25_to_75pc) 0.00, 0.98, 0.02;
  (Seminoma, 25_to_75pc) 0.00, 0.98, 0.02;
  (SLE, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mycobact_histiocytos, 25_to_75pc) 0.00, 0.95, 0.05;
  (Mast_cell_hyperplas, 25_to_75pc) 0.00, 0.95, 0.05;
  (LGV, 25_to_75pc) 0.00, 0.95, 0.05;
  (Histoplasmosis, 25_to_75pc) 0.00, 0.95, 0.05;
  (Coccidioidomycosis, 25_to_75pc) 0.00, 0.95, 0.05;
  (CMV, 25_to_75pc) 0.00, 0.95, 0.05;
  (Brucellosis, 25_to_75pc) 0.00, 0.95, 0.05;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, 25_to_75pc) 0.00, 0.98, 0.02;
  (AIDS_early, 75_to_90pc) 0.00, 0.05, 0.95;
  (AILD, 75_to_90pc) 0.00, 0.99, 0.01;
  (ALIP, 75_to_90pc) 0.00, 0.98, 0.02;
  (Cat_scratch_disease, 75_to_90pc) 0.0, 0.9, 0.1;
  (Dermatopathic_laden, 75_to_90pc) 0.00, 0.95, 0.05;
  (Florid_follic_hyperp, 75_to_90pc) 0.0, 0.8, 0.2;
  (GLH_hyaline_vascular, 75_to_90pc) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, 75_to_90pc) 0.0, 0.8, 0.2;
  (Granulomatous_laden, 75_to_90pc) 0.00, 0.95, 0.05;
  (Histiocytosis_x, 75_to_90pc) 0.00, 0.98, 0.02;
  (Infectious_mono, 75_to_90pc) 0.0, 0.9, 0.1;
  (Leprosy_lepromatous, 75_to_90pc) 0.00, 0.98, 0.02;
  (Lymphangiographic, 75_to_90pc) 0.00, 0.98, 0.02;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.00, 0.98, 0.02;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, 75_to_90pc) 0.0, 0.8, 0.2;
  (Sarcoidosis, 75_to_90pc) 0.00, 0.98, 0.02;
  (SHML, 75_to_90pc) 0.00, 0.98, 0.02;
  (Sinus_histiocytosis, 75_to_90pc) 0.00, 0.98, 0.02;
  (Syphilis, 75_to_90pc) 0.00, 0.95, 0.05;
  (Toxoplasmosis, 75_to_90pc) 0.00, 0.95, 0.05;
  (Tuberculosis, 75_to_90pc) 0.00, 0.98, 0.02;
  (Viral_NOS, 75_to_90pc) 0.0, 0.9, 0.1;
  (Whipple_s_disease, 75_to_90pc) 0.00, 0.98, 0.02;
  (L_H_nodular_HD, 75_to_90pc) 0.00, 0.98, 0.02;
  (L_H_diffuse_HD, 75_to_90pc) 0.00, 0.98, 0.02;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.00, 0.98, 0.02;
  (Cellular_phase_NSHD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Interfollicular_HD, 75_to_90pc) 0.00, 0.98, 0.02;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.00, 0.98, 0.02;
  (Reticular_type_HD, 75_to_90pc) 0.00, 0.98, 0.02;
  (Small_cleaved_fol, 75_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_fol, 75_to_90pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, 75_to_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, 75_to_90pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.00, 0.98, 0.02;
  (Small_cleaved_dif, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, 75_to_90pc) 0.00, 0.99, 0.01;
  (Large_cell_dif, 75_to_90pc) 0.00, 0.99, 0.01;
  (B_immunoblastic, 75_to_90pc) 0.00, 0.99, 0.01;
  (T_immunob_mixed, 75_to_90pc) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.00, 0.99, 0.01;
  (Japanese_ATL, 75_to_90pc) 0.00, 0.99, 0.01;
  (Lymphoblastic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, 75_to_90pc) 0.00, 0.99, 0.01;
  (True_histiocytic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.00, 0.99, 0.01;
  (Multiple_myeloma, 75_to_90pc) 0.00, 0.98, 0.02;
  (Mycosis_fungoides, 75_to_90pc) 0.00, 0.98, 0.02;
  (AML, 75_to_90pc) 0.00, 0.98, 0.02;
  (Hairy_cell_leukemia, 75_to_90pc) 0.00, 0.98, 0.02;
  (Carcinoma, 75_to_90pc) 0.00, 0.98, 0.02;
  (Melanoma, 75_to_90pc) 0.00, 0.98, 0.02;
  (EM_plasmacytoma, 75_to_90pc) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.0, 0.8, 0.2;
  (Mast_cell_disease, 75_to_90pc) 0.00, 0.99, 0.01;
  (AIDS_involutionary, 75_to_90pc) 0.0, 0.9, 0.1;
  (T_immunob_large, 75_to_90pc) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, 75_to_90pc) 0.0, 0.9, 0.1;
  (Nasopharyngeal_CA, 75_to_90pc) 0.00, 0.98, 0.02;
  (Seminoma, 75_to_90pc) 0.00, 0.98, 0.02;
  (SLE, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mycobact_histiocytos, 75_to_90pc) 0.00, 0.95, 0.05;
  (Mast_cell_hyperplas, 75_to_90pc) 0.00, 0.95, 0.05;
  (LGV, 75_to_90pc) 0.00, 0.95, 0.05;
  (Histoplasmosis, 75_to_90pc) 0.00, 0.95, 0.05;
  (Coccidioidomycosis, 75_to_90pc) 0.00, 0.95, 0.05;
  (CMV, 75_to_90pc) 0.00, 0.95, 0.05;
  (Brucellosis, 75_to_90pc) 0.00, 0.95, 0.05;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, 75_to_90pc) 0.00, 0.98, 0.02;
  (AIDS_early, GT_90pc) 0.00, 0.05, 0.95;
  (AILD, GT_90pc) 0.00, 0.99, 0.01;
  (ALIP, GT_90pc) 0.00, 0.98, 0.02;
  (Cat_scratch_disease, GT_90pc) 0.0, 0.9, 0.1;
  (Dermatopathic_laden, GT_90pc) 0.00, 0.95, 0.05;
  (Florid_follic_hyperp, GT_90pc) 0.0, 0.8, 0.2;
  (GLH_hyaline_vascular, GT_90pc) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, GT_90pc) 0.0, 0.8, 0.2;
  (Granulomatous_laden, GT_90pc) 0.00, 0.95, 0.05;
  (Histiocytosis_x, GT_90pc) 0.00, 0.98, 0.02;
  (Infectious_mono, GT_90pc) 0.0, 0.9, 0.1;
  (Leprosy_lepromatous, GT_90pc) 0.00, 0.98, 0.02;
  (Lymphangiographic, GT_90pc) 0.00, 0.98, 0.02;
  (Mantle_zone_hyperpla, GT_90pc) 0.00, 0.98, 0.02;
  (Necrotizing_Kikuchi, GT_90pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, GT_90pc) 0.0, 0.8, 0.2;
  (Sarcoidosis, GT_90pc) 0.00, 0.98, 0.02;
  (SHML, GT_90pc) 0.00, 0.98, 0.02;
  (Sinus_histiocytosis, GT_90pc) 0.00, 0.98, 0.02;
  (Syphilis, GT_90pc) 0.00, 0.95, 0.05;
  (Toxoplasmosis, GT_90pc) 0.00, 0.95, 0.05;
  (Tuberculosis, GT_90pc) 0.00, 0.98, 0.02;
  (Viral_NOS, GT_90pc) 0.0, 0.9, 0.1;
  (Whipple_s_disease, GT_90pc) 0.00, 0.98, 0.02;
  (L_H_nodular_HD, GT_90pc) 0.00, 0.98, 0.02;
  (L_H_diffuse_HD, GT_90pc) 0.00, 0.98, 0.02;
  (Nodular_sclerosis_HD, GT_90pc) 0.00, 0.98, 0.02;
  (Cellular_phase_NSHD, GT_90pc) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, GT_90pc) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, GT_90pc) 0.00, 0.99, 0.01;
  (Interfollicular_HD, GT_90pc) 0.00, 0.98, 0.02;
  (Diffuse_fibrosis_HD, GT_90pc) 0.00, 0.98, 0.02;
  (Reticular_type_HD, GT_90pc) 0.00, 0.98, 0.02;
  (Small_cleaved_fol, GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_fol, GT_90pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, GT_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, GT_90pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, GT_90pc) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, GT_90pc) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, GT_90pc) 0.00, 0.98, 0.02;
  (Small_cleaved_dif, GT_90pc) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, GT_90pc) 0.00, 0.99, 0.01;
  (Large_cell_dif, GT_90pc) 0.00, 0.99, 0.01;
  (B_immunoblastic, GT_90pc) 0.00, 0.99, 0.01;
  (T_immunob_mixed, GT_90pc) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, GT_90pc) 0.00, 0.99, 0.01;
  (Japanese_ATL, GT_90pc) 0.00, 0.99, 0.01;
  (Lymphoblastic, GT_90pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, GT_90pc) 0.00, 0.99, 0.01;
  (True_histiocytic, GT_90pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.00, 0.99, 0.01;
  (Multiple_myeloma, GT_90pc) 0.00, 0.98, 0.02;
  (Mycosis_fungoides, GT_90pc) 0.00, 0.98, 0.02;
  (AML, GT_90pc) 0.00, 0.98, 0.02;
  (Hairy_cell_leukemia, GT_90pc) 0.00, 0.98, 0.02;
  (Carcinoma, GT_90pc) 0.00, 0.98, 0.02;
  (Melanoma, GT_90pc) 0.00, 0.98, 0.02;
  (EM_plasmacytoma, GT_90pc) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, GT_90pc) 0.0, 0.8, 0.2;
  (Mast_cell_disease, GT_90pc) 0.00, 0.99, 0.01;
  (AIDS_involutionary, GT_90pc) 0.0, 0.9, 0.1;
  (T_immunob_large, GT_90pc) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, GT_90pc) 0.0, 0.9, 0.1;
  (Nasopharyngeal_CA, GT_90pc) 0.00, 0.98, 0.02;
  (Seminoma, GT_90pc) 0.00, 0.98, 0.02;
  (SLE, GT_90pc) 0.0, 0.9, 0.1;
  (Mycobact_histiocytos, GT_90pc) 0.00, 0.95, 0.05;
  (Mast_cell_hyperplas, GT_90pc) 0.00, 0.95, 0.05;
  (LGV, GT_90pc) 0.00, 0.95, 0.05;
  (Histoplasmosis, GT_90pc) 0.00, 0.95, 0.05;
  (Coccidioidomycosis, GT_90pc) 0.00, 0.95, 0.05;
  (CMV, GT_90pc) 0.00, 0.95, 0.05;
  (Brucellosis, GT_90pc) 0.00, 0.95, 0.05;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, GT_90pc) 0.00, 0.98, 0.02;
}
probability ( F_RPBV | Fault, F_CSA ) {
  (AIDS_early, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AILD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (ALIP, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (SHML, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AML, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (SLE, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (LGV, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (CMV, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Absent) 0.000, 0.989, 0.010, 0.001;
  (AILD, Absent) 0.000, 0.989, 0.010, 0.001;
  (ALIP, Absent) 0.000, 0.989, 0.010, 0.001;
  (Cat_scratch_disease, Absent) 0.000, 0.989, 0.010, 0.001;
  (Dermatopathic_laden, Absent) 0.000, 0.989, 0.010, 0.001;
  (Florid_follic_hyperp, Absent) 0.000, 0.989, 0.010, 0.001;
  (GLH_hyaline_vascular, Absent) 0.00000, 0.00001, 0.02000, 0.97999;
  (GLH_plasma_cell, Absent) 0.000, 0.988, 0.010, 0.002;
  (Granulomatous_laden, Absent) 0.000, 0.989, 0.010, 0.001;
  (Histiocytosis_x, Absent) 0.000, 0.989, 0.010, 0.001;
  (Infectious_mono, Absent) 0.000, 0.989, 0.010, 0.001;
  (Leprosy_lepromatous, Absent) 0.000, 0.989, 0.010, 0.001;
  (Lymphangiographic, Absent) 0.000, 0.989, 0.010, 0.001;
  (Mantle_zone_hyperpla, Absent) 0.000, 0.989, 0.010, 0.001;
  (Necrotizing_Kikuchi, Absent) 0.000, 0.989, 0.010, 0.001;
  (Necrotiz_non_Kikuchi, Absent) 0.000, 0.989, 0.010, 0.001;
  (Rheumatoid_arthritis, Absent) 0.000, 0.989, 0.010, 0.001;
  (Sarcoidosis, Absent) 0.000, 0.989, 0.010, 0.001;
  (SHML, Absent) 0.000, 0.989, 0.010, 0.001;
  (Sinus_histiocytosis, Absent) 0.000, 0.989, 0.010, 0.001;
  (Syphilis, Absent) 0.000, 0.989, 0.010, 0.001;
  (Toxoplasmosis, Absent) 0.000, 0.989, 0.010, 0.001;
  (Tuberculosis, Absent) 0.000, 0.989, 0.010, 0.001;
  (Viral_NOS, Absent) 0.000, 0.989, 0.010, 0.001;
  (Whipple_s_disease, Absent) 0.000, 0.989, 0.010, 0.001;
  (L_H_nodular_HD, Absent) 0.000, 0.989, 0.010, 0.001;
  (L_H_diffuse_HD, Absent) 0.000, 0.989, 0.010, 0.001;
  (Nodular_sclerosis_HD, Absent) 0.000, 0.989, 0.010, 0.001;
  (Cellular_phase_NSHD, Absent) 0.000, 0.989, 0.010, 0.001;
  (Syncytial_NSHD, Absent) 0.000, 0.989, 0.010, 0.001;
  (Mixed_cellularity_HD, Absent) 0.000, 0.989, 0.010, 0.001;
  (Interfollicular_HD, Absent) 0.000, 0.989, 0.010, 0.001;
  (Diffuse_fibrosis_HD, Absent) 0.000, 0.989, 0.010, 0.001;
  (Reticular_type_HD, Absent) 0.000, 0.989, 0.010, 0.001;
  (Small_cleaved_fol, Absent) 0.0000, 0.9998, 0.0001, 0.0001;
  (Mixed_fol, Absent) 0.0000, 0.9998, 0.0001, 0.0001;
  (Large_cell_fol, Absent) 0.0000, 0.9998, 0.0001, 0.0001;
  (Small_noncleaved_fol, Absent) 0.0000, 0.9998, 0.0001, 0.0001;
  (Small_lymphocytic, Absent) 0.000, 0.989, 0.010, 0.001;
  (Plasmacytoid_lyctic, Absent) 0.000, 0.989, 0.010, 0.001;
  (Mantle_zone_lymphoma, Absent) 0.000, 0.989, 0.010, 0.001;
  (Small_cleaved_dif, Absent) 0.000, 0.989, 0.010, 0.001;
  (Mixed_FCC_dif, Absent) 0.000, 0.989, 0.010, 0.001;
  (Large_cell_dif, Absent) 0.000, 0.989, 0.010, 0.001;
  (B_immunoblastic, Absent) 0.000, 0.989, 0.010, 0.001;
  (T_immunob_mixed, Absent) 0.000, 0.989, 0.010, 0.001;
  (AILD_like_T_cell_lym, Absent) 0.000, 0.989, 0.010, 0.001;
  (Japanese_ATL, Absent) 0.000, 0.989, 0.010, 0.001;
  (Lymphoblastic, Absent) 0.000, 0.989, 0.010, 0.001;
  (Small_noncleaved_dif, Absent) 0.000, 0.989, 0.010, 0.001;
  (True_histiocytic, Absent) 0.000, 0.989, 0.010, 0.001;
  (Ki_1_LC_anaplas_T, Absent) 0.000, 0.989, 0.010, 0.001;
  (Multiple_myeloma, Absent) 0.000, 0.989, 0.010, 0.001;
  (Mycosis_fungoides, Absent) 0.000, 0.989, 0.010, 0.001;
  (AML, Absent) 0.000, 0.989, 0.010, 0.001;
  (Hairy_cell_leukemia, Absent) 0.000, 0.989, 0.010, 0.001;
  (Carcinoma, Absent) 0.000, 0.989, 0.010, 0.001;
  (Melanoma, Absent) 0.000, 0.989, 0.010, 0.001;
  (EM_plasmacytoma, Absent) 0.000, 0.989, 0.010, 0.001;
  (Kaposi_s_sarcoma, Absent) 0.000, 0.988, 0.010, 0.002;
  (Mast_cell_disease, Absent) 0.000, 0.989, 0.010, 0.001;
  (AIDS_involutionary, Absent) 0.000, 0.988, 0.010, 0.002;
  (T_immunob_large, Absent) 0.000, 0.989, 0.010, 0.001;
  (Monocytoid_B_cell, Absent) 0.0000, 0.9989, 0.0010, 0.0001;
  (Nasopharyngeal_CA, Absent) 0.000, 0.989, 0.010, 0.001;
  (Seminoma, Absent) 0.000, 0.989, 0.010, 0.001;
  (SLE, Absent) 0.000, 0.989, 0.010, 0.001;
  (Mycobact_histiocytos, Absent) 0.000, 0.988, 0.010, 0.002;
  (Mast_cell_hyperplas, Absent) 0.000, 0.989, 0.010, 0.001;
  (LGV, Absent) 0.000, 0.989, 0.010, 0.001;
  (Histoplasmosis, Absent) 0.000, 0.988, 0.010, 0.002;
  (Coccidioidomycosis, Absent) 0.000, 0.988, 0.010, 0.002;
  (CMV, Absent) 0.000, 0.988, 0.010, 0.002;
  (Brucellosis, Absent) 0.000, 0.989, 0.010, 0.001;
  (Ki_1_LC_anaplas_B, Absent) 0.000, 0.989, 0.010, 0.001;
  (Intermed_lymphocytic, Absent) 0.000, 0.989, 0.010, 0.001;
  (AIDS_early, Present) 0.000, 0.989, 0.010, 0.001;
  (AILD, Present) 0.000, 0.989, 0.010, 0.001;
  (ALIP, Present) 0.000, 0.989, 0.010, 0.001;
  (Cat_scratch_disease, Present) 0.000, 0.989, 0.010, 0.001;
  (Dermatopathic_laden, Present) 0.000, 0.989, 0.010, 0.001;
  (Florid_follic_hyperp, Present) 0.000, 0.989, 0.010, 0.001;
  (GLH_hyaline_vascular, Present) 0.00000, 0.00001, 0.02000, 0.97999;
  (GLH_plasma_cell, Present) 0.000, 0.988, 0.010, 0.002;
  (Granulomatous_laden, Present) 0.000, 0.989, 0.010, 0.001;
  (Histiocytosis_x, Present) 0.000, 0.989, 0.010, 0.001;
  (Infectious_mono, Present) 0.000, 0.989, 0.010, 0.001;
  (Leprosy_lepromatous, Present) 0.000, 0.989, 0.010, 0.001;
  (Lymphangiographic, Present) 0.000, 0.989, 0.010, 0.001;
  (Mantle_zone_hyperpla, Present) 0.000, 0.989, 0.010, 0.001;
  (Necrotizing_Kikuchi, Present) 0.000, 0.989, 0.010, 0.001;
  (Necrotiz_non_Kikuchi, Present) 0.000, 0.989, 0.010, 0.001;
  (Rheumatoid_arthritis, Present) 0.000, 0.989, 0.010, 0.001;
  (Sarcoidosis, Present) 0.000, 0.989, 0.010, 0.001;
  (SHML, Present) 0.000, 0.989, 0.010, 0.001;
  (Sinus_histiocytosis, Present) 0.000, 0.989, 0.010, 0.001;
  (Syphilis, Present) 0.000, 0.989, 0.010, 0.001;
  (Toxoplasmosis, Present) 0.000, 0.989, 0.010, 0.001;
  (Tuberculosis, Present) 0.000, 0.989, 0.010, 0.001;
  (Viral_NOS, Present) 0.000, 0.989, 0.010, 0.001;
  (Whipple_s_disease, Present) 0.000, 0.989, 0.010, 0.001;
  (L_H_nodular_HD, Present) 0.000, 0.989, 0.010, 0.001;
  (L_H_diffuse_HD, Present) 0.000, 0.989, 0.010, 0.001;
  (Nodular_sclerosis_HD, Present) 0.000, 0.989, 0.010, 0.001;
  (Cellular_phase_NSHD, Present) 0.000, 0.989, 0.010, 0.001;
  (Syncytial_NSHD, Present) 0.000, 0.989, 0.010, 0.001;
  (Mixed_cellularity_HD, Present) 0.000, 0.989, 0.010, 0.001;
  (Interfollicular_HD, Present) 0.000, 0.989, 0.010, 0.001;
  (Diffuse_fibrosis_HD, Present) 0.000, 0.989, 0.010, 0.001;
  (Reticular_type_HD, Present) 0.000, 0.989, 0.010, 0.001;
  (Small_cleaved_fol, Present) 0.0000, 0.9998, 0.0001, 0.0001;
  (Mixed_fol, Present) 0.0000, 0.9998, 0.0001, 0.0001;
  (Large_cell_fol, Present) 0.0000, 0.9998, 0.0001, 0.0001;
  (Small_noncleaved_fol, Present) 0.0000, 0.9998, 0.0001, 0.0001;
  (Small_lymphocytic, Present) 0.000, 0.989, 0.010, 0.001;
  (Plasmacytoid_lyctic, Present) 0.000, 0.989, 0.010, 0.001;
  (Mantle_zone_lymphoma, Present) 0.000, 0.989, 0.010, 0.001;
  (Small_cleaved_dif, Present) 0.000, 0.989, 0.010, 0.001;
  (Mixed_FCC_dif, Present) 0.000, 0.989, 0.010, 0.001;
  (Large_cell_dif, Present) 0.000, 0.989, 0.010, 0.001;
  (B_immunoblastic, Present) 0.000, 0.989, 0.010, 0.001;
  (T_immunob_mixed, Present) 0.000, 0.989, 0.010, 0.001;
  (AILD_like_T_cell_lym, Present) 0.000, 0.989, 0.010, 0.001;
  (Japanese_ATL, Present) 0.000, 0.989, 0.010, 0.001;
  (Lymphoblastic, Present) 0.000, 0.989, 0.010, 0.001;
  (Small_noncleaved_dif, Present) 0.000, 0.989, 0.010, 0.001;
  (True_histiocytic, Present) 0.000, 0.989, 0.010, 0.001;
  (Ki_1_LC_anaplas_T, Present) 0.000, 0.989, 0.010, 0.001;
  (Multiple_myeloma, Present) 0.000, 0.989, 0.010, 0.001;
  (Mycosis_fungoides, Present) 0.000, 0.989, 0.010, 0.001;
  (AML, Present) 0.000, 0.989, 0.010, 0.001;
  (Hairy_cell_leukemia, Present) 0.000, 0.989, 0.010, 0.001;
  (Carcinoma, Present) 0.000, 0.989, 0.010, 0.001;
  (Melanoma, Present) 0.000, 0.989, 0.010, 0.001;
  (EM_plasmacytoma, Present) 0.000, 0.989, 0.010, 0.001;
  (Kaposi_s_sarcoma, Present) 0.000, 0.988, 0.010, 0.002;
  (Mast_cell_disease, Present) 0.000, 0.989, 0.010, 0.001;
  (AIDS_involutionary, Present) 0.000, 0.988, 0.010, 0.002;
  (T_immunob_large, Present) 0.000, 0.989, 0.010, 0.001;
  (Monocytoid_B_cell, Present) 0.0000, 0.9989, 0.0010, 0.0001;
  (Nasopharyngeal_CA, Present) 0.000, 0.989, 0.010, 0.001;
  (Seminoma, Present) 0.000, 0.989, 0.010, 0.001;
  (SLE, Present) 0.000, 0.989, 0.010, 0.001;
  (Mycobact_histiocytos, Present) 0.000, 0.988, 0.010, 0.002;
  (Mast_cell_hyperplas, Present) 0.000, 0.989, 0.010, 0.001;
  (LGV, Present) 0.000, 0.989, 0.010, 0.001;
  (Histoplasmosis, Present) 0.000, 0.988, 0.010, 0.002;
  (Coccidioidomycosis, Present) 0.000, 0.988, 0.010, 0.002;
  (CMV, Present) 0.000, 0.988, 0.010, 0.002;
  (Brucellosis, Present) 0.000, 0.989, 0.010, 0.001;
  (Ki_1_LC_anaplas_B, Present) 0.000, 0.989, 0.010, 0.001;
  (Intermed_lymphocytic, Present) 0.000, 0.989, 0.010, 0.001;
}
probability ( BH_LANG | Fault ) {
  (AIDS_early) 0.989, 0.010, 0.001, 0.000;
  (AILD) 0.989, 0.010, 0.001, 0.000;
  (ALIP) 0.989, 0.010, 0.001, 0.000;
  (Cat_scratch_disease) 0.989, 0.010, 0.001, 0.000;
  (Dermatopathic_laden) 0.83, 0.02, 0.10, 0.05;
  (Florid_follic_hyperp) 0.989, 0.010, 0.001, 0.000;
  (GLH_hyaline_vascular) 0.989, 0.010, 0.001, 0.000;
  (GLH_plasma_cell) 0.989, 0.010, 0.001, 0.000;
  (Granulomatous_laden) 0.989, 0.010, 0.001, 0.000;
  (Histiocytosis_x) 0.00, 0.00, 0.05, 0.95;
  (Infectious_mono) 0.989, 0.010, 0.001, 0.000;
  (Leprosy_lepromatous) 0.989, 0.010, 0.001, 0.000;
  (Lymphangiographic) 0.989, 0.010, 0.001, 0.000;
  (Mantle_zone_hyperpla) 0.989, 0.010, 0.001, 0.000;
  (Necrotizing_Kikuchi) 0.989, 0.010, 0.001, 0.000;
  (Necrotiz_non_Kikuchi) 0.989, 0.010, 0.001, 0.000;
  (Rheumatoid_arthritis) 0.989, 0.010, 0.001, 0.000;
  (Sarcoidosis) 0.989, 0.010, 0.001, 0.000;
  (SHML) 0.989, 0.010, 0.001, 0.000;
  (Sinus_histiocytosis) 0.989, 0.010, 0.001, 0.000;
  (Syphilis) 0.989, 0.010, 0.001, 0.000;
  (Toxoplasmosis) 0.989, 0.010, 0.001, 0.000;
  (Tuberculosis) 0.989, 0.010, 0.001, 0.000;
  (Viral_NOS) 0.989, 0.010, 0.001, 0.000;
  (Whipple_s_disease) 0.989, 0.010, 0.001, 0.000;
  (L_H_nodular_HD) 0.989, 0.010, 0.001, 0.000;
  (L_H_diffuse_HD) 0.989, 0.010, 0.001, 0.000;
  (Nodular_sclerosis_HD) 0.989, 0.010, 0.001, 0.000;
  (Cellular_phase_NSHD) 0.989, 0.010, 0.001, 0.000;
  (Syncytial_NSHD) 0.989, 0.010, 0.001, 0.000;
  (Mixed_cellularity_HD) 0.989, 0.010, 0.001, 0.000;
  (Interfollicular_HD) 0.989, 0.010, 0.001, 0.000;
  (Diffuse_fibrosis_HD) 0.989, 0.010, 0.001, 0.000;
  (Reticular_type_HD) 0.989, 0.010, 0.001, 0.000;
  (Small_cleaved_fol) 0.989, 0.010, 0.001, 0.000;
  (Mixed_fol) 0.989, 0.010, 0.001, 0.000;
  (Large_cell_fol) 0.989, 0.010, 0.001, 0.000;
  (Small_noncleaved_fol) 0.989, 0.010, 0.001, 0.000;
  (Small_lymphocytic) 0.989, 0.010, 0.001, 0.000;
  (Plasmacytoid_lyctic) 0.989, 0.010, 0.001, 0.000;
  (Mantle_zone_lymphoma) 0.989, 0.010, 0.001, 0.000;
  (Small_cleaved_dif) 0.989, 0.010, 0.001, 0.000;
  (Mixed_FCC_dif) 0.989, 0.010, 0.001, 0.000;
  (Large_cell_dif) 0.989, 0.010, 0.001, 0.000;
  (B_immunoblastic) 0.989, 0.010, 0.001, 0.000;
  (T_immunob_mixed) 0.989, 0.010, 0.001, 0.000;
  (AILD_like_T_cell_lym) 0.989, 0.010, 0.001, 0.000;
  (Japanese_ATL) 0.989, 0.010, 0.001, 0.000;
  (Lymphoblastic) 0.989, 0.010, 0.001, 0.000;
  (Small_noncleaved_dif) 0.989, 0.010, 0.001, 0.000;
  (True_histiocytic) 0.989, 0.010, 0.001, 0.000;
  (Ki_1_LC_anaplas_T) 0.989, 0.010, 0.001, 0.000;
  (Multiple_myeloma) 0.989, 0.010, 0.001, 0.000;
  (Mycosis_fungoides) 0.989, 0.010, 0.001, 0.000;
  (AML) 0.989, 0.010, 0.001, 0.000;
  (Hairy_cell_leukemia) 0.989, 0.010, 0.001, 0.000;
  (Carcinoma) 0.989, 0.010, 0.001, 0.000;
  (Melanoma) 0.989, 0.010, 0.001, 0.000;
  (EM_plasmacytoma) 0.989, 0.010, 0.001, 0.000;
  (Kaposi_s_sarcoma) 0.989, 0.010, 0.001, 0.000;
  (Mast_cell_disease) 0.989, 0.010, 0.001, 0.000;
  (AIDS_involutionary) 0.989, 0.010, 0.001, 0.000;
  (T_immunob_large) 0.989, 0.010, 0.001, 0.000;
  (Monocytoid_B_cell) 0.989, 0.010, 0.001, 0.000;
  (Nasopharyngeal_CA) 0.989, 0.010, 0.001, 0.000;
  (Seminoma) 0.989, 0.010, 0.001, 0.000;
  (SLE) 0.989, 0.010, 0.001, 0.000;
  (Mycobact_histiocytos) 0.989, 0.010, 0.001, 0.000;
  (Mast_cell_hyperplas) 0.989, 0.010, 0.001, 0.000;
  (LGV) 0.989, 0.010, 0.001, 0.000;
  (Histoplasmosis) 0.989, 0.010, 0.001, 0.000;
  (Coccidioidomycosis) 0.989, 0.010, 0.001, 0.000;
  (CMV) 0.989, 0.010, 0.001, 0.000;
  (Brucellosis) 0.989, 0.010, 0.001, 0.000;
  (Ki_1_LC_anaplas_B) 0.989, 0.010, 0.001, 0.000;
  (Intermed_lymphocytic) 0.989, 0.010, 0.001, 0.000;
}
probability ( BH_FOAM | Fault ) {
  (AIDS_early) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (AILD) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (ALIP) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Cat_scratch_disease) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Dermatopathic_laden) 0.28, 0.40, 0.20, 0.10, 0.02;
  (Florid_follic_hyperp) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (GLH_hyaline_vascular) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (GLH_plasma_cell) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Granulomatous_laden) 0.699300699, 0.199800200, 0.099900100, 0.000999001, 0.000000000;
  (Histiocytosis_x) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Infectious_mono) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Leprosy_lepromatous) 0.01, 0.54, 0.25, 0.15, 0.05;
  (Lymphangiographic) 0.00, 0.01, 0.09, 0.60, 0.30;
  (Mantle_zone_hyperpla) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Necrotizing_Kikuchi) 0.4899, 0.4000, 0.1000, 0.0100, 0.0001;
  (Necrotiz_non_Kikuchi) 0.4899, 0.4000, 0.1000, 0.0100, 0.0001;
  (Rheumatoid_arthritis) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Sarcoidosis) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (SHML) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Sinus_histiocytosis) 0.969, 0.020, 0.010, 0.001, 0.000;
  (Syphilis) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Toxoplasmosis) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Tuberculosis) 0.899100899, 0.089910090, 0.009990010, 0.000999001, 0.000000000;
  (Viral_NOS) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Whipple_s_disease) 0.00, 0.01, 0.09, 0.60, 0.30;
  (L_H_nodular_HD) 0.95, 0.01, 0.01, 0.02, 0.01;
  (L_H_diffuse_HD) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Nodular_sclerosis_HD) 0.94, 0.03, 0.02, 0.01, 0.00;
  (Cellular_phase_NSHD) 0.94, 0.03, 0.02, 0.01, 0.00;
  (Syncytial_NSHD) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Mixed_cellularity_HD) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Interfollicular_HD) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Diffuse_fibrosis_HD) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Reticular_type_HD) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Small_cleaved_fol) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Mixed_fol) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Large_cell_fol) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Small_noncleaved_fol) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Small_lymphocytic) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Plasmacytoid_lyctic) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Mantle_zone_lymphoma) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Small_cleaved_dif) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Mixed_FCC_dif) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Large_cell_dif) 0.95, 0.01, 0.01, 0.02, 0.01;
  (B_immunoblastic) 0.95, 0.01, 0.01, 0.02, 0.01;
  (T_immunob_mixed) 0.95, 0.01, 0.01, 0.02, 0.01;
  (AILD_like_T_cell_lym) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Japanese_ATL) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Lymphoblastic) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Small_noncleaved_dif) 0.95, 0.01, 0.01, 0.02, 0.01;
  (True_histiocytic) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Ki_1_LC_anaplas_T) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Multiple_myeloma) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Mycosis_fungoides) 0.95, 0.01, 0.01, 0.02, 0.01;
  (AML) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Hairy_cell_leukemia) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Carcinoma) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Melanoma) 0.95, 0.01, 0.01, 0.02, 0.01;
  (EM_plasmacytoma) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Kaposi_s_sarcoma) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Mast_cell_disease) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (AIDS_involutionary) 0.4899, 0.4000, 0.1000, 0.0100, 0.0001;
  (T_immunob_large) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Monocytoid_B_cell) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Nasopharyngeal_CA) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Seminoma) 0.95, 0.01, 0.01, 0.02, 0.01;
  (SLE) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Mycobact_histiocytos) 0.20, 0.45, 0.20, 0.10, 0.05;
  (Mast_cell_hyperplas) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (LGV) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Histoplasmosis) 0.8999, 0.0500, 0.0300, 0.0200, 0.0001;
  (Coccidioidomycosis) 0.8999, 0.0500, 0.0300, 0.0200, 0.0001;
  (CMV) 0.8999, 0.0500, 0.0300, 0.0200, 0.0001;
  (Brucellosis) 0.979020979, 0.019980020, 0.000999001, 0.000000000, 0.000000000;
  (Ki_1_LC_anaplas_B) 0.95, 0.01, 0.01, 0.02, 0.01;
  (Intermed_lymphocytic) 0.95, 0.01, 0.01, 0.02, 0.01;
}
probability ( BH_NOS | Fault, NECR ) {
  (AIDS_early, Absent) 0.99, 0.01, 0.00;
  (AILD, Absent) 0.95, 0.05, 0.00;
  (ALIP, Absent) 0.95, 0.05, 0.00;
  (Cat_scratch_disease, Absent) 0.70, 0.25, 0.05;
  (Dermatopathic_laden, Absent) 0.91, 0.05, 0.04;
  (Florid_follic_hyperp, Absent) 0.99, 0.01, 0.00;
  (GLH_hyaline_vascular, Absent) 0.99, 0.01, 0.00;
  (GLH_plasma_cell, Absent) 0.99, 0.01, 0.00;
  (Granulomatous_laden, Absent) 0.45, 0.50, 0.05;
  (Histiocytosis_x, Absent) 0.99, 0.01, 0.00;
  (Infectious_mono, Absent) 0.9, 0.1, 0.0;
  (Leprosy_lepromatous, Absent) 0.01, 0.74, 0.25;
  (Lymphangiographic, Absent) 0.75, 0.25, 0.00;
  (Mantle_zone_hyperpla, Absent) 0.99, 0.01, 0.00;
  (Necrotizing_Kikuchi, Absent) 0.02, 0.93, 0.05;
  (Necrotiz_non_Kikuchi, Absent) 0.3333333, 0.3333333, 0.3333333;
  (Rheumatoid_arthritis, Absent) 0.99, 0.01, 0.00;
  (Sarcoidosis, Absent) 0.99, 0.01, 0.00;
  (SHML, Absent) 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, Absent) 0.0, 0.8, 0.2;
  (Syphilis, Absent) 0.79, 0.20, 0.01;
  (Toxoplasmosis, Absent) 0.99, 0.01, 0.00;
  (Tuberculosis, Absent) 0.899, 0.100, 0.001;
  (Viral_NOS, Absent) 0.9, 0.1, 0.0;
  (Whipple_s_disease, Absent) 0.75, 0.25, 0.00;
  (L_H_nodular_HD, Absent) 0.99, 0.01, 0.00;
  (L_H_diffuse_HD, Absent) 0.99, 0.01, 0.00;
  (Nodular_sclerosis_HD, Absent) 0.99, 0.01, 0.00;
  (Cellular_phase_NSHD, Absent) 0.99, 0.01, 0.00;
  (Syncytial_NSHD, Absent) 0.99, 0.01, 0.00;
  (Mixed_cellularity_HD, Absent) 0.99, 0.01, 0.00;
  (Interfollicular_HD, Absent) 0.99, 0.01, 0.00;
  (Diffuse_fibrosis_HD, Absent) 0.99, 0.01, 0.00;
  (Reticular_type_HD, Absent) 0.99, 0.01, 0.00;
  (Small_cleaved_fol, Absent) 0.99, 0.01, 0.00;
  (Mixed_fol, Absent) 0.99, 0.01, 0.00;
  (Large_cell_fol, Absent) 0.99, 0.01, 0.00;
  (Small_noncleaved_fol, Absent) 0.99, 0.01, 0.00;
  (Small_lymphocytic, Absent) 0.99, 0.01, 0.00;
  (Plasmacytoid_lyctic, Absent) 0.99, 0.01, 0.00;
  (Mantle_zone_lymphoma, Absent) 0.99, 0.01, 0.00;
  (Small_cleaved_dif, Absent) 0.99, 0.01, 0.00;
  (Mixed_FCC_dif, Absent) 0.94, 0.05, 0.01;
  (Large_cell_dif, Absent) 0.99, 0.01, 0.00;
  (B_immunoblastic, Absent) 0.99, 0.01, 0.00;
  (T_immunob_mixed, Absent) 0.76, 0.20, 0.04;
  (AILD_like_T_cell_lym, Absent) 0.95, 0.05, 0.00;
  (Japanese_ATL, Absent) 0.95, 0.05, 0.00;
  (Lymphoblastic, Absent) 0.99, 0.01, 0.00;
  (Small_noncleaved_dif, Absent) 0.99, 0.01, 0.00;
  (True_histiocytic, Absent) 0.99, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Absent) 0.99, 0.01, 0.00;
  (Multiple_myeloma, Absent) 0.99, 0.01, 0.00;
  (Mycosis_fungoides, Absent) 0.99, 0.01, 0.00;
  (AML, Absent) 0.99, 0.01, 0.00;
  (Hairy_cell_leukemia, Absent) 0.99, 0.01, 0.00;
  (Carcinoma, Absent) 0.99, 0.01, 0.00;
  (Melanoma, Absent) 0.95, 0.05, 0.00;
  (EM_plasmacytoma, Absent) 0.99, 0.01, 0.00;
  (Kaposi_s_sarcoma, Absent) 0.95, 0.05, 0.00;
  (Mast_cell_disease, Absent) 0.99, 0.01, 0.00;
  (AIDS_involutionary, Absent) 0.9, 0.1, 0.0;
  (T_immunob_large, Absent) 0.985, 0.010, 0.005;
  (Monocytoid_B_cell, Absent) 0.99, 0.01, 0.00;
  (Nasopharyngeal_CA, Absent) 0.99, 0.01, 0.00;
  (Seminoma, Absent) 0.99, 0.01, 0.00;
  (SLE, Absent) 0.95, 0.05, 0.00;
  (Mycobact_histiocytos, Absent) 0.0, 0.1, 0.9;
  (Mast_cell_hyperplas, Absent) 0.99, 0.01, 0.00;
  (LGV, Absent) 0.70, 0.25, 0.05;
  (Histoplasmosis, Absent) 0.70, 0.25, 0.05;
  (Coccidioidomycosis, Absent) 0.70, 0.25, 0.05;
  (CMV, Absent) 0.95, 0.05, 0.00;
  (Brucellosis, Absent) 0.99, 0.01, 0.00;
  (Ki_1_LC_anaplas_B, Absent) 0.99, 0.01, 0.00;
  (Intermed_lymphocytic, Absent) 0.99, 0.01, 0.00;
  (AIDS_early, Focal_nonextensive) 0.97, 0.03, 0.00;
  (AILD, Focal_nonextensive) 0.93, 0.07, 0.00;
  (ALIP, Focal_nonextensive) 0.93, 0.07, 0.00;
  (Cat_scratch_disease, Focal_nonextensive) 0.68, 0.27, 0.05;
  (Dermatopathic_laden, Focal_nonextensive) 0.89, 0.07, 0.04;
  (Florid_follic_hyperp, Focal_nonextensive) 0.97, 0.03, 0.00;
  (GLH_hyaline_vascular, Focal_nonextensive) 0.97, 0.03, 0.00;
  (GLH_plasma_cell, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Granulomatous_laden, Focal_nonextensive) 0.43, 0.52, 0.05;
  (Histiocytosis_x, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Infectious_mono, Focal_nonextensive) 0.85, 0.15, 0.00;
  (Leprosy_lepromatous, Focal_nonextensive) 0.01, 0.74, 0.25;
  (Lymphangiographic, Focal_nonextensive) 0.7, 0.3, 0.0;
  (Mantle_zone_hyperpla, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Necrotizing_Kikuchi, Focal_nonextensive) 0.02, 0.93, 0.05;
  (Necrotiz_non_Kikuchi, Focal_nonextensive) 0.03, 0.96, 0.01;
  (Rheumatoid_arthritis, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Sarcoidosis, Focal_nonextensive) 0.97, 0.03, 0.00;
  (SHML, Focal_nonextensive) 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, Focal_nonextensive) 0.0, 0.8, 0.2;
  (Syphilis, Focal_nonextensive) 0.77, 0.22, 0.01;
  (Toxoplasmosis, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Tuberculosis, Focal_nonextensive) 0.879, 0.120, 0.001;
  (Viral_NOS, Focal_nonextensive) 0.85, 0.15, 0.00;
  (Whipple_s_disease, Focal_nonextensive) 0.7, 0.3, 0.0;
  (L_H_nodular_HD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (L_H_diffuse_HD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Nodular_sclerosis_HD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Cellular_phase_NSHD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Syncytial_NSHD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Mixed_cellularity_HD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Interfollicular_HD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Diffuse_fibrosis_HD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Reticular_type_HD, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Small_cleaved_fol, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Mixed_fol, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Large_cell_fol, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Small_noncleaved_fol, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Small_lymphocytic, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Plasmacytoid_lyctic, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Mantle_zone_lymphoma, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Small_cleaved_dif, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Mixed_FCC_dif, Focal_nonextensive) 0.92, 0.07, 0.01;
  (Large_cell_dif, Focal_nonextensive) 0.97, 0.03, 0.00;
  (B_immunoblastic, Focal_nonextensive) 0.97, 0.03, 0.00;
  (T_immunob_mixed, Focal_nonextensive) 0.74, 0.22, 0.04;
  (AILD_like_T_cell_lym, Focal_nonextensive) 0.93, 0.07, 0.00;
  (Japanese_ATL, Focal_nonextensive) 0.93, 0.07, 0.00;
  (Lymphoblastic, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Small_noncleaved_dif, Focal_nonextensive) 0.97, 0.03, 0.00;
  (True_histiocytic, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Ki_1_LC_anaplas_T, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Multiple_myeloma, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Mycosis_fungoides, Focal_nonextensive) 0.97, 0.03, 0.00;
  (AML, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Hairy_cell_leukemia, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Carcinoma, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Melanoma, Focal_nonextensive) 0.93, 0.07, 0.00;
  (EM_plasmacytoma, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Kaposi_s_sarcoma, Focal_nonextensive) 0.93, 0.07, 0.00;
  (Mast_cell_disease, Focal_nonextensive) 0.97, 0.03, 0.00;
  (AIDS_involutionary, Focal_nonextensive) 0.85, 0.15, 0.00;
  (T_immunob_large, Focal_nonextensive) 0.965, 0.030, 0.005;
  (Monocytoid_B_cell, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Nasopharyngeal_CA, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Seminoma, Focal_nonextensive) 0.97, 0.03, 0.00;
  (SLE, Focal_nonextensive) 0.93, 0.07, 0.00;
  (Mycobact_histiocytos, Focal_nonextensive) 0.0, 0.1, 0.9;
  (Mast_cell_hyperplas, Focal_nonextensive) 0.97, 0.03, 0.00;
  (LGV, Focal_nonextensive) 0.68, 0.27, 0.05;
  (Histoplasmosis, Focal_nonextensive) 0.68, 0.27, 0.05;
  (Coccidioidomycosis, Focal_nonextensive) 0.68, 0.27, 0.05;
  (CMV, Focal_nonextensive) 0.93, 0.07, 0.00;
  (Brucellosis, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Ki_1_LC_anaplas_B, Focal_nonextensive) 0.97, 0.03, 0.00;
  (Intermed_lymphocytic, Focal_nonextensive) 0.97, 0.03, 0.00;
  (AIDS_early, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (AILD, MultiFocal_nonextensive) 0.91, 0.09, 0.00;
  (ALIP, MultiFocal_nonextensive) 0.91, 0.09, 0.00;
  (Cat_scratch_disease, MultiFocal_nonextensive) 0.66, 0.29, 0.05;
  (Dermatopathic_laden, MultiFocal_nonextensive) 0.87, 0.09, 0.04;
  (Florid_follic_hyperp, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (GLH_hyaline_vascular, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (GLH_plasma_cell, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Granulomatous_laden, MultiFocal_nonextensive) 0.41, 0.54, 0.05;
  (Histiocytosis_x, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Infectious_mono, MultiFocal_nonextensive) 0.85, 0.15, 0.00;
  (Leprosy_lepromatous, MultiFocal_nonextensive) 0.01, 0.74, 0.25;
  (Lymphangiographic, MultiFocal_nonextensive) 0.7, 0.3, 0.0;
  (Mantle_zone_hyperpla, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Necrotizing_Kikuchi, MultiFocal_nonextensive) 0.02, 0.93, 0.05;
  (Necrotiz_non_Kikuchi, MultiFocal_nonextensive) 0.03, 0.96, 0.01;
  (Rheumatoid_arthritis, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Sarcoidosis, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (SHML, MultiFocal_nonextensive) 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, MultiFocal_nonextensive) 0.0, 0.8, 0.2;
  (Syphilis, MultiFocal_nonextensive) 0.75, 0.24, 0.01;
  (Toxoplasmosis, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Tuberculosis, MultiFocal_nonextensive) 0.859, 0.140, 0.001;
  (Viral_NOS, MultiFocal_nonextensive) 0.85, 0.15, 0.00;
  (Whipple_s_disease, MultiFocal_nonextensive) 0.7, 0.3, 0.0;
  (L_H_nodular_HD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (L_H_diffuse_HD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Nodular_sclerosis_HD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Cellular_phase_NSHD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Syncytial_NSHD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Mixed_cellularity_HD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Interfollicular_HD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Diffuse_fibrosis_HD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Reticular_type_HD, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Small_cleaved_fol, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Mixed_fol, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Large_cell_fol, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Small_noncleaved_fol, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Small_lymphocytic, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Plasmacytoid_lyctic, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Mantle_zone_lymphoma, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Small_cleaved_dif, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Mixed_FCC_dif, MultiFocal_nonextensive) 0.90, 0.09, 0.01;
  (Large_cell_dif, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (B_immunoblastic, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (T_immunob_mixed, MultiFocal_nonextensive) 0.72, 0.24, 0.04;
  (AILD_like_T_cell_lym, MultiFocal_nonextensive) 0.91, 0.09, 0.00;
  (Japanese_ATL, MultiFocal_nonextensive) 0.91, 0.09, 0.00;
  (Lymphoblastic, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Small_noncleaved_dif, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (True_histiocytic, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Ki_1_LC_anaplas_T, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Multiple_myeloma, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Mycosis_fungoides, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (AML, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Hairy_cell_leukemia, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Carcinoma, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Melanoma, MultiFocal_nonextensive) 0.91, 0.09, 0.00;
  (EM_plasmacytoma, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Kaposi_s_sarcoma, MultiFocal_nonextensive) 0.91, 0.09, 0.00;
  (Mast_cell_disease, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (AIDS_involutionary, MultiFocal_nonextensive) 0.85, 0.15, 0.00;
  (T_immunob_large, MultiFocal_nonextensive) 0.925, 0.070, 0.005;
  (Monocytoid_B_cell, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Nasopharyngeal_CA, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Seminoma, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (SLE, MultiFocal_nonextensive) 0.91, 0.09, 0.00;
  (Mycobact_histiocytos, MultiFocal_nonextensive) 0.0, 0.1, 0.9;
  (Mast_cell_hyperplas, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (LGV, MultiFocal_nonextensive) 0.66, 0.29, 0.05;
  (Histoplasmosis, MultiFocal_nonextensive) 0.66, 0.29, 0.05;
  (Coccidioidomycosis, MultiFocal_nonextensive) 0.66, 0.29, 0.05;
  (CMV, MultiFocal_nonextensive) 0.91, 0.09, 0.00;
  (Brucellosis, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Ki_1_LC_anaplas_B, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (Intermed_lymphocytic, MultiFocal_nonextensive) 0.95, 0.05, 0.00;
  (AIDS_early, Extensive) 0.95, 0.05, 0.00;
  (AILD, Extensive) 0.91, 0.09, 0.00;
  (ALIP, Extensive) 0.91, 0.09, 0.00;
  (Cat_scratch_disease, Extensive) 0.66, 0.29, 0.05;
  (Dermatopathic_laden, Extensive) 0.87, 0.09, 0.04;
  (Florid_follic_hyperp, Extensive) 0.95, 0.05, 0.00;
  (GLH_hyaline_vascular, Extensive) 0.95, 0.05, 0.00;
  (GLH_plasma_cell, Extensive) 0.95, 0.05, 0.00;
  (Granulomatous_laden, Extensive) 0.41, 0.54, 0.05;
  (Histiocytosis_x, Extensive) 0.95, 0.05, 0.00;
  (Infectious_mono, Extensive) 0.85, 0.15, 0.00;
  (Leprosy_lepromatous, Extensive) 0.01, 0.74, 0.25;
  (Lymphangiographic, Extensive) 0.7, 0.3, 0.0;
  (Mantle_zone_hyperpla, Extensive) 0.95, 0.05, 0.00;
  (Necrotizing_Kikuchi, Extensive) 0.02, 0.93, 0.05;
  (Necrotiz_non_Kikuchi, Extensive) 0.03, 0.96, 0.01;
  (Rheumatoid_arthritis, Extensive) 0.95, 0.05, 0.00;
  (Sarcoidosis, Extensive) 0.95, 0.05, 0.00;
  (SHML, Extensive) 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, Extensive) 0.0, 0.8, 0.2;
  (Syphilis, Extensive) 0.75, 0.24, 0.01;
  (Toxoplasmosis, Extensive) 0.95, 0.05, 0.00;
  (Tuberculosis, Extensive) 0.859, 0.140, 0.001;
  (Viral_NOS, Extensive) 0.85, 0.15, 0.00;
  (Whipple_s_disease, Extensive) 0.7, 0.3, 0.0;
  (L_H_nodular_HD, Extensive) 0.95, 0.05, 0.00;
  (L_H_diffuse_HD, Extensive) 0.95, 0.05, 0.00;
  (Nodular_sclerosis_HD, Extensive) 0.95, 0.05, 0.00;
  (Cellular_phase_NSHD, Extensive) 0.95, 0.05, 0.00;
  (Syncytial_NSHD, Extensive) 0.95, 0.05, 0.00;
  (Mixed_cellularity_HD, Extensive) 0.95, 0.05, 0.00;
  (Interfollicular_HD, Extensive) 0.95, 0.05, 0.00;
  (Diffuse_fibrosis_HD, Extensive) 0.95, 0.05, 0.00;
  (Reticular_type_HD, Extensive) 0.95, 0.05, 0.00;
  (Small_cleaved_fol, Extensive) 0.95, 0.05, 0.00;
  (Mixed_fol, Extensive) 0.95, 0.05, 0.00;
  (Large_cell_fol, Extensive) 0.95, 0.05, 0.00;
  (Small_noncleaved_fol, Extensive) 0.95, 0.05, 0.00;
  (Small_lymphocytic, Extensive) 0.95, 0.05, 0.00;
  (Plasmacytoid_lyctic, Extensive) 0.95, 0.05, 0.00;
  (Mantle_zone_lymphoma, Extensive) 0.95, 0.05, 0.00;
  (Small_cleaved_dif, Extensive) 0.95, 0.05, 0.00;
  (Mixed_FCC_dif, Extensive) 0.90, 0.09, 0.01;
  (Large_cell_dif, Extensive) 0.95, 0.05, 0.00;
  (B_immunoblastic, Extensive) 0.95, 0.05, 0.00;
  (T_immunob_mixed, Extensive) 0.72, 0.24, 0.04;
  (AILD_like_T_cell_lym, Extensive) 0.91, 0.09, 0.00;
  (Japanese_ATL, Extensive) 0.91, 0.09, 0.00;
  (Lymphoblastic, Extensive) 0.95, 0.05, 0.00;
  (Small_noncleaved_dif, Extensive) 0.95, 0.05, 0.00;
  (True_histiocytic, Extensive) 0.95, 0.05, 0.00;
  (Ki_1_LC_anaplas_T, Extensive) 0.95, 0.05, 0.00;
  (Multiple_myeloma, Extensive) 0.95, 0.05, 0.00;
  (Mycosis_fungoides, Extensive) 0.95, 0.05, 0.00;
  (AML, Extensive) 0.95, 0.05, 0.00;
  (Hairy_cell_leukemia, Extensive) 0.95, 0.05, 0.00;
  (Carcinoma, Extensive) 0.95, 0.05, 0.00;
  (Melanoma, Extensive) 0.91, 0.09, 0.00;
  (EM_plasmacytoma, Extensive) 0.95, 0.05, 0.00;
  (Kaposi_s_sarcoma, Extensive) 0.91, 0.09, 0.00;
  (Mast_cell_disease, Extensive) 0.95, 0.05, 0.00;
  (AIDS_involutionary, Extensive) 0.85, 0.15, 0.00;
  (T_immunob_large, Extensive) 0.925, 0.070, 0.005;
  (Monocytoid_B_cell, Extensive) 0.95, 0.05, 0.00;
  (Nasopharyngeal_CA, Extensive) 0.95, 0.05, 0.00;
  (Seminoma, Extensive) 0.95, 0.05, 0.00;
  (SLE, Extensive) 0.91, 0.09, 0.00;
  (Mycobact_histiocytos, Extensive) 0.0, 0.1, 0.9;
  (Mast_cell_hyperplas, Extensive) 0.95, 0.05, 0.00;
  (LGV, Extensive) 0.66, 0.29, 0.05;
  (Histoplasmosis, Extensive) 0.66, 0.29, 0.05;
  (Coccidioidomycosis, Extensive) 0.66, 0.29, 0.05;
  (CMV, Extensive) 0.91, 0.09, 0.00;
  (Brucellosis, Extensive) 0.95, 0.05, 0.00;
  (Ki_1_LC_anaplas_B, Extensive) 0.95, 0.05, 0.00;
  (Intermed_lymphocytic, Extensive) 0.95, 0.05, 0.00;
}
probability ( BH_SS | Fault ) {
  (AIDS_early) 0.900, 0.099, 0.001, 0.000, 0.000;
  (AILD) 0.694, 0.300, 0.005, 0.001, 0.000;
  (ALIP) 0.694, 0.300, 0.005, 0.001, 0.000;
  (Cat_scratch_disease) 0.739, 0.250, 0.010, 0.001, 0.000;
  (Dermatopathic_laden) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Florid_follic_hyperp) 0.900, 0.099, 0.001, 0.000, 0.000;
  (GLH_hyaline_vascular) 0.900, 0.099, 0.001, 0.000, 0.000;
  (GLH_plasma_cell) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Granulomatous_laden) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Histiocytosis_x) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Infectious_mono) 0.689, 0.250, 0.050, 0.010, 0.001;
  (Leprosy_lepromatous) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Lymphangiographic) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Mantle_zone_hyperpla) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Necrotizing_Kikuchi) 0.739, 0.250, 0.010, 0.001, 0.000;
  (Necrotiz_non_Kikuchi) 0.739, 0.250, 0.010, 0.001, 0.000;
  (Rheumatoid_arthritis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Sarcoidosis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (SHML) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Sinus_histiocytosis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Syphilis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Toxoplasmosis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Tuberculosis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Viral_NOS) 0.739, 0.250, 0.010, 0.001, 0.000;
  (Whipple_s_disease) 0.900, 0.099, 0.001, 0.000, 0.000;
  (L_H_nodular_HD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (L_H_diffuse_HD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Nodular_sclerosis_HD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Cellular_phase_NSHD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Syncytial_NSHD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Mixed_cellularity_HD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Interfollicular_HD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Diffuse_fibrosis_HD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Reticular_type_HD) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Small_cleaved_fol) 0.889, 0.100, 0.010, 0.001, 0.000;
  (Mixed_fol) 0.889, 0.100, 0.010, 0.001, 0.000;
  (Large_cell_fol) 0.919, 0.050, 0.020, 0.010, 0.001;
  (Small_noncleaved_fol) 0.919, 0.050, 0.020, 0.010, 0.001;
  (Small_lymphocytic) 0.694, 0.300, 0.005, 0.001, 0.000;
  (Plasmacytoid_lyctic) 0.694, 0.300, 0.005, 0.001, 0.000;
  (Mantle_zone_lymphoma) 0.900, 0.095, 0.005, 0.000, 0.000;
  (Small_cleaved_dif) 0.874, 0.070, 0.050, 0.005, 0.001;
  (Mixed_FCC_dif) 0.88, 0.05, 0.04, 0.02, 0.01;
  (Large_cell_dif) 0.65, 0.15, 0.10, 0.05, 0.05;
  (B_immunoblastic) 0.59, 0.15, 0.12, 0.07, 0.07;
  (T_immunob_mixed) 0.68, 0.10, 0.10, 0.07, 0.05;
  (AILD_like_T_cell_lym) 0.694, 0.300, 0.005, 0.001, 0.000;
  (Japanese_ATL) 0.68, 0.10, 0.10, 0.07, 0.05;
  (Lymphoblastic) 0.70, 0.05, 0.05, 0.10, 0.10;
  (Small_noncleaved_dif) 0.000999001, 0.009990010, 0.049950050, 0.199800200, 0.739260739;
  (True_histiocytic) 0.68, 0.10, 0.10, 0.07, 0.05;
  (Ki_1_LC_anaplas_T) 0.80, 0.10, 0.05, 0.03, 0.02;
  (Multiple_myeloma) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Mycosis_fungoides) 0.900, 0.099, 0.001, 0.000, 0.000;
  (AML) 0.68, 0.10, 0.10, 0.07, 0.05;
  (Hairy_cell_leukemia) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Carcinoma) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Melanoma) 0.900, 0.099, 0.001, 0.000, 0.000;
  (EM_plasmacytoma) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Kaposi_s_sarcoma) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Mast_cell_disease) 0.900, 0.099, 0.001, 0.000, 0.000;
  (AIDS_involutionary) 0.900, 0.099, 0.001, 0.000, 0.000;
  (T_immunob_large) 0.68, 0.10, 0.10, 0.07, 0.05;
  (Monocytoid_B_cell) 0.694, 0.300, 0.005, 0.001, 0.000;
  (Nasopharyngeal_CA) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Seminoma) 0.900, 0.099, 0.001, 0.000, 0.000;
  (SLE) 0.689, 0.250, 0.050, 0.010, 0.001;
  (Mycobact_histiocytos) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Mast_cell_hyperplas) 0.900, 0.099, 0.001, 0.000, 0.000;
  (LGV) 0.739, 0.250, 0.010, 0.001, 0.000;
  (Histoplasmosis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Coccidioidomycosis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (CMV) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Brucellosis) 0.900, 0.099, 0.001, 0.000, 0.000;
  (Ki_1_LC_anaplas_B) 0.80, 0.10, 0.05, 0.03, 0.02;
  (Intermed_lymphocytic) 0.89, 0.10, 0.01, 0.00, 0.00;
}
probability ( CA | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 0.0, 1.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 0.0, 1.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( SR | Fault, MONO ) {
  (AIDS_early, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0) 0.999, 0.001, 0.000, 0.000, 0.000;
  (ALIP, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Leprosy_lepromatous, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Whipple_s_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0) 0.95, 0.05, 0.00, 0.00, 0.00;
  (L_H_diffuse_HD, Absent_0) 0.95, 0.05, 0.00, 0.00, 0.00;
  (Nodular_sclerosis_HD, Absent_0) 0.000, 0.020, 0.825, 0.150, 0.005;
  (Cellular_phase_NSHD, Absent_0) 0.000, 0.020, 0.825, 0.150, 0.005;
  (Syncytial_NSHD, Absent_0) 0.00, 0.01, 0.59, 0.35, 0.05;
  (Mixed_cellularity_HD, Absent_0) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Interfollicular_HD, Absent_0) 0.00, 0.30, 0.65, 0.05, 0.00;
  (Diffuse_fibrosis_HD, Absent_0) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Reticular_type_HD, Absent_0) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_cleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Plasmacytoid_lyctic, Absent_0) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mantle_zone_lymphoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Large_cell_dif, Absent_0) 0.9799, 0.0100, 0.0100, 0.0001, 0.0000;
  (B_immunoblastic, Absent_0) 0.9749, 0.0200, 0.0050, 0.0001, 0.0000;
  (T_immunob_mixed, Absent_0) 0.99, 0.01, 0.00, 0.00, 0.00;
  (AILD_like_T_cell_lym, Absent_0) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Japanese_ATL, Absent_0) 0.94, 0.03, 0.02, 0.01, 0.00;
  (Lymphoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0) 0.9799, 0.0100, 0.0100, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, Absent_0) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Multiple_myeloma, Absent_0) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Mycosis_fungoides, Absent_0) 0.989, 0.010, 0.001, 0.000, 0.000;
  (AML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0) 0.969, 0.020, 0.010, 0.001, 0.000;
  (Melanoma, Absent_0) 0.969, 0.020, 0.010, 0.001, 0.000;
  (EM_plasmacytoma, Absent_0) 0.979, 0.020, 0.001, 0.000, 0.000;
  (Kaposi_s_sarcoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0) 0.9799, 0.0100, 0.0100, 0.0001, 0.0000;
  (Monocytoid_B_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0) 0.969, 0.020, 0.010, 0.001, 0.000;
  (Seminoma, Absent_0) 0.999, 0.001, 0.000, 0.000, 0.000;
  (SLE, Absent_0) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Mycobact_histiocytos, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0) 0.979, 0.020, 0.001, 0.000, 0.000;
  (Brucellosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Intermed_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000, 0.000;
  (ALIP, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Rare_1_to_2) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Leprosy_lepromatous, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Rare_1_to_2) 0.995002998, 0.004997002, 0.000000000, 0.000000000, 0.000000000;
  (Whipple_s_disease, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Rare_1_to_2) 0.0, 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Rare_1_to_2) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Rare_1_to_2) 0.000, 0.020, 0.825, 0.150, 0.005;
  (Cellular_phase_NSHD, Rare_1_to_2) 0.000, 0.020, 0.825, 0.150, 0.005;
  (Syncytial_NSHD, Rare_1_to_2) 0.00, 0.01, 0.59, 0.35, 0.05;
  (Mixed_cellularity_HD, Rare_1_to_2) 0.0, 0.0, 0.8, 0.2, 0.0;
  (Interfollicular_HD, Rare_1_to_2) 0.00, 0.30, 0.65, 0.05, 0.00;
  (Diffuse_fibrosis_HD, Rare_1_to_2) 0.00, 0.02, 0.62, 0.35, 0.01;
  (Reticular_type_HD, Rare_1_to_2) 0.00, 0.00, 0.01, 0.59, 0.40;
  (Small_cleaved_fol, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Plasmacytoid_lyctic, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mantle_zone_lymphoma, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Rare_1_to_2) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Large_cell_dif, Rare_1_to_2) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (B_immunoblastic, Rare_1_to_2) 0.9749, 0.0200, 0.0050, 0.0001, 0.0000;
  (T_immunob_mixed, Rare_1_to_2) 0.99, 0.01, 0.00, 0.00, 0.00;
  (AILD_like_T_cell_lym, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Japanese_ATL, Rare_1_to_2) 0.92, 0.05, 0.02, 0.01, 0.00;
  (Lymphoblastic, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Rare_1_to_2) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, Rare_1_to_2) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Multiple_myeloma, Rare_1_to_2) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Mycosis_fungoides, Rare_1_to_2) 0.989, 0.010, 0.001, 0.000, 0.000;
  (AML, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Rare_1_to_2) 0.97, 0.02, 0.01, 0.00, 0.00;
  (Melanoma, Rare_1_to_2) 0.97, 0.02, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Rare_1_to_2) 0.979, 0.020, 0.001, 0.000, 0.000;
  (Kaposi_s_sarcoma, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Rare_1_to_2) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Monocytoid_B_cell, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Rare_1_to_2) 0.97, 0.02, 0.01, 0.00, 0.00;
  (Seminoma, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000, 0.000;
  (SLE, Rare_1_to_2) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Mycobact_histiocytos, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Rare_1_to_2) 0.969, 0.030, 0.001, 0.000, 0.000;
  (Brucellosis, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Rare_1_to_2) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Intermed_lymphocytic, Rare_1_to_2) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AILD, Present_3_to_20) 0.9979, 0.0020, 0.0001, 0.0000, 0.0000;
  (ALIP, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Cat_scratch_disease, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Dermatopathic_laden, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Florid_follic_hyperp, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_hyaline_vascular, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_plasma_cell, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Granulomatous_laden, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histiocytosis_x, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Infectious_mono, Present_3_to_20) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Leprosy_lepromatous, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphangiographic, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_hyperpla, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotizing_Kikuchi, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotiz_non_Kikuchi, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Rheumatoid_arthritis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sarcoidosis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (SHML, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sinus_histiocytosis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Syphilis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Toxoplasmosis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Tuberculosis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Viral_NOS, Present_3_to_20) 0.995, 0.005, 0.000, 0.000, 0.000;
  (Whipple_s_disease, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_nodular_HD, Present_3_to_20) 0.0, 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Present_3_to_20) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Present_3_to_20) 0.00, 0.01, 0.76, 0.22, 0.01;
  (Cellular_phase_NSHD, Present_3_to_20) 0.00, 0.01, 0.76, 0.22, 0.01;
  (Syncytial_NSHD, Present_3_to_20) 0.00, 0.01, 0.29, 0.60, 0.10;
  (Mixed_cellularity_HD, Present_3_to_20) 0.0, 0.0, 0.7, 0.3, 0.0;
  (Interfollicular_HD, Present_3_to_20) 0.00, 0.30, 0.63, 0.07, 0.00;
  (Diffuse_fibrosis_HD, Present_3_to_20) 0.00, 0.02, 0.62, 0.35, 0.01;
  (Reticular_type_HD, Present_3_to_20) 0.00, 0.00, 0.01, 0.40, 0.59;
  (Small_cleaved_fol, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_fol, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_fol, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_fol, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_lymphocytic, Present_3_to_20) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Plasmacytoid_lyctic, Present_3_to_20) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mantle_zone_lymphoma, Present_3_to_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (Small_cleaved_dif, Present_3_to_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (Mixed_FCC_dif, Present_3_to_20) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Large_cell_dif, Present_3_to_20) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (B_immunoblastic, Present_3_to_20) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (T_immunob_mixed, Present_3_to_20) 0.99, 0.01, 0.00, 0.00, 0.00;
  (AILD_like_T_cell_lym, Present_3_to_20) 0.9979, 0.0020, 0.0001, 0.0000, 0.0000;
  (Japanese_ATL, Present_3_to_20) 0.92, 0.05, 0.02, 0.01, 0.00;
  (Lymphoblastic, Present_3_to_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (Small_noncleaved_dif, Present_3_to_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (True_histiocytic, Present_3_to_20) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, Present_3_to_20) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Multiple_myeloma, Present_3_to_20) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Mycosis_fungoides, Present_3_to_20) 0.989, 0.010, 0.001, 0.000, 0.000;
  (AML, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Hairy_cell_leukemia, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Carcinoma, Present_3_to_20) 0.96, 0.01, 0.02, 0.01, 0.00;
  (Melanoma, Present_3_to_20) 0.96, 0.01, 0.02, 0.01, 0.00;
  (EM_plasmacytoma, Present_3_to_20) 0.969, 0.030, 0.001, 0.000, 0.000;
  (Kaposi_s_sarcoma, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_disease, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_involutionary, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (T_immunob_large, Present_3_to_20) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Monocytoid_B_cell, Present_3_to_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (Nasopharyngeal_CA, Present_3_to_20) 0.96, 0.01, 0.02, 0.01, 0.00;
  (Seminoma, Present_3_to_20) 0.998, 0.002, 0.000, 0.000, 0.000;
  (SLE, Present_3_to_20) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Mycobact_histiocytos, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_hyperplas, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (LGV, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histoplasmosis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Coccidioidomycosis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (CMV, Present_3_to_20) 0.959, 0.040, 0.001, 0.000, 0.000;
  (Brucellosis, Present_3_to_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_B, Present_3_to_20) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Intermed_lymphocytic, Present_3_to_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (AIDS_early, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AILD, Many_GT_20) 0.989, 0.010, 0.001, 0.000, 0.000;
  (ALIP, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Cat_scratch_disease, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Dermatopathic_laden, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Florid_follic_hyperp, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_hyaline_vascular, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_plasma_cell, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Granulomatous_laden, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histiocytosis_x, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Infectious_mono, Many_GT_20) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Leprosy_lepromatous, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphangiographic, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_hyperpla, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotizing_Kikuchi, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotiz_non_Kikuchi, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Rheumatoid_arthritis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sarcoidosis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (SHML, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sinus_histiocytosis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Syphilis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Toxoplasmosis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Tuberculosis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Viral_NOS, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Whipple_s_disease, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_nodular_HD, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_diffuse_HD, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nodular_sclerosis_HD, Many_GT_20) 0.00, 0.01, 0.68, 0.30, 0.01;
  (Cellular_phase_NSHD, Many_GT_20) 0.00, 0.01, 0.68, 0.30, 0.01;
  (Syncytial_NSHD, Many_GT_20) 0.00, 0.01, 0.24, 0.65, 0.10;
  (Mixed_cellularity_HD, Many_GT_20) 0.00, 0.01, 0.59, 0.40, 0.00;
  (Interfollicular_HD, Many_GT_20) 0.00, 0.01, 0.69, 0.30, 0.00;
  (Diffuse_fibrosis_HD, Many_GT_20) 0.00, 0.00, 0.53, 0.45, 0.02;
  (Reticular_type_HD, Many_GT_20) 0.00, 0.00, 0.01, 0.25, 0.74;
  (Small_cleaved_fol, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_fol, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_fol, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_fol, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_lymphocytic, Many_GT_20) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Plasmacytoid_lyctic, Many_GT_20) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mantle_zone_lymphoma, Many_GT_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (Small_cleaved_dif, Many_GT_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (Mixed_FCC_dif, Many_GT_20) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Many_GT_20) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (B_immunoblastic, Many_GT_20) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (T_immunob_mixed, Many_GT_20) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (AILD_like_T_cell_lym, Many_GT_20) 0.989, 0.010, 0.001, 0.000, 0.000;
  (Japanese_ATL, Many_GT_20) 0.92, 0.05, 0.02, 0.01, 0.00;
  (Lymphoblastic, Many_GT_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (Small_noncleaved_dif, Many_GT_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (True_histiocytic, Many_GT_20) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, Many_GT_20) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Multiple_myeloma, Many_GT_20) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Mycosis_fungoides, Many_GT_20) 0.98, 0.02, 0.00, 0.00, 0.00;
  (AML, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Hairy_cell_leukemia, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Carcinoma, Many_GT_20) 0.94, 0.03, 0.02, 0.01, 0.00;
  (Melanoma, Many_GT_20) 0.94, 0.03, 0.02, 0.01, 0.00;
  (EM_plasmacytoma, Many_GT_20) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Kaposi_s_sarcoma, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_disease, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_involutionary, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (T_immunob_large, Many_GT_20) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Monocytoid_B_cell, Many_GT_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
  (Nasopharyngeal_CA, Many_GT_20) 0.96, 0.02, 0.01, 0.01, 0.00;
  (Seminoma, Many_GT_20) 0.998, 0.002, 0.000, 0.000, 0.000;
  (SLE, Many_GT_20) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Mycobact_histiocytos, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_hyperplas, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (LGV, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histoplasmosis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Coccidioidomycosis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (CMV, Many_GT_20) 0.949, 0.050, 0.001, 0.000, 0.000;
  (Brucellosis, Many_GT_20) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_B, Many_GT_20) 0.9699, 0.0200, 0.0100, 0.0001, 0.0000;
  (Intermed_lymphocytic, Many_GT_20) 0.9999, 0.0001, 0.0000, 0.0000, 0.0000;
}
probability ( DVS | Fault ) {
  (AIDS_early) 0.99999, 0.00001;
  (AILD) 0.99999, 0.00001;
  (ALIP) 0.99999, 0.00001;
  (Cat_scratch_disease) 0.99999, 0.00001;
  (Dermatopathic_laden) 0.99999, 0.00001;
  (Florid_follic_hyperp) 0.99999, 0.00001;
  (GLH_hyaline_vascular) 0.99999, 0.00001;
  (GLH_plasma_cell) 0.99999, 0.00001;
  (Granulomatous_laden) 0.99999, 0.00001;
  (Histiocytosis_x) 0.99999, 0.00001;
  (Infectious_mono) 0.99999, 0.00001;
  (Leprosy_lepromatous) 0.99999, 0.00001;
  (Lymphangiographic) 0.99999, 0.00001;
  (Mantle_zone_hyperpla) 0.99999, 0.00001;
  (Necrotizing_Kikuchi) 0.99999, 0.00001;
  (Necrotiz_non_Kikuchi) 0.99999, 0.00001;
  (Rheumatoid_arthritis) 0.99999, 0.00001;
  (Sarcoidosis) 0.99999, 0.00001;
  (SHML) 0.99999, 0.00001;
  (Sinus_histiocytosis) 0.99999, 0.00001;
  (Syphilis) 0.99999, 0.00001;
  (Toxoplasmosis) 0.99999, 0.00001;
  (Tuberculosis) 0.99999, 0.00001;
  (Viral_NOS) 0.99999, 0.00001;
  (Whipple_s_disease) 0.99999, 0.00001;
  (L_H_nodular_HD) 0.99999, 0.00001;
  (L_H_diffuse_HD) 0.99999, 0.00001;
  (Nodular_sclerosis_HD) 0.99999, 0.00001;
  (Cellular_phase_NSHD) 0.99999, 0.00001;
  (Syncytial_NSHD) 0.99999, 0.00001;
  (Mixed_cellularity_HD) 0.99999, 0.00001;
  (Interfollicular_HD) 0.99999, 0.00001;
  (Diffuse_fibrosis_HD) 0.99999, 0.00001;
  (Reticular_type_HD) 0.99999, 0.00001;
  (Small_cleaved_fol) 0.99999, 0.00001;
  (Mixed_fol) 0.99999, 0.00001;
  (Large_cell_fol) 0.99999, 0.00001;
  (Small_noncleaved_fol) 0.99999, 0.00001;
  (Small_lymphocytic) 0.99999, 0.00001;
  (Plasmacytoid_lyctic) 0.99999, 0.00001;
  (Mantle_zone_lymphoma) 0.99999, 0.00001;
  (Small_cleaved_dif) 0.99999, 0.00001;
  (Mixed_FCC_dif) 0.99999, 0.00001;
  (Large_cell_dif) 0.99999, 0.00001;
  (B_immunoblastic) 0.99999, 0.00001;
  (T_immunob_mixed) 0.99999, 0.00001;
  (AILD_like_T_cell_lym) 0.99999, 0.00001;
  (Japanese_ATL) 0.99999, 0.00001;
  (Lymphoblastic) 0.99999, 0.00001;
  (Small_noncleaved_dif) 0.99999, 0.00001;
  (True_histiocytic) 0.99999, 0.00001;
  (Ki_1_LC_anaplas_T) 0.99999, 0.00001;
  (Multiple_myeloma) 0.99999, 0.00001;
  (Mycosis_fungoides) 0.99999, 0.00001;
  (AML) 0.99999, 0.00001;
  (Hairy_cell_leukemia) 0.25, 0.75;
  (Carcinoma) 0.99999, 0.00001;
  (Melanoma) 0.99999, 0.00001;
  (EM_plasmacytoma) 0.99999, 0.00001;
  (Kaposi_s_sarcoma) 0.99, 0.01;
  (Mast_cell_disease) 0.99999, 0.00001;
  (AIDS_involutionary) 0.99999, 0.00001;
  (T_immunob_large) 0.99999, 0.00001;
  (Monocytoid_B_cell) 0.99999, 0.00001;
  (Nasopharyngeal_CA) 0.99999, 0.00001;
  (Seminoma) 0.99999, 0.00001;
  (SLE) 0.99999, 0.00001;
  (Mycobact_histiocytos) 0.99999, 0.00001;
  (Mast_cell_hyperplas) 0.99999, 0.00001;
  (LGV) 0.99999, 0.00001;
  (Histoplasmosis) 0.99999, 0.00001;
  (Coccidioidomycosis) 0.99999, 0.00001;
  (CMV) 0.99999, 0.00001;
  (Brucellosis) 0.99999, 0.00001;
  (Ki_1_LC_anaplas_B) 0.99999, 0.00001;
  (Intermed_lymphocytic) 0.99999, 0.00001;
}
probability ( EMPERI | Fault, BH_NOS ) {
  (AIDS_early, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (AILD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (ALIP, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (SHML, Absent_to_slight_LT_5pc) 0.5, 0.4, 0.1;
  (Sinus_histiocytosis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Syphilis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (AML, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Carcinoma, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Melanoma, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Seminoma, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (SLE, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (LGV, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (CMV, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Brucellosis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0;
  (AIDS_early, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (AILD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (ALIP, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Cat_scratch_disease, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Dermatopathic_laden, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Florid_follic_hyperp, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (GLH_hyaline_vascular, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (GLH_plasma_cell, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Granulomatous_laden, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Histiocytosis_x, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Infectious_mono, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Leprosy_lepromatous, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Lymphangiographic, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mantle_zone_hyperpla, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Necrotizing_Kikuchi, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Necrotiz_non_Kikuchi, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Rheumatoid_arthritis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Sarcoidosis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (SHML, Moderate_5_to_50pc) 9.99990e-06, 4.99995e-01, 4.99995e-01;
  (Sinus_histiocytosis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Syphilis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Toxoplasmosis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Tuberculosis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Viral_NOS, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Whipple_s_disease, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (L_H_nodular_HD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (L_H_diffuse_HD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Nodular_sclerosis_HD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Cellular_phase_NSHD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Syncytial_NSHD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mixed_cellularity_HD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Interfollicular_HD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Diffuse_fibrosis_HD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Reticular_type_HD, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Small_cleaved_fol, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mixed_fol, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Large_cell_fol, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Small_noncleaved_fol, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Small_lymphocytic, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Plasmacytoid_lyctic, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mantle_zone_lymphoma, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Small_cleaved_dif, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mixed_FCC_dif, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Large_cell_dif, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (B_immunoblastic, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (T_immunob_mixed, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (AILD_like_T_cell_lym, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Japanese_ATL, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Lymphoblastic, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Small_noncleaved_dif, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (True_histiocytic, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Ki_1_LC_anaplas_T, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Multiple_myeloma, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mycosis_fungoides, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (AML, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Hairy_cell_leukemia, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Carcinoma, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Melanoma, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (EM_plasmacytoma, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Kaposi_s_sarcoma, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mast_cell_disease, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (AIDS_involutionary, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (T_immunob_large, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Monocytoid_B_cell, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Nasopharyngeal_CA, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Seminoma, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (SLE, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mycobact_histiocytos, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Mast_cell_hyperplas, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (LGV, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Histoplasmosis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Coccidioidomycosis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (CMV, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Brucellosis, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Ki_1_LC_anaplas_B, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (Intermed_lymphocytic, Moderate_5_to_50pc) 9.9999e-01, 9.9999e-06, 0.0000e+00;
  (AIDS_early, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (AILD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (ALIP, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Cat_scratch_disease, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Dermatopathic_laden, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Florid_follic_hyperp, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (GLH_hyaline_vascular, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (GLH_plasma_cell, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Granulomatous_laden, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Histiocytosis_x, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Infectious_mono, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Leprosy_lepromatous, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Lymphangiographic, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mantle_zone_hyperpla, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Necrotizing_Kikuchi, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Necrotiz_non_Kikuchi, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Rheumatoid_arthritis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Sarcoidosis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (SHML, Marked_GT_50pc) 0.0, 0.3, 0.7;
  (Sinus_histiocytosis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Syphilis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Toxoplasmosis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Tuberculosis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Viral_NOS, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Whipple_s_disease, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (L_H_nodular_HD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (L_H_diffuse_HD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Nodular_sclerosis_HD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Cellular_phase_NSHD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Syncytial_NSHD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mixed_cellularity_HD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Interfollicular_HD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Diffuse_fibrosis_HD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Reticular_type_HD, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Small_cleaved_fol, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mixed_fol, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Large_cell_fol, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Small_noncleaved_fol, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Small_lymphocytic, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Plasmacytoid_lyctic, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mantle_zone_lymphoma, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Small_cleaved_dif, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mixed_FCC_dif, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Large_cell_dif, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (B_immunoblastic, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (T_immunob_mixed, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (AILD_like_T_cell_lym, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Japanese_ATL, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Lymphoblastic, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Small_noncleaved_dif, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (True_histiocytic, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Ki_1_LC_anaplas_T, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Multiple_myeloma, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mycosis_fungoides, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (AML, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Hairy_cell_leukemia, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Carcinoma, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Melanoma, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (EM_plasmacytoma, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Kaposi_s_sarcoma, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mast_cell_disease, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (AIDS_involutionary, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (T_immunob_large, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Monocytoid_B_cell, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Nasopharyngeal_CA, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Seminoma, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (SLE, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mycobact_histiocytos, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Mast_cell_hyperplas, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (LGV, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Histoplasmosis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Coccidioidomycosis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (CMV, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Brucellosis, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Ki_1_LC_anaplas_B, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
  (Intermed_lymphocytic, Marked_GT_50pc) 9.999e-01, 9.999e-05, 0.000e+00;
}
probability ( MA_EOSIN | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 0.9999, 0.0001;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 0.9999, 0.0001;
  (Histiocytosis_x) 0.6, 0.4;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 0.9999, 0.0001;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 0.99, 0.01;
  (Cellular_phase_NSHD) 0.99, 0.01;
  (Syncytial_NSHD) 0.99, 0.01;
  (Mixed_cellularity_HD) 0.99, 0.01;
  (Interfollicular_HD) 0.99, 0.01;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 0.9999, 0.0001;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 0.99, 0.01;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 0.9999, 0.0001;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( EMM | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 0.5, 0.5;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( EOSIN | Fault, EMM ) {
  (AIDS_early, Absent) 0.599, 0.400, 0.001;
  (AILD, Absent) 0.20, 0.75, 0.05;
  (ALIP, Absent) 0.20, 0.75, 0.05;
  (Cat_scratch_disease, Absent) 0.05, 0.90, 0.05;
  (Dermatopathic_laden, Absent) 0.15, 0.83, 0.02;
  (Florid_follic_hyperp, Absent) 0.599, 0.400, 0.001;
  (GLH_hyaline_vascular, Absent) 0.599, 0.400, 0.001;
  (GLH_plasma_cell, Absent) 0.599, 0.400, 0.001;
  (Granulomatous_laden, Absent) 0.05, 0.90, 0.05;
  (Histiocytosis_x, Absent) 0.01, 0.20, 0.79;
  (Infectious_mono, Absent) 0.15, 0.83, 0.02;
  (Leprosy_lepromatous, Absent) 0.599, 0.400, 0.001;
  (Lymphangiographic, Absent) 0.599, 0.400, 0.001;
  (Mantle_zone_hyperpla, Absent) 0.599, 0.400, 0.001;
  (Necrotizing_Kikuchi, Absent) 0.9799, 0.0200, 0.0001;
  (Necrotiz_non_Kikuchi, Absent) 0.05, 0.90, 0.05;
  (Rheumatoid_arthritis, Absent) 0.599, 0.400, 0.001;
  (Sarcoidosis, Absent) 0.599, 0.400, 0.001;
  (SHML, Absent) 0.599, 0.400, 0.001;
  (Sinus_histiocytosis, Absent) 0.599, 0.400, 0.001;
  (Syphilis, Absent) 0.15, 0.83, 0.02;
  (Toxoplasmosis, Absent) 0.599, 0.400, 0.001;
  (Tuberculosis, Absent) 0.599, 0.400, 0.001;
  (Viral_NOS, Absent) 0.15, 0.83, 0.02;
  (Whipple_s_disease, Absent) 0.599, 0.400, 0.001;
  (L_H_nodular_HD, Absent) 0.599, 0.400, 0.001;
  (L_H_diffuse_HD, Absent) 0.599, 0.400, 0.001;
  (Nodular_sclerosis_HD, Absent) 0.10, 0.75, 0.15;
  (Cellular_phase_NSHD, Absent) 0.10, 0.75, 0.15;
  (Syncytial_NSHD, Absent) 0.10, 0.75, 0.15;
  (Mixed_cellularity_HD, Absent) 0.10, 0.75, 0.15;
  (Interfollicular_HD, Absent) 0.10, 0.75, 0.15;
  (Diffuse_fibrosis_HD, Absent) 0.599, 0.400, 0.001;
  (Reticular_type_HD, Absent) 0.599, 0.400, 0.001;
  (Small_cleaved_fol, Absent) 0.599, 0.400, 0.001;
  (Mixed_fol, Absent) 0.599, 0.400, 0.001;
  (Large_cell_fol, Absent) 0.599, 0.400, 0.001;
  (Small_noncleaved_fol, Absent) 0.599, 0.400, 0.001;
  (Small_lymphocytic, Absent) 0.599, 0.400, 0.001;
  (Plasmacytoid_lyctic, Absent) 0.599, 0.400, 0.001;
  (Mantle_zone_lymphoma, Absent) 0.599, 0.400, 0.001;
  (Small_cleaved_dif, Absent) 0.599, 0.400, 0.001;
  (Mixed_FCC_dif, Absent) 0.599, 0.400, 0.001;
  (Large_cell_dif, Absent) 0.599, 0.400, 0.001;
  (B_immunoblastic, Absent) 0.599, 0.400, 0.001;
  (T_immunob_mixed, Absent) 0.35, 0.63, 0.02;
  (AILD_like_T_cell_lym, Absent) 0.20, 0.75, 0.05;
  (Japanese_ATL, Absent) 0.599, 0.400, 0.001;
  (Lymphoblastic, Absent) 0.599, 0.400, 0.001;
  (Small_noncleaved_dif, Absent) 0.599, 0.400, 0.001;
  (True_histiocytic, Absent) 0.599, 0.400, 0.001;
  (Ki_1_LC_anaplas_T, Absent) 0.599, 0.400, 0.001;
  (Multiple_myeloma, Absent) 0.599, 0.400, 0.001;
  (Mycosis_fungoides, Absent) 0.599, 0.400, 0.001;
  (AML, Absent) 0.94990501, 0.04999500, 0.00009999;
  (Hairy_cell_leukemia, Absent) 0.599, 0.400, 0.001;
  (Carcinoma, Absent) 0.599, 0.400, 0.001;
  (Melanoma, Absent) 0.599, 0.400, 0.001;
  (EM_plasmacytoma, Absent) 0.599, 0.400, 0.001;
  (Kaposi_s_sarcoma, Absent) 0.599, 0.400, 0.001;
  (Mast_cell_disease, Absent) 0.05, 0.90, 0.05;
  (AIDS_involutionary, Absent) 0.599, 0.400, 0.001;
  (T_immunob_large, Absent) 0.35, 0.63, 0.02;
  (Monocytoid_B_cell, Absent) 0.599, 0.400, 0.001;
  (Nasopharyngeal_CA, Absent) 0.10, 0.75, 0.15;
  (Seminoma, Absent) 0.599, 0.400, 0.001;
  (SLE, Absent) 0.15, 0.83, 0.02;
  (Mycobact_histiocytos, Absent) 0.599, 0.400, 0.001;
  (Mast_cell_hyperplas, Absent) 0.05, 0.90, 0.05;
  (LGV, Absent) 0.599, 0.400, 0.001;
  (Histoplasmosis, Absent) 0.599, 0.400, 0.001;
  (Coccidioidomycosis, Absent) 0.599, 0.400, 0.001;
  (CMV, Absent) 0.599, 0.400, 0.001;
  (Brucellosis, Absent) 0.599, 0.400, 0.001;
  (Ki_1_LC_anaplas_B, Absent) 0.599, 0.400, 0.001;
  (Intermed_lymphocytic, Absent) 0.599, 0.400, 0.001;
  (AIDS_early, Present) 0.3333333, 0.3333333, 0.3333333;
  (AILD, Present) 0.3333333, 0.3333333, 0.3333333;
  (ALIP, Present) 0.3333333, 0.3333333, 0.3333333;
  (Cat_scratch_disease, Present) 0.3333333, 0.3333333, 0.3333333;
  (Dermatopathic_laden, Present) 0.3333333, 0.3333333, 0.3333333;
  (Florid_follic_hyperp, Present) 0.3333333, 0.3333333, 0.3333333;
  (GLH_hyaline_vascular, Present) 0.3333333, 0.3333333, 0.3333333;
  (GLH_plasma_cell, Present) 0.3333333, 0.3333333, 0.3333333;
  (Granulomatous_laden, Present) 0.3333333, 0.3333333, 0.3333333;
  (Histiocytosis_x, Present) 0.3333333, 0.3333333, 0.3333333;
  (Infectious_mono, Present) 0.3333333, 0.3333333, 0.3333333;
  (Leprosy_lepromatous, Present) 0.3333333, 0.3333333, 0.3333333;
  (Lymphangiographic, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mantle_zone_hyperpla, Present) 0.3333333, 0.3333333, 0.3333333;
  (Necrotizing_Kikuchi, Present) 0.3333333, 0.3333333, 0.3333333;
  (Necrotiz_non_Kikuchi, Present) 0.3333333, 0.3333333, 0.3333333;
  (Rheumatoid_arthritis, Present) 0.3333333, 0.3333333, 0.3333333;
  (Sarcoidosis, Present) 0.3333333, 0.3333333, 0.3333333;
  (SHML, Present) 0.3333333, 0.3333333, 0.3333333;
  (Sinus_histiocytosis, Present) 0.3333333, 0.3333333, 0.3333333;
  (Syphilis, Present) 0.3333333, 0.3333333, 0.3333333;
  (Toxoplasmosis, Present) 0.3333333, 0.3333333, 0.3333333;
  (Tuberculosis, Present) 0.3333333, 0.3333333, 0.3333333;
  (Viral_NOS, Present) 0.3333333, 0.3333333, 0.3333333;
  (Whipple_s_disease, Present) 0.3333333, 0.3333333, 0.3333333;
  (L_H_nodular_HD, Present) 0.3333333, 0.3333333, 0.3333333;
  (L_H_diffuse_HD, Present) 0.3333333, 0.3333333, 0.3333333;
  (Nodular_sclerosis_HD, Present) 0.3333333, 0.3333333, 0.3333333;
  (Cellular_phase_NSHD, Present) 0.3333333, 0.3333333, 0.3333333;
  (Syncytial_NSHD, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mixed_cellularity_HD, Present) 0.3333333, 0.3333333, 0.3333333;
  (Interfollicular_HD, Present) 0.3333333, 0.3333333, 0.3333333;
  (Diffuse_fibrosis_HD, Present) 0.3333333, 0.3333333, 0.3333333;
  (Reticular_type_HD, Present) 0.3333333, 0.3333333, 0.3333333;
  (Small_cleaved_fol, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mixed_fol, Present) 0.3333333, 0.3333333, 0.3333333;
  (Large_cell_fol, Present) 0.3333333, 0.3333333, 0.3333333;
  (Small_noncleaved_fol, Present) 0.3333333, 0.3333333, 0.3333333;
  (Small_lymphocytic, Present) 0.3333333, 0.3333333, 0.3333333;
  (Plasmacytoid_lyctic, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mantle_zone_lymphoma, Present) 0.3333333, 0.3333333, 0.3333333;
  (Small_cleaved_dif, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mixed_FCC_dif, Present) 0.3333333, 0.3333333, 0.3333333;
  (Large_cell_dif, Present) 0.3333333, 0.3333333, 0.3333333;
  (B_immunoblastic, Present) 0.3333333, 0.3333333, 0.3333333;
  (T_immunob_mixed, Present) 0.3333333, 0.3333333, 0.3333333;
  (AILD_like_T_cell_lym, Present) 0.3333333, 0.3333333, 0.3333333;
  (Japanese_ATL, Present) 0.3333333, 0.3333333, 0.3333333;
  (Lymphoblastic, Present) 0.3333333, 0.3333333, 0.3333333;
  (Small_noncleaved_dif, Present) 0.3333333, 0.3333333, 0.3333333;
  (True_histiocytic, Present) 0.3333333, 0.3333333, 0.3333333;
  (Ki_1_LC_anaplas_T, Present) 0.3333333, 0.3333333, 0.3333333;
  (Multiple_myeloma, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mycosis_fungoides, Present) 0.3333333, 0.3333333, 0.3333333;
  (AML, Present) 0.01, 0.89, 0.10;
  (Hairy_cell_leukemia, Present) 0.3333333, 0.3333333, 0.3333333;
  (Carcinoma, Present) 0.3333333, 0.3333333, 0.3333333;
  (Melanoma, Present) 0.3333333, 0.3333333, 0.3333333;
  (EM_plasmacytoma, Present) 0.3333333, 0.3333333, 0.3333333;
  (Kaposi_s_sarcoma, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mast_cell_disease, Present) 0.3333333, 0.3333333, 0.3333333;
  (AIDS_involutionary, Present) 0.3333333, 0.3333333, 0.3333333;
  (T_immunob_large, Present) 0.3333333, 0.3333333, 0.3333333;
  (Monocytoid_B_cell, Present) 0.3333333, 0.3333333, 0.3333333;
  (Nasopharyngeal_CA, Present) 0.3333333, 0.3333333, 0.3333333;
  (Seminoma, Present) 0.3333333, 0.3333333, 0.3333333;
  (SLE, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mycobact_histiocytos, Present) 0.3333333, 0.3333333, 0.3333333;
  (Mast_cell_hyperplas, Present) 0.3333333, 0.3333333, 0.3333333;
  (LGV, Present) 0.3333333, 0.3333333, 0.3333333;
  (Histoplasmosis, Present) 0.3333333, 0.3333333, 0.3333333;
  (Coccidioidomycosis, Present) 0.3333333, 0.3333333, 0.3333333;
  (CMV, Present) 0.3333333, 0.3333333, 0.3333333;
  (Brucellosis, Present) 0.3333333, 0.3333333, 0.3333333;
  (Ki_1_LC_anaplas_B, Present) 0.3333333, 0.3333333, 0.3333333;
  (Intermed_lymphocytic, Present) 0.3333333, 0.3333333, 0.3333333;
}
probability ( EHC | Fault ) {
  (AIDS_early) 0.98, 0.02, 0.00;
  (AILD) 0.88, 0.10, 0.02;
  (ALIP) 0.98, 0.02, 0.00;
  (Cat_scratch_disease) 0.3, 0.6, 0.1;
  (Dermatopathic_laden) 0.79, 0.20, 0.01;
  (Florid_follic_hyperp) 0.98, 0.02, 0.00;
  (GLH_hyaline_vascular) 0.98, 0.02, 0.00;
  (GLH_plasma_cell) 0.98, 0.02, 0.00;
  (Granulomatous_laden) 0.0, 0.7, 0.3;
  (Histiocytosis_x) 0.98, 0.02, 0.00;
  (Infectious_mono) 0.25, 0.70, 0.05;
  (Leprosy_lepromatous) 0.02, 0.88, 0.10;
  (Lymphangiographic) 0.01, 0.79, 0.20;
  (Mantle_zone_hyperpla) 0.98, 0.02, 0.00;
  (Necrotizing_Kikuchi) 0.945, 0.050, 0.005;
  (Necrotiz_non_Kikuchi) 0.50, 0.45, 0.05;
  (Rheumatoid_arthritis) 0.98, 0.02, 0.00;
  (Sarcoidosis) 0.0, 0.0, 1.0;
  (SHML) 0.98, 0.02, 0.00;
  (Sinus_histiocytosis) 0.98, 0.02, 0.00;
  (Syphilis) 0.0, 0.7, 0.3;
  (Toxoplasmosis) 0.0, 0.6, 0.4;
  (Tuberculosis) 0.02, 0.88, 0.10;
  (Viral_NOS) 0.25, 0.70, 0.05;
  (Whipple_s_disease) 0.01, 0.79, 0.20;
  (L_H_nodular_HD) 0.25, 0.45, 0.30;
  (L_H_diffuse_HD) 0.25, 0.45, 0.30;
  (Nodular_sclerosis_HD) 0.950, 0.049, 0.001;
  (Cellular_phase_NSHD) 0.950, 0.049, 0.001;
  (Syncytial_NSHD) 0.950, 0.049, 0.001;
  (Mixed_cellularity_HD) 0.2, 0.3, 0.5;
  (Interfollicular_HD) 0.3, 0.6, 0.1;
  (Diffuse_fibrosis_HD) 0.98, 0.02, 0.00;
  (Reticular_type_HD) 0.98, 0.02, 0.00;
  (Small_cleaved_fol) 0.98, 0.02, 0.00;
  (Mixed_fol) 0.98, 0.02, 0.00;
  (Large_cell_fol) 0.98, 0.02, 0.00;
  (Small_noncleaved_fol) 0.98, 0.02, 0.00;
  (Small_lymphocytic) 0.98, 0.02, 0.00;
  (Plasmacytoid_lyctic) 0.98, 0.02, 0.00;
  (Mantle_zone_lymphoma) 0.98, 0.02, 0.00;
  (Small_cleaved_dif) 0.98, 0.02, 0.00;
  (Mixed_FCC_dif) 0.88, 0.10, 0.02;
  (Large_cell_dif) 0.975, 0.020, 0.005;
  (B_immunoblastic) 0.98, 0.02, 0.00;
  (T_immunob_mixed) 0.88, 0.10, 0.02;
  (AILD_like_T_cell_lym) 0.89, 0.10, 0.01;
  (Japanese_ATL) 0.91, 0.08, 0.01;
  (Lymphoblastic) 0.98, 0.02, 0.00;
  (Small_noncleaved_dif) 0.98, 0.02, 0.00;
  (True_histiocytic) 0.975, 0.020, 0.005;
  (Ki_1_LC_anaplas_T) 0.98, 0.02, 0.00;
  (Multiple_myeloma) 0.98, 0.02, 0.00;
  (Mycosis_fungoides) 0.91, 0.08, 0.01;
  (AML) 0.98, 0.02, 0.00;
  (Hairy_cell_leukemia) 0.98, 0.02, 0.00;
  (Carcinoma) 0.98, 0.02, 0.00;
  (Melanoma) 0.98, 0.02, 0.00;
  (EM_plasmacytoma) 0.98, 0.02, 0.00;
  (Kaposi_s_sarcoma) 0.98, 0.02, 0.00;
  (Mast_cell_disease) 0.3, 0.6, 0.1;
  (AIDS_involutionary) 0.3, 0.6, 0.1;
  (T_immunob_large) 0.91, 0.08, 0.01;
  (Monocytoid_B_cell) 0.975, 0.020, 0.005;
  (Nasopharyngeal_CA) 0.98, 0.02, 0.00;
  (Seminoma) 0.5, 0.2, 0.3;
  (SLE) 0.25, 0.70, 0.05;
  (Mycobact_histiocytos) 0.65, 0.34, 0.01;
  (Mast_cell_hyperplas) 0.3, 0.6, 0.1;
  (LGV) 0.65, 0.34, 0.01;
  (Histoplasmosis) 0.3, 0.6, 0.1;
  (Coccidioidomycosis) 0.3, 0.6, 0.1;
  (CMV) 0.3, 0.6, 0.1;
  (Brucellosis) 0.0, 0.6, 0.4;
  (Ki_1_LC_anaplas_B) 0.98, 0.02, 0.00;
  (Intermed_lymphocytic) 0.98, 0.02, 0.00;
}
probability ( EHC_ENC | Fault, FOLLICLE, EHC ) {
  (AIDS_early, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, 1_to_25pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, 25_to_75pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, 75_to_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, GT_90pc, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc, Present_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (ALIP, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Cat_scratch_disease, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Dermatopathic_laden, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (GLH_hyaline_vascular, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (GLH_plasma_cell, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Granulomatous_laden, 1_to_25pc, Present_LT_5pc) 0.00, 0.95, 0.05, 0.00;
  (Histiocytosis_x, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Infectious_mono, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Leprosy_lepromatous, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Necrotizing_Kikuchi, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Rheumatoid_arthritis, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Sarcoidosis, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Sinus_histiocytosis, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Syphilis, 1_to_25pc, Present_LT_5pc) 0.00, 0.95, 0.05, 0.00;
  (Toxoplasmosis, 1_to_25pc, Present_LT_5pc) 0.0, 0.0, 0.8, 0.2;
  (Tuberculosis, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Whipple_s_disease, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_diffuse_HD, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, 1_to_25pc, Present_LT_5pc) 0.00, 0.99, 0.01, 0.00;
  (Interfollicular_HD, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Reticular_type_HD, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_cleaved_fol, 1_to_25pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Mixed_fol, 1_to_25pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Large_cell_fol, 1_to_25pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, 1_to_25pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Small_lymphocytic, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Plasmacytoid_lyctic, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mantle_zone_lymphoma, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_cleaved_dif, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mixed_FCC_dif, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Large_cell_dif, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (B_immunoblastic, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (T_immunob_mixed, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (AILD_like_T_cell_lym, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Japanese_ATL, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Lymphoblastic, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_noncleaved_dif, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (True_histiocytic, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Multiple_myeloma, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mycosis_fungoides, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AML, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Hairy_cell_leukemia, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Carcinoma, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Melanoma, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (EM_plasmacytoma, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Kaposi_s_sarcoma, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mast_cell_disease, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Monocytoid_B_cell, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mycobact_histiocytos, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Histoplasmosis, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, 1_to_25pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, 1_to_25pc, Present_LT_5pc) 0.0, 0.0, 0.8, 0.2;
  (Ki_1_LC_anaplas_B, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Intermed_lymphocytic, 1_to_25pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (AIDS_early, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (ALIP, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Cat_scratch_disease, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Dermatopathic_laden, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (GLH_hyaline_vascular, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (GLH_plasma_cell, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Granulomatous_laden, 25_to_75pc, Present_LT_5pc) 0.00, 0.95, 0.05, 0.00;
  (Histiocytosis_x, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Infectious_mono, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Leprosy_lepromatous, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Necrotizing_Kikuchi, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Rheumatoid_arthritis, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Sarcoidosis, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Sinus_histiocytosis, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Syphilis, 25_to_75pc, Present_LT_5pc) 0.00, 0.95, 0.05, 0.00;
  (Toxoplasmosis, 25_to_75pc, Present_LT_5pc) 0.0, 0.0, 0.8, 0.2;
  (Tuberculosis, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Whipple_s_disease, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_diffuse_HD, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, 25_to_75pc, Present_LT_5pc) 0.00, 0.99, 0.01, 0.00;
  (Interfollicular_HD, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Reticular_type_HD, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_cleaved_fol, 25_to_75pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Mixed_fol, 25_to_75pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Large_cell_fol, 25_to_75pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, 25_to_75pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Small_lymphocytic, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Plasmacytoid_lyctic, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mantle_zone_lymphoma, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_cleaved_dif, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mixed_FCC_dif, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Large_cell_dif, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (B_immunoblastic, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (T_immunob_mixed, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (AILD_like_T_cell_lym, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Japanese_ATL, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Lymphoblastic, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_noncleaved_dif, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (True_histiocytic, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Multiple_myeloma, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mycosis_fungoides, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AML, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Hairy_cell_leukemia, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Carcinoma, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Melanoma, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (EM_plasmacytoma, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Kaposi_s_sarcoma, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mast_cell_disease, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Monocytoid_B_cell, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mycobact_histiocytos, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Histoplasmosis, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, 25_to_75pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, 25_to_75pc, Present_LT_5pc) 0.0, 0.0, 0.8, 0.2;
  (Ki_1_LC_anaplas_B, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Intermed_lymphocytic, 25_to_75pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (AIDS_early, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (ALIP, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Cat_scratch_disease, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Dermatopathic_laden, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (GLH_hyaline_vascular, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (GLH_plasma_cell, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Granulomatous_laden, 75_to_90pc, Present_LT_5pc) 0.00, 0.95, 0.05, 0.00;
  (Histiocytosis_x, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Infectious_mono, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Leprosy_lepromatous, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Necrotizing_Kikuchi, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Rheumatoid_arthritis, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Sarcoidosis, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Sinus_histiocytosis, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Syphilis, 75_to_90pc, Present_LT_5pc) 0.00, 0.95, 0.05, 0.00;
  (Toxoplasmosis, 75_to_90pc, Present_LT_5pc) 0.0, 0.0, 0.8, 0.2;
  (Tuberculosis, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Whipple_s_disease, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_diffuse_HD, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, 75_to_90pc, Present_LT_5pc) 0.00, 0.99, 0.01, 0.00;
  (Interfollicular_HD, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Reticular_type_HD, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_cleaved_fol, 75_to_90pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Mixed_fol, 75_to_90pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Large_cell_fol, 75_to_90pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, 75_to_90pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Small_lymphocytic, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Plasmacytoid_lyctic, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mantle_zone_lymphoma, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_cleaved_dif, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mixed_FCC_dif, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Large_cell_dif, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (B_immunoblastic, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (T_immunob_mixed, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (AILD_like_T_cell_lym, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Japanese_ATL, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Lymphoblastic, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_noncleaved_dif, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (True_histiocytic, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Multiple_myeloma, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mycosis_fungoides, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AML, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Hairy_cell_leukemia, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Carcinoma, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Melanoma, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (EM_plasmacytoma, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Kaposi_s_sarcoma, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mast_cell_disease, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Monocytoid_B_cell, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mycobact_histiocytos, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Histoplasmosis, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, 75_to_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, 75_to_90pc, Present_LT_5pc) 0.0, 0.0, 0.8, 0.2;
  (Ki_1_LC_anaplas_B, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Intermed_lymphocytic, 75_to_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (AIDS_early, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (ALIP, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Cat_scratch_disease, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Dermatopathic_laden, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (GLH_hyaline_vascular, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (GLH_plasma_cell, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Granulomatous_laden, GT_90pc, Present_LT_5pc) 0.00, 0.95, 0.05, 0.00;
  (Histiocytosis_x, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Infectious_mono, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Leprosy_lepromatous, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Necrotizing_Kikuchi, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Rheumatoid_arthritis, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Sarcoidosis, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Sinus_histiocytosis, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Syphilis, GT_90pc, Present_LT_5pc) 0.00, 0.95, 0.05, 0.00;
  (Toxoplasmosis, GT_90pc, Present_LT_5pc) 0.0, 0.0, 0.8, 0.2;
  (Tuberculosis, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Whipple_s_disease, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_diffuse_HD, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, GT_90pc, Present_LT_5pc) 0.00, 0.99, 0.01, 0.00;
  (Interfollicular_HD, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Reticular_type_HD, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_cleaved_fol, GT_90pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Mixed_fol, GT_90pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Large_cell_fol, GT_90pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, GT_90pc, Present_LT_5pc) 0.0, 1.0, 0.0, 0.0;
  (Small_lymphocytic, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Plasmacytoid_lyctic, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mantle_zone_lymphoma, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_cleaved_dif, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mixed_FCC_dif, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Large_cell_dif, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (B_immunoblastic, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (T_immunob_mixed, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (AILD_like_T_cell_lym, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Japanese_ATL, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Lymphoblastic, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Small_noncleaved_dif, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (True_histiocytic, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Multiple_myeloma, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mycosis_fungoides, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AML, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Hairy_cell_leukemia, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Carcinoma, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Melanoma, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (EM_plasmacytoma, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Kaposi_s_sarcoma, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Mast_cell_disease, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Monocytoid_B_cell, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mycobact_histiocytos, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Histoplasmosis, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, GT_90pc, Present_LT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, GT_90pc, Present_LT_5pc) 0.0, 0.0, 0.8, 0.2;
  (Ki_1_LC_anaplas_B, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (Intermed_lymphocytic, GT_90pc, Present_LT_5pc) 0.0000, 0.9999, 0.0001, 0.0000;
  (AIDS_early, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (ALIP, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Dermatopathic_laden, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.849, 0.150, 0.001;
  (Histiocytosis_x, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Leprosy_lepromatous, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Rheumatoid_arthritis, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.849, 0.150, 0.001;
  (Toxoplasmosis, 1_to_25pc, Prominent_GT_5pc) 0.0, 0.0, 0.4, 0.6;
  (Tuberculosis, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Whipple_s_disease, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (L_H_diffuse_HD, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Nodular_sclerosis_HD, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, 1_to_25pc, Prominent_GT_5pc) 0.00, 0.98, 0.02, 0.00;
  (Interfollicular_HD, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD_like_T_cell_lym, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Japanese_ATL, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AML, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Mycobact_histiocytos, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Histoplasmosis, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, 1_to_25pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, 1_to_25pc, Prominent_GT_5pc) 0.0, 0.0, 0.4, 0.6;
  (Ki_1_LC_anaplas_B, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, 1_to_25pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (ALIP, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Dermatopathic_laden, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.849, 0.150, 0.001;
  (Histiocytosis_x, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Leprosy_lepromatous, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Rheumatoid_arthritis, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.849, 0.150, 0.001;
  (Toxoplasmosis, 25_to_75pc, Prominent_GT_5pc) 0.0, 0.0, 0.4, 0.6;
  (Tuberculosis, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Whipple_s_disease, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (L_H_diffuse_HD, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Nodular_sclerosis_HD, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, 25_to_75pc, Prominent_GT_5pc) 0.00, 0.98, 0.02, 0.00;
  (Interfollicular_HD, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD_like_T_cell_lym, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Japanese_ATL, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AML, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Mycobact_histiocytos, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Histoplasmosis, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, 25_to_75pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, 25_to_75pc, Prominent_GT_5pc) 0.0, 0.0, 0.4, 0.6;
  (Ki_1_LC_anaplas_B, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, 25_to_75pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (ALIP, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Dermatopathic_laden, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.849, 0.150, 0.001;
  (Histiocytosis_x, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Leprosy_lepromatous, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Rheumatoid_arthritis, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.849, 0.150, 0.001;
  (Toxoplasmosis, 75_to_90pc, Prominent_GT_5pc) 0.0, 0.0, 0.4, 0.6;
  (Tuberculosis, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Whipple_s_disease, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (L_H_diffuse_HD, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Nodular_sclerosis_HD, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, 75_to_90pc, Prominent_GT_5pc) 0.00, 0.98, 0.02, 0.00;
  (Interfollicular_HD, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD_like_T_cell_lym, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Japanese_ATL, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AML, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Mycobact_histiocytos, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Histoplasmosis, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, 75_to_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, 75_to_90pc, Prominent_GT_5pc) 0.0, 0.0, 0.4, 0.6;
  (Ki_1_LC_anaplas_B, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, 75_to_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (ALIP, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, GT_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Dermatopathic_laden, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, GT_90pc, Prominent_GT_5pc) 0.000, 0.849, 0.150, 0.001;
  (Histiocytosis_x, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, GT_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Leprosy_lepromatous, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, GT_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Rheumatoid_arthritis, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, GT_90pc, Prominent_GT_5pc) 0.000, 0.849, 0.150, 0.001;
  (Toxoplasmosis, GT_90pc, Prominent_GT_5pc) 0.0, 0.0, 0.4, 0.6;
  (Tuberculosis, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, GT_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Whipple_s_disease, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, GT_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (L_H_diffuse_HD, GT_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Nodular_sclerosis_HD, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, GT_90pc, Prominent_GT_5pc) 0.00, 0.98, 0.02, 0.00;
  (Interfollicular_HD, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AILD_like_T_cell_lym, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Japanese_ATL, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AML, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, GT_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Mycobact_histiocytos, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, GT_90pc, Prominent_GT_5pc) 0.000, 0.995, 0.005, 0.000;
  (Histoplasmosis, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, GT_90pc, Prominent_GT_5pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, GT_90pc, Prominent_GT_5pc) 0.0, 0.0, 0.4, 0.6;
  (Ki_1_LC_anaplas_B, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, GT_90pc, Prominent_GT_5pc) 1.0, 0.0, 0.0, 0.0;
}
probability ( EH_NC | Fault ) {
  (AIDS_early) 0.9, 0.1, 0.0;
  (AILD) 0.80, 0.15, 0.05;
  (ALIP) 0.8999, 0.1000, 0.0001;
  (Cat_scratch_disease) 0.1, 0.8, 0.1;
  (Dermatopathic_laden) 0.05, 0.80, 0.15;
  (Florid_follic_hyperp) 0.8999, 0.1000, 0.0001;
  (GLH_hyaline_vascular) 0.8999, 0.1000, 0.0001;
  (GLH_plasma_cell) 0.8999, 0.1000, 0.0001;
  (Granulomatous_laden) 0.1, 0.8, 0.1;
  (Histiocytosis_x) 0.8999, 0.1000, 0.0001;
  (Infectious_mono) 0.899, 0.100, 0.001;
  (Leprosy_lepromatous) 0.05, 0.85, 0.10;
  (Lymphangiographic) 0.01, 0.80, 0.19;
  (Mantle_zone_hyperpla) 0.8999, 0.1000, 0.0001;
  (Necrotizing_Kikuchi) 0.89, 0.10, 0.01;
  (Necrotiz_non_Kikuchi) 0.05, 0.90, 0.05;
  (Rheumatoid_arthritis) 0.8999, 0.1000, 0.0001;
  (Sarcoidosis) 0.8999, 0.1000, 0.0001;
  (SHML) 0.8999, 0.1000, 0.0001;
  (Sinus_histiocytosis) 0.8999, 0.1000, 0.0001;
  (Syphilis) 0.1, 0.8, 0.1;
  (Toxoplasmosis) 0.899, 0.100, 0.001;
  (Tuberculosis) 0.05, 0.85, 0.10;
  (Viral_NOS) 0.899, 0.100, 0.001;
  (Whipple_s_disease) 0.01, 0.80, 0.19;
  (L_H_nodular_HD) 0.02, 0.70, 0.28;
  (L_H_diffuse_HD) 0.02, 0.70, 0.28;
  (Nodular_sclerosis_HD) 0.799, 0.200, 0.001;
  (Cellular_phase_NSHD) 0.799, 0.200, 0.001;
  (Syncytial_NSHD) 0.799, 0.200, 0.001;
  (Mixed_cellularity_HD) 0.30, 0.69, 0.01;
  (Interfollicular_HD) 0.20, 0.79, 0.01;
  (Diffuse_fibrosis_HD) 0.8999, 0.1000, 0.0001;
  (Reticular_type_HD) 0.8999, 0.1000, 0.0001;
  (Small_cleaved_fol) 0.8999, 0.1000, 0.0001;
  (Mixed_fol) 0.8999, 0.1000, 0.0001;
  (Large_cell_fol) 0.8999, 0.1000, 0.0001;
  (Small_noncleaved_fol) 0.8999, 0.1000, 0.0001;
  (Small_lymphocytic) 0.949, 0.050, 0.001;
  (Plasmacytoid_lyctic) 0.949, 0.050, 0.001;
  (Mantle_zone_lymphoma) 0.8999, 0.1000, 0.0001;
  (Small_cleaved_dif) 0.949, 0.050, 0.001;
  (Mixed_FCC_dif) 0.75, 0.20, 0.05;
  (Large_cell_dif) 0.949, 0.050, 0.001;
  (B_immunoblastic) 0.949, 0.050, 0.001;
  (T_immunob_mixed) 0.5, 0.4, 0.1;
  (AILD_like_T_cell_lym) 0.80, 0.15, 0.05;
  (Japanese_ATL) 0.949, 0.050, 0.001;
  (Lymphoblastic) 0.949, 0.050, 0.001;
  (Small_noncleaved_dif) 0.949, 0.050, 0.001;
  (True_histiocytic) 0.949, 0.050, 0.001;
  (Ki_1_LC_anaplas_T) 0.949, 0.050, 0.001;
  (Multiple_myeloma) 0.8999, 0.1000, 0.0001;
  (Mycosis_fungoides) 0.05, 0.80, 0.15;
  (AML) 0.8999, 0.1000, 0.0001;
  (Hairy_cell_leukemia) 0.8999, 0.1000, 0.0001;
  (Carcinoma) 0.8999, 0.1000, 0.0001;
  (Melanoma) 0.8999, 0.1000, 0.0001;
  (EM_plasmacytoma) 0.8999, 0.1000, 0.0001;
  (Kaposi_s_sarcoma) 0.30, 0.69, 0.01;
  (Mast_cell_disease) 0.20, 0.79, 0.01;
  (AIDS_involutionary) 0.10, 0.88, 0.02;
  (T_immunob_large) 0.68, 0.30, 0.02;
  (Monocytoid_B_cell) 0.87, 0.10, 0.03;
  (Nasopharyngeal_CA) 0.8999, 0.1000, 0.0001;
  (Seminoma) 0.79, 0.20, 0.01;
  (SLE) 0.899, 0.100, 0.001;
  (Mycobact_histiocytos) 0.01, 0.79, 0.20;
  (Mast_cell_hyperplas) 0.20, 0.79, 0.01;
  (LGV) 0.1, 0.8, 0.1;
  (Histoplasmosis) 0.1, 0.8, 0.1;
  (Coccidioidomycosis) 0.1, 0.8, 0.1;
  (CMV) 0.1, 0.8, 0.1;
  (Brucellosis) 0.899, 0.100, 0.001;
  (Ki_1_LC_anaplas_B) 0.949, 0.050, 0.001;
  (Intermed_lymphocytic) 0.8999, 0.1000, 0.0001;
}
probability ( ECCC | Fault, LLC_I, MLC_I ) {
  (AIDS_early, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (Leprosy_lepromatous, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (Mycobact_histiocytos, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_no, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Absent_no, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (AILD, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Dermatopathic_laden, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Leprosy_lepromatous, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Necrotiz_non_Kikuchi, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Rheumatoid_arthritis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (SHML, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Whipple_s_disease, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Cellular_phase_NSHD, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Syncytial_NSHD, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Mixed_cellularity_HD, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Present_yes, Absent_no) 0.98, 0.02, 0.00, 0.00;
  (B_immunoblastic, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Present_yes, Absent_no) 0.96, 0.02, 0.01, 0.01;
  (AILD_like_T_cell_lym, Present_yes, Absent_no) 0.00, 0.05, 0.50, 0.45;
  (Japanese_ATL, Present_yes, Absent_no) 0.97, 0.02, 0.01, 0.00;
  (Lymphoblastic, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Present_yes, Absent_no) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, Present_yes, Absent_no) 0.97, 0.02, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (AML, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Melanoma, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Present_yes, Absent_no) 0.96, 0.02, 0.01, 0.01;
  (Monocytoid_B_cell, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Seminoma, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (SLE, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Mycobact_histiocytos, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (LGV, Present_yes, Absent_no) 0.999, 0.001, 0.000, 0.000;
  (Histoplasmosis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (CMV, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Present_yes, Absent_no) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (Leprosy_lepromatous, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Absent_no, Present_yes) 0.98, 0.01, 0.01, 0.00;
  (Lymphoblastic, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_no, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (Carcinoma, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_no, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (AIDS_involutionary, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, Absent_no, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (Nasopharyngeal_CA, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (Mycobact_histiocytos, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_no, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (LGV, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_no, Present_yes) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Absent_no, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (AILD, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Present_yes, Present_yes) 0.995, 0.005, 0.000, 0.000;
  (Dermatopathic_laden, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Present_yes, Present_yes) 0.995, 0.005, 0.000, 0.000;
  (Leprosy_lepromatous, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Present_yes, Present_yes) 0.995, 0.005, 0.000, 0.000;
  (Necrotiz_non_Kikuchi, Present_yes, Present_yes) 0.995, 0.005, 0.000, 0.000;
  (Rheumatoid_arthritis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (SHML, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Present_yes, Present_yes) 0.995, 0.005, 0.000, 0.000;
  (Whipple_s_disease, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Present_yes, Present_yes) 0.9995, 0.0005, 0.0000, 0.0000;
  (Cellular_phase_NSHD, Present_yes, Present_yes) 0.9995, 0.0005, 0.0000, 0.0000;
  (Syncytial_NSHD, Present_yes, Present_yes) 0.9995, 0.0005, 0.0000, 0.0000;
  (Mixed_cellularity_HD, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Present_yes, Present_yes) 0.98, 0.02, 0.00, 0.00;
  (B_immunoblastic, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Present_yes, Present_yes) 0.96, 0.02, 0.01, 0.01;
  (AILD_like_T_cell_lym, Present_yes, Present_yes) 0.00, 0.05, 0.45, 0.50;
  (Japanese_ATL, Present_yes, Present_yes) 0.98, 0.01, 0.01, 0.00;
  (Lymphoblastic, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Present_yes, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (AML, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Present_yes, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (Carcinoma, Present_yes, Present_yes) 0.998, 0.001, 0.001, 0.000;
  (Melanoma, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Present_yes, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (AIDS_involutionary, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Present_yes, Present_yes) 0.94, 0.04, 0.01, 0.01;
  (Monocytoid_B_cell, Present_yes, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (Nasopharyngeal_CA, Present_yes, Present_yes) 0.998, 0.001, 0.001, 0.000;
  (Seminoma, Present_yes, Present_yes) 0.998, 0.001, 0.001, 0.000;
  (SLE, Present_yes, Present_yes) 0.995, 0.005, 0.000, 0.000;
  (Mycobact_histiocytos, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Present_yes, Present_yes) 0.97, 0.02, 0.01, 0.00;
  (LGV, Present_yes, Present_yes) 0.995, 0.005, 0.000, 0.000;
  (Histoplasmosis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (CMV, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Present_yes, Present_yes) 1.0, 0.0, 0.0, 0.0;
}
probability ( FCB | Fault, CT ) {
  (AIDS_early, Absent) 0.94, 0.05, 0.01;
  (AILD, Absent) 0.80, 0.15, 0.05;
  (ALIP, Absent) 0.94, 0.05, 0.01;
  (Cat_scratch_disease, Absent) 0.94, 0.05, 0.01;
  (Dermatopathic_laden, Absent) 0.94, 0.05, 0.01;
  (Florid_follic_hyperp, Absent) 0.94, 0.05, 0.01;
  (GLH_hyaline_vascular, Absent) 0.01, 0.64, 0.35;
  (GLH_plasma_cell, Absent) 0.94, 0.05, 0.01;
  (Granulomatous_laden, Absent) 0.78, 0.15, 0.07;
  (Histiocytosis_x, Absent) 0.94, 0.05, 0.01;
  (Infectious_mono, Absent) 0.94, 0.05, 0.01;
  (Leprosy_lepromatous, Absent) 0.94, 0.05, 0.01;
  (Lymphangiographic, Absent) 0.94, 0.05, 0.01;
  (Mantle_zone_hyperpla, Absent) 0.94, 0.05, 0.01;
  (Necrotizing_Kikuchi, Absent) 0.94, 0.05, 0.01;
  (Necrotiz_non_Kikuchi, Absent) 0.94, 0.05, 0.01;
  (Rheumatoid_arthritis, Absent) 0.78, 0.15, 0.07;
  (Sarcoidosis, Absent) 0.84, 0.15, 0.01;
  (SHML, Absent) 0.01, 0.94, 0.05;
  (Sinus_histiocytosis, Absent) 0.94, 0.05, 0.01;
  (Syphilis, Absent) 0.78, 0.15, 0.07;
  (Toxoplasmosis, Absent) 0.94, 0.05, 0.01;
  (Tuberculosis, Absent) 0.78, 0.15, 0.07;
  (Viral_NOS, Absent) 0.94, 0.05, 0.01;
  (Whipple_s_disease, Absent) 0.94, 0.05, 0.01;
  (L_H_nodular_HD, Absent) 0.94, 0.05, 0.01;
  (L_H_diffuse_HD, Absent) 0.94, 0.05, 0.01;
  (Nodular_sclerosis_HD, Absent) 0.0, 0.8, 0.2;
  (Cellular_phase_NSHD, Absent) 0.949, 0.050, 0.001;
  (Syncytial_NSHD, Absent) 0.00, 0.96, 0.04;
  (Mixed_cellularity_HD, Absent) 0.97, 0.02, 0.01;
  (Interfollicular_HD, Absent) 0.94, 0.05, 0.01;
  (Diffuse_fibrosis_HD, Absent) 0.1, 0.7, 0.2;
  (Reticular_type_HD, Absent) 0.94, 0.05, 0.01;
  (Small_cleaved_fol, Absent) 0.94, 0.05, 0.01;
  (Mixed_fol, Absent) 0.94, 0.05, 0.01;
  (Large_cell_fol, Absent) 0.94, 0.05, 0.01;
  (Small_noncleaved_fol, Absent) 0.94, 0.05, 0.01;
  (Small_lymphocytic, Absent) 0.94, 0.05, 0.01;
  (Plasmacytoid_lyctic, Absent) 0.94, 0.05, 0.01;
  (Mantle_zone_lymphoma, Absent) 0.94, 0.05, 0.01;
  (Small_cleaved_dif, Absent) 0.80, 0.15, 0.05;
  (Mixed_FCC_dif, Absent) 0.80, 0.15, 0.05;
  (Large_cell_dif, Absent) 0.80, 0.15, 0.05;
  (B_immunoblastic, Absent) 0.94, 0.05, 0.01;
  (T_immunob_mixed, Absent) 0.55, 0.40, 0.05;
  (AILD_like_T_cell_lym, Absent) 0.80, 0.15, 0.05;
  (Japanese_ATL, Absent) 0.94, 0.05, 0.01;
  (Lymphoblastic, Absent) 0.94, 0.05, 0.01;
  (Small_noncleaved_dif, Absent) 0.94, 0.05, 0.01;
  (True_histiocytic, Absent) 0.94, 0.05, 0.01;
  (Ki_1_LC_anaplas_T, Absent) 0.94, 0.05, 0.01;
  (Multiple_myeloma, Absent) 0.94, 0.05, 0.01;
  (Mycosis_fungoides, Absent) 0.94, 0.05, 0.01;
  (AML, Absent) 0.94, 0.05, 0.01;
  (Hairy_cell_leukemia, Absent) 0.94, 0.05, 0.01;
  (Carcinoma, Absent) 0.94, 0.05, 0.01;
  (Melanoma, Absent) 0.94, 0.05, 0.01;
  (EM_plasmacytoma, Absent) 0.94, 0.05, 0.01;
  (Kaposi_s_sarcoma, Absent) 0.94, 0.05, 0.01;
  (Mast_cell_disease, Absent) 0.1, 0.8, 0.1;
  (AIDS_involutionary, Absent) 0.94, 0.05, 0.01;
  (T_immunob_large, Absent) 0.80, 0.15, 0.05;
  (Monocytoid_B_cell, Absent) 0.94, 0.05, 0.01;
  (Nasopharyngeal_CA, Absent) 0.0, 0.8, 0.2;
  (Seminoma, Absent) 0.94, 0.05, 0.01;
  (SLE, Absent) 0.94, 0.05, 0.01;
  (Mycobact_histiocytos, Absent) 0.94, 0.05, 0.01;
  (Mast_cell_hyperplas, Absent) 0.94, 0.05, 0.01;
  (LGV, Absent) 0.94, 0.05, 0.01;
  (Histoplasmosis, Absent) 0.94, 0.05, 0.01;
  (Coccidioidomycosis, Absent) 0.94, 0.05, 0.01;
  (CMV, Absent) 0.94, 0.05, 0.01;
  (Brucellosis, Absent) 0.94, 0.05, 0.01;
  (Ki_1_LC_anaplas_B, Absent) 0.94, 0.05, 0.01;
  (Intermed_lymphocytic, Absent) 0.94, 0.05, 0.01;
  (AIDS_early, Slight_LT_10) 0.94, 0.05, 0.01;
  (AILD, Slight_LT_10) 0.80, 0.15, 0.05;
  (ALIP, Slight_LT_10) 0.94, 0.05, 0.01;
  (Cat_scratch_disease, Slight_LT_10) 0.94, 0.05, 0.01;
  (Dermatopathic_laden, Slight_LT_10) 0.94, 0.05, 0.01;
  (Florid_follic_hyperp, Slight_LT_10) 0.94, 0.05, 0.01;
  (GLH_hyaline_vascular, Slight_LT_10) 0.01, 0.64, 0.35;
  (GLH_plasma_cell, Slight_LT_10) 0.94, 0.05, 0.01;
  (Granulomatous_laden, Slight_LT_10) 0.78, 0.15, 0.07;
  (Histiocytosis_x, Slight_LT_10) 0.94, 0.05, 0.01;
  (Infectious_mono, Slight_LT_10) 0.94, 0.05, 0.01;
  (Leprosy_lepromatous, Slight_LT_10) 0.94, 0.05, 0.01;
  (Lymphangiographic, Slight_LT_10) 0.94, 0.05, 0.01;
  (Mantle_zone_hyperpla, Slight_LT_10) 0.94, 0.05, 0.01;
  (Necrotizing_Kikuchi, Slight_LT_10) 0.94, 0.05, 0.01;
  (Necrotiz_non_Kikuchi, Slight_LT_10) 0.94, 0.05, 0.01;
  (Rheumatoid_arthritis, Slight_LT_10) 0.78, 0.15, 0.07;
  (Sarcoidosis, Slight_LT_10) 0.84, 0.15, 0.01;
  (SHML, Slight_LT_10) 0.01, 0.89, 0.10;
  (Sinus_histiocytosis, Slight_LT_10) 0.94, 0.05, 0.01;
  (Syphilis, Slight_LT_10) 0.78, 0.15, 0.07;
  (Toxoplasmosis, Slight_LT_10) 0.94, 0.05, 0.01;
  (Tuberculosis, Slight_LT_10) 0.78, 0.15, 0.07;
  (Viral_NOS, Slight_LT_10) 0.94, 0.05, 0.01;
  (Whipple_s_disease, Slight_LT_10) 0.94, 0.05, 0.01;
  (L_H_nodular_HD, Slight_LT_10) 0.94, 0.05, 0.01;
  (L_H_diffuse_HD, Slight_LT_10) 0.94, 0.05, 0.01;
  (Nodular_sclerosis_HD, Slight_LT_10) 0.0, 0.7, 0.3;
  (Cellular_phase_NSHD, Slight_LT_10) 0.95, 0.05, 0.00;
  (Syncytial_NSHD, Slight_LT_10) 0.00, 0.85, 0.15;
  (Mixed_cellularity_HD, Slight_LT_10) 0.975, 0.020, 0.005;
  (Interfollicular_HD, Slight_LT_10) 0.94, 0.05, 0.01;
  (Diffuse_fibrosis_HD, Slight_LT_10) 0.1, 0.7, 0.2;
  (Reticular_type_HD, Slight_LT_10) 0.94, 0.05, 0.01;
  (Small_cleaved_fol, Slight_LT_10) 0.94, 0.05, 0.01;
  (Mixed_fol, Slight_LT_10) 0.94, 0.05, 0.01;
  (Large_cell_fol, Slight_LT_10) 0.94, 0.05, 0.01;
  (Small_noncleaved_fol, Slight_LT_10) 0.94, 0.05, 0.01;
  (Small_lymphocytic, Slight_LT_10) 0.94, 0.05, 0.01;
  (Plasmacytoid_lyctic, Slight_LT_10) 0.94, 0.05, 0.01;
  (Mantle_zone_lymphoma, Slight_LT_10) 0.94, 0.05, 0.01;
  (Small_cleaved_dif, Slight_LT_10) 0.80, 0.15, 0.05;
  (Mixed_FCC_dif, Slight_LT_10) 0.80, 0.15, 0.05;
  (Large_cell_dif, Slight_LT_10) 0.80, 0.15, 0.05;
  (B_immunoblastic, Slight_LT_10) 0.94, 0.05, 0.01;
  (T_immunob_mixed, Slight_LT_10) 0.55, 0.40, 0.05;
  (AILD_like_T_cell_lym, Slight_LT_10) 0.80, 0.15, 0.05;
  (Japanese_ATL, Slight_LT_10) 0.94, 0.05, 0.01;
  (Lymphoblastic, Slight_LT_10) 0.94, 0.05, 0.01;
  (Small_noncleaved_dif, Slight_LT_10) 0.94, 0.05, 0.01;
  (True_histiocytic, Slight_LT_10) 0.94, 0.05, 0.01;
  (Ki_1_LC_anaplas_T, Slight_LT_10) 0.94, 0.05, 0.01;
  (Multiple_myeloma, Slight_LT_10) 0.94, 0.05, 0.01;
  (Mycosis_fungoides, Slight_LT_10) 0.94, 0.05, 0.01;
  (AML, Slight_LT_10) 0.94, 0.05, 0.01;
  (Hairy_cell_leukemia, Slight_LT_10) 0.94, 0.05, 0.01;
  (Carcinoma, Slight_LT_10) 0.94, 0.05, 0.01;
  (Melanoma, Slight_LT_10) 0.94, 0.05, 0.01;
  (EM_plasmacytoma, Slight_LT_10) 0.94, 0.05, 0.01;
  (Kaposi_s_sarcoma, Slight_LT_10) 0.94, 0.05, 0.01;
  (Mast_cell_disease, Slight_LT_10) 0.1, 0.8, 0.1;
  (AIDS_involutionary, Slight_LT_10) 0.94, 0.05, 0.01;
  (T_immunob_large, Slight_LT_10) 0.80, 0.15, 0.05;
  (Monocytoid_B_cell, Slight_LT_10) 0.94, 0.05, 0.01;
  (Nasopharyngeal_CA, Slight_LT_10) 0.0, 0.7, 0.3;
  (Seminoma, Slight_LT_10) 0.94, 0.05, 0.01;
  (SLE, Slight_LT_10) 0.94, 0.05, 0.01;
  (Mycobact_histiocytos, Slight_LT_10) 0.94, 0.05, 0.01;
  (Mast_cell_hyperplas, Slight_LT_10) 0.94, 0.05, 0.01;
  (LGV, Slight_LT_10) 0.94, 0.05, 0.01;
  (Histoplasmosis, Slight_LT_10) 0.94, 0.05, 0.01;
  (Coccidioidomycosis, Slight_LT_10) 0.94, 0.05, 0.01;
  (CMV, Slight_LT_10) 0.94, 0.05, 0.01;
  (Brucellosis, Slight_LT_10) 0.94, 0.05, 0.01;
  (Ki_1_LC_anaplas_B, Slight_LT_10) 0.94, 0.05, 0.01;
  (Intermed_lymphocytic, Slight_LT_10) 0.94, 0.05, 0.01;
  (AIDS_early, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (AILD, Moderate_10_to_20) 0.80, 0.15, 0.05;
  (ALIP, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Cat_scratch_disease, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Dermatopathic_laden, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Florid_follic_hyperp, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (GLH_hyaline_vascular, Moderate_10_to_20) 0.01, 0.64, 0.35;
  (GLH_plasma_cell, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Granulomatous_laden, Moderate_10_to_20) 0.40, 0.45, 0.15;
  (Histiocytosis_x, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Infectious_mono, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Leprosy_lepromatous, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Lymphangiographic, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Mantle_zone_hyperpla, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Necrotizing_Kikuchi, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Necrotiz_non_Kikuchi, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Rheumatoid_arthritis, Moderate_10_to_20) 0.40, 0.45, 0.15;
  (Sarcoidosis, Moderate_10_to_20) 0.80, 0.18, 0.02;
  (SHML, Moderate_10_to_20) 0.01, 0.94, 0.05;
  (Sinus_histiocytosis, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Syphilis, Moderate_10_to_20) 0.40, 0.45, 0.15;
  (Toxoplasmosis, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Tuberculosis, Moderate_10_to_20) 0.40, 0.45, 0.15;
  (Viral_NOS, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Whipple_s_disease, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (L_H_nodular_HD, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (L_H_diffuse_HD, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Nodular_sclerosis_HD, Moderate_10_to_20) 0.0, 0.8, 0.2;
  (Cellular_phase_NSHD, Moderate_10_to_20) 0.95, 0.05, 0.00;
  (Syncytial_NSHD, Moderate_10_to_20) 0.00, 0.94, 0.06;
  (Mixed_cellularity_HD, Moderate_10_to_20) 0.94, 0.05, 0.01;
  (Interfollicular_HD, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Diffuse_fibrosis_HD, Moderate_10_to_20) 0.1, 0.7, 0.2;
  (Reticular_type_HD, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Small_cleaved_fol, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Mixed_fol, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Large_cell_fol, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Small_noncleaved_fol, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Small_lymphocytic, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Plasmacytoid_lyctic, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Mantle_zone_lymphoma, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Small_cleaved_dif, Moderate_10_to_20) 0.80, 0.15, 0.05;
  (Mixed_FCC_dif, Moderate_10_to_20) 0.80, 0.15, 0.05;
  (Large_cell_dif, Moderate_10_to_20) 0.80, 0.15, 0.05;
  (B_immunoblastic, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (T_immunob_mixed, Moderate_10_to_20) 0.48, 0.45, 0.07;
  (AILD_like_T_cell_lym, Moderate_10_to_20) 0.80, 0.15, 0.05;
  (Japanese_ATL, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Lymphoblastic, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Small_noncleaved_dif, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (True_histiocytic, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Ki_1_LC_anaplas_T, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Multiple_myeloma, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Mycosis_fungoides, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (AML, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Hairy_cell_leukemia, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Carcinoma, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Melanoma, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (EM_plasmacytoma, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Kaposi_s_sarcoma, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Mast_cell_disease, Moderate_10_to_20) 0.1, 0.8, 0.1;
  (AIDS_involutionary, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (T_immunob_large, Moderate_10_to_20) 0.80, 0.15, 0.05;
  (Monocytoid_B_cell, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Nasopharyngeal_CA, Moderate_10_to_20) 0.0, 0.8, 0.2;
  (Seminoma, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (SLE, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Mycobact_histiocytos, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Mast_cell_hyperplas, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (LGV, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Histoplasmosis, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Coccidioidomycosis, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (CMV, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Brucellosis, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Ki_1_LC_anaplas_B, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (Intermed_lymphocytic, Moderate_10_to_20) 0.90, 0.08, 0.02;
  (AIDS_early, Marked_GT_20) 0.90, 0.08, 0.02;
  (AILD, Marked_GT_20) 0.80, 0.15, 0.05;
  (ALIP, Marked_GT_20) 0.90, 0.08, 0.02;
  (Cat_scratch_disease, Marked_GT_20) 0.90, 0.08, 0.02;
  (Dermatopathic_laden, Marked_GT_20) 0.90, 0.08, 0.02;
  (Florid_follic_hyperp, Marked_GT_20) 0.90, 0.08, 0.02;
  (GLH_hyaline_vascular, Marked_GT_20) 0.01, 0.64, 0.35;
  (GLH_plasma_cell, Marked_GT_20) 0.90, 0.08, 0.02;
  (Granulomatous_laden, Marked_GT_20) 0.40, 0.45, 0.15;
  (Histiocytosis_x, Marked_GT_20) 0.90, 0.08, 0.02;
  (Infectious_mono, Marked_GT_20) 0.90, 0.08, 0.02;
  (Leprosy_lepromatous, Marked_GT_20) 0.90, 0.08, 0.02;
  (Lymphangiographic, Marked_GT_20) 0.90, 0.08, 0.02;
  (Mantle_zone_hyperpla, Marked_GT_20) 0.90, 0.08, 0.02;
  (Necrotizing_Kikuchi, Marked_GT_20) 0.90, 0.08, 0.02;
  (Necrotiz_non_Kikuchi, Marked_GT_20) 0.90, 0.08, 0.02;
  (Rheumatoid_arthritis, Marked_GT_20) 0.40, 0.45, 0.15;
  (Sarcoidosis, Marked_GT_20) 0.80, 0.18, 0.02;
  (SHML, Marked_GT_20) 0.01, 0.94, 0.05;
  (Sinus_histiocytosis, Marked_GT_20) 0.90, 0.08, 0.02;
  (Syphilis, Marked_GT_20) 0.40, 0.45, 0.15;
  (Toxoplasmosis, Marked_GT_20) 0.90, 0.08, 0.02;
  (Tuberculosis, Marked_GT_20) 0.40, 0.45, 0.15;
  (Viral_NOS, Marked_GT_20) 0.90, 0.08, 0.02;
  (Whipple_s_disease, Marked_GT_20) 0.90, 0.08, 0.02;
  (L_H_nodular_HD, Marked_GT_20) 0.90, 0.08, 0.02;
  (L_H_diffuse_HD, Marked_GT_20) 0.90, 0.08, 0.02;
  (Nodular_sclerosis_HD, Marked_GT_20) 0.0, 0.8, 0.2;
  (Cellular_phase_NSHD, Marked_GT_20) 0.95, 0.05, 0.00;
  (Syncytial_NSHD, Marked_GT_20) 0.00, 0.94, 0.06;
  (Mixed_cellularity_HD, Marked_GT_20) 0.94, 0.05, 0.01;
  (Interfollicular_HD, Marked_GT_20) 0.90, 0.08, 0.02;
  (Diffuse_fibrosis_HD, Marked_GT_20) 0.1, 0.7, 0.2;
  (Reticular_type_HD, Marked_GT_20) 0.90, 0.08, 0.02;
  (Small_cleaved_fol, Marked_GT_20) 0.90, 0.08, 0.02;
  (Mixed_fol, Marked_GT_20) 0.90, 0.08, 0.02;
  (Large_cell_fol, Marked_GT_20) 0.90, 0.08, 0.02;
  (Small_noncleaved_fol, Marked_GT_20) 0.90, 0.08, 0.02;
  (Small_lymphocytic, Marked_GT_20) 0.90, 0.08, 0.02;
  (Plasmacytoid_lyctic, Marked_GT_20) 0.90, 0.08, 0.02;
  (Mantle_zone_lymphoma, Marked_GT_20) 0.90, 0.08, 0.02;
  (Small_cleaved_dif, Marked_GT_20) 0.80, 0.15, 0.05;
  (Mixed_FCC_dif, Marked_GT_20) 0.80, 0.15, 0.05;
  (Large_cell_dif, Marked_GT_20) 0.80, 0.15, 0.05;
  (B_immunoblastic, Marked_GT_20) 0.90, 0.08, 0.02;
  (T_immunob_mixed, Marked_GT_20) 0.48, 0.45, 0.07;
  (AILD_like_T_cell_lym, Marked_GT_20) 0.80, 0.15, 0.05;
  (Japanese_ATL, Marked_GT_20) 0.90, 0.08, 0.02;
  (Lymphoblastic, Marked_GT_20) 0.90, 0.08, 0.02;
  (Small_noncleaved_dif, Marked_GT_20) 0.90, 0.08, 0.02;
  (True_histiocytic, Marked_GT_20) 0.90, 0.08, 0.02;
  (Ki_1_LC_anaplas_T, Marked_GT_20) 0.90, 0.08, 0.02;
  (Multiple_myeloma, Marked_GT_20) 0.90, 0.08, 0.02;
  (Mycosis_fungoides, Marked_GT_20) 0.90, 0.08, 0.02;
  (AML, Marked_GT_20) 0.90, 0.08, 0.02;
  (Hairy_cell_leukemia, Marked_GT_20) 0.90, 0.08, 0.02;
  (Carcinoma, Marked_GT_20) 0.90, 0.08, 0.02;
  (Melanoma, Marked_GT_20) 0.90, 0.08, 0.02;
  (EM_plasmacytoma, Marked_GT_20) 0.90, 0.08, 0.02;
  (Kaposi_s_sarcoma, Marked_GT_20) 0.90, 0.08, 0.02;
  (Mast_cell_disease, Marked_GT_20) 0.1, 0.8, 0.1;
  (AIDS_involutionary, Marked_GT_20) 0.90, 0.08, 0.02;
  (T_immunob_large, Marked_GT_20) 0.80, 0.15, 0.05;
  (Monocytoid_B_cell, Marked_GT_20) 0.90, 0.08, 0.02;
  (Nasopharyngeal_CA, Marked_GT_20) 0.0, 0.8, 0.2;
  (Seminoma, Marked_GT_20) 0.90, 0.08, 0.02;
  (SLE, Marked_GT_20) 0.90, 0.08, 0.02;
  (Mycobact_histiocytos, Marked_GT_20) 0.90, 0.08, 0.02;
  (Mast_cell_hyperplas, Marked_GT_20) 0.90, 0.08, 0.02;
  (LGV, Marked_GT_20) 0.90, 0.08, 0.02;
  (Histoplasmosis, Marked_GT_20) 0.90, 0.08, 0.02;
  (Coccidioidomycosis, Marked_GT_20) 0.90, 0.08, 0.02;
  (CMV, Marked_GT_20) 0.90, 0.08, 0.02;
  (Brucellosis, Marked_GT_20) 0.90, 0.08, 0.02;
  (Ki_1_LC_anaplas_B, Marked_GT_20) 0.90, 0.08, 0.02;
  (Intermed_lymphocytic, Marked_GT_20) 0.90, 0.08, 0.02;
}
probability ( FCB_NOD | Fault, FCB ) {
  (AIDS_early, Absent) 1.0, 0.0, 0.0;
  (AILD, Absent) 1.0, 0.0, 0.0;
  (ALIP, Absent) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent) 1.0, 0.0, 0.0;
  (SHML, Absent) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent) 1.0, 0.0, 0.0;
  (Syphilis, Absent) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent) 1.0, 0.0, 0.0;
  (AML, Absent) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent) 1.0, 0.0, 0.0;
  (Carcinoma, Absent) 1.0, 0.0, 0.0;
  (Melanoma, Absent) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent) 1.0, 0.0, 0.0;
  (Seminoma, Absent) 1.0, 0.0, 0.0;
  (SLE, Absent) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent) 1.0, 0.0, 0.0;
  (LGV, Absent) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent) 1.0, 0.0, 0.0;
  (CMV, Absent) 1.0, 0.0, 0.0;
  (Brucellosis, Absent) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent) 1.0, 0.0, 0.0;
  (AIDS_early, Present) 0.000, 0.995, 0.005;
  (AILD, Present) 0.000, 0.995, 0.005;
  (ALIP, Present) 0.000, 0.995, 0.005;
  (Cat_scratch_disease, Present) 0.000, 0.995, 0.005;
  (Dermatopathic_laden, Present) 0.000, 0.995, 0.005;
  (Florid_follic_hyperp, Present) 0.000, 0.995, 0.005;
  (GLH_hyaline_vascular, Present) 0.00, 0.95, 0.05;
  (GLH_plasma_cell, Present) 0.000, 0.995, 0.005;
  (Granulomatous_laden, Present) 0.00, 0.98, 0.02;
  (Histiocytosis_x, Present) 0.000, 0.995, 0.005;
  (Infectious_mono, Present) 0.000, 0.995, 0.005;
  (Leprosy_lepromatous, Present) 0.000, 0.995, 0.005;
  (Lymphangiographic, Present) 0.000, 0.995, 0.005;
  (Mantle_zone_hyperpla, Present) 0.000, 0.995, 0.005;
  (Necrotizing_Kikuchi, Present) 0.000, 0.995, 0.005;
  (Necrotiz_non_Kikuchi, Present) 0.000, 0.995, 0.005;
  (Rheumatoid_arthritis, Present) 0.00, 0.98, 0.02;
  (Sarcoidosis, Present) 0.000, 0.995, 0.005;
  (SHML, Present) 0.00, 0.95, 0.05;
  (Sinus_histiocytosis, Present) 0.000, 0.995, 0.005;
  (Syphilis, Present) 0.00, 0.98, 0.02;
  (Toxoplasmosis, Present) 0.000, 0.995, 0.005;
  (Tuberculosis, Present) 0.00, 0.98, 0.02;
  (Viral_NOS, Present) 0.000, 0.995, 0.005;
  (Whipple_s_disease, Present) 0.000, 0.995, 0.005;
  (L_H_nodular_HD, Present) 0.000, 0.995, 0.005;
  (L_H_diffuse_HD, Present) 0.000, 0.995, 0.005;
  (Nodular_sclerosis_HD, Present) 0.0, 0.0, 1.0;
  (Cellular_phase_NSHD, Present) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Present) 0.0, 0.0, 1.0;
  (Mixed_cellularity_HD, Present) 0.00, 0.99, 0.01;
  (Interfollicular_HD, Present) 0.000, 0.995, 0.005;
  (Diffuse_fibrosis_HD, Present) 0.0, 0.9, 0.1;
  (Reticular_type_HD, Present) 0.000, 0.995, 0.005;
  (Small_cleaved_fol, Present) 0.000, 0.995, 0.005;
  (Mixed_fol, Present) 0.000, 0.995, 0.005;
  (Large_cell_fol, Present) 0.000, 0.995, 0.005;
  (Small_noncleaved_fol, Present) 0.000, 0.995, 0.005;
  (Small_lymphocytic, Present) 0.000, 0.995, 0.005;
  (Plasmacytoid_lyctic, Present) 0.000, 0.995, 0.005;
  (Mantle_zone_lymphoma, Present) 0.000, 0.995, 0.005;
  (Small_cleaved_dif, Present) 0.0, 0.9, 0.1;
  (Mixed_FCC_dif, Present) 0.0, 0.9, 0.1;
  (Large_cell_dif, Present) 0.0, 0.9, 0.1;
  (B_immunoblastic, Present) 0.000, 0.995, 0.005;
  (T_immunob_mixed, Present) 0.0, 0.9, 0.1;
  (AILD_like_T_cell_lym, Present) 0.00, 0.97, 0.03;
  (Japanese_ATL, Present) 0.000, 0.995, 0.005;
  (Lymphoblastic, Present) 0.000, 0.995, 0.005;
  (Small_noncleaved_dif, Present) 0.000, 0.995, 0.005;
  (True_histiocytic, Present) 0.000, 0.995, 0.005;
  (Ki_1_LC_anaplas_T, Present) 0.000, 0.995, 0.005;
  (Multiple_myeloma, Present) 0.000, 0.995, 0.005;
  (Mycosis_fungoides, Present) 0.000, 0.995, 0.005;
  (AML, Present) 0.000, 0.995, 0.005;
  (Hairy_cell_leukemia, Present) 0.000, 0.995, 0.005;
  (Carcinoma, Present) 0.000, 0.995, 0.005;
  (Melanoma, Present) 0.000, 0.995, 0.005;
  (EM_plasmacytoma, Present) 0.000, 0.995, 0.005;
  (Kaposi_s_sarcoma, Present) 0.000, 0.995, 0.005;
  (Mast_cell_disease, Present) 0.00, 0.95, 0.05;
  (AIDS_involutionary, Present) 0.000, 0.995, 0.005;
  (T_immunob_large, Present) 0.00, 0.97, 0.03;
  (Monocytoid_B_cell, Present) 0.000, 0.995, 0.005;
  (Nasopharyngeal_CA, Present) 0.0, 0.0, 1.0;
  (Seminoma, Present) 0.000, 0.995, 0.005;
  (SLE, Present) 0.000, 0.995, 0.005;
  (Mycobact_histiocytos, Present) 0.000, 0.995, 0.005;
  (Mast_cell_hyperplas, Present) 0.000, 0.995, 0.005;
  (LGV, Present) 0.000, 0.995, 0.005;
  (Histoplasmosis, Present) 0.000, 0.995, 0.005;
  (Coccidioidomycosis, Present) 0.000, 0.995, 0.005;
  (CMV, Present) 0.000, 0.995, 0.005;
  (Brucellosis, Present) 0.000, 0.995, 0.005;
  (Ki_1_LC_anaplas_B, Present) 0.000, 0.995, 0.005;
  (Intermed_lymphocytic, Present) 0.000, 0.995, 0.005;
  (AIDS_early, Prominent) 0.00, 0.99, 0.01;
  (AILD, Prominent) 0.00, 0.99, 0.01;
  (ALIP, Prominent) 0.00, 0.99, 0.01;
  (Cat_scratch_disease, Prominent) 0.00, 0.99, 0.01;
  (Dermatopathic_laden, Prominent) 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, Prominent) 0.00, 0.99, 0.01;
  (GLH_hyaline_vascular, Prominent) 0.0, 0.8, 0.2;
  (GLH_plasma_cell, Prominent) 0.00, 0.99, 0.01;
  (Granulomatous_laden, Prominent) 0.00, 0.95, 0.05;
  (Histiocytosis_x, Prominent) 0.00, 0.99, 0.01;
  (Infectious_mono, Prominent) 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, Prominent) 0.00, 0.99, 0.01;
  (Lymphangiographic, Prominent) 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, Prominent) 0.00, 0.99, 0.01;
  (Necrotizing_Kikuchi, Prominent) 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, Prominent) 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, Prominent) 0.00, 0.95, 0.05;
  (Sarcoidosis, Prominent) 0.00, 0.99, 0.01;
  (SHML, Prominent) 0.0, 0.9, 0.1;
  (Sinus_histiocytosis, Prominent) 0.00, 0.99, 0.01;
  (Syphilis, Prominent) 0.00, 0.95, 0.05;
  (Toxoplasmosis, Prominent) 0.00, 0.99, 0.01;
  (Tuberculosis, Prominent) 0.00, 0.95, 0.05;
  (Viral_NOS, Prominent) 0.00, 0.99, 0.01;
  (Whipple_s_disease, Prominent) 0.00, 0.99, 0.01;
  (L_H_nodular_HD, Prominent) 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, Prominent) 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, Prominent) 0.0, 0.0, 1.0;
  (Cellular_phase_NSHD, Prominent) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Prominent) 0.0, 0.0, 1.0;
  (Mixed_cellularity_HD, Prominent) 0.00, 0.98, 0.02;
  (Interfollicular_HD, Prominent) 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, Prominent) 0.0, 0.8, 0.2;
  (Reticular_type_HD, Prominent) 0.00, 0.99, 0.01;
  (Small_cleaved_fol, Prominent) 0.00, 0.99, 0.01;
  (Mixed_fol, Prominent) 0.00, 0.99, 0.01;
  (Large_cell_fol, Prominent) 0.00, 0.99, 0.01;
  (Small_noncleaved_fol, Prominent) 0.00, 0.99, 0.01;
  (Small_lymphocytic, Prominent) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, Prominent) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, Prominent) 0.00, 0.99, 0.01;
  (Small_cleaved_dif, Prominent) 0.0, 0.9, 0.1;
  (Mixed_FCC_dif, Prominent) 0.0, 0.9, 0.1;
  (Large_cell_dif, Prominent) 0.0, 0.9, 0.1;
  (B_immunoblastic, Prominent) 0.00, 0.99, 0.01;
  (T_immunob_mixed, Prominent) 0.0, 0.9, 0.1;
  (AILD_like_T_cell_lym, Prominent) 0.0, 0.9, 0.1;
  (Japanese_ATL, Prominent) 0.00, 0.99, 0.01;
  (Lymphoblastic, Prominent) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, Prominent) 0.00, 0.99, 0.01;
  (True_histiocytic, Prominent) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, Prominent) 0.00, 0.99, 0.01;
  (Multiple_myeloma, Prominent) 0.00, 0.99, 0.01;
  (Mycosis_fungoides, Prominent) 0.00, 0.99, 0.01;
  (AML, Prominent) 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, Prominent) 0.00, 0.99, 0.01;
  (Carcinoma, Prominent) 0.00, 0.99, 0.01;
  (Melanoma, Prominent) 0.00, 0.99, 0.01;
  (EM_plasmacytoma, Prominent) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, Prominent) 0.00, 0.99, 0.01;
  (Mast_cell_disease, Prominent) 0.0, 0.9, 0.1;
  (AIDS_involutionary, Prominent) 0.00, 0.99, 0.01;
  (T_immunob_large, Prominent) 0.00, 0.95, 0.05;
  (Monocytoid_B_cell, Prominent) 0.00, 0.99, 0.01;
  (Nasopharyngeal_CA, Prominent) 0.0, 0.0, 1.0;
  (Seminoma, Prominent) 0.00, 0.99, 0.01;
  (SLE, Prominent) 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, Prominent) 0.00, 0.99, 0.01;
  (Mast_cell_hyperplas, Prominent) 0.00, 0.99, 0.01;
  (LGV, Prominent) 0.00, 0.99, 0.01;
  (Histoplasmosis, Prominent) 0.00, 0.99, 0.01;
  (Coccidioidomycosis, Prominent) 0.00, 0.99, 0.01;
  (CMV, Prominent) 0.00, 0.99, 0.01;
  (Brucellosis, Prominent) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, Prominent) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, Prominent) 0.00, 0.99, 0.01;
}
probability ( FIBROS | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 0.95, 0.05;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 0.95, 0.05;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 0.99, 0.01;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 0.95, 0.05;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 0.999, 0.001;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 0.0, 1.0;
  (Reticular_type_HD) 0.999, 0.001;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 0.95, 0.05;
  (Mast_cell_disease) 0.8, 0.2;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 0.999, 0.001;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 0.9, 0.1;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( FITE | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 0.01, 0.99;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( FBODY | Fault ) {
  (AIDS_early) 0.999, 0.001, 0.000;
  (AILD) 0.99, 0.01, 0.00;
  (ALIP) 0.999, 0.001, 0.000;
  (Cat_scratch_disease) 0.88, 0.10, 0.02;
  (Dermatopathic_laden) 0.999, 0.001, 0.000;
  (Florid_follic_hyperp) 0.999, 0.001, 0.000;
  (GLH_hyaline_vascular) 0.999, 0.001, 0.000;
  (GLH_plasma_cell) 0.999, 0.001, 0.000;
  (Granulomatous_laden) 0.40, 0.35, 0.25;
  (Histiocytosis_x) 0.93, 0.05, 0.02;
  (Infectious_mono) 0.999, 0.001, 0.000;
  (Leprosy_lepromatous) 0.87, 0.10, 0.03;
  (Lymphangiographic) 0.01, 0.29, 0.70;
  (Mantle_zone_hyperpla) 0.999, 0.001, 0.000;
  (Necrotizing_Kikuchi) 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi) 0.94, 0.05, 0.01;
  (Rheumatoid_arthritis) 0.999, 0.001, 0.000;
  (Sarcoidosis) 0.90, 0.09, 0.01;
  (SHML) 0.999, 0.001, 0.000;
  (Sinus_histiocytosis) 0.999, 0.001, 0.000;
  (Syphilis) 0.88, 0.10, 0.02;
  (Toxoplasmosis) 0.999, 0.001, 0.000;
  (Tuberculosis) 0.87, 0.10, 0.03;
  (Viral_NOS) 0.999, 0.001, 0.000;
  (Whipple_s_disease) 0.01, 0.29, 0.70;
  (L_H_nodular_HD) 0.999, 0.001, 0.000;
  (L_H_diffuse_HD) 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD) 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD) 0.999, 0.001, 0.000;
  (Syncytial_NSHD) 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD) 0.95, 0.04, 0.01;
  (Interfollicular_HD) 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD) 0.999, 0.001, 0.000;
  (Reticular_type_HD) 0.999, 0.001, 0.000;
  (Small_cleaved_fol) 0.999, 0.001, 0.000;
  (Mixed_fol) 0.999, 0.001, 0.000;
  (Large_cell_fol) 0.999, 0.001, 0.000;
  (Small_noncleaved_fol) 0.999, 0.001, 0.000;
  (Small_lymphocytic) 0.999, 0.001, 0.000;
  (Plasmacytoid_lyctic) 0.999, 0.001, 0.000;
  (Mantle_zone_lymphoma) 0.999, 0.001, 0.000;
  (Small_cleaved_dif) 0.999, 0.001, 0.000;
  (Mixed_FCC_dif) 0.999, 0.001, 0.000;
  (Large_cell_dif) 0.999, 0.001, 0.000;
  (B_immunoblastic) 0.999, 0.001, 0.000;
  (T_immunob_mixed) 0.999, 0.001, 0.000;
  (AILD_like_T_cell_lym) 0.99, 0.01, 0.00;
  (Japanese_ATL) 0.999, 0.001, 0.000;
  (Lymphoblastic) 0.999, 0.001, 0.000;
  (Small_noncleaved_dif) 0.999, 0.001, 0.000;
  (True_histiocytic) 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_T) 0.999, 0.001, 0.000;
  (Multiple_myeloma) 0.999, 0.001, 0.000;
  (Mycosis_fungoides) 0.999, 0.001, 0.000;
  (AML) 0.999, 0.001, 0.000;
  (Hairy_cell_leukemia) 0.999, 0.001, 0.000;
  (Carcinoma) 0.999, 0.001, 0.000;
  (Melanoma) 0.999, 0.001, 0.000;
  (EM_plasmacytoma) 0.999, 0.001, 0.000;
  (Kaposi_s_sarcoma) 0.999, 0.001, 0.000;
  (Mast_cell_disease) 0.97, 0.02, 0.01;
  (AIDS_involutionary) 0.999, 0.001, 0.000;
  (T_immunob_large) 0.999, 0.001, 0.000;
  (Monocytoid_B_cell) 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA) 0.999, 0.001, 0.000;
  (Seminoma) 0.999, 0.001, 0.000;
  (SLE) 0.999, 0.001, 0.000;
  (Mycobact_histiocytos) 0.88, 0.10, 0.02;
  (Mast_cell_hyperplas) 0.97, 0.02, 0.01;
  (LGV) 0.88, 0.10, 0.02;
  (Histoplasmosis) 0.88, 0.10, 0.02;
  (Coccidioidomycosis) 0.88, 0.10, 0.02;
  (CMV) 0.88, 0.10, 0.02;
  (Brucellosis) 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_B) 0.999, 0.001, 0.000;
  (Intermed_lymphocytic) 0.999, 0.001, 0.000;
}
probability ( GENE_TC | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 0.4, 0.6;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 0.95, 0.05;
  (Nodular_sclerosis_HD) 0.95, 0.05;
  (Cellular_phase_NSHD) 0.95, 0.05;
  (Syncytial_NSHD) 0.95, 0.05;
  (Mixed_cellularity_HD) 0.95, 0.05;
  (Interfollicular_HD) 0.95, 0.05;
  (Diffuse_fibrosis_HD) 0.95, 0.05;
  (Reticular_type_HD) 0.95, 0.05;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 0.0, 1.0;
  (AILD_like_T_cell_lym) 0.0, 1.0;
  (Japanese_ATL) 0.0, 1.0;
  (Lymphoblastic) 0.0, 1.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 0.0, 1.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 0.0, 1.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 0.0, 1.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( HAIRY | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 0.0, 1.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( HTLV_I | Fault ) {
  (AIDS_early) 0.999, 0.001;
  (AILD) 0.999, 0.001;
  (ALIP) 0.999, 0.001;
  (Cat_scratch_disease) 0.999, 0.001;
  (Dermatopathic_laden) 0.999, 0.001;
  (Florid_follic_hyperp) 0.999, 0.001;
  (GLH_hyaline_vascular) 0.999, 0.001;
  (GLH_plasma_cell) 0.999, 0.001;
  (Granulomatous_laden) 0.999, 0.001;
  (Histiocytosis_x) 0.999, 0.001;
  (Infectious_mono) 0.999, 0.001;
  (Leprosy_lepromatous) 0.999, 0.001;
  (Lymphangiographic) 0.999, 0.001;
  (Mantle_zone_hyperpla) 0.999, 0.001;
  (Necrotizing_Kikuchi) 0.999, 0.001;
  (Necrotiz_non_Kikuchi) 0.999, 0.001;
  (Rheumatoid_arthritis) 0.999, 0.001;
  (Sarcoidosis) 0.999, 0.001;
  (SHML) 0.999, 0.001;
  (Sinus_histiocytosis) 0.999, 0.001;
  (Syphilis) 0.999, 0.001;
  (Toxoplasmosis) 0.999, 0.001;
  (Tuberculosis) 0.999, 0.001;
  (Viral_NOS) 0.999, 0.001;
  (Whipple_s_disease) 0.999, 0.001;
  (L_H_nodular_HD) 0.999, 0.001;
  (L_H_diffuse_HD) 0.999, 0.001;
  (Nodular_sclerosis_HD) 0.999, 0.001;
  (Cellular_phase_NSHD) 0.999, 0.001;
  (Syncytial_NSHD) 0.999, 0.001;
  (Mixed_cellularity_HD) 0.999, 0.001;
  (Interfollicular_HD) 0.999, 0.001;
  (Diffuse_fibrosis_HD) 0.999, 0.001;
  (Reticular_type_HD) 0.999, 0.001;
  (Small_cleaved_fol) 0.999, 0.001;
  (Mixed_fol) 0.999, 0.001;
  (Large_cell_fol) 0.999, 0.001;
  (Small_noncleaved_fol) 0.999, 0.001;
  (Small_lymphocytic) 0.999, 0.001;
  (Plasmacytoid_lyctic) 0.999, 0.001;
  (Mantle_zone_lymphoma) 0.999, 0.001;
  (Small_cleaved_dif) 0.999, 0.001;
  (Mixed_FCC_dif) 0.999, 0.001;
  (Large_cell_dif) 0.999, 0.001;
  (B_immunoblastic) 0.999, 0.001;
  (T_immunob_mixed) 0.999, 0.001;
  (AILD_like_T_cell_lym) 0.999, 0.001;
  (Japanese_ATL) 0.001, 0.999;
  (Lymphoblastic) 0.999, 0.001;
  (Small_noncleaved_dif) 0.999, 0.001;
  (True_histiocytic) 0.999, 0.001;
  (Ki_1_LC_anaplas_T) 0.999, 0.001;
  (Multiple_myeloma) 0.999, 0.001;
  (Mycosis_fungoides) 0.999, 0.001;
  (AML) 0.999, 0.001;
  (Hairy_cell_leukemia) 0.999, 0.001;
  (Carcinoma) 0.999, 0.001;
  (Melanoma) 0.999, 0.001;
  (EM_plasmacytoma) 0.999, 0.001;
  (Kaposi_s_sarcoma) 0.999, 0.001;
  (Mast_cell_disease) 0.999, 0.001;
  (AIDS_involutionary) 0.999, 0.001;
  (T_immunob_large) 0.999, 0.001;
  (Monocytoid_B_cell) 0.999, 0.001;
  (Nasopharyngeal_CA) 0.999, 0.001;
  (Seminoma) 0.999, 0.001;
  (SLE) 0.999, 0.001;
  (Mycobact_histiocytos) 0.999, 0.001;
  (Mast_cell_hyperplas) 0.999, 0.001;
  (LGV) 0.999, 0.001;
  (Histoplasmosis) 0.999, 0.001;
  (Coccidioidomycosis) 0.999, 0.001;
  (CMV) 0.999, 0.001;
  (Brucellosis) 0.999, 0.001;
  (Ki_1_LC_anaplas_B) 0.999, 0.001;
  (Intermed_lymphocytic) 0.999, 0.001;
}
probability ( HIV | HIV_ST ) {
  (Negative) 0.9999, 0.0001;
  (Positive_Asymptomatic) 0.0001, 0.9999;
  (Positive_Symptomatic) 0.0001, 0.9999;
}
probability ( INTFOL | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 0.0, 0.0, 1.0;
  (AILD, Absent_0pc) 0.0, 0.0, 1.0;
  (ALIP, Absent_0pc) 0.0, 0.0, 1.0;
  (Cat_scratch_disease, Absent_0pc) 0.0, 0.0, 1.0;
  (Dermatopathic_laden, Absent_0pc) 0.0, 0.0, 1.0;
  (Florid_follic_hyperp, Absent_0pc) 0.0, 0.0, 1.0;
  (GLH_hyaline_vascular, Absent_0pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, Absent_0pc) 0.0, 0.0, 1.0;
  (Granulomatous_laden, Absent_0pc) 0.0, 0.0, 1.0;
  (Histiocytosis_x, Absent_0pc) 0.0, 0.0, 1.0;
  (Infectious_mono, Absent_0pc) 0.0, 0.0, 1.0;
  (Leprosy_lepromatous, Absent_0pc) 0.0, 0.0, 1.0;
  (Lymphangiographic, Absent_0pc) 0.0, 0.0, 1.0;
  (Mantle_zone_hyperpla, Absent_0pc) 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, Absent_0pc) 0.0, 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 0.0, 0.0, 1.0;
  (Rheumatoid_arthritis, Absent_0pc) 0.0, 0.0, 1.0;
  (Sarcoidosis, Absent_0pc) 0.0, 0.0, 1.0;
  (SHML, Absent_0pc) 0.0, 0.0, 1.0;
  (Sinus_histiocytosis, Absent_0pc) 0.0, 0.0, 1.0;
  (Syphilis, Absent_0pc) 0.0, 0.0, 1.0;
  (Toxoplasmosis, Absent_0pc) 0.0, 0.0, 1.0;
  (Tuberculosis, Absent_0pc) 0.0, 0.0, 1.0;
  (Viral_NOS, Absent_0pc) 0.0, 0.0, 1.0;
  (Whipple_s_disease, Absent_0pc) 0.0, 0.0, 1.0;
  (L_H_nodular_HD, Absent_0pc) 0.0, 0.0, 1.0;
  (L_H_diffuse_HD, Absent_0pc) 0.0, 0.0, 1.0;
  (Nodular_sclerosis_HD, Absent_0pc) 0.0, 0.0, 1.0;
  (Cellular_phase_NSHD, Absent_0pc) 0.0, 0.0, 1.0;
  (Syncytial_NSHD, Absent_0pc) 0.0, 0.0, 1.0;
  (Mixed_cellularity_HD, Absent_0pc) 0.0, 0.0, 1.0;
  (Interfollicular_HD, Absent_0pc) 0.0, 0.0, 1.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 0.0, 0.0, 1.0;
  (Reticular_type_HD, Absent_0pc) 0.0, 0.0, 1.0;
  (Small_cleaved_fol, Absent_0pc) 0.0, 0.0, 1.0;
  (Mixed_fol, Absent_0pc) 0.0, 0.0, 1.0;
  (Large_cell_fol, Absent_0pc) 0.0, 0.0, 1.0;
  (Small_noncleaved_fol, Absent_0pc) 0.0, 0.0, 1.0;
  (Small_lymphocytic, Absent_0pc) 0.0, 0.0, 1.0;
  (Plasmacytoid_lyctic, Absent_0pc) 0.0, 0.0, 1.0;
  (Mantle_zone_lymphoma, Absent_0pc) 0.0, 0.0, 1.0;
  (Small_cleaved_dif, Absent_0pc) 0.0, 0.0, 1.0;
  (Mixed_FCC_dif, Absent_0pc) 0.0, 0.0, 1.0;
  (Large_cell_dif, Absent_0pc) 0.0, 0.0, 1.0;
  (B_immunoblastic, Absent_0pc) 0.0, 0.0, 1.0;
  (T_immunob_mixed, Absent_0pc) 0.0, 0.0, 1.0;
  (AILD_like_T_cell_lym, Absent_0pc) 0.0, 0.0, 1.0;
  (Japanese_ATL, Absent_0pc) 0.0, 0.0, 1.0;
  (Lymphoblastic, Absent_0pc) 0.0, 0.0, 1.0;
  (Small_noncleaved_dif, Absent_0pc) 0.0, 0.0, 1.0;
  (True_histiocytic, Absent_0pc) 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 0.0, 0.0, 1.0;
  (Multiple_myeloma, Absent_0pc) 0.0, 0.0, 1.0;
  (Mycosis_fungoides, Absent_0pc) 0.0, 0.0, 1.0;
  (AML, Absent_0pc) 0.0, 0.0, 1.0;
  (Hairy_cell_leukemia, Absent_0pc) 0.0, 0.0, 1.0;
  (Carcinoma, Absent_0pc) 0.0, 0.0, 1.0;
  (Melanoma, Absent_0pc) 0.0, 0.0, 1.0;
  (EM_plasmacytoma, Absent_0pc) 0.0, 0.0, 1.0;
  (Kaposi_s_sarcoma, Absent_0pc) 0.0, 0.0, 1.0;
  (Mast_cell_disease, Absent_0pc) 0.0, 0.0, 1.0;
  (AIDS_involutionary, Absent_0pc) 0.0, 0.0, 1.0;
  (T_immunob_large, Absent_0pc) 0.0, 0.0, 1.0;
  (Monocytoid_B_cell, Absent_0pc) 0.0, 0.0, 1.0;
  (Nasopharyngeal_CA, Absent_0pc) 0.0, 0.0, 1.0;
  (Seminoma, Absent_0pc) 0.0, 0.0, 1.0;
  (SLE, Absent_0pc) 0.0, 0.0, 1.0;
  (Mycobact_histiocytos, Absent_0pc) 0.0, 0.0, 1.0;
  (Mast_cell_hyperplas, Absent_0pc) 0.0, 0.0, 1.0;
  (LGV, Absent_0pc) 0.0, 0.0, 1.0;
  (Histoplasmosis, Absent_0pc) 0.0, 0.0, 1.0;
  (Coccidioidomycosis, Absent_0pc) 0.0, 0.0, 1.0;
  (CMV, Absent_0pc) 0.0, 0.0, 1.0;
  (Brucellosis, Absent_0pc) 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 0.0, 0.0, 1.0;
  (Intermed_lymphocytic, Absent_0pc) 0.0, 0.0, 1.0;
  (AIDS_early, 1_to_25pc) 0.3333333, 0.3333333, 0.3333333;
  (AILD, 1_to_25pc) 0.0, 0.0, 1.0;
  (ALIP, 1_to_25pc) 0.0, 0.0, 1.0;
  (Cat_scratch_disease, 1_to_25pc) 0.01, 0.74, 0.25;
  (Dermatopathic_laden, 1_to_25pc) 0.01, 0.84, 0.15;
  (Florid_follic_hyperp, 1_to_25pc) 0.3333333, 0.3333333, 0.3333333;
  (GLH_hyaline_vascular, 1_to_25pc) 0.01, 0.84, 0.15;
  (GLH_plasma_cell, 1_to_25pc) 0.01, 0.84, 0.15;
  (Granulomatous_laden, 1_to_25pc) 0.01, 0.74, 0.25;
  (Histiocytosis_x, 1_to_25pc) 0.02, 0.78, 0.20;
  (Infectious_mono, 1_to_25pc) 0.05, 0.65, 0.30;
  (Leprosy_lepromatous, 1_to_25pc) 0.02, 0.68, 0.30;
  (Lymphangiographic, 1_to_25pc) 0.01, 0.59, 0.40;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.9, 0.1, 0.0;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.01, 0.74, 0.25;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.01, 0.74, 0.25;
  (Rheumatoid_arthritis, 1_to_25pc) 0.01, 0.84, 0.15;
  (Sarcoidosis, 1_to_25pc) 0.02, 0.68, 0.30;
  (SHML, 1_to_25pc) 0.969, 0.030, 0.001;
  (Sinus_histiocytosis, 1_to_25pc) 0.969, 0.030, 0.001;
  (Syphilis, 1_to_25pc) 0.01, 0.84, 0.15;
  (Toxoplasmosis, 1_to_25pc) 0.01, 0.84, 0.15;
  (Tuberculosis, 1_to_25pc) 0.02, 0.68, 0.30;
  (Viral_NOS, 1_to_25pc) 0.05, 0.65, 0.30;
  (Whipple_s_disease, 1_to_25pc) 0.01, 0.59, 0.40;
  (L_H_nodular_HD, 1_to_25pc) 0.05, 0.05, 0.90;
  (L_H_diffuse_HD, 1_to_25pc) 0.05, 0.05, 0.90;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.01, 0.31, 0.68;
  (Cellular_phase_NSHD, 1_to_25pc) 0.01, 0.31, 0.68;
  (Syncytial_NSHD, 1_to_25pc) 0.01, 0.31, 0.68;
  (Mixed_cellularity_HD, 1_to_25pc) 0.01, 0.31, 0.68;
  (Interfollicular_HD, 1_to_25pc) 0.1, 0.4, 0.5;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.00, 0.01, 0.99;
  (Reticular_type_HD, 1_to_25pc) 0.00, 0.01, 0.99;
  (Small_cleaved_fol, 1_to_25pc) 0.45, 0.10, 0.45;
  (Mixed_fol, 1_to_25pc) 0.45, 0.10, 0.45;
  (Large_cell_fol, 1_to_25pc) 0.45, 0.10, 0.45;
  (Small_noncleaved_fol, 1_to_25pc) 0.45, 0.10, 0.45;
  (Small_lymphocytic, 1_to_25pc) 0.00, 0.06, 0.94;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.00, 0.06, 0.94;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.01, 0.05, 0.94;
  (Small_cleaved_dif, 1_to_25pc) 0.00, 0.02, 0.98;
  (Mixed_FCC_dif, 1_to_25pc) 0.00, 0.02, 0.98;
  (Large_cell_dif, 1_to_25pc) 0.00, 0.02, 0.98;
  (B_immunoblastic, 1_to_25pc) 0.00, 0.02, 0.98;
  (T_immunob_mixed, 1_to_25pc) 0.00, 0.02, 0.98;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.00, 0.02, 0.98;
  (Japanese_ATL, 1_to_25pc) 0.00, 0.02, 0.98;
  (Lymphoblastic, 1_to_25pc) 0.00, 0.03, 0.97;
  (Small_noncleaved_dif, 1_to_25pc) 0.00, 0.02, 0.98;
  (True_histiocytic, 1_to_25pc) 0.00, 0.02, 0.98;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.001, 0.200, 0.799;
  (Multiple_myeloma, 1_to_25pc) 0.45, 0.10, 0.45;
  (Mycosis_fungoides, 1_to_25pc) 0.45, 0.10, 0.45;
  (AML, 1_to_25pc) 0.45, 0.10, 0.45;
  (Hairy_cell_leukemia, 1_to_25pc) 0.45, 0.10, 0.45;
  (Carcinoma, 1_to_25pc) 0.45, 0.10, 0.45;
  (Melanoma, 1_to_25pc) 0.45, 0.10, 0.45;
  (EM_plasmacytoma, 1_to_25pc) 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.2, 0.4, 0.4;
  (Mast_cell_disease, 1_to_25pc) 0.0, 0.3, 0.7;
  (AIDS_involutionary, 1_to_25pc) 0.01, 0.84, 0.15;
  (T_immunob_large, 1_to_25pc) 0.00, 0.02, 0.98;
  (Monocytoid_B_cell, 1_to_25pc) 0.00, 0.05, 0.95;
  (Nasopharyngeal_CA, 1_to_25pc) 0.45, 0.10, 0.45;
  (Seminoma, 1_to_25pc) 0.45, 0.10, 0.45;
  (SLE, 1_to_25pc) 0.05, 0.65, 0.30;
  (Mycobact_histiocytos, 1_to_25pc) 0.01, 0.84, 0.15;
  (Mast_cell_hyperplas, 1_to_25pc) 0.01, 0.84, 0.15;
  (LGV, 1_to_25pc) 0.01, 0.74, 0.25;
  (Histoplasmosis, 1_to_25pc) 0.01, 0.84, 0.15;
  (Coccidioidomycosis, 1_to_25pc) 0.01, 0.84, 0.15;
  (CMV, 1_to_25pc) 0.01, 0.84, 0.15;
  (Brucellosis, 1_to_25pc) 0.01, 0.84, 0.15;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.001, 0.200, 0.799;
  (Intermed_lymphocytic, 1_to_25pc) 0.01, 0.03, 0.96;
  (AIDS_early, 25_to_75pc) 0.60, 0.39, 0.01;
  (AILD, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (ALIP, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Cat_scratch_disease, 25_to_75pc) 0.50, 0.49, 0.01;
  (Dermatopathic_laden, 25_to_75pc) 0.50, 0.49, 0.01;
  (Florid_follic_hyperp, 25_to_75pc) 0.60, 0.39, 0.01;
  (GLH_hyaline_vascular, 25_to_75pc) 0.50, 0.49, 0.01;
  (GLH_plasma_cell, 25_to_75pc) 0.50, 0.49, 0.01;
  (Granulomatous_laden, 25_to_75pc) 0.50, 0.49, 0.01;
  (Histiocytosis_x, 25_to_75pc) 0.50, 0.49, 0.01;
  (Infectious_mono, 25_to_75pc) 0.15, 0.75, 0.10;
  (Leprosy_lepromatous, 25_to_75pc) 0.10, 0.75, 0.15;
  (Lymphangiographic, 25_to_75pc) 0.50, 0.49, 0.01;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.95, 0.05, 0.00;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.50, 0.49, 0.01;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.50, 0.49, 0.01;
  (Rheumatoid_arthritis, 25_to_75pc) 0.50, 0.49, 0.01;
  (Sarcoidosis, 25_to_75pc) 0.10, 0.75, 0.15;
  (SHML, 25_to_75pc) 0.990, 0.009, 0.001;
  (Sinus_histiocytosis, 25_to_75pc) 0.990, 0.009, 0.001;
  (Syphilis, 25_to_75pc) 0.50, 0.49, 0.01;
  (Toxoplasmosis, 25_to_75pc) 0.50, 0.49, 0.01;
  (Tuberculosis, 25_to_75pc) 0.10, 0.75, 0.15;
  (Viral_NOS, 25_to_75pc) 0.15, 0.75, 0.10;
  (Whipple_s_disease, 25_to_75pc) 0.50, 0.49, 0.01;
  (L_H_nodular_HD, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (L_H_diffuse_HD, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.01, 0.31, 0.68;
  (Cellular_phase_NSHD, 25_to_75pc) 0.01, 0.31, 0.68;
  (Syncytial_NSHD, 25_to_75pc) 0.01, 0.31, 0.68;
  (Mixed_cellularity_HD, 25_to_75pc) 0.01, 0.31, 0.68;
  (Interfollicular_HD, 25_to_75pc) 0.1, 0.4, 0.5;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Reticular_type_HD, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Small_cleaved_fol, 25_to_75pc) 0.50, 0.05, 0.45;
  (Mixed_fol, 25_to_75pc) 0.50, 0.05, 0.45;
  (Large_cell_fol, 25_to_75pc) 0.50, 0.05, 0.45;
  (Small_noncleaved_fol, 25_to_75pc) 0.50, 0.05, 0.45;
  (Small_lymphocytic, 25_to_75pc) 0.00, 0.06, 0.94;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.00, 0.06, 0.94;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.25, 0.25, 0.50;
  (Small_cleaved_dif, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Mixed_FCC_dif, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Large_cell_dif, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (B_immunoblastic, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (T_immunob_mixed, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Japanese_ATL, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Lymphoblastic, 25_to_75pc) 0.00, 0.03, 0.97;
  (Small_noncleaved_dif, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (True_histiocytic, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.01, 0.25, 0.74;
  (Multiple_myeloma, 25_to_75pc) 0.55, 0.10, 0.35;
  (Mycosis_fungoides, 25_to_75pc) 0.55, 0.10, 0.35;
  (AML, 25_to_75pc) 0.55, 0.10, 0.35;
  (Hairy_cell_leukemia, 25_to_75pc) 0.55, 0.10, 0.35;
  (Carcinoma, 25_to_75pc) 0.55, 0.10, 0.35;
  (Melanoma, 25_to_75pc) 0.55, 0.10, 0.35;
  (EM_plasmacytoma, 25_to_75pc) 0.01, 0.40, 0.59;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.4, 0.4, 0.2;
  (Mast_cell_disease, 25_to_75pc) 0.05, 0.45, 0.50;
  (AIDS_involutionary, 25_to_75pc) 0.50, 0.49, 0.01;
  (T_immunob_large, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (Monocytoid_B_cell, 25_to_75pc) 0.01, 0.10, 0.89;
  (Nasopharyngeal_CA, 25_to_75pc) 0.55, 0.10, 0.35;
  (Seminoma, 25_to_75pc) 0.55, 0.10, 0.35;
  (SLE, 25_to_75pc) 0.15, 0.75, 0.10;
  (Mycobact_histiocytos, 25_to_75pc) 0.50, 0.49, 0.01;
  (Mast_cell_hyperplas, 25_to_75pc) 0.50, 0.49, 0.01;
  (LGV, 25_to_75pc) 0.50, 0.49, 0.01;
  (Histoplasmosis, 25_to_75pc) 0.50, 0.49, 0.01;
  (Coccidioidomycosis, 25_to_75pc) 0.50, 0.49, 0.01;
  (CMV, 25_to_75pc) 0.50, 0.49, 0.01;
  (Brucellosis, 25_to_75pc) 0.50, 0.49, 0.01;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.01, 0.25, 0.74;
  (Intermed_lymphocytic, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (AIDS_early, 75_to_90pc) 0.99, 0.01, 0.00;
  (AILD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (ALIP, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Cat_scratch_disease, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Dermatopathic_laden, 75_to_90pc) 0.95, 0.05, 0.00;
  (Florid_follic_hyperp, 75_to_90pc) 0.99, 0.01, 0.00;
  (GLH_hyaline_vascular, 75_to_90pc) 0.95, 0.05, 0.00;
  (GLH_plasma_cell, 75_to_90pc) 0.95, 0.05, 0.00;
  (Granulomatous_laden, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Histiocytosis_x, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Infectious_mono, 75_to_90pc) 0.95, 0.05, 0.00;
  (Leprosy_lepromatous, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Lymphangiographic, 75_to_90pc) 0.95, 0.05, 0.00;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.99, 0.01, 0.00;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Rheumatoid_arthritis, 75_to_90pc) 0.95, 0.05, 0.00;
  (Sarcoidosis, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (SHML, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Sinus_histiocytosis, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Syphilis, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Toxoplasmosis, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Tuberculosis, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Viral_NOS, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Whipple_s_disease, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (L_H_nodular_HD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (L_H_diffuse_HD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Cellular_phase_NSHD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Syncytial_NSHD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mixed_cellularity_HD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Interfollicular_HD, 75_to_90pc) 0.95, 0.05, 0.00;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Reticular_type_HD, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Small_cleaved_fol, 75_to_90pc) 0.99, 0.01, 0.00;
  (Mixed_fol, 75_to_90pc) 0.99, 0.01, 0.00;
  (Large_cell_fol, 75_to_90pc) 0.99, 0.01, 0.00;
  (Small_noncleaved_fol, 75_to_90pc) 0.99, 0.01, 0.00;
  (Small_lymphocytic, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.75, 0.20, 0.05;
  (Small_cleaved_dif, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mixed_FCC_dif, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Large_cell_dif, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (B_immunoblastic, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (T_immunob_mixed, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Japanese_ATL, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Lymphoblastic, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Small_noncleaved_dif, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (True_histiocytic, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Multiple_myeloma, 75_to_90pc) 0.99, 0.01, 0.00;
  (Mycosis_fungoides, 75_to_90pc) 0.99, 0.01, 0.00;
  (AML, 75_to_90pc) 0.99, 0.01, 0.00;
  (Hairy_cell_leukemia, 75_to_90pc) 0.99, 0.01, 0.00;
  (Carcinoma, 75_to_90pc) 0.99, 0.01, 0.00;
  (Melanoma, 75_to_90pc) 0.99, 0.01, 0.00;
  (EM_plasmacytoma, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.95, 0.05, 0.00;
  (Mast_cell_disease, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (AIDS_involutionary, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (T_immunob_large, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Monocytoid_B_cell, 75_to_90pc) 0.95, 0.05, 0.00;
  (Nasopharyngeal_CA, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Seminoma, 75_to_90pc) 0.99, 0.01, 0.00;
  (SLE, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mycobact_histiocytos, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mast_cell_hyperplas, 75_to_90pc) 0.95, 0.05, 0.00;
  (LGV, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Histoplasmosis, 75_to_90pc) 0.95, 0.05, 0.00;
  (Coccidioidomycosis, 75_to_90pc) 0.95, 0.05, 0.00;
  (CMV, 75_to_90pc) 0.95, 0.05, 0.00;
  (Brucellosis, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Intermed_lymphocytic, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (AIDS_early, GT_90pc) 0.999, 0.001, 0.000;
  (AILD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (ALIP, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Cat_scratch_disease, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Dermatopathic_laden, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Florid_follic_hyperp, GT_90pc) 0.999, 0.001, 0.000;
  (GLH_hyaline_vascular, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (GLH_plasma_cell, GT_90pc) 0.999, 0.001, 0.000;
  (Granulomatous_laden, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Histiocytosis_x, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Infectious_mono, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Leprosy_lepromatous, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Lymphangiographic, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mantle_zone_hyperpla, GT_90pc) 0.999, 0.001, 0.000;
  (Necrotizing_Kikuchi, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Rheumatoid_arthritis, GT_90pc) 0.999, 0.001, 0.000;
  (Sarcoidosis, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (SHML, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Sinus_histiocytosis, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Syphilis, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Toxoplasmosis, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Tuberculosis, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Viral_NOS, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Whipple_s_disease, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (L_H_nodular_HD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (L_H_diffuse_HD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Nodular_sclerosis_HD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Cellular_phase_NSHD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Syncytial_NSHD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mixed_cellularity_HD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Interfollicular_HD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Diffuse_fibrosis_HD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Reticular_type_HD, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Small_cleaved_fol, GT_90pc) 0.999, 0.001, 0.000;
  (Mixed_fol, GT_90pc) 0.999, 0.001, 0.000;
  (Large_cell_fol, GT_90pc) 0.999, 0.001, 0.000;
  (Small_noncleaved_fol, GT_90pc) 0.999, 0.001, 0.000;
  (Small_lymphocytic, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Plasmacytoid_lyctic, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mantle_zone_lymphoma, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Small_cleaved_dif, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mixed_FCC_dif, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Large_cell_dif, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (B_immunoblastic, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (T_immunob_mixed, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (AILD_like_T_cell_lym, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Japanese_ATL, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Lymphoblastic, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Small_noncleaved_dif, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (True_histiocytic, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Multiple_myeloma, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mycosis_fungoides, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (AML, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Hairy_cell_leukemia, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Carcinoma, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Melanoma, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (EM_plasmacytoma, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Kaposi_s_sarcoma, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mast_cell_disease, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (AIDS_involutionary, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (T_immunob_large, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Monocytoid_B_cell, GT_90pc) 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Seminoma, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (SLE, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mycobact_histiocytos, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Mast_cell_hyperplas, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (LGV, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Histoplasmosis, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Coccidioidomycosis, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (CMV, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Brucellosis, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Intermed_lymphocytic, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
}
probability ( ICLC | Fault, ECCC, LLC_I, MLC_I ) {
  (AIDS_early, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (AILD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (ALIP, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Cat_scratch_disease, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Dermatopathic_laden, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (GLH_plasma_cell, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Granulomatous_laden, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Histiocytosis_x, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Infectious_mono, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Leprosy_lepromatous, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Lymphangiographic, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Sarcoidosis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (SHML, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Syphilis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Toxoplasmosis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Tuberculosis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Viral_NOS, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Whipple_s_disease, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (L_H_nodular_HD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Syncytial_NSHD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Interfollicular_HD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Reticular_type_HD, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Small_cleaved_fol, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Mixed_fol, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Large_cell_fol, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Small_lymphocytic, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Small_cleaved_dif, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Large_cell_dif, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (B_immunoblastic, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (T_immunob_mixed, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (AILD_like_T_cell_lym, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Japanese_ATL, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Lymphoblastic, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_noncleaved_dif, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (True_histiocytic, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Multiple_myeloma, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Mycosis_fungoides, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (AML, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Carcinoma, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Melanoma, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (EM_plasmacytoma, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Mast_cell_disease, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (AIDS_involutionary, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (T_immunob_large, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Monocytoid_B_cell, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Seminoma, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (SLE, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mycobact_histiocytos, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (LGV, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Histoplasmosis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Coccidioidomycosis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (CMV, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Brucellosis, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Absent_no, Absent_no) 0.5, 0.5;
  (Intermed_lymphocytic, Absent_0pc, Absent_no, Absent_no) 1.0, 0.0;
  (AIDS_early, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (AILD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (ALIP, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Cat_scratch_disease, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Dermatopathic_laden, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Florid_follic_hyperp, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (GLH_hyaline_vascular, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (GLH_plasma_cell, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Granulomatous_laden, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Histiocytosis_x, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Infectious_mono, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Leprosy_lepromatous, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Lymphangiographic, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mantle_zone_hyperpla, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Necrotizing_Kikuchi, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Rheumatoid_arthritis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Sarcoidosis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (SHML, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Sinus_histiocytosis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Syphilis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Toxoplasmosis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Tuberculosis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Viral_NOS, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Whipple_s_disease, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (L_H_nodular_HD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (L_H_diffuse_HD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Nodular_sclerosis_HD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Cellular_phase_NSHD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Syncytial_NSHD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_cellularity_HD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Interfollicular_HD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Reticular_type_HD, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_cleaved_fol, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_fol, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Large_cell_fol, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_noncleaved_fol, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_lymphocytic, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Plasmacytoid_lyctic, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mantle_zone_lymphoma, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_cleaved_dif, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_FCC_dif, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Large_cell_dif, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (B_immunoblastic, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (T_immunob_mixed, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (AILD_like_T_cell_lym, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Japanese_ATL, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Lymphoblastic, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_noncleaved_dif, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (True_histiocytic, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Multiple_myeloma, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mycosis_fungoides, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (AML, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Hairy_cell_leukemia, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Carcinoma, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Melanoma, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (EM_plasmacytoma, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Kaposi_s_sarcoma, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mast_cell_disease, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (AIDS_involutionary, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (T_immunob_large, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Monocytoid_B_cell, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Nasopharyngeal_CA, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Seminoma, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (SLE, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mycobact_histiocytos, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mast_cell_hyperplas, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (LGV, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Histoplasmosis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Coccidioidomycosis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (CMV, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Brucellosis, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (Intermed_lymphocytic, Rare_1_to_10pc, Absent_no, Absent_no) 0.5, 0.5;
  (AIDS_early, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (AILD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (ALIP, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Cat_scratch_disease, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Dermatopathic_laden, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Florid_follic_hyperp, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (GLH_hyaline_vascular, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (GLH_plasma_cell, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Granulomatous_laden, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Histiocytosis_x, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Infectious_mono, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Leprosy_lepromatous, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Lymphangiographic, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mantle_zone_hyperpla, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Necrotizing_Kikuchi, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Rheumatoid_arthritis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Sarcoidosis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (SHML, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Sinus_histiocytosis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Syphilis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Toxoplasmosis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Tuberculosis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Viral_NOS, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Whipple_s_disease, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (L_H_nodular_HD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (L_H_diffuse_HD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Nodular_sclerosis_HD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Cellular_phase_NSHD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Syncytial_NSHD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_cellularity_HD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Interfollicular_HD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Reticular_type_HD, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_cleaved_fol, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_fol, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Large_cell_fol, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_noncleaved_fol, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_lymphocytic, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Plasmacytoid_lyctic, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mantle_zone_lymphoma, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_cleaved_dif, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_FCC_dif, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Large_cell_dif, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (B_immunoblastic, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (T_immunob_mixed, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (AILD_like_T_cell_lym, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Japanese_ATL, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Lymphoblastic, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_noncleaved_dif, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (True_histiocytic, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Multiple_myeloma, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mycosis_fungoides, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (AML, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Hairy_cell_leukemia, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Carcinoma, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Melanoma, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (EM_plasmacytoma, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Kaposi_s_sarcoma, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mast_cell_disease, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (AIDS_involutionary, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (T_immunob_large, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Monocytoid_B_cell, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Nasopharyngeal_CA, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Seminoma, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (SLE, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mycobact_histiocytos, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mast_cell_hyperplas, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (LGV, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Histoplasmosis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Coccidioidomycosis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (CMV, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Brucellosis, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (Intermed_lymphocytic, Present_11_to_50pc, Absent_no, Absent_no) 0.5, 0.5;
  (AIDS_early, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (AILD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (ALIP, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Cat_scratch_disease, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Dermatopathic_laden, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Florid_follic_hyperp, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (GLH_hyaline_vascular, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (GLH_plasma_cell, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Granulomatous_laden, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Histiocytosis_x, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Infectious_mono, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Leprosy_lepromatous, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Lymphangiographic, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mantle_zone_hyperpla, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Necrotizing_Kikuchi, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Rheumatoid_arthritis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Sarcoidosis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (SHML, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Sinus_histiocytosis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Syphilis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Toxoplasmosis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Tuberculosis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Viral_NOS, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Whipple_s_disease, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (L_H_nodular_HD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (L_H_diffuse_HD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Nodular_sclerosis_HD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Cellular_phase_NSHD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Syncytial_NSHD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_cellularity_HD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Interfollicular_HD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Reticular_type_HD, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_cleaved_fol, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_fol, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Large_cell_fol, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_noncleaved_fol, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_lymphocytic, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Plasmacytoid_lyctic, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mantle_zone_lymphoma, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_cleaved_dif, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mixed_FCC_dif, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Large_cell_dif, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (B_immunoblastic, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (T_immunob_mixed, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (AILD_like_T_cell_lym, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Japanese_ATL, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Lymphoblastic, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Small_noncleaved_dif, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (True_histiocytic, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Multiple_myeloma, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mycosis_fungoides, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (AML, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Hairy_cell_leukemia, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Carcinoma, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Melanoma, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (EM_plasmacytoma, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Kaposi_s_sarcoma, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mast_cell_disease, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (AIDS_involutionary, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (T_immunob_large, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Monocytoid_B_cell, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Nasopharyngeal_CA, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Seminoma, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (SLE, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mycobact_histiocytos, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Mast_cell_hyperplas, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (LGV, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Histoplasmosis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Coccidioidomycosis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (CMV, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Brucellosis, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (Intermed_lymphocytic, Many_51_to_70pc, Absent_no, Absent_no) 0.5, 0.5;
  (AIDS_early, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (AILD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (ALIP, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Cat_scratch_disease, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Dermatopathic_laden, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Florid_follic_hyperp, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (GLH_hyaline_vascular, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (GLH_plasma_cell, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Granulomatous_laden, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Histiocytosis_x, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Infectious_mono, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Leprosy_lepromatous, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Lymphangiographic, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Mantle_zone_hyperpla, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Necrotizing_Kikuchi, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Necrotiz_non_Kikuchi, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Rheumatoid_arthritis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Sarcoidosis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (SHML, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Sinus_histiocytosis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Syphilis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Toxoplasmosis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Tuberculosis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Viral_NOS, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Whipple_s_disease, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (L_H_nodular_HD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (L_H_diffuse_HD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Nodular_sclerosis_HD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Cellular_phase_NSHD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Syncytial_NSHD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Mixed_cellularity_HD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Interfollicular_HD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Diffuse_fibrosis_HD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Reticular_type_HD, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Small_cleaved_fol, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Mixed_fol, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Large_cell_fol, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Small_noncleaved_fol, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Small_lymphocytic, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Plasmacytoid_lyctic, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Mantle_zone_lymphoma, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Small_cleaved_dif, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Mixed_FCC_dif, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Large_cell_dif, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (B_immunoblastic, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (T_immunob_mixed, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (AILD_like_T_cell_lym, Absent_0pc, Present_yes, Absent_no) 0.5, 0.5;
  (Japanese_ATL, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Lymphoblastic, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Small_noncleaved_dif, Absent_0pc, Present_yes, Absent_no) 0.5, 0.5;
  (True_histiocytic, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Ki_1_LC_anaplas_T, Absent_0pc, Present_yes, Absent_no) 0.7, 0.3;
  (Multiple_myeloma, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Mycosis_fungoides, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (AML, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Hairy_cell_leukemia, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Carcinoma, Absent_0pc, Present_yes, Absent_no) 0.9, 0.1;
  (Melanoma, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (EM_plasmacytoma, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Kaposi_s_sarcoma, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Mast_cell_disease, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (AIDS_involutionary, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (T_immunob_large, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Monocytoid_B_cell, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Nasopharyngeal_CA, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Seminoma, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (SLE, Absent_0pc, Present_yes, Absent_no) 0.99, 0.01;
  (Mycobact_histiocytos, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Mast_cell_hyperplas, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (LGV, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Histoplasmosis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Coccidioidomycosis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (CMV, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Brucellosis, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_B, Absent_0pc, Present_yes, Absent_no) 0.7, 0.3;
  (Intermed_lymphocytic, Absent_0pc, Present_yes, Absent_no) 0.9999, 0.0001;
  (AIDS_early, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (AILD, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (ALIP, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Cat_scratch_disease, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Dermatopathic_laden, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Florid_follic_hyperp, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (GLH_hyaline_vascular, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (GLH_plasma_cell, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Granulomatous_laden, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Histiocytosis_x, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Infectious_mono, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Leprosy_lepromatous, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Lymphangiographic, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mantle_zone_hyperpla, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Necrotizing_Kikuchi, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Necrotiz_non_Kikuchi, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Rheumatoid_arthritis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Sarcoidosis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (SHML, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Sinus_histiocytosis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Syphilis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Toxoplasmosis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Tuberculosis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Viral_NOS, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Whipple_s_disease, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (L_H_nodular_HD, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (L_H_diffuse_HD, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Nodular_sclerosis_HD, Rare_1_to_10pc, Present_yes, Absent_no) 0.999, 0.001;
  (Cellular_phase_NSHD, Rare_1_to_10pc, Present_yes, Absent_no) 0.999, 0.001;
  (Syncytial_NSHD, Rare_1_to_10pc, Present_yes, Absent_no) 0.999, 0.001;
  (Mixed_cellularity_HD, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Interfollicular_HD, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Reticular_type_HD, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_cleaved_fol, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mixed_fol, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Large_cell_fol, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_noncleaved_fol, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_lymphocytic, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Plasmacytoid_lyctic, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mantle_zone_lymphoma, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_cleaved_dif, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mixed_FCC_dif, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Large_cell_dif, Rare_1_to_10pc, Present_yes, Absent_no) 0.995, 0.005;
  (B_immunoblastic, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (T_immunob_mixed, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (AILD_like_T_cell_lym, Rare_1_to_10pc, Present_yes, Absent_no) 0.9, 0.1;
  (Japanese_ATL, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Lymphoblastic, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_noncleaved_dif, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (True_histiocytic, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Ki_1_LC_anaplas_T, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Multiple_myeloma, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mycosis_fungoides, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (AML, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Hairy_cell_leukemia, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Carcinoma, Rare_1_to_10pc, Present_yes, Absent_no) 0.999, 0.001;
  (Melanoma, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (EM_plasmacytoma, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Kaposi_s_sarcoma, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mast_cell_disease, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (AIDS_involutionary, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (T_immunob_large, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Monocytoid_B_cell, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Nasopharyngeal_CA, Rare_1_to_10pc, Present_yes, Absent_no) 0.999, 0.001;
  (Seminoma, Rare_1_to_10pc, Present_yes, Absent_no) 0.999, 0.001;
  (SLE, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Mycobact_histiocytos, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mast_cell_hyperplas, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (LGV, Rare_1_to_10pc, Present_yes, Absent_no) 0.99, 0.01;
  (Histoplasmosis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Coccidioidomycosis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (CMV, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Brucellosis, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (Intermed_lymphocytic, Rare_1_to_10pc, Present_yes, Absent_no) 0.5, 0.5;
  (AIDS_early, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (AILD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (ALIP, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Cat_scratch_disease, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Dermatopathic_laden, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Florid_follic_hyperp, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (GLH_hyaline_vascular, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (GLH_plasma_cell, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Granulomatous_laden, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Histiocytosis_x, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Infectious_mono, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Leprosy_lepromatous, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Lymphangiographic, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mantle_zone_hyperpla, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Necrotizing_Kikuchi, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Rheumatoid_arthritis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Sarcoidosis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (SHML, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Sinus_histiocytosis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Syphilis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Toxoplasmosis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Tuberculosis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Viral_NOS, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Whipple_s_disease, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (L_H_nodular_HD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (L_H_diffuse_HD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Nodular_sclerosis_HD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Cellular_phase_NSHD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Syncytial_NSHD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mixed_cellularity_HD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Interfollicular_HD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Reticular_type_HD, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_cleaved_fol, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mixed_fol, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Large_cell_fol, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_noncleaved_fol, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_lymphocytic, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Plasmacytoid_lyctic, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mantle_zone_lymphoma, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_cleaved_dif, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mixed_FCC_dif, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Large_cell_dif, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (B_immunoblastic, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (T_immunob_mixed, Present_11_to_50pc, Present_yes, Absent_no) 0.98, 0.02;
  (AILD_like_T_cell_lym, Present_11_to_50pc, Present_yes, Absent_no) 0.8, 0.2;
  (Japanese_ATL, Present_11_to_50pc, Present_yes, Absent_no) 0.98, 0.02;
  (Lymphoblastic, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_noncleaved_dif, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (True_histiocytic, Present_11_to_50pc, Present_yes, Absent_no) 0.98, 0.02;
  (Ki_1_LC_anaplas_T, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Multiple_myeloma, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mycosis_fungoides, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (AML, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Hairy_cell_leukemia, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Carcinoma, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Melanoma, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (EM_plasmacytoma, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Kaposi_s_sarcoma, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mast_cell_disease, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (AIDS_involutionary, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (T_immunob_large, Present_11_to_50pc, Present_yes, Absent_no) 0.98, 0.02;
  (Monocytoid_B_cell, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Nasopharyngeal_CA, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Seminoma, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (SLE, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mycobact_histiocytos, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mast_cell_hyperplas, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (LGV, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Histoplasmosis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Coccidioidomycosis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (CMV, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Brucellosis, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (Intermed_lymphocytic, Present_11_to_50pc, Present_yes, Absent_no) 0.5, 0.5;
  (AIDS_early, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (AILD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (ALIP, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Cat_scratch_disease, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Dermatopathic_laden, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Florid_follic_hyperp, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (GLH_hyaline_vascular, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (GLH_plasma_cell, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Granulomatous_laden, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Histiocytosis_x, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Infectious_mono, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Leprosy_lepromatous, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Lymphangiographic, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mantle_zone_hyperpla, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Necrotizing_Kikuchi, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Rheumatoid_arthritis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Sarcoidosis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (SHML, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Sinus_histiocytosis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Syphilis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Toxoplasmosis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Tuberculosis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Viral_NOS, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Whipple_s_disease, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (L_H_nodular_HD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (L_H_diffuse_HD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Nodular_sclerosis_HD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Cellular_phase_NSHD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Syncytial_NSHD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mixed_cellularity_HD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Interfollicular_HD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Reticular_type_HD, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_cleaved_fol, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mixed_fol, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Large_cell_fol, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_noncleaved_fol, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_lymphocytic, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Plasmacytoid_lyctic, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mantle_zone_lymphoma, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_cleaved_dif, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mixed_FCC_dif, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Large_cell_dif, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (B_immunoblastic, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (T_immunob_mixed, Many_51_to_70pc, Present_yes, Absent_no) 0.99, 0.01;
  (AILD_like_T_cell_lym, Many_51_to_70pc, Present_yes, Absent_no) 0.3, 0.7;
  (Japanese_ATL, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Lymphoblastic, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Small_noncleaved_dif, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (True_histiocytic, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Multiple_myeloma, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mycosis_fungoides, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (AML, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Hairy_cell_leukemia, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Carcinoma, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Melanoma, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (EM_plasmacytoma, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Kaposi_s_sarcoma, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mast_cell_disease, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (AIDS_involutionary, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (T_immunob_large, Many_51_to_70pc, Present_yes, Absent_no) 0.99, 0.01;
  (Monocytoid_B_cell, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Nasopharyngeal_CA, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Seminoma, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (SLE, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mycobact_histiocytos, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Mast_cell_hyperplas, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (LGV, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Histoplasmosis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Coccidioidomycosis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (CMV, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Brucellosis, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (Intermed_lymphocytic, Many_51_to_70pc, Present_yes, Absent_no) 0.5, 0.5;
  (AIDS_early, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (AILD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (ALIP, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Cat_scratch_disease, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Dermatopathic_laden, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (GLH_plasma_cell, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Granulomatous_laden, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Histiocytosis_x, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Infectious_mono, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (Leprosy_lepromatous, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Lymphangiographic, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Sarcoidosis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (SHML, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Syphilis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Toxoplasmosis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Tuberculosis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Viral_NOS, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (Whipple_s_disease, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (L_H_nodular_HD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Syncytial_NSHD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Interfollicular_HD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Reticular_type_HD, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Small_cleaved_fol, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Mixed_fol, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Large_cell_fol, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Small_lymphocytic, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Small_cleaved_dif, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Large_cell_dif, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (B_immunoblastic, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (T_immunob_mixed, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (AILD_like_T_cell_lym, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (Japanese_ATL, Absent_0pc, Absent_no, Present_yes) 0.999, 0.001;
  (Lymphoblastic, Absent_0pc, Absent_no, Present_yes) 0.99, 0.01;
  (Small_noncleaved_dif, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (True_histiocytic, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (Multiple_myeloma, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Mycosis_fungoides, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (AML, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc, Absent_no, Present_yes) 0.999, 0.001;
  (Carcinoma, Absent_0pc, Absent_no, Present_yes) 0.999, 0.001;
  (Melanoma, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (EM_plasmacytoma, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Mast_cell_disease, Absent_0pc, Absent_no, Present_yes) 0.999, 0.001;
  (AIDS_involutionary, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (T_immunob_large, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (Monocytoid_B_cell, Absent_0pc, Absent_no, Present_yes) 0.999, 0.001;
  (Nasopharyngeal_CA, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Seminoma, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (SLE, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mycobact_histiocytos, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc, Absent_no, Present_yes) 0.999, 0.001;
  (LGV, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Histoplasmosis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Coccidioidomycosis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (CMV, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Brucellosis, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Absent_no, Present_yes) 0.5, 0.5;
  (Intermed_lymphocytic, Absent_0pc, Absent_no, Present_yes) 1.0, 0.0;
  (AIDS_early, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (AILD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (ALIP, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Cat_scratch_disease, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Dermatopathic_laden, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Florid_follic_hyperp, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (GLH_hyaline_vascular, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (GLH_plasma_cell, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Granulomatous_laden, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Histiocytosis_x, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Infectious_mono, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Leprosy_lepromatous, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Lymphangiographic, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mantle_zone_hyperpla, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Necrotizing_Kikuchi, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Rheumatoid_arthritis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Sarcoidosis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (SHML, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Sinus_histiocytosis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Syphilis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Toxoplasmosis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Tuberculosis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Viral_NOS, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Whipple_s_disease, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (L_H_nodular_HD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (L_H_diffuse_HD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Nodular_sclerosis_HD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Cellular_phase_NSHD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Syncytial_NSHD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_cellularity_HD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Interfollicular_HD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Reticular_type_HD, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_cleaved_fol, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_fol, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Large_cell_fol, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_noncleaved_fol, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_lymphocytic, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Plasmacytoid_lyctic, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mantle_zone_lymphoma, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_cleaved_dif, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_FCC_dif, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Large_cell_dif, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (B_immunoblastic, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (T_immunob_mixed, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (AILD_like_T_cell_lym, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Japanese_ATL, Rare_1_to_10pc, Absent_no, Present_yes) 0.999, 0.001;
  (Lymphoblastic, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_noncleaved_dif, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (True_histiocytic, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Multiple_myeloma, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mycosis_fungoides, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (AML, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Hairy_cell_leukemia, Rare_1_to_10pc, Absent_no, Present_yes) 0.99, 0.01;
  (Carcinoma, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Melanoma, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (EM_plasmacytoma, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Kaposi_s_sarcoma, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mast_cell_disease, Rare_1_to_10pc, Absent_no, Present_yes) 0.999, 0.001;
  (AIDS_involutionary, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (T_immunob_large, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Monocytoid_B_cell, Rare_1_to_10pc, Absent_no, Present_yes) 0.999, 0.001;
  (Nasopharyngeal_CA, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Seminoma, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (SLE, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mycobact_histiocytos, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mast_cell_hyperplas, Rare_1_to_10pc, Absent_no, Present_yes) 0.999, 0.001;
  (LGV, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Histoplasmosis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Coccidioidomycosis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (CMV, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Brucellosis, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (Intermed_lymphocytic, Rare_1_to_10pc, Absent_no, Present_yes) 0.5, 0.5;
  (AIDS_early, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (AILD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (ALIP, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Cat_scratch_disease, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Dermatopathic_laden, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Florid_follic_hyperp, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (GLH_hyaline_vascular, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (GLH_plasma_cell, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Granulomatous_laden, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Histiocytosis_x, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Infectious_mono, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Leprosy_lepromatous, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Lymphangiographic, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mantle_zone_hyperpla, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Necrotizing_Kikuchi, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Rheumatoid_arthritis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Sarcoidosis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (SHML, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Sinus_histiocytosis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Syphilis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Toxoplasmosis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Tuberculosis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Viral_NOS, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Whipple_s_disease, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (L_H_nodular_HD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (L_H_diffuse_HD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Nodular_sclerosis_HD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Cellular_phase_NSHD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Syncytial_NSHD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_cellularity_HD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Interfollicular_HD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Reticular_type_HD, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_cleaved_fol, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_fol, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Large_cell_fol, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_noncleaved_fol, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_lymphocytic, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Plasmacytoid_lyctic, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mantle_zone_lymphoma, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_cleaved_dif, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_FCC_dif, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Large_cell_dif, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (B_immunoblastic, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (T_immunob_mixed, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (AILD_like_T_cell_lym, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Japanese_ATL, Present_11_to_50pc, Absent_no, Present_yes) 0.99, 0.01;
  (Lymphoblastic, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_noncleaved_dif, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (True_histiocytic, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Multiple_myeloma, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mycosis_fungoides, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (AML, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Hairy_cell_leukemia, Present_11_to_50pc, Absent_no, Present_yes) 0.99, 0.01;
  (Carcinoma, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Melanoma, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (EM_plasmacytoma, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Kaposi_s_sarcoma, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mast_cell_disease, Present_11_to_50pc, Absent_no, Present_yes) 0.999, 0.001;
  (AIDS_involutionary, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (T_immunob_large, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Monocytoid_B_cell, Present_11_to_50pc, Absent_no, Present_yes) 0.999, 0.001;
  (Nasopharyngeal_CA, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Seminoma, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (SLE, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mycobact_histiocytos, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mast_cell_hyperplas, Present_11_to_50pc, Absent_no, Present_yes) 0.999, 0.001;
  (LGV, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Histoplasmosis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Coccidioidomycosis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (CMV, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Brucellosis, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (Intermed_lymphocytic, Present_11_to_50pc, Absent_no, Present_yes) 0.5, 0.5;
  (AIDS_early, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (AILD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (ALIP, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Cat_scratch_disease, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Dermatopathic_laden, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Florid_follic_hyperp, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (GLH_hyaline_vascular, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (GLH_plasma_cell, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Granulomatous_laden, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Histiocytosis_x, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Infectious_mono, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Leprosy_lepromatous, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Lymphangiographic, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mantle_zone_hyperpla, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Necrotizing_Kikuchi, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Rheumatoid_arthritis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Sarcoidosis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (SHML, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Sinus_histiocytosis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Syphilis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Toxoplasmosis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Tuberculosis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Viral_NOS, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Whipple_s_disease, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (L_H_nodular_HD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (L_H_diffuse_HD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Nodular_sclerosis_HD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Cellular_phase_NSHD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Syncytial_NSHD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_cellularity_HD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Interfollicular_HD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Reticular_type_HD, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_cleaved_fol, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_fol, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Large_cell_fol, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_noncleaved_fol, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_lymphocytic, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Plasmacytoid_lyctic, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mantle_zone_lymphoma, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_cleaved_dif, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mixed_FCC_dif, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Large_cell_dif, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (B_immunoblastic, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (T_immunob_mixed, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (AILD_like_T_cell_lym, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Japanese_ATL, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Lymphoblastic, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Small_noncleaved_dif, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (True_histiocytic, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Multiple_myeloma, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mycosis_fungoides, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (AML, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Hairy_cell_leukemia, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Carcinoma, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Melanoma, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (EM_plasmacytoma, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Kaposi_s_sarcoma, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mast_cell_disease, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (AIDS_involutionary, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (T_immunob_large, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Monocytoid_B_cell, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Nasopharyngeal_CA, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Seminoma, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (SLE, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mycobact_histiocytos, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Mast_cell_hyperplas, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (LGV, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Histoplasmosis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Coccidioidomycosis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (CMV, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Brucellosis, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (Intermed_lymphocytic, Many_51_to_70pc, Absent_no, Present_yes) 0.5, 0.5;
  (AIDS_early, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (AILD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (ALIP, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Cat_scratch_disease, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Dermatopathic_laden, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Florid_follic_hyperp, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (GLH_hyaline_vascular, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (GLH_plasma_cell, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Granulomatous_laden, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Histiocytosis_x, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Infectious_mono, Absent_0pc, Present_yes, Present_yes) 0.98, 0.02;
  (Leprosy_lepromatous, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Lymphangiographic, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Mantle_zone_hyperpla, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Necrotizing_Kikuchi, Absent_0pc, Present_yes, Present_yes) 0.98, 0.02;
  (Necrotiz_non_Kikuchi, Absent_0pc, Present_yes, Present_yes) 0.98, 0.02;
  (Rheumatoid_arthritis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Sarcoidosis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (SHML, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Sinus_histiocytosis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Syphilis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Toxoplasmosis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Tuberculosis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Viral_NOS, Absent_0pc, Present_yes, Present_yes) 0.98, 0.02;
  (Whipple_s_disease, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (L_H_nodular_HD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (L_H_diffuse_HD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Nodular_sclerosis_HD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Cellular_phase_NSHD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Syncytial_NSHD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Mixed_cellularity_HD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Interfollicular_HD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Diffuse_fibrosis_HD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Reticular_type_HD, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Small_cleaved_fol, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Mixed_fol, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Large_cell_fol, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Small_noncleaved_fol, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Small_lymphocytic, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Plasmacytoid_lyctic, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Mantle_zone_lymphoma, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Small_cleaved_dif, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Mixed_FCC_dif, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Large_cell_dif, Absent_0pc, Present_yes, Present_yes) 0.99, 0.01;
  (B_immunoblastic, Absent_0pc, Present_yes, Present_yes) 0.99, 0.01;
  (T_immunob_mixed, Absent_0pc, Present_yes, Present_yes) 0.99, 0.01;
  (AILD_like_T_cell_lym, Absent_0pc, Present_yes, Present_yes) 0.5, 0.5;
  (Japanese_ATL, Absent_0pc, Present_yes, Present_yes) 0.99, 0.01;
  (Lymphoblastic, Absent_0pc, Present_yes, Present_yes) 0.95, 0.05;
  (Small_noncleaved_dif, Absent_0pc, Present_yes, Present_yes) 0.99, 0.01;
  (True_histiocytic, Absent_0pc, Present_yes, Present_yes) 0.99, 0.01;
  (Ki_1_LC_anaplas_T, Absent_0pc, Present_yes, Present_yes) 0.7, 0.3;
  (Multiple_myeloma, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Mycosis_fungoides, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (AML, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Hairy_cell_leukemia, Absent_0pc, Present_yes, Present_yes) 0.99, 0.01;
  (Carcinoma, Absent_0pc, Present_yes, Present_yes) 0.9, 0.1;
  (Melanoma, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (EM_plasmacytoma, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Kaposi_s_sarcoma, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Mast_cell_disease, Absent_0pc, Present_yes, Present_yes) 0.999, 0.001;
  (AIDS_involutionary, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (T_immunob_large, Absent_0pc, Present_yes, Present_yes) 0.99, 0.01;
  (Monocytoid_B_cell, Absent_0pc, Present_yes, Present_yes) 0.999, 0.001;
  (Nasopharyngeal_CA, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Seminoma, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (SLE, Absent_0pc, Present_yes, Present_yes) 0.98, 0.02;
  (Mycobact_histiocytos, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Mast_cell_hyperplas, Absent_0pc, Present_yes, Present_yes) 0.999, 0.001;
  (LGV, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Histoplasmosis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Coccidioidomycosis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (CMV, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Brucellosis, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_B, Absent_0pc, Present_yes, Present_yes) 0.7, 0.3;
  (Intermed_lymphocytic, Absent_0pc, Present_yes, Present_yes) 0.9999, 0.0001;
  (AIDS_early, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (AILD, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (ALIP, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Cat_scratch_disease, Rare_1_to_10pc, Present_yes, Present_yes) 0.99, 0.01;
  (Dermatopathic_laden, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Florid_follic_hyperp, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (GLH_hyaline_vascular, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (GLH_plasma_cell, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Granulomatous_laden, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Histiocytosis_x, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Infectious_mono, Rare_1_to_10pc, Present_yes, Present_yes) 0.98, 0.02;
  (Leprosy_lepromatous, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Lymphangiographic, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mantle_zone_hyperpla, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Necrotizing_Kikuchi, Rare_1_to_10pc, Present_yes, Present_yes) 0.98, 0.02;
  (Necrotiz_non_Kikuchi, Rare_1_to_10pc, Present_yes, Present_yes) 0.98, 0.02;
  (Rheumatoid_arthritis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Sarcoidosis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (SHML, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Sinus_histiocytosis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Syphilis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Toxoplasmosis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Tuberculosis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Viral_NOS, Rare_1_to_10pc, Present_yes, Present_yes) 0.98, 0.02;
  (Whipple_s_disease, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (L_H_nodular_HD, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (L_H_diffuse_HD, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Nodular_sclerosis_HD, Rare_1_to_10pc, Present_yes, Present_yes) 0.99, 0.01;
  (Cellular_phase_NSHD, Rare_1_to_10pc, Present_yes, Present_yes) 0.99, 0.01;
  (Syncytial_NSHD, Rare_1_to_10pc, Present_yes, Present_yes) 0.99, 0.01;
  (Mixed_cellularity_HD, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Interfollicular_HD, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Reticular_type_HD, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_cleaved_fol, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mixed_fol, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Large_cell_fol, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_noncleaved_fol, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_lymphocytic, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Plasmacytoid_lyctic, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mantle_zone_lymphoma, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_cleaved_dif, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mixed_FCC_dif, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Large_cell_dif, Rare_1_to_10pc, Present_yes, Present_yes) 0.99, 0.01;
  (B_immunoblastic, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (T_immunob_mixed, Rare_1_to_10pc, Present_yes, Present_yes) 0.99, 0.01;
  (AILD_like_T_cell_lym, Rare_1_to_10pc, Present_yes, Present_yes) 0.9, 0.1;
  (Japanese_ATL, Rare_1_to_10pc, Present_yes, Present_yes) 0.96, 0.04;
  (Lymphoblastic, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_noncleaved_dif, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (True_histiocytic, Rare_1_to_10pc, Present_yes, Present_yes) 0.97, 0.03;
  (Ki_1_LC_anaplas_T, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Multiple_myeloma, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mycosis_fungoides, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (AML, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Hairy_cell_leukemia, Rare_1_to_10pc, Present_yes, Present_yes) 0.99, 0.01;
  (Carcinoma, Rare_1_to_10pc, Present_yes, Present_yes) 0.999, 0.001;
  (Melanoma, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (EM_plasmacytoma, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Kaposi_s_sarcoma, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mast_cell_disease, Rare_1_to_10pc, Present_yes, Present_yes) 0.999, 0.001;
  (AIDS_involutionary, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (T_immunob_large, Rare_1_to_10pc, Present_yes, Present_yes) 0.97, 0.03;
  (Monocytoid_B_cell, Rare_1_to_10pc, Present_yes, Present_yes) 0.999, 0.001;
  (Nasopharyngeal_CA, Rare_1_to_10pc, Present_yes, Present_yes) 0.999, 0.001;
  (Seminoma, Rare_1_to_10pc, Present_yes, Present_yes) 0.999, 0.001;
  (SLE, Rare_1_to_10pc, Present_yes, Present_yes) 0.98, 0.02;
  (Mycobact_histiocytos, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mast_cell_hyperplas, Rare_1_to_10pc, Present_yes, Present_yes) 0.999, 0.001;
  (LGV, Rare_1_to_10pc, Present_yes, Present_yes) 0.99, 0.01;
  (Histoplasmosis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Coccidioidomycosis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (CMV, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Brucellosis, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (Intermed_lymphocytic, Rare_1_to_10pc, Present_yes, Present_yes) 0.5, 0.5;
  (AIDS_early, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (AILD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (ALIP, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Cat_scratch_disease, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Dermatopathic_laden, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Florid_follic_hyperp, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (GLH_hyaline_vascular, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (GLH_plasma_cell, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Granulomatous_laden, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Histiocytosis_x, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Infectious_mono, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Leprosy_lepromatous, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Lymphangiographic, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mantle_zone_hyperpla, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Necrotizing_Kikuchi, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Rheumatoid_arthritis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Sarcoidosis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (SHML, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Sinus_histiocytosis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Syphilis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Toxoplasmosis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Tuberculosis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Viral_NOS, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Whipple_s_disease, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (L_H_nodular_HD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (L_H_diffuse_HD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Nodular_sclerosis_HD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Cellular_phase_NSHD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Syncytial_NSHD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mixed_cellularity_HD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Interfollicular_HD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Reticular_type_HD, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_cleaved_fol, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mixed_fol, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Large_cell_fol, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_noncleaved_fol, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_lymphocytic, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Plasmacytoid_lyctic, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mantle_zone_lymphoma, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_cleaved_dif, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mixed_FCC_dif, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Large_cell_dif, Present_11_to_50pc, Present_yes, Present_yes) 0.99, 0.01;
  (B_immunoblastic, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (T_immunob_mixed, Present_11_to_50pc, Present_yes, Present_yes) 0.98, 0.02;
  (AILD_like_T_cell_lym, Present_11_to_50pc, Present_yes, Present_yes) 0.8, 0.2;
  (Japanese_ATL, Present_11_to_50pc, Present_yes, Present_yes) 0.98, 0.02;
  (Lymphoblastic, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_noncleaved_dif, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (True_histiocytic, Present_11_to_50pc, Present_yes, Present_yes) 0.98, 0.02;
  (Ki_1_LC_anaplas_T, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Multiple_myeloma, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mycosis_fungoides, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (AML, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Hairy_cell_leukemia, Present_11_to_50pc, Present_yes, Present_yes) 0.99, 0.01;
  (Carcinoma, Present_11_to_50pc, Present_yes, Present_yes) 0.999, 0.001;
  (Melanoma, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (EM_plasmacytoma, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Kaposi_s_sarcoma, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mast_cell_disease, Present_11_to_50pc, Present_yes, Present_yes) 0.999, 0.001;
  (AIDS_involutionary, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (T_immunob_large, Present_11_to_50pc, Present_yes, Present_yes) 0.98, 0.02;
  (Monocytoid_B_cell, Present_11_to_50pc, Present_yes, Present_yes) 0.999, 0.001;
  (Nasopharyngeal_CA, Present_11_to_50pc, Present_yes, Present_yes) 0.999, 0.001;
  (Seminoma, Present_11_to_50pc, Present_yes, Present_yes) 0.999, 0.001;
  (SLE, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mycobact_histiocytos, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mast_cell_hyperplas, Present_11_to_50pc, Present_yes, Present_yes) 0.999, 0.001;
  (LGV, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Histoplasmosis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Coccidioidomycosis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (CMV, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Brucellosis, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (Intermed_lymphocytic, Present_11_to_50pc, Present_yes, Present_yes) 0.5, 0.5;
  (AIDS_early, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (AILD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (ALIP, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Cat_scratch_disease, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Dermatopathic_laden, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Florid_follic_hyperp, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (GLH_hyaline_vascular, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (GLH_plasma_cell, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Granulomatous_laden, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Histiocytosis_x, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Infectious_mono, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Leprosy_lepromatous, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Lymphangiographic, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mantle_zone_hyperpla, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Necrotizing_Kikuchi, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Rheumatoid_arthritis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Sarcoidosis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (SHML, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Sinus_histiocytosis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Syphilis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Toxoplasmosis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Tuberculosis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Viral_NOS, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Whipple_s_disease, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (L_H_nodular_HD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (L_H_diffuse_HD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Nodular_sclerosis_HD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Cellular_phase_NSHD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Syncytial_NSHD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mixed_cellularity_HD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Interfollicular_HD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Reticular_type_HD, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_cleaved_fol, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mixed_fol, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Large_cell_fol, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_noncleaved_fol, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_lymphocytic, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Plasmacytoid_lyctic, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mantle_zone_lymphoma, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_cleaved_dif, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mixed_FCC_dif, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Large_cell_dif, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (B_immunoblastic, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (T_immunob_mixed, Many_51_to_70pc, Present_yes, Present_yes) 0.9, 0.1;
  (AILD_like_T_cell_lym, Many_51_to_70pc, Present_yes, Present_yes) 0.3, 0.7;
  (Japanese_ATL, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Lymphoblastic, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Small_noncleaved_dif, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (True_histiocytic, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Multiple_myeloma, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mycosis_fungoides, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (AML, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Hairy_cell_leukemia, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Carcinoma, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Melanoma, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (EM_plasmacytoma, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Kaposi_s_sarcoma, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mast_cell_disease, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (AIDS_involutionary, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (T_immunob_large, Many_51_to_70pc, Present_yes, Present_yes) 0.98, 0.02;
  (Monocytoid_B_cell, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Nasopharyngeal_CA, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Seminoma, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (SLE, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mycobact_histiocytos, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Mast_cell_hyperplas, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (LGV, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Histoplasmosis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Coccidioidomycosis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (CMV, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Brucellosis, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
  (Intermed_lymphocytic, Many_51_to_70pc, Present_yes, Present_yes) 0.5, 0.5;
}
probability ( KARYO | Fault, NECR ) {
  (AIDS_early, Absent) 0.999, 0.001, 0.000;
  (AILD, Absent) 0.999, 0.001, 0.000;
  (ALIP, Absent) 0.999, 0.001, 0.000;
  (Cat_scratch_disease, Absent) 0.38, 0.60, 0.02;
  (Dermatopathic_laden, Absent) 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, Absent) 0.999, 0.001, 0.000;
  (GLH_hyaline_vascular, Absent) 0.999, 0.001, 0.000;
  (GLH_plasma_cell, Absent) 0.999, 0.001, 0.000;
  (Granulomatous_laden, Absent) 0.89, 0.10, 0.01;
  (Histiocytosis_x, Absent) 0.9999, 0.0001, 0.0000;
  (Infectious_mono, Absent) 0.95, 0.05, 0.00;
  (Leprosy_lepromatous, Absent) 0.89, 0.10, 0.01;
  (Lymphangiographic, Absent) 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, Absent) 0.999, 0.001, 0.000;
  (Necrotizing_Kikuchi, Absent) 0.38, 0.60, 0.02;
  (Necrotiz_non_Kikuchi, Absent) 0.38, 0.60, 0.02;
  (Rheumatoid_arthritis, Absent) 0.999, 0.001, 0.000;
  (Sarcoidosis, Absent) 0.999, 0.001, 0.000;
  (SHML, Absent) 0.999, 0.001, 0.000;
  (Sinus_histiocytosis, Absent) 0.999, 0.001, 0.000;
  (Syphilis, Absent) 0.999, 0.001, 0.000;
  (Toxoplasmosis, Absent) 0.999, 0.001, 0.000;
  (Tuberculosis, Absent) 0.89, 0.10, 0.01;
  (Viral_NOS, Absent) 0.95, 0.05, 0.00;
  (Whipple_s_disease, Absent) 0.999, 0.001, 0.000;
  (L_H_nodular_HD, Absent) 0.999, 0.001, 0.000;
  (L_H_diffuse_HD, Absent) 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD, Absent) 0.95, 0.05, 0.00;
  (Cellular_phase_NSHD, Absent) 0.95, 0.05, 0.00;
  (Syncytial_NSHD, Absent) 0.95, 0.05, 0.00;
  (Mixed_cellularity_HD, Absent) 0.95, 0.05, 0.00;
  (Interfollicular_HD, Absent) 0.95, 0.05, 0.00;
  (Diffuse_fibrosis_HD, Absent) 0.999, 0.001, 0.000;
  (Reticular_type_HD, Absent) 0.999, 0.001, 0.000;
  (Small_cleaved_fol, Absent) 0.999, 0.001, 0.000;
  (Mixed_fol, Absent) 0.999, 0.001, 0.000;
  (Large_cell_fol, Absent) 0.999, 0.001, 0.000;
  (Small_noncleaved_fol, Absent) 0.999, 0.001, 0.000;
  (Small_lymphocytic, Absent) 0.999, 0.001, 0.000;
  (Plasmacytoid_lyctic, Absent) 0.999, 0.001, 0.000;
  (Mantle_zone_lymphoma, Absent) 0.999, 0.001, 0.000;
  (Small_cleaved_dif, Absent) 0.999, 0.001, 0.000;
  (Mixed_FCC_dif, Absent) 0.999, 0.001, 0.000;
  (Large_cell_dif, Absent) 0.999, 0.001, 0.000;
  (B_immunoblastic, Absent) 0.999, 0.001, 0.000;
  (T_immunob_mixed, Absent) 0.999, 0.001, 0.000;
  (AILD_like_T_cell_lym, Absent) 0.999, 0.001, 0.000;
  (Japanese_ATL, Absent) 0.999, 0.001, 0.000;
  (Lymphoblastic, Absent) 0.999, 0.001, 0.000;
  (Small_noncleaved_dif, Absent) 0.80, 0.19, 0.01;
  (True_histiocytic, Absent) 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_T, Absent) 0.999, 0.001, 0.000;
  (Multiple_myeloma, Absent) 0.999, 0.001, 0.000;
  (Mycosis_fungoides, Absent) 0.999, 0.001, 0.000;
  (AML, Absent) 0.999, 0.001, 0.000;
  (Hairy_cell_leukemia, Absent) 0.999, 0.001, 0.000;
  (Carcinoma, Absent) 0.999, 0.001, 0.000;
  (Melanoma, Absent) 0.999, 0.001, 0.000;
  (EM_plasmacytoma, Absent) 0.999, 0.001, 0.000;
  (Kaposi_s_sarcoma, Absent) 0.999, 0.001, 0.000;
  (Mast_cell_disease, Absent) 0.95, 0.05, 0.00;
  (AIDS_involutionary, Absent) 0.999, 0.001, 0.000;
  (T_immunob_large, Absent) 0.999, 0.001, 0.000;
  (Monocytoid_B_cell, Absent) 0.999, 0.001, 0.000;
  (Nasopharyngeal_CA, Absent) 0.95, 0.05, 0.00;
  (Seminoma, Absent) 0.999, 0.001, 0.000;
  (SLE, Absent) 0.999, 0.001, 0.000;
  (Mycobact_histiocytos, Absent) 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, Absent) 0.95, 0.05, 0.00;
  (LGV, Absent) 0.38, 0.60, 0.02;
  (Histoplasmosis, Absent) 0.999, 0.001, 0.000;
  (Coccidioidomycosis, Absent) 0.999, 0.001, 0.000;
  (CMV, Absent) 0.999, 0.001, 0.000;
  (Brucellosis, Absent) 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_B, Absent) 0.999, 0.001, 0.000;
  (Intermed_lymphocytic, Absent) 0.999, 0.001, 0.000;
  (AIDS_early, Focal_nonextensive) 0.90, 0.09, 0.01;
  (AILD, Focal_nonextensive) 0.90, 0.09, 0.01;
  (ALIP, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Cat_scratch_disease, Focal_nonextensive) 0.25, 0.60, 0.15;
  (Dermatopathic_laden, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Florid_follic_hyperp, Focal_nonextensive) 0.90, 0.09, 0.01;
  (GLH_hyaline_vascular, Focal_nonextensive) 0.90, 0.09, 0.01;
  (GLH_plasma_cell, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Granulomatous_laden, Focal_nonextensive) 0.5, 0.4, 0.1;
  (Histiocytosis_x, Focal_nonextensive) 0.97, 0.02, 0.01;
  (Infectious_mono, Focal_nonextensive) 0.95, 0.04, 0.01;
  (Leprosy_lepromatous, Focal_nonextensive) 0.88, 0.10, 0.02;
  (Lymphangiographic, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Mantle_zone_hyperpla, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Necrotizing_Kikuchi, Focal_nonextensive) 0.25, 0.60, 0.15;
  (Necrotiz_non_Kikuchi, Focal_nonextensive) 0.25, 0.60, 0.15;
  (Rheumatoid_arthritis, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Sarcoidosis, Focal_nonextensive) 0.90, 0.09, 0.01;
  (SHML, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Sinus_histiocytosis, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Syphilis, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Toxoplasmosis, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Tuberculosis, Focal_nonextensive) 0.88, 0.10, 0.02;
  (Viral_NOS, Focal_nonextensive) 0.95, 0.04, 0.01;
  (Whipple_s_disease, Focal_nonextensive) 0.90, 0.09, 0.01;
  (L_H_nodular_HD, Focal_nonextensive) 0.90, 0.09, 0.01;
  (L_H_diffuse_HD, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Nodular_sclerosis_HD, Focal_nonextensive) 0.89, 0.10, 0.01;
  (Cellular_phase_NSHD, Focal_nonextensive) 0.89, 0.10, 0.01;
  (Syncytial_NSHD, Focal_nonextensive) 0.89, 0.10, 0.01;
  (Mixed_cellularity_HD, Focal_nonextensive) 0.89, 0.10, 0.01;
  (Interfollicular_HD, Focal_nonextensive) 0.89, 0.10, 0.01;
  (Diffuse_fibrosis_HD, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Reticular_type_HD, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Small_cleaved_fol, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Mixed_fol, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Large_cell_fol, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Small_noncleaved_fol, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Small_lymphocytic, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Plasmacytoid_lyctic, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Mantle_zone_lymphoma, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Small_cleaved_dif, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Mixed_FCC_dif, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Large_cell_dif, Focal_nonextensive) 0.90, 0.09, 0.01;
  (B_immunoblastic, Focal_nonextensive) 0.90, 0.09, 0.01;
  (T_immunob_mixed, Focal_nonextensive) 0.90, 0.09, 0.01;
  (AILD_like_T_cell_lym, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Japanese_ATL, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Lymphoblastic, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Small_noncleaved_dif, Focal_nonextensive) 0.80, 0.18, 0.02;
  (True_histiocytic, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Ki_1_LC_anaplas_T, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Multiple_myeloma, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Mycosis_fungoides, Focal_nonextensive) 0.90, 0.09, 0.01;
  (AML, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Hairy_cell_leukemia, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Carcinoma, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Melanoma, Focal_nonextensive) 0.90, 0.09, 0.01;
  (EM_plasmacytoma, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Kaposi_s_sarcoma, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Mast_cell_disease, Focal_nonextensive) 0.89, 0.10, 0.01;
  (AIDS_involutionary, Focal_nonextensive) 0.90, 0.09, 0.01;
  (T_immunob_large, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Monocytoid_B_cell, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Nasopharyngeal_CA, Focal_nonextensive) 0.89, 0.10, 0.01;
  (Seminoma, Focal_nonextensive) 0.90, 0.09, 0.01;
  (SLE, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Mycobact_histiocytos, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Mast_cell_hyperplas, Focal_nonextensive) 0.89, 0.10, 0.01;
  (LGV, Focal_nonextensive) 0.25, 0.60, 0.15;
  (Histoplasmosis, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Coccidioidomycosis, Focal_nonextensive) 0.90, 0.09, 0.01;
  (CMV, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Brucellosis, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Ki_1_LC_anaplas_B, Focal_nonextensive) 0.90, 0.09, 0.01;
  (Intermed_lymphocytic, Focal_nonextensive) 0.90, 0.09, 0.01;
  (AIDS_early, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (AILD, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (ALIP, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Cat_scratch_disease, MultiFocal_nonextensive) 0.01, 0.74, 0.25;
  (Dermatopathic_laden, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Florid_follic_hyperp, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (GLH_hyaline_vascular, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (GLH_plasma_cell, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Granulomatous_laden, MultiFocal_nonextensive) 0.01, 0.79, 0.20;
  (Histiocytosis_x, MultiFocal_nonextensive) 0.93, 0.05, 0.02;
  (Infectious_mono, MultiFocal_nonextensive) 0.01, 0.90, 0.09;
  (Leprosy_lepromatous, MultiFocal_nonextensive) 0.85, 0.12, 0.03;
  (Lymphangiographic, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Mantle_zone_hyperpla, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Necrotizing_Kikuchi, MultiFocal_nonextensive) 0.01, 0.74, 0.25;
  (Necrotiz_non_Kikuchi, MultiFocal_nonextensive) 0.01, 0.74, 0.25;
  (Rheumatoid_arthritis, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Sarcoidosis, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (SHML, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Sinus_histiocytosis, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Syphilis, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Toxoplasmosis, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Tuberculosis, MultiFocal_nonextensive) 0.85, 0.12, 0.03;
  (Viral_NOS, MultiFocal_nonextensive) 0.01, 0.90, 0.09;
  (Whipple_s_disease, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (L_H_nodular_HD, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (L_H_diffuse_HD, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Nodular_sclerosis_HD, MultiFocal_nonextensive) 0.86, 0.12, 0.02;
  (Cellular_phase_NSHD, MultiFocal_nonextensive) 0.86, 0.12, 0.02;
  (Syncytial_NSHD, MultiFocal_nonextensive) 0.86, 0.12, 0.02;
  (Mixed_cellularity_HD, MultiFocal_nonextensive) 0.86, 0.12, 0.02;
  (Interfollicular_HD, MultiFocal_nonextensive) 0.86, 0.12, 0.02;
  (Diffuse_fibrosis_HD, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Reticular_type_HD, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Small_cleaved_fol, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Mixed_fol, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Large_cell_fol, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Small_noncleaved_fol, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Small_lymphocytic, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Plasmacytoid_lyctic, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Mantle_zone_lymphoma, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Small_cleaved_dif, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Mixed_FCC_dif, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Large_cell_dif, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (B_immunoblastic, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (T_immunob_mixed, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (AILD_like_T_cell_lym, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Japanese_ATL, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Lymphoblastic, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Small_noncleaved_dif, MultiFocal_nonextensive) 0.75, 0.20, 0.05;
  (True_histiocytic, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Ki_1_LC_anaplas_T, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Multiple_myeloma, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Mycosis_fungoides, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (AML, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Hairy_cell_leukemia, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Carcinoma, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Melanoma, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (EM_plasmacytoma, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Kaposi_s_sarcoma, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Mast_cell_disease, MultiFocal_nonextensive) 0.86, 0.12, 0.02;
  (AIDS_involutionary, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (T_immunob_large, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Monocytoid_B_cell, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Nasopharyngeal_CA, MultiFocal_nonextensive) 0.86, 0.12, 0.02;
  (Seminoma, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (SLE, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Mycobact_histiocytos, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Mast_cell_hyperplas, MultiFocal_nonextensive) 0.86, 0.12, 0.02;
  (LGV, MultiFocal_nonextensive) 0.01, 0.74, 0.25;
  (Histoplasmosis, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Coccidioidomycosis, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (CMV, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Brucellosis, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Ki_1_LC_anaplas_B, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (Intermed_lymphocytic, MultiFocal_nonextensive) 0.80, 0.18, 0.02;
  (AIDS_early, Extensive) 0.75, 0.20, 0.05;
  (AILD, Extensive) 0.75, 0.20, 0.05;
  (ALIP, Extensive) 0.75, 0.20, 0.05;
  (Cat_scratch_disease, Extensive) 0.01, 0.49, 0.50;
  (Dermatopathic_laden, Extensive) 0.75, 0.20, 0.05;
  (Florid_follic_hyperp, Extensive) 0.75, 0.20, 0.05;
  (GLH_hyaline_vascular, Extensive) 0.75, 0.20, 0.05;
  (GLH_plasma_cell, Extensive) 0.75, 0.20, 0.05;
  (Granulomatous_laden, Extensive) 0.05, 0.70, 0.25;
  (Histiocytosis_x, Extensive) 0.89, 0.08, 0.03;
  (Infectious_mono, Extensive) 0.05, 0.75, 0.20;
  (Leprosy_lepromatous, Extensive) 0.50, 0.45, 0.05;
  (Lymphangiographic, Extensive) 0.75, 0.20, 0.05;
  (Mantle_zone_hyperpla, Extensive) 0.75, 0.20, 0.05;
  (Necrotizing_Kikuchi, Extensive) 0.01, 0.49, 0.50;
  (Necrotiz_non_Kikuchi, Extensive) 0.01, 0.49, 0.50;
  (Rheumatoid_arthritis, Extensive) 0.75, 0.20, 0.05;
  (Sarcoidosis, Extensive) 0.75, 0.20, 0.05;
  (SHML, Extensive) 0.75, 0.20, 0.05;
  (Sinus_histiocytosis, Extensive) 0.75, 0.20, 0.05;
  (Syphilis, Extensive) 0.75, 0.20, 0.05;
  (Toxoplasmosis, Extensive) 0.75, 0.20, 0.05;
  (Tuberculosis, Extensive) 0.50, 0.45, 0.05;
  (Viral_NOS, Extensive) 0.05, 0.75, 0.20;
  (Whipple_s_disease, Extensive) 0.75, 0.20, 0.05;
  (L_H_nodular_HD, Extensive) 0.75, 0.20, 0.05;
  (L_H_diffuse_HD, Extensive) 0.75, 0.20, 0.05;
  (Nodular_sclerosis_HD, Extensive) 0.55, 0.40, 0.05;
  (Cellular_phase_NSHD, Extensive) 0.55, 0.40, 0.05;
  (Syncytial_NSHD, Extensive) 0.55, 0.40, 0.05;
  (Mixed_cellularity_HD, Extensive) 0.55, 0.40, 0.05;
  (Interfollicular_HD, Extensive) 0.55, 0.40, 0.05;
  (Diffuse_fibrosis_HD, Extensive) 0.75, 0.20, 0.05;
  (Reticular_type_HD, Extensive) 0.75, 0.20, 0.05;
  (Small_cleaved_fol, Extensive) 0.75, 0.20, 0.05;
  (Mixed_fol, Extensive) 0.75, 0.20, 0.05;
  (Large_cell_fol, Extensive) 0.75, 0.20, 0.05;
  (Small_noncleaved_fol, Extensive) 0.75, 0.20, 0.05;
  (Small_lymphocytic, Extensive) 0.75, 0.20, 0.05;
  (Plasmacytoid_lyctic, Extensive) 0.75, 0.20, 0.05;
  (Mantle_zone_lymphoma, Extensive) 0.75, 0.20, 0.05;
  (Small_cleaved_dif, Extensive) 0.75, 0.20, 0.05;
  (Mixed_FCC_dif, Extensive) 0.75, 0.20, 0.05;
  (Large_cell_dif, Extensive) 0.75, 0.20, 0.05;
  (B_immunoblastic, Extensive) 0.75, 0.20, 0.05;
  (T_immunob_mixed, Extensive) 0.75, 0.20, 0.05;
  (AILD_like_T_cell_lym, Extensive) 0.75, 0.20, 0.05;
  (Japanese_ATL, Extensive) 0.75, 0.20, 0.05;
  (Lymphoblastic, Extensive) 0.75, 0.20, 0.05;
  (Small_noncleaved_dif, Extensive) 0.25, 0.60, 0.15;
  (True_histiocytic, Extensive) 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_T, Extensive) 0.75, 0.20, 0.05;
  (Multiple_myeloma, Extensive) 0.75, 0.20, 0.05;
  (Mycosis_fungoides, Extensive) 0.75, 0.20, 0.05;
  (AML, Extensive) 0.75, 0.20, 0.05;
  (Hairy_cell_leukemia, Extensive) 0.75, 0.20, 0.05;
  (Carcinoma, Extensive) 0.75, 0.20, 0.05;
  (Melanoma, Extensive) 0.75, 0.20, 0.05;
  (EM_plasmacytoma, Extensive) 0.75, 0.20, 0.05;
  (Kaposi_s_sarcoma, Extensive) 0.75, 0.20, 0.05;
  (Mast_cell_disease, Extensive) 0.55, 0.40, 0.05;
  (AIDS_involutionary, Extensive) 0.75, 0.20, 0.05;
  (T_immunob_large, Extensive) 0.75, 0.20, 0.05;
  (Monocytoid_B_cell, Extensive) 0.75, 0.20, 0.05;
  (Nasopharyngeal_CA, Extensive) 0.55, 0.40, 0.05;
  (Seminoma, Extensive) 0.75, 0.20, 0.05;
  (SLE, Extensive) 0.75, 0.20, 0.05;
  (Mycobact_histiocytos, Extensive) 0.75, 0.20, 0.05;
  (Mast_cell_hyperplas, Extensive) 0.55, 0.40, 0.05;
  (LGV, Extensive) 0.01, 0.49, 0.50;
  (Histoplasmosis, Extensive) 0.75, 0.20, 0.05;
  (Coccidioidomycosis, Extensive) 0.75, 0.20, 0.05;
  (CMV, Extensive) 0.75, 0.20, 0.05;
  (Brucellosis, Extensive) 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_B, Extensive) 0.75, 0.20, 0.05;
  (Intermed_lymphocytic, Extensive) 0.75, 0.20, 0.05;
}
probability ( L_and_H | Fault, LH_NOD ) {
  (AIDS_early, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (AILD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Cat_scratch_disease, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Dermatopathic_laden, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Florid_follic_hyperp, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (GLH_hyaline_vascular, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (GLH_plasma_cell, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Granulomatous_laden, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Histiocytosis_x, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Infectious_mono, Absent) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Leprosy_lepromatous, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Lymphangiographic, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mantle_zone_hyperpla, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Necrotizing_Kikuchi, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Necrotiz_non_Kikuchi, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Rheumatoid_arthritis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Sarcoidosis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (SHML, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Sinus_histiocytosis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Syphilis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Toxoplasmosis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Tuberculosis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Viral_NOS, Absent) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Whipple_s_disease, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (L_H_nodular_HD, Absent) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_diffuse_HD, Absent) 0.00, 0.01, 0.20, 0.69, 0.10;
  (Nodular_sclerosis_HD, Absent) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, Absent) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Syncytial_NSHD, Absent) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Mixed_cellularity_HD, Absent) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Interfollicular_HD, Absent) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mixed_fol, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Large_cell_fol, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_noncleaved_fol, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_lymphocytic, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Plasmacytoid_lyctic, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mantle_zone_lymphoma, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_cleaved_dif, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mixed_FCC_dif, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Large_cell_dif, Absent) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (B_immunoblastic, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (T_immunob_mixed, Absent) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (AILD_like_T_cell_lym, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Lymphoblastic, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_noncleaved_dif, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (True_histiocytic, Absent) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, Absent) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Multiple_myeloma, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mycosis_fungoides, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (AML, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Hairy_cell_leukemia, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Carcinoma, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Melanoma, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (EM_plasmacytoma, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Kaposi_s_sarcoma, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mast_cell_disease, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (AIDS_involutionary, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (T_immunob_large, Absent) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Monocytoid_B_cell, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Nasopharyngeal_CA, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Seminoma, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (SLE, Absent) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Mycobact_histiocytos, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mast_cell_hyperplas, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (LGV, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Histoplasmosis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Coccidioidomycosis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (CMV, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Brucellosis, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Ki_1_LC_anaplas_B, Absent) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Intermed_lymphocytic, Absent) 0.999, 0.001, 0.000, 0.000, 0.000;
  (AIDS_early, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (AILD, Present) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Cat_scratch_disease, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Dermatopathic_laden, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Florid_follic_hyperp, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (GLH_hyaline_vascular, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (GLH_plasma_cell, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Granulomatous_laden, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Histiocytosis_x, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Infectious_mono, Present) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Leprosy_lepromatous, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Lymphangiographic, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mantle_zone_hyperpla, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Necrotizing_Kikuchi, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Necrotiz_non_Kikuchi, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Rheumatoid_arthritis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Sarcoidosis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (SHML, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Sinus_histiocytosis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Syphilis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Toxoplasmosis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Tuberculosis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Viral_NOS, Present) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Whipple_s_disease, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (L_H_nodular_HD, Present) 0.00, 0.01, 0.20, 0.69, 0.10;
  (L_H_diffuse_HD, Present) 0.00, 0.01, 0.20, 0.69, 0.10;
  (Nodular_sclerosis_HD, Present) 0.849, 0.100, 0.050, 0.001, 0.000;
  (Cellular_phase_NSHD, Present) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Syncytial_NSHD, Present) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Mixed_cellularity_HD, Present) 0.849, 0.100, 0.050, 0.001, 0.000;
  (Interfollicular_HD, Present) 0.95, 0.04, 0.01, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Present) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Present) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mixed_fol, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Large_cell_fol, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_noncleaved_fol, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_lymphocytic, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Plasmacytoid_lyctic, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mantle_zone_lymphoma, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_cleaved_dif, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mixed_FCC_dif, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Large_cell_dif, Present) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (B_immunoblastic, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (T_immunob_mixed, Present) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (AILD_like_T_cell_lym, Present) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Present) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Lymphoblastic, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_noncleaved_dif, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (True_histiocytic, Present) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T, Present) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Multiple_myeloma, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mycosis_fungoides, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (AML, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Hairy_cell_leukemia, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Carcinoma, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Melanoma, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (EM_plasmacytoma, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Kaposi_s_sarcoma, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mast_cell_disease, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (AIDS_involutionary, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (T_immunob_large, Present) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Monocytoid_B_cell, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Nasopharyngeal_CA, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Seminoma, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (SLE, Present) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Mycobact_histiocytos, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Mast_cell_hyperplas, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (LGV, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Histoplasmosis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Coccidioidomycosis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (CMV, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Brucellosis, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Ki_1_LC_anaplas_B, Present) 0.9889, 0.0100, 0.0010, 0.0001, 0.0000;
  (Intermed_lymphocytic, Present) 0.999, 0.001, 0.000, 0.000, 0.000;
}
probability ( LH_NOD | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 0.0, 1.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 0.995, 0.005;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 0.995, 0.005;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( LACUN | Fault ) {
  (AIDS_early) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (AILD) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (ALIP) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Cat_scratch_disease) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Dermatopathic_laden) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Florid_follic_hyperp) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (GLH_hyaline_vascular) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (GLH_plasma_cell) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Granulomatous_laden) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Histiocytosis_x) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Infectious_mono) 0.99, 0.01, 0.00, 0.00, 0.00, 0.00;
  (Leprosy_lepromatous) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Lymphangiographic) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Mantle_zone_hyperpla) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Necrotizing_Kikuchi) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Necrotiz_non_Kikuchi) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Rheumatoid_arthritis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Sarcoidosis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (SHML) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Sinus_histiocytosis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Syphilis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Toxoplasmosis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Tuberculosis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Viral_NOS) 0.99, 0.01, 0.00, 0.00, 0.00, 0.00;
  (Whipple_s_disease) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (L_H_nodular_HD) 0.94, 0.05, 0.01, 0.00, 0.00, 0.00;
  (L_H_diffuse_HD) 0.94, 0.05, 0.01, 0.00, 0.00, 0.00;
  (Nodular_sclerosis_HD) 0.00, 0.01, 0.40, 0.58, 0.01, 0.00;
  (Cellular_phase_NSHD) 0.00, 0.01, 0.40, 0.58, 0.01, 0.00;
  (Syncytial_NSHD) 0.0, 0.0, 0.0, 0.0, 0.2, 0.8;
  (Mixed_cellularity_HD) 0.989, 0.010, 0.001, 0.000, 0.000, 0.000;
  (Interfollicular_HD) 0.989, 0.010, 0.001, 0.000, 0.000, 0.000;
  (Diffuse_fibrosis_HD) 0.90, 0.09, 0.01, 0.00, 0.00, 0.00;
  (Reticular_type_HD) 0.90, 0.09, 0.01, 0.00, 0.00, 0.00;
  (Small_cleaved_fol) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Mixed_fol) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Large_cell_fol) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Small_noncleaved_fol) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Small_lymphocytic) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Plasmacytoid_lyctic) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Mantle_zone_lymphoma) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Small_cleaved_dif) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Mixed_FCC_dif) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Large_cell_dif) 0.8389, 0.1000, 0.0500, 0.0100, 0.0010, 0.0001;
  (B_immunoblastic) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (T_immunob_mixed) 0.84, 0.10, 0.05, 0.01, 0.00, 0.00;
  (AILD_like_T_cell_lym) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Japanese_ATL) 0.84, 0.10, 0.05, 0.01, 0.00, 0.00;
  (Lymphoblastic) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Small_noncleaved_dif) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (True_histiocytic) 0.8389, 0.1000, 0.0500, 0.0100, 0.0010, 0.0001;
  (Ki_1_LC_anaplas_T) 0.8389, 0.1000, 0.0500, 0.0100, 0.0010, 0.0001;
  (Multiple_myeloma) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Mycosis_fungoides) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (AML) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Hairy_cell_leukemia) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Carcinoma) 0.919, 0.050, 0.020, 0.010, 0.001, 0.000;
  (Melanoma) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (EM_plasmacytoma) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Kaposi_s_sarcoma) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Mast_cell_disease) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (AIDS_involutionary) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (T_immunob_large) 0.8389, 0.1000, 0.0500, 0.0100, 0.0010, 0.0001;
  (Monocytoid_B_cell) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Nasopharyngeal_CA) 0.919, 0.050, 0.020, 0.010, 0.001, 0.000;
  (Seminoma) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (SLE) 0.99, 0.01, 0.00, 0.00, 0.00, 0.00;
  (Mycobact_histiocytos) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Mast_cell_hyperplas) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (LGV) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Histoplasmosis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Coccidioidomycosis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (CMV) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Brucellosis) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
  (Ki_1_LC_anaplas_B) 0.8389, 0.1000, 0.0500, 0.0100, 0.0010, 0.0001;
  (Intermed_lymphocytic) 0.999, 0.001, 0.000, 0.000, 0.000, 0.000;
}
probability ( LANG | Fault ) {
  (AIDS_early) 0.9999, 0.0001, 0.0000;
  (AILD) 0.999, 0.001, 0.000;
  (ALIP) 0.9999, 0.0001, 0.0000;
  (Cat_scratch_disease) 0.80, 0.17, 0.03;
  (Dermatopathic_laden) 0.9999, 0.0001, 0.0000;
  (Florid_follic_hyperp) 0.9999, 0.0001, 0.0000;
  (GLH_hyaline_vascular) 0.9999, 0.0001, 0.0000;
  (GLH_plasma_cell) 0.9999, 0.0001, 0.0000;
  (Granulomatous_laden) 0.80, 0.15, 0.05;
  (Histiocytosis_x) 0.9999, 0.0001, 0.0000;
  (Infectious_mono) 0.9999, 0.0001, 0.0000;
  (Leprosy_lepromatous) 0.4, 0.5, 0.1;
  (Lymphangiographic) 0.70, 0.25, 0.05;
  (Mantle_zone_hyperpla) 0.9999, 0.0001, 0.0000;
  (Necrotizing_Kikuchi) 0.9999, 0.0001, 0.0000;
  (Necrotiz_non_Kikuchi) 0.97, 0.02, 0.01;
  (Rheumatoid_arthritis) 0.9999, 0.0001, 0.0000;
  (Sarcoidosis) 0.90, 0.09, 0.01;
  (SHML) 0.9999, 0.0001, 0.0000;
  (Sinus_histiocytosis) 0.9999, 0.0001, 0.0000;
  (Syphilis) 0.97, 0.02, 0.01;
  (Toxoplasmosis) 0.9999, 0.0001, 0.0000;
  (Tuberculosis) 0.05, 0.60, 0.35;
  (Viral_NOS) 0.9999, 0.0001, 0.0000;
  (Whipple_s_disease) 0.70, 0.25, 0.05;
  (L_H_nodular_HD) 0.9999, 0.0001, 0.0000;
  (L_H_diffuse_HD) 0.9999, 0.0001, 0.0000;
  (Nodular_sclerosis_HD) 0.9999, 0.0001, 0.0000;
  (Cellular_phase_NSHD) 0.9999, 0.0001, 0.0000;
  (Syncytial_NSHD) 0.9999, 0.0001, 0.0000;
  (Mixed_cellularity_HD) 0.975, 0.020, 0.005;
  (Interfollicular_HD) 0.9999, 0.0001, 0.0000;
  (Diffuse_fibrosis_HD) 0.9999, 0.0001, 0.0000;
  (Reticular_type_HD) 0.9999, 0.0001, 0.0000;
  (Small_cleaved_fol) 0.9999, 0.0001, 0.0000;
  (Mixed_fol) 0.9999, 0.0001, 0.0000;
  (Large_cell_fol) 0.9999, 0.0001, 0.0000;
  (Small_noncleaved_fol) 0.9999, 0.0001, 0.0000;
  (Small_lymphocytic) 0.9999, 0.0001, 0.0000;
  (Plasmacytoid_lyctic) 0.9999, 0.0001, 0.0000;
  (Mantle_zone_lymphoma) 0.9999, 0.0001, 0.0000;
  (Small_cleaved_dif) 0.9999, 0.0001, 0.0000;
  (Mixed_FCC_dif) 0.9999, 0.0001, 0.0000;
  (Large_cell_dif) 0.9999, 0.0001, 0.0000;
  (B_immunoblastic) 0.9999, 0.0001, 0.0000;
  (T_immunob_mixed) 0.9999, 0.0001, 0.0000;
  (AILD_like_T_cell_lym) 0.999, 0.001, 0.000;
  (Japanese_ATL) 0.9999, 0.0001, 0.0000;
  (Lymphoblastic) 0.9999, 0.0001, 0.0000;
  (Small_noncleaved_dif) 0.9999, 0.0001, 0.0000;
  (True_histiocytic) 0.9999, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T) 0.9999, 0.0001, 0.0000;
  (Multiple_myeloma) 0.9999, 0.0001, 0.0000;
  (Mycosis_fungoides) 0.9999, 0.0001, 0.0000;
  (AML) 0.9999, 0.0001, 0.0000;
  (Hairy_cell_leukemia) 0.9999, 0.0001, 0.0000;
  (Carcinoma) 0.9999, 0.0001, 0.0000;
  (Melanoma) 0.9999, 0.0001, 0.0000;
  (EM_plasmacytoma) 0.9999, 0.0001, 0.0000;
  (Kaposi_s_sarcoma) 0.9999, 0.0001, 0.0000;
  (Mast_cell_disease) 0.9999, 0.0001, 0.0000;
  (AIDS_involutionary) 0.9999, 0.0001, 0.0000;
  (T_immunob_large) 0.9999, 0.0001, 0.0000;
  (Monocytoid_B_cell) 0.9999, 0.0001, 0.0000;
  (Nasopharyngeal_CA) 0.9999, 0.0001, 0.0000;
  (Seminoma) 0.9999, 0.0001, 0.0000;
  (SLE) 0.9999, 0.0001, 0.0000;
  (Mycobact_histiocytos) 0.90, 0.08, 0.02;
  (Mast_cell_hyperplas) 0.9999, 0.0001, 0.0000;
  (LGV) 0.80, 0.17, 0.03;
  (Histoplasmosis) 0.80, 0.15, 0.05;
  (Coccidioidomycosis) 0.80, 0.15, 0.05;
  (CMV) 0.80, 0.15, 0.05;
  (Brucellosis) 0.9999, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_B) 0.9999, 0.0001, 0.0000;
  (Intermed_lymphocytic) 0.9999, 0.0001, 0.0000;
}
probability ( LEUK | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 0.0, 1.0;
  (Hairy_cell_leukemia) 0.1, 0.9;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( LLC_CY | Fault, LLC_ID ) {
  (AIDS_early, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AILD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (ALIP, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (SHML, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AML, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (SLE, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (LGV, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (CMV, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Other) 0.0, 0.6, 0.2, 0.2;
  (AILD, Other) 0.0, 0.6, 0.2, 0.2;
  (ALIP, Other) 0.0, 0.6, 0.2, 0.2;
  (Cat_scratch_disease, Other) 0.00, 0.70, 0.15, 0.15;
  (Dermatopathic_laden, Other) 0.0, 0.6, 0.2, 0.2;
  (Florid_follic_hyperp, Other) 0.0, 0.6, 0.2, 0.2;
  (GLH_hyaline_vascular, Other) 0.0, 0.6, 0.2, 0.2;
  (GLH_plasma_cell, Other) 0.00, 0.70, 0.15, 0.15;
  (Granulomatous_laden, Other) 0.00, 0.70, 0.15, 0.15;
  (Histiocytosis_x, Other) 0.0, 0.6, 0.2, 0.2;
  (Infectious_mono, Other) 0.00, 0.70, 0.15, 0.15;
  (Leprosy_lepromatous, Other) 0.0, 0.6, 0.2, 0.2;
  (Lymphangiographic, Other) 0.0, 0.6, 0.2, 0.2;
  (Mantle_zone_hyperpla, Other) 0.0, 0.6, 0.2, 0.2;
  (Necrotizing_Kikuchi, Other) 0.00, 0.70, 0.15, 0.15;
  (Necrotiz_non_Kikuchi, Other) 0.00, 0.70, 0.15, 0.15;
  (Rheumatoid_arthritis, Other) 0.0, 0.6, 0.2, 0.2;
  (Sarcoidosis, Other) 0.0, 0.6, 0.2, 0.2;
  (SHML, Other) 0.0, 0.6, 0.2, 0.2;
  (Sinus_histiocytosis, Other) 0.0, 0.6, 0.2, 0.2;
  (Syphilis, Other) 0.0, 0.6, 0.2, 0.2;
  (Toxoplasmosis, Other) 0.0, 0.6, 0.2, 0.2;
  (Tuberculosis, Other) 0.0, 0.6, 0.2, 0.2;
  (Viral_NOS, Other) 0.00, 0.70, 0.15, 0.15;
  (Whipple_s_disease, Other) 0.0, 0.6, 0.2, 0.2;
  (L_H_nodular_HD, Other) 0.00, 0.80, 0.19, 0.01;
  (L_H_diffuse_HD, Other) 0.00, 0.80, 0.19, 0.01;
  (Nodular_sclerosis_HD, Other) 0.00, 0.80, 0.19, 0.01;
  (Cellular_phase_NSHD, Other) 0.00, 0.80, 0.19, 0.01;
  (Syncytial_NSHD, Other) 0.00, 0.80, 0.19, 0.01;
  (Mixed_cellularity_HD, Other) 0.00, 0.80, 0.19, 0.01;
  (Interfollicular_HD, Other) 0.00, 0.80, 0.19, 0.01;
  (Diffuse_fibrosis_HD, Other) 0.00, 0.80, 0.19, 0.01;
  (Reticular_type_HD, Other) 0.00, 0.80, 0.19, 0.01;
  (Small_cleaved_fol, Other) 0.000, 0.975, 0.020, 0.005;
  (Mixed_fol, Other) 0.00, 0.96, 0.03, 0.01;
  (Large_cell_fol, Other) 0.00, 0.94, 0.05, 0.01;
  (Small_noncleaved_fol, Other) 0.00, 0.96, 0.03, 0.01;
  (Small_lymphocytic, Other) 0.00, 0.79, 0.20, 0.01;
  (Plasmacytoid_lyctic, Other) 0.00, 0.89, 0.01, 0.10;
  (Mantle_zone_lymphoma, Other) 0.0, 0.6, 0.2, 0.2;
  (Small_cleaved_dif, Other) 0.000, 0.975, 0.020, 0.005;
  (Mixed_FCC_dif, Other) 0.00, 0.96, 0.03, 0.01;
  (Large_cell_dif, Other) 0.00, 0.94, 0.05, 0.01;
  (B_immunoblastic, Other) 0.0, 0.2, 0.0, 0.8;
  (T_immunob_mixed, Other) 0.00, 0.50, 0.48, 0.02;
  (AILD_like_T_cell_lym, Other) 0.0, 0.1, 0.8, 0.1;
  (Japanese_ATL, Other) 0.00, 0.50, 0.25, 0.25;
  (Lymphoblastic, Other) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Other) 0.00, 0.96, 0.03, 0.01;
  (True_histiocytic, Other) 0.00, 0.01, 0.90, 0.09;
  (Ki_1_LC_anaplas_T, Other) 0.0, 0.2, 0.2, 0.6;
  (Multiple_myeloma, Other) 0.0, 0.2, 0.0, 0.8;
  (Mycosis_fungoides, Other) 0.00, 0.55, 0.40, 0.05;
  (AML, Other) 0.00, 0.98, 0.01, 0.01;
  (Hairy_cell_leukemia, Other) 0.0, 0.7, 0.3, 0.0;
  (Carcinoma, Other) 0.00, 0.30, 0.52, 0.18;
  (Melanoma, Other) 0.00, 0.10, 0.01, 0.89;
  (EM_plasmacytoma, Other) 0.0, 0.3, 0.0, 0.7;
  (Kaposi_s_sarcoma, Other) 0.0, 0.6, 0.2, 0.2;
  (Mast_cell_disease, Other) 0.00, 0.70, 0.28, 0.02;
  (AIDS_involutionary, Other) 0.0, 0.6, 0.2, 0.2;
  (T_immunob_large, Other) 0.00, 0.40, 0.58, 0.02;
  (Monocytoid_B_cell, Other) 0.00, 0.50, 0.45, 0.05;
  (Nasopharyngeal_CA, Other) 0.00, 0.30, 0.52, 0.18;
  (Seminoma, Other) 0.00, 0.02, 0.80, 0.18;
  (SLE, Other) 0.00, 0.70, 0.15, 0.15;
  (Mycobact_histiocytos, Other) 0.0, 0.6, 0.2, 0.2;
  (Mast_cell_hyperplas, Other) 0.00, 0.70, 0.28, 0.02;
  (LGV, Other) 0.00, 0.70, 0.15, 0.15;
  (Histoplasmosis, Other) 0.0, 0.6, 0.2, 0.2;
  (Coccidioidomycosis, Other) 0.0, 0.6, 0.2, 0.2;
  (CMV, Other) 0.0, 0.6, 0.2, 0.2;
  (Brucellosis, Other) 0.0, 0.6, 0.2, 0.2;
  (Ki_1_LC_anaplas_B, Other) 0.0, 0.2, 0.2, 0.6;
  (Intermed_lymphocytic, Other) 0.0, 0.6, 0.2, 0.2;
  (AIDS_early, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (AILD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (ALIP, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Cat_scratch_disease, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Dermatopathic_laden, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Florid_follic_hyperp, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (GLH_hyaline_vascular, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (GLH_plasma_cell, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Granulomatous_laden, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Histiocytosis_x, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Infectious_mono, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Leprosy_lepromatous, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Lymphangiographic, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mantle_zone_hyperpla, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Necrotizing_Kikuchi, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Necrotiz_non_Kikuchi, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Rheumatoid_arthritis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Sarcoidosis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (SHML, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Sinus_histiocytosis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Syphilis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Toxoplasmosis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Tuberculosis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Viral_NOS, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Whipple_s_disease, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (L_H_nodular_HD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (L_H_diffuse_HD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Nodular_sclerosis_HD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Cellular_phase_NSHD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Syncytial_NSHD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mixed_cellularity_HD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Interfollicular_HD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Diffuse_fibrosis_HD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Reticular_type_HD, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Small_cleaved_fol, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mixed_fol, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Large_cell_fol, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Small_noncleaved_fol, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Small_lymphocytic, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Plasmacytoid_lyctic, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mantle_zone_lymphoma, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Small_cleaved_dif, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mixed_FCC_dif, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Large_cell_dif, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (B_immunoblastic, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (T_immunob_mixed, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (AILD_like_T_cell_lym, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Japanese_ATL, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Lymphoblastic, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Small_noncleaved_dif, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (True_histiocytic, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Ki_1_LC_anaplas_T, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Multiple_myeloma, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mycosis_fungoides, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (AML, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Hairy_cell_leukemia, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Carcinoma, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Melanoma, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (EM_plasmacytoma, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Kaposi_s_sarcoma, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mast_cell_disease, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (AIDS_involutionary, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (T_immunob_large, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Monocytoid_B_cell, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Nasopharyngeal_CA, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Seminoma, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (SLE, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mycobact_histiocytos, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Mast_cell_hyperplas, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (LGV, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Histoplasmosis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Coccidioidomycosis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (CMV, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Brucellosis, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Ki_1_LC_anaplas_B, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (Intermed_lymphocytic, Large_cleaved) 0.000, 0.998, 0.001, 0.001;
  (AIDS_early, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (AILD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (ALIP, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Cat_scratch_disease, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Dermatopathic_laden, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Florid_follic_hyperp, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (GLH_hyaline_vascular, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (GLH_plasma_cell, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Granulomatous_laden, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Histiocytosis_x, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Infectious_mono, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Leprosy_lepromatous, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Lymphangiographic, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mantle_zone_hyperpla, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Necrotizing_Kikuchi, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Necrotiz_non_Kikuchi, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Rheumatoid_arthritis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Sarcoidosis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (SHML, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Sinus_histiocytosis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Syphilis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Toxoplasmosis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Tuberculosis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Viral_NOS, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Whipple_s_disease, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (L_H_nodular_HD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (L_H_diffuse_HD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Nodular_sclerosis_HD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Cellular_phase_NSHD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Syncytial_NSHD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mixed_cellularity_HD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Interfollicular_HD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Diffuse_fibrosis_HD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Reticular_type_HD, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Small_cleaved_fol, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mixed_fol, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Large_cell_fol, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Small_noncleaved_fol, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Small_lymphocytic, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Plasmacytoid_lyctic, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mantle_zone_lymphoma, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Small_cleaved_dif, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mixed_FCC_dif, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Large_cell_dif, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (B_immunoblastic, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (T_immunob_mixed, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (AILD_like_T_cell_lym, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Japanese_ATL, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Lymphoblastic, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Small_noncleaved_dif, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (True_histiocytic, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Ki_1_LC_anaplas_T, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Multiple_myeloma, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mycosis_fungoides, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (AML, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Hairy_cell_leukemia, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Carcinoma, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Melanoma, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (EM_plasmacytoma, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Kaposi_s_sarcoma, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mast_cell_disease, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (AIDS_involutionary, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (T_immunob_large, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Monocytoid_B_cell, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Nasopharyngeal_CA, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Seminoma, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (SLE, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mycobact_histiocytos, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Mast_cell_hyperplas, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (LGV, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Histoplasmosis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Coccidioidomycosis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (CMV, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Brucellosis, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Ki_1_LC_anaplas_B, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
  (Intermed_lymphocytic, Large_noncleaved) 0.000, 0.990, 0.005, 0.005;
}
probability ( LLC_NS | Fault, LLC_ID ) {
  (AIDS_early, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AML, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (AILD, Other) 0.00, 0.00, 0.00, 0.00, 0.05, 0.95;
  (ALIP, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Cat_scratch_disease, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Dermatopathic_laden, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Florid_follic_hyperp, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_hyaline_vascular, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_plasma_cell, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Granulomatous_laden, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Histiocytosis_x, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Infectious_mono, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Leprosy_lepromatous, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Lymphangiographic, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_hyperpla, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotizing_Kikuchi, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Necrotiz_non_Kikuchi, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Rheumatoid_arthritis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sarcoidosis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (SHML, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sinus_histiocytosis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Syphilis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Toxoplasmosis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Tuberculosis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Viral_NOS, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Whipple_s_disease, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (L_H_nodular_HD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (L_H_diffuse_HD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (Nodular_sclerosis_HD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (Cellular_phase_NSHD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (Syncytial_NSHD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (Mixed_cellularity_HD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (Interfollicular_HD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (Diffuse_fibrosis_HD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (Reticular_type_HD, Other) 0.00, 0.01, 0.00, 0.00, 0.09, 0.90;
  (Small_cleaved_fol, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mixed_fol, Other) 0.00, 0.03, 0.00, 0.01, 0.15, 0.81;
  (Large_cell_fol, Other) 0.00, 0.03, 0.00, 0.01, 0.15, 0.81;
  (Small_noncleaved_fol, Other) 0.000, 0.001, 0.000, 0.010, 0.100, 0.889;
  (Small_lymphocytic, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Plasmacytoid_lyctic, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_lymphoma, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_cleaved_dif, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mixed_FCC_dif, Other) 0.00, 0.03, 0.00, 0.01, 0.15, 0.81;
  (Large_cell_dif, Other) 0.00, 0.03, 0.00, 0.01, 0.15, 0.81;
  (B_immunoblastic, Other) 0.000, 0.010, 0.000, 0.005, 0.050, 0.935;
  (T_immunob_mixed, Other) 0.000, 0.030, 0.001, 0.010, 0.150, 0.809;
  (AILD_like_T_cell_lym, Other) 0.00, 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Other) 0.00, 0.10, 0.20, 0.25, 0.42, 0.03;
  (Lymphoblastic, Other) 0.00, 0.01, 0.01, 0.01, 0.10, 0.87;
  (Small_noncleaved_dif, Other) 0.000, 0.001, 0.000, 0.010, 0.100, 0.889;
  (True_histiocytic, Other) 0.000, 0.030, 0.001, 0.010, 0.150, 0.809;
  (Ki_1_LC_anaplas_T, Other) 0.000, 0.010, 0.000, 0.005, 0.050, 0.935;
  (Multiple_myeloma, Other) 0.000, 0.010, 0.000, 0.005, 0.050, 0.935;
  (Mycosis_fungoides, Other) 0.000, 0.005, 0.250, 0.100, 0.200, 0.445;
  (AML, Other) 0.00, 0.03, 0.00, 0.01, 0.15, 0.81;
  (Hairy_cell_leukemia, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Carcinoma, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Melanoma, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (EM_plasmacytoma, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Kaposi_s_sarcoma, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_disease, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_involutionary, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_large, Other) 0.000, 0.030, 0.001, 0.010, 0.150, 0.809;
  (Monocytoid_B_cell, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Nasopharyngeal_CA, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Seminoma, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (SLE, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Mycobact_histiocytos, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_hyperplas, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (LGV, Other) 0.00, 0.00, 0.00, 0.00, 0.02, 0.98;
  (Histoplasmosis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Coccidioidomycosis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (CMV, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Brucellosis, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Ki_1_LC_anaplas_B, Other) 0.000, 0.010, 0.000, 0.005, 0.050, 0.935;
  (Intermed_lymphocytic, Other) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_early, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (AILD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (ALIP, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Cat_scratch_disease, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Dermatopathic_laden, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (GLH_hyaline_vascular, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (GLH_plasma_cell, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Granulomatous_laden, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Histiocytosis_x, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Infectious_mono, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Lymphangiographic, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Necrotizing_Kikuchi, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Sarcoidosis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (SHML, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Sinus_histiocytosis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Syphilis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Toxoplasmosis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Tuberculosis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Viral_NOS, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Whipple_s_disease, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (L_H_nodular_HD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Cellular_phase_NSHD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Syncytial_NSHD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Interfollicular_HD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Reticular_type_HD, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Small_cleaved_fol, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mixed_fol, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Large_cell_fol, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Small_noncleaved_fol, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Small_lymphocytic, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Small_cleaved_dif, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Large_cell_dif, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (B_immunoblastic, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (T_immunob_mixed, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Japanese_ATL, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Lymphoblastic, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (True_histiocytic, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Multiple_myeloma, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mycosis_fungoides, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (AML, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Carcinoma, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Melanoma, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (EM_plasmacytoma, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mast_cell_disease, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (AIDS_involutionary, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (T_immunob_large, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Nasopharyngeal_CA, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Seminoma, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (SLE, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Mast_cell_hyperplas, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (LGV, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Histoplasmosis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Coccidioidomycosis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (CMV, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Brucellosis, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, Large_cleaved) 0.00, 0.00, 0.00, 0.00, 0.99, 0.01;
  (AIDS_early, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (AILD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (ALIP, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Cat_scratch_disease, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Dermatopathic_laden, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Florid_follic_hyperp, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_hyaline_vascular, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_plasma_cell, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Granulomatous_laden, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histiocytosis_x, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Infectious_mono, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Leprosy_lepromatous, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Lymphangiographic, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_hyperpla, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotizing_Kikuchi, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotiz_non_Kikuchi, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Rheumatoid_arthritis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sarcoidosis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (SHML, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sinus_histiocytosis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Syphilis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Toxoplasmosis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Tuberculosis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Viral_NOS, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Whipple_s_disease, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (L_H_nodular_HD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (L_H_diffuse_HD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Nodular_sclerosis_HD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Cellular_phase_NSHD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Syncytial_NSHD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mixed_cellularity_HD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Interfollicular_HD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Diffuse_fibrosis_HD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Reticular_type_HD, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_cleaved_fol, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mixed_fol, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Large_cell_fol, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_noncleaved_fol, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_lymphocytic, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Plasmacytoid_lyctic, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_lymphoma, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_cleaved_dif, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mixed_FCC_dif, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Large_cell_dif, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (B_immunoblastic, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_mixed, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (AILD_like_T_cell_lym, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Japanese_ATL, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Lymphoblastic, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_noncleaved_dif, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (True_histiocytic, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Ki_1_LC_anaplas_T, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Multiple_myeloma, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycosis_fungoides, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (AML, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Hairy_cell_leukemia, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Carcinoma, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Melanoma, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (EM_plasmacytoma, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Kaposi_s_sarcoma, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_disease, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_involutionary, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_large, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Monocytoid_B_cell, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Nasopharyngeal_CA, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Seminoma, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (SLE, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycobact_histiocytos, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_hyperplas, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (LGV, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histoplasmosis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Coccidioidomycosis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (CMV, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Brucellosis, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Ki_1_LC_anaplas_B, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
  (Intermed_lymphocytic, Large_noncleaved) 0.00, 0.00, 0.00, 0.00, 0.01, 0.99;
}
probability ( LLC | Fault ) {
  (AIDS_early) 0.94, 0.05, 0.01, 0.00, 0.00;
  (AILD) 0.0, 0.3, 0.7, 0.0, 0.0;
  (ALIP) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Cat_scratch_disease) 0.20, 0.79, 0.01, 0.00, 0.00;
  (Dermatopathic_laden) 0.30, 0.69, 0.01, 0.00, 0.00;
  (Florid_follic_hyperp) 0.94, 0.05, 0.01, 0.00, 0.00;
  (GLH_hyaline_vascular) 0.30, 0.69, 0.01, 0.00, 0.00;
  (GLH_plasma_cell) 0.30, 0.69, 0.01, 0.00, 0.00;
  (Granulomatous_laden) 0.30, 0.69, 0.01, 0.00, 0.00;
  (Histiocytosis_x) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Infectious_mono) 0.00000, 0.69999, 0.29000, 0.01000, 0.00001;
  (Leprosy_lepromatous) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Lymphangiographic) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Mantle_zone_hyperpla) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Necrotizing_Kikuchi) 0.1, 0.6, 0.3, 0.0, 0.0;
  (Necrotiz_non_Kikuchi) 0.25, 0.70, 0.05, 0.00, 0.00;
  (Rheumatoid_arthritis) 0.94, 0.05, 0.01, 0.00, 0.00;
  (Sarcoidosis) 0.985, 0.010, 0.005, 0.000, 0.000;
  (SHML) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Sinus_histiocytosis) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Syphilis) 0.94, 0.05, 0.01, 0.00, 0.00;
  (Toxoplasmosis) 0.94, 0.05, 0.01, 0.00, 0.00;
  (Tuberculosis) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Viral_NOS) 0.0000, 0.7999, 0.2000, 0.0001, 0.0000;
  (Whipple_s_disease) 0.985, 0.010, 0.005, 0.000, 0.000;
  (L_H_nodular_HD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (L_H_diffuse_HD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (Nodular_sclerosis_HD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (Cellular_phase_NSHD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (Syncytial_NSHD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (Mixed_cellularity_HD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (Interfollicular_HD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (Diffuse_fibrosis_HD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (Reticular_type_HD) 0.300, 0.686, 0.014, 0.000, 0.000;
  (Small_cleaved_fol) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Mixed_fol) 0.80, 0.15, 0.05, 0.00, 0.00;
  (Large_cell_fol) 0.0500, 0.2375, 0.2375, 0.2375, 0.2375;
  (Small_noncleaved_fol) 0.66, 0.30, 0.04, 0.00, 0.00;
  (Small_lymphocytic) 0.0500, 0.9025, 0.0475, 0.0000, 0.0000;
  (Plasmacytoid_lyctic) 0.900, 0.095, 0.005, 0.000, 0.000;
  (Mantle_zone_lymphoma) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Small_cleaved_dif) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Mixed_FCC_dif) 0.00, 0.65, 0.35, 0.00, 0.00;
  (Large_cell_dif) 0.00, 0.00, 0.02, 0.23, 0.75;
  (B_immunoblastic) 0.00, 0.00, 0.01, 0.24, 0.75;
  (T_immunob_mixed) 0.0, 0.3, 0.7, 0.0, 0.0;
  (AILD_like_T_cell_lym) 0.00, 0.25, 0.70, 0.05, 0.00;
  (Japanese_ATL) 0.01, 0.02, 0.22, 0.15, 0.60;
  (Lymphoblastic) 0.99, 0.01, 0.00, 0.00, 0.00;
  (Small_noncleaved_dif) 0.66, 0.30, 0.04, 0.00, 0.00;
  (True_histiocytic) 0.00, 0.00, 0.01, 0.14, 0.85;
  (Ki_1_LC_anaplas_T) 0.00, 0.00, 0.05, 0.60, 0.35;
  (Multiple_myeloma) 0.0, 0.0, 0.1, 0.8, 0.1;
  (Mycosis_fungoides) 0.399, 0.280, 0.300, 0.020, 0.001;
  (AML) 0.3, 0.1, 0.1, 0.2, 0.3;
  (Hairy_cell_leukemia) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Carcinoma) 0.996, 0.001, 0.001, 0.001, 0.001;
  (Melanoma) 0.996, 0.001, 0.001, 0.001, 0.001;
  (EM_plasmacytoma) 0.94, 0.05, 0.01, 0.00, 0.00;
  (Kaposi_s_sarcoma) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Mast_cell_disease) 0.985, 0.010, 0.005, 0.000, 0.000;
  (AIDS_involutionary) 0.79, 0.20, 0.01, 0.00, 0.00;
  (T_immunob_large) 0.00, 0.00, 0.02, 0.48, 0.50;
  (Monocytoid_B_cell) 0.010, 0.189, 0.800, 0.001, 0.000;
  (Nasopharyngeal_CA) 0.996, 0.001, 0.001, 0.001, 0.001;
  (Seminoma) 0.996, 0.001, 0.001, 0.001, 0.001;
  (SLE) 0.00000, 0.69999, 0.29000, 0.01000, 0.00001;
  (Mycobact_histiocytos) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Mast_cell_hyperplas) 0.985, 0.010, 0.005, 0.000, 0.000;
  (LGV) 0.20, 0.79, 0.01, 0.00, 0.00;
  (Histoplasmosis) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Coccidioidomycosis) 0.985, 0.010, 0.005, 0.000, 0.000;
  (CMV) 0.985, 0.010, 0.005, 0.000, 0.000;
  (Brucellosis) 0.94, 0.05, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_B) 0.00, 0.00, 0.05, 0.60, 0.35;
  (Intermed_lymphocytic) 0.99, 0.01, 0.00, 0.00, 0.00;
}
probability ( F_POPU | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.00, 0.02, 0.01, 0.03, 0.94;
  (AILD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (ALIP, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Cat_scratch_disease, 1_to_25pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Dermatopathic_laden, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Florid_follic_hyperp, 1_to_25pc) 0.00, 0.02, 0.01, 0.03, 0.94;
  (GLH_hyaline_vascular, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (GLH_plasma_cell, 1_to_25pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Granulomatous_laden, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Histiocytosis_x, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Infectious_mono, 1_to_25pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Leprosy_lepromatous, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Lymphangiographic, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Rheumatoid_arthritis, 1_to_25pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Sarcoidosis, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (SHML, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Sinus_histiocytosis, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Syphilis, 1_to_25pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Toxoplasmosis, 1_to_25pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Tuberculosis, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Viral_NOS, 1_to_25pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Whipple_s_disease, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (L_H_nodular_HD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (L_H_diffuse_HD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Cellular_phase_NSHD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Syncytial_NSHD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mixed_cellularity_HD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Interfollicular_HD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Reticular_type_HD, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_cleaved_fol, 1_to_25pc) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 1_to_25pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Large_cell_fol, 1_to_25pc) 0.00, 0.00, 0.00, 0.95, 0.05;
  (Small_noncleaved_fol, 1_to_25pc) 0.0, 0.0, 1.0, 0.0, 0.0;
  (Small_lymphocytic, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_cleaved_dif, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mixed_FCC_dif, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Large_cell_dif, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (B_immunoblastic, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (T_immunob_mixed, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Japanese_ATL, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Lymphoblastic, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_noncleaved_dif, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (True_histiocytic, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Multiple_myeloma, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mycosis_fungoides, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AML, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Hairy_cell_leukemia, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Carcinoma, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Melanoma, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (EM_plasmacytoma, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mast_cell_disease, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AIDS_involutionary, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (T_immunob_large, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Monocytoid_B_cell, 1_to_25pc) 0.000, 0.400, 0.001, 0.001, 0.598;
  (Nasopharyngeal_CA, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Seminoma, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (SLE, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mycobact_histiocytos, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mast_cell_hyperplas, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (LGV, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Histoplasmosis, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Coccidioidomycosis, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (CMV, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Brucellosis, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Intermed_lymphocytic, 1_to_25pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AIDS_early, 25_to_75pc) 0.00, 0.02, 0.01, 0.03, 0.94;
  (AILD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (ALIP, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Cat_scratch_disease, 25_to_75pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Dermatopathic_laden, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Florid_follic_hyperp, 25_to_75pc) 0.00, 0.02, 0.01, 0.03, 0.94;
  (GLH_hyaline_vascular, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (GLH_plasma_cell, 25_to_75pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Granulomatous_laden, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Histiocytosis_x, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Infectious_mono, 25_to_75pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Leprosy_lepromatous, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Lymphangiographic, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Rheumatoid_arthritis, 25_to_75pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Sarcoidosis, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (SHML, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Sinus_histiocytosis, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Syphilis, 25_to_75pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Toxoplasmosis, 25_to_75pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Tuberculosis, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Viral_NOS, 25_to_75pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Whipple_s_disease, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (L_H_nodular_HD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (L_H_diffuse_HD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Cellular_phase_NSHD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Syncytial_NSHD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mixed_cellularity_HD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Interfollicular_HD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Reticular_type_HD, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_cleaved_fol, 25_to_75pc) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 25_to_75pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Large_cell_fol, 25_to_75pc) 0.00, 0.00, 0.00, 0.95, 0.05;
  (Small_noncleaved_fol, 25_to_75pc) 0.0, 0.0, 1.0, 0.0, 0.0;
  (Small_lymphocytic, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_cleaved_dif, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mixed_FCC_dif, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Large_cell_dif, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (B_immunoblastic, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (T_immunob_mixed, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Japanese_ATL, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Lymphoblastic, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_noncleaved_dif, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (True_histiocytic, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Multiple_myeloma, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mycosis_fungoides, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AML, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Hairy_cell_leukemia, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Carcinoma, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Melanoma, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (EM_plasmacytoma, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mast_cell_disease, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AIDS_involutionary, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (T_immunob_large, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Monocytoid_B_cell, 25_to_75pc) 0.000, 0.400, 0.001, 0.001, 0.598;
  (Nasopharyngeal_CA, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Seminoma, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (SLE, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mycobact_histiocytos, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mast_cell_hyperplas, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (LGV, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Histoplasmosis, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Coccidioidomycosis, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (CMV, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Brucellosis, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Intermed_lymphocytic, 25_to_75pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AIDS_early, 75_to_90pc) 0.00, 0.02, 0.01, 0.03, 0.94;
  (AILD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (ALIP, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Cat_scratch_disease, 75_to_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Dermatopathic_laden, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Florid_follic_hyperp, 75_to_90pc) 0.00, 0.02, 0.01, 0.03, 0.94;
  (GLH_hyaline_vascular, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (GLH_plasma_cell, 75_to_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Granulomatous_laden, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Histiocytosis_x, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Infectious_mono, 75_to_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Leprosy_lepromatous, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Lymphangiographic, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Rheumatoid_arthritis, 75_to_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Sarcoidosis, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (SHML, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Sinus_histiocytosis, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Syphilis, 75_to_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Toxoplasmosis, 75_to_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Tuberculosis, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Viral_NOS, 75_to_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Whipple_s_disease, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (L_H_nodular_HD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (L_H_diffuse_HD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Cellular_phase_NSHD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Syncytial_NSHD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mixed_cellularity_HD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Interfollicular_HD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Reticular_type_HD, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_cleaved_fol, 75_to_90pc) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, 75_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Large_cell_fol, 75_to_90pc) 0.00, 0.00, 0.00, 0.95, 0.05;
  (Small_noncleaved_fol, 75_to_90pc) 0.0, 0.0, 1.0, 0.0, 0.0;
  (Small_lymphocytic, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_cleaved_dif, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mixed_FCC_dif, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Large_cell_dif, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (B_immunoblastic, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (T_immunob_mixed, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Japanese_ATL, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Lymphoblastic, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_noncleaved_dif, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (True_histiocytic, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Multiple_myeloma, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mycosis_fungoides, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AML, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Hairy_cell_leukemia, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Carcinoma, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Melanoma, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (EM_plasmacytoma, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mast_cell_disease, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AIDS_involutionary, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (T_immunob_large, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Monocytoid_B_cell, 75_to_90pc) 0.000, 0.400, 0.001, 0.001, 0.598;
  (Nasopharyngeal_CA, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Seminoma, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (SLE, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mycobact_histiocytos, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mast_cell_hyperplas, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (LGV, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Histoplasmosis, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Coccidioidomycosis, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (CMV, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Brucellosis, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Intermed_lymphocytic, 75_to_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AIDS_early, GT_90pc) 0.00, 0.02, 0.01, 0.03, 0.94;
  (AILD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (ALIP, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Cat_scratch_disease, GT_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Dermatopathic_laden, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Florid_follic_hyperp, GT_90pc) 0.00, 0.02, 0.01, 0.03, 0.94;
  (GLH_hyaline_vascular, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (GLH_plasma_cell, GT_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Granulomatous_laden, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Histiocytosis_x, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Infectious_mono, GT_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Leprosy_lepromatous, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Lymphangiographic, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mantle_zone_hyperpla, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Necrotizing_Kikuchi, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Rheumatoid_arthritis, GT_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Sarcoidosis, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (SHML, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Sinus_histiocytosis, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Syphilis, GT_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Toxoplasmosis, GT_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Tuberculosis, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Viral_NOS, GT_90pc) 0.000, 0.100, 0.001, 0.001, 0.898;
  (Whipple_s_disease, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (L_H_nodular_HD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (L_H_diffuse_HD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Nodular_sclerosis_HD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Cellular_phase_NSHD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Syncytial_NSHD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mixed_cellularity_HD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Interfollicular_HD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Diffuse_fibrosis_HD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Reticular_type_HD, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_cleaved_fol, GT_90pc) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Large_cell_fol, GT_90pc) 0.00, 0.00, 0.00, 0.95, 0.05;
  (Small_noncleaved_fol, GT_90pc) 0.0, 0.0, 1.0, 0.0, 0.0;
  (Small_lymphocytic, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Plasmacytoid_lyctic, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mantle_zone_lymphoma, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_cleaved_dif, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mixed_FCC_dif, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Large_cell_dif, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (B_immunoblastic, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (T_immunob_mixed, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AILD_like_T_cell_lym, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Japanese_ATL, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Lymphoblastic, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Small_noncleaved_dif, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (True_histiocytic, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Multiple_myeloma, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mycosis_fungoides, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AML, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Hairy_cell_leukemia, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Carcinoma, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Melanoma, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (EM_plasmacytoma, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Kaposi_s_sarcoma, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mast_cell_disease, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (AIDS_involutionary, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (T_immunob_large, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Monocytoid_B_cell, GT_90pc) 0.000, 0.400, 0.001, 0.001, 0.598;
  (Nasopharyngeal_CA, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Seminoma, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (SLE, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mycobact_histiocytos, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Mast_cell_hyperplas, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (LGV, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Histoplasmosis, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Coccidioidomycosis, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (CMV, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Brucellosis, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
  (Intermed_lymphocytic, GT_90pc) 0.000, 0.200, 0.001, 0.001, 0.798;
}
probability ( MAST | Fault ) {
  (AIDS_early) 0.9, 0.1, 0.0;
  (AILD) 0.9, 0.1, 0.0;
  (ALIP) 0.9, 0.1, 0.0;
  (Cat_scratch_disease) 0.9, 0.1, 0.0;
  (Dermatopathic_laden) 0.9, 0.1, 0.0;
  (Florid_follic_hyperp) 0.9, 0.1, 0.0;
  (GLH_hyaline_vascular) 0.9, 0.1, 0.0;
  (GLH_plasma_cell) 0.9, 0.1, 0.0;
  (Granulomatous_laden) 0.9, 0.1, 0.0;
  (Histiocytosis_x) 0.9, 0.1, 0.0;
  (Infectious_mono) 0.9, 0.1, 0.0;
  (Leprosy_lepromatous) 0.9, 0.1, 0.0;
  (Lymphangiographic) 0.9, 0.1, 0.0;
  (Mantle_zone_hyperpla) 0.9, 0.1, 0.0;
  (Necrotizing_Kikuchi) 0.9, 0.1, 0.0;
  (Necrotiz_non_Kikuchi) 0.9, 0.1, 0.0;
  (Rheumatoid_arthritis) 0.9, 0.1, 0.0;
  (Sarcoidosis) 0.9, 0.1, 0.0;
  (SHML) 0.9, 0.1, 0.0;
  (Sinus_histiocytosis) 0.9, 0.1, 0.0;
  (Syphilis) 0.9, 0.1, 0.0;
  (Toxoplasmosis) 0.9, 0.1, 0.0;
  (Tuberculosis) 0.9, 0.1, 0.0;
  (Viral_NOS) 0.9, 0.1, 0.0;
  (Whipple_s_disease) 0.9, 0.1, 0.0;
  (L_H_nodular_HD) 0.9, 0.1, 0.0;
  (L_H_diffuse_HD) 0.9, 0.1, 0.0;
  (Nodular_sclerosis_HD) 0.9, 0.1, 0.0;
  (Cellular_phase_NSHD) 0.9, 0.1, 0.0;
  (Syncytial_NSHD) 0.9, 0.1, 0.0;
  (Mixed_cellularity_HD) 0.9, 0.1, 0.0;
  (Interfollicular_HD) 0.9, 0.1, 0.0;
  (Diffuse_fibrosis_HD) 0.9, 0.1, 0.0;
  (Reticular_type_HD) 0.9, 0.1, 0.0;
  (Small_cleaved_fol) 0.9, 0.1, 0.0;
  (Mixed_fol) 0.9, 0.1, 0.0;
  (Large_cell_fol) 0.9, 0.1, 0.0;
  (Small_noncleaved_fol) 0.9, 0.1, 0.0;
  (Small_lymphocytic) 0.9, 0.1, 0.0;
  (Plasmacytoid_lyctic) 0.9, 0.1, 0.0;
  (Mantle_zone_lymphoma) 0.9, 0.1, 0.0;
  (Small_cleaved_dif) 0.9, 0.1, 0.0;
  (Mixed_FCC_dif) 0.9, 0.1, 0.0;
  (Large_cell_dif) 0.9, 0.1, 0.0;
  (B_immunoblastic) 0.9, 0.1, 0.0;
  (T_immunob_mixed) 0.9, 0.1, 0.0;
  (AILD_like_T_cell_lym) 0.9, 0.1, 0.0;
  (Japanese_ATL) 0.9, 0.1, 0.0;
  (Lymphoblastic) 0.9, 0.1, 0.0;
  (Small_noncleaved_dif) 0.9, 0.1, 0.0;
  (True_histiocytic) 0.9, 0.1, 0.0;
  (Ki_1_LC_anaplas_T) 0.9, 0.1, 0.0;
  (Multiple_myeloma) 0.9, 0.1, 0.0;
  (Mycosis_fungoides) 0.9, 0.1, 0.0;
  (AML) 0.9, 0.1, 0.0;
  (Hairy_cell_leukemia) 0.9, 0.1, 0.0;
  (Carcinoma) 0.9, 0.1, 0.0;
  (Melanoma) 0.9, 0.1, 0.0;
  (EM_plasmacytoma) 0.9, 0.1, 0.0;
  (Kaposi_s_sarcoma) 0.9, 0.1, 0.0;
  (Mast_cell_disease) 0.0, 0.3, 0.7;
  (AIDS_involutionary) 0.9, 0.1, 0.0;
  (T_immunob_large) 0.9, 0.1, 0.0;
  (Monocytoid_B_cell) 0.9, 0.1, 0.0;
  (Nasopharyngeal_CA) 0.9, 0.1, 0.0;
  (Seminoma) 0.9, 0.1, 0.0;
  (SLE) 0.9, 0.1, 0.0;
  (Mycobact_histiocytos) 0.9, 0.1, 0.0;
  (Mast_cell_hyperplas) 0.0, 0.9, 0.1;
  (LGV) 0.9, 0.1, 0.0;
  (Histoplasmosis) 0.9, 0.1, 0.0;
  (Coccidioidomycosis) 0.9, 0.1, 0.0;
  (CMV) 0.9, 0.1, 0.0;
  (Brucellosis) 0.9, 0.1, 0.0;
  (Ki_1_LC_anaplas_B) 0.9, 0.1, 0.0;
  (Intermed_lymphocytic) 0.9, 0.1, 0.0;
}
probability ( MLC | Fault ) {
  (AIDS_early) 0.79, 0.20, 0.01, 0.00, 0.00;
  (AILD) 0.01, 0.79, 0.20, 0.00, 0.00;
  (ALIP) 0.01, 0.94, 0.05, 0.00, 0.00;
  (Cat_scratch_disease) 0.25, 0.70, 0.05, 0.00, 0.00;
  (Dermatopathic_laden) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Florid_follic_hyperp) 0.60, 0.39, 0.01, 0.00, 0.00;
  (GLH_hyaline_vascular) 0.79, 0.20, 0.01, 0.00, 0.00;
  (GLH_plasma_cell) 0.25, 0.65, 0.10, 0.00, 0.00;
  (Granulomatous_laden) 0.25, 0.65, 0.10, 0.00, 0.00;
  (Histiocytosis_x) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Infectious_mono) 0.010, 0.693, 0.297, 0.000, 0.000;
  (Leprosy_lepromatous) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Lymphangiographic) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Necrotizing_Kikuchi) 0.25, 0.65, 0.10, 0.00, 0.00;
  (Necrotiz_non_Kikuchi) 0.25, 0.65, 0.10, 0.00, 0.00;
  (Rheumatoid_arthritis) 0.60, 0.39, 0.01, 0.00, 0.00;
  (Sarcoidosis) 0.79, 0.20, 0.01, 0.00, 0.00;
  (SHML) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Sinus_histiocytosis) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Syphilis) 0.60, 0.39, 0.01, 0.00, 0.00;
  (Toxoplasmosis) 0.60, 0.39, 0.01, 0.00, 0.00;
  (Tuberculosis) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Viral_NOS) 0.010, 0.693, 0.297, 0.000, 0.000;
  (Whipple_s_disease) 0.79, 0.20, 0.01, 0.00, 0.00;
  (L_H_nodular_HD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (L_H_diffuse_HD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (Nodular_sclerosis_HD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (Cellular_phase_NSHD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (Syncytial_NSHD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (Mixed_cellularity_HD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (Interfollicular_HD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (Diffuse_fibrosis_HD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (Reticular_type_HD) 0.20, 0.76, 0.04, 0.00, 0.00;
  (Small_cleaved_fol) 0.50, 0.49, 0.01, 0.00, 0.00;
  (Mixed_fol) 0.30, 0.69, 0.01, 0.00, 0.00;
  (Large_cell_fol) 0.10, 0.85, 0.05, 0.00, 0.00;
  (Small_noncleaved_fol) 0.05, 0.10, 0.15, 0.40, 0.30;
  (Small_lymphocytic) 0.10, 0.83, 0.07, 0.00, 0.00;
  (Plasmacytoid_lyctic) 0.84, 0.15, 0.01, 0.00, 0.00;
  (Mantle_zone_lymphoma) 0.95, 0.05, 0.00, 0.00, 0.00;
  (Small_cleaved_dif) 0.95, 0.05, 0.00, 0.00, 0.00;
  (Mixed_FCC_dif) 0.10, 0.65, 0.25, 0.00, 0.00;
  (Large_cell_dif) 0.1, 0.7, 0.2, 0.0, 0.0;
  (B_immunoblastic) 0.80, 0.19, 0.01, 0.00, 0.00;
  (T_immunob_mixed) 0.10, 0.65, 0.25, 0.00, 0.00;
  (AILD_like_T_cell_lym) 0.01, 0.84, 0.15, 0.00, 0.00;
  (Japanese_ATL) 0.100, 0.805, 0.090, 0.005, 0.000;
  (Lymphoblastic) 0.00, 0.00, 0.01, 0.19, 0.80;
  (Small_noncleaved_dif) 0.00, 0.00, 0.01, 0.05, 0.94;
  (True_histiocytic) 0.9500, 0.0475, 0.0025, 0.0000, 0.0000;
  (Ki_1_LC_anaplas_T) 0.949, 0.050, 0.001, 0.000, 0.000;
  (Multiple_myeloma) 0.300, 0.665, 0.035, 0.000, 0.000;
  (Mycosis_fungoides) 0.010, 0.100, 0.855, 0.030, 0.005;
  (AML) 0.25, 0.10, 0.45, 0.10, 0.10;
  (Hairy_cell_leukemia) 0.05, 0.85, 0.10, 0.00, 0.00;
  (Carcinoma) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Melanoma) 0.79, 0.20, 0.01, 0.00, 0.00;
  (EM_plasmacytoma) 0.200, 0.792, 0.008, 0.000, 0.000;
  (Kaposi_s_sarcoma) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Mast_cell_disease) 0.55, 0.40, 0.05, 0.00, 0.00;
  (AIDS_involutionary) 0.79, 0.20, 0.01, 0.00, 0.00;
  (T_immunob_large) 0.1, 0.8, 0.1, 0.0, 0.0;
  (Monocytoid_B_cell) 0.65000, 0.24999, 0.10000, 0.00001, 0.00000;
  (Nasopharyngeal_CA) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Seminoma) 0.79, 0.20, 0.01, 0.00, 0.00;
  (SLE) 0.010, 0.693, 0.297, 0.000, 0.000;
  (Mycobact_histiocytos) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Mast_cell_hyperplas) 0.60, 0.36, 0.04, 0.00, 0.00;
  (LGV) 0.25, 0.70, 0.05, 0.00, 0.00;
  (Histoplasmosis) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Coccidioidomycosis) 0.79, 0.20, 0.01, 0.00, 0.00;
  (CMV) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Brucellosis) 0.79, 0.20, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_B) 0.949, 0.050, 0.001, 0.000, 0.000;
  (Intermed_lymphocytic) 0.95, 0.05, 0.00, 0.00, 0.00;
}
probability ( MELANOMA | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 0.0, 1.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( MF10HP | Fault ) {
  (AIDS_early) 0.899, 0.100, 0.001, 0.000;
  (AILD) 0.00, 0.01, 0.89, 0.10;
  (ALIP) 0.00, 0.05, 0.93, 0.02;
  (Cat_scratch_disease) 0.899, 0.100, 0.001, 0.000;
  (Dermatopathic_laden) 0.899, 0.100, 0.001, 0.000;
  (Florid_follic_hyperp) 0.899, 0.100, 0.001, 0.000;
  (GLH_hyaline_vascular) 0.899, 0.100, 0.001, 0.000;
  (GLH_plasma_cell) 0.899, 0.100, 0.001, 0.000;
  (Granulomatous_laden) 0.899, 0.100, 0.001, 0.000;
  (Histiocytosis_x) 0.899, 0.100, 0.001, 0.000;
  (Infectious_mono) 0.05, 0.65, 0.29, 0.01;
  (Leprosy_lepromatous) 0.899, 0.100, 0.001, 0.000;
  (Lymphangiographic) 0.899, 0.100, 0.001, 0.000;
  (Mantle_zone_hyperpla) 0.899, 0.100, 0.001, 0.000;
  (Necrotizing_Kikuchi) 0.0010, 0.7000, 0.2989, 0.0001;
  (Necrotiz_non_Kikuchi) 0.0010, 0.7000, 0.2989, 0.0001;
  (Rheumatoid_arthritis) 0.899, 0.100, 0.001, 0.000;
  (Sarcoidosis) 0.899, 0.100, 0.001, 0.000;
  (SHML) 0.899, 0.100, 0.001, 0.000;
  (Sinus_histiocytosis) 0.899, 0.100, 0.001, 0.000;
  (Syphilis) 0.899, 0.100, 0.001, 0.000;
  (Toxoplasmosis) 0.899, 0.100, 0.001, 0.000;
  (Tuberculosis) 0.899, 0.100, 0.001, 0.000;
  (Viral_NOS) 0.05, 0.65, 0.29, 0.01;
  (Whipple_s_disease) 0.899, 0.100, 0.001, 0.000;
  (L_H_nodular_HD) 0.02, 0.50, 0.47, 0.01;
  (L_H_diffuse_HD) 0.02, 0.50, 0.47, 0.01;
  (Nodular_sclerosis_HD) 0.02, 0.50, 0.47, 0.01;
  (Cellular_phase_NSHD) 0.02, 0.50, 0.47, 0.01;
  (Syncytial_NSHD) 0.02, 0.50, 0.47, 0.01;
  (Mixed_cellularity_HD) 0.02, 0.50, 0.47, 0.01;
  (Interfollicular_HD) 0.02, 0.50, 0.47, 0.01;
  (Diffuse_fibrosis_HD) 0.0, 0.4, 0.5, 0.1;
  (Reticular_type_HD) 0.0, 0.4, 0.5, 0.1;
  (Small_cleaved_fol) 0.2000, 0.6999, 0.1000, 0.0001;
  (Mixed_fol) 0.2000, 0.6999, 0.1000, 0.0001;
  (Large_cell_fol) 0.10, 0.35, 0.43, 0.12;
  (Small_noncleaved_fol) 0.10, 0.35, 0.43, 0.12;
  (Small_lymphocytic) 0.3000, 0.6000, 0.0999, 0.0001;
  (Plasmacytoid_lyctic) 0.3000, 0.6000, 0.0999, 0.0001;
  (Mantle_zone_lymphoma) 0.100, 0.700, 0.199, 0.001;
  (Small_cleaved_dif) 0.00, 0.05, 0.85, 0.10;
  (Mixed_FCC_dif) 0.000, 0.005, 0.745, 0.250;
  (Large_cell_dif) 0.000, 0.001, 0.200, 0.799;
  (B_immunoblastic) 0.000, 0.001, 0.200, 0.799;
  (T_immunob_mixed) 0.000, 0.005, 0.450, 0.545;
  (AILD_like_T_cell_lym) 0.000, 0.005, 0.795, 0.200;
  (Japanese_ATL) 0.000, 0.001, 0.200, 0.799;
  (Lymphoblastic) 0.000, 0.001, 0.020, 0.979;
  (Small_noncleaved_dif) 0.000, 0.001, 0.020, 0.979;
  (True_histiocytic) 0.000, 0.001, 0.200, 0.799;
  (Ki_1_LC_anaplas_T) 0.000, 0.001, 0.200, 0.799;
  (Multiple_myeloma) 0.000, 0.001, 0.200, 0.799;
  (Mycosis_fungoides) 0.005, 0.295, 0.650, 0.050;
  (AML) 0.00, 0.05, 0.40, 0.55;
  (Hairy_cell_leukemia) 0.799, 0.200, 0.001, 0.000;
  (Carcinoma) 0.0, 0.3, 0.6, 0.1;
  (Melanoma) 0.0, 0.3, 0.6, 0.1;
  (EM_plasmacytoma) 0.01, 0.40, 0.58, 0.01;
  (Kaposi_s_sarcoma) 0.01, 0.40, 0.58, 0.01;
  (Mast_cell_disease) 0.20, 0.75, 0.04, 0.01;
  (AIDS_involutionary) 0.899, 0.100, 0.001, 0.000;
  (T_immunob_large) 0.000, 0.001, 0.200, 0.799;
  (Monocytoid_B_cell) 0.00, 0.01, 0.94, 0.05;
  (Nasopharyngeal_CA) 0.00, 0.55, 0.40, 0.05;
  (Seminoma) 0.0, 0.3, 0.6, 0.1;
  (SLE) 0.05, 0.65, 0.29, 0.01;
  (Mycobact_histiocytos) 0.899, 0.100, 0.001, 0.000;
  (Mast_cell_hyperplas) 0.899, 0.100, 0.001, 0.000;
  (LGV) 0.899, 0.100, 0.001, 0.000;
  (Histoplasmosis) 0.899, 0.100, 0.001, 0.000;
  (Coccidioidomycosis) 0.899, 0.100, 0.001, 0.000;
  (CMV) 0.899, 0.100, 0.001, 0.000;
  (Brucellosis) 0.899, 0.100, 0.001, 0.000;
  (Ki_1_LC_anaplas_B) 0.000, 0.001, 0.200, 0.799;
  (Intermed_lymphocytic) 0.050, 0.595, 0.350, 0.005;
}
probability ( MLC_CY | Fault, MLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (AILD, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (ALIP, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Cat_scratch_disease, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Dermatopathic_laden, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Florid_follic_hyperp, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (GLH_hyaline_vascular, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (GLH_plasma_cell, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Granulomatous_laden, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Histiocytosis_x, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Infectious_mono, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Leprosy_lepromatous, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Lymphangiographic, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Mantle_zone_hyperpla, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Necrotizing_Kikuchi, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Rheumatoid_arthritis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Sarcoidosis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (SHML, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Sinus_histiocytosis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Syphilis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Toxoplasmosis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Tuberculosis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Viral_NOS, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Whipple_s_disease, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (L_H_nodular_HD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (L_H_diffuse_HD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (Syncytial_NSHD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (Interfollicular_HD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (Reticular_type_HD, Sparse_LT_10pc) 0.0, 0.8, 0.2, 0.0;
  (Small_cleaved_fol, Sparse_LT_10pc) 0.00, 0.98, 0.01, 0.01;
  (Mixed_fol, Sparse_LT_10pc) 0.00, 0.98, 0.01, 0.01;
  (Large_cell_fol, Sparse_LT_10pc) 0.00, 0.98, 0.01, 0.01;
  (Small_noncleaved_fol, Sparse_LT_10pc) 0.00, 0.98, 0.01, 0.01;
  (Small_lymphocytic, Sparse_LT_10pc) 0.00, 0.79, 0.20, 0.01;
  (Plasmacytoid_lyctic, Sparse_LT_10pc) 0.00, 0.89, 0.01, 0.10;
  (Mantle_zone_lymphoma, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Small_cleaved_dif, Sparse_LT_10pc) 0.00, 0.98, 0.01, 0.01;
  (Mixed_FCC_dif, Sparse_LT_10pc) 0.00, 0.98, 0.01, 0.01;
  (Large_cell_dif, Sparse_LT_10pc) 0.00, 0.98, 0.01, 0.01;
  (B_immunoblastic, Sparse_LT_10pc) 0.0, 0.7, 0.0, 0.3;
  (T_immunob_mixed, Sparse_LT_10pc) 0.00, 0.50, 0.48, 0.02;
  (AILD_like_T_cell_lym, Sparse_LT_10pc) 0.00, 0.02, 0.97, 0.01;
  (Japanese_ATL, Sparse_LT_10pc) 0.00, 0.70, 0.15, 0.15;
  (Lymphoblastic, Sparse_LT_10pc) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Sparse_LT_10pc) 0.00, 0.98, 0.01, 0.01;
  (True_histiocytic, Sparse_LT_10pc) 0.00, 0.60, 0.35, 0.05;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc) 0.0, 0.4, 0.4, 0.2;
  (Multiple_myeloma, Sparse_LT_10pc) 0.0, 0.7, 0.0, 0.3;
  (Mycosis_fungoides, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (AML, Sparse_LT_10pc) 0.000000000, 0.988900101, 0.001009082, 0.010090817;
  (Hairy_cell_leukemia, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Carcinoma, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Melanoma, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (EM_plasmacytoma, Sparse_LT_10pc) 0.0, 0.6, 0.0, 0.4;
  (Kaposi_s_sarcoma, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Mast_cell_disease, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (AIDS_involutionary, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (T_immunob_large, Sparse_LT_10pc) 0.00, 0.50, 0.45, 0.05;
  (Monocytoid_B_cell, Sparse_LT_10pc) 0.00, 0.20, 0.78, 0.02;
  (Nasopharyngeal_CA, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Seminoma, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (SLE, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Mycobact_histiocytos, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Mast_cell_hyperplas, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (LGV, Sparse_LT_10pc) 0.0, 0.8, 0.1, 0.1;
  (Histoplasmosis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Coccidioidomycosis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (CMV, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Brucellosis, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc) 0.0, 0.4, 0.4, 0.2;
  (Intermed_lymphocytic, Sparse_LT_10pc) 0.00, 0.90, 0.05, 0.05;
  (AIDS_early, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (AILD, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (ALIP, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Infectious_mono, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Lymphangiographic, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Sarcoidosis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (SHML, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Syphilis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Tuberculosis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Viral_NOS, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.0, 0.8, 0.2, 0.0;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (Mixed_fol, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (Large_cell_fol, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.00, 0.79, 0.20, 0.01;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.00, 0.89, 0.01, 0.10;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (Large_cell_dif, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (B_immunoblastic, Moderate_11_to_50pc) 0.0, 0.7, 0.0, 0.3;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.00, 0.50, 0.48, 0.02;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.00, 0.02, 0.97, 0.01;
  (Japanese_ATL, Moderate_11_to_50pc) 0.00, 0.70, 0.15, 0.15;
  (Lymphoblastic, Moderate_11_to_50pc) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (True_histiocytic, Moderate_11_to_50pc) 0.00, 0.60, 0.35, 0.05;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.0, 0.4, 0.4, 0.2;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.0, 0.7, 0.0, 0.3;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (AML, Moderate_11_to_50pc) 0.000000000, 0.988900101, 0.001009082, 0.010090817;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Carcinoma, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Melanoma, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.0, 0.6, 0.0, 0.4;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (T_immunob_large, Moderate_11_to_50pc) 0.00, 0.50, 0.45, 0.05;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.00, 0.20, 0.78, 0.02;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Seminoma, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (SLE, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (LGV, Moderate_11_to_50pc) 0.0, 0.8, 0.1, 0.1;
  (Histoplasmosis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (CMV, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Brucellosis, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.0, 0.4, 0.4, 0.2;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.00, 0.90, 0.05, 0.05;
  (AIDS_early, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (AILD, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (ALIP, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Infectious_mono, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Lymphangiographic, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Sarcoidosis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (SHML, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Syphilis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Tuberculosis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Viral_NOS, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.0, 0.8, 0.2, 0.0;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (Mixed_fol, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (Large_cell_fol, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.00, 0.79, 0.20, 0.01;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.00, 0.89, 0.01, 0.10;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (Large_cell_dif, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (B_immunoblastic, Numerous_51_to_90pc) 0.0, 0.7, 0.0, 0.3;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.00, 0.50, 0.48, 0.02;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.00, 0.02, 0.97, 0.01;
  (Japanese_ATL, Numerous_51_to_90pc) 0.00, 0.70, 0.15, 0.15;
  (Lymphoblastic, Numerous_51_to_90pc) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (True_histiocytic, Numerous_51_to_90pc) 0.00, 0.60, 0.35, 0.05;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.0, 0.4, 0.4, 0.2;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.0, 0.7, 0.0, 0.3;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (AML, Numerous_51_to_90pc) 0.000000000, 0.988900101, 0.001009082, 0.010090817;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Carcinoma, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Melanoma, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.0, 0.6, 0.0, 0.4;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (T_immunob_large, Numerous_51_to_90pc) 0.00, 0.50, 0.45, 0.05;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.00, 0.20, 0.78, 0.02;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Seminoma, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (SLE, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (LGV, Numerous_51_to_90pc) 0.0, 0.8, 0.1, 0.1;
  (Histoplasmosis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (CMV, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Brucellosis, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.0, 0.4, 0.4, 0.2;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.00, 0.90, 0.05, 0.05;
  (AIDS_early, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (AILD, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (ALIP, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Cat_scratch_disease, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Dermatopathic_laden, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (GLH_plasma_cell, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Granulomatous_laden, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Histiocytosis_x, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Infectious_mono, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Lymphangiographic, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Sarcoidosis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (SHML, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Syphilis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Toxoplasmosis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Tuberculosis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Viral_NOS, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Whipple_s_disease, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (L_H_nodular_HD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (Syncytial_NSHD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (Interfollicular_HD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (Reticular_type_HD, Striking_GT_90pc) 0.0, 0.8, 0.2, 0.0;
  (Small_cleaved_fol, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (Mixed_fol, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (Large_cell_fol, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (Small_lymphocytic, Striking_GT_90pc) 0.00, 0.79, 0.20, 0.01;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.00, 0.89, 0.01, 0.10;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Small_cleaved_dif, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (Large_cell_dif, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (B_immunoblastic, Striking_GT_90pc) 0.0, 0.7, 0.0, 0.3;
  (T_immunob_mixed, Striking_GT_90pc) 0.00, 0.50, 0.48, 0.02;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.00, 0.02, 0.97, 0.01;
  (Japanese_ATL, Striking_GT_90pc) 0.00, 0.70, 0.15, 0.15;
  (Lymphoblastic, Striking_GT_90pc) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (True_histiocytic, Striking_GT_90pc) 0.00, 0.60, 0.35, 0.05;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.0, 0.4, 0.4, 0.2;
  (Multiple_myeloma, Striking_GT_90pc) 0.0, 0.7, 0.0, 0.3;
  (Mycosis_fungoides, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (AML, Striking_GT_90pc) 0.000000000, 0.988900101, 0.001009082, 0.010090817;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Carcinoma, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Melanoma, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (EM_plasmacytoma, Striking_GT_90pc) 0.0, 0.6, 0.0, 0.4;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Mast_cell_disease, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (AIDS_involutionary, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (T_immunob_large, Striking_GT_90pc) 0.00, 0.50, 0.45, 0.05;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.00, 0.20, 0.78, 0.02;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Seminoma, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (SLE, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (LGV, Striking_GT_90pc) 0.0, 0.8, 0.1, 0.1;
  (Histoplasmosis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Coccidioidomycosis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (CMV, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Brucellosis, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.0, 0.4, 0.4, 0.2;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.00, 0.90, 0.05, 0.05;
}
probability ( MLC_NS | Fault, MLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AILD, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (ALIP, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Cat_scratch_disease, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Dermatopathic_laden, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Florid_follic_hyperp, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_hyaline_vascular, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_plasma_cell, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Granulomatous_laden, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histiocytosis_x, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Infectious_mono, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Leprosy_lepromatous, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Lymphangiographic, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_hyperpla, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotizing_Kikuchi, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Rheumatoid_arthritis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sarcoidosis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (SHML, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sinus_histiocytosis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Syphilis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Toxoplasmosis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Tuberculosis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Viral_NOS, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Whipple_s_disease, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (L_H_nodular_HD, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (L_H_diffuse_HD, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Nodular_sclerosis_HD, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Cellular_phase_NSHD, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Syncytial_NSHD, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Mixed_cellularity_HD, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Interfollicular_HD, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Reticular_type_HD, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Small_cleaved_fol, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Mixed_fol, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Large_cell_fol, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Small_noncleaved_fol, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_lymphocytic, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Plasmacytoid_lyctic, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_lymphoma, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_cleaved_dif, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Mixed_FCC_dif, Sparse_LT_10pc) 0.00, 0.00, 0.01, 0.45, 0.54;
  (Large_cell_dif, Sparse_LT_10pc) 0.00, 0.00, 0.01, 0.45, 0.54;
  (B_immunoblastic, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_mixed, Sparse_LT_10pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (AILD_like_T_cell_lym, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Sparse_LT_10pc) 0.00, 0.20, 0.29, 0.50, 0.01;
  (Lymphoblastic, Sparse_LT_10pc) 0.000, 0.001, 0.250, 0.600, 0.149;
  (Small_noncleaved_dif, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (True_histiocytic, Sparse_LT_10pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Multiple_myeloma, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycosis_fungoides, Sparse_LT_10pc) 0.00, 0.60, 0.35, 0.05, 0.00;
  (AML, Sparse_LT_10pc) 0.00, 0.00, 0.01, 0.04, 0.95;
  (Hairy_cell_leukemia, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Carcinoma, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Melanoma, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (EM_plasmacytoma, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Kaposi_s_sarcoma, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_disease, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_involutionary, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_large, Sparse_LT_10pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (Monocytoid_B_cell, Sparse_LT_10pc) 0.000, 0.000, 0.001, 0.149, 0.850;
  (Nasopharyngeal_CA, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Seminoma, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (SLE, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycobact_histiocytos, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_hyperplas, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (LGV, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histoplasmosis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Coccidioidomycosis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (CMV, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Brucellosis, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Intermed_lymphocytic, Sparse_LT_10pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_early, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AILD, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (ALIP, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Infectious_mono, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Lymphangiographic, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sarcoidosis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (SHML, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Syphilis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Tuberculosis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Viral_NOS, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Mixed_fol, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Large_cell_fol, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.00, 0.00, 0.01, 0.45, 0.54;
  (Large_cell_dif, Moderate_11_to_50pc) 0.00, 0.00, 0.01, 0.45, 0.54;
  (B_immunoblastic, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Moderate_11_to_50pc) 0.00, 0.20, 0.29, 0.50, 0.01;
  (Lymphoblastic, Moderate_11_to_50pc) 0.000, 0.001, 0.250, 0.600, 0.149;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (True_histiocytic, Moderate_11_to_50pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.00, 0.60, 0.35, 0.05, 0.00;
  (AML, Moderate_11_to_50pc) 0.00, 0.00, 0.01, 0.04, 0.95;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Carcinoma, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Melanoma, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_large, Moderate_11_to_50pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.149, 0.850;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Seminoma, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (SLE, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (LGV, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histoplasmosis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (CMV, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Brucellosis, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_early, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AILD, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (ALIP, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Infectious_mono, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Lymphangiographic, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sarcoidosis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (SHML, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Syphilis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Tuberculosis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Viral_NOS, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Mixed_fol, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Large_cell_fol, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.00, 0.00, 0.01, 0.45, 0.54;
  (Large_cell_dif, Numerous_51_to_90pc) 0.00, 0.00, 0.01, 0.45, 0.54;
  (B_immunoblastic, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Numerous_51_to_90pc) 0.00, 0.20, 0.29, 0.50, 0.01;
  (Lymphoblastic, Numerous_51_to_90pc) 0.000, 0.001, 0.250, 0.600, 0.149;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (True_histiocytic, Numerous_51_to_90pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.00, 0.60, 0.35, 0.05, 0.00;
  (AML, Numerous_51_to_90pc) 0.00, 0.00, 0.01, 0.04, 0.95;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Carcinoma, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Melanoma, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_large, Numerous_51_to_90pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.149, 0.850;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Seminoma, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (SLE, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (LGV, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histoplasmosis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (CMV, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Brucellosis, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_early, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AILD, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (ALIP, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Cat_scratch_disease, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Dermatopathic_laden, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (GLH_plasma_cell, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Granulomatous_laden, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histiocytosis_x, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Infectious_mono, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Lymphangiographic, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sarcoidosis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (SHML, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Syphilis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Toxoplasmosis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Tuberculosis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Viral_NOS, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Whipple_s_disease, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (L_H_nodular_HD, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Syncytial_NSHD, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Interfollicular_HD, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Reticular_type_HD, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.020, 0.979;
  (Small_cleaved_fol, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Mixed_fol, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Large_cell_fol, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_lymphocytic, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Small_cleaved_dif, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.050, 0.949;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.00, 0.00, 0.01, 0.45, 0.54;
  (Large_cell_dif, Striking_GT_90pc) 0.00, 0.00, 0.01, 0.45, 0.54;
  (B_immunoblastic, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_mixed, Striking_GT_90pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Striking_GT_90pc) 0.00, 0.20, 0.29, 0.50, 0.01;
  (Lymphoblastic, Striking_GT_90pc) 0.000, 0.001, 0.250, 0.600, 0.149;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (True_histiocytic, Striking_GT_90pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Multiple_myeloma, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycosis_fungoides, Striking_GT_90pc) 0.00, 0.60, 0.35, 0.05, 0.00;
  (AML, Striking_GT_90pc) 0.00, 0.00, 0.01, 0.04, 0.95;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Carcinoma, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Melanoma, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (EM_plasmacytoma, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_disease, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (AIDS_involutionary, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (T_immunob_large, Striking_GT_90pc) 0.0000, 0.0001, 0.0100, 0.4500, 0.5399;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.149, 0.850;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Seminoma, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (SLE, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (LGV, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Histoplasmosis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Coccidioidomycosis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (CMV, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Brucellosis, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.01, 0.99;
}
probability ( MLC_NI | Fault, MLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (AILD, Sparse_LT_10pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (ALIP, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Cat_scratch_disease, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Dermatopathic_laden, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Florid_follic_hyperp, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (GLH_hyaline_vascular, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (GLH_plasma_cell, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Granulomatous_laden, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Histiocytosis_x, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Infectious_mono, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Leprosy_lepromatous, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Lymphangiographic, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mantle_zone_hyperpla, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Necrotizing_Kikuchi, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Rheumatoid_arthritis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Sarcoidosis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (SHML, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Sinus_histiocytosis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Syphilis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Toxoplasmosis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Tuberculosis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Viral_NOS, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Whipple_s_disease, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (L_H_nodular_HD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (L_H_diffuse_HD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Nodular_sclerosis_HD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Cellular_phase_NSHD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Syncytial_NSHD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Mixed_cellularity_HD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Interfollicular_HD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Reticular_type_HD, Sparse_LT_10pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Small_cleaved_fol, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Mixed_fol, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Large_cell_fol, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_noncleaved_fol, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_lymphocytic, Sparse_LT_10pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Plasmacytoid_lyctic, Sparse_LT_10pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Mantle_zone_lymphoma, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_cleaved_dif, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Mixed_FCC_dif, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Large_cell_dif, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (B_immunoblastic, Sparse_LT_10pc) 0.00, 0.01, 0.93, 0.05, 0.01;
  (T_immunob_mixed, Sparse_LT_10pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (AILD_like_T_cell_lym, Sparse_LT_10pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Japanese_ATL, Sparse_LT_10pc) 0.00, 0.10, 0.59, 0.30, 0.01;
  (Lymphoblastic, Sparse_LT_10pc) 0.00, 0.97, 0.00, 0.02, 0.01;
  (Small_noncleaved_dif, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (True_histiocytic, Sparse_LT_10pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc) 0.00, 0.04, 0.76, 0.19, 0.01;
  (Multiple_myeloma, Sparse_LT_10pc) 0.00, 0.01, 0.93, 0.05, 0.01;
  (Mycosis_fungoides, Sparse_LT_10pc) 0.00, 0.44, 0.25, 0.30, 0.01;
  (AML, Sparse_LT_10pc) 0.00, 0.10, 0.35, 0.54, 0.01;
  (Hairy_cell_leukemia, Sparse_LT_10pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Carcinoma, Sparse_LT_10pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (Melanoma, Sparse_LT_10pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (EM_plasmacytoma, Sparse_LT_10pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Kaposi_s_sarcoma, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mast_cell_disease, Sparse_LT_10pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_involutionary, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (T_immunob_large, Sparse_LT_10pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Monocytoid_B_cell, Sparse_LT_10pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Nasopharyngeal_CA, Sparse_LT_10pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (Seminoma, Sparse_LT_10pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (SLE, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mycobact_histiocytos, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mast_cell_hyperplas, Sparse_LT_10pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (LGV, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Histoplasmosis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Coccidioidomycosis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (CMV, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Brucellosis, Sparse_LT_10pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc) 0.00, 0.04, 0.76, 0.19, 0.01;
  (Intermed_lymphocytic, Sparse_LT_10pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (AIDS_early, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (AILD, Moderate_11_to_50pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (ALIP, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Infectious_mono, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Lymphangiographic, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Sarcoidosis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (SHML, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Syphilis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Tuberculosis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Viral_NOS, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Mixed_fol, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Large_cell_fol, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Large_cell_dif, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (B_immunoblastic, Moderate_11_to_50pc) 0.00, 0.01, 0.93, 0.05, 0.01;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Japanese_ATL, Moderate_11_to_50pc) 0.00, 0.10, 0.59, 0.30, 0.01;
  (Lymphoblastic, Moderate_11_to_50pc) 0.00, 0.97, 0.00, 0.02, 0.01;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (True_histiocytic, Moderate_11_to_50pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.00, 0.04, 0.76, 0.19, 0.01;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.00, 0.01, 0.93, 0.05, 0.01;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.00, 0.44, 0.25, 0.30, 0.01;
  (AML, Moderate_11_to_50pc) 0.00, 0.10, 0.35, 0.54, 0.01;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Carcinoma, Moderate_11_to_50pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (Melanoma, Moderate_11_to_50pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (T_immunob_large, Moderate_11_to_50pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (Seminoma, Moderate_11_to_50pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (SLE, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (LGV, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Histoplasmosis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (CMV, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Brucellosis, Moderate_11_to_50pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.00, 0.04, 0.76, 0.19, 0.01;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (AIDS_early, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (AILD, Numerous_51_to_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (ALIP, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Infectious_mono, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Lymphangiographic, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Sarcoidosis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (SHML, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Syphilis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Tuberculosis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Viral_NOS, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Mixed_fol, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Large_cell_fol, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Large_cell_dif, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (B_immunoblastic, Numerous_51_to_90pc) 0.00, 0.01, 0.93, 0.05, 0.01;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Japanese_ATL, Numerous_51_to_90pc) 0.00, 0.10, 0.59, 0.30, 0.01;
  (Lymphoblastic, Numerous_51_to_90pc) 0.00, 0.97, 0.00, 0.02, 0.01;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (True_histiocytic, Numerous_51_to_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.00, 0.04, 0.76, 0.19, 0.01;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.00, 0.01, 0.93, 0.05, 0.01;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.00, 0.44, 0.25, 0.30, 0.01;
  (AML, Numerous_51_to_90pc) 0.00, 0.10, 0.35, 0.54, 0.01;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Carcinoma, Numerous_51_to_90pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (Melanoma, Numerous_51_to_90pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (T_immunob_large, Numerous_51_to_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (Seminoma, Numerous_51_to_90pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (SLE, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (LGV, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Histoplasmosis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (CMV, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Brucellosis, Numerous_51_to_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.00, 0.04, 0.76, 0.19, 0.01;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (AIDS_early, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (AILD, Striking_GT_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (ALIP, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Cat_scratch_disease, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Dermatopathic_laden, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (GLH_plasma_cell, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Granulomatous_laden, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Histiocytosis_x, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Infectious_mono, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Lymphangiographic, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Sarcoidosis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (SHML, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Syphilis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Toxoplasmosis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Tuberculosis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Viral_NOS, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Whipple_s_disease, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (L_H_nodular_HD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Syncytial_NSHD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Interfollicular_HD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Reticular_type_HD, Striking_GT_90pc) 0.00, 0.15, 0.25, 0.59, 0.01;
  (Small_cleaved_fol, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Mixed_fol, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Large_cell_fol, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_lymphocytic, Striking_GT_90pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Small_cleaved_dif, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (Large_cell_dif, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (B_immunoblastic, Striking_GT_90pc) 0.00, 0.01, 0.93, 0.05, 0.01;
  (T_immunob_mixed, Striking_GT_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Japanese_ATL, Striking_GT_90pc) 0.00, 0.10, 0.59, 0.30, 0.01;
  (Lymphoblastic, Striking_GT_90pc) 0.00, 0.97, 0.00, 0.02, 0.01;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
  (True_histiocytic, Striking_GT_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.00, 0.04, 0.76, 0.19, 0.01;
  (Multiple_myeloma, Striking_GT_90pc) 0.00, 0.01, 0.93, 0.05, 0.01;
  (Mycosis_fungoides, Striking_GT_90pc) 0.00, 0.44, 0.25, 0.30, 0.01;
  (AML, Striking_GT_90pc) 0.00, 0.10, 0.35, 0.54, 0.01;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Carcinoma, Striking_GT_90pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (Melanoma, Striking_GT_90pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (EM_plasmacytoma, Striking_GT_90pc) 0.00, 0.01, 0.96, 0.02, 0.01;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mast_cell_disease, Striking_GT_90pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_involutionary, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (T_immunob_large, Striking_GT_90pc) 0.000, 0.051, 0.739, 0.200, 0.010;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (Seminoma, Striking_GT_90pc) 0.00, 0.05, 0.40, 0.54, 0.01;
  (SLE, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.00, 0.30, 0.30, 0.39, 0.01;
  (LGV, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Histoplasmosis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Coccidioidomycosis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (CMV, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Brucellosis, Striking_GT_90pc) 0.00, 0.10, 0.40, 0.49, 0.01;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.00, 0.04, 0.76, 0.19, 0.01;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.00, 0.05, 0.01, 0.93, 0.01;
}
probability ( MCC | Fault ) {
  (AIDS_early) 0.05, 0.85, 0.10, 0.00;
  (AILD) 0.99999, 0.00001, 0.00000, 0.00000;
  (ALIP) 0.99999, 0.00001, 0.00000, 0.00000;
  (Cat_scratch_disease) 0.94, 0.05, 0.01, 0.00;
  (Dermatopathic_laden) 0.99999, 0.00001, 0.00000, 0.00000;
  (Florid_follic_hyperp) 0.96, 0.03, 0.01, 0.00;
  (GLH_hyaline_vascular) 0.99999, 0.00001, 0.00000, 0.00000;
  (GLH_plasma_cell) 0.99999, 0.00001, 0.00000, 0.00000;
  (Granulomatous_laden) 0.97, 0.02, 0.01, 0.00;
  (Histiocytosis_x) 0.99999, 0.00001, 0.00000, 0.00000;
  (Infectious_mono) 0.25, 0.70, 0.05, 0.00;
  (Leprosy_lepromatous) 0.99999, 0.00001, 0.00000, 0.00000;
  (Lymphangiographic) 0.99999, 0.00001, 0.00000, 0.00000;
  (Mantle_zone_hyperpla) 0.99999, 0.00001, 0.00000, 0.00000;
  (Necrotizing_Kikuchi) 0.97, 0.02, 0.01, 0.00;
  (Necrotiz_non_Kikuchi) 0.97, 0.02, 0.01, 0.00;
  (Rheumatoid_arthritis) 0.99999, 0.00001, 0.00000, 0.00000;
  (Sarcoidosis) 0.99999, 0.00001, 0.00000, 0.00000;
  (SHML) 0.99999, 0.00001, 0.00000, 0.00000;
  (Sinus_histiocytosis) 0.99999, 0.00001, 0.00000, 0.00000;
  (Syphilis) 0.94, 0.05, 0.01, 0.00;
  (Toxoplasmosis) 0.0, 0.6, 0.4, 0.0;
  (Tuberculosis) 0.99999, 0.00001, 0.00000, 0.00000;
  (Viral_NOS) 0.25, 0.70, 0.05, 0.00;
  (Whipple_s_disease) 0.99999, 0.00001, 0.00000, 0.00000;
  (L_H_nodular_HD) 0.999, 0.001, 0.000, 0.000;
  (L_H_diffuse_HD) 0.999, 0.001, 0.000, 0.000;
  (Nodular_sclerosis_HD) 0.97, 0.02, 0.01, 0.00;
  (Cellular_phase_NSHD) 0.97, 0.02, 0.01, 0.00;
  (Syncytial_NSHD) 0.999, 0.001, 0.000, 0.000;
  (Mixed_cellularity_HD) 0.97, 0.02, 0.01, 0.00;
  (Interfollicular_HD) 0.97, 0.02, 0.01, 0.00;
  (Diffuse_fibrosis_HD) 0.999, 0.001, 0.000, 0.000;
  (Reticular_type_HD) 0.999, 0.001, 0.000, 0.000;
  (Small_cleaved_fol) 0.91, 0.04, 0.03, 0.02;
  (Mixed_fol) 0.91, 0.04, 0.03, 0.02;
  (Large_cell_fol) 0.91, 0.04, 0.03, 0.02;
  (Small_noncleaved_fol) 0.91, 0.04, 0.03, 0.02;
  (Small_lymphocytic) 0.91, 0.04, 0.03, 0.02;
  (Plasmacytoid_lyctic) 0.91, 0.04, 0.03, 0.02;
  (Mantle_zone_lymphoma) 0.91, 0.04, 0.03, 0.02;
  (Small_cleaved_dif) 0.984, 0.010, 0.001, 0.005;
  (Mixed_FCC_dif) 0.984, 0.010, 0.001, 0.005;
  (Large_cell_dif) 0.984, 0.010, 0.001, 0.005;
  (B_immunoblastic) 0.99999, 0.00001, 0.00000, 0.00000;
  (T_immunob_mixed) 0.99999, 0.00001, 0.00000, 0.00000;
  (AILD_like_T_cell_lym) 0.99999, 0.00001, 0.00000, 0.00000;
  (Japanese_ATL) 0.99999, 0.00001, 0.00000, 0.00000;
  (Lymphoblastic) 0.99999, 0.00001, 0.00000, 0.00000;
  (Small_noncleaved_dif) 0.984, 0.010, 0.001, 0.005;
  (True_histiocytic) 0.99999, 0.00001, 0.00000, 0.00000;
  (Ki_1_LC_anaplas_T) 0.99999, 0.00001, 0.00000, 0.00000;
  (Multiple_myeloma) 0.99999, 0.00001, 0.00000, 0.00000;
  (Mycosis_fungoides) 0.99999, 0.00001, 0.00000, 0.00000;
  (AML) 0.99999, 0.00001, 0.00000, 0.00000;
  (Hairy_cell_leukemia) 0.985, 0.010, 0.005, 0.000;
  (Carcinoma) 0.99999, 0.00001, 0.00000, 0.00000;
  (Melanoma) 0.99999, 0.00001, 0.00000, 0.00000;
  (EM_plasmacytoma) 0.99999, 0.00001, 0.00000, 0.00000;
  (Kaposi_s_sarcoma) 0.99999, 0.00001, 0.00000, 0.00000;
  (Mast_cell_disease) 0.985, 0.010, 0.005, 0.000;
  (AIDS_involutionary) 0.75, 0.20, 0.05, 0.00;
  (T_immunob_large) 0.99999, 0.00001, 0.00000, 0.00000;
  (Monocytoid_B_cell) 0.00, 0.01, 0.15, 0.84;
  (Nasopharyngeal_CA) 0.99999, 0.00001, 0.00000, 0.00000;
  (Seminoma) 0.99999, 0.00001, 0.00000, 0.00000;
  (SLE) 0.25, 0.70, 0.05, 0.00;
  (Mycobact_histiocytos) 0.99999, 0.00001, 0.00000, 0.00000;
  (Mast_cell_hyperplas) 0.985, 0.010, 0.005, 0.000;
  (LGV) 0.99999, 0.00001, 0.00000, 0.00000;
  (Histoplasmosis) 0.94, 0.05, 0.01, 0.00;
  (Coccidioidomycosis) 0.94, 0.05, 0.01, 0.00;
  (CMV) 0.94, 0.05, 0.01, 0.00;
  (Brucellosis) 0.0, 0.6, 0.4, 0.0;
  (Ki_1_LC_anaplas_B) 0.99999, 0.00001, 0.00000, 0.00000;
  (Intermed_lymphocytic) 0.91, 0.04, 0.03, 0.02;
}
probability ( MONO | Fault, MUMMY ) {
  (AIDS_early, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (AILD, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (ALIP, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Cat_scratch_disease, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Dermatopathic_laden, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Florid_follic_hyperp, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (GLH_hyaline_vascular, Absent_0) 0.98, 0.02, 0.00, 0.00;
  (GLH_plasma_cell, Absent_0) 0.98, 0.02, 0.00, 0.00;
  (Granulomatous_laden, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Histiocytosis_x, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Infectious_mono, Absent_0) 0.969, 0.030, 0.001, 0.000;
  (Leprosy_lepromatous, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Lymphangiographic, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Mantle_zone_hyperpla, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Necrotizing_Kikuchi, Absent_0) 0.99, 0.01, 0.00, 0.00;
  (Necrotiz_non_Kikuchi, Absent_0) 0.99, 0.01, 0.00, 0.00;
  (Rheumatoid_arthritis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Sarcoidosis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (SHML, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Sinus_histiocytosis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Syphilis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Toxoplasmosis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Tuberculosis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Viral_NOS, Absent_0) 0.989, 0.010, 0.001, 0.000;
  (Whipple_s_disease, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (L_H_nodular_HD, Absent_0) 0.01, 0.98, 0.01, 0.00;
  (L_H_diffuse_HD, Absent_0) 0.01, 0.98, 0.01, 0.00;
  (Nodular_sclerosis_HD, Absent_0) 0.00, 0.05, 0.85, 0.10;
  (Cellular_phase_NSHD, Absent_0) 0.00, 0.05, 0.85, 0.10;
  (Syncytial_NSHD, Absent_0) 0.00, 0.05, 0.85, 0.10;
  (Mixed_cellularity_HD, Absent_0) 0.000, 0.001, 0.849, 0.150;
  (Interfollicular_HD, Absent_0) 0.00, 0.20, 0.75, 0.05;
  (Diffuse_fibrosis_HD, Absent_0) 0.00, 0.05, 0.15, 0.80;
  (Reticular_type_HD, Absent_0) 0.00, 0.01, 0.20, 0.79;
  (Small_cleaved_fol, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Mixed_fol, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Large_cell_fol, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Small_noncleaved_fol, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Small_lymphocytic, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Plasmacytoid_lyctic, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Mantle_zone_lymphoma, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Small_cleaved_dif, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Mixed_FCC_dif, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Large_cell_dif, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (B_immunoblastic, Absent_0) 0.88, 0.07, 0.04, 0.01;
  (T_immunob_mixed, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (AILD_like_T_cell_lym, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Japanese_ATL, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Lymphoblastic, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Small_noncleaved_dif, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (True_histiocytic, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Ki_1_LC_anaplas_T, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Multiple_myeloma, Absent_0) 0.45, 0.30, 0.20, 0.05;
  (Mycosis_fungoides, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (AML, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Hairy_cell_leukemia, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Carcinoma, Absent_0) 0.9499, 0.0400, 0.0100, 0.0001;
  (Melanoma, Absent_0) 0.9499, 0.0400, 0.0100, 0.0001;
  (EM_plasmacytoma, Absent_0) 0.80, 0.15, 0.04, 0.01;
  (Kaposi_s_sarcoma, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Mast_cell_disease, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (AIDS_involutionary, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (T_immunob_large, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Monocytoid_B_cell, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Nasopharyngeal_CA, Absent_0) 0.9499, 0.0400, 0.0100, 0.0001;
  (Seminoma, Absent_0) 0.949, 0.040, 0.010, 0.001;
  (SLE, Absent_0) 0.969, 0.030, 0.001, 0.000;
  (Mycobact_histiocytos, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Mast_cell_hyperplas, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (LGV, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Histoplasmosis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Coccidioidomycosis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (CMV, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Brucellosis, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (Ki_1_LC_anaplas_B, Absent_0) 0.969, 0.020, 0.010, 0.001;
  (Intermed_lymphocytic, Absent_0) 0.9999, 0.0001, 0.0000, 0.0000;
  (AIDS_early, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (AILD, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (ALIP, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Cat_scratch_disease, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Dermatopathic_laden, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Florid_follic_hyperp, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (GLH_hyaline_vascular, Rare_1_to_2) 0.98, 0.02, 0.00, 0.00;
  (GLH_plasma_cell, Rare_1_to_2) 0.98, 0.02, 0.00, 0.00;
  (Granulomatous_laden, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Histiocytosis_x, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Infectious_mono, Rare_1_to_2) 0.969, 0.030, 0.001, 0.000;
  (Leprosy_lepromatous, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Lymphangiographic, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Mantle_zone_hyperpla, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Necrotizing_Kikuchi, Rare_1_to_2) 0.99, 0.01, 0.00, 0.00;
  (Necrotiz_non_Kikuchi, Rare_1_to_2) 0.99, 0.01, 0.00, 0.00;
  (Rheumatoid_arthritis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Sarcoidosis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (SHML, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Sinus_histiocytosis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Syphilis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Toxoplasmosis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Tuberculosis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Viral_NOS, Rare_1_to_2) 0.989, 0.010, 0.001, 0.000;
  (Whipple_s_disease, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (L_H_nodular_HD, Rare_1_to_2) 0.01, 0.98, 0.01, 0.00;
  (L_H_diffuse_HD, Rare_1_to_2) 0.01, 0.98, 0.01, 0.00;
  (Nodular_sclerosis_HD, Rare_1_to_2) 0.00, 0.05, 0.85, 0.10;
  (Cellular_phase_NSHD, Rare_1_to_2) 0.00, 0.05, 0.85, 0.10;
  (Syncytial_NSHD, Rare_1_to_2) 0.00, 0.05, 0.85, 0.10;
  (Mixed_cellularity_HD, Rare_1_to_2) 0.000, 0.001, 0.849, 0.150;
  (Interfollicular_HD, Rare_1_to_2) 0.00, 0.20, 0.75, 0.05;
  (Diffuse_fibrosis_HD, Rare_1_to_2) 0.00, 0.05, 0.15, 0.80;
  (Reticular_type_HD, Rare_1_to_2) 0.00, 0.01, 0.20, 0.79;
  (Small_cleaved_fol, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (Mixed_fol, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (Large_cell_fol, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (Small_noncleaved_fol, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (Small_lymphocytic, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Plasmacytoid_lyctic, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Mantle_zone_lymphoma, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (Small_cleaved_dif, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (Mixed_FCC_dif, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Large_cell_dif, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (B_immunoblastic, Rare_1_to_2) 0.88, 0.07, 0.04, 0.01;
  (T_immunob_mixed, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (AILD_like_T_cell_lym, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Japanese_ATL, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Lymphoblastic, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (Small_noncleaved_dif, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (True_histiocytic, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Ki_1_LC_anaplas_T, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Multiple_myeloma, Rare_1_to_2) 0.45, 0.30, 0.20, 0.05;
  (Mycosis_fungoides, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (AML, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Hairy_cell_leukemia, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Carcinoma, Rare_1_to_2) 0.9499, 0.0400, 0.0100, 0.0001;
  (Melanoma, Rare_1_to_2) 0.9499, 0.0400, 0.0100, 0.0001;
  (EM_plasmacytoma, Rare_1_to_2) 0.80, 0.15, 0.04, 0.01;
  (Kaposi_s_sarcoma, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Mast_cell_disease, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (AIDS_involutionary, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (T_immunob_large, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Monocytoid_B_cell, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (Nasopharyngeal_CA, Rare_1_to_2) 0.9499, 0.0400, 0.0100, 0.0001;
  (Seminoma, Rare_1_to_2) 0.9499, 0.0400, 0.0100, 0.0001;
  (SLE, Rare_1_to_2) 0.969, 0.030, 0.001, 0.000;
  (Mycobact_histiocytos, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Mast_cell_hyperplas, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (LGV, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Histoplasmosis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Coccidioidomycosis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (CMV, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Brucellosis, Rare_1_to_2) 0.999, 0.001, 0.000, 0.000;
  (Ki_1_LC_anaplas_B, Rare_1_to_2) 0.969, 0.020, 0.010, 0.001;
  (Intermed_lymphocytic, Rare_1_to_2) 0.9999, 0.0001, 0.0000, 0.0000;
  (AIDS_early, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (AILD, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (ALIP, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, Present_3_to_20) 0.959, 0.030, 0.010, 0.001;
  (Leprosy_lepromatous, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (SHML, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Present_3_to_20) 0.96, 0.03, 0.01, 0.00;
  (Whipple_s_disease, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, Present_3_to_20) 0.01, 0.98, 0.01, 0.00;
  (L_H_diffuse_HD, Present_3_to_20) 0.01, 0.98, 0.01, 0.00;
  (Nodular_sclerosis_HD, Present_3_to_20) 0.00, 0.02, 0.83, 0.15;
  (Cellular_phase_NSHD, Present_3_to_20) 0.00, 0.02, 0.83, 0.15;
  (Syncytial_NSHD, Present_3_to_20) 0.00, 0.02, 0.83, 0.15;
  (Mixed_cellularity_HD, Present_3_to_20) 0.00, 0.01, 0.84, 0.15;
  (Interfollicular_HD, Present_3_to_20) 0.00, 0.05, 0.83, 0.12;
  (Diffuse_fibrosis_HD, Present_3_to_20) 0.00, 0.02, 0.15, 0.83;
  (Reticular_type_HD, Present_3_to_20) 0.00, 0.00, 0.15, 0.85;
  (Small_cleaved_fol, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_fol, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, Present_3_to_20) 0.939, 0.040, 0.020, 0.001;
  (Plasmacytoid_lyctic, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Mantle_zone_lymphoma, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Small_cleaved_dif, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Mixed_FCC_dif, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Large_cell_dif, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (B_immunoblastic, Present_3_to_20) 0.88, 0.07, 0.04, 0.01;
  (T_immunob_mixed, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (AILD_like_T_cell_lym, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Japanese_ATL, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Lymphoblastic, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Small_noncleaved_dif, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (True_histiocytic, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Ki_1_LC_anaplas_T, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Multiple_myeloma, Present_3_to_20) 0.30, 0.35, 0.25, 0.10;
  (Mycosis_fungoides, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (AML, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Hairy_cell_leukemia, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, Present_3_to_20) 0.59, 0.30, 0.10, 0.01;
  (Melanoma, Present_3_to_20) 0.59, 0.30, 0.10, 0.01;
  (EM_plasmacytoma, Present_3_to_20) 0.60, 0.25, 0.10, 0.05;
  (Kaposi_s_sarcoma, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Monocytoid_B_cell, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Nasopharyngeal_CA, Present_3_to_20) 0.59, 0.30, 0.10, 0.01;
  (Seminoma, Present_3_to_20) 0.59, 0.30, 0.10, 0.01;
  (SLE, Present_3_to_20) 0.96, 0.03, 0.01, 0.00;
  (Mycobact_histiocytos, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (LGV, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (CMV, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Brucellosis, Present_3_to_20) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (Intermed_lymphocytic, Present_3_to_20) 0.969, 0.020, 0.010, 0.001;
  (AIDS_early, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (AILD, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, Many_GT_20) 0.01, 0.93, 0.05, 0.01;
  (Leprosy_lepromatous, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (SHML, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, Many_GT_20) 0.000000000, 0.000999001, 0.749250749, 0.249750250;
  (Cellular_phase_NSHD, Many_GT_20) 0.000000000, 0.000999001, 0.749250749, 0.249750250;
  (Syncytial_NSHD, Many_GT_20) 0.000000000, 0.000999001, 0.749250749, 0.249750250;
  (Mixed_cellularity_HD, Many_GT_20) 0.00, 0.00, 0.65, 0.35;
  (Interfollicular_HD, Many_GT_20) 0.00, 0.05, 0.80, 0.15;
  (Diffuse_fibrosis_HD, Many_GT_20) 0.000000000, 0.000999001, 0.099900100, 0.899100899;
  (Reticular_type_HD, Many_GT_20) 0.00000000, 0.00009999, 0.04999500, 0.94990501;
  (Small_cleaved_fol, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_fol, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, Many_GT_20) 0.80, 0.10, 0.09, 0.01;
  (Mantle_zone_lymphoma, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_dif, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, Many_GT_20) 0.925, 0.050, 0.020, 0.005;
  (B_immunoblastic, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Many_GT_20) 0.969, 0.020, 0.010, 0.001;
  (Lymphoblastic, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Many_GT_20) 0.925, 0.050, 0.020, 0.005;
  (True_histiocytic, Many_GT_20) 0.925, 0.050, 0.020, 0.005;
  (Ki_1_LC_anaplas_T, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Many_GT_20) 0.000000000, 0.000999001, 0.599400599, 0.399600400;
  (Mycosis_fungoides, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (AML, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Hairy_cell_leukemia, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Melanoma, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (EM_plasmacytoma, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Many_GT_20) 0.969, 0.020, 0.010, 0.001;
  (Monocytoid_B_cell, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Nasopharyngeal_CA, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Seminoma, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (SLE, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Mycobact_histiocytos, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (LGV, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (CMV, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Brucellosis, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Many_GT_20) 0.25, 0.25, 0.25, 0.25;
}
probability ( MOT_HIST | Fault ) {
  (AIDS_early) 0.64, 0.25, 0.10, 0.01;
  (AILD) 0.82, 0.10, 0.05, 0.03;
  (ALIP) 0.82, 0.10, 0.05, 0.03;
  (Cat_scratch_disease) 0.64, 0.25, 0.10, 0.01;
  (Dermatopathic_laden) 0.05, 0.30, 0.55, 0.10;
  (Florid_follic_hyperp) 0.64, 0.25, 0.10, 0.01;
  (GLH_hyaline_vascular) 0.9699, 0.0200, 0.0100, 0.0001;
  (GLH_plasma_cell) 0.9699, 0.0200, 0.0100, 0.0001;
  (Granulomatous_laden) 0.64, 0.25, 0.10, 0.01;
  (Histiocytosis_x) 0.9699, 0.0200, 0.0100, 0.0001;
  (Infectious_mono) 0.84, 0.10, 0.05, 0.01;
  (Leprosy_lepromatous) 0.64, 0.25, 0.10, 0.01;
  (Lymphangiographic) 0.9699, 0.0200, 0.0100, 0.0001;
  (Mantle_zone_hyperpla) 0.9699, 0.0200, 0.0100, 0.0001;
  (Necrotizing_Kikuchi) 0.64, 0.25, 0.10, 0.01;
  (Necrotiz_non_Kikuchi) 0.64, 0.25, 0.10, 0.01;
  (Rheumatoid_arthritis) 0.9699, 0.0200, 0.0100, 0.0001;
  (Sarcoidosis) 0.9699, 0.0200, 0.0100, 0.0001;
  (SHML) 0.9699, 0.0200, 0.0100, 0.0001;
  (Sinus_histiocytosis) 0.9699, 0.0200, 0.0100, 0.0001;
  (Syphilis) 0.64, 0.25, 0.10, 0.01;
  (Toxoplasmosis) 0.9699, 0.0200, 0.0100, 0.0001;
  (Tuberculosis) 0.9699, 0.0200, 0.0100, 0.0001;
  (Viral_NOS) 0.84, 0.10, 0.05, 0.01;
  (Whipple_s_disease) 0.9699, 0.0200, 0.0100, 0.0001;
  (L_H_nodular_HD) 0.9699, 0.0200, 0.0100, 0.0001;
  (L_H_diffuse_HD) 0.9699, 0.0200, 0.0100, 0.0001;
  (Nodular_sclerosis_HD) 0.9699, 0.0200, 0.0100, 0.0001;
  (Cellular_phase_NSHD) 0.9699, 0.0200, 0.0100, 0.0001;
  (Syncytial_NSHD) 0.9699, 0.0200, 0.0100, 0.0001;
  (Mixed_cellularity_HD) 0.9699, 0.0200, 0.0100, 0.0001;
  (Interfollicular_HD) 0.9699, 0.0200, 0.0100, 0.0001;
  (Diffuse_fibrosis_HD) 0.9699, 0.0200, 0.0100, 0.0001;
  (Reticular_type_HD) 0.9699, 0.0200, 0.0100, 0.0001;
  (Small_cleaved_fol) 0.9699, 0.0200, 0.0100, 0.0001;
  (Mixed_fol) 0.9699, 0.0200, 0.0100, 0.0001;
  (Large_cell_fol) 0.9699, 0.0200, 0.0100, 0.0001;
  (Small_noncleaved_fol) 0.9699, 0.0200, 0.0100, 0.0001;
  (Small_lymphocytic) 0.9699, 0.0200, 0.0100, 0.0001;
  (Plasmacytoid_lyctic) 0.9699, 0.0200, 0.0100, 0.0001;
  (Mantle_zone_lymphoma) 0.9699, 0.0200, 0.0100, 0.0001;
  (Small_cleaved_dif) 0.9699, 0.0200, 0.0100, 0.0001;
  (Mixed_FCC_dif) 0.9699, 0.0200, 0.0100, 0.0001;
  (Large_cell_dif) 0.9699, 0.0200, 0.0100, 0.0001;
  (B_immunoblastic) 0.9699, 0.0200, 0.0100, 0.0001;
  (T_immunob_mixed) 0.9699, 0.0200, 0.0100, 0.0001;
  (AILD_like_T_cell_lym) 0.82, 0.10, 0.05, 0.03;
  (Japanese_ATL) 0.35, 0.20, 0.40, 0.05;
  (Lymphoblastic) 0.9699, 0.0200, 0.0100, 0.0001;
  (Small_noncleaved_dif) 0.9699, 0.0200, 0.0100, 0.0001;
  (True_histiocytic) 0.9699, 0.0200, 0.0100, 0.0001;
  (Ki_1_LC_anaplas_T) 0.9699, 0.0200, 0.0100, 0.0001;
  (Multiple_myeloma) 0.9699, 0.0200, 0.0100, 0.0001;
  (Mycosis_fungoides) 0.15, 0.35, 0.45, 0.05;
  (AML) 0.9699, 0.0200, 0.0100, 0.0001;
  (Hairy_cell_leukemia) 0.9699, 0.0200, 0.0100, 0.0001;
  (Carcinoma) 0.9699, 0.0200, 0.0100, 0.0001;
  (Melanoma) 0.64, 0.25, 0.10, 0.01;
  (EM_plasmacytoma) 0.9699, 0.0200, 0.0100, 0.0001;
  (Kaposi_s_sarcoma) 0.64, 0.25, 0.10, 0.01;
  (Mast_cell_disease) 0.9699, 0.0200, 0.0100, 0.0001;
  (AIDS_involutionary) 0.64, 0.25, 0.10, 0.01;
  (T_immunob_large) 0.9699, 0.0200, 0.0100, 0.0001;
  (Monocytoid_B_cell) 0.9699, 0.0200, 0.0100, 0.0001;
  (Nasopharyngeal_CA) 0.9699, 0.0200, 0.0100, 0.0001;
  (Seminoma) 0.9699, 0.0200, 0.0100, 0.0001;
  (SLE) 0.84, 0.10, 0.05, 0.01;
  (Mycobact_histiocytos) 0.9699, 0.0200, 0.0100, 0.0001;
  (Mast_cell_hyperplas) 0.9699, 0.0200, 0.0100, 0.0001;
  (LGV) 0.64, 0.25, 0.10, 0.01;
  (Histoplasmosis) 0.64, 0.25, 0.10, 0.01;
  (Coccidioidomycosis) 0.64, 0.25, 0.10, 0.01;
  (CMV) 0.64, 0.25, 0.10, 0.01;
  (Brucellosis) 0.9699, 0.0200, 0.0100, 0.0001;
  (Ki_1_LC_anaplas_B) 0.9699, 0.0200, 0.0100, 0.0001;
  (Intermed_lymphocytic) 0.9699, 0.0200, 0.0100, 0.0001;
}
probability ( MOT_LLC | Fault, LLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (AILD, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (ALIP, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Cat_scratch_disease, Sparse_LT_10pc) 0.42, 0.45, 0.08, 0.05;
  (Dermatopathic_laden, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Florid_follic_hyperp, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (GLH_hyaline_vascular, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (GLH_plasma_cell, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (Granulomatous_laden, Sparse_LT_10pc) 0.42, 0.45, 0.08, 0.05;
  (Histiocytosis_x, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Infectious_mono, Sparse_LT_10pc) 0.01, 0.20, 0.64, 0.15;
  (Leprosy_lepromatous, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Lymphangiographic, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Mantle_zone_hyperpla, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Necrotizing_Kikuchi, Sparse_LT_10pc) 0.01, 0.20, 0.64, 0.15;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc) 0.42, 0.45, 0.08, 0.05;
  (Rheumatoid_arthritis, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (Sarcoidosis, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (SHML, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Sinus_histiocytosis, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Syphilis, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Toxoplasmosis, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (Tuberculosis, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Viral_NOS, Sparse_LT_10pc) 0.01, 0.20, 0.64, 0.15;
  (Whipple_s_disease, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (L_H_nodular_HD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (L_H_diffuse_HD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Nodular_sclerosis_HD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Cellular_phase_NSHD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Syncytial_NSHD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Mixed_cellularity_HD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Interfollicular_HD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Reticular_type_HD, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Small_cleaved_fol, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Mixed_fol, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Large_cell_fol, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Small_noncleaved_fol, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Small_lymphocytic, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Plasmacytoid_lyctic, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Mantle_zone_lymphoma, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Small_cleaved_dif, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Mixed_FCC_dif, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Large_cell_dif, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (B_immunoblastic, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (T_immunob_mixed, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (AILD_like_T_cell_lym, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Japanese_ATL, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Lymphoblastic, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Small_noncleaved_dif, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (True_histiocytic, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Multiple_myeloma, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Mycosis_fungoides, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (AML, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Hairy_cell_leukemia, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Carcinoma, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Melanoma, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (EM_plasmacytoma, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Kaposi_s_sarcoma, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (Mast_cell_disease, Sparse_LT_10pc) 0.989, 0.010, 0.001, 0.000;
  (AIDS_involutionary, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (T_immunob_large, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Monocytoid_B_cell, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Nasopharyngeal_CA, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Seminoma, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (SLE, Sparse_LT_10pc) 0.01, 0.20, 0.64, 0.15;
  (Mycobact_histiocytos, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Mast_cell_hyperplas, Sparse_LT_10pc) 0.989, 0.010, 0.001, 0.000;
  (LGV, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Histoplasmosis, Sparse_LT_10pc) 0.939, 0.050, 0.010, 0.001;
  (Coccidioidomycosis, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (CMV, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (Brucellosis, Sparse_LT_10pc) 0.885, 0.100, 0.010, 0.005;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (Intermed_lymphocytic, Sparse_LT_10pc) 0.999, 0.001, 0.000, 0.000;
  (AIDS_early, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (AILD, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (ALIP, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.42, 0.45, 0.08, 0.05;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.42, 0.45, 0.08, 0.05;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Infectious_mono, Moderate_11_to_50pc) 0.01, 0.20, 0.64, 0.15;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Lymphangiographic, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.01, 0.20, 0.64, 0.15;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.42, 0.45, 0.08, 0.05;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (Sarcoidosis, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (SHML, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Syphilis, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (Tuberculosis, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Viral_NOS, Moderate_11_to_50pc) 0.01, 0.20, 0.64, 0.15;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Mixed_fol, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Large_cell_fol, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Large_cell_dif, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (B_immunoblastic, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Japanese_ATL, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Lymphoblastic, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (True_histiocytic, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (AML, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Carcinoma, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Melanoma, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (T_immunob_large, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Seminoma, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (SLE, Moderate_11_to_50pc) 0.01, 0.20, 0.64, 0.15;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (LGV, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Histoplasmosis, Moderate_11_to_50pc) 0.939, 0.050, 0.010, 0.001;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (CMV, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (Brucellosis, Moderate_11_to_50pc) 0.885, 0.100, 0.010, 0.005;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.999, 0.001, 0.000, 0.000;
  (AIDS_early, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Numerous_51_to_90pc) 0.879, 0.100, 0.020, 0.001;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.879, 0.100, 0.020, 0.001;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Numerous_51_to_90pc) 0.879, 0.100, 0.020, 0.001;
  (Whipple_s_disease, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Numerous_51_to_90pc) 0.879, 0.100, 0.020, 0.001;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Striking_GT_90pc) 1.0, 0.0, 0.0, 0.0;
}
probability ( MUMMY | Fault ) {
  (AIDS_early) 0.999, 0.001, 0.000, 0.000;
  (AILD) 0.985, 0.010, 0.005, 0.000;
  (ALIP) 0.999, 0.001, 0.000, 0.000;
  (Cat_scratch_disease) 0.999, 0.001, 0.000, 0.000;
  (Dermatopathic_laden) 0.999, 0.001, 0.000, 0.000;
  (Florid_follic_hyperp) 0.999, 0.001, 0.000, 0.000;
  (GLH_hyaline_vascular) 0.999, 0.001, 0.000, 0.000;
  (GLH_plasma_cell) 0.999, 0.001, 0.000, 0.000;
  (Granulomatous_laden) 0.999, 0.001, 0.000, 0.000;
  (Histiocytosis_x) 0.999, 0.001, 0.000, 0.000;
  (Infectious_mono) 0.959, 0.030, 0.010, 0.001;
  (Leprosy_lepromatous) 0.999, 0.001, 0.000, 0.000;
  (Lymphangiographic) 0.999, 0.001, 0.000, 0.000;
  (Mantle_zone_hyperpla) 0.999, 0.001, 0.000, 0.000;
  (Necrotizing_Kikuchi) 0.999, 0.001, 0.000, 0.000;
  (Necrotiz_non_Kikuchi) 0.999, 0.001, 0.000, 0.000;
  (Rheumatoid_arthritis) 0.999, 0.001, 0.000, 0.000;
  (Sarcoidosis) 0.999, 0.001, 0.000, 0.000;
  (SHML) 0.999, 0.001, 0.000, 0.000;
  (Sinus_histiocytosis) 0.999, 0.001, 0.000, 0.000;
  (Syphilis) 0.999, 0.001, 0.000, 0.000;
  (Toxoplasmosis) 0.999, 0.001, 0.000, 0.000;
  (Tuberculosis) 0.999, 0.001, 0.000, 0.000;
  (Viral_NOS) 0.985, 0.010, 0.005, 0.000;
  (Whipple_s_disease) 0.999, 0.001, 0.000, 0.000;
  (L_H_nodular_HD) 0.80, 0.19, 0.01, 0.00;
  (L_H_diffuse_HD) 0.80, 0.19, 0.01, 0.00;
  (Nodular_sclerosis_HD) 0.25, 0.50, 0.20, 0.05;
  (Cellular_phase_NSHD) 0.25, 0.50, 0.20, 0.05;
  (Syncytial_NSHD) 0.25, 0.50, 0.20, 0.05;
  (Mixed_cellularity_HD) 0.35, 0.50, 0.10, 0.05;
  (Interfollicular_HD) 0.30, 0.60, 0.07, 0.03;
  (Diffuse_fibrosis_HD) 0.70, 0.15, 0.10, 0.05;
  (Reticular_type_HD) 0.70, 0.15, 0.10, 0.05;
  (Small_cleaved_fol) 0.999, 0.001, 0.000, 0.000;
  (Mixed_fol) 0.999, 0.001, 0.000, 0.000;
  (Large_cell_fol) 0.999, 0.001, 0.000, 0.000;
  (Small_noncleaved_fol) 0.999, 0.001, 0.000, 0.000;
  (Small_lymphocytic) 0.985, 0.010, 0.005, 0.000;
  (Plasmacytoid_lyctic) 0.985, 0.010, 0.005, 0.000;
  (Mantle_zone_lymphoma) 0.985, 0.010, 0.005, 0.000;
  (Small_cleaved_dif) 0.985, 0.010, 0.005, 0.000;
  (Mixed_FCC_dif) 0.985, 0.010, 0.005, 0.000;
  (Large_cell_dif) 0.985, 0.010, 0.005, 0.000;
  (B_immunoblastic) 0.98, 0.01, 0.01, 0.00;
  (T_immunob_mixed) 0.98, 0.01, 0.01, 0.00;
  (AILD_like_T_cell_lym) 0.985, 0.010, 0.005, 0.000;
  (Japanese_ATL) 0.949, 0.030, 0.020, 0.001;
  (Lymphoblastic) 0.985, 0.010, 0.005, 0.000;
  (Small_noncleaved_dif) 0.985, 0.010, 0.005, 0.000;
  (True_histiocytic) 0.985, 0.010, 0.005, 0.000;
  (Ki_1_LC_anaplas_T) 0.98, 0.01, 0.01, 0.00;
  (Multiple_myeloma) 0.79, 0.15, 0.05, 0.01;
  (Mycosis_fungoides) 0.999, 0.001, 0.000, 0.000;
  (AML) 0.999, 0.001, 0.000, 0.000;
  (Hairy_cell_leukemia) 0.999, 0.001, 0.000, 0.000;
  (Carcinoma) 0.9985, 0.0010, 0.0005, 0.0000;
  (Melanoma) 0.9985, 0.0010, 0.0005, 0.0000;
  (EM_plasmacytoma) 0.999, 0.001, 0.000, 0.000;
  (Kaposi_s_sarcoma) 0.999, 0.001, 0.000, 0.000;
  (Mast_cell_disease) 0.999, 0.001, 0.000, 0.000;
  (AIDS_involutionary) 0.999, 0.001, 0.000, 0.000;
  (T_immunob_large) 0.949, 0.030, 0.020, 0.001;
  (Monocytoid_B_cell) 0.985, 0.010, 0.005, 0.000;
  (Nasopharyngeal_CA) 0.9985, 0.0010, 0.0005, 0.0000;
  (Seminoma) 0.9985, 0.0010, 0.0005, 0.0000;
  (SLE) 0.96, 0.03, 0.01, 0.00;
  (Mycobact_histiocytos) 0.999, 0.001, 0.000, 0.000;
  (Mast_cell_hyperplas) 0.999, 0.001, 0.000, 0.000;
  (LGV) 0.999, 0.001, 0.000, 0.000;
  (Histoplasmosis) 0.999, 0.001, 0.000, 0.000;
  (Coccidioidomycosis) 0.999, 0.001, 0.000, 0.000;
  (CMV) 0.97, 0.02, 0.01, 0.00;
  (Brucellosis) 0.999, 0.001, 0.000, 0.000;
  (Ki_1_LC_anaplas_B) 0.98, 0.01, 0.01, 0.00;
  (Intermed_lymphocytic) 0.985, 0.010, 0.005, 0.000;
}
probability ( NECR | Fault ) {
  (AIDS_early) 0.99, 0.01, 0.00, 0.00;
  (AILD) 0.99, 0.01, 0.00, 0.00;
  (ALIP) 0.99, 0.01, 0.00, 0.00;
  (Cat_scratch_disease) 0.05, 0.35, 0.55, 0.05;
  (Dermatopathic_laden) 0.99, 0.01, 0.00, 0.00;
  (Florid_follic_hyperp) 0.99, 0.01, 0.00, 0.00;
  (GLH_hyaline_vascular) 0.99, 0.01, 0.00, 0.00;
  (GLH_plasma_cell) 0.99, 0.01, 0.00, 0.00;
  (Granulomatous_laden) 0.4, 0.2, 0.2, 0.2;
  (Histiocytosis_x) 0.25, 0.50, 0.20, 0.05;
  (Infectious_mono) 0.91, 0.05, 0.03, 0.01;
  (Leprosy_lepromatous) 0.92, 0.05, 0.02, 0.01;
  (Lymphangiographic) 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla) 0.99, 0.01, 0.00, 0.00;
  (Necrotizing_Kikuchi) 0.3, 0.1, 0.4, 0.2;
  (Necrotiz_non_Kikuchi) 0.0, 0.1, 0.3, 0.6;
  (Rheumatoid_arthritis) 0.99, 0.01, 0.00, 0.00;
  (Sarcoidosis) 0.99, 0.01, 0.00, 0.00;
  (SHML) 0.99, 0.01, 0.00, 0.00;
  (Sinus_histiocytosis) 0.99, 0.01, 0.00, 0.00;
  (Syphilis) 0.99, 0.01, 0.00, 0.00;
  (Toxoplasmosis) 0.99, 0.01, 0.00, 0.00;
  (Tuberculosis) 0.05, 0.30, 0.35, 0.30;
  (Viral_NOS) 0.91, 0.05, 0.03, 0.01;
  (Whipple_s_disease) 0.92, 0.05, 0.02, 0.01;
  (L_H_nodular_HD) 0.989, 0.010, 0.001, 0.000;
  (L_H_diffuse_HD) 0.989, 0.010, 0.001, 0.000;
  (Nodular_sclerosis_HD) 0.49, 0.20, 0.30, 0.01;
  (Cellular_phase_NSHD) 0.49, 0.20, 0.30, 0.01;
  (Syncytial_NSHD) 0.49, 0.20, 0.30, 0.01;
  (Mixed_cellularity_HD) 0.84158416, 0.12871287, 0.01980198, 0.00990099;
  (Interfollicular_HD) 0.84158416, 0.12871287, 0.01980198, 0.00990099;
  (Diffuse_fibrosis_HD) 0.78, 0.10, 0.07, 0.05;
  (Reticular_type_HD) 0.78, 0.10, 0.07, 0.05;
  (Small_cleaved_fol) 0.97, 0.01, 0.01, 0.01;
  (Mixed_fol) 0.97, 0.01, 0.01, 0.01;
  (Large_cell_fol) 0.97, 0.01, 0.01, 0.01;
  (Small_noncleaved_fol) 0.97, 0.01, 0.01, 0.01;
  (Small_lymphocytic) 0.94, 0.03, 0.02, 0.01;
  (Plasmacytoid_lyctic) 0.94, 0.03, 0.02, 0.01;
  (Mantle_zone_lymphoma) 0.94, 0.03, 0.02, 0.01;
  (Small_cleaved_dif) 0.94, 0.03, 0.02, 0.01;
  (Mixed_FCC_dif) 0.94, 0.03, 0.02, 0.01;
  (Large_cell_dif) 0.88, 0.07, 0.03, 0.02;
  (B_immunoblastic) 0.88, 0.07, 0.03, 0.02;
  (T_immunob_mixed) 0.88, 0.07, 0.03, 0.02;
  (AILD_like_T_cell_lym) 0.88, 0.07, 0.03, 0.02;
  (Japanese_ATL) 0.88, 0.07, 0.03, 0.02;
  (Lymphoblastic) 0.88, 0.07, 0.03, 0.02;
  (Small_noncleaved_dif) 0.88, 0.07, 0.03, 0.02;
  (True_histiocytic) 0.88, 0.07, 0.03, 0.02;
  (Ki_1_LC_anaplas_T) 0.88, 0.07, 0.03, 0.02;
  (Multiple_myeloma) 0.88, 0.07, 0.03, 0.02;
  (Mycosis_fungoides) 0.88, 0.07, 0.03, 0.02;
  (AML) 0.88, 0.07, 0.03, 0.02;
  (Hairy_cell_leukemia) 0.99, 0.01, 0.00, 0.00;
  (Carcinoma) 0.84, 0.10, 0.05, 0.01;
  (Melanoma) 0.84, 0.10, 0.05, 0.01;
  (EM_plasmacytoma) 0.99, 0.01, 0.00, 0.00;
  (Kaposi_s_sarcoma) 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_disease) 0.94, 0.03, 0.02, 0.01;
  (AIDS_involutionary) 0.99, 0.01, 0.00, 0.00;
  (T_immunob_large) 0.88, 0.07, 0.03, 0.02;
  (Monocytoid_B_cell) 0.97, 0.01, 0.01, 0.01;
  (Nasopharyngeal_CA) 0.84, 0.10, 0.05, 0.01;
  (Seminoma) 0.84, 0.10, 0.05, 0.01;
  (SLE) 0.91, 0.05, 0.03, 0.01;
  (Mycobact_histiocytos) 0.92, 0.05, 0.02, 0.01;
  (Mast_cell_hyperplas) 0.99, 0.01, 0.00, 0.00;
  (LGV) 0.0, 0.1, 0.6, 0.3;
  (Histoplasmosis) 0.99, 0.01, 0.00, 0.00;
  (Coccidioidomycosis) 0.99, 0.01, 0.00, 0.00;
  (CMV) 0.99, 0.01, 0.00, 0.00;
  (Brucellosis) 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_B) 0.88, 0.07, 0.03, 0.02;
  (Intermed_lymphocytic) 0.94, 0.03, 0.02, 0.01;
}
probability ( MA_NEUT | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 0.9, 0.1;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 0.95, 0.05;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 0.995, 0.005;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 0.9, 0.1;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 0.995, 0.005;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 0.995, 0.005;
  (Whipple_s_disease) 0.995, 0.005;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 0.995, 0.005;
  (Cellular_phase_NSHD) 0.995, 0.005;
  (Syncytial_NSHD) 0.995, 0.005;
  (Mixed_cellularity_HD) 0.995, 0.005;
  (Interfollicular_HD) 0.995, 0.005;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 0.995, 0.005;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 0.97, 0.03;
  (Nasopharyngeal_CA) 0.995, 0.005;
  (Seminoma) 1.0, 0.0;
  (SLE) 0.995, 0.005;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 0.995, 0.005;
  (LGV) 0.7, 0.3;
  (Histoplasmosis) 0.995, 0.005;
  (Coccidioidomycosis) 0.995, 0.005;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( NEUTRO | Fault ) {
  (AIDS_early) 0.691, 0.300, 0.009;
  (AILD) 0.80, 0.19, 0.01;
  (ALIP) 0.691, 0.300, 0.009;
  (Cat_scratch_disease) 0.0, 0.6, 0.4;
  (Dermatopathic_laden) 0.691, 0.300, 0.009;
  (Florid_follic_hyperp) 0.691, 0.300, 0.009;
  (GLH_hyaline_vascular) 0.691, 0.300, 0.009;
  (GLH_plasma_cell) 0.691, 0.300, 0.009;
  (Granulomatous_laden) 0.1, 0.7, 0.2;
  (Histiocytosis_x) 0.691, 0.300, 0.009;
  (Infectious_mono) 0.37, 0.60, 0.03;
  (Leprosy_lepromatous) 0.691, 0.300, 0.009;
  (Lymphangiographic) 0.691, 0.300, 0.009;
  (Mantle_zone_hyperpla) 0.691, 0.300, 0.009;
  (Necrotizing_Kikuchi) 0.89, 0.11, 0.00;
  (Necrotiz_non_Kikuchi) 0.0, 0.6, 0.4;
  (Rheumatoid_arthritis) 0.35, 0.60, 0.05;
  (Sarcoidosis) 0.691, 0.300, 0.009;
  (SHML) 0.691, 0.300, 0.009;
  (Sinus_histiocytosis) 0.691, 0.300, 0.009;
  (Syphilis) 0.37, 0.60, 0.03;
  (Toxoplasmosis) 0.691, 0.300, 0.009;
  (Tuberculosis) 0.691, 0.300, 0.009;
  (Viral_NOS) 0.37, 0.60, 0.03;
  (Whipple_s_disease) 0.691, 0.300, 0.009;
  (L_H_nodular_HD) 0.691, 0.300, 0.009;
  (L_H_diffuse_HD) 0.691, 0.300, 0.009;
  (Nodular_sclerosis_HD) 0.10, 0.85, 0.05;
  (Cellular_phase_NSHD) 0.10, 0.85, 0.05;
  (Syncytial_NSHD) 0.10, 0.85, 0.05;
  (Mixed_cellularity_HD) 0.10, 0.85, 0.05;
  (Interfollicular_HD) 0.10, 0.85, 0.05;
  (Diffuse_fibrosis_HD) 0.691, 0.300, 0.009;
  (Reticular_type_HD) 0.691, 0.300, 0.009;
  (Small_cleaved_fol) 0.691, 0.300, 0.009;
  (Mixed_fol) 0.691, 0.300, 0.009;
  (Large_cell_fol) 0.691, 0.300, 0.009;
  (Small_noncleaved_fol) 0.691, 0.300, 0.009;
  (Small_lymphocytic) 0.691, 0.300, 0.009;
  (Plasmacytoid_lyctic) 0.691, 0.300, 0.009;
  (Mantle_zone_lymphoma) 0.691, 0.300, 0.009;
  (Small_cleaved_dif) 0.691, 0.300, 0.009;
  (Mixed_FCC_dif) 0.691, 0.300, 0.009;
  (Large_cell_dif) 0.691, 0.300, 0.009;
  (B_immunoblastic) 0.691, 0.300, 0.009;
  (T_immunob_mixed) 0.691, 0.300, 0.009;
  (AILD_like_T_cell_lym) 0.80, 0.19, 0.01;
  (Japanese_ATL) 0.691, 0.300, 0.009;
  (Lymphoblastic) 0.691, 0.300, 0.009;
  (Small_noncleaved_dif) 0.691, 0.300, 0.009;
  (True_histiocytic) 0.691, 0.300, 0.009;
  (Ki_1_LC_anaplas_T) 0.691, 0.300, 0.009;
  (Multiple_myeloma) 0.691, 0.300, 0.009;
  (Mycosis_fungoides) 0.691, 0.300, 0.009;
  (AML) 0.691, 0.300, 0.009;
  (Hairy_cell_leukemia) 0.691, 0.300, 0.009;
  (Carcinoma) 0.691, 0.300, 0.009;
  (Melanoma) 0.691, 0.300, 0.009;
  (EM_plasmacytoma) 0.691, 0.300, 0.009;
  (Kaposi_s_sarcoma) 0.691, 0.300, 0.009;
  (Mast_cell_disease) 0.05, 0.75, 0.20;
  (AIDS_involutionary) 0.691, 0.300, 0.009;
  (T_immunob_large) 0.691, 0.300, 0.009;
  (Monocytoid_B_cell) 0.03, 0.77, 0.20;
  (Nasopharyngeal_CA) 0.10, 0.85, 0.05;
  (Seminoma) 0.691, 0.300, 0.009;
  (SLE) 0.37, 0.60, 0.03;
  (Mycobact_histiocytos) 0.60, 0.39, 0.01;
  (Mast_cell_hyperplas) 0.05, 0.75, 0.20;
  (LGV) 0.0, 0.6, 0.4;
  (Histoplasmosis) 0.37, 0.60, 0.03;
  (Coccidioidomycosis) 0.37, 0.60, 0.03;
  (CMV) 0.37, 0.60, 0.03;
  (Brucellosis) 0.691, 0.300, 0.009;
  (Ki_1_LC_anaplas_B) 0.691, 0.300, 0.009;
  (Intermed_lymphocytic) 0.691, 0.300, 0.009;
}
probability ( PAS | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 0.0, 1.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( PI | Fault ) {
  (AIDS_early) 0.95, 0.04, 0.01;
  (AILD) 0.65, 0.30, 0.05;
  (ALIP) 0.95, 0.04, 0.01;
  (Cat_scratch_disease) 0.4, 0.5, 0.1;
  (Dermatopathic_laden) 0.95, 0.04, 0.01;
  (Florid_follic_hyperp) 0.95, 0.04, 0.01;
  (GLH_hyaline_vascular) 0.95, 0.04, 0.01;
  (GLH_plasma_cell) 0.95, 0.04, 0.01;
  (Granulomatous_laden) 0.85, 0.13, 0.02;
  (Histiocytosis_x) 0.95, 0.04, 0.01;
  (Infectious_mono) 0.55, 0.35, 0.10;
  (Leprosy_lepromatous) 0.95, 0.04, 0.01;
  (Lymphangiographic) 0.95, 0.04, 0.01;
  (Mantle_zone_hyperpla) 0.95, 0.04, 0.01;
  (Necrotizing_Kikuchi) 0.4, 0.5, 0.1;
  (Necrotiz_non_Kikuchi) 0.4, 0.5, 0.1;
  (Rheumatoid_arthritis) 0.95, 0.04, 0.01;
  (Sarcoidosis) 0.95, 0.04, 0.01;
  (SHML) 0.95, 0.04, 0.01;
  (Sinus_histiocytosis) 0.95, 0.04, 0.01;
  (Syphilis) 0.85, 0.13, 0.02;
  (Toxoplasmosis) 0.95, 0.04, 0.01;
  (Tuberculosis) 0.95, 0.04, 0.01;
  (Viral_NOS) 0.70, 0.25, 0.05;
  (Whipple_s_disease) 0.95, 0.04, 0.01;
  (L_H_nodular_HD) 0.93, 0.05, 0.02;
  (L_H_diffuse_HD) 0.93, 0.05, 0.02;
  (Nodular_sclerosis_HD) 0.35, 0.45, 0.20;
  (Cellular_phase_NSHD) 0.35, 0.45, 0.20;
  (Syncytial_NSHD) 0.35, 0.45, 0.20;
  (Mixed_cellularity_HD) 0.93, 0.05, 0.02;
  (Interfollicular_HD) 0.93, 0.05, 0.02;
  (Diffuse_fibrosis_HD) 0.75, 0.20, 0.05;
  (Reticular_type_HD) 0.75, 0.20, 0.05;
  (Small_cleaved_fol) 0.5, 0.4, 0.1;
  (Mixed_fol) 0.5, 0.4, 0.1;
  (Large_cell_fol) 0.30, 0.55, 0.15;
  (Small_noncleaved_fol) 0.30, 0.55, 0.15;
  (Small_lymphocytic) 0.60, 0.25, 0.15;
  (Plasmacytoid_lyctic) 0.7, 0.2, 0.1;
  (Mantle_zone_lymphoma) 0.7, 0.2, 0.1;
  (Small_cleaved_dif) 0.6, 0.3, 0.1;
  (Mixed_FCC_dif) 0.6, 0.3, 0.1;
  (Large_cell_dif) 0.2, 0.6, 0.2;
  (B_immunoblastic) 0.2, 0.6, 0.2;
  (T_immunob_mixed) 0.2, 0.6, 0.2;
  (AILD_like_T_cell_lym) 0.2, 0.6, 0.2;
  (Japanese_ATL) 0.2, 0.6, 0.2;
  (Lymphoblastic) 0.2, 0.6, 0.2;
  (Small_noncleaved_dif) 0.2, 0.6, 0.2;
  (True_histiocytic) 0.2, 0.6, 0.2;
  (Ki_1_LC_anaplas_T) 0.2, 0.6, 0.2;
  (Multiple_myeloma) 0.2, 0.6, 0.2;
  (Mycosis_fungoides) 0.2, 0.6, 0.2;
  (AML) 0.2, 0.6, 0.2;
  (Hairy_cell_leukemia) 0.90, 0.09, 0.01;
  (Carcinoma) 0.90, 0.09, 0.01;
  (Melanoma) 0.90, 0.09, 0.01;
  (EM_plasmacytoma) 0.80, 0.15, 0.05;
  (Kaposi_s_sarcoma) 0.3, 0.4, 0.3;
  (Mast_cell_disease) 0.80, 0.15, 0.05;
  (AIDS_involutionary) 0.95, 0.04, 0.01;
  (T_immunob_large) 0.2, 0.6, 0.2;
  (Monocytoid_B_cell) 0.5, 0.4, 0.1;
  (Nasopharyngeal_CA) 0.90, 0.09, 0.01;
  (Seminoma) 0.90, 0.09, 0.01;
  (SLE) 0.55, 0.35, 0.10;
  (Mycobact_histiocytos) 0.95, 0.04, 0.01;
  (Mast_cell_hyperplas) 0.80, 0.15, 0.05;
  (LGV) 0.4, 0.5, 0.1;
  (Histoplasmosis) 0.95, 0.04, 0.01;
  (Coccidioidomycosis) 0.95, 0.04, 0.01;
  (CMV) 0.95, 0.04, 0.01;
  (Brucellosis) 0.95, 0.04, 0.01;
  (Ki_1_LC_anaplas_B) 0.2, 0.6, 0.2;
  (Intermed_lymphocytic) 0.7, 0.2, 0.1;
}
probability ( PLASMA | Fault, MOT_HIST ) {
  (AIDS_early, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AILD, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (ALIP, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Cat_scratch_disease, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Dermatopathic_laden, Absent) 0.005, 0.250, 0.695, 0.050, 0.000, 0.000;
  (Florid_follic_hyperp, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (GLH_hyaline_vascular, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (GLH_plasma_cell, Absent) 0.000, 0.000, 0.200, 0.799, 0.001, 0.000;
  (Granulomatous_laden, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Histiocytosis_x, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Infectious_mono, Absent) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Leprosy_lepromatous, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Lymphangiographic, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mantle_zone_hyperpla, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Necrotizing_Kikuchi, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Necrotiz_non_Kikuchi, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Rheumatoid_arthritis, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Sarcoidosis, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (SHML, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Sinus_histiocytosis, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Syphilis, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Toxoplasmosis, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Tuberculosis, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Viral_NOS, Absent) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Whipple_s_disease, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (L_H_nodular_HD, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (L_H_diffuse_HD, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Nodular_sclerosis_HD, Absent) 0.10, 0.80, 0.09, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Syncytial_NSHD, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_cellularity_HD, Absent) 0.10, 0.80, 0.09, 0.01, 0.00, 0.00;
  (Interfollicular_HD, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Diffuse_fibrosis_HD, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Reticular_type_HD, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_cleaved_fol, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_fol, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Large_cell_fol, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_noncleaved_fol, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_lymphocytic, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Plasmacytoid_lyctic, Absent) 0.000, 0.149, 0.650, 0.200, 0.001, 0.000;
  (Mantle_zone_lymphoma, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_cleaved_dif, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_FCC_dif, Absent) 0.37, 0.46, 0.15, 0.02, 0.00, 0.00;
  (Large_cell_dif, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (B_immunoblastic, Absent) 0.15, 0.70, 0.10, 0.05, 0.00, 0.00;
  (T_immunob_mixed, Absent) 0.37, 0.46, 0.15, 0.02, 0.00, 0.00;
  (AILD_like_T_cell_lym, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Japanese_ATL, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Lymphoblastic, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_noncleaved_dif, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (True_histiocytic, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Ki_1_LC_anaplas_T, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Multiple_myeloma, Absent) 0.00, 0.10, 0.65, 0.25, 0.00, 0.00;
  (Mycosis_fungoides, Absent) 0.75, 0.20, 0.04, 0.01, 0.00, 0.00;
  (AML, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Hairy_cell_leukemia, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Carcinoma, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Melanoma, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (EM_plasmacytoma, Absent) 0.00, 0.00, 0.00, 0.10, 0.55, 0.35;
  (Kaposi_s_sarcoma, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Mast_cell_disease, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AIDS_involutionary, Absent) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (T_immunob_large, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Monocytoid_B_cell, Absent) 0.10, 0.70, 0.19, 0.01, 0.00, 0.00;
  (Nasopharyngeal_CA, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Seminoma, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (SLE, Absent) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Mycobact_histiocytos, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mast_cell_hyperplas, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (LGV, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Histoplasmosis, Absent) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Coccidioidomycosis, Absent) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (CMV, Absent) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Brucellosis, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Ki_1_LC_anaplas_B, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Intermed_lymphocytic, Absent) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AIDS_early, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AILD, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (ALIP, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Cat_scratch_disease, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Dermatopathic_laden, Focal_nonextensive) 0.005, 0.250, 0.695, 0.050, 0.000, 0.000;
  (Florid_follic_hyperp, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (GLH_hyaline_vascular, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (GLH_plasma_cell, Focal_nonextensive) 0.000, 0.000, 0.200, 0.799, 0.001, 0.000;
  (Granulomatous_laden, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Histiocytosis_x, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Infectious_mono, Focal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Leprosy_lepromatous, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Lymphangiographic, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mantle_zone_hyperpla, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Necrotizing_Kikuchi, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Necrotiz_non_Kikuchi, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Rheumatoid_arthritis, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Sarcoidosis, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (SHML, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Sinus_histiocytosis, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Syphilis, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Toxoplasmosis, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Tuberculosis, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Viral_NOS, Focal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Whipple_s_disease, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (L_H_nodular_HD, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (L_H_diffuse_HD, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Nodular_sclerosis_HD, Focal_nonextensive) 0.10, 0.80, 0.09, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Syncytial_NSHD, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_cellularity_HD, Focal_nonextensive) 0.10, 0.80, 0.09, 0.01, 0.00, 0.00;
  (Interfollicular_HD, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Diffuse_fibrosis_HD, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Reticular_type_HD, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_cleaved_fol, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_fol, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Large_cell_fol, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_noncleaved_fol, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_lymphocytic, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Plasmacytoid_lyctic, Focal_nonextensive) 0.000, 0.149, 0.650, 0.200, 0.001, 0.000;
  (Mantle_zone_lymphoma, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_cleaved_dif, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_FCC_dif, Focal_nonextensive) 0.37, 0.46, 0.15, 0.02, 0.00, 0.00;
  (Large_cell_dif, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (B_immunoblastic, Focal_nonextensive) 0.15, 0.70, 0.10, 0.05, 0.00, 0.00;
  (T_immunob_mixed, Focal_nonextensive) 0.37, 0.46, 0.15, 0.02, 0.00, 0.00;
  (AILD_like_T_cell_lym, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Japanese_ATL, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Lymphoblastic, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_noncleaved_dif, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (True_histiocytic, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Ki_1_LC_anaplas_T, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Multiple_myeloma, Focal_nonextensive) 0.00, 0.10, 0.65, 0.25, 0.00, 0.00;
  (Mycosis_fungoides, Focal_nonextensive) 0.75, 0.20, 0.04, 0.01, 0.00, 0.00;
  (AML, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Hairy_cell_leukemia, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Carcinoma, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Melanoma, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (EM_plasmacytoma, Focal_nonextensive) 0.00, 0.00, 0.00, 0.10, 0.55, 0.35;
  (Kaposi_s_sarcoma, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Mast_cell_disease, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AIDS_involutionary, Focal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (T_immunob_large, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Monocytoid_B_cell, Focal_nonextensive) 0.10, 0.70, 0.19, 0.01, 0.00, 0.00;
  (Nasopharyngeal_CA, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Seminoma, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (SLE, Focal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Mycobact_histiocytos, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mast_cell_hyperplas, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (LGV, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Histoplasmosis, Focal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Coccidioidomycosis, Focal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (CMV, Focal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Brucellosis, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Ki_1_LC_anaplas_B, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Intermed_lymphocytic, Focal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AIDS_early, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AILD, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (ALIP, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Cat_scratch_disease, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Dermatopathic_laden, MultiFocal_nonextensive) 0.005, 0.250, 0.695, 0.050, 0.000, 0.000;
  (Florid_follic_hyperp, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (GLH_hyaline_vascular, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (GLH_plasma_cell, MultiFocal_nonextensive) 0.000, 0.000, 0.200, 0.799, 0.001, 0.000;
  (Granulomatous_laden, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Histiocytosis_x, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Infectious_mono, MultiFocal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Leprosy_lepromatous, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Lymphangiographic, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mantle_zone_hyperpla, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Necrotizing_Kikuchi, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Necrotiz_non_Kikuchi, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Rheumatoid_arthritis, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Sarcoidosis, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (SHML, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Sinus_histiocytosis, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Syphilis, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Toxoplasmosis, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Tuberculosis, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Viral_NOS, MultiFocal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Whipple_s_disease, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (L_H_nodular_HD, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (L_H_diffuse_HD, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Nodular_sclerosis_HD, MultiFocal_nonextensive) 0.10, 0.80, 0.09, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Syncytial_NSHD, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_cellularity_HD, MultiFocal_nonextensive) 0.10, 0.80, 0.09, 0.01, 0.00, 0.00;
  (Interfollicular_HD, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Diffuse_fibrosis_HD, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Reticular_type_HD, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_cleaved_fol, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_fol, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Large_cell_fol, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_noncleaved_fol, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_lymphocytic, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Plasmacytoid_lyctic, MultiFocal_nonextensive) 0.000, 0.149, 0.650, 0.200, 0.001, 0.000;
  (Mantle_zone_lymphoma, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_cleaved_dif, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mixed_FCC_dif, MultiFocal_nonextensive) 0.37, 0.46, 0.15, 0.02, 0.00, 0.00;
  (Large_cell_dif, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (B_immunoblastic, MultiFocal_nonextensive) 0.15, 0.70, 0.10, 0.05, 0.00, 0.00;
  (T_immunob_mixed, MultiFocal_nonextensive) 0.37, 0.46, 0.15, 0.02, 0.00, 0.00;
  (AILD_like_T_cell_lym, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Japanese_ATL, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Lymphoblastic, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Small_noncleaved_dif, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (True_histiocytic, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Ki_1_LC_anaplas_T, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Multiple_myeloma, MultiFocal_nonextensive) 0.00, 0.10, 0.65, 0.25, 0.00, 0.00;
  (Mycosis_fungoides, MultiFocal_nonextensive) 0.75, 0.20, 0.04, 0.01, 0.00, 0.00;
  (AML, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Hairy_cell_leukemia, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Carcinoma, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Melanoma, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (EM_plasmacytoma, MultiFocal_nonextensive) 0.00, 0.00, 0.00, 0.10, 0.55, 0.35;
  (Kaposi_s_sarcoma, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (Mast_cell_disease, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AIDS_involutionary, MultiFocal_nonextensive) 0.00, 0.01, 0.79, 0.20, 0.00, 0.00;
  (T_immunob_large, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Monocytoid_B_cell, MultiFocal_nonextensive) 0.10, 0.70, 0.19, 0.01, 0.00, 0.00;
  (Nasopharyngeal_CA, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Seminoma, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (SLE, MultiFocal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Mycobact_histiocytos, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Mast_cell_hyperplas, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (LGV, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Histoplasmosis, MultiFocal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Coccidioidomycosis, MultiFocal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (CMV, MultiFocal_nonextensive) 0.10, 0.74, 0.15, 0.01, 0.00, 0.00;
  (Brucellosis, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Ki_1_LC_anaplas_B, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (Intermed_lymphocytic, MultiFocal_nonextensive) 0.500, 0.480, 0.015, 0.005, 0.000, 0.000;
  (AIDS_early, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (AILD, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (ALIP, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (Cat_scratch_disease, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Dermatopathic_laden, Extensive) 0.005, 0.250, 0.605, 0.140, 0.000, 0.000;
  (Florid_follic_hyperp, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (GLH_hyaline_vascular, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (GLH_plasma_cell, Extensive) 0.000, 0.000, 0.200, 0.799, 0.001, 0.000;
  (Granulomatous_laden, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Histiocytosis_x, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Infectious_mono, Extensive) 0.10, 0.62, 0.18, 0.10, 0.00, 0.00;
  (Leprosy_lepromatous, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Lymphangiographic, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Mantle_zone_hyperpla, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Necrotizing_Kikuchi, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Necrotiz_non_Kikuchi, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Rheumatoid_arthritis, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (Sarcoidosis, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (SHML, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (Sinus_histiocytosis, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Syphilis, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (Toxoplasmosis, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Tuberculosis, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Viral_NOS, Extensive) 0.10, 0.62, 0.18, 0.10, 0.00, 0.00;
  (Whipple_s_disease, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (L_H_nodular_HD, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (L_H_diffuse_HD, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Nodular_sclerosis_HD, Extensive) 0.10, 0.68, 0.12, 0.10, 0.00, 0.00;
  (Cellular_phase_NSHD, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Syncytial_NSHD, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Mixed_cellularity_HD, Extensive) 0.10, 0.68, 0.12, 0.10, 0.00, 0.00;
  (Interfollicular_HD, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Diffuse_fibrosis_HD, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Reticular_type_HD, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Small_cleaved_fol, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Mixed_fol, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Large_cell_fol, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Small_noncleaved_fol, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Small_lymphocytic, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Plasmacytoid_lyctic, Extensive) 0.000, 0.149, 0.650, 0.200, 0.001, 0.000;
  (Mantle_zone_lymphoma, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Small_cleaved_dif, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Mixed_FCC_dif, Extensive) 0.27, 0.46, 0.17, 0.10, 0.00, 0.00;
  (Large_cell_dif, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (B_immunoblastic, Extensive) 0.25, 0.58, 0.07, 0.10, 0.00, 0.00;
  (T_immunob_mixed, Extensive) 0.27, 0.46, 0.17, 0.10, 0.00, 0.00;
  (AILD_like_T_cell_lym, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (Japanese_ATL, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Lymphoblastic, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Small_noncleaved_dif, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (True_histiocytic, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Ki_1_LC_anaplas_T, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Multiple_myeloma, Extensive) 0.00, 0.10, 0.56, 0.34, 0.00, 0.00;
  (Mycosis_fungoides, Extensive) 0.59, 0.24, 0.07, 0.10, 0.00, 0.00;
  (AML, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Hairy_cell_leukemia, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Carcinoma, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Melanoma, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (EM_plasmacytoma, Extensive) 0.00, 0.00, 0.05, 0.05, 0.60, 0.30;
  (Kaposi_s_sarcoma, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (Mast_cell_disease, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (AIDS_involutionary, Extensive) 0.00, 0.01, 0.70, 0.29, 0.00, 0.00;
  (T_immunob_large, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Monocytoid_B_cell, Extensive) 0.100, 0.778, 0.022, 0.050, 0.050, 0.000;
  (Nasopharyngeal_CA, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Seminoma, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (SLE, Extensive) 0.10, 0.62, 0.18, 0.10, 0.00, 0.00;
  (Mycobact_histiocytos, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Mast_cell_hyperplas, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (LGV, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Histoplasmosis, Extensive) 0.10, 0.62, 0.18, 0.10, 0.00, 0.00;
  (Coccidioidomycosis, Extensive) 0.10, 0.62, 0.18, 0.10, 0.00, 0.00;
  (CMV, Extensive) 0.10, 0.62, 0.18, 0.10, 0.00, 0.00;
  (Brucellosis, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Ki_1_LC_anaplas_B, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
  (Intermed_lymphocytic, Extensive) 0.500, 0.370, 0.035, 0.095, 0.000, 0.000;
}
probability ( PC_TP | Fault, PLASMA ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD, Few_LT_5pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (ALIP, Few_LT_5pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Cat_scratch_disease, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Dermatopathic_laden, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Florid_follic_hyperp, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_hyaline_vascular, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_plasma_cell, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Granulomatous_laden, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histiocytosis_x, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Infectious_mono, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Leprosy_lepromatous, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphangiographic, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mantle_zone_hyperpla, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotizing_Kikuchi, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotiz_non_Kikuchi, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Rheumatoid_arthritis, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sarcoidosis, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SHML, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sinus_histiocytosis, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syphilis, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Toxoplasmosis, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Tuberculosis, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Viral_NOS, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Whipple_s_disease, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_nodular_HD, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_diffuse_HD, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Nodular_sclerosis_HD, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Cellular_phase_NSHD, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syncytial_NSHD, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_cellularity_HD, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Interfollicular_HD, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Diffuse_fibrosis_HD, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Reticular_type_HD, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_fol, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_fol, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_fol, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_fol, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_lymphocytic, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Plasmacytoid_lyctic, Few_LT_5pc) 0.000, 0.928, 0.020, 0.001, 0.001, 0.050;
  (Mantle_zone_lymphoma, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_dif, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_FCC_dif, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_dif, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (B_immunoblastic, Few_LT_5pc) 0.00, 0.92, 0.01, 0.01, 0.01, 0.05;
  (T_immunob_mixed, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD_like_T_cell_lym, Few_LT_5pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Japanese_ATL, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphoblastic, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_dif, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (True_histiocytic, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_T, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Multiple_myeloma, Few_LT_5pc) 0.00, 0.02, 0.30, 0.05, 0.15, 0.48;
  (Mycosis_fungoides, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AML, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Hairy_cell_leukemia, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Carcinoma, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Melanoma, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (EM_plasmacytoma, Few_LT_5pc) 0.1666667, 0.1666667, 0.1666667, 0.1666667, 0.1666667, 0.1666667;
  (Kaposi_s_sarcoma, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mast_cell_disease, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_involutionary, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (T_immunob_large, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Monocytoid_B_cell, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Nasopharyngeal_CA, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Seminoma, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SLE, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mycobact_histiocytos, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mast_cell_hyperplas, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (LGV, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histoplasmosis, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Coccidioidomycosis, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (CMV, Few_LT_5pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Brucellosis, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_B, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Intermed_lymphocytic, Few_LT_5pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_early, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD, Moderate_6_to_20pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (ALIP, Moderate_6_to_20pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Cat_scratch_disease, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Dermatopathic_laden, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Florid_follic_hyperp, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_hyaline_vascular, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_plasma_cell, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Granulomatous_laden, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histiocytosis_x, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Infectious_mono, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Leprosy_lepromatous, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphangiographic, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mantle_zone_hyperpla, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotizing_Kikuchi, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotiz_non_Kikuchi, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Rheumatoid_arthritis, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sarcoidosis, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SHML, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sinus_histiocytosis, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syphilis, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Toxoplasmosis, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Tuberculosis, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Viral_NOS, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Whipple_s_disease, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_nodular_HD, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_diffuse_HD, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Nodular_sclerosis_HD, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Cellular_phase_NSHD, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syncytial_NSHD, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_cellularity_HD, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Interfollicular_HD, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Diffuse_fibrosis_HD, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Reticular_type_HD, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_fol, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_fol, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_fol, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_fol, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_lymphocytic, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Plasmacytoid_lyctic, Moderate_6_to_20pc) 0.000, 0.928, 0.020, 0.001, 0.001, 0.050;
  (Mantle_zone_lymphoma, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_dif, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_FCC_dif, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_dif, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (B_immunoblastic, Moderate_6_to_20pc) 0.00, 0.92, 0.01, 0.01, 0.01, 0.05;
  (T_immunob_mixed, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD_like_T_cell_lym, Moderate_6_to_20pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Japanese_ATL, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphoblastic, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_dif, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (True_histiocytic, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_T, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Multiple_myeloma, Moderate_6_to_20pc) 0.00, 0.02, 0.30, 0.05, 0.15, 0.48;
  (Mycosis_fungoides, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AML, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Hairy_cell_leukemia, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Carcinoma, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Melanoma, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (EM_plasmacytoma, Moderate_6_to_20pc) 0.00, 0.65, 0.10, 0.03, 0.02, 0.20;
  (Kaposi_s_sarcoma, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mast_cell_disease, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_involutionary, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (T_immunob_large, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Monocytoid_B_cell, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Nasopharyngeal_CA, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Seminoma, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SLE, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mycobact_histiocytos, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mast_cell_hyperplas, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (LGV, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histoplasmosis, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Coccidioidomycosis, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (CMV, Moderate_6_to_20pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Brucellosis, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_B, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Intermed_lymphocytic, Moderate_6_to_20pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_early, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD, Marked_21_to_50pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (ALIP, Marked_21_to_50pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Cat_scratch_disease, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Dermatopathic_laden, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Florid_follic_hyperp, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_hyaline_vascular, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_plasma_cell, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Granulomatous_laden, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histiocytosis_x, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Infectious_mono, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Leprosy_lepromatous, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphangiographic, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mantle_zone_hyperpla, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotizing_Kikuchi, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotiz_non_Kikuchi, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Rheumatoid_arthritis, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sarcoidosis, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SHML, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sinus_histiocytosis, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syphilis, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Toxoplasmosis, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Tuberculosis, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Viral_NOS, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Whipple_s_disease, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_nodular_HD, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_diffuse_HD, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Nodular_sclerosis_HD, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Cellular_phase_NSHD, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syncytial_NSHD, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_cellularity_HD, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Interfollicular_HD, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Diffuse_fibrosis_HD, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Reticular_type_HD, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_fol, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_fol, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_fol, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_fol, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_lymphocytic, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Plasmacytoid_lyctic, Marked_21_to_50pc) 0.000, 0.928, 0.020, 0.001, 0.001, 0.050;
  (Mantle_zone_lymphoma, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_dif, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_FCC_dif, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_dif, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (B_immunoblastic, Marked_21_to_50pc) 0.00, 0.92, 0.01, 0.01, 0.01, 0.05;
  (T_immunob_mixed, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD_like_T_cell_lym, Marked_21_to_50pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Japanese_ATL, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphoblastic, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_dif, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (True_histiocytic, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_T, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Multiple_myeloma, Marked_21_to_50pc) 0.00, 0.02, 0.30, 0.05, 0.15, 0.48;
  (Mycosis_fungoides, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AML, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Hairy_cell_leukemia, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Carcinoma, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Melanoma, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (EM_plasmacytoma, Marked_21_to_50pc) 0.00, 0.65, 0.10, 0.03, 0.02, 0.20;
  (Kaposi_s_sarcoma, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mast_cell_disease, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_involutionary, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (T_immunob_large, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Monocytoid_B_cell, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Nasopharyngeal_CA, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Seminoma, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SLE, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mycobact_histiocytos, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mast_cell_hyperplas, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (LGV, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histoplasmosis, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Coccidioidomycosis, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (CMV, Marked_21_to_50pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Brucellosis, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_B, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Intermed_lymphocytic, Marked_21_to_50pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_early, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD, Striking_51_to_90pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (ALIP, Striking_51_to_90pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Cat_scratch_disease, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Dermatopathic_laden, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Florid_follic_hyperp, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_hyaline_vascular, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_plasma_cell, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Granulomatous_laden, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histiocytosis_x, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Infectious_mono, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Leprosy_lepromatous, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphangiographic, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mantle_zone_hyperpla, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotizing_Kikuchi, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotiz_non_Kikuchi, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Rheumatoid_arthritis, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sarcoidosis, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SHML, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sinus_histiocytosis, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syphilis, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Toxoplasmosis, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Tuberculosis, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Viral_NOS, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Whipple_s_disease, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_nodular_HD, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_diffuse_HD, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Nodular_sclerosis_HD, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Cellular_phase_NSHD, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syncytial_NSHD, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_cellularity_HD, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Interfollicular_HD, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Diffuse_fibrosis_HD, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Reticular_type_HD, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_fol, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_fol, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_fol, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_fol, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_lymphocytic, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Plasmacytoid_lyctic, Striking_51_to_90pc) 0.000, 0.928, 0.020, 0.001, 0.001, 0.050;
  (Mantle_zone_lymphoma, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_dif, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_FCC_dif, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_dif, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (B_immunoblastic, Striking_51_to_90pc) 0.00, 0.92, 0.01, 0.01, 0.01, 0.05;
  (T_immunob_mixed, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD_like_T_cell_lym, Striking_51_to_90pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Japanese_ATL, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphoblastic, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_dif, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (True_histiocytic, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_T, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Multiple_myeloma, Striking_51_to_90pc) 0.00, 0.02, 0.30, 0.05, 0.15, 0.48;
  (Mycosis_fungoides, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AML, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Hairy_cell_leukemia, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Carcinoma, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Melanoma, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (EM_plasmacytoma, Striking_51_to_90pc) 0.00, 0.65, 0.10, 0.03, 0.02, 0.20;
  (Kaposi_s_sarcoma, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mast_cell_disease, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_involutionary, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (T_immunob_large, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Monocytoid_B_cell, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Nasopharyngeal_CA, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Seminoma, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SLE, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mycobact_histiocytos, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mast_cell_hyperplas, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (LGV, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histoplasmosis, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Coccidioidomycosis, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (CMV, Striking_51_to_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Brucellosis, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_B, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Intermed_lymphocytic, Striking_51_to_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_early, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD, Sheets_GT_90pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (ALIP, Sheets_GT_90pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Cat_scratch_disease, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Dermatopathic_laden, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Florid_follic_hyperp, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_hyaline_vascular, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (GLH_plasma_cell, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Granulomatous_laden, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histiocytosis_x, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Infectious_mono, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Leprosy_lepromatous, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphangiographic, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mantle_zone_hyperpla, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotizing_Kikuchi, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Necrotiz_non_Kikuchi, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Rheumatoid_arthritis, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sarcoidosis, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SHML, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Sinus_histiocytosis, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syphilis, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Toxoplasmosis, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Tuberculosis, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Viral_NOS, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Whipple_s_disease, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_nodular_HD, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (L_H_diffuse_HD, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Nodular_sclerosis_HD, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Cellular_phase_NSHD, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Syncytial_NSHD, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_cellularity_HD, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Interfollicular_HD, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Diffuse_fibrosis_HD, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Reticular_type_HD, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_fol, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_fol, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_fol, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_fol, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_lymphocytic, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Plasmacytoid_lyctic, Sheets_GT_90pc) 0.000, 0.928, 0.020, 0.001, 0.001, 0.050;
  (Mantle_zone_lymphoma, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_cleaved_dif, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mixed_FCC_dif, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Large_cell_dif, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (B_immunoblastic, Sheets_GT_90pc) 0.00, 0.92, 0.01, 0.01, 0.01, 0.05;
  (T_immunob_mixed, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (AILD_like_T_cell_lym, Sheets_GT_90pc) 0.000, 0.948, 0.001, 0.000, 0.001, 0.050;
  (Japanese_ATL, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Lymphoblastic, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Small_noncleaved_dif, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (True_histiocytic, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_T, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Multiple_myeloma, Sheets_GT_90pc) 0.00, 0.02, 0.30, 0.05, 0.15, 0.48;
  (Mycosis_fungoides, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AML, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Hairy_cell_leukemia, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Carcinoma, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Melanoma, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (EM_plasmacytoma, Sheets_GT_90pc) 0.00, 0.65, 0.10, 0.03, 0.02, 0.20;
  (Kaposi_s_sarcoma, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mast_cell_disease, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (AIDS_involutionary, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (T_immunob_large, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Monocytoid_B_cell, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Nasopharyngeal_CA, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Seminoma, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (SLE, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Mycobact_histiocytos, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Mast_cell_hyperplas, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (LGV, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Histoplasmosis, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Coccidioidomycosis, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (CMV, Sheets_GT_90pc) 0.000, 0.929, 0.020, 0.000, 0.001, 0.050;
  (Brucellosis, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Ki_1_LC_anaplas_B, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
  (Intermed_lymphocytic, Sheets_GT_90pc) 0.000, 0.978, 0.001, 0.000, 0.001, 0.020;
}
probability ( PLEO | Fault ) {
  (AIDS_early) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD) 0.74, 0.20, 0.05, 0.01, 0.00;
  (Cellular_phase_NSHD) 0.74, 0.20, 0.05, 0.01, 0.00;
  (Syncytial_NSHD) 0.74, 0.20, 0.05, 0.01, 0.00;
  (Mixed_cellularity_HD) 0.98990101, 0.00999900, 0.00009999, 0.00000000, 0.00000000;
  (Interfollicular_HD) 0.98990101, 0.00999900, 0.00009999, 0.00000000, 0.00000000;
  (Diffuse_fibrosis_HD) 0.01, 0.60, 0.38, 0.01, 0.00;
  (Reticular_type_HD) 0.0, 0.0, 0.2, 0.2, 0.6;
  (Small_cleaved_fol) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic) 0.97, 0.02, 0.01, 0.00, 0.00;
  (T_immunob_mixed) 0.97, 0.02, 0.01, 0.00, 0.00;
  (AILD_like_T_cell_lym) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL) 0.9589, 0.0300, 0.0100, 0.0010, 0.0001;
  (Lymphoblastic) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic) 0.9299, 0.0500, 0.0200, 0.0001, 0.0000;
  (Ki_1_LC_anaplas_T) 0.9299, 0.0500, 0.0200, 0.0001, 0.0000;
  (Multiple_myeloma) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma) 0.96, 0.02, 0.01, 0.01, 0.00;
  (Melanoma) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large) 0.97, 0.02, 0.01, 0.00, 0.00;
  (Monocytoid_B_cell) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA) 0.96, 0.02, 0.01, 0.01, 0.00;
  (Seminoma) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B) 0.9299, 0.0500, 0.0200, 0.0001, 0.0000;
  (Intermed_lymphocytic) 1.0, 0.0, 0.0, 0.0, 0.0;
}
probability ( PFP | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 0.1, 0.9;
  (Plasmacytoid_lyctic) 0.98, 0.02;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( PTGC_NOD | Fault ) {
  (AIDS_early) 0.98, 0.02;
  (AILD) 0.995, 0.005;
  (ALIP) 0.99, 0.01;
  (Cat_scratch_disease) 0.99, 0.01;
  (Dermatopathic_laden) 0.99, 0.01;
  (Florid_follic_hyperp) 0.93, 0.07;
  (GLH_hyaline_vascular) 0.99, 0.01;
  (GLH_plasma_cell) 0.99, 0.01;
  (Granulomatous_laden) 0.99, 0.01;
  (Histiocytosis_x) 0.99, 0.01;
  (Infectious_mono) 0.99, 0.01;
  (Leprosy_lepromatous) 0.99, 0.01;
  (Lymphangiographic) 0.99, 0.01;
  (Mantle_zone_hyperpla) 0.99, 0.01;
  (Necrotizing_Kikuchi) 0.99, 0.01;
  (Necrotiz_non_Kikuchi) 0.99, 0.01;
  (Rheumatoid_arthritis) 0.98, 0.02;
  (Sarcoidosis) 0.99, 0.01;
  (SHML) 0.99, 0.01;
  (Sinus_histiocytosis) 0.99, 0.01;
  (Syphilis) 0.98, 0.02;
  (Toxoplasmosis) 0.98, 0.02;
  (Tuberculosis) 0.99, 0.01;
  (Viral_NOS) 0.99, 0.01;
  (Whipple_s_disease) 0.99, 0.01;
  (L_H_nodular_HD) 0.75, 0.25;
  (L_H_diffuse_HD) 0.995, 0.005;
  (Nodular_sclerosis_HD) 0.995, 0.005;
  (Cellular_phase_NSHD) 0.995, 0.005;
  (Syncytial_NSHD) 0.995, 0.005;
  (Mixed_cellularity_HD) 0.995, 0.005;
  (Interfollicular_HD) 0.995, 0.005;
  (Diffuse_fibrosis_HD) 0.995, 0.005;
  (Reticular_type_HD) 0.995, 0.005;
  (Small_cleaved_fol) 0.995, 0.005;
  (Mixed_fol) 0.995, 0.005;
  (Large_cell_fol) 0.995, 0.005;
  (Small_noncleaved_fol) 0.995, 0.005;
  (Small_lymphocytic) 0.995, 0.005;
  (Plasmacytoid_lyctic) 0.995, 0.005;
  (Mantle_zone_lymphoma) 0.995, 0.005;
  (Small_cleaved_dif) 0.995, 0.005;
  (Mixed_FCC_dif) 0.995, 0.005;
  (Large_cell_dif) 0.995, 0.005;
  (B_immunoblastic) 0.995, 0.005;
  (T_immunob_mixed) 0.995, 0.005;
  (AILD_like_T_cell_lym) 0.995, 0.005;
  (Japanese_ATL) 0.995, 0.005;
  (Lymphoblastic) 0.995, 0.005;
  (Small_noncleaved_dif) 0.995, 0.005;
  (True_histiocytic) 0.995, 0.005;
  (Ki_1_LC_anaplas_T) 0.995, 0.005;
  (Multiple_myeloma) 0.995, 0.005;
  (Mycosis_fungoides) 0.995, 0.005;
  (AML) 0.995, 0.005;
  (Hairy_cell_leukemia) 0.995, 0.005;
  (Carcinoma) 0.995, 0.005;
  (Melanoma) 0.995, 0.005;
  (EM_plasmacytoma) 0.995, 0.005;
  (Kaposi_s_sarcoma) 0.995, 0.005;
  (Mast_cell_disease) 0.995, 0.005;
  (AIDS_involutionary) 0.995, 0.005;
  (T_immunob_large) 0.995, 0.005;
  (Monocytoid_B_cell) 0.995, 0.005;
  (Nasopharyngeal_CA) 0.995, 0.005;
  (Seminoma) 0.995, 0.005;
  (SLE) 0.99, 0.01;
  (Mycobact_histiocytos) 0.995, 0.005;
  (Mast_cell_hyperplas) 0.99, 0.01;
  (LGV) 0.99, 0.01;
  (Histoplasmosis) 0.995, 0.005;
  (Coccidioidomycosis) 0.995, 0.005;
  (CMV) 0.995, 0.005;
  (Brucellosis) 0.98, 0.02;
  (Ki_1_LC_anaplas_B) 0.995, 0.005;
  (Intermed_lymphocytic) 0.995, 0.005;
}
probability ( RD_BOD | Fault, PLASMA ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0;
  (AIDS_early, Few_LT_5pc) 0.9999, 0.0001;
  (AILD, Few_LT_5pc) 0.99999, 0.00001;
  (ALIP, Few_LT_5pc) 0.999999, 0.000001;
  (Cat_scratch_disease, Few_LT_5pc) 0.999999, 0.000001;
  (Dermatopathic_laden, Few_LT_5pc) 0.9999, 0.0001;
  (Florid_follic_hyperp, Few_LT_5pc) 0.999999, 0.000001;
  (GLH_hyaline_vascular, Few_LT_5pc) 0.999999, 0.000001;
  (GLH_plasma_cell, Few_LT_5pc) 0.9999, 0.0001;
  (Granulomatous_laden, Few_LT_5pc) 0.999999, 0.000001;
  (Histiocytosis_x, Few_LT_5pc) 0.999999, 0.000001;
  (Infectious_mono, Few_LT_5pc) 0.99999, 0.00001;
  (Leprosy_lepromatous, Few_LT_5pc) 0.999999, 0.000001;
  (Lymphangiographic, Few_LT_5pc) 0.999999, 0.000001;
  (Mantle_zone_hyperpla, Few_LT_5pc) 0.999999, 0.000001;
  (Necrotizing_Kikuchi, Few_LT_5pc) 0.999999, 0.000001;
  (Necrotiz_non_Kikuchi, Few_LT_5pc) 0.999999, 0.000001;
  (Rheumatoid_arthritis, Few_LT_5pc) 0.9999, 0.0001;
  (Sarcoidosis, Few_LT_5pc) 0.999999, 0.000001;
  (SHML, Few_LT_5pc) 0.9999, 0.0001;
  (Sinus_histiocytosis, Few_LT_5pc) 0.999999, 0.000001;
  (Syphilis, Few_LT_5pc) 0.9999, 0.0001;
  (Toxoplasmosis, Few_LT_5pc) 0.999999, 0.000001;
  (Tuberculosis, Few_LT_5pc) 0.999999, 0.000001;
  (Viral_NOS, Few_LT_5pc) 0.99999, 0.00001;
  (Whipple_s_disease, Few_LT_5pc) 0.999999, 0.000001;
  (L_H_nodular_HD, Few_LT_5pc) 0.999999, 0.000001;
  (L_H_diffuse_HD, Few_LT_5pc) 0.999999, 0.000001;
  (Nodular_sclerosis_HD, Few_LT_5pc) 0.99999, 0.00001;
  (Cellular_phase_NSHD, Few_LT_5pc) 0.999999, 0.000001;
  (Syncytial_NSHD, Few_LT_5pc) 0.999999, 0.000001;
  (Mixed_cellularity_HD, Few_LT_5pc) 0.99999, 0.00001;
  (Interfollicular_HD, Few_LT_5pc) 0.999999, 0.000001;
  (Diffuse_fibrosis_HD, Few_LT_5pc) 0.999999, 0.000001;
  (Reticular_type_HD, Few_LT_5pc) 0.999999, 0.000001;
  (Small_cleaved_fol, Few_LT_5pc) 0.999999, 0.000001;
  (Mixed_fol, Few_LT_5pc) 0.999999, 0.000001;
  (Large_cell_fol, Few_LT_5pc) 0.999999, 0.000001;
  (Small_noncleaved_fol, Few_LT_5pc) 0.999999, 0.000001;
  (Small_lymphocytic, Few_LT_5pc) 0.999999, 0.000001;
  (Plasmacytoid_lyctic, Few_LT_5pc) 0.5, 0.5;
  (Mantle_zone_lymphoma, Few_LT_5pc) 0.999999, 0.000001;
  (Small_cleaved_dif, Few_LT_5pc) 0.999999, 0.000001;
  (Mixed_FCC_dif, Few_LT_5pc) 0.999999, 0.000001;
  (Large_cell_dif, Few_LT_5pc) 0.999999, 0.000001;
  (B_immunoblastic, Few_LT_5pc) 0.99999, 0.00001;
  (T_immunob_mixed, Few_LT_5pc) 0.99999, 0.00001;
  (AILD_like_T_cell_lym, Few_LT_5pc) 0.99999, 0.00001;
  (Japanese_ATL, Few_LT_5pc) 0.999999, 0.000001;
  (Lymphoblastic, Few_LT_5pc) 0.999999, 0.000001;
  (Small_noncleaved_dif, Few_LT_5pc) 0.999999, 0.000001;
  (True_histiocytic, Few_LT_5pc) 0.999999, 0.000001;
  (Ki_1_LC_anaplas_T, Few_LT_5pc) 0.999999, 0.000001;
  (Multiple_myeloma, Few_LT_5pc) 0.99, 0.01;
  (Mycosis_fungoides, Few_LT_5pc) 0.99999, 0.00001;
  (AML, Few_LT_5pc) 0.999999, 0.000001;
  (Hairy_cell_leukemia, Few_LT_5pc) 0.999999, 0.000001;
  (Carcinoma, Few_LT_5pc) 0.999999, 0.000001;
  (Melanoma, Few_LT_5pc) 0.9999, 0.0001;
  (EM_plasmacytoma, Few_LT_5pc) 0.5, 0.5;
  (Kaposi_s_sarcoma, Few_LT_5pc) 0.9999, 0.0001;
  (Mast_cell_disease, Few_LT_5pc) 0.999999, 0.000001;
  (AIDS_involutionary, Few_LT_5pc) 0.9999, 0.0001;
  (T_immunob_large, Few_LT_5pc) 0.999999, 0.000001;
  (Monocytoid_B_cell, Few_LT_5pc) 0.999, 0.001;
  (Nasopharyngeal_CA, Few_LT_5pc) 0.999999, 0.000001;
  (Seminoma, Few_LT_5pc) 0.999999, 0.000001;
  (SLE, Few_LT_5pc) 0.99999, 0.00001;
  (Mycobact_histiocytos, Few_LT_5pc) 0.999999, 0.000001;
  (Mast_cell_hyperplas, Few_LT_5pc) 0.999999, 0.000001;
  (LGV, Few_LT_5pc) 0.999999, 0.000001;
  (Histoplasmosis, Few_LT_5pc) 0.999999, 0.000001;
  (Coccidioidomycosis, Few_LT_5pc) 0.999999, 0.000001;
  (CMV, Few_LT_5pc) 0.999999, 0.000001;
  (Brucellosis, Few_LT_5pc) 0.999999, 0.000001;
  (Ki_1_LC_anaplas_B, Few_LT_5pc) 0.999999, 0.000001;
  (Intermed_lymphocytic, Few_LT_5pc) 0.999999, 0.000001;
  (AIDS_early, Moderate_6_to_20pc) 0.999, 0.001;
  (AILD, Moderate_6_to_20pc) 0.9999, 0.0001;
  (ALIP, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Cat_scratch_disease, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Dermatopathic_laden, Moderate_6_to_20pc) 0.999, 0.001;
  (Florid_follic_hyperp, Moderate_6_to_20pc) 0.99999, 0.00001;
  (GLH_hyaline_vascular, Moderate_6_to_20pc) 0.99999, 0.00001;
  (GLH_plasma_cell, Moderate_6_to_20pc) 0.999, 0.001;
  (Granulomatous_laden, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Histiocytosis_x, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Infectious_mono, Moderate_6_to_20pc) 0.9999, 0.0001;
  (Leprosy_lepromatous, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Lymphangiographic, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Mantle_zone_hyperpla, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Necrotizing_Kikuchi, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Necrotiz_non_Kikuchi, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Rheumatoid_arthritis, Moderate_6_to_20pc) 0.999, 0.001;
  (Sarcoidosis, Moderate_6_to_20pc) 0.99999, 0.00001;
  (SHML, Moderate_6_to_20pc) 0.999, 0.001;
  (Sinus_histiocytosis, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Syphilis, Moderate_6_to_20pc) 0.999, 0.001;
  (Toxoplasmosis, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Tuberculosis, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Viral_NOS, Moderate_6_to_20pc) 0.9999, 0.0001;
  (Whipple_s_disease, Moderate_6_to_20pc) 0.99999, 0.00001;
  (L_H_nodular_HD, Moderate_6_to_20pc) 0.99999, 0.00001;
  (L_H_diffuse_HD, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Nodular_sclerosis_HD, Moderate_6_to_20pc) 0.9999, 0.0001;
  (Cellular_phase_NSHD, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Syncytial_NSHD, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Mixed_cellularity_HD, Moderate_6_to_20pc) 0.9999, 0.0001;
  (Interfollicular_HD, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Diffuse_fibrosis_HD, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Reticular_type_HD, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Small_cleaved_fol, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Mixed_fol, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Large_cell_fol, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Small_noncleaved_fol, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Small_lymphocytic, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Plasmacytoid_lyctic, Moderate_6_to_20pc) 0.4, 0.6;
  (Mantle_zone_lymphoma, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Small_cleaved_dif, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Mixed_FCC_dif, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Large_cell_dif, Moderate_6_to_20pc) 0.99999, 0.00001;
  (B_immunoblastic, Moderate_6_to_20pc) 0.9999, 0.0001;
  (T_immunob_mixed, Moderate_6_to_20pc) 0.9999, 0.0001;
  (AILD_like_T_cell_lym, Moderate_6_to_20pc) 0.9999, 0.0001;
  (Japanese_ATL, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Lymphoblastic, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Small_noncleaved_dif, Moderate_6_to_20pc) 0.99999, 0.00001;
  (True_histiocytic, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Ki_1_LC_anaplas_T, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Multiple_myeloma, Moderate_6_to_20pc) 0.98, 0.02;
  (Mycosis_fungoides, Moderate_6_to_20pc) 0.9999, 0.0001;
  (AML, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Hairy_cell_leukemia, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Carcinoma, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Melanoma, Moderate_6_to_20pc) 0.999, 0.001;
  (EM_plasmacytoma, Moderate_6_to_20pc) 0.9, 0.1;
  (Kaposi_s_sarcoma, Moderate_6_to_20pc) 0.999, 0.001;
  (Mast_cell_disease, Moderate_6_to_20pc) 0.99999, 0.00001;
  (AIDS_involutionary, Moderate_6_to_20pc) 0.999, 0.001;
  (T_immunob_large, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Monocytoid_B_cell, Moderate_6_to_20pc) 0.9, 0.1;
  (Nasopharyngeal_CA, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Seminoma, Moderate_6_to_20pc) 0.99999, 0.00001;
  (SLE, Moderate_6_to_20pc) 0.9999, 0.0001;
  (Mycobact_histiocytos, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Mast_cell_hyperplas, Moderate_6_to_20pc) 0.99999, 0.00001;
  (LGV, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Histoplasmosis, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Coccidioidomycosis, Moderate_6_to_20pc) 0.99999, 0.00001;
  (CMV, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Brucellosis, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Ki_1_LC_anaplas_B, Moderate_6_to_20pc) 0.99999, 0.00001;
  (Intermed_lymphocytic, Moderate_6_to_20pc) 0.99999, 0.00001;
  (AIDS_early, Marked_21_to_50pc) 0.99, 0.01;
  (AILD, Marked_21_to_50pc) 0.999, 0.001;
  (ALIP, Marked_21_to_50pc) 0.9999, 0.0001;
  (Cat_scratch_disease, Marked_21_to_50pc) 0.9999, 0.0001;
  (Dermatopathic_laden, Marked_21_to_50pc) 0.99, 0.01;
  (Florid_follic_hyperp, Marked_21_to_50pc) 0.9999, 0.0001;
  (GLH_hyaline_vascular, Marked_21_to_50pc) 0.9999, 0.0001;
  (GLH_plasma_cell, Marked_21_to_50pc) 0.99, 0.01;
  (Granulomatous_laden, Marked_21_to_50pc) 0.9999, 0.0001;
  (Histiocytosis_x, Marked_21_to_50pc) 0.9999, 0.0001;
  (Infectious_mono, Marked_21_to_50pc) 0.999, 0.001;
  (Leprosy_lepromatous, Marked_21_to_50pc) 0.9999, 0.0001;
  (Lymphangiographic, Marked_21_to_50pc) 0.9999, 0.0001;
  (Mantle_zone_hyperpla, Marked_21_to_50pc) 0.9999, 0.0001;
  (Necrotizing_Kikuchi, Marked_21_to_50pc) 0.9999, 0.0001;
  (Necrotiz_non_Kikuchi, Marked_21_to_50pc) 0.9999, 0.0001;
  (Rheumatoid_arthritis, Marked_21_to_50pc) 0.99, 0.01;
  (Sarcoidosis, Marked_21_to_50pc) 0.9999, 0.0001;
  (SHML, Marked_21_to_50pc) 0.99, 0.01;
  (Sinus_histiocytosis, Marked_21_to_50pc) 0.9999, 0.0001;
  (Syphilis, Marked_21_to_50pc) 0.99, 0.01;
  (Toxoplasmosis, Marked_21_to_50pc) 0.9999, 0.0001;
  (Tuberculosis, Marked_21_to_50pc) 0.9999, 0.0001;
  (Viral_NOS, Marked_21_to_50pc) 0.999, 0.001;
  (Whipple_s_disease, Marked_21_to_50pc) 0.9999, 0.0001;
  (L_H_nodular_HD, Marked_21_to_50pc) 0.9999, 0.0001;
  (L_H_diffuse_HD, Marked_21_to_50pc) 0.9999, 0.0001;
  (Nodular_sclerosis_HD, Marked_21_to_50pc) 0.999, 0.001;
  (Cellular_phase_NSHD, Marked_21_to_50pc) 0.9999, 0.0001;
  (Syncytial_NSHD, Marked_21_to_50pc) 0.9999, 0.0001;
  (Mixed_cellularity_HD, Marked_21_to_50pc) 0.999, 0.001;
  (Interfollicular_HD, Marked_21_to_50pc) 0.9999, 0.0001;
  (Diffuse_fibrosis_HD, Marked_21_to_50pc) 0.9999, 0.0001;
  (Reticular_type_HD, Marked_21_to_50pc) 0.9999, 0.0001;
  (Small_cleaved_fol, Marked_21_to_50pc) 0.9999, 0.0001;
  (Mixed_fol, Marked_21_to_50pc) 0.9999, 0.0001;
  (Large_cell_fol, Marked_21_to_50pc) 0.9999, 0.0001;
  (Small_noncleaved_fol, Marked_21_to_50pc) 0.9999, 0.0001;
  (Small_lymphocytic, Marked_21_to_50pc) 0.9999, 0.0001;
  (Plasmacytoid_lyctic, Marked_21_to_50pc) 0.3, 0.7;
  (Mantle_zone_lymphoma, Marked_21_to_50pc) 0.9999, 0.0001;
  (Small_cleaved_dif, Marked_21_to_50pc) 0.9999, 0.0001;
  (Mixed_FCC_dif, Marked_21_to_50pc) 0.9999, 0.0001;
  (Large_cell_dif, Marked_21_to_50pc) 0.9999, 0.0001;
  (B_immunoblastic, Marked_21_to_50pc) 0.999, 0.001;
  (T_immunob_mixed, Marked_21_to_50pc) 0.999, 0.001;
  (AILD_like_T_cell_lym, Marked_21_to_50pc) 0.999, 0.001;
  (Japanese_ATL, Marked_21_to_50pc) 0.9999, 0.0001;
  (Lymphoblastic, Marked_21_to_50pc) 0.9999, 0.0001;
  (Small_noncleaved_dif, Marked_21_to_50pc) 0.9999, 0.0001;
  (True_histiocytic, Marked_21_to_50pc) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_T, Marked_21_to_50pc) 0.9999, 0.0001;
  (Multiple_myeloma, Marked_21_to_50pc) 0.97, 0.03;
  (Mycosis_fungoides, Marked_21_to_50pc) 0.999, 0.001;
  (AML, Marked_21_to_50pc) 0.9999, 0.0001;
  (Hairy_cell_leukemia, Marked_21_to_50pc) 0.9999, 0.0001;
  (Carcinoma, Marked_21_to_50pc) 0.9999, 0.0001;
  (Melanoma, Marked_21_to_50pc) 0.99, 0.01;
  (EM_plasmacytoma, Marked_21_to_50pc) 0.99, 0.01;
  (Kaposi_s_sarcoma, Marked_21_to_50pc) 0.99, 0.01;
  (Mast_cell_disease, Marked_21_to_50pc) 0.9999, 0.0001;
  (AIDS_involutionary, Marked_21_to_50pc) 0.99, 0.01;
  (T_immunob_large, Marked_21_to_50pc) 0.9999, 0.0001;
  (Monocytoid_B_cell, Marked_21_to_50pc) 0.9, 0.1;
  (Nasopharyngeal_CA, Marked_21_to_50pc) 0.9999, 0.0001;
  (Seminoma, Marked_21_to_50pc) 0.9999, 0.0001;
  (SLE, Marked_21_to_50pc) 0.999, 0.001;
  (Mycobact_histiocytos, Marked_21_to_50pc) 0.9999, 0.0001;
  (Mast_cell_hyperplas, Marked_21_to_50pc) 0.9999, 0.0001;
  (LGV, Marked_21_to_50pc) 0.9999, 0.0001;
  (Histoplasmosis, Marked_21_to_50pc) 0.9999, 0.0001;
  (Coccidioidomycosis, Marked_21_to_50pc) 0.9999, 0.0001;
  (CMV, Marked_21_to_50pc) 0.9999, 0.0001;
  (Brucellosis, Marked_21_to_50pc) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_B, Marked_21_to_50pc) 0.9999, 0.0001;
  (Intermed_lymphocytic, Marked_21_to_50pc) 0.9999, 0.0001;
  (AIDS_early, Striking_51_to_90pc) 0.98, 0.02;
  (AILD, Striking_51_to_90pc) 0.99, 0.01;
  (ALIP, Striking_51_to_90pc) 0.9999, 0.0001;
  (Cat_scratch_disease, Striking_51_to_90pc) 0.9999, 0.0001;
  (Dermatopathic_laden, Striking_51_to_90pc) 0.98, 0.02;
  (Florid_follic_hyperp, Striking_51_to_90pc) 0.9999, 0.0001;
  (GLH_hyaline_vascular, Striking_51_to_90pc) 0.9999, 0.0001;
  (GLH_plasma_cell, Striking_51_to_90pc) 0.98, 0.02;
  (Granulomatous_laden, Striking_51_to_90pc) 0.9999, 0.0001;
  (Histiocytosis_x, Striking_51_to_90pc) 0.9999, 0.0001;
  (Infectious_mono, Striking_51_to_90pc) 0.99, 0.01;
  (Leprosy_lepromatous, Striking_51_to_90pc) 0.9999, 0.0001;
  (Lymphangiographic, Striking_51_to_90pc) 0.9999, 0.0001;
  (Mantle_zone_hyperpla, Striking_51_to_90pc) 0.9999, 0.0001;
  (Necrotizing_Kikuchi, Striking_51_to_90pc) 0.9999, 0.0001;
  (Necrotiz_non_Kikuchi, Striking_51_to_90pc) 0.9999, 0.0001;
  (Rheumatoid_arthritis, Striking_51_to_90pc) 0.98, 0.02;
  (Sarcoidosis, Striking_51_to_90pc) 0.9999, 0.0001;
  (SHML, Striking_51_to_90pc) 0.98, 0.02;
  (Sinus_histiocytosis, Striking_51_to_90pc) 0.9999, 0.0001;
  (Syphilis, Striking_51_to_90pc) 0.98, 0.02;
  (Toxoplasmosis, Striking_51_to_90pc) 0.9999, 0.0001;
  (Tuberculosis, Striking_51_to_90pc) 0.9999, 0.0001;
  (Viral_NOS, Striking_51_to_90pc) 0.99, 0.01;
  (Whipple_s_disease, Striking_51_to_90pc) 0.9999, 0.0001;
  (L_H_nodular_HD, Striking_51_to_90pc) 0.9999, 0.0001;
  (L_H_diffuse_HD, Striking_51_to_90pc) 0.9999, 0.0001;
  (Nodular_sclerosis_HD, Striking_51_to_90pc) 0.99, 0.01;
  (Cellular_phase_NSHD, Striking_51_to_90pc) 0.9999, 0.0001;
  (Syncytial_NSHD, Striking_51_to_90pc) 0.9999, 0.0001;
  (Mixed_cellularity_HD, Striking_51_to_90pc) 0.99, 0.01;
  (Interfollicular_HD, Striking_51_to_90pc) 0.9999, 0.0001;
  (Diffuse_fibrosis_HD, Striking_51_to_90pc) 0.9999, 0.0001;
  (Reticular_type_HD, Striking_51_to_90pc) 0.9999, 0.0001;
  (Small_cleaved_fol, Striking_51_to_90pc) 0.9999, 0.0001;
  (Mixed_fol, Striking_51_to_90pc) 0.9999, 0.0001;
  (Large_cell_fol, Striking_51_to_90pc) 0.9999, 0.0001;
  (Small_noncleaved_fol, Striking_51_to_90pc) 0.9999, 0.0001;
  (Small_lymphocytic, Striking_51_to_90pc) 0.9999, 0.0001;
  (Plasmacytoid_lyctic, Striking_51_to_90pc) 0.2, 0.8;
  (Mantle_zone_lymphoma, Striking_51_to_90pc) 0.9999, 0.0001;
  (Small_cleaved_dif, Striking_51_to_90pc) 0.9999, 0.0001;
  (Mixed_FCC_dif, Striking_51_to_90pc) 0.9999, 0.0001;
  (Large_cell_dif, Striking_51_to_90pc) 0.9999, 0.0001;
  (B_immunoblastic, Striking_51_to_90pc) 0.99, 0.01;
  (T_immunob_mixed, Striking_51_to_90pc) 0.99, 0.01;
  (AILD_like_T_cell_lym, Striking_51_to_90pc) 0.99, 0.01;
  (Japanese_ATL, Striking_51_to_90pc) 0.9999, 0.0001;
  (Lymphoblastic, Striking_51_to_90pc) 0.9999, 0.0001;
  (Small_noncleaved_dif, Striking_51_to_90pc) 0.9999, 0.0001;
  (True_histiocytic, Striking_51_to_90pc) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_T, Striking_51_to_90pc) 0.9999, 0.0001;
  (Multiple_myeloma, Striking_51_to_90pc) 0.96, 0.04;
  (Mycosis_fungoides, Striking_51_to_90pc) 0.99, 0.01;
  (AML, Striking_51_to_90pc) 0.9999, 0.0001;
  (Hairy_cell_leukemia, Striking_51_to_90pc) 0.9999, 0.0001;
  (Carcinoma, Striking_51_to_90pc) 0.9999, 0.0001;
  (Melanoma, Striking_51_to_90pc) 0.98, 0.02;
  (EM_plasmacytoma, Striking_51_to_90pc) 0.98, 0.02;
  (Kaposi_s_sarcoma, Striking_51_to_90pc) 0.98, 0.02;
  (Mast_cell_disease, Striking_51_to_90pc) 0.9999, 0.0001;
  (AIDS_involutionary, Striking_51_to_90pc) 0.98, 0.02;
  (T_immunob_large, Striking_51_to_90pc) 0.9999, 0.0001;
  (Monocytoid_B_cell, Striking_51_to_90pc) 0.9, 0.1;
  (Nasopharyngeal_CA, Striking_51_to_90pc) 0.9999, 0.0001;
  (Seminoma, Striking_51_to_90pc) 0.9999, 0.0001;
  (SLE, Striking_51_to_90pc) 0.99, 0.01;
  (Mycobact_histiocytos, Striking_51_to_90pc) 0.9999, 0.0001;
  (Mast_cell_hyperplas, Striking_51_to_90pc) 0.9999, 0.0001;
  (LGV, Striking_51_to_90pc) 0.9999, 0.0001;
  (Histoplasmosis, Striking_51_to_90pc) 0.9999, 0.0001;
  (Coccidioidomycosis, Striking_51_to_90pc) 0.9999, 0.0001;
  (CMV, Striking_51_to_90pc) 0.9999, 0.0001;
  (Brucellosis, Striking_51_to_90pc) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_B, Striking_51_to_90pc) 0.9999, 0.0001;
  (Intermed_lymphocytic, Striking_51_to_90pc) 0.9999, 0.0001;
  (AIDS_early, Sheets_GT_90pc) 0.5, 0.5;
  (AILD, Sheets_GT_90pc) 0.5, 0.5;
  (ALIP, Sheets_GT_90pc) 0.5, 0.5;
  (Cat_scratch_disease, Sheets_GT_90pc) 0.5, 0.5;
  (Dermatopathic_laden, Sheets_GT_90pc) 0.5, 0.5;
  (Florid_follic_hyperp, Sheets_GT_90pc) 0.5, 0.5;
  (GLH_hyaline_vascular, Sheets_GT_90pc) 0.5, 0.5;
  (GLH_plasma_cell, Sheets_GT_90pc) 0.5, 0.5;
  (Granulomatous_laden, Sheets_GT_90pc) 0.5, 0.5;
  (Histiocytosis_x, Sheets_GT_90pc) 0.5, 0.5;
  (Infectious_mono, Sheets_GT_90pc) 0.5, 0.5;
  (Leprosy_lepromatous, Sheets_GT_90pc) 0.5, 0.5;
  (Lymphangiographic, Sheets_GT_90pc) 0.5, 0.5;
  (Mantle_zone_hyperpla, Sheets_GT_90pc) 0.5, 0.5;
  (Necrotizing_Kikuchi, Sheets_GT_90pc) 0.5, 0.5;
  (Necrotiz_non_Kikuchi, Sheets_GT_90pc) 0.5, 0.5;
  (Rheumatoid_arthritis, Sheets_GT_90pc) 0.5, 0.5;
  (Sarcoidosis, Sheets_GT_90pc) 0.5, 0.5;
  (SHML, Sheets_GT_90pc) 0.5, 0.5;
  (Sinus_histiocytosis, Sheets_GT_90pc) 0.5, 0.5;
  (Syphilis, Sheets_GT_90pc) 0.5, 0.5;
  (Toxoplasmosis, Sheets_GT_90pc) 0.5, 0.5;
  (Tuberculosis, Sheets_GT_90pc) 0.5, 0.5;
  (Viral_NOS, Sheets_GT_90pc) 0.5, 0.5;
  (Whipple_s_disease, Sheets_GT_90pc) 0.5, 0.5;
  (L_H_nodular_HD, Sheets_GT_90pc) 0.5, 0.5;
  (L_H_diffuse_HD, Sheets_GT_90pc) 0.5, 0.5;
  (Nodular_sclerosis_HD, Sheets_GT_90pc) 0.5, 0.5;
  (Cellular_phase_NSHD, Sheets_GT_90pc) 0.5, 0.5;
  (Syncytial_NSHD, Sheets_GT_90pc) 0.5, 0.5;
  (Mixed_cellularity_HD, Sheets_GT_90pc) 0.5, 0.5;
  (Interfollicular_HD, Sheets_GT_90pc) 0.5, 0.5;
  (Diffuse_fibrosis_HD, Sheets_GT_90pc) 0.5, 0.5;
  (Reticular_type_HD, Sheets_GT_90pc) 0.5, 0.5;
  (Small_cleaved_fol, Sheets_GT_90pc) 0.5, 0.5;
  (Mixed_fol, Sheets_GT_90pc) 0.5, 0.5;
  (Large_cell_fol, Sheets_GT_90pc) 0.5, 0.5;
  (Small_noncleaved_fol, Sheets_GT_90pc) 0.5, 0.5;
  (Small_lymphocytic, Sheets_GT_90pc) 0.5, 0.5;
  (Plasmacytoid_lyctic, Sheets_GT_90pc) 0.5, 0.5;
  (Mantle_zone_lymphoma, Sheets_GT_90pc) 0.5, 0.5;
  (Small_cleaved_dif, Sheets_GT_90pc) 0.5, 0.5;
  (Mixed_FCC_dif, Sheets_GT_90pc) 0.5, 0.5;
  (Large_cell_dif, Sheets_GT_90pc) 0.5, 0.5;
  (B_immunoblastic, Sheets_GT_90pc) 0.5, 0.5;
  (T_immunob_mixed, Sheets_GT_90pc) 0.5, 0.5;
  (AILD_like_T_cell_lym, Sheets_GT_90pc) 0.5, 0.5;
  (Japanese_ATL, Sheets_GT_90pc) 0.5, 0.5;
  (Lymphoblastic, Sheets_GT_90pc) 0.5, 0.5;
  (Small_noncleaved_dif, Sheets_GT_90pc) 0.5, 0.5;
  (True_histiocytic, Sheets_GT_90pc) 0.5, 0.5;
  (Ki_1_LC_anaplas_T, Sheets_GT_90pc) 0.5, 0.5;
  (Multiple_myeloma, Sheets_GT_90pc) 0.95, 0.05;
  (Mycosis_fungoides, Sheets_GT_90pc) 0.5, 0.5;
  (AML, Sheets_GT_90pc) 0.5, 0.5;
  (Hairy_cell_leukemia, Sheets_GT_90pc) 0.5, 0.5;
  (Carcinoma, Sheets_GT_90pc) 0.5, 0.5;
  (Melanoma, Sheets_GT_90pc) 0.5, 0.5;
  (EM_plasmacytoma, Sheets_GT_90pc) 0.95, 0.05;
  (Kaposi_s_sarcoma, Sheets_GT_90pc) 0.5, 0.5;
  (Mast_cell_disease, Sheets_GT_90pc) 0.5, 0.5;
  (AIDS_involutionary, Sheets_GT_90pc) 0.5, 0.5;
  (T_immunob_large, Sheets_GT_90pc) 0.5, 0.5;
  (Monocytoid_B_cell, Sheets_GT_90pc) 0.5, 0.5;
  (Nasopharyngeal_CA, Sheets_GT_90pc) 0.5, 0.5;
  (Seminoma, Sheets_GT_90pc) 0.5, 0.5;
  (SLE, Sheets_GT_90pc) 0.5, 0.5;
  (Mycobact_histiocytos, Sheets_GT_90pc) 0.5, 0.5;
  (Mast_cell_hyperplas, Sheets_GT_90pc) 0.5, 0.5;
  (LGV, Sheets_GT_90pc) 0.5, 0.5;
  (Histoplasmosis, Sheets_GT_90pc) 0.5, 0.5;
  (Coccidioidomycosis, Sheets_GT_90pc) 0.5, 0.5;
  (CMV, Sheets_GT_90pc) 0.5, 0.5;
  (Brucellosis, Sheets_GT_90pc) 0.5, 0.5;
  (Ki_1_LC_anaplas_B, Sheets_GT_90pc) 0.5, 0.5;
  (Intermed_lymphocytic, Sheets_GT_90pc) 0.5, 0.5;
}
probability ( SARCOMA | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 0.01, 0.99;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( SCHAUM | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 0.6, 0.4;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( S_RING | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 0.999, 0.001;
  (Mixed_fol) 0.999, 0.001;
  (Large_cell_fol) 0.999, 0.001;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 0.999, 0.001;
  (Mixed_FCC_dif) 0.999, 0.001;
  (Large_cell_dif) 0.999, 0.001;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 0.9999, 0.0001;
  (Melanoma) 0.9999, 0.0001;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 0.999, 0.001;
  (Nasopharyngeal_CA) 0.9999, 0.0001;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( SLC_CY | Fault, SLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (AILD, Sparse_1_to_10pc) 0.000, 0.999, 0.001, 0.000;
  (ALIP, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Cat_scratch_disease, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Dermatopathic_laden, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Florid_follic_hyperp, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (GLH_hyaline_vascular, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (GLH_plasma_cell, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Granulomatous_laden, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Histiocytosis_x, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Infectious_mono, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Leprosy_lepromatous, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Lymphangiographic, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Mantle_zone_hyperpla, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Necrotizing_Kikuchi, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Necrotiz_non_Kikuchi, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Rheumatoid_arthritis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Sarcoidosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (SHML, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Sinus_histiocytosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Syphilis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Toxoplasmosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Tuberculosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Viral_NOS, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Whipple_s_disease, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (L_H_nodular_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (L_H_diffuse_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Nodular_sclerosis_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Cellular_phase_NSHD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Syncytial_NSHD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Mixed_cellularity_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Interfollicular_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Diffuse_fibrosis_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Reticular_type_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Small_cleaved_fol, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Mixed_fol, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Large_cell_fol, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Small_noncleaved_fol, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Small_lymphocytic, Sparse_1_to_10pc) 0.00, 0.95, 0.05, 0.00;
  (Plasmacytoid_lyctic, Sparse_1_to_10pc) 0.00, 0.85, 0.00, 0.15;
  (Mantle_zone_lymphoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Small_cleaved_dif, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Mixed_FCC_dif, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Large_cell_dif, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (B_immunoblastic, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (T_immunob_mixed, Sparse_1_to_10pc) 0.00, 0.91, 0.09, 0.00;
  (AILD_like_T_cell_lym, Sparse_1_to_10pc) 0.0, 0.7, 0.3, 0.0;
  (Japanese_ATL, Sparse_1_to_10pc) 0.00, 0.98, 0.02, 0.00;
  (Lymphoblastic, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Small_noncleaved_dif, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (True_histiocytic, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Multiple_myeloma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Mycosis_fungoides, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (AML, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Hairy_cell_leukemia, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Carcinoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Melanoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (EM_plasmacytoma, Sparse_1_to_10pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Mast_cell_disease, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (AIDS_involutionary, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (T_immunob_large, Sparse_1_to_10pc) 0.00, 0.91, 0.09, 0.00;
  (Monocytoid_B_cell, Sparse_1_to_10pc) 0.00, 0.98, 0.01, 0.01;
  (Nasopharyngeal_CA, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Seminoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (SLE, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Mycobact_histiocytos, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Mast_cell_hyperplas, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (LGV, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Histoplasmosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Coccidioidomycosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (CMV, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Brucellosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Ki_1_LC_anaplas_B, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (Intermed_lymphocytic, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00;
  (AIDS_early, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (ALIP, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Infectious_mono, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Sarcoidosis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Syphilis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Tuberculosis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_fol, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Large_cell_fol, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.00, 0.85, 0.00, 0.15;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Large_cell_dif, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (B_immunoblastic, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.00, 0.91, 0.09, 0.00;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.0, 0.7, 0.3, 0.0;
  (Japanese_ATL, Moderate_11_to_50pc) 0.00, 0.98, 0.02, 0.00;
  (Lymphoblastic, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (True_histiocytic, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (AML, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Carcinoma, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Melanoma, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, Moderate_11_to_50pc) 0.00, 0.91, 0.09, 0.00;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.00, 0.79, 0.20, 0.01;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Histoplasmosis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_early, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (ALIP, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Infectious_mono, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Sarcoidosis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Syphilis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Tuberculosis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_fol, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Large_cell_fol, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.00, 0.85, 0.00, 0.15;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Large_cell_dif, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (B_immunoblastic, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.00, 0.91, 0.09, 0.00;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.0, 0.7, 0.3, 0.0;
  (Japanese_ATL, Numerous_51_to_90pc) 0.00, 0.98, 0.02, 0.00;
  (Lymphoblastic, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (True_histiocytic, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (AML, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Carcinoma, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Melanoma, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, Numerous_51_to_90pc) 0.00, 0.91, 0.09, 0.00;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.00, 0.79, 0.20, 0.01;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Histoplasmosis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_early, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (AILD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (ALIP, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Cat_scratch_disease, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Dermatopathic_laden, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (GLH_plasma_cell, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Granulomatous_laden, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Histiocytosis_x, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Infectious_mono, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Lymphangiographic, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Sarcoidosis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (SHML, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Syphilis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Toxoplasmosis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Tuberculosis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Viral_NOS, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Whipple_s_disease, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_nodular_HD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Syncytial_NSHD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Interfollicular_HD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Reticular_type_HD, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_cleaved_fol, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_fol, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Large_cell_fol, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_lymphocytic, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.00, 0.85, 0.00, 0.15;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_cleaved_dif, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Large_cell_dif, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (B_immunoblastic, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_mixed, Striking_GT_90pc) 0.00, 0.91, 0.09, 0.00;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.0, 0.7, 0.3, 0.0;
  (Japanese_ATL, Striking_GT_90pc) 0.00, 0.98, 0.02, 0.00;
  (Lymphoblastic, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (True_histiocytic, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Multiple_myeloma, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mycosis_fungoides, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (AML, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Carcinoma, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Melanoma, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (EM_plasmacytoma, Striking_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_disease, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (AIDS_involutionary, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (T_immunob_large, Striking_GT_90pc) 0.00, 0.91, 0.09, 0.00;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.00, 0.79, 0.20, 0.01;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Seminoma, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (SLE, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (LGV, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Histoplasmosis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Coccidioidomycosis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (CMV, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Brucellosis, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.000, 0.999, 0.001, 0.000;
}
probability ( SLC_NS | Fault, SLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (AILD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (ALIP, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Cat_scratch_disease, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Dermatopathic_laden, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Florid_follic_hyperp, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_hyaline_vascular, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_plasma_cell, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Granulomatous_laden, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Histiocytosis_x, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Infectious_mono, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Leprosy_lepromatous, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Lymphangiographic, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mantle_zone_hyperpla, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Rheumatoid_arthritis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Sarcoidosis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (SHML, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Sinus_histiocytosis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Syphilis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Toxoplasmosis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Tuberculosis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Viral_NOS, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Whipple_s_disease, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (L_H_nodular_HD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (L_H_diffuse_HD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Nodular_sclerosis_HD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Cellular_phase_NSHD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Syncytial_NSHD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mixed_cellularity_HD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Interfollicular_HD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Diffuse_fibrosis_HD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Reticular_type_HD, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Small_cleaved_fol, Sparse_1_to_10pc) 0.00000, 0.00000, 0.00001, 0.20000, 0.79999;
  (Mixed_fol, Sparse_1_to_10pc) 0.00000, 0.00000, 0.00001, 0.20000, 0.79999;
  (Large_cell_fol, Sparse_1_to_10pc) 0.00, 0.00, 0.00, 0.03, 0.97;
  (Small_noncleaved_fol, Sparse_1_to_10pc) 0.00, 0.00, 0.00, 0.03, 0.97;
  (Small_lymphocytic, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Plasmacytoid_lyctic, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mantle_zone_lymphoma, Sparse_1_to_10pc) 0.000, 0.000, 0.001, 0.099, 0.900;
  (Small_cleaved_dif, Sparse_1_to_10pc) 0.000, 0.000, 0.001, 0.998, 0.001;
  (Mixed_FCC_dif, Sparse_1_to_10pc) 0.000, 0.000, 0.001, 0.998, 0.001;
  (Large_cell_dif, Sparse_1_to_10pc) 0.00, 0.00, 0.00, 0.04, 0.96;
  (B_immunoblastic, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (T_immunob_mixed, Sparse_1_to_10pc) 0.000, 0.000, 0.005, 0.795, 0.200;
  (AILD_like_T_cell_lym, Sparse_1_to_10pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Sparse_1_to_10pc) 0.000, 0.100, 0.100, 0.799, 0.001;
  (Lymphoblastic, Sparse_1_to_10pc) 0.00, 0.00, 0.01, 0.05, 0.94;
  (Small_noncleaved_dif, Sparse_1_to_10pc) 0.00, 0.00, 0.00, 0.04, 0.96;
  (True_histiocytic, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Multiple_myeloma, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mycosis_fungoides, Sparse_1_to_10pc) 0.000, 0.599, 0.300, 0.100, 0.001;
  (AML, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Hairy_cell_leukemia, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Carcinoma, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Melanoma, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (EM_plasmacytoma, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Kaposi_s_sarcoma, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mast_cell_disease, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (AIDS_involutionary, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (T_immunob_large, Sparse_1_to_10pc) 0.000, 0.000, 0.005, 0.795, 0.200;
  (Monocytoid_B_cell, Sparse_1_to_10pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Nasopharyngeal_CA, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Seminoma, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (SLE, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mycobact_histiocytos, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mast_cell_hyperplas, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (LGV, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Histoplasmosis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Coccidioidomycosis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (CMV, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Brucellosis, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Sparse_1_to_10pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Intermed_lymphocytic, Sparse_1_to_10pc) 0.000, 0.000, 0.001, 0.099, 0.900;
  (AIDS_early, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (AILD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (ALIP, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Infectious_mono, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Lymphangiographic, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Sarcoidosis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (SHML, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Syphilis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Tuberculosis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Viral_NOS, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.00000, 0.00000, 0.00001, 0.20000, 0.79999;
  (Mixed_fol, Moderate_11_to_50pc) 0.00000, 0.00000, 0.00001, 0.20000, 0.79999;
  (Large_cell_fol, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.03, 0.97;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.03, 0.97;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.099, 0.900;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.979, 0.020;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.979, 0.020;
  (Large_cell_dif, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.04, 0.96;
  (B_immunoblastic, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.000, 0.000, 0.005, 0.795, 0.200;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Moderate_11_to_50pc) 0.000, 0.100, 0.100, 0.799, 0.001;
  (Lymphoblastic, Moderate_11_to_50pc) 0.00, 0.00, 0.01, 0.05, 0.94;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.04, 0.96;
  (True_histiocytic, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.000, 0.599, 0.300, 0.100, 0.001;
  (AML, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Carcinoma, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Melanoma, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (T_immunob_large, Moderate_11_to_50pc) 0.000, 0.000, 0.005, 0.795, 0.200;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Seminoma, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (SLE, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (LGV, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Histoplasmosis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (CMV, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Brucellosis, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.000, 0.000, 0.001, 0.099, 0.900;
  (AIDS_early, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (AILD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (ALIP, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Infectious_mono, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Lymphangiographic, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Sarcoidosis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (SHML, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Syphilis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Tuberculosis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Viral_NOS, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.00000, 0.00000, 0.00001, 0.20000, 0.79999;
  (Mixed_fol, Numerous_51_to_90pc) 0.00000, 0.00000, 0.00001, 0.20000, 0.79999;
  (Large_cell_fol, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.03, 0.97;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.03, 0.97;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.099, 0.900;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.0000, 0.0000, 0.0001, 0.9799, 0.0200;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.0000, 0.0000, 0.0001, 0.9799, 0.0200;
  (Large_cell_dif, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.04, 0.96;
  (B_immunoblastic, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.000, 0.000, 0.005, 0.795, 0.200;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Numerous_51_to_90pc) 0.000, 0.100, 0.100, 0.799, 0.001;
  (Lymphoblastic, Numerous_51_to_90pc) 0.00, 0.00, 0.01, 0.05, 0.94;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.04, 0.96;
  (True_histiocytic, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.000, 0.599, 0.300, 0.100, 0.001;
  (AML, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Carcinoma, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Melanoma, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (T_immunob_large, Numerous_51_to_90pc) 0.000, 0.000, 0.005, 0.795, 0.200;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Seminoma, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (SLE, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (LGV, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Histoplasmosis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (CMV, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Brucellosis, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.000, 0.000, 0.001, 0.099, 0.900;
  (AIDS_early, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (AILD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (ALIP, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Cat_scratch_disease, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Dermatopathic_laden, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_plasma_cell, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Granulomatous_laden, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Histiocytosis_x, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Infectious_mono, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Lymphangiographic, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Sarcoidosis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (SHML, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Syphilis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Toxoplasmosis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Tuberculosis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Viral_NOS, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Whipple_s_disease, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (L_H_nodular_HD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Syncytial_NSHD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Interfollicular_HD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Reticular_type_HD, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Small_cleaved_fol, Striking_GT_90pc) 0.00000, 0.00000, 0.00001, 0.20000, 0.79999;
  (Mixed_fol, Striking_GT_90pc) 0.00000, 0.00000, 0.00001, 0.20000, 0.79999;
  (Large_cell_fol, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.03, 0.97;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.03, 0.97;
  (Small_lymphocytic, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.099, 0.900;
  (Small_cleaved_dif, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.979, 0.020;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.979, 0.020;
  (Large_cell_dif, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.04, 0.96;
  (B_immunoblastic, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (T_immunob_mixed, Striking_GT_90pc) 0.000, 0.000, 0.005, 0.795, 0.200;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, Striking_GT_90pc) 0.000, 0.100, 0.100, 0.799, 0.001;
  (Lymphoblastic, Striking_GT_90pc) 0.00, 0.00, 0.01, 0.05, 0.94;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.04, 0.96;
  (True_histiocytic, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Multiple_myeloma, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mycosis_fungoides, Striking_GT_90pc) 0.000, 0.599, 0.300, 0.100, 0.001;
  (AML, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Carcinoma, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Melanoma, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (EM_plasmacytoma, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mast_cell_disease, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (AIDS_involutionary, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (T_immunob_large, Striking_GT_90pc) 0.000, 0.000, 0.005, 0.795, 0.200;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Seminoma, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (SLE, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (LGV, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Histoplasmosis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Coccidioidomycosis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (CMV, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Brucellosis, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.000, 0.000, 0.001, 0.099, 0.900;
}
probability ( SLC | Fault ) {
  (AIDS_early) 0.00, 0.00, 0.01, 0.29, 0.70;
  (AILD) 0.00, 0.00, 0.00, 0.99, 0.01;
  (ALIP) 0.00, 0.00, 0.00, 0.99, 0.01;
  (Cat_scratch_disease) 0.000, 0.001, 0.050, 0.850, 0.099;
  (Dermatopathic_laden) 0.000, 0.001, 0.300, 0.680, 0.019;
  (Florid_follic_hyperp) 0.00, 0.00, 0.01, 0.29, 0.70;
  (GLH_hyaline_vascular) 0.000, 0.001, 0.050, 0.850, 0.099;
  (GLH_plasma_cell) 0.000, 0.001, 0.489, 0.500, 0.010;
  (Granulomatous_laden) 0.000, 0.001, 0.449, 0.500, 0.050;
  (Histiocytosis_x) 0.000, 0.001, 0.050, 0.850, 0.099;
  (Infectious_mono) 0.000, 0.001, 0.050, 0.849, 0.100;
  (Leprosy_lepromatous) 0.01, 0.30, 0.68, 0.01, 0.00;
  (Lymphangiographic) 0.00, 0.01, 0.37, 0.60, 0.02;
  (Mantle_zone_hyperpla) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Necrotizing_Kikuchi) 0.00, 0.01, 0.25, 0.64, 0.10;
  (Necrotiz_non_Kikuchi) 0.00, 0.01, 0.25, 0.64, 0.10;
  (Rheumatoid_arthritis) 0.000, 0.001, 0.300, 0.680, 0.019;
  (Sarcoidosis) 0.000, 0.001, 0.300, 0.680, 0.019;
  (SHML) 0.000, 0.001, 0.300, 0.680, 0.019;
  (Sinus_histiocytosis) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Syphilis) 0.000, 0.001, 0.300, 0.680, 0.019;
  (Toxoplasmosis) 0.000, 0.001, 0.050, 0.850, 0.099;
  (Tuberculosis) 0.01, 0.20, 0.69, 0.10, 0.00;
  (Viral_NOS) 0.00, 0.00, 0.01, 0.89, 0.10;
  (Whipple_s_disease) 0.00, 0.01, 0.37, 0.60, 0.02;
  (L_H_nodular_HD) 0.00, 0.00, 0.01, 0.69, 0.30;
  (L_H_diffuse_HD) 0.00, 0.00, 0.01, 0.69, 0.30;
  (Nodular_sclerosis_HD) 0.00, 0.00, 0.10, 0.85, 0.05;
  (Cellular_phase_NSHD) 0.00, 0.00, 0.10, 0.85, 0.05;
  (Syncytial_NSHD) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Mixed_cellularity_HD) 0.00, 0.00, 0.25, 0.70, 0.05;
  (Interfollicular_HD) 0.00, 0.00, 0.02, 0.88, 0.10;
  (Diffuse_fibrosis_HD) 0.0, 0.6, 0.4, 0.0, 0.0;
  (Reticular_type_HD) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Small_cleaved_fol) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Mixed_fol) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Large_cell_fol) 0.01, 0.36, 0.50, 0.10, 0.03;
  (Small_noncleaved_fol) 0.01, 0.36, 0.50, 0.10, 0.03;
  (Small_lymphocytic) 0.00, 0.00, 0.00, 0.25, 0.75;
  (Plasmacytoid_lyctic) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Mantle_zone_lymphoma) 0.000, 0.000, 0.000, 0.001, 0.999;
  (Small_cleaved_dif) 0.000, 0.000, 0.000, 0.001, 0.999;
  (Mixed_FCC_dif) 0.000, 0.000, 0.010, 0.989, 0.001;
  (Large_cell_dif) 0.01, 0.94, 0.05, 0.00, 0.00;
  (B_immunoblastic) 0.01, 0.94, 0.05, 0.00, 0.00;
  (T_immunob_mixed) 0.000, 0.000, 0.010, 0.989, 0.001;
  (AILD_like_T_cell_lym) 0.00, 0.01, 0.84, 0.15, 0.00;
  (Japanese_ATL) 0.02, 0.88, 0.05, 0.05, 0.00;
  (Lymphoblastic) 0.01, 0.97, 0.02, 0.00, 0.00;
  (Small_noncleaved_dif) 0.01, 0.94, 0.05, 0.00, 0.00;
  (True_histiocytic) 0.01, 0.98, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T) 0.01, 0.98, 0.01, 0.00, 0.00;
  (Multiple_myeloma) 0.01, 0.98, 0.01, 0.00, 0.00;
  (Mycosis_fungoides) 0.005, 0.050, 0.295, 0.350, 0.300;
  (AML) 0.01, 0.98, 0.01, 0.00, 0.00;
  (Hairy_cell_leukemia) 0.20, 0.60, 0.10, 0.05, 0.05;
  (Carcinoma) 0.01, 0.05, 0.83, 0.10, 0.01;
  (Melanoma) 0.01, 0.05, 0.83, 0.10, 0.01;
  (EM_plasmacytoma) 0.01, 0.68, 0.30, 0.01, 0.00;
  (Kaposi_s_sarcoma) 0.01, 0.05, 0.83, 0.10, 0.01;
  (Mast_cell_disease) 0.02, 0.37, 0.60, 0.01, 0.00;
  (AIDS_involutionary) 0.000, 0.001, 0.300, 0.680, 0.019;
  (T_immunob_large) 0.01, 0.98, 0.01, 0.00, 0.00;
  (Monocytoid_B_cell) 0.01, 0.05, 0.83, 0.10, 0.01;
  (Nasopharyngeal_CA) 0.01, 0.05, 0.83, 0.10, 0.01;
  (Seminoma) 0.01, 0.05, 0.83, 0.10, 0.01;
  (SLE) 0.000, 0.001, 0.050, 0.849, 0.100;
  (Mycobact_histiocytos) 0.01, 0.40, 0.58, 0.01, 0.00;
  (Mast_cell_hyperplas) 0.00, 0.10, 0.85, 0.05, 0.00;
  (LGV) 0.000, 0.001, 0.050, 0.850, 0.099;
  (Histoplasmosis) 0.000, 0.001, 0.050, 0.850, 0.099;
  (Coccidioidomycosis) 0.000, 0.001, 0.050, 0.850, 0.099;
  (CMV) 0.000, 0.001, 0.050, 0.850, 0.099;
  (Brucellosis) 0.000, 0.001, 0.050, 0.850, 0.099;
  (Ki_1_LC_anaplas_B) 0.01, 0.98, 0.01, 0.00, 0.00;
  (Intermed_lymphocytic) 0.000, 0.000, 0.000, 0.001, 0.999;
}
probability ( SINUSES | Fault, INTFOL, FOLLICLE ) {
  (AIDS_early, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Leprosy_lepromatous, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (SHML, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Cellular_phase_NSHD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Syncytial_NSHD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_cellularity_HD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Interfollicular_HD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Diffuse_fibrosis_HD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_fol, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_dif, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphoblastic, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mycosis_fungoides, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AML, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Hairy_cell_leukemia, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Melanoma, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (EM_plasmacytoma, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Nasopharyngeal_CA, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Seminoma, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (SLE, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mycobact_histiocytos, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (LGV, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (CMV, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Brucellosis, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, No_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_early, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Leprosy_lepromatous, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (SHML, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Cellular_phase_NSHD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Syncytial_NSHD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_cellularity_HD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Interfollicular_HD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Diffuse_fibrosis_HD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_fol, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_dif, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphoblastic, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mycosis_fungoides, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AML, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Hairy_cell_leukemia, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Melanoma, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (EM_plasmacytoma, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Nasopharyngeal_CA, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Seminoma, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (SLE, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mycobact_histiocytos, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (LGV, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (CMV, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Brucellosis, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Mild_moderate_expansion, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_early, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.000, 0.001, 0.200, 0.799;
  (ALIP, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.000, 0.001, 0.200, 0.799;
  (Cat_scratch_disease, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.10, 0.50, 0.39;
  (Dermatopathic_laden, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (Florid_follic_hyperp, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (Histiocytosis_x, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.00, 0.19, 0.80;
  (Infectious_mono, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.10, 0.48, 0.41;
  (Leprosy_lepromatous, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (Lymphangiographic, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.40, 0.05, 0.10, 0.45;
  (Mantle_zone_hyperpla, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.10, 0.50, 0.39;
  (Necrotiz_non_Kikuchi, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.10, 0.50, 0.39;
  (Rheumatoid_arthritis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (SHML, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.9, 0.1, 0.0, 0.0;
  (Syphilis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (Viral_NOS, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.10, 0.48, 0.41;
  (Whipple_s_disease, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.3, 0.1, 0.1, 0.5;
  (L_H_nodular_HD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Syncytial_NSHD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Interfollicular_HD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Diffuse_fibrosis_HD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Reticular_type_HD, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_fol, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_fol, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.2, 0.8;
  (Small_cleaved_dif, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Large_cell_dif, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (B_immunoblastic, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_mixed, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Japanese_ATL, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphoblastic, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (True_histiocytic, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.30, 0.05, 0.40, 0.25;
  (Multiple_myeloma, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Mycosis_fungoides, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.2, 0.8;
  (AML, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.4, 0.6;
  (Hairy_cell_leukemia, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.05, 0.01, 0.10, 0.84;
  (Carcinoma, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.3, 0.7;
  (Melanoma, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.3, 0.7;
  (EM_plasmacytoma, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.00, 0.01, 0.30, 0.69;
  (Mast_cell_disease, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.001, 0.010, 0.200, 0.789;
  (AIDS_involutionary, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (T_immunob_large, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.00, 0.20, 0.79;
  (Nasopharyngeal_CA, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.1, 0.9;
  (Seminoma, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.3, 0.7;
  (SLE, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.10, 0.48, 0.41;
  (Mycobact_histiocytos, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (Mast_cell_hyperplas, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.001, 0.010, 0.789, 0.200;
  (LGV, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.10, 0.50, 0.39;
  (Histoplasmosis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (Coccidioidomycosis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (CMV, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.01, 0.15, 0.45, 0.39;
  (Brucellosis, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.30, 0.05, 0.40, 0.25;
  (Intermed_lymphocytic, Unif_mrkd_expan_No_follicles, Absent_0pc) 0.0, 0.0, 0.2, 0.8;
  (AIDS_early, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (AILD, No_expansion, 1_to_25pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, No_expansion, 1_to_25pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Dermatopathic_laden, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Florid_follic_hyperp, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (GLH_hyaline_vascular, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (GLH_plasma_cell, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Granulomatous_laden, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Histiocytosis_x, No_expansion, 1_to_25pc) 0.6, 0.4, 0.0, 0.0;
  (Infectious_mono, No_expansion, 1_to_25pc) 0.2, 0.8, 0.0, 0.0;
  (Leprosy_lepromatous, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Lymphangiographic, No_expansion, 1_to_25pc) 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Necrotizing_Kikuchi, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Necrotiz_non_Kikuchi, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Rheumatoid_arthritis, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Sarcoidosis, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (SHML, No_expansion, 1_to_25pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_expansion, 1_to_25pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Toxoplasmosis, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Tuberculosis, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Viral_NOS, No_expansion, 1_to_25pc) 0.2, 0.8, 0.0, 0.0;
  (Whipple_s_disease, No_expansion, 1_to_25pc) 0.99, 0.01, 0.00, 0.00;
  (L_H_nodular_HD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (L_H_diffuse_HD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Nodular_sclerosis_HD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Cellular_phase_NSHD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Syncytial_NSHD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Mixed_cellularity_HD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Interfollicular_HD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Diffuse_fibrosis_HD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Reticular_type_HD, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Small_cleaved_fol, No_expansion, 1_to_25pc) 0.01, 0.89, 0.10, 0.00;
  (Mixed_fol, No_expansion, 1_to_25pc) 0.01, 0.89, 0.10, 0.00;
  (Large_cell_fol, No_expansion, 1_to_25pc) 0.01, 0.89, 0.10, 0.00;
  (Small_noncleaved_fol, No_expansion, 1_to_25pc) 0.01, 0.89, 0.10, 0.00;
  (Small_lymphocytic, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Plasmacytoid_lyctic, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Mantle_zone_lymphoma, No_expansion, 1_to_25pc) 0.01, 0.89, 0.10, 0.00;
  (Small_cleaved_dif, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Mixed_FCC_dif, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Large_cell_dif, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (B_immunoblastic, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (T_immunob_mixed, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (AILD_like_T_cell_lym, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Japanese_ATL, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Lymphoblastic, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Small_noncleaved_dif, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (True_histiocytic, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, No_expansion, 1_to_25pc) 0.95, 0.05, 0.00, 0.00;
  (Multiple_myeloma, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Mycosis_fungoides, No_expansion, 1_to_25pc) 0.1, 0.9, 0.0, 0.0;
  (AML, No_expansion, 1_to_25pc) 0.6, 0.4, 0.0, 0.0;
  (Hairy_cell_leukemia, No_expansion, 1_to_25pc) 0.6, 0.4, 0.0, 0.0;
  (Carcinoma, No_expansion, 1_to_25pc) 0.05, 0.95, 0.00, 0.00;
  (Melanoma, No_expansion, 1_to_25pc) 0.05, 0.95, 0.00, 0.00;
  (EM_plasmacytoma, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Kaposi_s_sarcoma, No_expansion, 1_to_25pc) 0.3, 0.7, 0.0, 0.0;
  (Mast_cell_disease, No_expansion, 1_to_25pc) 0.1, 0.9, 0.0, 0.0;
  (AIDS_involutionary, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (T_immunob_large, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Monocytoid_B_cell, No_expansion, 1_to_25pc) 0.99, 0.01, 0.00, 0.00;
  (Nasopharyngeal_CA, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Seminoma, No_expansion, 1_to_25pc) 0.05, 0.95, 0.00, 0.00;
  (SLE, No_expansion, 1_to_25pc) 0.2, 0.8, 0.0, 0.0;
  (Mycobact_histiocytos, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Mast_cell_hyperplas, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (LGV, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Histoplasmosis, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Coccidioidomycosis, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (CMV, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Brucellosis, No_expansion, 1_to_25pc) 0.01, 0.99, 0.00, 0.00;
  (Ki_1_LC_anaplas_B, No_expansion, 1_to_25pc) 0.95, 0.05, 0.00, 0.00;
  (Intermed_lymphocytic, No_expansion, 1_to_25pc) 0.01, 0.89, 0.10, 0.00;
  (AIDS_early, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (AILD, Mild_moderate_expansion, 1_to_25pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Mild_moderate_expansion, 1_to_25pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Mild_moderate_expansion, 1_to_25pc) 0.01, 0.50, 0.42, 0.07;
  (Dermatopathic_laden, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Florid_follic_hyperp, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (GLH_hyaline_vascular, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (GLH_plasma_cell, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Granulomatous_laden, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Histiocytosis_x, Mild_moderate_expansion, 1_to_25pc) 0.3, 0.3, 0.2, 0.2;
  (Infectious_mono, Mild_moderate_expansion, 1_to_25pc) 0.05, 0.20, 0.65, 0.10;
  (Leprosy_lepromatous, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Lymphangiographic, Mild_moderate_expansion, 1_to_25pc) 0.70, 0.05, 0.20, 0.05;
  (Mantle_zone_hyperpla, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Necrotizing_Kikuchi, Mild_moderate_expansion, 1_to_25pc) 0.01, 0.50, 0.42, 0.07;
  (Necrotiz_non_Kikuchi, Mild_moderate_expansion, 1_to_25pc) 0.01, 0.50, 0.42, 0.07;
  (Rheumatoid_arthritis, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Sarcoidosis, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (SHML, Mild_moderate_expansion, 1_to_25pc) 0.949050949, 0.049950050, 0.000999001, 0.000000000;
  (Sinus_histiocytosis, Mild_moderate_expansion, 1_to_25pc) 0.949050949, 0.049950050, 0.000999001, 0.000000000;
  (Syphilis, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Toxoplasmosis, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Tuberculosis, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Viral_NOS, Mild_moderate_expansion, 1_to_25pc) 0.05, 0.20, 0.65, 0.10;
  (Whipple_s_disease, Mild_moderate_expansion, 1_to_25pc) 0.70, 0.05, 0.20, 0.05;
  (L_H_nodular_HD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.59, 0.40;
  (L_H_diffuse_HD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.59, 0.40;
  (Nodular_sclerosis_HD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.59, 0.40;
  (Cellular_phase_NSHD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.59, 0.40;
  (Syncytial_NSHD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.59, 0.40;
  (Mixed_cellularity_HD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.59, 0.40;
  (Interfollicular_HD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.59, 0.40;
  (Diffuse_fibrosis_HD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.39, 0.60;
  (Reticular_type_HD, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.39, 0.60;
  (Small_cleaved_fol, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.399, 0.600;
  (Mixed_fol, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.399, 0.600;
  (Large_cell_fol, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.399, 0.600;
  (Small_noncleaved_fol, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.399, 0.600;
  (Small_lymphocytic, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Plasmacytoid_lyctic, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Mantle_zone_lymphoma, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.399, 0.600;
  (Small_cleaved_dif, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Mixed_FCC_dif, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Large_cell_dif, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (B_immunoblastic, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (T_immunob_mixed, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (AILD_like_T_cell_lym, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Japanese_ATL, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Lymphoblastic, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Small_noncleaved_dif, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (True_histiocytic, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Ki_1_LC_anaplas_T, Mild_moderate_expansion, 1_to_25pc) 0.75, 0.10, 0.05, 0.10;
  (Multiple_myeloma, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Mycosis_fungoides, Mild_moderate_expansion, 1_to_25pc) 0.02, 0.10, 0.58, 0.30;
  (AML, Mild_moderate_expansion, 1_to_25pc) 0.01, 0.02, 0.72, 0.25;
  (Hairy_cell_leukemia, Mild_moderate_expansion, 1_to_25pc) 0.3, 0.3, 0.2, 0.2;
  (Carcinoma, Mild_moderate_expansion, 1_to_25pc) 0.15, 0.55, 0.05, 0.25;
  (Melanoma, Mild_moderate_expansion, 1_to_25pc) 0.15, 0.55, 0.05, 0.25;
  (EM_plasmacytoma, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Kaposi_s_sarcoma, Mild_moderate_expansion, 1_to_25pc) 0.01, 0.01, 0.58, 0.40;
  (Mast_cell_disease, Mild_moderate_expansion, 1_to_25pc) 0.02, 0.10, 0.58, 0.30;
  (AIDS_involutionary, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (T_immunob_large, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.549, 0.450;
  (Monocytoid_B_cell, Mild_moderate_expansion, 1_to_25pc) 0.100, 0.005, 0.495, 0.400;
  (Nasopharyngeal_CA, Mild_moderate_expansion, 1_to_25pc) 0.00, 0.01, 0.59, 0.40;
  (Seminoma, Mild_moderate_expansion, 1_to_25pc) 0.15, 0.55, 0.05, 0.25;
  (SLE, Mild_moderate_expansion, 1_to_25pc) 0.05, 0.20, 0.65, 0.10;
  (Mycobact_histiocytos, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Mast_cell_hyperplas, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (LGV, Mild_moderate_expansion, 1_to_25pc) 0.01, 0.50, 0.42, 0.07;
  (Histoplasmosis, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Coccidioidomycosis, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (CMV, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Brucellosis, Mild_moderate_expansion, 1_to_25pc) 0.001, 0.050, 0.919, 0.030;
  (Ki_1_LC_anaplas_B, Mild_moderate_expansion, 1_to_25pc) 0.75, 0.10, 0.05, 0.10;
  (Intermed_lymphocytic, Mild_moderate_expansion, 1_to_25pc) 0.000, 0.001, 0.399, 0.600;
  (AIDS_early, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.00000000, 0.00000000, 0.02097902, 0.97902098;
  (ALIP, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.00000000, 0.00000000, 0.02097902, 0.97902098;
  (Cat_scratch_disease, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.01, 0.10, 0.79, 0.10;
  (Dermatopathic_laden, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Florid_follic_hyperp, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (GLH_plasma_cell, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Granulomatous_laden, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Histiocytosis_x, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.05, 0.15, 0.75, 0.05;
  (Infectious_mono, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.03, 0.05, 0.32, 0.60;
  (Leprosy_lepromatous, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Lymphangiographic, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.20, 0.01, 0.64, 0.15;
  (Mantle_zone_hyperpla, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.01, 0.10, 0.79, 0.10;
  (Necrotiz_non_Kikuchi, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.01, 0.10, 0.79, 0.10;
  (Rheumatoid_arthritis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Sarcoidosis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (SHML, Unif_mrkd_expan_No_follicles, 1_to_25pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.95, 0.05, 0.00, 0.00;
  (Syphilis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Toxoplasmosis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Tuberculosis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Viral_NOS, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.03, 0.05, 0.72, 0.20;
  (Whipple_s_disease, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.20, 0.01, 0.64, 0.15;
  (L_H_nodular_HD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (L_H_diffuse_HD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Nodular_sclerosis_HD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Cellular_phase_NSHD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Syncytial_NSHD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Mixed_cellularity_HD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Interfollicular_HD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Diffuse_fibrosis_HD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Reticular_type_HD, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Small_cleaved_fol, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000, 0.001, 0.019, 0.980;
  (Mixed_fol, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000, 0.001, 0.019, 0.980;
  (Large_cell_fol, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000, 0.001, 0.019, 0.980;
  (Small_noncleaved_fol, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000, 0.001, 0.019, 0.980;
  (Small_lymphocytic, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Plasmacytoid_lyctic, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Mantle_zone_lymphoma, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000, 0.001, 0.019, 0.980;
  (Small_cleaved_dif, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Mixed_FCC_dif, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Large_cell_dif, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (B_immunoblastic, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (T_immunob_mixed, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (AILD_like_T_cell_lym, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Japanese_ATL, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Lymphoblastic, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Small_noncleaved_dif, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (True_histiocytic, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Ki_1_LC_anaplas_T, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.59, 0.20, 0.10, 0.11;
  (Multiple_myeloma, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Mycosis_fungoides, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.00, 0.01, 0.15, 0.84;
  (AML, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.00, 0.01, 0.15, 0.84;
  (Hairy_cell_leukemia, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.05, 0.15, 0.60, 0.20;
  (Carcinoma, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.05, 0.15, 0.05, 0.75;
  (Melanoma, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.05, 0.15, 0.05, 0.75;
  (EM_plasmacytoma, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Kaposi_s_sarcoma, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.00, 0.04, 0.02, 0.94;
  (Mast_cell_disease, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.00, 0.01, 0.15, 0.84;
  (AIDS_involutionary, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (T_immunob_large, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Monocytoid_B_cell, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.050, 0.001, 0.100, 0.849;
  (Nasopharyngeal_CA, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Seminoma, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.05, 0.15, 0.05, 0.75;
  (SLE, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.03, 0.05, 0.42, 0.50;
  (Mycobact_histiocytos, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (LGV, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.01, 0.10, 0.79, 0.10;
  (Histoplasmosis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Coccidioidomycosis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (CMV, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Brucellosis, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.0, 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_B, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.59, 0.20, 0.10, 0.11;
  (Intermed_lymphocytic, Unif_mrkd_expan_No_follicles, 1_to_25pc) 0.000, 0.001, 0.019, 0.980;
  (AIDS_early, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (AILD, No_expansion, 25_to_75pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, No_expansion, 25_to_75pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, No_expansion, 25_to_75pc) 0.01, 0.98, 0.01, 0.00;
  (Dermatopathic_laden, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Florid_follic_hyperp, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (GLH_hyaline_vascular, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (GLH_plasma_cell, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Granulomatous_laden, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Histiocytosis_x, No_expansion, 25_to_75pc) 0.60, 0.34, 0.06, 0.00;
  (Infectious_mono, No_expansion, 25_to_75pc) 0.2, 0.7, 0.1, 0.0;
  (Leprosy_lepromatous, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Lymphangiographic, No_expansion, 25_to_75pc) 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Necrotizing_Kikuchi, No_expansion, 25_to_75pc) 0.01, 0.98, 0.01, 0.00;
  (Necrotiz_non_Kikuchi, No_expansion, 25_to_75pc) 0.01, 0.98, 0.01, 0.00;
  (Rheumatoid_arthritis, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Sarcoidosis, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (SHML, No_expansion, 25_to_75pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_expansion, 25_to_75pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Toxoplasmosis, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Tuberculosis, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Viral_NOS, No_expansion, 25_to_75pc) 0.2, 0.7, 0.1, 0.0;
  (Whipple_s_disease, No_expansion, 25_to_75pc) 0.99, 0.01, 0.00, 0.00;
  (L_H_nodular_HD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (L_H_diffuse_HD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Nodular_sclerosis_HD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Cellular_phase_NSHD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Syncytial_NSHD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Mixed_cellularity_HD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Interfollicular_HD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Diffuse_fibrosis_HD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Reticular_type_HD, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Small_cleaved_fol, No_expansion, 25_to_75pc) 0.01, 0.54, 0.40, 0.05;
  (Mixed_fol, No_expansion, 25_to_75pc) 0.01, 0.54, 0.40, 0.05;
  (Large_cell_fol, No_expansion, 25_to_75pc) 0.01, 0.54, 0.40, 0.05;
  (Small_noncleaved_fol, No_expansion, 25_to_75pc) 0.01, 0.54, 0.40, 0.05;
  (Small_lymphocytic, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Plasmacytoid_lyctic, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Mantle_zone_lymphoma, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Small_cleaved_dif, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Mixed_FCC_dif, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Large_cell_dif, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (B_immunoblastic, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (T_immunob_mixed, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (AILD_like_T_cell_lym, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Japanese_ATL, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Lymphoblastic, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Small_noncleaved_dif, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (True_histiocytic, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Ki_1_LC_anaplas_T, No_expansion, 25_to_75pc) 0.95, 0.03, 0.02, 0.00;
  (Multiple_myeloma, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Mycosis_fungoides, No_expansion, 25_to_75pc) 0.1, 0.8, 0.1, 0.0;
  (AML, No_expansion, 25_to_75pc) 0.60, 0.39, 0.01, 0.00;
  (Hairy_cell_leukemia, No_expansion, 25_to_75pc) 0.60, 0.34, 0.06, 0.00;
  (Carcinoma, No_expansion, 25_to_75pc) 0.05, 0.92, 0.03, 0.00;
  (Melanoma, No_expansion, 25_to_75pc) 0.05, 0.92, 0.03, 0.00;
  (EM_plasmacytoma, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Kaposi_s_sarcoma, No_expansion, 25_to_75pc) 0.3, 0.6, 0.1, 0.0;
  (Mast_cell_disease, No_expansion, 25_to_75pc) 0.1, 0.8, 0.1, 0.0;
  (AIDS_involutionary, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (T_immunob_large, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (Monocytoid_B_cell, No_expansion, 25_to_75pc) 0.95, 0.03, 0.02, 0.00;
  (Nasopharyngeal_CA, No_expansion, 25_to_75pc) 0.01, 0.90, 0.09, 0.00;
  (Seminoma, No_expansion, 25_to_75pc) 0.05, 0.92, 0.03, 0.00;
  (SLE, No_expansion, 25_to_75pc) 0.2, 0.7, 0.1, 0.0;
  (Mycobact_histiocytos, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Mast_cell_hyperplas, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (LGV, No_expansion, 25_to_75pc) 0.01, 0.98, 0.01, 0.00;
  (Histoplasmosis, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Coccidioidomycosis, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (CMV, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Brucellosis, No_expansion, 25_to_75pc) 0.01, 0.95, 0.04, 0.00;
  (Ki_1_LC_anaplas_B, No_expansion, 25_to_75pc) 0.95, 0.03, 0.02, 0.00;
  (Intermed_lymphocytic, No_expansion, 25_to_75pc) 0.01, 0.59, 0.40, 0.00;
  (AIDS_early, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (AILD, Mild_moderate_expansion, 25_to_75pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Mild_moderate_expansion, 25_to_75pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Mild_moderate_expansion, 25_to_75pc) 0.01, 0.50, 0.44, 0.05;
  (Dermatopathic_laden, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Florid_follic_hyperp, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (GLH_hyaline_vascular, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (GLH_plasma_cell, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Granulomatous_laden, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Histiocytosis_x, Mild_moderate_expansion, 25_to_75pc) 0.30, 0.30, 0.37, 0.03;
  (Infectious_mono, Mild_moderate_expansion, 25_to_75pc) 0.05, 0.20, 0.68, 0.07;
  (Leprosy_lepromatous, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Lymphangiographic, Mild_moderate_expansion, 25_to_75pc) 0.70, 0.05, 0.22, 0.03;
  (Mantle_zone_hyperpla, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Necrotizing_Kikuchi, Mild_moderate_expansion, 25_to_75pc) 0.01, 0.50, 0.44, 0.05;
  (Necrotiz_non_Kikuchi, Mild_moderate_expansion, 25_to_75pc) 0.01, 0.50, 0.44, 0.05;
  (Rheumatoid_arthritis, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Sarcoidosis, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (SHML, Mild_moderate_expansion, 25_to_75pc) 0.949050949, 0.049950050, 0.000999001, 0.000000000;
  (Sinus_histiocytosis, Mild_moderate_expansion, 25_to_75pc) 0.949050949, 0.049950050, 0.000999001, 0.000000000;
  (Syphilis, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Toxoplasmosis, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Tuberculosis, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Viral_NOS, Mild_moderate_expansion, 25_to_75pc) 0.05, 0.20, 0.71, 0.04;
  (Whipple_s_disease, Mild_moderate_expansion, 25_to_75pc) 0.70, 0.05, 0.22, 0.03;
  (L_H_nodular_HD, Mild_moderate_expansion, 25_to_75pc) 0.00, 0.01, 0.84, 0.15;
  (L_H_diffuse_HD, Mild_moderate_expansion, 25_to_75pc) 0.00, 0.01, 0.84, 0.15;
  (Nodular_sclerosis_HD, Mild_moderate_expansion, 25_to_75pc) 0.00, 0.01, 0.84, 0.15;
  (Cellular_phase_NSHD, Mild_moderate_expansion, 25_to_75pc) 0.00, 0.01, 0.84, 0.15;
  (Syncytial_NSHD, Mild_moderate_expansion, 25_to_75pc) 0.00, 0.01, 0.84, 0.15;
  (Mixed_cellularity_HD, Mild_moderate_expansion, 25_to_75pc) 0.00, 0.01, 0.84, 0.15;
  (Interfollicular_HD, Mild_moderate_expansion, 25_to_75pc) 0.00, 0.01, 0.84, 0.15;
  (Diffuse_fibrosis_HD, Mild_moderate_expansion, 25_to_75pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, Mild_moderate_expansion, 25_to_75pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, Mild_moderate_expansion, 25_to_75pc) 0.000000000, 0.000999001, 0.099900100, 0.899100899;
  (Mixed_fol, Mild_moderate_expansion, 25_to_75pc) 0.000000000, 0.000999001, 0.099900100, 0.899100899;
  (Large_cell_fol, Mild_moderate_expansion, 25_to_75pc) 0.000000000, 0.000999001, 0.099900100, 0.899100899;
  (Small_noncleaved_fol, Mild_moderate_expansion, 25_to_75pc) 0.000000000, 0.000999001, 0.099900100, 0.899100899;
  (Small_lymphocytic, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Plasmacytoid_lyctic, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Mantle_zone_lymphoma, Mild_moderate_expansion, 25_to_75pc) 0.000000000, 0.000999001, 0.099900100, 0.899100899;
  (Small_cleaved_dif, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Mixed_FCC_dif, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Large_cell_dif, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (B_immunoblastic, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (T_immunob_mixed, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (AILD_like_T_cell_lym, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Japanese_ATL, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Lymphoblastic, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Small_noncleaved_dif, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (True_histiocytic, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Ki_1_LC_anaplas_T, Mild_moderate_expansion, 25_to_75pc) 0.81, 0.10, 0.05, 0.04;
  (Multiple_myeloma, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Mycosis_fungoides, Mild_moderate_expansion, 25_to_75pc) 0.02, 0.10, 0.78, 0.10;
  (AML, Mild_moderate_expansion, 25_to_75pc) 0.01, 0.02, 0.82, 0.15;
  (Hairy_cell_leukemia, Mild_moderate_expansion, 25_to_75pc) 0.30, 0.30, 0.36, 0.04;
  (Carcinoma, Mild_moderate_expansion, 25_to_75pc) 0.15, 0.55, 0.26, 0.04;
  (Melanoma, Mild_moderate_expansion, 25_to_75pc) 0.15, 0.55, 0.26, 0.04;
  (EM_plasmacytoma, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Kaposi_s_sarcoma, Mild_moderate_expansion, 25_to_75pc) 0.01, 0.01, 0.83, 0.15;
  (Mast_cell_disease, Mild_moderate_expansion, 25_to_75pc) 0.02, 0.10, 0.78, 0.10;
  (AIDS_involutionary, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (T_immunob_large, Mild_moderate_expansion, 25_to_75pc) 0.000, 0.001, 0.849, 0.150;
  (Monocytoid_B_cell, Mild_moderate_expansion, 25_to_75pc) 0.10, 0.02, 0.48, 0.40;
  (Nasopharyngeal_CA, Mild_moderate_expansion, 25_to_75pc) 0.00, 0.01, 0.84, 0.15;
  (Seminoma, Mild_moderate_expansion, 25_to_75pc) 0.15, 0.55, 0.26, 0.04;
  (SLE, Mild_moderate_expansion, 25_to_75pc) 0.05, 0.20, 0.69, 0.06;
  (Mycobact_histiocytos, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Mast_cell_hyperplas, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (LGV, Mild_moderate_expansion, 25_to_75pc) 0.01, 0.50, 0.44, 0.05;
  (Histoplasmosis, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Coccidioidomycosis, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (CMV, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Brucellosis, Mild_moderate_expansion, 25_to_75pc) 0.000999001, 0.049950050, 0.899100899, 0.049950050;
  (Ki_1_LC_anaplas_B, Mild_moderate_expansion, 25_to_75pc) 0.81, 0.10, 0.05, 0.04;
  (Intermed_lymphocytic, Mild_moderate_expansion, 25_to_75pc) 0.000000000, 0.000999001, 0.099900100, 0.899100899;
  (AIDS_early, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (AILD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.01, 0.10, 0.79, 0.10;
  (Dermatopathic_laden, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Florid_follic_hyperp, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (GLH_plasma_cell, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Granulomatous_laden, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Histiocytosis_x, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.05, 0.15, 0.75, 0.05;
  (Infectious_mono, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.03, 0.05, 0.32, 0.60;
  (Leprosy_lepromatous, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Lymphangiographic, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.20, 0.01, 0.64, 0.15;
  (Mantle_zone_hyperpla, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Necrotizing_Kikuchi, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.01, 0.10, 0.79, 0.10;
  (Necrotiz_non_Kikuchi, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.01, 0.10, 0.79, 0.10;
  (Rheumatoid_arthritis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Sarcoidosis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (SHML, Unif_mrkd_expan_No_follicles, 25_to_75pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.95, 0.05, 0.00, 0.00;
  (Syphilis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Toxoplasmosis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Tuberculosis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Viral_NOS, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.03, 0.05, 0.72, 0.20;
  (Whipple_s_disease, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.20, 0.01, 0.64, 0.15;
  (L_H_nodular_HD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (L_H_diffuse_HD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Nodular_sclerosis_HD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Cellular_phase_NSHD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Syncytial_NSHD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Mixed_cellularity_HD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Interfollicular_HD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Diffuse_fibrosis_HD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Reticular_type_HD, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Small_cleaved_fol, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000, 0.001, 0.019, 0.980;
  (Mixed_fol, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000, 0.001, 0.019, 0.980;
  (Large_cell_fol, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000, 0.001, 0.019, 0.980;
  (Small_noncleaved_fol, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000, 0.001, 0.019, 0.980;
  (Small_lymphocytic, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Plasmacytoid_lyctic, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Mantle_zone_lymphoma, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000, 0.001, 0.019, 0.980;
  (Small_cleaved_dif, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Mixed_FCC_dif, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Large_cell_dif, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (B_immunoblastic, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (T_immunob_mixed, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (AILD_like_T_cell_lym, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Japanese_ATL, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Lymphoblastic, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Small_noncleaved_dif, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (True_histiocytic, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Ki_1_LC_anaplas_T, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.59, 0.20, 0.10, 0.11;
  (Multiple_myeloma, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Mycosis_fungoides, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.00, 0.01, 0.15, 0.84;
  (AML, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.00, 0.01, 0.15, 0.84;
  (Hairy_cell_leukemia, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.05, 0.15, 0.60, 0.20;
  (Carcinoma, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.05, 0.15, 0.05, 0.75;
  (Melanoma, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.05, 0.15, 0.05, 0.75;
  (EM_plasmacytoma, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Kaposi_s_sarcoma, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.01, 0.01, 0.25, 0.73;
  (Mast_cell_disease, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.00, 0.01, 0.15, 0.84;
  (AIDS_involutionary, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (T_immunob_large, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0000000000, 0.0009940358, 0.0248508946, 0.9741550696;
  (Monocytoid_B_cell, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.050, 0.001, 0.100, 0.849;
  (Nasopharyngeal_CA, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000000000, 0.004975124, 0.029850746, 0.965174129;
  (Seminoma, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.05, 0.15, 0.05, 0.75;
  (SLE, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.03, 0.05, 0.42, 0.50;
  (Mycobact_histiocytos, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (LGV, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.01, 0.10, 0.79, 0.10;
  (Histoplasmosis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Coccidioidomycosis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (CMV, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Brucellosis, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.0, 0.0, 0.9, 0.1;
  (Ki_1_LC_anaplas_B, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.59, 0.20, 0.10, 0.11;
  (Intermed_lymphocytic, Unif_mrkd_expan_No_follicles, 25_to_75pc) 0.000, 0.001, 0.019, 0.980;
  (AIDS_early, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (AILD, No_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, No_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, No_expansion, 75_to_90pc) 0.01, 0.98, 0.01, 0.00;
  (Dermatopathic_laden, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Florid_follic_hyperp, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (GLH_hyaline_vascular, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (GLH_plasma_cell, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Granulomatous_laden, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Histiocytosis_x, No_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, No_expansion, 75_to_90pc) 0.2020202, 0.6969697, 0.1010101, 0.0000000;
  (Leprosy_lepromatous, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Lymphangiographic, No_expansion, 75_to_90pc) 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Necrotizing_Kikuchi, No_expansion, 75_to_90pc) 0.01, 0.98, 0.01, 0.00;
  (Necrotiz_non_Kikuchi, No_expansion, 75_to_90pc) 0.01, 0.98, 0.01, 0.00;
  (Rheumatoid_arthritis, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Sarcoidosis, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (SHML, No_expansion, 75_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_expansion, 75_to_90pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Toxoplasmosis, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Tuberculosis, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Viral_NOS, No_expansion, 75_to_90pc) 0.2020202, 0.6969697, 0.1010101, 0.0000000;
  (Whipple_s_disease, No_expansion, 75_to_90pc) 0.99, 0.01, 0.00, 0.00;
  (L_H_nodular_HD, No_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, No_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, No_expansion, 75_to_90pc) 0.000999001, 0.799200799, 0.199800200, 0.000000000;
  (Cellular_phase_NSHD, No_expansion, 75_to_90pc) 0.000999001, 0.799200799, 0.199800200, 0.000000000;
  (Syncytial_NSHD, No_expansion, 75_to_90pc) 0.000999001, 0.799200799, 0.199800200, 0.000000000;
  (Mixed_cellularity_HD, No_expansion, 75_to_90pc) 0.000999001, 0.799200799, 0.199800200, 0.000000000;
  (Interfollicular_HD, No_expansion, 75_to_90pc) 0.000999001, 0.799200799, 0.199800200, 0.000000000;
  (Diffuse_fibrosis_HD, No_expansion, 75_to_90pc) 0.000999001, 0.799200799, 0.199800200, 0.000000000;
  (Reticular_type_HD, No_expansion, 75_to_90pc) 0.000999001, 0.799200799, 0.199800200, 0.000000000;
  (Small_cleaved_fol, No_expansion, 75_to_90pc) 0.000998004, 0.000998004, 0.109780439, 0.888223553;
  (Mixed_fol, No_expansion, 75_to_90pc) 0.000998004, 0.000998004, 0.109780439, 0.888223553;
  (Large_cell_fol, No_expansion, 75_to_90pc) 0.000998004, 0.000998004, 0.109780439, 0.888223553;
  (Small_noncleaved_fol, No_expansion, 75_to_90pc) 0.000998004, 0.000998004, 0.109780439, 0.888223553;
  (Small_lymphocytic, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Plasmacytoid_lyctic, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Mantle_zone_lymphoma, No_expansion, 75_to_90pc) 0.000998004, 0.000998004, 0.109780439, 0.888223553;
  (Small_cleaved_dif, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Mixed_FCC_dif, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Large_cell_dif, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (B_immunoblastic, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (T_immunob_mixed, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (AILD_like_T_cell_lym, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Japanese_ATL, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Lymphoblastic, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Small_noncleaved_dif, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (True_histiocytic, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Ki_1_LC_anaplas_T, No_expansion, 75_to_90pc) 0.70, 0.25, 0.05, 0.00;
  (Multiple_myeloma, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Mycosis_fungoides, No_expansion, 75_to_90pc) 0.10, 0.89, 0.01, 0.00;
  (AML, No_expansion, 75_to_90pc) 0.05, 0.75, 0.20, 0.00;
  (Hairy_cell_leukemia, No_expansion, 75_to_90pc) 0.60606061, 0.34343434, 0.05050505, 0.00000000;
  (Carcinoma, No_expansion, 75_to_90pc) 0.28, 0.70, 0.02, 0.00;
  (Melanoma, No_expansion, 75_to_90pc) 0.28, 0.70, 0.02, 0.00;
  (EM_plasmacytoma, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Kaposi_s_sarcoma, No_expansion, 75_to_90pc) 0.20, 0.65, 0.10, 0.05;
  (Mast_cell_disease, No_expansion, 75_to_90pc) 0.10, 0.89, 0.01, 0.00;
  (AIDS_involutionary, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (T_immunob_large, No_expansion, 75_to_90pc) 0.02, 0.93, 0.05, 0.00;
  (Monocytoid_B_cell, No_expansion, 75_to_90pc) 0.050, 0.001, 0.479, 0.470;
  (Nasopharyngeal_CA, No_expansion, 75_to_90pc) 0.000999001, 0.799200799, 0.199800200, 0.000000000;
  (Seminoma, No_expansion, 75_to_90pc) 0.28, 0.70, 0.02, 0.00;
  (SLE, No_expansion, 75_to_90pc) 0.2020202, 0.6969697, 0.1010101, 0.0000000;
  (Mycobact_histiocytos, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Mast_cell_hyperplas, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (LGV, No_expansion, 75_to_90pc) 0.01, 0.98, 0.01, 0.00;
  (Histoplasmosis, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Coccidioidomycosis, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (CMV, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Brucellosis, No_expansion, 75_to_90pc) 0.02, 0.96, 0.02, 0.00;
  (Ki_1_LC_anaplas_B, No_expansion, 75_to_90pc) 0.70, 0.25, 0.05, 0.00;
  (Intermed_lymphocytic, No_expansion, 75_to_90pc) 0.000998004, 0.000998004, 0.109780439, 0.888223553;
  (AIDS_early, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (AILD, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Mild_moderate_expansion, 75_to_90pc) 0.55, 0.10, 0.33, 0.02;
  (Dermatopathic_laden, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Florid_follic_hyperp, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (GLH_hyaline_vascular, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (GLH_plasma_cell, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Granulomatous_laden, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Mild_moderate_expansion, 75_to_90pc) 0.15, 0.45, 0.38, 0.02;
  (Infectious_mono, Mild_moderate_expansion, 75_to_90pc) 0.05, 0.25, 0.67, 0.03;
  (Leprosy_lepromatous, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Mild_moderate_expansion, 75_to_90pc) 0.55, 0.10, 0.35, 0.00;
  (Mantle_zone_hyperpla, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Necrotizing_Kikuchi, Mild_moderate_expansion, 75_to_90pc) 0.55, 0.10, 0.33, 0.02;
  (Necrotiz_non_Kikuchi, Mild_moderate_expansion, 75_to_90pc) 0.55, 0.10, 0.33, 0.02;
  (Rheumatoid_arthritis, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Sarcoidosis, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (SHML, Mild_moderate_expansion, 75_to_90pc) 0.55, 0.10, 0.35, 0.00;
  (Sinus_histiocytosis, Mild_moderate_expansion, 75_to_90pc) 0.55, 0.10, 0.35, 0.00;
  (Syphilis, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Toxoplasmosis, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Tuberculosis, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Mild_moderate_expansion, 75_to_90pc) 0.05, 0.25, 0.67, 0.03;
  (Whipple_s_disease, Mild_moderate_expansion, 75_to_90pc) 0.55, 0.10, 0.35, 0.00;
  (L_H_nodular_HD, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, Mild_moderate_expansion, 75_to_90pc) 0.000999001, 0.049950050, 0.799200799, 0.149850150;
  (Cellular_phase_NSHD, Mild_moderate_expansion, 75_to_90pc) 0.000999001, 0.049950050, 0.799200799, 0.149850150;
  (Syncytial_NSHD, Mild_moderate_expansion, 75_to_90pc) 0.000999001, 0.049950050, 0.799200799, 0.149850150;
  (Mixed_cellularity_HD, Mild_moderate_expansion, 75_to_90pc) 0.000999001, 0.049950050, 0.799200799, 0.149850150;
  (Interfollicular_HD, Mild_moderate_expansion, 75_to_90pc) 0.001, 0.050, 0.849, 0.100;
  (Diffuse_fibrosis_HD, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.01, 0.05, 0.94;
  (Mixed_fol, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.01, 0.05, 0.94;
  (Large_cell_fol, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.01, 0.05, 0.94;
  (Small_noncleaved_fol, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.01, 0.05, 0.94;
  (Small_lymphocytic, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, Mild_moderate_expansion, 75_to_90pc) 0.001, 0.030, 0.300, 0.669;
  (Small_cleaved_dif, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphoblastic, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Mild_moderate_expansion, 75_to_90pc) 0.01, 0.10, 0.80, 0.09;
  (Mycosis_fungoides, Mild_moderate_expansion, 75_to_90pc) 0.01, 0.05, 0.91, 0.03;
  (AML, Mild_moderate_expansion, 75_to_90pc) 0.01, 0.05, 0.89, 0.05;
  (Hairy_cell_leukemia, Mild_moderate_expansion, 75_to_90pc) 0.60, 0.35, 0.05, 0.00;
  (Carcinoma, Mild_moderate_expansion, 75_to_90pc) 0.01, 0.05, 0.89, 0.05;
  (Melanoma, Mild_moderate_expansion, 75_to_90pc) 0.01, 0.05, 0.89, 0.05;
  (EM_plasmacytoma, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, Mild_moderate_expansion, 75_to_90pc) 0.05, 0.30, 0.63, 0.02;
  (Mast_cell_disease, Mild_moderate_expansion, 75_to_90pc) 0.01, 0.05, 0.91, 0.03;
  (AIDS_involutionary, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, Mild_moderate_expansion, 75_to_90pc) 0.05, 0.01, 0.24, 0.70;
  (Nasopharyngeal_CA, Mild_moderate_expansion, 75_to_90pc) 0.000999001, 0.049950050, 0.799200799, 0.149850150;
  (Seminoma, Mild_moderate_expansion, 75_to_90pc) 0.01, 0.05, 0.89, 0.05;
  (SLE, Mild_moderate_expansion, 75_to_90pc) 0.05, 0.25, 0.67, 0.03;
  (Mycobact_histiocytos, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (LGV, Mild_moderate_expansion, 75_to_90pc) 0.55, 0.10, 0.33, 0.02;
  (Histoplasmosis, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Coccidioidomycosis, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (CMV, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Brucellosis, Mild_moderate_expansion, 75_to_90pc) 0.00, 0.25, 0.72, 0.03;
  (Ki_1_LC_anaplas_B, Mild_moderate_expansion, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Mild_moderate_expansion, 75_to_90pc) 0.001, 0.030, 0.300, 0.669;
  (AIDS_early, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.01, 0.01, 0.93, 0.05;
  (Dermatopathic_laden, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.000, 0.001, 0.899, 0.100;
  (Leprosy_lepromatous, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.01, 0.01, 0.93, 0.05;
  (Necrotiz_non_Kikuchi, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.01, 0.01, 0.93, 0.05;
  (Rheumatoid_arthritis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (SHML, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.000, 0.001, 0.899, 0.100;
  (Whipple_s_disease, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.00, 0.00, 0.85, 0.15;
  (Cellular_phase_NSHD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.00, 0.00, 0.85, 0.15;
  (Syncytial_NSHD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.00, 0.00, 0.85, 0.15;
  (Mixed_cellularity_HD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.00, 0.00, 0.85, 0.15;
  (Interfollicular_HD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.00, 0.00, 0.85, 0.15;
  (Diffuse_fibrosis_HD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_fol, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.00, 0.01, 0.10, 0.89;
  (Small_cleaved_dif, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphoblastic, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mycosis_fungoides, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.0, 0.0, 0.9, 0.1;
  (AML, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Hairy_cell_leukemia, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Melanoma, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (EM_plasmacytoma, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.0, 0.0, 0.9, 0.1;
  (Mast_cell_disease, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.0, 0.0, 0.9, 0.1;
  (AIDS_involutionary, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.001, 0.001, 0.248, 0.750;
  (Nasopharyngeal_CA, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.00, 0.00, 0.85, 0.15;
  (Seminoma, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (SLE, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.000, 0.001, 0.899, 0.100;
  (Mycobact_histiocytos, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (LGV, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.01, 0.01, 0.93, 0.05;
  (Histoplasmosis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (CMV, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Brucellosis, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Unif_mrkd_expan_No_follicles, 75_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_early, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (AILD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Florid_follic_hyperp, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (GLH_hyaline_vascular, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (GLH_plasma_cell, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Granulomatous_laden, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Histiocytosis_x, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Leprosy_lepromatous, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Lymphangiographic, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Necrotizing_Kikuchi, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Sarcoidosis, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (SHML, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Toxoplasmosis, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Tuberculosis, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Viral_NOS, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cellular_phase_NSHD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syncytial_NSHD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_cellularity_HD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Interfollicular_HD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Diffuse_fibrosis_HD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, No_expansion, GT_90pc) 0.000998004, 0.000998004, 0.049900200, 0.948103792;
  (Mixed_fol, No_expansion, GT_90pc) 0.000998004, 0.000998004, 0.049900200, 0.948103792;
  (Large_cell_fol, No_expansion, GT_90pc) 0.000998004, 0.000998004, 0.049900200, 0.948103792;
  (Small_noncleaved_fol, No_expansion, GT_90pc) 0.000998004, 0.000998004, 0.049900200, 0.948103792;
  (Small_lymphocytic, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, No_expansion, GT_90pc) 0.000998004, 0.000998004, 0.049900200, 0.948103792;
  (Small_cleaved_dif, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphoblastic, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mycosis_fungoides, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AML, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Hairy_cell_leukemia, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Melanoma, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (EM_plasmacytoma, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (T_immunob_large, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, No_expansion, GT_90pc) 0.000998004, 0.000998004, 0.199600798, 0.798403194;
  (Nasopharyngeal_CA, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Seminoma, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (SLE, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mycobact_histiocytos, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Mast_cell_hyperplas, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (LGV, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Coccidioidomycosis, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (CMV, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Brucellosis, No_expansion, GT_90pc) 0.01, 0.01, 0.40, 0.58;
  (Ki_1_LC_anaplas_B, No_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, No_expansion, GT_90pc) 0.000998004, 0.000998004, 0.049900200, 0.948103792;
  (AIDS_early, Mild_moderate_expansion, GT_90pc) 0.00, 0.01, 0.10, 0.89;
  (AILD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Mild_moderate_expansion, GT_90pc) 0.00, 0.01, 0.10, 0.89;
  (GLH_hyaline_vascular, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Mild_moderate_expansion, GT_90pc) 0.00, 0.01, 0.10, 0.89;
  (Granulomatous_laden, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Leprosy_lepromatous, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, Mild_moderate_expansion, GT_90pc) 0.00, 0.01, 0.10, 0.89;
  (Necrotizing_Kikuchi, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, Mild_moderate_expansion, GT_90pc) 0.00, 0.01, 0.10, 0.89;
  (Sarcoidosis, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (SHML, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cellular_phase_NSHD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syncytial_NSHD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_cellularity_HD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Interfollicular_HD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Diffuse_fibrosis_HD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, Mild_moderate_expansion, GT_90pc) 0.000, 0.005, 0.050, 0.945;
  (Mixed_fol, Mild_moderate_expansion, GT_90pc) 0.000, 0.005, 0.050, 0.945;
  (Large_cell_fol, Mild_moderate_expansion, GT_90pc) 0.000, 0.005, 0.050, 0.945;
  (Small_noncleaved_fol, Mild_moderate_expansion, GT_90pc) 0.000, 0.005, 0.050, 0.945;
  (Small_lymphocytic, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_dif, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphoblastic, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mycosis_fungoides, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AML, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Hairy_cell_leukemia, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Melanoma, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (EM_plasmacytoma, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, Mild_moderate_expansion, GT_90pc) 0.000, 0.005, 0.050, 0.945;
  (Nasopharyngeal_CA, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Seminoma, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (SLE, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mycobact_histiocytos, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (LGV, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (CMV, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Brucellosis, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Mild_moderate_expansion, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_early, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Leprosy_lepromatous, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (SHML, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cellular_phase_NSHD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syncytial_NSHD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_cellularity_HD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Interfollicular_HD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Diffuse_fibrosis_HD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_fol, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_dif, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphoblastic, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mycosis_fungoides, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AML, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Hairy_cell_leukemia, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Melanoma, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (EM_plasmacytoma, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nasopharyngeal_CA, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Seminoma, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (SLE, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mycobact_histiocytos, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (LGV, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (CMV, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Brucellosis, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Unif_mrkd_expan_No_follicles, GT_90pc) 0.25, 0.25, 0.25, 0.25;
}
probability ( VASC_C | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 0.4, 0.6;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( VASC_NS | Fault ) {
  (AIDS_early) 0.05, 0.73, 0.20, 0.02, 0.00;
  (AILD) 0.00, 0.00, 0.01, 0.79, 0.20;
  (ALIP) 0.01, 0.35, 0.50, 0.13, 0.01;
  (Cat_scratch_disease) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Dermatopathic_laden) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Florid_follic_hyperp) 0.05, 0.73, 0.20, 0.02, 0.00;
  (GLH_hyaline_vascular) 0.00, 0.00, 0.01, 0.89, 0.10;
  (GLH_plasma_cell) 0.100, 0.449, 0.300, 0.150, 0.001;
  (Granulomatous_laden) 0.10, 0.60, 0.25, 0.05, 0.00;
  (Histiocytosis_x) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Infectious_mono) 0.01, 0.56, 0.35, 0.08, 0.00;
  (Leprosy_lepromatous) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Lymphangiographic) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Mantle_zone_hyperpla) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Necrotizing_Kikuchi) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Necrotiz_non_Kikuchi) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Rheumatoid_arthritis) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Sarcoidosis) 0.05, 0.73, 0.20, 0.02, 0.00;
  (SHML) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Sinus_histiocytosis) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Syphilis) 0.01, 0.56, 0.35, 0.08, 0.00;
  (Toxoplasmosis) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Tuberculosis) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Viral_NOS) 0.01, 0.56, 0.35, 0.08, 0.00;
  (Whipple_s_disease) 0.05, 0.73, 0.20, 0.02, 0.00;
  (L_H_nodular_HD) 0.05, 0.73, 0.20, 0.02, 0.00;
  (L_H_diffuse_HD) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Nodular_sclerosis_HD) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Cellular_phase_NSHD) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Syncytial_NSHD) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Mixed_cellularity_HD) 0.01, 0.56, 0.35, 0.08, 0.00;
  (Interfollicular_HD) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Diffuse_fibrosis_HD) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Reticular_type_HD) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Small_cleaved_fol) 0.01, 0.65, 0.32, 0.02, 0.00;
  (Mixed_fol) 0.01, 0.65, 0.32, 0.02, 0.00;
  (Large_cell_fol) 0.01, 0.65, 0.32, 0.02, 0.00;
  (Small_noncleaved_fol) 0.01, 0.65, 0.32, 0.02, 0.00;
  (Small_lymphocytic) 0.05, 0.65, 0.29, 0.01, 0.00;
  (Plasmacytoid_lyctic) 0.05, 0.65, 0.29, 0.01, 0.00;
  (Mantle_zone_lymphoma) 0.05, 0.65, 0.29, 0.01, 0.00;
  (Small_cleaved_dif) 0.05, 0.65, 0.29, 0.01, 0.00;
  (Mixed_FCC_dif) 0.01, 0.60, 0.31, 0.08, 0.00;
  (Large_cell_dif) 0.01, 0.66, 0.31, 0.02, 0.00;
  (B_immunoblastic) 0.01, 0.66, 0.31, 0.02, 0.00;
  (T_immunob_mixed) 0.01, 0.60, 0.31, 0.08, 0.00;
  (AILD_like_T_cell_lym) 0.00, 0.00, 0.01, 0.79, 0.20;
  (Japanese_ATL) 0.01, 0.66, 0.31, 0.02, 0.00;
  (Lymphoblastic) 0.01, 0.66, 0.31, 0.02, 0.00;
  (Small_noncleaved_dif) 0.01, 0.66, 0.31, 0.02, 0.00;
  (True_histiocytic) 0.01, 0.66, 0.31, 0.02, 0.00;
  (Ki_1_LC_anaplas_T) 0.01, 0.66, 0.31, 0.02, 0.00;
  (Multiple_myeloma) 0.05, 0.74, 0.20, 0.01, 0.00;
  (Mycosis_fungoides) 0.05, 0.65, 0.29, 0.01, 0.00;
  (AML) 0.05, 0.65, 0.29, 0.01, 0.00;
  (Hairy_cell_leukemia) 0.01, 0.70, 0.28, 0.01, 0.00;
  (Carcinoma) 0.05, 0.65, 0.29, 0.01, 0.00;
  (Melanoma) 0.05, 0.65, 0.29, 0.01, 0.00;
  (EM_plasmacytoma) 0.05, 0.74, 0.20, 0.01, 0.00;
  (Kaposi_s_sarcoma) 0.01, 0.68, 0.30, 0.01, 0.00;
  (Mast_cell_disease) 0.05, 0.73, 0.20, 0.02, 0.00;
  (AIDS_involutionary) 0.01, 0.49, 0.40, 0.10, 0.00;
  (T_immunob_large) 0.01, 0.66, 0.31, 0.02, 0.00;
  (Monocytoid_B_cell) 0.01, 0.65, 0.32, 0.02, 0.00;
  (Nasopharyngeal_CA) 0.05, 0.65, 0.29, 0.01, 0.00;
  (Seminoma) 0.05, 0.65, 0.29, 0.01, 0.00;
  (SLE) 0.01, 0.56, 0.35, 0.08, 0.00;
  (Mycobact_histiocytos) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Mast_cell_hyperplas) 0.05, 0.73, 0.20, 0.02, 0.00;
  (LGV) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Histoplasmosis) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Coccidioidomycosis) 0.05, 0.73, 0.20, 0.02, 0.00;
  (CMV) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Brucellosis) 0.05, 0.73, 0.20, 0.02, 0.00;
  (Ki_1_LC_anaplas_B) 0.01, 0.66, 0.31, 0.02, 0.00;
  (Intermed_lymphocytic) 0.05, 0.65, 0.29, 0.01, 0.00;
}
probability ( VASC_S | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 0.01, 0.99;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( F_HEM | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.00, 0.55, 0.45;
  (AILD, 1_to_25pc) 0.00, 0.99, 0.01;
  (ALIP, 1_to_25pc) 0.00, 0.99, 0.01;
  (Cat_scratch_disease, 1_to_25pc) 0.00, 0.99, 0.01;
  (Dermatopathic_laden, 1_to_25pc) 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, 1_to_25pc) 0.00, 0.95, 0.05;
  (GLH_hyaline_vascular, 1_to_25pc) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, 1_to_25pc) 0.00, 0.99, 0.01;
  (Granulomatous_laden, 1_to_25pc) 0.00, 0.99, 0.01;
  (Histiocytosis_x, 1_to_25pc) 0.00, 0.99, 0.01;
  (Infectious_mono, 1_to_25pc) 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, 1_to_25pc) 0.00, 0.99, 0.01;
  (Lymphangiographic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.00, 0.99, 0.01;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, 1_to_25pc) 0.00, 0.99, 0.01;
  (Sarcoidosis, 1_to_25pc) 0.00, 0.99, 0.01;
  (SHML, 1_to_25pc) 0.00, 0.99, 0.01;
  (Sinus_histiocytosis, 1_to_25pc) 0.00, 0.99, 0.01;
  (Syphilis, 1_to_25pc) 0.00, 0.99, 0.01;
  (Toxoplasmosis, 1_to_25pc) 0.00, 0.99, 0.01;
  (Tuberculosis, 1_to_25pc) 0.00, 0.99, 0.01;
  (Viral_NOS, 1_to_25pc) 0.00, 0.99, 0.01;
  (Whipple_s_disease, 1_to_25pc) 0.00, 0.99, 0.01;
  (L_H_nodular_HD, 1_to_25pc) 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Cellular_phase_NSHD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Interfollicular_HD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Reticular_type_HD, 1_to_25pc) 0.00, 0.99, 0.01;
  (Small_cleaved_fol, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mixed_fol, 1_to_25pc) 0.00, 0.99, 0.01;
  (Large_cell_fol, 1_to_25pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_fol, 1_to_25pc) 0.00, 0.99, 0.01;
  (Small_lymphocytic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.00, 0.99, 0.01;
  (Small_cleaved_dif, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, 1_to_25pc) 0.00, 0.99, 0.01;
  (Large_cell_dif, 1_to_25pc) 0.00, 0.99, 0.01;
  (B_immunoblastic, 1_to_25pc) 0.00, 0.99, 0.01;
  (T_immunob_mixed, 1_to_25pc) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.00, 0.99, 0.01;
  (Japanese_ATL, 1_to_25pc) 0.00, 0.99, 0.01;
  (Lymphoblastic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, 1_to_25pc) 0.00, 0.99, 0.01;
  (True_histiocytic, 1_to_25pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.00, 0.99, 0.01;
  (Multiple_myeloma, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mycosis_fungoides, 1_to_25pc) 0.00, 0.99, 0.01;
  (AML, 1_to_25pc) 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, 1_to_25pc) 0.00, 0.99, 0.01;
  (Carcinoma, 1_to_25pc) 0.00, 0.99, 0.01;
  (Melanoma, 1_to_25pc) 0.00, 0.99, 0.01;
  (EM_plasmacytoma, 1_to_25pc) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mast_cell_disease, 1_to_25pc) 0.00, 0.99, 0.01;
  (AIDS_involutionary, 1_to_25pc) 0.0, 0.5, 0.5;
  (T_immunob_large, 1_to_25pc) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, 1_to_25pc) 0.00, 0.99, 0.01;
  (Nasopharyngeal_CA, 1_to_25pc) 0.00, 0.99, 0.01;
  (Seminoma, 1_to_25pc) 0.00, 0.99, 0.01;
  (SLE, 1_to_25pc) 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, 1_to_25pc) 0.00, 0.99, 0.01;
  (LGV, 1_to_25pc) 0.00, 0.99, 0.01;
  (Histoplasmosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (CMV, 1_to_25pc) 0.0, 0.9, 0.1;
  (Brucellosis, 1_to_25pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, 1_to_25pc) 0.00, 0.99, 0.01;
  (AIDS_early, 25_to_75pc) 0.00, 0.55, 0.45;
  (AILD, 25_to_75pc) 0.00, 0.99, 0.01;
  (ALIP, 25_to_75pc) 0.00, 0.99, 0.01;
  (Cat_scratch_disease, 25_to_75pc) 0.00, 0.99, 0.01;
  (Dermatopathic_laden, 25_to_75pc) 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, 25_to_75pc) 0.00, 0.95, 0.05;
  (GLH_hyaline_vascular, 25_to_75pc) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, 25_to_75pc) 0.00, 0.99, 0.01;
  (Granulomatous_laden, 25_to_75pc) 0.00, 0.99, 0.01;
  (Histiocytosis_x, 25_to_75pc) 0.00, 0.99, 0.01;
  (Infectious_mono, 25_to_75pc) 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, 25_to_75pc) 0.00, 0.99, 0.01;
  (Lymphangiographic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.00, 0.99, 0.01;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, 25_to_75pc) 0.00, 0.99, 0.01;
  (Sarcoidosis, 25_to_75pc) 0.00, 0.99, 0.01;
  (SHML, 25_to_75pc) 0.00, 0.99, 0.01;
  (Sinus_histiocytosis, 25_to_75pc) 0.00, 0.99, 0.01;
  (Syphilis, 25_to_75pc) 0.00, 0.99, 0.01;
  (Toxoplasmosis, 25_to_75pc) 0.00, 0.99, 0.01;
  (Tuberculosis, 25_to_75pc) 0.00, 0.99, 0.01;
  (Viral_NOS, 25_to_75pc) 0.00, 0.99, 0.01;
  (Whipple_s_disease, 25_to_75pc) 0.00, 0.99, 0.01;
  (L_H_nodular_HD, 25_to_75pc) 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Cellular_phase_NSHD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Interfollicular_HD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Reticular_type_HD, 25_to_75pc) 0.00, 0.99, 0.01;
  (Small_cleaved_fol, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mixed_fol, 25_to_75pc) 0.00, 0.99, 0.01;
  (Large_cell_fol, 25_to_75pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_fol, 25_to_75pc) 0.00, 0.99, 0.01;
  (Small_lymphocytic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.00, 0.99, 0.01;
  (Small_cleaved_dif, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, 25_to_75pc) 0.00, 0.99, 0.01;
  (Large_cell_dif, 25_to_75pc) 0.00, 0.99, 0.01;
  (B_immunoblastic, 25_to_75pc) 0.00, 0.99, 0.01;
  (T_immunob_mixed, 25_to_75pc) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.00, 0.99, 0.01;
  (Japanese_ATL, 25_to_75pc) 0.00, 0.99, 0.01;
  (Lymphoblastic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, 25_to_75pc) 0.00, 0.99, 0.01;
  (True_histiocytic, 25_to_75pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.00, 0.99, 0.01;
  (Multiple_myeloma, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mycosis_fungoides, 25_to_75pc) 0.00, 0.99, 0.01;
  (AML, 25_to_75pc) 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, 25_to_75pc) 0.00, 0.99, 0.01;
  (Carcinoma, 25_to_75pc) 0.00, 0.99, 0.01;
  (Melanoma, 25_to_75pc) 0.00, 0.99, 0.01;
  (EM_plasmacytoma, 25_to_75pc) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mast_cell_disease, 25_to_75pc) 0.00, 0.99, 0.01;
  (AIDS_involutionary, 25_to_75pc) 0.0, 0.5, 0.5;
  (T_immunob_large, 25_to_75pc) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, 25_to_75pc) 0.00, 0.99, 0.01;
  (Nasopharyngeal_CA, 25_to_75pc) 0.00, 0.99, 0.01;
  (Seminoma, 25_to_75pc) 0.00, 0.99, 0.01;
  (SLE, 25_to_75pc) 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, 25_to_75pc) 0.00, 0.99, 0.01;
  (LGV, 25_to_75pc) 0.00, 0.99, 0.01;
  (Histoplasmosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (CMV, 25_to_75pc) 0.0, 0.9, 0.1;
  (Brucellosis, 25_to_75pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, 25_to_75pc) 0.00, 0.99, 0.01;
  (AIDS_early, 75_to_90pc) 0.00, 0.55, 0.45;
  (AILD, 75_to_90pc) 0.00, 0.99, 0.01;
  (ALIP, 75_to_90pc) 0.00, 0.99, 0.01;
  (Cat_scratch_disease, 75_to_90pc) 0.00, 0.99, 0.01;
  (Dermatopathic_laden, 75_to_90pc) 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, 75_to_90pc) 0.00, 0.95, 0.05;
  (GLH_hyaline_vascular, 75_to_90pc) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, 75_to_90pc) 0.00, 0.99, 0.01;
  (Granulomatous_laden, 75_to_90pc) 0.00, 0.99, 0.01;
  (Histiocytosis_x, 75_to_90pc) 0.00, 0.99, 0.01;
  (Infectious_mono, 75_to_90pc) 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, 75_to_90pc) 0.00, 0.99, 0.01;
  (Lymphangiographic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.00, 0.99, 0.01;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, 75_to_90pc) 0.00, 0.99, 0.01;
  (Sarcoidosis, 75_to_90pc) 0.00, 0.99, 0.01;
  (SHML, 75_to_90pc) 0.00, 0.99, 0.01;
  (Sinus_histiocytosis, 75_to_90pc) 0.00, 0.99, 0.01;
  (Syphilis, 75_to_90pc) 0.00, 0.99, 0.01;
  (Toxoplasmosis, 75_to_90pc) 0.00, 0.99, 0.01;
  (Tuberculosis, 75_to_90pc) 0.00, 0.99, 0.01;
  (Viral_NOS, 75_to_90pc) 0.00, 0.99, 0.01;
  (Whipple_s_disease, 75_to_90pc) 0.00, 0.99, 0.01;
  (L_H_nodular_HD, 75_to_90pc) 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Cellular_phase_NSHD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Interfollicular_HD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Reticular_type_HD, 75_to_90pc) 0.00, 0.99, 0.01;
  (Small_cleaved_fol, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mixed_fol, 75_to_90pc) 0.00, 0.99, 0.01;
  (Large_cell_fol, 75_to_90pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_fol, 75_to_90pc) 0.00, 0.99, 0.01;
  (Small_lymphocytic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.00, 0.99, 0.01;
  (Small_cleaved_dif, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, 75_to_90pc) 0.00, 0.99, 0.01;
  (Large_cell_dif, 75_to_90pc) 0.00, 0.99, 0.01;
  (B_immunoblastic, 75_to_90pc) 0.00, 0.99, 0.01;
  (T_immunob_mixed, 75_to_90pc) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.00, 0.99, 0.01;
  (Japanese_ATL, 75_to_90pc) 0.00, 0.99, 0.01;
  (Lymphoblastic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, 75_to_90pc) 0.00, 0.99, 0.01;
  (True_histiocytic, 75_to_90pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.00, 0.99, 0.01;
  (Multiple_myeloma, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mycosis_fungoides, 75_to_90pc) 0.00, 0.99, 0.01;
  (AML, 75_to_90pc) 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, 75_to_90pc) 0.00, 0.99, 0.01;
  (Carcinoma, 75_to_90pc) 0.00, 0.99, 0.01;
  (Melanoma, 75_to_90pc) 0.00, 0.99, 0.01;
  (EM_plasmacytoma, 75_to_90pc) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mast_cell_disease, 75_to_90pc) 0.00, 0.99, 0.01;
  (AIDS_involutionary, 75_to_90pc) 0.0, 0.5, 0.5;
  (T_immunob_large, 75_to_90pc) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, 75_to_90pc) 0.00, 0.99, 0.01;
  (Nasopharyngeal_CA, 75_to_90pc) 0.00, 0.99, 0.01;
  (Seminoma, 75_to_90pc) 0.00, 0.99, 0.01;
  (SLE, 75_to_90pc) 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, 75_to_90pc) 0.00, 0.99, 0.01;
  (LGV, 75_to_90pc) 0.00, 0.99, 0.01;
  (Histoplasmosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (CMV, 75_to_90pc) 0.0, 0.9, 0.1;
  (Brucellosis, 75_to_90pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, 75_to_90pc) 0.00, 0.99, 0.01;
  (AIDS_early, GT_90pc) 0.00, 0.55, 0.45;
  (AILD, GT_90pc) 0.00, 0.99, 0.01;
  (ALIP, GT_90pc) 0.00, 0.99, 0.01;
  (Cat_scratch_disease, GT_90pc) 0.00, 0.99, 0.01;
  (Dermatopathic_laden, GT_90pc) 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, GT_90pc) 0.00, 0.95, 0.05;
  (GLH_hyaline_vascular, GT_90pc) 0.00, 0.99, 0.01;
  (GLH_plasma_cell, GT_90pc) 0.00, 0.99, 0.01;
  (Granulomatous_laden, GT_90pc) 0.00, 0.99, 0.01;
  (Histiocytosis_x, GT_90pc) 0.00, 0.99, 0.01;
  (Infectious_mono, GT_90pc) 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, GT_90pc) 0.00, 0.99, 0.01;
  (Lymphangiographic, GT_90pc) 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, GT_90pc) 0.00, 0.99, 0.01;
  (Necrotizing_Kikuchi, GT_90pc) 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, GT_90pc) 0.00, 0.99, 0.01;
  (Sarcoidosis, GT_90pc) 0.00, 0.99, 0.01;
  (SHML, GT_90pc) 0.00, 0.99, 0.01;
  (Sinus_histiocytosis, GT_90pc) 0.00, 0.99, 0.01;
  (Syphilis, GT_90pc) 0.00, 0.99, 0.01;
  (Toxoplasmosis, GT_90pc) 0.00, 0.99, 0.01;
  (Tuberculosis, GT_90pc) 0.00, 0.99, 0.01;
  (Viral_NOS, GT_90pc) 0.00, 0.99, 0.01;
  (Whipple_s_disease, GT_90pc) 0.00, 0.99, 0.01;
  (L_H_nodular_HD, GT_90pc) 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, GT_90pc) 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, GT_90pc) 0.00, 0.99, 0.01;
  (Cellular_phase_NSHD, GT_90pc) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, GT_90pc) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, GT_90pc) 0.00, 0.99, 0.01;
  (Interfollicular_HD, GT_90pc) 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, GT_90pc) 0.00, 0.99, 0.01;
  (Reticular_type_HD, GT_90pc) 0.00, 0.99, 0.01;
  (Small_cleaved_fol, GT_90pc) 0.00, 0.99, 0.01;
  (Mixed_fol, GT_90pc) 0.00, 0.99, 0.01;
  (Large_cell_fol, GT_90pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_fol, GT_90pc) 0.00, 0.99, 0.01;
  (Small_lymphocytic, GT_90pc) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, GT_90pc) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, GT_90pc) 0.00, 0.99, 0.01;
  (Small_cleaved_dif, GT_90pc) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, GT_90pc) 0.00, 0.99, 0.01;
  (Large_cell_dif, GT_90pc) 0.00, 0.99, 0.01;
  (B_immunoblastic, GT_90pc) 0.00, 0.99, 0.01;
  (T_immunob_mixed, GT_90pc) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, GT_90pc) 0.00, 0.99, 0.01;
  (Japanese_ATL, GT_90pc) 0.00, 0.99, 0.01;
  (Lymphoblastic, GT_90pc) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, GT_90pc) 0.00, 0.99, 0.01;
  (True_histiocytic, GT_90pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.00, 0.99, 0.01;
  (Multiple_myeloma, GT_90pc) 0.00, 0.99, 0.01;
  (Mycosis_fungoides, GT_90pc) 0.00, 0.99, 0.01;
  (AML, GT_90pc) 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, GT_90pc) 0.00, 0.99, 0.01;
  (Carcinoma, GT_90pc) 0.00, 0.99, 0.01;
  (Melanoma, GT_90pc) 0.00, 0.99, 0.01;
  (EM_plasmacytoma, GT_90pc) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, GT_90pc) 0.00, 0.99, 0.01;
  (Mast_cell_disease, GT_90pc) 0.00, 0.99, 0.01;
  (AIDS_involutionary, GT_90pc) 0.0, 0.5, 0.5;
  (T_immunob_large, GT_90pc) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, GT_90pc) 0.00, 0.99, 0.01;
  (Nasopharyngeal_CA, GT_90pc) 0.00, 0.99, 0.01;
  (Seminoma, GT_90pc) 0.00, 0.99, 0.01;
  (SLE, GT_90pc) 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, GT_90pc) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, GT_90pc) 0.00, 0.99, 0.01;
  (LGV, GT_90pc) 0.00, 0.99, 0.01;
  (Histoplasmosis, GT_90pc) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, GT_90pc) 0.0, 0.9, 0.1;
  (CMV, GT_90pc) 0.0, 0.9, 0.1;
  (Brucellosis, GT_90pc) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, GT_90pc) 0.00, 0.99, 0.01;
}
probability ( TAB | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 0.95, 0.05;
  (Nodular_sclerosis_HD) 0.95, 0.05;
  (Cellular_phase_NSHD) 0.95, 0.05;
  (Syncytial_NSHD) 0.95, 0.05;
  (Mixed_cellularity_HD) 0.95, 0.05;
  (Interfollicular_HD) 0.95, 0.05;
  (Diffuse_fibrosis_HD) 0.95, 0.05;
  (Reticular_type_HD) 0.95, 0.05;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 0.2, 0.8;
  (AILD_like_T_cell_lym) 0.2, 0.8;
  (Japanese_ATL) 0.2, 0.8;
  (Lymphoblastic) 0.2, 0.8;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 0.2, 0.8;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 0.2, 0.8;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 0.2, 0.8;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( CT | Fault ) {
  (AIDS_early) 0.775, 0.200, 0.020, 0.005;
  (AILD) 0.775, 0.200, 0.020, 0.005;
  (ALIP) 0.775, 0.200, 0.020, 0.005;
  (Cat_scratch_disease) 0.75, 0.20, 0.04, 0.01;
  (Dermatopathic_laden) 0.775, 0.200, 0.020, 0.005;
  (Florid_follic_hyperp) 0.775, 0.200, 0.020, 0.005;
  (GLH_hyaline_vascular) 0.01, 0.25, 0.65, 0.09;
  (GLH_plasma_cell) 0.775, 0.200, 0.020, 0.005;
  (Granulomatous_laden) 0.01, 0.25, 0.65, 0.09;
  (Histiocytosis_x) 0.775, 0.200, 0.020, 0.005;
  (Infectious_mono) 0.775, 0.200, 0.020, 0.005;
  (Leprosy_lepromatous) 0.20, 0.60, 0.15, 0.05;
  (Lymphangiographic) 0.775, 0.200, 0.020, 0.005;
  (Mantle_zone_hyperpla) 0.775, 0.200, 0.020, 0.005;
  (Necrotizing_Kikuchi) 0.775, 0.200, 0.020, 0.005;
  (Necrotiz_non_Kikuchi) 0.775, 0.200, 0.020, 0.005;
  (Rheumatoid_arthritis) 0.01, 0.25, 0.65, 0.09;
  (Sarcoidosis) 0.01, 0.25, 0.65, 0.09;
  (SHML) 0.01, 0.25, 0.65, 0.09;
  (Sinus_histiocytosis) 0.775, 0.200, 0.020, 0.005;
  (Syphilis) 0.01, 0.25, 0.65, 0.09;
  (Toxoplasmosis) 0.01, 0.25, 0.65, 0.09;
  (Tuberculosis) 0.20, 0.60, 0.15, 0.05;
  (Viral_NOS) 0.775, 0.200, 0.020, 0.005;
  (Whipple_s_disease) 0.775, 0.200, 0.020, 0.005;
  (L_H_nodular_HD) 0.70, 0.20, 0.09, 0.01;
  (L_H_diffuse_HD) 0.70, 0.20, 0.09, 0.01;
  (Nodular_sclerosis_HD) 0.01, 0.10, 0.40, 0.49;
  (Cellular_phase_NSHD) 0.01, 0.30, 0.40, 0.29;
  (Syncytial_NSHD) 0.01, 0.20, 0.39, 0.40;
  (Mixed_cellularity_HD) 0.70, 0.20, 0.09, 0.01;
  (Interfollicular_HD) 0.70, 0.20, 0.09, 0.01;
  (Diffuse_fibrosis_HD) 0.70, 0.20, 0.09, 0.01;
  (Reticular_type_HD) 0.70, 0.20, 0.09, 0.01;
  (Small_cleaved_fol) 0.775, 0.200, 0.020, 0.005;
  (Mixed_fol) 0.775, 0.200, 0.020, 0.005;
  (Large_cell_fol) 0.775, 0.200, 0.020, 0.005;
  (Small_noncleaved_fol) 0.775, 0.200, 0.020, 0.005;
  (Small_lymphocytic) 0.775, 0.200, 0.020, 0.005;
  (Plasmacytoid_lyctic) 0.775, 0.200, 0.020, 0.005;
  (Mantle_zone_lymphoma) 0.775, 0.200, 0.020, 0.005;
  (Small_cleaved_dif) 0.775, 0.200, 0.020, 0.005;
  (Mixed_FCC_dif) 0.775, 0.200, 0.020, 0.005;
  (Large_cell_dif) 0.775, 0.200, 0.020, 0.005;
  (B_immunoblastic) 0.775, 0.200, 0.020, 0.005;
  (T_immunob_mixed) 0.775, 0.200, 0.020, 0.005;
  (AILD_like_T_cell_lym) 0.775, 0.200, 0.020, 0.005;
  (Japanese_ATL) 0.775, 0.200, 0.020, 0.005;
  (Lymphoblastic) 0.775, 0.200, 0.020, 0.005;
  (Small_noncleaved_dif) 0.775, 0.200, 0.020, 0.005;
  (True_histiocytic) 0.775, 0.200, 0.020, 0.005;
  (Ki_1_LC_anaplas_T) 0.775, 0.200, 0.020, 0.005;
  (Multiple_myeloma) 0.775, 0.200, 0.020, 0.005;
  (Mycosis_fungoides) 0.775, 0.200, 0.020, 0.005;
  (AML) 0.775, 0.200, 0.020, 0.005;
  (Hairy_cell_leukemia) 0.775, 0.200, 0.020, 0.005;
  (Carcinoma) 0.775, 0.200, 0.020, 0.005;
  (Melanoma) 0.775, 0.200, 0.020, 0.005;
  (EM_plasmacytoma) 0.775, 0.200, 0.020, 0.005;
  (Kaposi_s_sarcoma) 0.55, 0.20, 0.15, 0.10;
  (Mast_cell_disease) 0.70, 0.20, 0.09, 0.01;
  (AIDS_involutionary) 0.775, 0.200, 0.020, 0.005;
  (T_immunob_large) 0.775, 0.200, 0.020, 0.005;
  (Monocytoid_B_cell) 0.750, 0.230, 0.017, 0.003;
  (Nasopharyngeal_CA) 0.01, 0.10, 0.40, 0.49;
  (Seminoma) 0.775, 0.200, 0.020, 0.005;
  (SLE) 0.775, 0.200, 0.020, 0.005;
  (Mycobact_histiocytos) 0.775, 0.200, 0.020, 0.005;
  (Mast_cell_hyperplas) 0.64, 0.30, 0.05, 0.01;
  (LGV) 0.75, 0.20, 0.04, 0.01;
  (Histoplasmosis) 0.775, 0.200, 0.020, 0.005;
  (Coccidioidomycosis) 0.775, 0.200, 0.020, 0.005;
  (CMV) 0.775, 0.200, 0.020, 0.005;
  (Brucellosis) 0.01, 0.25, 0.65, 0.09;
  (Ki_1_LC_anaplas_B) 0.775, 0.200, 0.020, 0.005;
  (Intermed_lymphocytic) 0.775, 0.200, 0.020, 0.005;
}
probability ( GENE_IG | Fault ) {
  (AIDS_early) 0.99, 0.01;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 0.55, 0.45;
  (L_H_diffuse_HD) 0.9, 0.1;
  (Nodular_sclerosis_HD) 0.9, 0.1;
  (Cellular_phase_NSHD) 0.9, 0.1;
  (Syncytial_NSHD) 0.9, 0.1;
  (Mixed_cellularity_HD) 0.9, 0.1;
  (Interfollicular_HD) 0.9, 0.1;
  (Diffuse_fibrosis_HD) 0.9, 0.1;
  (Reticular_type_HD) 0.9, 0.1;
  (Small_cleaved_fol) 0.001, 0.999;
  (Mixed_fol) 0.001, 0.999;
  (Large_cell_fol) 0.001, 0.999;
  (Small_noncleaved_fol) 0.001, 0.999;
  (Small_lymphocytic) 0.001, 0.999;
  (Plasmacytoid_lyctic) 0.001, 0.999;
  (Mantle_zone_lymphoma) 0.001, 0.999;
  (Small_cleaved_dif) 0.001, 0.999;
  (Mixed_FCC_dif) 0.001, 0.999;
  (Large_cell_dif) 0.001, 0.999;
  (B_immunoblastic) 0.001, 0.999;
  (T_immunob_mixed) 0.999, 0.001;
  (AILD_like_T_cell_lym) 0.999, 0.001;
  (Japanese_ATL) 0.999, 0.001;
  (Lymphoblastic) 0.999, 0.001;
  (Small_noncleaved_dif) 0.001, 0.999;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 0.999, 0.001;
  (Multiple_myeloma) 0.001, 0.999;
  (Mycosis_fungoides) 0.999, 0.001;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 0.001, 0.999;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 0.99, 0.01;
  (T_immunob_large) 0.999, 0.001;
  (Monocytoid_B_cell) 0.001, 0.999;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 0.001, 0.999;
  (Intermed_lymphocytic) 0.001, 0.999;
}
probability ( HIV_ST | Fault ) {
  (AIDS_early) 0.00, 0.03, 0.97;
  (AILD) 0.9989, 0.0010, 0.0001;
  (ALIP) 0.9989, 0.0010, 0.0001;
  (Cat_scratch_disease) 0.9989, 0.0010, 0.0001;
  (Dermatopathic_laden) 0.9989, 0.0010, 0.0001;
  (Florid_follic_hyperp) 0.9989, 0.0010, 0.0001;
  (GLH_hyaline_vascular) 0.975, 0.005, 0.020;
  (GLH_plasma_cell) 0.975, 0.005, 0.020;
  (Granulomatous_laden) 0.9989, 0.0010, 0.0001;
  (Histiocytosis_x) 0.9989, 0.0010, 0.0001;
  (Infectious_mono) 0.9989, 0.0010, 0.0001;
  (Leprosy_lepromatous) 0.9989, 0.0010, 0.0001;
  (Lymphangiographic) 0.9989, 0.0010, 0.0001;
  (Mantle_zone_hyperpla) 0.9989, 0.0010, 0.0001;
  (Necrotizing_Kikuchi) 0.9989, 0.0010, 0.0001;
  (Necrotiz_non_Kikuchi) 0.9989, 0.0010, 0.0001;
  (Rheumatoid_arthritis) 0.9989, 0.0010, 0.0001;
  (Sarcoidosis) 0.9989, 0.0010, 0.0001;
  (SHML) 0.9989, 0.0010, 0.0001;
  (Sinus_histiocytosis) 0.9989, 0.0010, 0.0001;
  (Syphilis) 0.65, 0.05, 0.30;
  (Toxoplasmosis) 0.75, 0.05, 0.20;
  (Tuberculosis) 0.4, 0.1, 0.5;
  (Viral_NOS) 0.9989, 0.0010, 0.0001;
  (Whipple_s_disease) 0.9989, 0.0010, 0.0001;
  (L_H_nodular_HD) 0.93, 0.05, 0.02;
  (L_H_diffuse_HD) 0.93, 0.05, 0.02;
  (Nodular_sclerosis_HD) 0.93, 0.05, 0.02;
  (Cellular_phase_NSHD) 0.93, 0.05, 0.02;
  (Syncytial_NSHD) 0.93, 0.05, 0.02;
  (Mixed_cellularity_HD) 0.93, 0.05, 0.02;
  (Interfollicular_HD) 0.93, 0.05, 0.02;
  (Diffuse_fibrosis_HD) 0.93, 0.05, 0.02;
  (Reticular_type_HD) 0.93, 0.05, 0.02;
  (Small_cleaved_fol) 0.9875, 0.0025, 0.0100;
  (Mixed_fol) 0.9875, 0.0025, 0.0100;
  (Large_cell_fol) 0.9875, 0.0025, 0.0100;
  (Small_noncleaved_fol) 0.9875, 0.0025, 0.0100;
  (Small_lymphocytic) 0.975, 0.005, 0.020;
  (Plasmacytoid_lyctic) 0.975, 0.005, 0.020;
  (Mantle_zone_lymphoma) 0.9875, 0.0025, 0.0100;
  (Small_cleaved_dif) 0.975, 0.005, 0.020;
  (Mixed_FCC_dif) 0.975, 0.005, 0.020;
  (Large_cell_dif) 0.78, 0.02, 0.20;
  (B_immunoblastic) 0.78, 0.02, 0.20;
  (T_immunob_mixed) 0.975, 0.005, 0.020;
  (AILD_like_T_cell_lym) 0.975, 0.005, 0.020;
  (Japanese_ATL) 0.975, 0.005, 0.020;
  (Lymphoblastic) 0.975, 0.005, 0.020;
  (Small_noncleaved_dif) 0.78, 0.02, 0.20;
  (True_histiocytic) 0.975, 0.005, 0.020;
  (Ki_1_LC_anaplas_T) 0.975, 0.005, 0.020;
  (Multiple_myeloma) 0.9989, 0.0010, 0.0001;
  (Mycosis_fungoides) 0.9989, 0.0010, 0.0001;
  (AML) 0.9989, 0.0010, 0.0001;
  (Hairy_cell_leukemia) 0.9989, 0.0010, 0.0001;
  (Carcinoma) 0.9989, 0.0010, 0.0001;
  (Melanoma) 0.9989, 0.0010, 0.0001;
  (EM_plasmacytoma) 0.9989, 0.0010, 0.0001;
  (Kaposi_s_sarcoma) 0.15, 0.20, 0.65;
  (Mast_cell_disease) 0.9989, 0.0010, 0.0001;
  (AIDS_involutionary) 0.00, 0.03, 0.97;
  (T_immunob_large) 0.975, 0.005, 0.020;
  (Monocytoid_B_cell) 0.975, 0.005, 0.020;
  (Nasopharyngeal_CA) 0.9989, 0.0010, 0.0001;
  (Seminoma) 0.9989, 0.0010, 0.0001;
  (SLE) 0.9989, 0.0010, 0.0001;
  (Mycobact_histiocytos) 0.01, 0.04, 0.95;
  (Mast_cell_hyperplas) 0.9989, 0.0010, 0.0001;
  (LGV) 0.65, 0.05, 0.30;
  (Histoplasmosis) 0.5, 0.2, 0.3;
  (Coccidioidomycosis) 0.5, 0.2, 0.3;
  (CMV) 0.5, 0.2, 0.3;
  (Brucellosis) 0.9989, 0.0010, 0.0001;
  (Ki_1_LC_anaplas_B) 0.975, 0.005, 0.020;
  (Intermed_lymphocytic) 0.9875, 0.0025, 0.0100;
}
probability ( MLC_LLC | Fault, LLC, MLC ) {
  (AIDS_early, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (AILD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (ALIP, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Cat_scratch_disease, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Dermatopathic_laden, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (GLH_plasma_cell, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Granulomatous_laden, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Histiocytosis_x, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Infectious_mono, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Lymphangiographic, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Sarcoidosis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (SHML, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Syphilis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Toxoplasmosis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Tuberculosis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Viral_NOS, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Whipple_s_disease, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (L_H_nodular_HD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Syncytial_NSHD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Interfollicular_HD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Reticular_type_HD, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Small_cleaved_fol, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mixed_fol, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Large_cell_fol, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Small_lymphocytic, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Small_cleaved_dif, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Large_cell_dif, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (B_immunoblastic, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (T_immunob_mixed, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Japanese_ATL, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Lymphoblastic, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (True_histiocytic, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Multiple_myeloma, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mycosis_fungoides, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (AML, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Carcinoma, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Melanoma, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (EM_plasmacytoma, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mast_cell_disease, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (AIDS_involutionary, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (T_immunob_large, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Seminoma, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (SLE, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (LGV, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Histoplasmosis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Coccidioidomycosis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (CMV, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Brucellosis, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc, Absent_0pc) 1.0, 0.0;
  (AIDS_early, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (AILD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (ALIP, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Cat_scratch_disease, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Dermatopathic_laden, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Florid_follic_hyperp, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (GLH_plasma_cell, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Granulomatous_laden, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Histiocytosis_x, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Infectious_mono, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Leprosy_lepromatous, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Lymphangiographic, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Sarcoidosis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (SHML, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Sinus_histiocytosis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Syphilis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Toxoplasmosis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Tuberculosis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Viral_NOS, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Whipple_s_disease, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (L_H_nodular_HD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (L_H_diffuse_HD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Syncytial_NSHD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Interfollicular_HD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Reticular_type_HD, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Small_cleaved_fol, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mixed_fol, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Large_cell_fol, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Small_noncleaved_fol, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Small_lymphocytic, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Small_cleaved_dif, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mixed_FCC_dif, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Large_cell_dif, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (B_immunoblastic, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (T_immunob_mixed, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Japanese_ATL, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Lymphoblastic, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Small_noncleaved_dif, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (True_histiocytic, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Multiple_myeloma, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mycosis_fungoides, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (AML, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Hairy_cell_leukemia, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Carcinoma, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Melanoma, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (EM_plasmacytoma, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mast_cell_disease, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (AIDS_involutionary, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (T_immunob_large, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Monocytoid_B_cell, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Seminoma, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (SLE, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mycobact_histiocytos, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (LGV, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Histoplasmosis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Coccidioidomycosis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (CMV, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Brucellosis, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (Intermed_lymphocytic, Sparse_LT_10pc, Absent_0pc) 1.0, 0.0;
  (AIDS_early, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (AILD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (ALIP, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Cat_scratch_disease, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Dermatopathic_laden, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Florid_follic_hyperp, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (GLH_plasma_cell, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Granulomatous_laden, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Histiocytosis_x, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Infectious_mono, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Leprosy_lepromatous, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Lymphangiographic, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Sarcoidosis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (SHML, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Syphilis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Toxoplasmosis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Tuberculosis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Viral_NOS, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Whipple_s_disease, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (L_H_nodular_HD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Syncytial_NSHD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Interfollicular_HD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Reticular_type_HD, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Small_cleaved_fol, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mixed_fol, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Large_cell_fol, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Small_noncleaved_fol, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Small_lymphocytic, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Small_cleaved_dif, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Large_cell_dif, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (B_immunoblastic, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (T_immunob_mixed, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Japanese_ATL, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Lymphoblastic, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Small_noncleaved_dif, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (True_histiocytic, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Multiple_myeloma, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mycosis_fungoides, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (AML, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Hairy_cell_leukemia, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Carcinoma, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Melanoma, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (EM_plasmacytoma, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mast_cell_disease, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (AIDS_involutionary, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (T_immunob_large, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Monocytoid_B_cell, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Seminoma, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (SLE, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mycobact_histiocytos, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (LGV, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Histoplasmosis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Coccidioidomycosis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (CMV, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Brucellosis, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc, Absent_0pc) 1.0, 0.0;
  (AIDS_early, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (AILD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (ALIP, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Cat_scratch_disease, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Dermatopathic_laden, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Florid_follic_hyperp, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (GLH_plasma_cell, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Granulomatous_laden, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Histiocytosis_x, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Infectious_mono, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Lymphangiographic, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Sarcoidosis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (SHML, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Syphilis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Toxoplasmosis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Tuberculosis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Viral_NOS, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Whipple_s_disease, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (L_H_nodular_HD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Syncytial_NSHD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Interfollicular_HD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Reticular_type_HD, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Small_cleaved_fol, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mixed_fol, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Large_cell_fol, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Small_lymphocytic, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Small_cleaved_dif, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Large_cell_dif, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (B_immunoblastic, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (T_immunob_mixed, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Japanese_ATL, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Lymphoblastic, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Small_noncleaved_dif, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (True_histiocytic, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Multiple_myeloma, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mycosis_fungoides, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (AML, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Carcinoma, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Melanoma, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (EM_plasmacytoma, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mast_cell_disease, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (AIDS_involutionary, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (T_immunob_large, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Seminoma, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (SLE, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (LGV, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Histoplasmosis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Coccidioidomycosis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (CMV, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Brucellosis, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc, Absent_0pc) 0.0, 1.0;
  (AIDS_early, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (AILD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (ALIP, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Cat_scratch_disease, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Dermatopathic_laden, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Florid_follic_hyperp, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (GLH_plasma_cell, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Granulomatous_laden, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Histiocytosis_x, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Infectious_mono, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Leprosy_lepromatous, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Lymphangiographic, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Sarcoidosis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (SHML, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Sinus_histiocytosis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Syphilis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Toxoplasmosis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Tuberculosis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Viral_NOS, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Whipple_s_disease, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (L_H_nodular_HD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (L_H_diffuse_HD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Syncytial_NSHD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Interfollicular_HD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Reticular_type_HD, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Small_cleaved_fol, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mixed_fol, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Large_cell_fol, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Small_noncleaved_fol, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Small_lymphocytic, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Small_cleaved_dif, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mixed_FCC_dif, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Large_cell_dif, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (B_immunoblastic, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (T_immunob_mixed, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Japanese_ATL, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Lymphoblastic, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Small_noncleaved_dif, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (True_histiocytic, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Multiple_myeloma, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mycosis_fungoides, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (AML, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Carcinoma, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Melanoma, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (EM_plasmacytoma, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mast_cell_disease, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (AIDS_involutionary, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (T_immunob_large, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Monocytoid_B_cell, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Seminoma, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (SLE, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mycobact_histiocytos, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (LGV, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Histoplasmosis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Coccidioidomycosis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (CMV, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Brucellosis, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (Intermed_lymphocytic, Striking_GT_90pc, Absent_0pc) 0.0, 1.0;
  (AIDS_early, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (AILD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (ALIP, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Cat_scratch_disease, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Dermatopathic_laden, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (GLH_plasma_cell, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Granulomatous_laden, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Histiocytosis_x, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Infectious_mono, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Lymphangiographic, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Sarcoidosis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (SHML, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Syphilis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Toxoplasmosis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Tuberculosis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Viral_NOS, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Whipple_s_disease, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (L_H_nodular_HD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Syncytial_NSHD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Interfollicular_HD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Reticular_type_HD, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_cleaved_fol, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_fol, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Large_cell_fol, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_lymphocytic, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_cleaved_dif, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Large_cell_dif, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (B_immunoblastic, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (T_immunob_mixed, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Japanese_ATL, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Lymphoblastic, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (True_histiocytic, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Multiple_myeloma, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mycosis_fungoides, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (AML, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Carcinoma, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Melanoma, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (EM_plasmacytoma, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mast_cell_disease, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (AIDS_involutionary, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (T_immunob_large, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Seminoma, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (SLE, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (LGV, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Histoplasmosis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Coccidioidomycosis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (CMV, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Brucellosis, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc, Sparse_LT_10pc) 1.0, 0.0;
  (AIDS_early, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (AILD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (ALIP, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Cat_scratch_disease, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Dermatopathic_laden, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Florid_follic_hyperp, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (GLH_plasma_cell, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Granulomatous_laden, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Histiocytosis_x, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Infectious_mono, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Leprosy_lepromatous, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Lymphangiographic, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Sarcoidosis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (SHML, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Sinus_histiocytosis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Syphilis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Toxoplasmosis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Tuberculosis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Viral_NOS, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Whipple_s_disease, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (L_H_nodular_HD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (L_H_diffuse_HD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Syncytial_NSHD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Interfollicular_HD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Reticular_type_HD, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_cleaved_fol, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_fol, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Large_cell_fol, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_noncleaved_fol, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_lymphocytic, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_cleaved_dif, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_FCC_dif, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Large_cell_dif, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (B_immunoblastic, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (T_immunob_mixed, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Japanese_ATL, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Lymphoblastic, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_noncleaved_dif, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (True_histiocytic, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Multiple_myeloma, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mycosis_fungoides, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (AML, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Hairy_cell_leukemia, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Carcinoma, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Melanoma, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (EM_plasmacytoma, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mast_cell_disease, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (AIDS_involutionary, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (T_immunob_large, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Monocytoid_B_cell, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Seminoma, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (SLE, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mycobact_histiocytos, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (LGV, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Histoplasmosis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Coccidioidomycosis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (CMV, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Brucellosis, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (Intermed_lymphocytic, Sparse_LT_10pc, Sparse_LT_10pc) 1.0, 0.0;
  (AIDS_early, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (AILD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (ALIP, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Cat_scratch_disease, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Dermatopathic_laden, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Florid_follic_hyperp, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (GLH_plasma_cell, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Granulomatous_laden, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Histiocytosis_x, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Infectious_mono, Moderate_11_to_50pc, Sparse_LT_10pc) 0.98, 0.02;
  (Leprosy_lepromatous, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Lymphangiographic, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Sarcoidosis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (SHML, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Syphilis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Toxoplasmosis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Tuberculosis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Viral_NOS, Moderate_11_to_50pc, Sparse_LT_10pc) 0.999, 0.001;
  (Whipple_s_disease, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (L_H_nodular_HD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Syncytial_NSHD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Interfollicular_HD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Reticular_type_HD, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_cleaved_fol, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_fol, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Large_cell_fol, Moderate_11_to_50pc, Sparse_LT_10pc) 0.7, 0.3;
  (Small_noncleaved_fol, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_lymphocytic, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_cleaved_dif, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Large_cell_dif, Moderate_11_to_50pc, Sparse_LT_10pc) 0.0, 1.0;
  (B_immunoblastic, Moderate_11_to_50pc, Sparse_LT_10pc) 0.0, 1.0;
  (T_immunob_mixed, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc, Sparse_LT_10pc) 0.8, 0.2;
  (Japanese_ATL, Moderate_11_to_50pc, Sparse_LT_10pc) 0.8, 0.2;
  (Lymphoblastic, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Small_noncleaved_dif, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (True_histiocytic, Moderate_11_to_50pc, Sparse_LT_10pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc, Sparse_LT_10pc) 0.0, 1.0;
  (Multiple_myeloma, Moderate_11_to_50pc, Sparse_LT_10pc) 0.75, 0.25;
  (Mycosis_fungoides, Moderate_11_to_50pc, Sparse_LT_10pc) 0.8, 0.2;
  (AML, Moderate_11_to_50pc, Sparse_LT_10pc) 0.99, 0.01;
  (Hairy_cell_leukemia, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Carcinoma, Moderate_11_to_50pc, Sparse_LT_10pc) 0.99, 0.01;
  (Melanoma, Moderate_11_to_50pc, Sparse_LT_10pc) 0.99, 0.01;
  (EM_plasmacytoma, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mast_cell_disease, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (AIDS_involutionary, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (T_immunob_large, Moderate_11_to_50pc, Sparse_LT_10pc) 0.0, 1.0;
  (Monocytoid_B_cell, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Moderate_11_to_50pc, Sparse_LT_10pc) 0.99, 0.01;
  (Seminoma, Moderate_11_to_50pc, Sparse_LT_10pc) 0.99, 0.01;
  (SLE, Moderate_11_to_50pc, Sparse_LT_10pc) 0.98, 0.02;
  (Mycobact_histiocytos, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (LGV, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Histoplasmosis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Coccidioidomycosis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (CMV, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Brucellosis, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc, Sparse_LT_10pc) 0.0, 1.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc, Sparse_LT_10pc) 1.0, 0.0;
  (AIDS_early, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AILD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (ALIP, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Cat_scratch_disease, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Dermatopathic_laden, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Florid_follic_hyperp, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (GLH_plasma_cell, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Granulomatous_laden, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Histiocytosis_x, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Infectious_mono, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Lymphangiographic, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Sarcoidosis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (SHML, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Syphilis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Toxoplasmosis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Tuberculosis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Viral_NOS, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Whipple_s_disease, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (L_H_nodular_HD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Syncytial_NSHD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Interfollicular_HD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Reticular_type_HD, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_cleaved_fol, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mixed_fol, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Large_cell_fol, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_lymphocytic, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_cleaved_dif, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Large_cell_dif, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (B_immunoblastic, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (T_immunob_mixed, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Japanese_ATL, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Lymphoblastic, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_noncleaved_dif, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (True_histiocytic, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Multiple_myeloma, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mycosis_fungoides, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AML, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Carcinoma, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Melanoma, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (EM_plasmacytoma, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mast_cell_disease, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AIDS_involutionary, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (T_immunob_large, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Seminoma, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (SLE, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (LGV, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Histoplasmosis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Coccidioidomycosis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (CMV, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Brucellosis, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AIDS_early, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AILD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (ALIP, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Cat_scratch_disease, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Dermatopathic_laden, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Florid_follic_hyperp, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (GLH_plasma_cell, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Granulomatous_laden, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Histiocytosis_x, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Infectious_mono, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Leprosy_lepromatous, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Lymphangiographic, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Sarcoidosis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (SHML, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Sinus_histiocytosis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Syphilis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Toxoplasmosis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Tuberculosis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Viral_NOS, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Whipple_s_disease, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (L_H_nodular_HD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (L_H_diffuse_HD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Syncytial_NSHD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Interfollicular_HD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Reticular_type_HD, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_cleaved_fol, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mixed_fol, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Large_cell_fol, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_noncleaved_fol, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_lymphocytic, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_cleaved_dif, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mixed_FCC_dif, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Large_cell_dif, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (B_immunoblastic, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (T_immunob_mixed, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Japanese_ATL, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Lymphoblastic, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Small_noncleaved_dif, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (True_histiocytic, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Multiple_myeloma, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mycosis_fungoides, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AML, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Carcinoma, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Melanoma, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (EM_plasmacytoma, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mast_cell_disease, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AIDS_involutionary, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (T_immunob_large, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Monocytoid_B_cell, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Seminoma, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (SLE, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mycobact_histiocytos, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (LGV, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Histoplasmosis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Coccidioidomycosis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (CMV, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Brucellosis, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (Intermed_lymphocytic, Striking_GT_90pc, Sparse_LT_10pc) 0.0, 1.0;
  (AIDS_early, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AILD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (ALIP, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Cat_scratch_disease, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Dermatopathic_laden, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (GLH_plasma_cell, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Granulomatous_laden, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Histiocytosis_x, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Infectious_mono, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Lymphangiographic, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Sarcoidosis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (SHML, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Syphilis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Toxoplasmosis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Tuberculosis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Viral_NOS, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Whipple_s_disease, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (L_H_nodular_HD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Syncytial_NSHD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Interfollicular_HD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Reticular_type_HD, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_cleaved_fol, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_fol, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Large_cell_fol, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_lymphocytic, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_cleaved_dif, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Large_cell_dif, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (B_immunoblastic, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (T_immunob_mixed, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Japanese_ATL, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Lymphoblastic, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (True_histiocytic, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Multiple_myeloma, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mycosis_fungoides, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AML, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Carcinoma, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Melanoma, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (EM_plasmacytoma, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mast_cell_disease, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AIDS_involutionary, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (T_immunob_large, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Seminoma, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (SLE, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (LGV, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Histoplasmosis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Coccidioidomycosis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (CMV, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Brucellosis, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AIDS_early, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AILD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (ALIP, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Cat_scratch_disease, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Dermatopathic_laden, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Florid_follic_hyperp, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (GLH_plasma_cell, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Granulomatous_laden, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Histiocytosis_x, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Infectious_mono, Sparse_LT_10pc, Moderate_11_to_50pc) 0.98, 0.02;
  (Leprosy_lepromatous, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Lymphangiographic, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Sarcoidosis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (SHML, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Sinus_histiocytosis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Syphilis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Toxoplasmosis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Tuberculosis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Viral_NOS, Sparse_LT_10pc, Moderate_11_to_50pc) 0.999, 0.001;
  (Whipple_s_disease, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (L_H_nodular_HD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (L_H_diffuse_HD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Syncytial_NSHD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Interfollicular_HD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Reticular_type_HD, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_cleaved_fol, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_fol, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Large_cell_fol, Sparse_LT_10pc, Moderate_11_to_50pc) 0.95, 0.05;
  (Small_noncleaved_fol, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_lymphocytic, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_cleaved_dif, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_FCC_dif, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Large_cell_dif, Sparse_LT_10pc, Moderate_11_to_50pc) 0.0, 1.0;
  (B_immunoblastic, Sparse_LT_10pc, Moderate_11_to_50pc) 0.0, 1.0;
  (T_immunob_mixed, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Sparse_LT_10pc, Moderate_11_to_50pc) 0.9, 0.1;
  (Japanese_ATL, Sparse_LT_10pc, Moderate_11_to_50pc) 0.92, 0.08;
  (Lymphoblastic, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_noncleaved_dif, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (True_histiocytic, Sparse_LT_10pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Multiple_myeloma, Sparse_LT_10pc, Moderate_11_to_50pc) 0.9, 0.1;
  (Mycosis_fungoides, Sparse_LT_10pc, Moderate_11_to_50pc) 0.9, 0.1;
  (AML, Sparse_LT_10pc, Moderate_11_to_50pc) 0.99, 0.01;
  (Hairy_cell_leukemia, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Carcinoma, Sparse_LT_10pc, Moderate_11_to_50pc) 0.99, 0.01;
  (Melanoma, Sparse_LT_10pc, Moderate_11_to_50pc) 0.99, 0.01;
  (EM_plasmacytoma, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mast_cell_disease, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AIDS_involutionary, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (T_immunob_large, Sparse_LT_10pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Monocytoid_B_cell, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Sparse_LT_10pc, Moderate_11_to_50pc) 0.99, 0.01;
  (Seminoma, Sparse_LT_10pc, Moderate_11_to_50pc) 0.99, 0.01;
  (SLE, Sparse_LT_10pc, Moderate_11_to_50pc) 0.98, 0.02;
  (Mycobact_histiocytos, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (LGV, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Histoplasmosis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Coccidioidomycosis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (CMV, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Brucellosis, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Intermed_lymphocytic, Sparse_LT_10pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AIDS_early, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AILD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (ALIP, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Cat_scratch_disease, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Dermatopathic_laden, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Florid_follic_hyperp, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (GLH_plasma_cell, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Granulomatous_laden, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Histiocytosis_x, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Infectious_mono, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.98, 0.02;
  (Leprosy_lepromatous, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Lymphangiographic, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Rheumatoid_arthritis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Sarcoidosis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (SHML, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Syphilis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Toxoplasmosis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Tuberculosis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Viral_NOS, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.999, 0.001;
  (Whipple_s_disease, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (L_H_nodular_HD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Syncytial_NSHD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Interfollicular_HD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Reticular_type_HD, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_cleaved_fol, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_fol, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Large_cell_fol, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.5, 0.5;
  (Small_noncleaved_fol, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_lymphocytic, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_cleaved_dif, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Large_cell_dif, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.0, 1.0;
  (B_immunoblastic, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.0, 1.0;
  (T_immunob_mixed, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.7, 0.3;
  (Japanese_ATL, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.5, 0.5;
  (Lymphoblastic, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Small_noncleaved_dif, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (True_histiocytic, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Multiple_myeloma, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.7, 0.3;
  (Mycosis_fungoides, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.8, 0.2;
  (AML, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.99, 0.01;
  (Hairy_cell_leukemia, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Carcinoma, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.99, 0.01;
  (Melanoma, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.99, 0.01;
  (EM_plasmacytoma, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mast_cell_disease, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AIDS_involutionary, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (T_immunob_large, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Monocytoid_B_cell, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Nasopharyngeal_CA, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.99, 0.01;
  (Seminoma, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.99, 0.01;
  (SLE, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.98, 0.02;
  (Mycobact_histiocytos, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (LGV, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Histoplasmosis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Coccidioidomycosis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (CMV, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Brucellosis, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc, Moderate_11_to_50pc) 1.0, 0.0;
  (AIDS_early, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AILD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (ALIP, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Cat_scratch_disease, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Dermatopathic_laden, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Florid_follic_hyperp, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (GLH_plasma_cell, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Granulomatous_laden, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Histiocytosis_x, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Infectious_mono, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Lymphangiographic, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Sarcoidosis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (SHML, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Syphilis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Toxoplasmosis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Tuberculosis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Viral_NOS, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Whipple_s_disease, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (L_H_nodular_HD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Syncytial_NSHD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Interfollicular_HD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Reticular_type_HD, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_cleaved_fol, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mixed_fol, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Large_cell_fol, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_lymphocytic, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_cleaved_dif, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Large_cell_dif, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (B_immunoblastic, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (T_immunob_mixed, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Japanese_ATL, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Lymphoblastic, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_noncleaved_dif, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (True_histiocytic, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Multiple_myeloma, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mycosis_fungoides, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AML, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Carcinoma, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Melanoma, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (EM_plasmacytoma, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mast_cell_disease, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AIDS_involutionary, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (T_immunob_large, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Seminoma, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (SLE, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (LGV, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Histoplasmosis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Coccidioidomycosis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (CMV, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Brucellosis, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AIDS_early, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AILD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (ALIP, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Cat_scratch_disease, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Dermatopathic_laden, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Florid_follic_hyperp, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (GLH_plasma_cell, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Granulomatous_laden, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Histiocytosis_x, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Infectious_mono, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Leprosy_lepromatous, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Lymphangiographic, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Sarcoidosis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (SHML, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Sinus_histiocytosis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Syphilis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Toxoplasmosis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Tuberculosis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Viral_NOS, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Whipple_s_disease, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (L_H_nodular_HD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (L_H_diffuse_HD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Syncytial_NSHD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Interfollicular_HD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Reticular_type_HD, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_cleaved_fol, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mixed_fol, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Large_cell_fol, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_noncleaved_fol, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_lymphocytic, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_cleaved_dif, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mixed_FCC_dif, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Large_cell_dif, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (B_immunoblastic, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (T_immunob_mixed, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Japanese_ATL, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Lymphoblastic, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Small_noncleaved_dif, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (True_histiocytic, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Multiple_myeloma, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mycosis_fungoides, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AML, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Carcinoma, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Melanoma, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (EM_plasmacytoma, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mast_cell_disease, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AIDS_involutionary, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (T_immunob_large, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Monocytoid_B_cell, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Seminoma, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (SLE, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mycobact_histiocytos, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (LGV, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Histoplasmosis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Coccidioidomycosis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (CMV, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Brucellosis, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (Intermed_lymphocytic, Striking_GT_90pc, Moderate_11_to_50pc) 0.0, 1.0;
  (AIDS_early, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (ALIP, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Granulomatous_laden, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histiocytosis_x, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Infectious_mono, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphangiographic, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sarcoidosis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SHML, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syphilis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Toxoplasmosis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Tuberculosis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Viral_NOS, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Whipple_s_disease, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Interfollicular_HD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Reticular_type_HD, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_fol, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_fol, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_lymphocytic, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_dif, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (B_immunoblastic, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_mixed, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Japanese_ATL, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphoblastic, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (True_histiocytic, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Multiple_myeloma, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AML, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Carcinoma, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Melanoma, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_disease, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_involutionary, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_large, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Seminoma, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SLE, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (LGV, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histoplasmosis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (CMV, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Brucellosis, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Absent_0pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_early, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (ALIP, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Granulomatous_laden, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histiocytosis_x, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Infectious_mono, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphangiographic, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sarcoidosis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SHML, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syphilis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Toxoplasmosis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Tuberculosis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Viral_NOS, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Whipple_s_disease, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Interfollicular_HD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Reticular_type_HD, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_fol, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_fol, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_lymphocytic, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_dif, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (B_immunoblastic, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_mixed, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Japanese_ATL, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphoblastic, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (True_histiocytic, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Multiple_myeloma, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AML, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Carcinoma, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Melanoma, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_disease, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_involutionary, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_large, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Seminoma, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SLE, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (LGV, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histoplasmosis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (CMV, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Brucellosis, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Sparse_LT_10pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_early, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (ALIP, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Granulomatous_laden, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histiocytosis_x, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Infectious_mono, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphangiographic, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sarcoidosis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SHML, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syphilis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Toxoplasmosis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Tuberculosis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Viral_NOS, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Whipple_s_disease, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Interfollicular_HD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Reticular_type_HD, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_fol, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_fol, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_lymphocytic, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_dif, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (B_immunoblastic, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_mixed, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Japanese_ATL, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphoblastic, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (True_histiocytic, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Multiple_myeloma, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AML, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Carcinoma, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Melanoma, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_disease, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_involutionary, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_large, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Seminoma, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SLE, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (LGV, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histoplasmosis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (CMV, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Brucellosis, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_early, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (ALIP, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Granulomatous_laden, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histiocytosis_x, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Infectious_mono, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphangiographic, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sarcoidosis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SHML, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syphilis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Toxoplasmosis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Tuberculosis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Viral_NOS, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Whipple_s_disease, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Interfollicular_HD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Reticular_type_HD, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_fol, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_fol, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_lymphocytic, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_dif, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (B_immunoblastic, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_mixed, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Japanese_ATL, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphoblastic, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (True_histiocytic, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Multiple_myeloma, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AML, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Carcinoma, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Melanoma, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_disease, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_involutionary, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_large, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Seminoma, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SLE, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (LGV, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histoplasmosis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (CMV, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Brucellosis, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_early, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (ALIP, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Granulomatous_laden, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histiocytosis_x, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Infectious_mono, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphangiographic, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sarcoidosis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SHML, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syphilis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Toxoplasmosis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Tuberculosis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Viral_NOS, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Whipple_s_disease, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Interfollicular_HD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Reticular_type_HD, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_fol, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_fol, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_lymphocytic, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Large_cell_dif, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (B_immunoblastic, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_mixed, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Japanese_ATL, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Lymphoblastic, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (True_histiocytic, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Multiple_myeloma, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AML, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Carcinoma, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Melanoma, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_disease, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_involutionary, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (T_immunob_large, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Seminoma, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (SLE, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (LGV, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Histoplasmosis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (CMV, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Brucellosis, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Striking_GT_90pc, Numerous_51_to_90pc) 0.0, 1.0;
  (AIDS_early, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (ALIP, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Granulomatous_laden, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Histiocytosis_x, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Infectious_mono, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphangiographic, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Sarcoidosis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (SHML, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Syphilis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Toxoplasmosis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Tuberculosis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Viral_NOS, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Whipple_s_disease, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Interfollicular_HD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Reticular_type_HD, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_fol, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_fol, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_lymphocytic, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_dif, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (B_immunoblastic, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_mixed, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Japanese_ATL, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphoblastic, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (True_histiocytic, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Multiple_myeloma, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (AML, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Carcinoma, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Melanoma, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_disease, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_involutionary, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_large, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Seminoma, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (SLE, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (LGV, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Histoplasmosis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (CMV, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Brucellosis, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Absent_0pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_early, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (ALIP, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Granulomatous_laden, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Histiocytosis_x, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Infectious_mono, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphangiographic, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Sarcoidosis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (SHML, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Syphilis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Toxoplasmosis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Tuberculosis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Viral_NOS, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Whipple_s_disease, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Interfollicular_HD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Reticular_type_HD, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_fol, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_fol, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_lymphocytic, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_dif, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (B_immunoblastic, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_mixed, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Japanese_ATL, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphoblastic, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (True_histiocytic, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Multiple_myeloma, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (AML, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Carcinoma, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Melanoma, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_disease, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_involutionary, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_large, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Seminoma, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (SLE, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (LGV, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Histoplasmosis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (CMV, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Brucellosis, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Sparse_LT_10pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_early, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (ALIP, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Granulomatous_laden, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Histiocytosis_x, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Infectious_mono, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphangiographic, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Sarcoidosis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (SHML, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Syphilis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Toxoplasmosis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Tuberculosis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Viral_NOS, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Whipple_s_disease, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Interfollicular_HD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Reticular_type_HD, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_fol, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_fol, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_lymphocytic, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_dif, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (B_immunoblastic, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_mixed, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Japanese_ATL, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphoblastic, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (True_histiocytic, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Multiple_myeloma, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (AML, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Carcinoma, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Melanoma, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_disease, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_involutionary, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_large, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Seminoma, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (SLE, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (LGV, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Histoplasmosis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (CMV, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Brucellosis, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_early, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (ALIP, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Granulomatous_laden, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Histiocytosis_x, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Infectious_mono, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphangiographic, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Sarcoidosis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (SHML, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Syphilis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Toxoplasmosis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Tuberculosis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Viral_NOS, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Whipple_s_disease, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Interfollicular_HD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Reticular_type_HD, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_fol, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_fol, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_lymphocytic, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_dif, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (B_immunoblastic, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_mixed, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Japanese_ATL, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphoblastic, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (True_histiocytic, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Multiple_myeloma, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AML, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Carcinoma, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Melanoma, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_disease, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_involutionary, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_large, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Seminoma, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (SLE, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (LGV, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Histoplasmosis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (CMV, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Brucellosis, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_early, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (ALIP, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Cat_scratch_disease, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Dermatopathic_laden, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Florid_follic_hyperp, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_hyaline_vascular, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (GLH_plasma_cell, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Granulomatous_laden, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Histiocytosis_x, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Infectious_mono, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Leprosy_lepromatous, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphangiographic, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Rheumatoid_arthritis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Sarcoidosis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (SHML, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Sinus_histiocytosis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Syphilis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Toxoplasmosis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Tuberculosis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Viral_NOS, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Whipple_s_disease, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_nodular_HD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (L_H_diffuse_HD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Cellular_phase_NSHD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Syncytial_NSHD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_cellularity_HD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Interfollicular_HD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Reticular_type_HD, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_fol, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_fol, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_fol, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_fol, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_lymphocytic, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_cleaved_dif, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mixed_FCC_dif, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Large_cell_dif, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (B_immunoblastic, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_mixed, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Japanese_ATL, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Lymphoblastic, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Small_noncleaved_dif, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (True_histiocytic, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Multiple_myeloma, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycosis_fungoides, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AML, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Hairy_cell_leukemia, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Carcinoma, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Melanoma, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (EM_plasmacytoma, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_disease, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (AIDS_involutionary, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (T_immunob_large, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Monocytoid_B_cell, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Nasopharyngeal_CA, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Seminoma, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (SLE, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mycobact_histiocytos, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Mast_cell_hyperplas, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (LGV, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Histoplasmosis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Coccidioidomycosis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (CMV, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Brucellosis, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
  (Intermed_lymphocytic, Striking_GT_90pc, Striking_GT_90pc) 0.0, 1.0;
}
probability ( LLC_NI | Fault, LLC_ID ) {
  (AIDS_early, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (AILD, Other) 0.00, 0.03, 0.76, 0.20, 0.01;
  (ALIP, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Cat_scratch_disease, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Dermatopathic_laden, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Florid_follic_hyperp, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (GLH_hyaline_vascular, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (GLH_plasma_cell, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Granulomatous_laden, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Histiocytosis_x, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Infectious_mono, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Leprosy_lepromatous, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Lymphangiographic, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mantle_zone_hyperpla, Other) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Necrotizing_Kikuchi, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Necrotiz_non_Kikuchi, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Rheumatoid_arthritis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Sarcoidosis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (SHML, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Sinus_histiocytosis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Syphilis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Toxoplasmosis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Tuberculosis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Viral_NOS, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Whipple_s_disease, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (L_H_nodular_HD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (L_H_diffuse_HD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Nodular_sclerosis_HD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Cellular_phase_NSHD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Syncytial_NSHD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Mixed_cellularity_HD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Interfollicular_HD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Diffuse_fibrosis_HD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Reticular_type_HD, Other) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Small_cleaved_fol, Other) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Mixed_fol, Other) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Large_cell_fol, Other) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Small_noncleaved_fol, Other) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Small_lymphocytic, Other) 0.00, 0.00, 0.94, 0.05, 0.01;
  (Plasmacytoid_lyctic, Other) 0.00, 0.00, 0.98, 0.01, 0.01;
  (Mantle_zone_lymphoma, Other) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Small_cleaved_dif, Other) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Mixed_FCC_dif, Other) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Large_cell_dif, Other) 0.00, 0.05, 0.03, 0.91, 0.01;
  (B_immunoblastic, Other) 0.00, 0.00, 0.97, 0.02, 0.01;
  (T_immunob_mixed, Other) 0.00, 0.03, 0.76, 0.20, 0.01;
  (AILD_like_T_cell_lym, Other) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Japanese_ATL, Other) 0.00, 0.10, 0.64, 0.25, 0.01;
  (Lymphoblastic, Other) 0.00, 0.97, 0.00, 0.02, 0.01;
  (Small_noncleaved_dif, Other) 0.00, 0.05, 0.03, 0.91, 0.01;
  (True_histiocytic, Other) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Ki_1_LC_anaplas_T, Other) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Multiple_myeloma, Other) 0.00, 0.00, 0.97, 0.02, 0.01;
  (Mycosis_fungoides, Other) 0.00, 0.59, 0.15, 0.25, 0.01;
  (AML, Other) 0.00, 0.01, 0.97, 0.01, 0.01;
  (Hairy_cell_leukemia, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Carcinoma, Other) 0.00, 0.03, 0.91, 0.05, 0.01;
  (Melanoma, Other) 0.00, 0.01, 0.97, 0.01, 0.01;
  (EM_plasmacytoma, Other) 0.00, 0.00, 0.97, 0.02, 0.01;
  (Kaposi_s_sarcoma, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mast_cell_disease, Other) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_involutionary, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (T_immunob_large, Other) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Monocytoid_B_cell, Other) 0.00, 0.44, 0.30, 0.25, 0.01;
  (Nasopharyngeal_CA, Other) 0.00, 0.01, 0.97, 0.01, 0.01;
  (Seminoma, Other) 0.00, 0.01, 0.93, 0.05, 0.01;
  (SLE, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mycobact_histiocytos, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mast_cell_hyperplas, Other) 0.00, 0.30, 0.30, 0.39, 0.01;
  (LGV, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Histoplasmosis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Coccidioidomycosis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (CMV, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Brucellosis, Other) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Ki_1_LC_anaplas_B, Other) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Intermed_lymphocytic, Other) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_early, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (AILD, Large_cleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (ALIP, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Cat_scratch_disease, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Dermatopathic_laden, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Florid_follic_hyperp, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (GLH_hyaline_vascular, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (GLH_plasma_cell, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Granulomatous_laden, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Histiocytosis_x, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Infectious_mono, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Leprosy_lepromatous, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Lymphangiographic, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mantle_zone_hyperpla, Large_cleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Necrotizing_Kikuchi, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Necrotiz_non_Kikuchi, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Rheumatoid_arthritis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Sarcoidosis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (SHML, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Sinus_histiocytosis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Syphilis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Toxoplasmosis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Tuberculosis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Viral_NOS, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Whipple_s_disease, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (L_H_nodular_HD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (L_H_diffuse_HD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Nodular_sclerosis_HD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Cellular_phase_NSHD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Syncytial_NSHD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Mixed_cellularity_HD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Interfollicular_HD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Diffuse_fibrosis_HD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Reticular_type_HD, Large_cleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Small_cleaved_fol, Large_cleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Mixed_fol, Large_cleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Large_cell_fol, Large_cleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Small_noncleaved_fol, Large_cleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Small_lymphocytic, Large_cleaved) 0.00, 0.00, 0.94, 0.05, 0.01;
  (Plasmacytoid_lyctic, Large_cleaved) 0.00, 0.00, 0.98, 0.01, 0.01;
  (Mantle_zone_lymphoma, Large_cleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Small_cleaved_dif, Large_cleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Mixed_FCC_dif, Large_cleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Large_cell_dif, Large_cleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (B_immunoblastic, Large_cleaved) 0.00, 0.00, 0.97, 0.02, 0.01;
  (T_immunob_mixed, Large_cleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (AILD_like_T_cell_lym, Large_cleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Japanese_ATL, Large_cleaved) 0.00, 0.10, 0.64, 0.25, 0.01;
  (Lymphoblastic, Large_cleaved) 0.00, 0.97, 0.00, 0.02, 0.01;
  (Small_noncleaved_dif, Large_cleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (True_histiocytic, Large_cleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Ki_1_LC_anaplas_T, Large_cleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Multiple_myeloma, Large_cleaved) 0.00, 0.00, 0.97, 0.02, 0.01;
  (Mycosis_fungoides, Large_cleaved) 0.00, 0.59, 0.15, 0.25, 0.01;
  (AML, Large_cleaved) 0.00, 0.01, 0.97, 0.01, 0.01;
  (Hairy_cell_leukemia, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Carcinoma, Large_cleaved) 0.00, 0.03, 0.91, 0.05, 0.01;
  (Melanoma, Large_cleaved) 0.00, 0.01, 0.97, 0.01, 0.01;
  (EM_plasmacytoma, Large_cleaved) 0.00, 0.00, 0.97, 0.02, 0.01;
  (Kaposi_s_sarcoma, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mast_cell_disease, Large_cleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_involutionary, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (T_immunob_large, Large_cleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Monocytoid_B_cell, Large_cleaved) 0.00, 0.44, 0.30, 0.25, 0.01;
  (Nasopharyngeal_CA, Large_cleaved) 0.00, 0.01, 0.97, 0.01, 0.01;
  (Seminoma, Large_cleaved) 0.00, 0.01, 0.93, 0.05, 0.01;
  (SLE, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mycobact_histiocytos, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mast_cell_hyperplas, Large_cleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (LGV, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Histoplasmosis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Coccidioidomycosis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (CMV, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Brucellosis, Large_cleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Ki_1_LC_anaplas_B, Large_cleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Intermed_lymphocytic, Large_cleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_early, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (AILD, Large_noncleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (ALIP, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Cat_scratch_disease, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Dermatopathic_laden, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Florid_follic_hyperp, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (GLH_hyaline_vascular, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (GLH_plasma_cell, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Granulomatous_laden, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Histiocytosis_x, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Infectious_mono, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Leprosy_lepromatous, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Lymphangiographic, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mantle_zone_hyperpla, Large_noncleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Necrotizing_Kikuchi, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Necrotiz_non_Kikuchi, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Rheumatoid_arthritis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Sarcoidosis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (SHML, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Sinus_histiocytosis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Syphilis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Toxoplasmosis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Tuberculosis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Viral_NOS, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Whipple_s_disease, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (L_H_nodular_HD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (L_H_diffuse_HD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Nodular_sclerosis_HD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Cellular_phase_NSHD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Syncytial_NSHD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Mixed_cellularity_HD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Interfollicular_HD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Diffuse_fibrosis_HD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Reticular_type_HD, Large_noncleaved) 0.00, 0.10, 0.15, 0.74, 0.01;
  (Small_cleaved_fol, Large_noncleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Mixed_fol, Large_noncleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Large_cell_fol, Large_noncleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Small_noncleaved_fol, Large_noncleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Small_lymphocytic, Large_noncleaved) 0.00, 0.00, 0.94, 0.05, 0.01;
  (Plasmacytoid_lyctic, Large_noncleaved) 0.00, 0.00, 0.98, 0.01, 0.01;
  (Mantle_zone_lymphoma, Large_noncleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (Small_cleaved_dif, Large_noncleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Mixed_FCC_dif, Large_noncleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (Large_cell_dif, Large_noncleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (B_immunoblastic, Large_noncleaved) 0.00, 0.00, 0.97, 0.02, 0.01;
  (T_immunob_mixed, Large_noncleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (AILD_like_T_cell_lym, Large_noncleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Japanese_ATL, Large_noncleaved) 0.00, 0.10, 0.64, 0.25, 0.01;
  (Lymphoblastic, Large_noncleaved) 0.00, 0.97, 0.00, 0.02, 0.01;
  (Small_noncleaved_dif, Large_noncleaved) 0.00, 0.05, 0.03, 0.91, 0.01;
  (True_histiocytic, Large_noncleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Ki_1_LC_anaplas_T, Large_noncleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Multiple_myeloma, Large_noncleaved) 0.00, 0.00, 0.97, 0.02, 0.01;
  (Mycosis_fungoides, Large_noncleaved) 0.00, 0.59, 0.15, 0.25, 0.01;
  (AML, Large_noncleaved) 0.00, 0.01, 0.97, 0.01, 0.01;
  (Hairy_cell_leukemia, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Carcinoma, Large_noncleaved) 0.00, 0.03, 0.91, 0.05, 0.01;
  (Melanoma, Large_noncleaved) 0.00, 0.01, 0.97, 0.01, 0.01;
  (EM_plasmacytoma, Large_noncleaved) 0.00, 0.00, 0.97, 0.02, 0.01;
  (Kaposi_s_sarcoma, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mast_cell_disease, Large_noncleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (AIDS_involutionary, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (T_immunob_large, Large_noncleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Monocytoid_B_cell, Large_noncleaved) 0.00, 0.44, 0.30, 0.25, 0.01;
  (Nasopharyngeal_CA, Large_noncleaved) 0.00, 0.01, 0.97, 0.01, 0.01;
  (Seminoma, Large_noncleaved) 0.00, 0.01, 0.93, 0.05, 0.01;
  (SLE, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mycobact_histiocytos, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Mast_cell_hyperplas, Large_noncleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
  (LGV, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Histoplasmosis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Coccidioidomycosis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (CMV, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Brucellosis, Large_noncleaved) 0.00, 0.05, 0.59, 0.35, 0.01;
  (Ki_1_LC_anaplas_B, Large_noncleaved) 0.00, 0.03, 0.76, 0.20, 0.01;
  (Intermed_lymphocytic, Large_noncleaved) 0.00, 0.30, 0.30, 0.39, 0.01;
}
probability ( SLC_CS | Fault, SLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (ALIP, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cat_scratch_disease, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Dermatopathic_laden, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Florid_follic_hyperp, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_hyaline_vascular, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_plasma_cell, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Granulomatous_laden, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histiocytosis_x, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Infectious_mono, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Leprosy_lepromatous, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphangiographic, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotizing_Kikuchi, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotiz_non_Kikuchi, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Rheumatoid_arthritis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sarcoidosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SHML, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sinus_histiocytosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syphilis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Toxoplasmosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Tuberculosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Viral_NOS, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Whipple_s_disease, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_nodular_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_diffuse_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Nodular_sclerosis_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syncytial_NSHD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_cellularity_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Interfollicular_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Reticular_type_HD, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_fol, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_fol, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Large_cell_fol, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_noncleaved_fol, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_lymphocytic, Sparse_1_to_10pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Plasmacytoid_lyctic, Sparse_1_to_10pc) 0.00, 0.69, 0.01, 0.00, 0.30;
  (Mantle_zone_lymphoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_dif, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_FCC_dif, Sparse_1_to_10pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Large_cell_dif, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (B_immunoblastic, Sparse_1_to_10pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (T_immunob_mixed, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD_like_T_cell_lym, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Japanese_ATL, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphoblastic, Sparse_1_to_10pc) 0.00, 0.79, 0.01, 0.20, 0.00;
  (Small_noncleaved_dif, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (True_histiocytic, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Multiple_myeloma, Sparse_1_to_10pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Mycosis_fungoides, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AML, Sparse_1_to_10pc) 0.00, 0.90, 0.01, 0.09, 0.00;
  (Hairy_cell_leukemia, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Sparse_1_to_10pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Kaposi_s_sarcoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_disease, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AIDS_involutionary, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (T_immunob_large, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Monocytoid_B_cell, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.00, 0.02;
  (Nasopharyngeal_CA, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mycobact_histiocytos, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_hyperplas, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (LGV, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histoplasmosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Coccidioidomycosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (CMV, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Brucellosis, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_B, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Intermed_lymphocytic, Sparse_1_to_10pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AIDS_early, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (ALIP, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Infectious_mono, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphangiographic, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sarcoidosis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SHML, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syphilis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Tuberculosis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Viral_NOS, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_fol, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Large_cell_fol, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.00, 0.69, 0.01, 0.00, 0.30;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Large_cell_dif, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (B_immunoblastic, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Japanese_ATL, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphoblastic, Moderate_11_to_50pc) 0.00, 0.79, 0.01, 0.20, 0.00;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (True_histiocytic, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AML, Moderate_11_to_50pc) 0.00, 0.90, 0.01, 0.09, 0.00;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (T_immunob_large, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.00, 0.97, 0.01, 0.00, 0.02;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (LGV, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histoplasmosis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (CMV, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Brucellosis, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AIDS_early, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (ALIP, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Infectious_mono, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphangiographic, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sarcoidosis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SHML, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syphilis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Tuberculosis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Viral_NOS, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_fol, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Large_cell_fol, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.00, 0.69, 0.01, 0.00, 0.30;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Large_cell_dif, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (B_immunoblastic, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Japanese_ATL, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphoblastic, Numerous_51_to_90pc) 0.00, 0.79, 0.01, 0.20, 0.00;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (True_histiocytic, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AML, Numerous_51_to_90pc) 0.00, 0.90, 0.01, 0.09, 0.00;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (T_immunob_large, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.00, 0.97, 0.01, 0.00, 0.02;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (LGV, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histoplasmosis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (CMV, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Brucellosis, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AIDS_early, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (ALIP, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cat_scratch_disease, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Dermatopathic_laden, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_plasma_cell, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Granulomatous_laden, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histiocytosis_x, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Infectious_mono, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphangiographic, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sarcoidosis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SHML, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syphilis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Toxoplasmosis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Tuberculosis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Viral_NOS, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Whipple_s_disease, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_nodular_HD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syncytial_NSHD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Interfollicular_HD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Reticular_type_HD, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_fol, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_fol, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Large_cell_fol, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_lymphocytic, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.00, 0.69, 0.01, 0.00, 0.30;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_dif, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Large_cell_dif, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (B_immunoblastic, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (T_immunob_mixed, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Japanese_ATL, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphoblastic, Striking_GT_90pc) 0.00, 0.79, 0.01, 0.20, 0.00;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (True_histiocytic, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Multiple_myeloma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Mycosis_fungoides, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AML, Striking_GT_90pc) 0.00, 0.90, 0.01, 0.09, 0.00;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.00, 0.01;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_disease, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AIDS_involutionary, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (T_immunob_large, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.00, 0.97, 0.01, 0.00, 0.02;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (LGV, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histoplasmosis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Coccidioidomycosis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (CMV, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Brucellosis, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.00, 0.99, 0.01, 0.00, 0.00;
}
probability ( LLC_ID | Fault, LLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (AILD, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (ALIP, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Cat_scratch_disease, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Dermatopathic_laden, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Florid_follic_hyperp, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (GLH_hyaline_vascular, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (GLH_plasma_cell, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Granulomatous_laden, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Histiocytosis_x, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Infectious_mono, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Leprosy_lepromatous, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Lymphangiographic, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Mantle_zone_hyperpla, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Necrotizing_Kikuchi, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Rheumatoid_arthritis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Sarcoidosis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (SHML, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Sinus_histiocytosis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Syphilis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Toxoplasmosis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Tuberculosis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Viral_NOS, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Whipple_s_disease, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (L_H_nodular_HD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (L_H_diffuse_HD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (Nodular_sclerosis_HD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (Cellular_phase_NSHD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (Syncytial_NSHD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (Mixed_cellularity_HD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (Interfollicular_HD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (Reticular_type_HD, Sparse_LT_10pc) 0.0, 0.7, 0.1, 0.2;
  (Small_cleaved_fol, Sparse_LT_10pc) 0.00, 0.01, 0.05, 0.94;
  (Mixed_fol, Sparse_LT_10pc) 0.00, 0.01, 0.15, 0.84;
  (Large_cell_fol, Sparse_LT_10pc) 0.00, 0.01, 0.05, 0.94;
  (Small_noncleaved_fol, Sparse_LT_10pc) 0.00, 0.01, 0.05, 0.94;
  (Small_lymphocytic, Sparse_LT_10pc) 0.00, 0.89, 0.01, 0.10;
  (Plasmacytoid_lyctic, Sparse_LT_10pc) 0.00, 0.89, 0.01, 0.10;
  (Mantle_zone_lymphoma, Sparse_LT_10pc) 0.00, 0.01, 0.05, 0.94;
  (Small_cleaved_dif, Sparse_LT_10pc) 0.00, 0.01, 0.05, 0.94;
  (Mixed_FCC_dif, Sparse_LT_10pc) 0.00, 0.01, 0.15, 0.84;
  (Large_cell_dif, Sparse_LT_10pc) 0.25, 0.25, 0.25, 0.25;
  (B_immunoblastic, Sparse_LT_10pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_mixed, Sparse_LT_10pc) 0.00, 0.91, 0.02, 0.07;
  (AILD_like_T_cell_lym, Sparse_LT_10pc) 0.00, 0.69, 0.01, 0.30;
  (Japanese_ATL, Sparse_LT_10pc) 0.00, 0.97, 0.01, 0.02;
  (Lymphoblastic, Sparse_LT_10pc) 0.00, 0.84, 0.15, 0.01;
  (Small_noncleaved_dif, Sparse_LT_10pc) 0.00, 0.01, 0.05, 0.94;
  (True_histiocytic, Sparse_LT_10pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc) 0.25, 0.25, 0.25, 0.25;
  (Multiple_myeloma, Sparse_LT_10pc) 0.25, 0.25, 0.25, 0.25;
  (Mycosis_fungoides, Sparse_LT_10pc) 0.00, 0.64, 0.35, 0.01;
  (AML, Sparse_LT_10pc) 0.00, 0.67, 0.03, 0.30;
  (Hairy_cell_leukemia, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Carcinoma, Sparse_LT_10pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Sparse_LT_10pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Sparse_LT_10pc) 0.0, 0.9, 0.0, 0.1;
  (Kaposi_s_sarcoma, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Mast_cell_disease, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (AIDS_involutionary, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (T_immunob_large, Sparse_LT_10pc) 0.25, 0.25, 0.25, 0.25;
  (Monocytoid_B_cell, Sparse_LT_10pc) 0.00, 0.39, 0.01, 0.60;
  (Nasopharyngeal_CA, Sparse_LT_10pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Sparse_LT_10pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Mycobact_histiocytos, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Mast_cell_hyperplas, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (LGV, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Histoplasmosis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Coccidioidomycosis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (CMV, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Brucellosis, Sparse_LT_10pc) 0.00, 0.50, 0.05, 0.45;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc) 0.25, 0.25, 0.25, 0.25;
  (Intermed_lymphocytic, Sparse_LT_10pc) 0.00, 0.01, 0.05, 0.94;
  (AIDS_early, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (AILD, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (ALIP, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Infectious_mono, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Lymphangiographic, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Sarcoidosis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (SHML, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Syphilis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Tuberculosis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Viral_NOS, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.0, 0.7, 0.1, 0.2;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Moderate_11_to_50pc) 0.00, 0.01, 0.15, 0.84;
  (Large_cell_fol, Moderate_11_to_50pc) 0.00, 0.01, 0.05, 0.94;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.00, 0.02, 0.05, 0.93;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.00, 0.90, 0.01, 0.09;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.00, 0.90, 0.01, 0.09;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.00, 0.01, 0.15, 0.84;
  (Large_cell_dif, Moderate_11_to_50pc) 0.00, 0.05, 0.05, 0.90;
  (B_immunoblastic, Moderate_11_to_50pc) 0.00, 0.97, 0.00, 0.03;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.00, 0.91, 0.02, 0.07;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.00, 0.69, 0.01, 0.30;
  (Japanese_ATL, Moderate_11_to_50pc) 0.00, 0.97, 0.01, 0.02;
  (Lymphoblastic, Moderate_11_to_50pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.00, 0.02, 0.05, 0.93;
  (True_histiocytic, Moderate_11_to_50pc) 0.00, 0.97, 0.01, 0.02;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.00, 0.95, 0.00, 0.05;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.00, 0.97, 0.00, 0.03;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.00, 0.64, 0.35, 0.01;
  (AML, Moderate_11_to_50pc) 0.00, 0.67, 0.03, 0.30;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Carcinoma, Moderate_11_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Moderate_11_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.0, 0.9, 0.0, 0.1;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (T_immunob_large, Moderate_11_to_50pc) 0.00, 0.91, 0.02, 0.07;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.00, 0.39, 0.01, 0.60;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Moderate_11_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (LGV, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Histoplasmosis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (CMV, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Brucellosis, Moderate_11_to_50pc) 0.00, 0.50, 0.05, 0.45;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.00, 0.95, 0.00, 0.05;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_early, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, Numerous_51_to_90pc) 0.00, 0.50, 0.05, 0.45;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (SHML, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Numerous_51_to_90pc) 0.00, 0.50, 0.05, 0.45;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, Numerous_51_to_90pc) 0.00, 0.05, 0.05, 0.90;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, Numerous_51_to_90pc) 0.00, 0.05, 0.05, 0.90;
  (B_immunoblastic, Numerous_51_to_90pc) 0.00, 0.97, 0.00, 0.03;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.00, 0.69, 0.01, 0.30;
  (Japanese_ATL, Numerous_51_to_90pc) 0.00, 0.97, 0.01, 0.02;
  (Lymphoblastic, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, Numerous_51_to_90pc) 0.00, 0.97, 0.01, 0.02;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.00, 0.97, 0.00, 0.03;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.00, 0.64, 0.35, 0.01;
  (AML, Numerous_51_to_90pc) 0.00, 0.67, 0.03, 0.30;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, Numerous_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Numerous_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Numerous_51_to_90pc) 0.00, 0.91, 0.02, 0.07;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.00, 0.39, 0.01, 0.60;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Numerous_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Numerous_51_to_90pc) 0.00, 0.50, 0.05, 0.45;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (LGV, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (CMV, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Brucellosis, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_early, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (ALIP, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cat_scratch_disease, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Dermatopathic_laden, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (GLH_plasma_cell, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Granulomatous_laden, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histiocytosis_x, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Infectious_mono, Striking_GT_90pc) 0.00, 0.50, 0.05, 0.45;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Lymphangiographic, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sarcoidosis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (SHML, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syphilis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Toxoplasmosis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Tuberculosis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Viral_NOS, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Whipple_s_disease, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_nodular_HD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Syncytial_NSHD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Interfollicular_HD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Reticular_type_HD, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_fol, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_fol, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_fol, Striking_GT_90pc) 0.00, 0.05, 0.05, 0.90;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_lymphocytic, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_cleaved_dif, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Large_cell_dif, Striking_GT_90pc) 0.00, 0.05, 0.05, 0.90;
  (B_immunoblastic, Striking_GT_90pc) 0.00, 0.97, 0.00, 0.03;
  (T_immunob_mixed, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Japanese_ATL, Striking_GT_90pc) 0.00, 0.97, 0.01, 0.02;
  (Lymphoblastic, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (True_histiocytic, Striking_GT_90pc) 0.00, 0.97, 0.01, 0.02;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (Multiple_myeloma, Striking_GT_90pc) 0.00, 0.97, 0.00, 0.03;
  (Mycosis_fungoides, Striking_GT_90pc) 0.00, 0.64, 0.35, 0.01;
  (AML, Striking_GT_90pc) 0.00, 0.67, 0.03, 0.30;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Carcinoma, Striking_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Striking_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_disease, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (AIDS_involutionary, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (T_immunob_large, Striking_GT_90pc) 0.00, 0.91, 0.02, 0.07;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Striking_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Striking_GT_90pc) 0.00, 0.50, 0.05, 0.45;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (LGV, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Histoplasmosis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Coccidioidomycosis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (CMV, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Brucellosis, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.25, 0.25, 0.25, 0.25;
}
probability ( FOLLICLE | Fault ) {
  (AIDS_early) 0.00, 0.00, 0.21, 0.74, 0.05;
  (AILD) 0.95, 0.05, 0.00, 0.00, 0.00;
  (ALIP) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Cat_scratch_disease) 0.01, 0.59, 0.40, 0.00, 0.00;
  (Dermatopathic_laden) 0.01, 0.58, 0.40, 0.01, 0.00;
  (Florid_follic_hyperp) 0.00, 0.00, 0.21, 0.74, 0.05;
  (GLH_hyaline_vascular) 0.00, 0.79, 0.20, 0.01, 0.00;
  (GLH_plasma_cell) 0.00, 0.34, 0.60, 0.05, 0.01;
  (Granulomatous_laden) 0.01, 0.59, 0.40, 0.00, 0.00;
  (Histiocytosis_x) 0.01, 0.59, 0.40, 0.00, 0.00;
  (Infectious_mono) 0.0099901098, 0.6923146085, 0.2967062608, 0.0009890209, 0.0000000000;
  (Leprosy_lepromatous) 0.200, 0.799, 0.001, 0.000, 0.000;
  (Lymphangiographic) 0.010, 0.979, 0.010, 0.001, 0.000;
  (Mantle_zone_hyperpla) 0.00000000, 0.09999000, 0.88991101, 0.00999900, 0.00009999;
  (Necrotizing_Kikuchi) 0.01, 0.59, 0.40, 0.00, 0.00;
  (Necrotiz_non_Kikuchi) 0.01, 0.59, 0.40, 0.00, 0.00;
  (Rheumatoid_arthritis) 0.00, 0.34, 0.60, 0.05, 0.01;
  (Sarcoidosis) 0.200, 0.799, 0.001, 0.000, 0.000;
  (SHML) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sinus_histiocytosis) 0.02, 0.96, 0.02, 0.00, 0.00;
  (Syphilis) 0.0, 0.3, 0.7, 0.0, 0.0;
  (Toxoplasmosis) 0.0, 0.3, 0.7, 0.0, 0.0;
  (Tuberculosis) 0.200, 0.799, 0.001, 0.000, 0.000;
  (Viral_NOS) 0.01, 0.59, 0.40, 0.00, 0.00;
  (Whipple_s_disease) 0.01, 0.98, 0.01, 0.00, 0.00;
  (L_H_nodular_HD) 0.85, 0.15, 0.00, 0.00, 0.00;
  (L_H_diffuse_HD) 0.95, 0.05, 0.00, 0.00, 0.00;
  (Nodular_sclerosis_HD) 0.800, 0.198, 0.002, 0.000, 0.000;
  (Cellular_phase_NSHD) 0.800, 0.198, 0.002, 0.000, 0.000;
  (Syncytial_NSHD) 0.800, 0.198, 0.002, 0.000, 0.000;
  (Mixed_cellularity_HD) 0.7, 0.3, 0.0, 0.0, 0.0;
  (Interfollicular_HD) 0.000, 0.399, 0.600, 0.001, 0.000;
  (Diffuse_fibrosis_HD) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Reticular_type_HD) 0.999, 0.001, 0.000, 0.000, 0.000;
  (Small_cleaved_fol) 0.00, 0.05, 0.10, 0.15, 0.70;
  (Mixed_fol) 0.00, 0.06, 0.15, 0.20, 0.59;
  (Large_cell_fol) 0.0, 0.5, 0.2, 0.2, 0.1;
  (Small_noncleaved_fol) 0.00, 0.65, 0.20, 0.10, 0.05;
  (Small_lymphocytic) 0.9, 0.1, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Mantle_zone_lymphoma) 0.0000, 0.6999, 0.3000, 0.0001, 0.0000;
  (Small_cleaved_dif) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Mixed_FCC_dif) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Large_cell_dif) 0.98, 0.02, 0.00, 0.00, 0.00;
  (B_immunoblastic) 0.98, 0.02, 0.00, 0.00, 0.00;
  (T_immunob_mixed) 0.9, 0.1, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym) 0.95, 0.05, 0.00, 0.00, 0.00;
  (Japanese_ATL) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Lymphoblastic) 0.94049524, 0.04950396, 0.01000080, 0.00000000, 0.00000000;
  (Small_noncleaved_dif) 0.98, 0.02, 0.00, 0.00, 0.00;
  (True_histiocytic) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Ki_1_LC_anaplas_T) 0.25, 0.70, 0.05, 0.00, 0.00;
  (Multiple_myeloma) 0.1999840013, 0.7599392049, 0.0399968003, 0.0000799936, 0.0000000000;
  (Mycosis_fungoides) 0.1999840013, 0.7599392049, 0.0399968003, 0.0000799936, 0.0000000000;
  (AML) 0.1999840013, 0.7599392049, 0.0399968003, 0.0000799936, 0.0000000000;
  (Hairy_cell_leukemia) 0.1999840013, 0.7599392049, 0.0399968003, 0.0000799936, 0.0000000000;
  (Carcinoma) 0.1999840013, 0.7599392049, 0.0399968003, 0.0000799936, 0.0000000000;
  (Melanoma) 0.1999840013, 0.7599392049, 0.0399968003, 0.0000799936, 0.0000000000;
  (EM_plasmacytoma) 0.500, 0.475, 0.025, 0.000, 0.000;
  (Kaposi_s_sarcoma) 0.0500, 0.8550, 0.0855, 0.0095, 0.0000;
  (Mast_cell_disease) 0.500, 0.475, 0.025, 0.000, 0.000;
  (AIDS_involutionary) 0.0500, 0.9025, 0.0475, 0.0000, 0.0000;
  (T_immunob_large) 0.98, 0.02, 0.00, 0.00, 0.00;
  (Monocytoid_B_cell) 0.01, 0.71, 0.25, 0.02, 0.01;
  (Nasopharyngeal_CA) 0.200, 0.792, 0.008, 0.000, 0.000;
  (Seminoma) 0.1999840013, 0.7599392049, 0.0399968003, 0.0000799936, 0.0000000000;
  (SLE) 0.01, 0.59, 0.40, 0.00, 0.00;
  (Mycobact_histiocytos) 0.0500, 0.9025, 0.0475, 0.0000, 0.0000;
  (Mast_cell_hyperplas) 0.049529470, 0.564635958, 0.376423972, 0.009410599, 0.000000000;
  (LGV) 0.01, 0.59, 0.40, 0.00, 0.00;
  (Histoplasmosis) 0.049529470, 0.564635958, 0.376423972, 0.009410599, 0.000000000;
  (Coccidioidomycosis) 0.049529470, 0.564635958, 0.376423972, 0.009410599, 0.000000000;
  (CMV) 0.049529470, 0.564635958, 0.376423972, 0.009410599, 0.000000000;
  (Brucellosis) 0.0, 0.3, 0.7, 0.0, 0.0;
  (Ki_1_LC_anaplas_B) 0.25, 0.70, 0.05, 0.00, 0.00;
  (Intermed_lymphocytic) 0.8, 0.2, 0.0, 0.0, 0.0;
}
probability ( F_DEN | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.00, 0.00, 0.01, 0.50, 0.49;
  (AILD, 1_to_25pc) 0.0, 0.0, 0.0, 0.0, 1.0;
  (ALIP, 1_to_25pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Cat_scratch_disease, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Dermatopathic_laden, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Florid_follic_hyperp, 1_to_25pc) 0.00, 0.00, 0.01, 0.50, 0.49;
  (GLH_hyaline_vascular, 1_to_25pc) 0.00, 0.00, 0.00, 0.15, 0.85;
  (GLH_plasma_cell, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Granulomatous_laden, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Histiocytosis_x, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Infectious_mono, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Leprosy_lepromatous, 1_to_25pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Lymphangiographic, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.00, 0.00, 0.01, 0.80, 0.19;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Rheumatoid_arthritis, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Sarcoidosis, 1_to_25pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (SHML, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Sinus_histiocytosis, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Syphilis, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Toxoplasmosis, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Tuberculosis, 1_to_25pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Viral_NOS, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Whipple_s_disease, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (L_H_nodular_HD, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (L_H_diffuse_HD, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Cellular_phase_NSHD, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Syncytial_NSHD, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Mixed_cellularity_HD, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Interfollicular_HD, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Reticular_type_HD, 1_to_25pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_fol, 1_to_25pc) 0.0000, 0.7799, 0.2000, 0.0200, 0.0001;
  (Mixed_fol, 1_to_25pc) 0.0000, 0.7799, 0.2000, 0.0200, 0.0001;
  (Large_cell_fol, 1_to_25pc) 0.0000, 0.7799, 0.2000, 0.0200, 0.0001;
  (Small_noncleaved_fol, 1_to_25pc) 0.0000, 0.7799, 0.2000, 0.0200, 0.0001;
  (Small_lymphocytic, 1_to_25pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.00, 0.00, 0.01, 0.30, 0.69;
  (Small_cleaved_dif, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Mixed_FCC_dif, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Large_cell_dif, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (B_immunoblastic, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (T_immunob_mixed, 1_to_25pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Japanese_ATL, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Lymphoblastic, 1_to_25pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (True_histiocytic, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Multiple_myeloma, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Mycosis_fungoides, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (AML, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Hairy_cell_leukemia, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Carcinoma, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Melanoma, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (EM_plasmacytoma, 1_to_25pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.00, 0.00, 0.00, 0.15, 0.85;
  (Mast_cell_disease, 1_to_25pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (AIDS_involutionary, 1_to_25pc) 0.00, 0.00, 0.00, 0.15, 0.85;
  (T_immunob_large, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Monocytoid_B_cell, 1_to_25pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Nasopharyngeal_CA, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Seminoma, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (SLE, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Mycobact_histiocytos, 1_to_25pc) 0.00, 0.00, 0.00, 0.15, 0.85;
  (Mast_cell_hyperplas, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (LGV, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Histoplasmosis, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Coccidioidomycosis, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (CMV, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Brucellosis, 1_to_25pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Intermed_lymphocytic, 1_to_25pc) 0.000, 0.000, 0.005, 0.150, 0.845;
  (AIDS_early, 25_to_75pc) 0.00, 0.00, 0.01, 0.50, 0.49;
  (AILD, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (ALIP, 25_to_75pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Cat_scratch_disease, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Dermatopathic_laden, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Florid_follic_hyperp, 25_to_75pc) 0.00, 0.00, 0.01, 0.50, 0.49;
  (GLH_hyaline_vascular, 25_to_75pc) 0.00, 0.00, 0.00, 0.15, 0.85;
  (GLH_plasma_cell, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Granulomatous_laden, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Histiocytosis_x, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Infectious_mono, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Leprosy_lepromatous, 25_to_75pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Lymphangiographic, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.00, 0.00, 0.01, 0.80, 0.19;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Rheumatoid_arthritis, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Sarcoidosis, 25_to_75pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (SHML, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Sinus_histiocytosis, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Syphilis, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Toxoplasmosis, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Tuberculosis, 25_to_75pc) 0.00, 0.00, 0.00, 0.02, 0.98;
  (Viral_NOS, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Whipple_s_disease, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (L_H_nodular_HD, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (L_H_diffuse_HD, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Cellular_phase_NSHD, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Syncytial_NSHD, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Mixed_cellularity_HD, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Interfollicular_HD, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Reticular_type_HD, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_cleaved_fol, 25_to_75pc) 0.0000, 0.7799, 0.2000, 0.0200, 0.0001;
  (Mixed_fol, 25_to_75pc) 0.0000, 0.7799, 0.2000, 0.0200, 0.0001;
  (Large_cell_fol, 25_to_75pc) 0.0000, 0.7799, 0.2000, 0.0200, 0.0001;
  (Small_noncleaved_fol, 25_to_75pc) 0.0000, 0.7799, 0.2000, 0.0200, 0.0001;
  (Small_lymphocytic, 25_to_75pc) 0.00, 0.00, 0.01, 0.01, 0.98;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.0000, 0.0001, 0.0300, 0.5000, 0.4699;
  (Small_cleaved_dif, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_FCC_dif, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_dif, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (B_immunoblastic, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (T_immunob_mixed, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Japanese_ATL, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphoblastic, 25_to_75pc) 0.00, 0.00, 0.01, 0.01, 0.98;
  (Small_noncleaved_dif, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (True_histiocytic, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Multiple_myeloma, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Mycosis_fungoides, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (AML, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Hairy_cell_leukemia, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Carcinoma, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Melanoma, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (EM_plasmacytoma, 25_to_75pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.00, 0.00, 0.00, 0.15, 0.85;
  (Mast_cell_disease, 25_to_75pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (AIDS_involutionary, 25_to_75pc) 0.00, 0.00, 0.00, 0.15, 0.85;
  (T_immunob_large, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Monocytoid_B_cell, 25_to_75pc) 0.0, 0.0, 0.0, 0.1, 0.9;
  (Nasopharyngeal_CA, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (Seminoma, 25_to_75pc) 0.00, 0.00, 0.00, 0.05, 0.95;
  (SLE, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Mycobact_histiocytos, 25_to_75pc) 0.00, 0.00, 0.00, 0.15, 0.85;
  (Mast_cell_hyperplas, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (LGV, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Histoplasmosis, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Coccidioidomycosis, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (CMV, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Brucellosis, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.0, 0.0, 0.0, 0.2, 0.8;
  (Intermed_lymphocytic, 25_to_75pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_early, 75_to_90pc) 0.000, 0.200, 0.795, 0.005, 0.000;
  (AILD, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (ALIP, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Cat_scratch_disease, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Dermatopathic_laden, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Florid_follic_hyperp, 75_to_90pc) 0.000, 0.200, 0.795, 0.005, 0.000;
  (GLH_hyaline_vascular, 75_to_90pc) 0.000, 0.200, 0.795, 0.005, 0.000;
  (GLH_plasma_cell, 75_to_90pc) 0.000, 0.200, 0.795, 0.005, 0.000;
  (Granulomatous_laden, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histiocytosis_x, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Infectious_mono, 75_to_90pc) 0.000, 0.200, 0.795, 0.005, 0.000;
  (Leprosy_lepromatous, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphangiographic, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.000, 0.200, 0.795, 0.005, 0.000;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Rheumatoid_arthritis, 75_to_90pc) 0.000, 0.200, 0.795, 0.005, 0.000;
  (Sarcoidosis, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (SHML, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sinus_histiocytosis, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Syphilis, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Toxoplasmosis, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Tuberculosis, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Viral_NOS, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Whipple_s_disease, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_nodular_HD, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_diffuse_HD, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Cellular_phase_NSHD, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Syncytial_NSHD, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_cellularity_HD, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Interfollicular_HD, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Diffuse_fibrosis_HD, 75_to_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, 75_to_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, 75_to_90pc) 0.000, 0.300, 0.699, 0.001, 0.000;
  (Mixed_fol, 75_to_90pc) 0.000, 0.300, 0.699, 0.001, 0.000;
  (Large_cell_fol, 75_to_90pc) 0.000, 0.300, 0.699, 0.001, 0.000;
  (Small_noncleaved_fol, 75_to_90pc) 0.000, 0.300, 0.699, 0.001, 0.000;
  (Small_lymphocytic, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.000, 0.300, 0.699, 0.001, 0.000;
  (Small_cleaved_dif, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_FCC_dif, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_dif, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (B_immunoblastic, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (T_immunob_mixed, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Japanese_ATL, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphoblastic, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_dif, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (True_histiocytic, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Multiple_myeloma, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Mycosis_fungoides, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (AML, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Hairy_cell_leukemia, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Carcinoma, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Melanoma, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (EM_plasmacytoma, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Mast_cell_disease, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_involutionary, 75_to_90pc) 0.000, 0.200, 0.795, 0.005, 0.000;
  (T_immunob_large, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Monocytoid_B_cell, 75_to_90pc) 0.000, 0.300, 0.699, 0.001, 0.000;
  (Nasopharyngeal_CA, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Seminoma, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (SLE, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mycobact_histiocytos, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_hyperplas, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (LGV, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Histoplasmosis, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Coccidioidomycosis, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (CMV, 75_to_90pc) 0.00, 0.20, 0.79, 0.01, 0.00;
  (Brucellosis, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Intermed_lymphocytic, 75_to_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_early, GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (AILD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (GLH_hyaline_vascular, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, GT_90pc) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Granulomatous_laden, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, GT_90pc) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Necrotizing_Kikuchi, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, GT_90pc) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Sarcoidosis, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, GT_90pc) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Mixed_fol, GT_90pc) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Large_cell_fol, GT_90pc) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Small_noncleaved_fol, GT_90pc) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Small_lymphocytic, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (T_immunob_large, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, GT_90pc) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Nasopharyngeal_CA, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, GT_90pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, GT_90pc) 0.2, 0.2, 0.2, 0.2, 0.2;
}
probability ( F_SS | Fault, F_POL ) {
  (AIDS_early, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Absent) 0.00, 0.94, 0.03, 0.02, 0.01;
  (AILD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (ALIP, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Cat_scratch_disease, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Dermatopathic_laden, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Florid_follic_hyperp, Absent) 0.00, 0.70, 0.15, 0.10, 0.05;
  (GLH_hyaline_vascular, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (GLH_plasma_cell, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Granulomatous_laden, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Histiocytosis_x, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Infectious_mono, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Leprosy_lepromatous, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Lymphangiographic, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Mantle_zone_hyperpla, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Necrotizing_Kikuchi, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Necrotiz_non_Kikuchi, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Rheumatoid_arthritis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Sarcoidosis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (SHML, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Sinus_histiocytosis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Syphilis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Toxoplasmosis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Tuberculosis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Viral_NOS, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Whipple_s_disease, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (L_H_nodular_HD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (L_H_diffuse_HD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Nodular_sclerosis_HD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Cellular_phase_NSHD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Syncytial_NSHD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Mixed_cellularity_HD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Interfollicular_HD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Diffuse_fibrosis_HD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Reticular_type_HD, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Small_cleaved_fol, Absent) 0.0000, 0.9889, 0.0100, 0.0010, 0.0001;
  (Mixed_fol, Absent) 0.0000, 0.9889, 0.0100, 0.0010, 0.0001;
  (Large_cell_fol, Absent) 0.000, 0.969, 0.020, 0.010, 0.001;
  (Small_noncleaved_fol, Absent) 0.000, 0.929, 0.050, 0.020, 0.001;
  (Small_lymphocytic, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Plasmacytoid_lyctic, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Mantle_zone_lymphoma, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Small_cleaved_dif, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Mixed_FCC_dif, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Large_cell_dif, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (B_immunoblastic, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (T_immunob_mixed, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (AILD_like_T_cell_lym, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Japanese_ATL, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Lymphoblastic, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Small_noncleaved_dif, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (True_histiocytic, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Ki_1_LC_anaplas_T, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Multiple_myeloma, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Mycosis_fungoides, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (AML, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Hairy_cell_leukemia, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Carcinoma, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Melanoma, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (EM_plasmacytoma, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Kaposi_s_sarcoma, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Mast_cell_disease, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (AIDS_involutionary, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (T_immunob_large, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Monocytoid_B_cell, Absent) 0.000, 0.969, 0.020, 0.010, 0.001;
  (Nasopharyngeal_CA, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Seminoma, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (SLE, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Mycobact_histiocytos, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Mast_cell_hyperplas, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (LGV, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Histoplasmosis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Coccidioidomycosis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (CMV, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Brucellosis, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Ki_1_LC_anaplas_B, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (Intermed_lymphocytic, Absent) 0.000, 0.965, 0.020, 0.010, 0.005;
  (AIDS_early, Present) 0.00, 0.00, 0.01, 0.15, 0.84;
  (AILD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (ALIP, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Cat_scratch_disease, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Dermatopathic_laden, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Florid_follic_hyperp, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (GLH_hyaline_vascular, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (GLH_plasma_cell, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Granulomatous_laden, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Histiocytosis_x, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Infectious_mono, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Leprosy_lepromatous, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Lymphangiographic, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Mantle_zone_hyperpla, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Necrotizing_Kikuchi, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Necrotiz_non_Kikuchi, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Rheumatoid_arthritis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Sarcoidosis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (SHML, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Sinus_histiocytosis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Syphilis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Toxoplasmosis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Tuberculosis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Viral_NOS, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Whipple_s_disease, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (L_H_nodular_HD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (L_H_diffuse_HD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Nodular_sclerosis_HD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Cellular_phase_NSHD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Syncytial_NSHD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Mixed_cellularity_HD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Interfollicular_HD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Diffuse_fibrosis_HD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Reticular_type_HD, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Small_cleaved_fol, Present) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_fol, Present) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_fol, Present) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_fol, Present) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_lymphocytic, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Plasmacytoid_lyctic, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Mantle_zone_lymphoma, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Small_cleaved_dif, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Mixed_FCC_dif, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Large_cell_dif, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (B_immunoblastic, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (T_immunob_mixed, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (AILD_like_T_cell_lym, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Japanese_ATL, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Lymphoblastic, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Small_noncleaved_dif, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (True_histiocytic, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Ki_1_LC_anaplas_T, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Multiple_myeloma, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Mycosis_fungoides, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (AML, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Hairy_cell_leukemia, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Carcinoma, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Melanoma, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (EM_plasmacytoma, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Kaposi_s_sarcoma, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Mast_cell_disease, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (AIDS_involutionary, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (T_immunob_large, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Monocytoid_B_cell, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Nasopharyngeal_CA, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Seminoma, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (SLE, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Mycobact_histiocytos, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Mast_cell_hyperplas, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (LGV, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Histoplasmosis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Coccidioidomycosis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (CMV, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Brucellosis, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Ki_1_LC_anaplas_B, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
  (Intermed_lymphocytic, Present) 0.00, 0.00, 0.01, 0.24, 0.75;
}
probability ( F_MZSTAT | Fault, F_MZ ) {
  (AIDS_early, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Present) 0.0000, 0.9399, 0.0500, 0.0100, 0.0001;
  (AILD, Present) 0.00, 0.25, 0.20, 0.25, 0.30;
  (ALIP, Present) 0.00, 0.25, 0.20, 0.25, 0.30;
  (Cat_scratch_disease, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Dermatopathic_laden, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Florid_follic_hyperp, Present) 0.000, 0.879, 0.100, 0.020, 0.001;
  (GLH_hyaline_vascular, Present) 0.0, 0.0, 0.0, 0.0, 1.0;
  (GLH_plasma_cell, Present) 0.00, 0.10, 0.15, 0.55, 0.20;
  (Granulomatous_laden, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Histiocytosis_x, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Infectious_mono, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Leprosy_lepromatous, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Lymphangiographic, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Mantle_zone_hyperpla, Present) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Necrotiz_non_Kikuchi, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Rheumatoid_arthritis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Sarcoidosis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (SHML, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Sinus_histiocytosis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Syphilis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Toxoplasmosis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Tuberculosis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Viral_NOS, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Whipple_s_disease, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (L_H_nodular_HD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (L_H_diffuse_HD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Nodular_sclerosis_HD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Cellular_phase_NSHD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Syncytial_NSHD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Mixed_cellularity_HD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Interfollicular_HD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Diffuse_fibrosis_HD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Reticular_type_HD, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Small_cleaved_fol, Present) 0.00, 0.79, 0.20, 0.01, 0.00;
  (Mixed_fol, Present) 0.00, 0.79, 0.20, 0.01, 0.00;
  (Large_cell_fol, Present) 0.00, 0.79, 0.20, 0.01, 0.00;
  (Small_noncleaved_fol, Present) 0.00, 0.79, 0.20, 0.01, 0.00;
  (Small_lymphocytic, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Plasmacytoid_lyctic, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Mantle_zone_lymphoma, Present) 0.0, 0.0, 0.0, 0.0, 1.0;
  (Small_cleaved_dif, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Mixed_FCC_dif, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Large_cell_dif, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (B_immunoblastic, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (T_immunob_mixed, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (AILD_like_T_cell_lym, Present) 0.00, 0.25, 0.20, 0.25, 0.30;
  (Japanese_ATL, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Lymphoblastic, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Small_noncleaved_dif, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (True_histiocytic, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Ki_1_LC_anaplas_T, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Multiple_myeloma, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Mycosis_fungoides, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (AML, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Hairy_cell_leukemia, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Carcinoma, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Melanoma, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (EM_plasmacytoma, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Kaposi_s_sarcoma, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Mast_cell_disease, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (AIDS_involutionary, Present) 0.000, 0.650, 0.299, 0.050, 0.001;
  (T_immunob_large, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Monocytoid_B_cell, Present) 0.00, 0.55, 0.10, 0.30, 0.05;
  (Nasopharyngeal_CA, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Seminoma, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (SLE, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Mycobact_histiocytos, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Mast_cell_hyperplas, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (LGV, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Histoplasmosis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Coccidioidomycosis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (CMV, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Brucellosis, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Ki_1_LC_anaplas_B, Present) 0.00, 0.05, 0.07, 0.30, 0.58;
  (Intermed_lymphocytic, Present) 0.0, 0.0, 0.0, 0.0, 1.0;
}
probability ( F_MZCM | Fault, F_MZ ) {
  (AIDS_early, No_follicles) 1.0, 0.0, 0.0;
  (AILD, No_follicles) 1.0, 0.0, 0.0;
  (ALIP, No_follicles) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, No_follicles) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, No_follicles) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_follicles) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_follicles) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, No_follicles) 1.0, 0.0, 0.0;
  (Granulomatous_laden, No_follicles) 1.0, 0.0, 0.0;
  (Histiocytosis_x, No_follicles) 1.0, 0.0, 0.0;
  (Infectious_mono, No_follicles) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_follicles) 1.0, 0.0, 0.0;
  (Lymphangiographic, No_follicles) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_follicles) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_follicles) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_follicles) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_follicles) 1.0, 0.0, 0.0;
  (Sarcoidosis, No_follicles) 1.0, 0.0, 0.0;
  (SHML, No_follicles) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_follicles) 1.0, 0.0, 0.0;
  (Syphilis, No_follicles) 1.0, 0.0, 0.0;
  (Toxoplasmosis, No_follicles) 1.0, 0.0, 0.0;
  (Tuberculosis, No_follicles) 1.0, 0.0, 0.0;
  (Viral_NOS, No_follicles) 1.0, 0.0, 0.0;
  (Whipple_s_disease, No_follicles) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, No_follicles) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_follicles) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_follicles) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_follicles) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, No_follicles) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_follicles) 1.0, 0.0, 0.0;
  (Interfollicular_HD, No_follicles) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_follicles) 1.0, 0.0, 0.0;
  (Reticular_type_HD, No_follicles) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, No_follicles) 1.0, 0.0, 0.0;
  (Mixed_fol, No_follicles) 1.0, 0.0, 0.0;
  (Large_cell_fol, No_follicles) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_follicles) 1.0, 0.0, 0.0;
  (Small_lymphocytic, No_follicles) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_follicles) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_follicles) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, No_follicles) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_follicles) 1.0, 0.0, 0.0;
  (Large_cell_dif, No_follicles) 1.0, 0.0, 0.0;
  (B_immunoblastic, No_follicles) 1.0, 0.0, 0.0;
  (T_immunob_mixed, No_follicles) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_follicles) 1.0, 0.0, 0.0;
  (Japanese_ATL, No_follicles) 1.0, 0.0, 0.0;
  (Lymphoblastic, No_follicles) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_follicles) 1.0, 0.0, 0.0;
  (True_histiocytic, No_follicles) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_follicles) 1.0, 0.0, 0.0;
  (Multiple_myeloma, No_follicles) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, No_follicles) 1.0, 0.0, 0.0;
  (AML, No_follicles) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_follicles) 1.0, 0.0, 0.0;
  (Carcinoma, No_follicles) 1.0, 0.0, 0.0;
  (Melanoma, No_follicles) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, No_follicles) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_follicles) 1.0, 0.0, 0.0;
  (Mast_cell_disease, No_follicles) 1.0, 0.0, 0.0;
  (AIDS_involutionary, No_follicles) 1.0, 0.0, 0.0;
  (T_immunob_large, No_follicles) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_follicles) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_follicles) 1.0, 0.0, 0.0;
  (Seminoma, No_follicles) 1.0, 0.0, 0.0;
  (SLE, No_follicles) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_follicles) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_follicles) 1.0, 0.0, 0.0;
  (LGV, No_follicles) 1.0, 0.0, 0.0;
  (Histoplasmosis, No_follicles) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, No_follicles) 1.0, 0.0, 0.0;
  (CMV, No_follicles) 1.0, 0.0, 0.0;
  (Brucellosis, No_follicles) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_follicles) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_follicles) 1.0, 0.0, 0.0;
  (AIDS_early, Absent) 1.0, 0.0, 0.0;
  (AILD, Absent) 1.0, 0.0, 0.0;
  (ALIP, Absent) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent) 1.0, 0.0, 0.0;
  (SHML, Absent) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent) 1.0, 0.0, 0.0;
  (Syphilis, Absent) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent) 1.0, 0.0, 0.0;
  (AML, Absent) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent) 1.0, 0.0, 0.0;
  (Carcinoma, Absent) 1.0, 0.0, 0.0;
  (Melanoma, Absent) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent) 1.0, 0.0, 0.0;
  (Seminoma, Absent) 1.0, 0.0, 0.0;
  (SLE, Absent) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent) 1.0, 0.0, 0.0;
  (LGV, Absent) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent) 1.0, 0.0, 0.0;
  (CMV, Absent) 1.0, 0.0, 0.0;
  (Brucellosis, Absent) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent) 1.0, 0.0, 0.0;
  (AIDS_early, Present) 0.00, 0.99, 0.01;
  (AILD, Present) 0.00, 0.99, 0.01;
  (ALIP, Present) 0.00, 0.99, 0.01;
  (Cat_scratch_disease, Present) 0.00, 0.99, 0.01;
  (Dermatopathic_laden, Present) 0.00, 0.99, 0.01;
  (Florid_follic_hyperp, Present) 0.00, 0.99, 0.01;
  (GLH_hyaline_vascular, Present) 0.00, 0.01, 0.99;
  (GLH_plasma_cell, Present) 0.00, 0.99, 0.01;
  (Granulomatous_laden, Present) 0.00, 0.99, 0.01;
  (Histiocytosis_x, Present) 0.00, 0.99, 0.01;
  (Infectious_mono, Present) 0.00, 0.99, 0.01;
  (Leprosy_lepromatous, Present) 0.00, 0.99, 0.01;
  (Lymphangiographic, Present) 0.00, 0.99, 0.01;
  (Mantle_zone_hyperpla, Present) 0.0, 0.9, 0.1;
  (Necrotizing_Kikuchi, Present) 0.00, 0.99, 0.01;
  (Necrotiz_non_Kikuchi, Present) 0.00, 0.99, 0.01;
  (Rheumatoid_arthritis, Present) 0.00, 0.99, 0.01;
  (Sarcoidosis, Present) 0.00, 0.99, 0.01;
  (SHML, Present) 0.00, 0.99, 0.01;
  (Sinus_histiocytosis, Present) 0.00, 0.99, 0.01;
  (Syphilis, Present) 0.00, 0.99, 0.01;
  (Toxoplasmosis, Present) 0.00, 0.99, 0.01;
  (Tuberculosis, Present) 0.00, 0.99, 0.01;
  (Viral_NOS, Present) 0.00, 0.99, 0.01;
  (Whipple_s_disease, Present) 0.00, 0.99, 0.01;
  (L_H_nodular_HD, Present) 0.00, 0.99, 0.01;
  (L_H_diffuse_HD, Present) 0.00, 0.99, 0.01;
  (Nodular_sclerosis_HD, Present) 0.00, 0.99, 0.01;
  (Cellular_phase_NSHD, Present) 0.00, 0.99, 0.01;
  (Syncytial_NSHD, Present) 0.00, 0.99, 0.01;
  (Mixed_cellularity_HD, Present) 0.00, 0.99, 0.01;
  (Interfollicular_HD, Present) 0.00, 0.99, 0.01;
  (Diffuse_fibrosis_HD, Present) 0.00, 0.99, 0.01;
  (Reticular_type_HD, Present) 0.00, 0.99, 0.01;
  (Small_cleaved_fol, Present) 0.000, 0.999, 0.001;
  (Mixed_fol, Present) 0.000, 0.999, 0.001;
  (Large_cell_fol, Present) 0.000, 0.999, 0.001;
  (Small_noncleaved_fol, Present) 0.000, 0.999, 0.001;
  (Small_lymphocytic, Present) 0.00, 0.99, 0.01;
  (Plasmacytoid_lyctic, Present) 0.00, 0.99, 0.01;
  (Mantle_zone_lymphoma, Present) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Present) 0.00, 0.99, 0.01;
  (Mixed_FCC_dif, Present) 0.00, 0.99, 0.01;
  (Large_cell_dif, Present) 0.00, 0.99, 0.01;
  (B_immunoblastic, Present) 0.00, 0.99, 0.01;
  (T_immunob_mixed, Present) 0.00, 0.99, 0.01;
  (AILD_like_T_cell_lym, Present) 0.00, 0.99, 0.01;
  (Japanese_ATL, Present) 0.00, 0.99, 0.01;
  (Lymphoblastic, Present) 0.00, 0.99, 0.01;
  (Small_noncleaved_dif, Present) 0.00, 0.99, 0.01;
  (True_histiocytic, Present) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_T, Present) 0.00, 0.99, 0.01;
  (Multiple_myeloma, Present) 0.00, 0.99, 0.01;
  (Mycosis_fungoides, Present) 0.00, 0.99, 0.01;
  (AML, Present) 0.00, 0.99, 0.01;
  (Hairy_cell_leukemia, Present) 0.00, 0.99, 0.01;
  (Carcinoma, Present) 0.00, 0.99, 0.01;
  (Melanoma, Present) 0.00, 0.99, 0.01;
  (EM_plasmacytoma, Present) 0.00, 0.99, 0.01;
  (Kaposi_s_sarcoma, Present) 0.00, 0.99, 0.01;
  (Mast_cell_disease, Present) 0.00, 0.99, 0.01;
  (AIDS_involutionary, Present) 0.00, 0.99, 0.01;
  (T_immunob_large, Present) 0.00, 0.99, 0.01;
  (Monocytoid_B_cell, Present) 0.000, 0.999, 0.001;
  (Nasopharyngeal_CA, Present) 0.00, 0.99, 0.01;
  (Seminoma, Present) 0.00, 0.99, 0.01;
  (SLE, Present) 0.00, 0.99, 0.01;
  (Mycobact_histiocytos, Present) 0.00, 0.99, 0.01;
  (Mast_cell_hyperplas, Present) 0.00, 0.99, 0.01;
  (LGV, Present) 0.00, 0.99, 0.01;
  (Histoplasmosis, Present) 0.00, 0.99, 0.01;
  (Coccidioidomycosis, Present) 0.00, 0.99, 0.01;
  (CMV, Present) 0.00, 0.99, 0.01;
  (Brucellosis, Present) 0.00, 0.99, 0.01;
  (Ki_1_LC_anaplas_B, Present) 0.00, 0.99, 0.01;
  (Intermed_lymphocytic, Present) 0.0, 1.0, 0.0;
}
probability ( F_DEF | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.00, 0.83, 0.15, 0.02;
  (AILD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (ALIP, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Cat_scratch_disease, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Dermatopathic_laden, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Florid_follic_hyperp, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (GLH_hyaline_vascular, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (GLH_plasma_cell, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Granulomatous_laden, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Histiocytosis_x, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Infectious_mono, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Leprosy_lepromatous, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Lymphangiographic, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Rheumatoid_arthritis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Sarcoidosis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (SHML, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Sinus_histiocytosis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Syphilis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Toxoplasmosis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Tuberculosis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Viral_NOS, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Whipple_s_disease, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (L_H_nodular_HD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (L_H_diffuse_HD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Cellular_phase_NSHD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Syncytial_NSHD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_cellularity_HD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Interfollicular_HD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Reticular_type_HD, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Small_cleaved_fol, 1_to_25pc) 0.00, 0.05, 0.25, 0.70;
  (Mixed_fol, 1_to_25pc) 0.00, 0.05, 0.25, 0.70;
  (Large_cell_fol, 1_to_25pc) 0.00, 0.05, 0.25, 0.70;
  (Small_noncleaved_fol, 1_to_25pc) 0.00, 0.05, 0.25, 0.70;
  (Small_lymphocytic, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Small_cleaved_dif, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_FCC_dif, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Large_cell_dif, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (B_immunoblastic, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (T_immunob_mixed, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Japanese_ATL, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Lymphoblastic, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Small_noncleaved_dif, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (True_histiocytic, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Multiple_myeloma, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mycosis_fungoides, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (AML, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Hairy_cell_leukemia, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Carcinoma, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Melanoma, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (EM_plasmacytoma, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mast_cell_disease, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (AIDS_involutionary, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (T_immunob_large, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Monocytoid_B_cell, 1_to_25pc) 0.00, 0.35, 0.45, 0.20;
  (Nasopharyngeal_CA, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Seminoma, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (SLE, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mycobact_histiocytos, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mast_cell_hyperplas, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (LGV, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Histoplasmosis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Coccidioidomycosis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (CMV, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Brucellosis, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Intermed_lymphocytic, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (AIDS_early, 25_to_75pc) 0.00, 0.83, 0.15, 0.02;
  (AILD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (ALIP, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Cat_scratch_disease, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Dermatopathic_laden, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Florid_follic_hyperp, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (GLH_hyaline_vascular, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (GLH_plasma_cell, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Granulomatous_laden, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Histiocytosis_x, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Infectious_mono, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Leprosy_lepromatous, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Lymphangiographic, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Rheumatoid_arthritis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Sarcoidosis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (SHML, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Sinus_histiocytosis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Syphilis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Toxoplasmosis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Tuberculosis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Viral_NOS, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Whipple_s_disease, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (L_H_nodular_HD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (L_H_diffuse_HD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Cellular_phase_NSHD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Syncytial_NSHD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_cellularity_HD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Interfollicular_HD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Reticular_type_HD, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Small_cleaved_fol, 25_to_75pc) 0.00, 0.05, 0.25, 0.70;
  (Mixed_fol, 25_to_75pc) 0.00, 0.05, 0.25, 0.70;
  (Large_cell_fol, 25_to_75pc) 0.00, 0.05, 0.25, 0.70;
  (Small_noncleaved_fol, 25_to_75pc) 0.00, 0.05, 0.25, 0.70;
  (Small_lymphocytic, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Small_cleaved_dif, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_FCC_dif, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Large_cell_dif, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (B_immunoblastic, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (T_immunob_mixed, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Japanese_ATL, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Lymphoblastic, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Small_noncleaved_dif, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (True_histiocytic, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Multiple_myeloma, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mycosis_fungoides, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (AML, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Hairy_cell_leukemia, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Carcinoma, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Melanoma, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (EM_plasmacytoma, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mast_cell_disease, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (AIDS_involutionary, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (T_immunob_large, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Monocytoid_B_cell, 25_to_75pc) 0.00, 0.35, 0.45, 0.20;
  (Nasopharyngeal_CA, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Seminoma, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (SLE, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mycobact_histiocytos, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mast_cell_hyperplas, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (LGV, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Histoplasmosis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Coccidioidomycosis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (CMV, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Brucellosis, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Intermed_lymphocytic, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (AIDS_early, 75_to_90pc) 0.00, 0.83, 0.15, 0.02;
  (AILD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (ALIP, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Cat_scratch_disease, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Dermatopathic_laden, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Florid_follic_hyperp, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (GLH_hyaline_vascular, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (GLH_plasma_cell, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Granulomatous_laden, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Histiocytosis_x, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Infectious_mono, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Leprosy_lepromatous, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Lymphangiographic, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Rheumatoid_arthritis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Sarcoidosis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (SHML, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Sinus_histiocytosis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Syphilis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Toxoplasmosis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Tuberculosis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Viral_NOS, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Whipple_s_disease, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (L_H_nodular_HD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (L_H_diffuse_HD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Cellular_phase_NSHD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Syncytial_NSHD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_cellularity_HD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Interfollicular_HD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Reticular_type_HD, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Small_cleaved_fol, 75_to_90pc) 0.00, 0.05, 0.25, 0.70;
  (Mixed_fol, 75_to_90pc) 0.00, 0.05, 0.25, 0.70;
  (Large_cell_fol, 75_to_90pc) 0.00, 0.05, 0.25, 0.70;
  (Small_noncleaved_fol, 75_to_90pc) 0.00, 0.05, 0.25, 0.70;
  (Small_lymphocytic, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Small_cleaved_dif, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_FCC_dif, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Large_cell_dif, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (B_immunoblastic, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (T_immunob_mixed, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Japanese_ATL, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Lymphoblastic, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Small_noncleaved_dif, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (True_histiocytic, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Multiple_myeloma, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mycosis_fungoides, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (AML, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Hairy_cell_leukemia, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Carcinoma, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Melanoma, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (EM_plasmacytoma, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mast_cell_disease, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (AIDS_involutionary, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (T_immunob_large, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Monocytoid_B_cell, 75_to_90pc) 0.00, 0.35, 0.45, 0.20;
  (Nasopharyngeal_CA, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Seminoma, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (SLE, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mycobact_histiocytos, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mast_cell_hyperplas, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (LGV, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Histoplasmosis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Coccidioidomycosis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (CMV, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Brucellosis, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Intermed_lymphocytic, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (AIDS_early, GT_90pc) 0.00, 0.83, 0.15, 0.02;
  (AILD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (ALIP, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Cat_scratch_disease, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Dermatopathic_laden, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Florid_follic_hyperp, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (GLH_hyaline_vascular, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (GLH_plasma_cell, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Granulomatous_laden, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Histiocytosis_x, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Infectious_mono, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Leprosy_lepromatous, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Lymphangiographic, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mantle_zone_hyperpla, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Necrotizing_Kikuchi, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Rheumatoid_arthritis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Sarcoidosis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (SHML, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Sinus_histiocytosis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Syphilis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Toxoplasmosis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Tuberculosis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Viral_NOS, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Whipple_s_disease, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (L_H_nodular_HD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (L_H_diffuse_HD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Nodular_sclerosis_HD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Cellular_phase_NSHD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Syncytial_NSHD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_cellularity_HD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Interfollicular_HD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Diffuse_fibrosis_HD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Reticular_type_HD, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Small_cleaved_fol, GT_90pc) 0.00, 0.05, 0.25, 0.70;
  (Mixed_fol, GT_90pc) 0.00, 0.05, 0.25, 0.70;
  (Large_cell_fol, GT_90pc) 0.00, 0.05, 0.25, 0.70;
  (Small_noncleaved_fol, GT_90pc) 0.00, 0.05, 0.25, 0.70;
  (Small_lymphocytic, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Plasmacytoid_lyctic, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mantle_zone_lymphoma, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Small_cleaved_dif, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_FCC_dif, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Large_cell_dif, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (B_immunoblastic, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (T_immunob_mixed, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (AILD_like_T_cell_lym, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Japanese_ATL, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Lymphoblastic, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Small_noncleaved_dif, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (True_histiocytic, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Multiple_myeloma, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mycosis_fungoides, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (AML, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Hairy_cell_leukemia, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Carcinoma, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Melanoma, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (EM_plasmacytoma, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Kaposi_s_sarcoma, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mast_cell_disease, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (AIDS_involutionary, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (T_immunob_large, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Monocytoid_B_cell, GT_90pc) 0.00, 0.35, 0.45, 0.20;
  (Nasopharyngeal_CA, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Seminoma, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (SLE, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mycobact_histiocytos, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mast_cell_hyperplas, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (LGV, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Histoplasmosis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Coccidioidomycosis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (CMV, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Brucellosis, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Intermed_lymphocytic, GT_90pc) 0.00, 0.75, 0.20, 0.05;
}
probability ( F_MITO | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.00, 0.05, 0.15, 0.80;
  (AILD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (ALIP, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Cat_scratch_disease, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Dermatopathic_laden, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Florid_follic_hyperp, 1_to_25pc) 0.00, 0.05, 0.15, 0.80;
  (GLH_hyaline_vascular, 1_to_25pc) 0.00, 0.95, 0.04, 0.01;
  (GLH_plasma_cell, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Granulomatous_laden, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Histiocytosis_x, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Infectious_mono, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Leprosy_lepromatous, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Lymphangiographic, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Rheumatoid_arthritis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Sarcoidosis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (SHML, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Sinus_histiocytosis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Syphilis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Toxoplasmosis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Tuberculosis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Viral_NOS, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Whipple_s_disease, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (L_H_nodular_HD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (L_H_diffuse_HD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Cellular_phase_NSHD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Syncytial_NSHD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Mixed_cellularity_HD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Interfollicular_HD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Reticular_type_HD, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Small_cleaved_fol, 1_to_25pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_fol, 1_to_25pc) 0.00, 0.70, 0.25, 0.05;
  (Large_cell_fol, 1_to_25pc) 0.0, 0.3, 0.5, 0.2;
  (Small_noncleaved_fol, 1_to_25pc) 0.00, 0.10, 0.55, 0.35;
  (Small_lymphocytic, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Small_cleaved_dif, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Mixed_FCC_dif, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Large_cell_dif, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (B_immunoblastic, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (T_immunob_mixed, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Japanese_ATL, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Lymphoblastic, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Small_noncleaved_dif, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (True_histiocytic, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Multiple_myeloma, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Mycosis_fungoides, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (AML, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Hairy_cell_leukemia, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Carcinoma, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Melanoma, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (EM_plasmacytoma, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.00, 0.15, 0.20, 0.65;
  (Mast_cell_disease, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (AIDS_involutionary, 1_to_25pc) 0.00, 0.65, 0.20, 0.15;
  (T_immunob_large, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Monocytoid_B_cell, 1_to_25pc) 0.0, 0.3, 0.4, 0.3;
  (Nasopharyngeal_CA, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Seminoma, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (SLE, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Mycobact_histiocytos, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Mast_cell_hyperplas, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (LGV, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Histoplasmosis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Coccidioidomycosis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (CMV, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Brucellosis, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (Intermed_lymphocytic, 1_to_25pc) 0.0, 0.2, 0.4, 0.4;
  (AIDS_early, 25_to_75pc) 0.00, 0.05, 0.15, 0.80;
  (AILD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (ALIP, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Cat_scratch_disease, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Dermatopathic_laden, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Florid_follic_hyperp, 25_to_75pc) 0.00, 0.05, 0.15, 0.80;
  (GLH_hyaline_vascular, 25_to_75pc) 0.00, 0.95, 0.04, 0.01;
  (GLH_plasma_cell, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Granulomatous_laden, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Histiocytosis_x, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Infectious_mono, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Leprosy_lepromatous, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Lymphangiographic, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Rheumatoid_arthritis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Sarcoidosis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (SHML, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Sinus_histiocytosis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Syphilis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Toxoplasmosis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Tuberculosis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Viral_NOS, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Whipple_s_disease, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (L_H_nodular_HD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (L_H_diffuse_HD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Cellular_phase_NSHD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Syncytial_NSHD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Mixed_cellularity_HD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Interfollicular_HD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Reticular_type_HD, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Small_cleaved_fol, 25_to_75pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_fol, 25_to_75pc) 0.00, 0.70, 0.25, 0.05;
  (Large_cell_fol, 25_to_75pc) 0.0, 0.3, 0.5, 0.2;
  (Small_noncleaved_fol, 25_to_75pc) 0.00, 0.10, 0.55, 0.35;
  (Small_lymphocytic, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Small_cleaved_dif, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Mixed_FCC_dif, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Large_cell_dif, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (B_immunoblastic, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (T_immunob_mixed, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Japanese_ATL, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Lymphoblastic, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Small_noncleaved_dif, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (True_histiocytic, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Multiple_myeloma, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Mycosis_fungoides, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (AML, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Hairy_cell_leukemia, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Carcinoma, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Melanoma, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (EM_plasmacytoma, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.00, 0.15, 0.20, 0.65;
  (Mast_cell_disease, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (AIDS_involutionary, 25_to_75pc) 0.00, 0.65, 0.20, 0.15;
  (T_immunob_large, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Monocytoid_B_cell, 25_to_75pc) 0.0, 0.3, 0.4, 0.3;
  (Nasopharyngeal_CA, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Seminoma, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (SLE, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Mycobact_histiocytos, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Mast_cell_hyperplas, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (LGV, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Histoplasmosis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Coccidioidomycosis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (CMV, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Brucellosis, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (Intermed_lymphocytic, 25_to_75pc) 0.0, 0.2, 0.4, 0.4;
  (AIDS_early, 75_to_90pc) 0.00, 0.05, 0.15, 0.80;
  (AILD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (ALIP, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Cat_scratch_disease, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Dermatopathic_laden, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Florid_follic_hyperp, 75_to_90pc) 0.00, 0.05, 0.15, 0.80;
  (GLH_hyaline_vascular, 75_to_90pc) 0.00, 0.95, 0.04, 0.01;
  (GLH_plasma_cell, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Granulomatous_laden, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Histiocytosis_x, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Infectious_mono, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Leprosy_lepromatous, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Lymphangiographic, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Rheumatoid_arthritis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Sarcoidosis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (SHML, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Sinus_histiocytosis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Syphilis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Toxoplasmosis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Tuberculosis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Viral_NOS, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Whipple_s_disease, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (L_H_nodular_HD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (L_H_diffuse_HD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Cellular_phase_NSHD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Syncytial_NSHD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mixed_cellularity_HD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Interfollicular_HD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Reticular_type_HD, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Small_cleaved_fol, 75_to_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_fol, 75_to_90pc) 0.00, 0.70, 0.25, 0.05;
  (Large_cell_fol, 75_to_90pc) 0.0, 0.3, 0.5, 0.2;
  (Small_noncleaved_fol, 75_to_90pc) 0.00, 0.10, 0.55, 0.35;
  (Small_lymphocytic, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Small_cleaved_dif, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mixed_FCC_dif, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Large_cell_dif, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (B_immunoblastic, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (T_immunob_mixed, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Japanese_ATL, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Lymphoblastic, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Small_noncleaved_dif, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (True_histiocytic, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Multiple_myeloma, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mycosis_fungoides, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (AML, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Hairy_cell_leukemia, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Carcinoma, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Melanoma, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (EM_plasmacytoma, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.00, 0.15, 0.20, 0.65;
  (Mast_cell_disease, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (AIDS_involutionary, 75_to_90pc) 0.00, 0.65, 0.20, 0.15;
  (T_immunob_large, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Monocytoid_B_cell, 75_to_90pc) 0.0, 0.3, 0.4, 0.3;
  (Nasopharyngeal_CA, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Seminoma, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (SLE, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mycobact_histiocytos, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mast_cell_hyperplas, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (LGV, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Histoplasmosis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Coccidioidomycosis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (CMV, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Brucellosis, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (Intermed_lymphocytic, 75_to_90pc) 0.0, 0.2, 0.4, 0.4;
  (AIDS_early, GT_90pc) 0.00, 0.05, 0.15, 0.80;
  (AILD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (ALIP, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Cat_scratch_disease, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Dermatopathic_laden, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Florid_follic_hyperp, GT_90pc) 0.00, 0.05, 0.15, 0.80;
  (GLH_hyaline_vascular, GT_90pc) 0.00, 0.95, 0.04, 0.01;
  (GLH_plasma_cell, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Granulomatous_laden, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Histiocytosis_x, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Infectious_mono, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Leprosy_lepromatous, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Lymphangiographic, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mantle_zone_hyperpla, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Necrotizing_Kikuchi, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Rheumatoid_arthritis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Sarcoidosis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (SHML, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Sinus_histiocytosis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Syphilis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Toxoplasmosis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Tuberculosis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Viral_NOS, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Whipple_s_disease, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (L_H_nodular_HD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (L_H_diffuse_HD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Nodular_sclerosis_HD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Cellular_phase_NSHD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Syncytial_NSHD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mixed_cellularity_HD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Interfollicular_HD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Diffuse_fibrosis_HD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Reticular_type_HD, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Small_cleaved_fol, GT_90pc) 0.00, 0.75, 0.20, 0.05;
  (Mixed_fol, GT_90pc) 0.00, 0.70, 0.25, 0.05;
  (Large_cell_fol, GT_90pc) 0.0, 0.3, 0.5, 0.2;
  (Small_noncleaved_fol, GT_90pc) 0.00, 0.10, 0.55, 0.35;
  (Small_lymphocytic, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Plasmacytoid_lyctic, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mantle_zone_lymphoma, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Small_cleaved_dif, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mixed_FCC_dif, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Large_cell_dif, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (B_immunoblastic, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (T_immunob_mixed, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (AILD_like_T_cell_lym, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Japanese_ATL, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Lymphoblastic, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Small_noncleaved_dif, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (True_histiocytic, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Multiple_myeloma, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mycosis_fungoides, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (AML, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Hairy_cell_leukemia, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Carcinoma, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Melanoma, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (EM_plasmacytoma, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Kaposi_s_sarcoma, GT_90pc) 0.00, 0.15, 0.20, 0.65;
  (Mast_cell_disease, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (AIDS_involutionary, GT_90pc) 0.00, 0.65, 0.20, 0.15;
  (T_immunob_large, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Monocytoid_B_cell, GT_90pc) 0.0, 0.3, 0.4, 0.3;
  (Nasopharyngeal_CA, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Seminoma, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (SLE, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mycobact_histiocytos, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Mast_cell_hyperplas, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (LGV, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Histoplasmosis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Coccidioidomycosis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (CMV, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Brucellosis, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.0, 0.2, 0.4, 0.4;
  (Intermed_lymphocytic, GT_90pc) 0.0, 0.2, 0.4, 0.4;
}
probability ( F_MZ | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.00, 0.95, 0.05;
  (AILD, 1_to_25pc) 0.0, 0.1, 0.9;
  (ALIP, 1_to_25pc) 0.0, 0.1, 0.9;
  (Cat_scratch_disease, 1_to_25pc) 0.0, 0.1, 0.9;
  (Dermatopathic_laden, 1_to_25pc) 0.0, 0.1, 0.9;
  (Florid_follic_hyperp, 1_to_25pc) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, 1_to_25pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, 1_to_25pc) 0.0, 0.1, 0.9;
  (Granulomatous_laden, 1_to_25pc) 0.0, 0.1, 0.9;
  (Histiocytosis_x, 1_to_25pc) 0.0, 0.1, 0.9;
  (Infectious_mono, 1_to_25pc) 0.0, 0.1, 0.9;
  (Leprosy_lepromatous, 1_to_25pc) 0.0, 0.1, 0.9;
  (Lymphangiographic, 1_to_25pc) 0.0, 0.1, 0.9;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.0, 0.1, 0.9;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.0, 0.1, 0.9;
  (Rheumatoid_arthritis, 1_to_25pc) 0.0, 0.1, 0.9;
  (Sarcoidosis, 1_to_25pc) 0.0, 0.1, 0.9;
  (SHML, 1_to_25pc) 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, 1_to_25pc) 0.0, 0.1, 0.9;
  (Syphilis, 1_to_25pc) 0.0, 0.1, 0.9;
  (Toxoplasmosis, 1_to_25pc) 0.0, 0.1, 0.9;
  (Tuberculosis, 1_to_25pc) 0.0, 0.1, 0.9;
  (Viral_NOS, 1_to_25pc) 0.0, 0.1, 0.9;
  (Whipple_s_disease, 1_to_25pc) 0.0, 0.1, 0.9;
  (L_H_nodular_HD, 1_to_25pc) 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, 1_to_25pc) 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, 1_to_25pc) 0.0, 0.1, 0.9;
  (Syncytial_NSHD, 1_to_25pc) 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, 1_to_25pc) 0.0, 0.1, 0.9;
  (Interfollicular_HD, 1_to_25pc) 0.0, 0.1, 0.9;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.0, 0.1, 0.9;
  (Reticular_type_HD, 1_to_25pc) 0.0, 0.1, 0.9;
  (Small_cleaved_fol, 1_to_25pc) 0.0, 0.8, 0.2;
  (Mixed_fol, 1_to_25pc) 0.0, 0.8, 0.2;
  (Large_cell_fol, 1_to_25pc) 0.0, 0.9, 0.1;
  (Small_noncleaved_fol, 1_to_25pc) 0.00, 0.95, 0.05;
  (Small_lymphocytic, 1_to_25pc) 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.0, 0.0, 1.0;
  (Small_cleaved_dif, 1_to_25pc) 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, 1_to_25pc) 0.0, 0.1, 0.9;
  (Large_cell_dif, 1_to_25pc) 0.0, 0.1, 0.9;
  (B_immunoblastic, 1_to_25pc) 0.0, 0.1, 0.9;
  (T_immunob_mixed, 1_to_25pc) 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.0, 0.1, 0.9;
  (Japanese_ATL, 1_to_25pc) 0.0, 0.1, 0.9;
  (Lymphoblastic, 1_to_25pc) 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, 1_to_25pc) 0.0, 0.1, 0.9;
  (True_histiocytic, 1_to_25pc) 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.0, 0.1, 0.9;
  (Multiple_myeloma, 1_to_25pc) 0.0, 0.1, 0.9;
  (Mycosis_fungoides, 1_to_25pc) 0.0, 0.1, 0.9;
  (AML, 1_to_25pc) 0.0, 0.1, 0.9;
  (Hairy_cell_leukemia, 1_to_25pc) 0.0, 0.1, 0.9;
  (Carcinoma, 1_to_25pc) 0.0, 0.1, 0.9;
  (Melanoma, 1_to_25pc) 0.0, 0.1, 0.9;
  (EM_plasmacytoma, 1_to_25pc) 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.0, 0.1, 0.9;
  (Mast_cell_disease, 1_to_25pc) 0.0, 0.1, 0.9;
  (AIDS_involutionary, 1_to_25pc) 0.0, 0.9, 0.1;
  (T_immunob_large, 1_to_25pc) 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, 1_to_25pc) 0.00, 0.25, 0.75;
  (Nasopharyngeal_CA, 1_to_25pc) 0.0, 0.1, 0.9;
  (Seminoma, 1_to_25pc) 0.0, 0.1, 0.9;
  (SLE, 1_to_25pc) 0.0, 0.1, 0.9;
  (Mycobact_histiocytos, 1_to_25pc) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, 1_to_25pc) 0.0, 0.1, 0.9;
  (LGV, 1_to_25pc) 0.0, 0.1, 0.9;
  (Histoplasmosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, 1_to_25pc) 0.0, 0.9, 0.1;
  (CMV, 1_to_25pc) 0.0, 0.9, 0.1;
  (Brucellosis, 1_to_25pc) 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.0, 0.1, 0.9;
  (Intermed_lymphocytic, 1_to_25pc) 0.0, 0.0, 1.0;
  (AIDS_early, 25_to_75pc) 0.00, 0.95, 0.05;
  (AILD, 25_to_75pc) 0.0, 0.1, 0.9;
  (ALIP, 25_to_75pc) 0.0, 0.1, 0.9;
  (Cat_scratch_disease, 25_to_75pc) 0.0, 0.1, 0.9;
  (Dermatopathic_laden, 25_to_75pc) 0.0, 0.1, 0.9;
  (Florid_follic_hyperp, 25_to_75pc) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, 25_to_75pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, 25_to_75pc) 0.0, 0.1, 0.9;
  (Granulomatous_laden, 25_to_75pc) 0.0, 0.1, 0.9;
  (Histiocytosis_x, 25_to_75pc) 0.0, 0.1, 0.9;
  (Infectious_mono, 25_to_75pc) 0.0, 0.1, 0.9;
  (Leprosy_lepromatous, 25_to_75pc) 0.0, 0.1, 0.9;
  (Lymphangiographic, 25_to_75pc) 0.0, 0.1, 0.9;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.0, 0.1, 0.9;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.0, 0.1, 0.9;
  (Rheumatoid_arthritis, 25_to_75pc) 0.0, 0.1, 0.9;
  (Sarcoidosis, 25_to_75pc) 0.0, 0.1, 0.9;
  (SHML, 25_to_75pc) 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, 25_to_75pc) 0.0, 0.1, 0.9;
  (Syphilis, 25_to_75pc) 0.0, 0.1, 0.9;
  (Toxoplasmosis, 25_to_75pc) 0.0, 0.1, 0.9;
  (Tuberculosis, 25_to_75pc) 0.0, 0.1, 0.9;
  (Viral_NOS, 25_to_75pc) 0.0, 0.1, 0.9;
  (Whipple_s_disease, 25_to_75pc) 0.0, 0.1, 0.9;
  (L_H_nodular_HD, 25_to_75pc) 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, 25_to_75pc) 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, 25_to_75pc) 0.0, 0.1, 0.9;
  (Syncytial_NSHD, 25_to_75pc) 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, 25_to_75pc) 0.0, 0.1, 0.9;
  (Interfollicular_HD, 25_to_75pc) 0.0, 0.1, 0.9;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.0, 0.1, 0.9;
  (Reticular_type_HD, 25_to_75pc) 0.0, 0.1, 0.9;
  (Small_cleaved_fol, 25_to_75pc) 0.0, 0.8, 0.2;
  (Mixed_fol, 25_to_75pc) 0.0, 0.8, 0.2;
  (Large_cell_fol, 25_to_75pc) 0.0, 0.9, 0.1;
  (Small_noncleaved_fol, 25_to_75pc) 0.00, 0.95, 0.05;
  (Small_lymphocytic, 25_to_75pc) 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.0, 0.0, 1.0;
  (Small_cleaved_dif, 25_to_75pc) 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, 25_to_75pc) 0.0, 0.1, 0.9;
  (Large_cell_dif, 25_to_75pc) 0.0, 0.1, 0.9;
  (B_immunoblastic, 25_to_75pc) 0.0, 0.1, 0.9;
  (T_immunob_mixed, 25_to_75pc) 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.0, 0.1, 0.9;
  (Japanese_ATL, 25_to_75pc) 0.0, 0.1, 0.9;
  (Lymphoblastic, 25_to_75pc) 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, 25_to_75pc) 0.0, 0.1, 0.9;
  (True_histiocytic, 25_to_75pc) 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.0, 0.1, 0.9;
  (Multiple_myeloma, 25_to_75pc) 0.0, 0.1, 0.9;
  (Mycosis_fungoides, 25_to_75pc) 0.0, 0.1, 0.9;
  (AML, 25_to_75pc) 0.0, 0.1, 0.9;
  (Hairy_cell_leukemia, 25_to_75pc) 0.0, 0.1, 0.9;
  (Carcinoma, 25_to_75pc) 0.0, 0.1, 0.9;
  (Melanoma, 25_to_75pc) 0.0, 0.1, 0.9;
  (EM_plasmacytoma, 25_to_75pc) 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.0, 0.1, 0.9;
  (Mast_cell_disease, 25_to_75pc) 0.0, 0.1, 0.9;
  (AIDS_involutionary, 25_to_75pc) 0.0, 0.9, 0.1;
  (T_immunob_large, 25_to_75pc) 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, 25_to_75pc) 0.00, 0.25, 0.75;
  (Nasopharyngeal_CA, 25_to_75pc) 0.0, 0.1, 0.9;
  (Seminoma, 25_to_75pc) 0.0, 0.1, 0.9;
  (SLE, 25_to_75pc) 0.0, 0.1, 0.9;
  (Mycobact_histiocytos, 25_to_75pc) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, 25_to_75pc) 0.0, 0.1, 0.9;
  (LGV, 25_to_75pc) 0.0, 0.1, 0.9;
  (Histoplasmosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, 25_to_75pc) 0.0, 0.9, 0.1;
  (CMV, 25_to_75pc) 0.0, 0.9, 0.1;
  (Brucellosis, 25_to_75pc) 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.0, 0.1, 0.9;
  (Intermed_lymphocytic, 25_to_75pc) 0.3333333, 0.3333333, 0.3333333;
  (AIDS_early, 75_to_90pc) 0.00, 0.95, 0.05;
  (AILD, 75_to_90pc) 0.0, 0.1, 0.9;
  (ALIP, 75_to_90pc) 0.0, 0.1, 0.9;
  (Cat_scratch_disease, 75_to_90pc) 0.0, 0.1, 0.9;
  (Dermatopathic_laden, 75_to_90pc) 0.0, 0.1, 0.9;
  (Florid_follic_hyperp, 75_to_90pc) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, 75_to_90pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, 75_to_90pc) 0.0, 0.1, 0.9;
  (Granulomatous_laden, 75_to_90pc) 0.0, 0.1, 0.9;
  (Histiocytosis_x, 75_to_90pc) 0.0, 0.1, 0.9;
  (Infectious_mono, 75_to_90pc) 0.0, 0.1, 0.9;
  (Leprosy_lepromatous, 75_to_90pc) 0.0, 0.1, 0.9;
  (Lymphangiographic, 75_to_90pc) 0.0, 0.1, 0.9;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.0, 0.1, 0.9;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.0, 0.1, 0.9;
  (Rheumatoid_arthritis, 75_to_90pc) 0.0, 0.1, 0.9;
  (Sarcoidosis, 75_to_90pc) 0.0, 0.1, 0.9;
  (SHML, 75_to_90pc) 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, 75_to_90pc) 0.0, 0.1, 0.9;
  (Syphilis, 75_to_90pc) 0.0, 0.1, 0.9;
  (Toxoplasmosis, 75_to_90pc) 0.0, 0.1, 0.9;
  (Tuberculosis, 75_to_90pc) 0.0, 0.1, 0.9;
  (Viral_NOS, 75_to_90pc) 0.0, 0.1, 0.9;
  (Whipple_s_disease, 75_to_90pc) 0.0, 0.1, 0.9;
  (L_H_nodular_HD, 75_to_90pc) 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, 75_to_90pc) 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, 75_to_90pc) 0.0, 0.1, 0.9;
  (Syncytial_NSHD, 75_to_90pc) 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, 75_to_90pc) 0.0, 0.1, 0.9;
  (Interfollicular_HD, 75_to_90pc) 0.0, 0.1, 0.9;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.0, 0.1, 0.9;
  (Reticular_type_HD, 75_to_90pc) 0.0, 0.1, 0.9;
  (Small_cleaved_fol, 75_to_90pc) 0.0, 0.8, 0.2;
  (Mixed_fol, 75_to_90pc) 0.0, 0.8, 0.2;
  (Large_cell_fol, 75_to_90pc) 0.0, 0.9, 0.1;
  (Small_noncleaved_fol, 75_to_90pc) 0.00, 0.95, 0.05;
  (Small_lymphocytic, 75_to_90pc) 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.0, 0.0, 1.0;
  (Small_cleaved_dif, 75_to_90pc) 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, 75_to_90pc) 0.0, 0.1, 0.9;
  (Large_cell_dif, 75_to_90pc) 0.0, 0.1, 0.9;
  (B_immunoblastic, 75_to_90pc) 0.0, 0.1, 0.9;
  (T_immunob_mixed, 75_to_90pc) 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.0, 0.1, 0.9;
  (Japanese_ATL, 75_to_90pc) 0.0, 0.1, 0.9;
  (Lymphoblastic, 75_to_90pc) 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, 75_to_90pc) 0.0, 0.1, 0.9;
  (True_histiocytic, 75_to_90pc) 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.0, 0.1, 0.9;
  (Multiple_myeloma, 75_to_90pc) 0.0, 0.1, 0.9;
  (Mycosis_fungoides, 75_to_90pc) 0.0, 0.1, 0.9;
  (AML, 75_to_90pc) 0.0, 0.1, 0.9;
  (Hairy_cell_leukemia, 75_to_90pc) 0.0, 0.1, 0.9;
  (Carcinoma, 75_to_90pc) 0.0, 0.1, 0.9;
  (Melanoma, 75_to_90pc) 0.0, 0.1, 0.9;
  (EM_plasmacytoma, 75_to_90pc) 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.0, 0.1, 0.9;
  (Mast_cell_disease, 75_to_90pc) 0.0, 0.1, 0.9;
  (AIDS_involutionary, 75_to_90pc) 0.0, 0.9, 0.1;
  (T_immunob_large, 75_to_90pc) 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, 75_to_90pc) 0.00, 0.25, 0.75;
  (Nasopharyngeal_CA, 75_to_90pc) 0.0, 0.1, 0.9;
  (Seminoma, 75_to_90pc) 0.0, 0.1, 0.9;
  (SLE, 75_to_90pc) 0.0, 0.1, 0.9;
  (Mycobact_histiocytos, 75_to_90pc) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, 75_to_90pc) 0.0, 0.1, 0.9;
  (LGV, 75_to_90pc) 0.0, 0.1, 0.9;
  (Histoplasmosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, 75_to_90pc) 0.0, 0.9, 0.1;
  (CMV, 75_to_90pc) 0.0, 0.9, 0.1;
  (Brucellosis, 75_to_90pc) 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.0, 0.1, 0.9;
  (Intermed_lymphocytic, 75_to_90pc) 0.3333333, 0.3333333, 0.3333333;
  (AIDS_early, GT_90pc) 0.00, 0.95, 0.05;
  (AILD, GT_90pc) 0.0, 0.1, 0.9;
  (ALIP, GT_90pc) 0.0, 0.1, 0.9;
  (Cat_scratch_disease, GT_90pc) 0.0, 0.1, 0.9;
  (Dermatopathic_laden, GT_90pc) 0.0, 0.1, 0.9;
  (Florid_follic_hyperp, GT_90pc) 0.0, 0.9, 0.1;
  (GLH_hyaline_vascular, GT_90pc) 0.0, 0.0, 1.0;
  (GLH_plasma_cell, GT_90pc) 0.0, 0.1, 0.9;
  (Granulomatous_laden, GT_90pc) 0.0, 0.1, 0.9;
  (Histiocytosis_x, GT_90pc) 0.0, 0.1, 0.9;
  (Infectious_mono, GT_90pc) 0.0, 0.1, 0.9;
  (Leprosy_lepromatous, GT_90pc) 0.0, 0.1, 0.9;
  (Lymphangiographic, GT_90pc) 0.0, 0.1, 0.9;
  (Mantle_zone_hyperpla, GT_90pc) 0.0, 0.0, 1.0;
  (Necrotizing_Kikuchi, GT_90pc) 0.0, 0.1, 0.9;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.0, 0.1, 0.9;
  (Rheumatoid_arthritis, GT_90pc) 0.0, 0.1, 0.9;
  (Sarcoidosis, GT_90pc) 0.0, 0.1, 0.9;
  (SHML, GT_90pc) 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, GT_90pc) 0.0, 0.1, 0.9;
  (Syphilis, GT_90pc) 0.0, 0.1, 0.9;
  (Toxoplasmosis, GT_90pc) 0.0, 0.1, 0.9;
  (Tuberculosis, GT_90pc) 0.0, 0.1, 0.9;
  (Viral_NOS, GT_90pc) 0.0, 0.1, 0.9;
  (Whipple_s_disease, GT_90pc) 0.0, 0.1, 0.9;
  (L_H_nodular_HD, GT_90pc) 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, GT_90pc) 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, GT_90pc) 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, GT_90pc) 0.0, 0.1, 0.9;
  (Syncytial_NSHD, GT_90pc) 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, GT_90pc) 0.0, 0.1, 0.9;
  (Interfollicular_HD, GT_90pc) 0.0, 0.1, 0.9;
  (Diffuse_fibrosis_HD, GT_90pc) 0.0, 0.1, 0.9;
  (Reticular_type_HD, GT_90pc) 0.0, 0.1, 0.9;
  (Small_cleaved_fol, GT_90pc) 0.0, 0.8, 0.2;
  (Mixed_fol, GT_90pc) 0.0, 0.8, 0.2;
  (Large_cell_fol, GT_90pc) 0.0, 0.9, 0.1;
  (Small_noncleaved_fol, GT_90pc) 0.00, 0.95, 0.05;
  (Small_lymphocytic, GT_90pc) 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, GT_90pc) 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
  (Small_cleaved_dif, GT_90pc) 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, GT_90pc) 0.0, 0.1, 0.9;
  (Large_cell_dif, GT_90pc) 0.0, 0.1, 0.9;
  (B_immunoblastic, GT_90pc) 0.0, 0.1, 0.9;
  (T_immunob_mixed, GT_90pc) 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, GT_90pc) 0.0, 0.1, 0.9;
  (Japanese_ATL, GT_90pc) 0.0, 0.1, 0.9;
  (Lymphoblastic, GT_90pc) 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, GT_90pc) 0.0, 0.1, 0.9;
  (True_histiocytic, GT_90pc) 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.0, 0.1, 0.9;
  (Multiple_myeloma, GT_90pc) 0.0, 0.1, 0.9;
  (Mycosis_fungoides, GT_90pc) 0.0, 0.1, 0.9;
  (AML, GT_90pc) 0.0, 0.1, 0.9;
  (Hairy_cell_leukemia, GT_90pc) 0.0, 0.1, 0.9;
  (Carcinoma, GT_90pc) 0.0, 0.1, 0.9;
  (Melanoma, GT_90pc) 0.0, 0.1, 0.9;
  (EM_plasmacytoma, GT_90pc) 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, GT_90pc) 0.0, 0.1, 0.9;
  (Mast_cell_disease, GT_90pc) 0.0, 0.1, 0.9;
  (AIDS_involutionary, GT_90pc) 0.0, 0.9, 0.1;
  (T_immunob_large, GT_90pc) 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, GT_90pc) 0.00, 0.25, 0.75;
  (Nasopharyngeal_CA, GT_90pc) 0.0, 0.1, 0.9;
  (Seminoma, GT_90pc) 0.0, 0.1, 0.9;
  (SLE, GT_90pc) 0.0, 0.1, 0.9;
  (Mycobact_histiocytos, GT_90pc) 0.0, 0.9, 0.1;
  (Mast_cell_hyperplas, GT_90pc) 0.0, 0.1, 0.9;
  (LGV, GT_90pc) 0.0, 0.1, 0.9;
  (Histoplasmosis, GT_90pc) 0.0, 0.9, 0.1;
  (Coccidioidomycosis, GT_90pc) 0.0, 0.9, 0.1;
  (CMV, GT_90pc) 0.0, 0.9, 0.1;
  (Brucellosis, GT_90pc) 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.0, 0.1, 0.9;
  (Intermed_lymphocytic, GT_90pc) 0.3333333, 0.3333333, 0.3333333;
}
probability ( F_CIO | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (AILD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (ALIP, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Cat_scratch_disease, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Dermatopathic_laden, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Florid_follic_hyperp, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (GLH_hyaline_vascular, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (GLH_plasma_cell, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Granulomatous_laden, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Histiocytosis_x, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Infectious_mono, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Leprosy_lepromatous, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphangiographic, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Rheumatoid_arthritis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Sarcoidosis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (SHML, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Syphilis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Toxoplasmosis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Tuberculosis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Viral_NOS, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Whipple_s_disease, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_nodular_HD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Syncytial_NSHD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Interfollicular_HD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Reticular_type_HD, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_fol, 1_to_25pc) 0.0, 0.5, 0.4, 0.1;
  (Mixed_fol, 1_to_25pc) 0.0, 0.5, 0.4, 0.1;
  (Large_cell_fol, 1_to_25pc) 0.00, 0.80, 0.15, 0.05;
  (Small_noncleaved_fol, 1_to_25pc) 0.00, 0.90, 0.08, 0.02;
  (Small_lymphocytic, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_dif, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Large_cell_dif, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (B_immunoblastic, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_mixed, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Japanese_ATL, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphoblastic, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (True_histiocytic, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Multiple_myeloma, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Mycosis_fungoides, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (AML, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Hairy_cell_leukemia, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Carcinoma, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Melanoma, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (EM_plasmacytoma, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Mast_cell_disease, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (AIDS_involutionary, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_large, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, 1_to_25pc) 0.00, 0.05, 0.03, 0.92;
  (Nasopharyngeal_CA, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Seminoma, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (SLE, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Mycobact_histiocytos, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Mast_cell_hyperplas, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (LGV, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Histoplasmosis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Coccidioidomycosis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (CMV, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Brucellosis, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (Intermed_lymphocytic, 1_to_25pc) 0.0, 0.0, 0.1, 0.9;
  (AIDS_early, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (AILD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (ALIP, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Cat_scratch_disease, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Dermatopathic_laden, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Florid_follic_hyperp, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (GLH_hyaline_vascular, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (GLH_plasma_cell, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Granulomatous_laden, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Histiocytosis_x, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Infectious_mono, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Leprosy_lepromatous, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphangiographic, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Rheumatoid_arthritis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Sarcoidosis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (SHML, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Syphilis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Toxoplasmosis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Tuberculosis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Viral_NOS, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Whipple_s_disease, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_nodular_HD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Syncytial_NSHD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Interfollicular_HD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Reticular_type_HD, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_fol, 25_to_75pc) 0.0, 0.5, 0.4, 0.1;
  (Mixed_fol, 25_to_75pc) 0.0, 0.5, 0.4, 0.1;
  (Large_cell_fol, 25_to_75pc) 0.00, 0.80, 0.15, 0.05;
  (Small_noncleaved_fol, 25_to_75pc) 0.00, 0.90, 0.08, 0.02;
  (Small_lymphocytic, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_dif, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Large_cell_dif, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (B_immunoblastic, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_mixed, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Japanese_ATL, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphoblastic, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (True_histiocytic, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Multiple_myeloma, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Mycosis_fungoides, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (AML, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Hairy_cell_leukemia, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Carcinoma, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Melanoma, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (EM_plasmacytoma, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Mast_cell_disease, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (AIDS_involutionary, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_large, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, 25_to_75pc) 0.00, 0.05, 0.03, 0.92;
  (Nasopharyngeal_CA, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Seminoma, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (SLE, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Mycobact_histiocytos, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Mast_cell_hyperplas, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (LGV, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Histoplasmosis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Coccidioidomycosis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (CMV, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Brucellosis, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (Intermed_lymphocytic, 25_to_75pc) 0.0, 0.0, 0.1, 0.9;
  (AIDS_early, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (AILD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (ALIP, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Cat_scratch_disease, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Dermatopathic_laden, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Florid_follic_hyperp, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (GLH_hyaline_vascular, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (GLH_plasma_cell, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Granulomatous_laden, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Histiocytosis_x, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Infectious_mono, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Leprosy_lepromatous, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphangiographic, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Rheumatoid_arthritis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Sarcoidosis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (SHML, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Syphilis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Toxoplasmosis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Tuberculosis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Viral_NOS, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Whipple_s_disease, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_nodular_HD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Syncytial_NSHD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Interfollicular_HD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Reticular_type_HD, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_fol, 75_to_90pc) 0.0, 0.5, 0.4, 0.1;
  (Mixed_fol, 75_to_90pc) 0.0, 0.5, 0.4, 0.1;
  (Large_cell_fol, 75_to_90pc) 0.00, 0.80, 0.13, 0.07;
  (Small_noncleaved_fol, 75_to_90pc) 0.00, 0.85, 0.10, 0.05;
  (Small_lymphocytic, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_dif, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Large_cell_dif, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (B_immunoblastic, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_mixed, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Japanese_ATL, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphoblastic, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (True_histiocytic, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Multiple_myeloma, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mycosis_fungoides, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (AML, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Hairy_cell_leukemia, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Carcinoma, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Melanoma, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (EM_plasmacytoma, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mast_cell_disease, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (AIDS_involutionary, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_large, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, 75_to_90pc) 0.00, 0.05, 0.03, 0.92;
  (Nasopharyngeal_CA, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Seminoma, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (SLE, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mycobact_histiocytos, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mast_cell_hyperplas, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (LGV, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Histoplasmosis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Coccidioidomycosis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (CMV, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Brucellosis, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (Intermed_lymphocytic, 75_to_90pc) 0.0, 0.0, 0.1, 0.9;
  (AIDS_early, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (AILD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (ALIP, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Cat_scratch_disease, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Dermatopathic_laden, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Florid_follic_hyperp, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (GLH_hyaline_vascular, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (GLH_plasma_cell, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Granulomatous_laden, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Histiocytosis_x, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Infectious_mono, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Leprosy_lepromatous, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphangiographic, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_hyperpla, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Necrotizing_Kikuchi, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Rheumatoid_arthritis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Sarcoidosis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (SHML, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Sinus_histiocytosis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Syphilis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Toxoplasmosis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Tuberculosis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Viral_NOS, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Whipple_s_disease, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_nodular_HD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (L_H_diffuse_HD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Nodular_sclerosis_HD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Cellular_phase_NSHD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Syncytial_NSHD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_cellularity_HD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Interfollicular_HD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Diffuse_fibrosis_HD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Reticular_type_HD, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_fol, GT_90pc) 0.0, 0.5, 0.4, 0.1;
  (Mixed_fol, GT_90pc) 0.0, 0.5, 0.4, 0.1;
  (Large_cell_fol, GT_90pc) 0.0, 0.7, 0.2, 0.1;
  (Small_noncleaved_fol, GT_90pc) 0.00, 0.85, 0.10, 0.05;
  (Small_lymphocytic, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Plasmacytoid_lyctic, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mantle_zone_lymphoma, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Small_cleaved_dif, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mixed_FCC_dif, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Large_cell_dif, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (B_immunoblastic, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_mixed, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (AILD_like_T_cell_lym, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Japanese_ATL, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Lymphoblastic, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Small_noncleaved_dif, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (True_histiocytic, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Multiple_myeloma, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mycosis_fungoides, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (AML, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Hairy_cell_leukemia, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Carcinoma, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Melanoma, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (EM_plasmacytoma, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Kaposi_s_sarcoma, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mast_cell_disease, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (AIDS_involutionary, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (T_immunob_large, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Monocytoid_B_cell, GT_90pc) 0.00, 0.07, 0.03, 0.90;
  (Nasopharyngeal_CA, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Seminoma, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (SLE, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mycobact_histiocytos, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Mast_cell_hyperplas, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (LGV, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Histoplasmosis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Coccidioidomycosis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (CMV, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Brucellosis, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.0, 0.0, 0.1, 0.9;
  (Intermed_lymphocytic, GT_90pc) 0.0, 0.0, 0.1, 0.9;
}
probability ( LLC_KL | Fault, LLC_ID ) {
  (AIDS_early, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AILD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (ALIP, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (SHML, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AML, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (SLE, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (LGV, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (CMV, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_LLCs) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Other) 0.0, 0.1, 0.0, 0.9;
  (AILD, Other) 0.0, 0.1, 0.0, 0.9;
  (ALIP, Other) 0.0, 0.1, 0.0, 0.9;
  (Cat_scratch_disease, Other) 0.0, 0.1, 0.0, 0.9;
  (Dermatopathic_laden, Other) 0.0, 0.1, 0.0, 0.9;
  (Florid_follic_hyperp, Other) 0.0, 0.1, 0.0, 0.9;
  (GLH_hyaline_vascular, Other) 0.0, 0.1, 0.0, 0.9;
  (GLH_plasma_cell, Other) 0.0, 0.1, 0.0, 0.9;
  (Granulomatous_laden, Other) 0.0, 0.1, 0.0, 0.9;
  (Histiocytosis_x, Other) 0.0, 0.1, 0.0, 0.9;
  (Infectious_mono, Other) 0.0, 0.1, 0.0, 0.9;
  (Leprosy_lepromatous, Other) 0.0, 0.1, 0.0, 0.9;
  (Lymphangiographic, Other) 0.0, 0.1, 0.0, 0.9;
  (Mantle_zone_hyperpla, Other) 0.0, 0.1, 0.0, 0.9;
  (Necrotizing_Kikuchi, Other) 0.0, 0.1, 0.0, 0.9;
  (Necrotiz_non_Kikuchi, Other) 0.0, 0.1, 0.0, 0.9;
  (Rheumatoid_arthritis, Other) 0.0, 0.1, 0.0, 0.9;
  (Sarcoidosis, Other) 0.0, 0.1, 0.0, 0.9;
  (SHML, Other) 0.0, 0.1, 0.0, 0.9;
  (Sinus_histiocytosis, Other) 0.0, 0.1, 0.0, 0.9;
  (Syphilis, Other) 0.0, 0.1, 0.0, 0.9;
  (Toxoplasmosis, Other) 0.0, 0.1, 0.0, 0.9;
  (Tuberculosis, Other) 0.0, 0.1, 0.0, 0.9;
  (Viral_NOS, Other) 0.0, 0.1, 0.0, 0.9;
  (Whipple_s_disease, Other) 0.0, 0.1, 0.0, 0.9;
  (L_H_nodular_HD, Other) 0.0, 0.1, 0.0, 0.9;
  (L_H_diffuse_HD, Other) 0.0, 0.1, 0.0, 0.9;
  (Nodular_sclerosis_HD, Other) 0.0, 0.1, 0.0, 0.9;
  (Cellular_phase_NSHD, Other) 0.0, 0.1, 0.0, 0.9;
  (Syncytial_NSHD, Other) 0.0, 0.1, 0.0, 0.9;
  (Mixed_cellularity_HD, Other) 0.0, 0.1, 0.0, 0.9;
  (Interfollicular_HD, Other) 0.0, 0.1, 0.0, 0.9;
  (Diffuse_fibrosis_HD, Other) 0.0, 0.1, 0.0, 0.9;
  (Reticular_type_HD, Other) 0.0, 0.1, 0.0, 0.9;
  (Small_cleaved_fol, Other) 0.000, 0.050, 0.094, 0.856;
  (Mixed_fol, Other) 0.000, 0.050, 0.094, 0.856;
  (Large_cell_fol, Other) 0.000, 0.050, 0.094, 0.856;
  (Small_noncleaved_fol, Other) 0.000, 0.050, 0.094, 0.856;
  (Small_lymphocytic, Other) 0.00, 0.15, 0.84, 0.01;
  (Plasmacytoid_lyctic, Other) 0.00, 0.15, 0.84, 0.01;
  (Mantle_zone_lymphoma, Other) 0.00, 0.05, 0.94, 0.01;
  (Small_cleaved_dif, Other) 0.00, 0.15, 0.84, 0.01;
  (Mixed_FCC_dif, Other) 0.00, 0.15, 0.84, 0.01;
  (Large_cell_dif, Other) 0.00, 0.15, 0.84, 0.01;
  (B_immunoblastic, Other) 0.00, 0.15, 0.84, 0.01;
  (T_immunob_mixed, Other) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Other) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Other) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Other) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Other) 0.00, 0.15, 0.84, 0.01;
  (True_histiocytic, Other) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Other) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Other) 0.00, 0.15, 0.84, 0.01;
  (Mycosis_fungoides, Other) 0.0, 0.1, 0.0, 0.9;
  (AML, Other) 0.0, 0.1, 0.0, 0.9;
  (Hairy_cell_leukemia, Other) 0.0, 0.1, 0.0, 0.9;
  (Carcinoma, Other) 0.0, 0.1, 0.0, 0.9;
  (Melanoma, Other) 0.0, 0.1, 0.0, 0.9;
  (EM_plasmacytoma, Other) 0.00, 0.04, 0.95, 0.01;
  (Kaposi_s_sarcoma, Other) 0.0, 0.1, 0.0, 0.9;
  (Mast_cell_disease, Other) 0.0, 0.1, 0.0, 0.9;
  (AIDS_involutionary, Other) 0.0, 0.1, 0.0, 0.9;
  (T_immunob_large, Other) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Other) 0.00, 0.15, 0.84, 0.01;
  (Nasopharyngeal_CA, Other) 0.0, 0.1, 0.0, 0.9;
  (Seminoma, Other) 0.0, 0.1, 0.0, 0.9;
  (SLE, Other) 0.0, 0.1, 0.0, 0.9;
  (Mycobact_histiocytos, Other) 0.0, 0.1, 0.0, 0.9;
  (Mast_cell_hyperplas, Other) 0.0, 0.1, 0.0, 0.9;
  (LGV, Other) 0.0, 0.1, 0.0, 0.9;
  (Histoplasmosis, Other) 0.0, 0.1, 0.0, 0.9;
  (Coccidioidomycosis, Other) 0.0, 0.1, 0.0, 0.9;
  (CMV, Other) 0.0, 0.1, 0.0, 0.9;
  (Brucellosis, Other) 0.0, 0.1, 0.0, 0.9;
  (Ki_1_LC_anaplas_B, Other) 0.00, 0.15, 0.84, 0.01;
  (Intermed_lymphocytic, Other) 0.00, 0.05, 0.94, 0.01;
  (AIDS_early, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (AILD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (ALIP, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Cat_scratch_disease, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Dermatopathic_laden, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Florid_follic_hyperp, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (GLH_hyaline_vascular, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (GLH_plasma_cell, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Granulomatous_laden, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Histiocytosis_x, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Infectious_mono, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Leprosy_lepromatous, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Lymphangiographic, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Mantle_zone_hyperpla, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Necrotizing_Kikuchi, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Necrotiz_non_Kikuchi, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Rheumatoid_arthritis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Sarcoidosis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (SHML, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Sinus_histiocytosis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Syphilis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Toxoplasmosis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Tuberculosis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Viral_NOS, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Whipple_s_disease, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (L_H_nodular_HD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (L_H_diffuse_HD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Nodular_sclerosis_HD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Cellular_phase_NSHD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Syncytial_NSHD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Mixed_cellularity_HD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Interfollicular_HD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Diffuse_fibrosis_HD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Reticular_type_HD, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Small_cleaved_fol, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Mixed_fol, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Large_cell_fol, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Small_noncleaved_fol, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Small_lymphocytic, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Plasmacytoid_lyctic, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Mantle_zone_lymphoma, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Small_cleaved_dif, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Mixed_FCC_dif, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Large_cell_dif, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (B_immunoblastic, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (T_immunob_mixed, Large_cleaved) 0.000, 0.995, 0.000, 0.005;
  (AILD_like_T_cell_lym, Large_cleaved) 0.000, 0.995, 0.000, 0.005;
  (Japanese_ATL, Large_cleaved) 0.000, 0.995, 0.000, 0.005;
  (Lymphoblastic, Large_cleaved) 0.000, 0.995, 0.000, 0.005;
  (Small_noncleaved_dif, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (True_histiocytic, Large_cleaved) 0.000, 0.995, 0.000, 0.005;
  (Ki_1_LC_anaplas_T, Large_cleaved) 0.000, 0.995, 0.000, 0.005;
  (Multiple_myeloma, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Mycosis_fungoides, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (AML, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Hairy_cell_leukemia, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Carcinoma, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Melanoma, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (EM_plasmacytoma, Large_cleaved) 0.00, 0.04, 0.95, 0.01;
  (Kaposi_s_sarcoma, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Mast_cell_disease, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (AIDS_involutionary, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (T_immunob_large, Large_cleaved) 0.000, 0.995, 0.000, 0.005;
  (Monocytoid_B_cell, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Nasopharyngeal_CA, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Seminoma, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (SLE, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Mycobact_histiocytos, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Mast_cell_hyperplas, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (LGV, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Histoplasmosis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Coccidioidomycosis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (CMV, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Brucellosis, Large_cleaved) 0.0, 0.1, 0.0, 0.9;
  (Ki_1_LC_anaplas_B, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (Intermed_lymphocytic, Large_cleaved) 0.0, 0.3, 0.7, 0.0;
  (AIDS_early, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (AILD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (ALIP, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Cat_scratch_disease, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Dermatopathic_laden, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Florid_follic_hyperp, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (GLH_hyaline_vascular, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (GLH_plasma_cell, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Granulomatous_laden, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Histiocytosis_x, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Infectious_mono, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Leprosy_lepromatous, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Lymphangiographic, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Mantle_zone_hyperpla, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Necrotizing_Kikuchi, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Necrotiz_non_Kikuchi, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Rheumatoid_arthritis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Sarcoidosis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (SHML, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Sinus_histiocytosis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Syphilis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Toxoplasmosis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Tuberculosis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Viral_NOS, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Whipple_s_disease, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (L_H_nodular_HD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (L_H_diffuse_HD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Nodular_sclerosis_HD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Cellular_phase_NSHD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Syncytial_NSHD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Mixed_cellularity_HD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Interfollicular_HD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Diffuse_fibrosis_HD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Reticular_type_HD, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Small_cleaved_fol, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Mixed_fol, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Large_cell_fol, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Small_noncleaved_fol, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Small_lymphocytic, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Plasmacytoid_lyctic, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Mantle_zone_lymphoma, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Small_cleaved_dif, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Mixed_FCC_dif, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Large_cell_dif, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (B_immunoblastic, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (T_immunob_mixed, Large_noncleaved) 0.000, 0.995, 0.000, 0.005;
  (AILD_like_T_cell_lym, Large_noncleaved) 0.000, 0.995, 0.000, 0.005;
  (Japanese_ATL, Large_noncleaved) 0.000, 0.995, 0.000, 0.005;
  (Lymphoblastic, Large_noncleaved) 0.000, 0.995, 0.000, 0.005;
  (Small_noncleaved_dif, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (True_histiocytic, Large_noncleaved) 0.000, 0.995, 0.000, 0.005;
  (Ki_1_LC_anaplas_T, Large_noncleaved) 0.000, 0.995, 0.000, 0.005;
  (Multiple_myeloma, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Mycosis_fungoides, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (AML, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Hairy_cell_leukemia, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Carcinoma, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Melanoma, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (EM_plasmacytoma, Large_noncleaved) 0.00, 0.04, 0.95, 0.01;
  (Kaposi_s_sarcoma, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Mast_cell_disease, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (AIDS_involutionary, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (T_immunob_large, Large_noncleaved) 0.000, 0.995, 0.000, 0.005;
  (Monocytoid_B_cell, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Nasopharyngeal_CA, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Seminoma, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (SLE, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Mycobact_histiocytos, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Mast_cell_hyperplas, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (LGV, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Histoplasmosis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Coccidioidomycosis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (CMV, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Brucellosis, Large_noncleaved) 0.0, 0.1, 0.0, 0.9;
  (Ki_1_LC_anaplas_B, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
  (Intermed_lymphocytic, Large_noncleaved) 0.0, 0.3, 0.7, 0.0;
}
probability ( PLAS_KL | Fault, PLASMA ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, Few_LT_5pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_fol, Few_LT_5pc) 0.00, 0.97, 0.02, 0.01;
  (Large_cell_fol, Few_LT_5pc) 0.00, 0.97, 0.02, 0.01;
  (Small_noncleaved_fol, Few_LT_5pc) 0.00, 0.97, 0.02, 0.01;
  (Small_lymphocytic, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Plasmacytoid_lyctic, Few_LT_5pc) 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Few_LT_5pc) 0.00, 0.98, 0.01, 0.01;
  (Small_cleaved_dif, Few_LT_5pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_FCC_dif, Few_LT_5pc) 0.00, 0.89, 0.10, 0.01;
  (Large_cell_dif, Few_LT_5pc) 0.00, 0.97, 0.02, 0.01;
  (B_immunoblastic, Few_LT_5pc) 0.00, 0.88, 0.10, 0.02;
  (T_immunob_mixed, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Few_LT_5pc) 0.00, 0.97, 0.02, 0.01;
  (True_histiocytic, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Few_LT_5pc) 0.00, 0.01, 0.95, 0.04;
  (Mycosis_fungoides, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AML, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Few_LT_5pc) 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Few_LT_5pc) 0.00, 0.35, 0.64, 0.01;
  (Nasopharyngeal_CA, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, Few_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, Few_LT_5pc) 0.00, 0.98, 0.01, 0.01;
  (AIDS_early, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, Moderate_6_to_20pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_fol, Moderate_6_to_20pc) 0.00, 0.97, 0.02, 0.01;
  (Large_cell_fol, Moderate_6_to_20pc) 0.00, 0.97, 0.02, 0.01;
  (Small_noncleaved_fol, Moderate_6_to_20pc) 0.00, 0.97, 0.02, 0.01;
  (Small_lymphocytic, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Plasmacytoid_lyctic, Moderate_6_to_20pc) 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Moderate_6_to_20pc) 0.00, 0.98, 0.01, 0.01;
  (Small_cleaved_dif, Moderate_6_to_20pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_FCC_dif, Moderate_6_to_20pc) 0.00, 0.89, 0.10, 0.01;
  (Large_cell_dif, Moderate_6_to_20pc) 0.00, 0.97, 0.02, 0.01;
  (B_immunoblastic, Moderate_6_to_20pc) 0.00, 0.88, 0.10, 0.02;
  (T_immunob_mixed, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Moderate_6_to_20pc) 0.00, 0.97, 0.02, 0.01;
  (True_histiocytic, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Moderate_6_to_20pc) 0.00, 0.01, 0.95, 0.04;
  (Mycosis_fungoides, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (AML, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Moderate_6_to_20pc) 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Moderate_6_to_20pc) 0.00, 0.35, 0.64, 0.01;
  (Nasopharyngeal_CA, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, Moderate_6_to_20pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, Moderate_6_to_20pc) 0.00, 0.98, 0.01, 0.01;
  (AIDS_early, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, Marked_21_to_50pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_fol, Marked_21_to_50pc) 0.00, 0.97, 0.02, 0.01;
  (Large_cell_fol, Marked_21_to_50pc) 0.00, 0.97, 0.02, 0.01;
  (Small_noncleaved_fol, Marked_21_to_50pc) 0.00, 0.97, 0.02, 0.01;
  (Small_lymphocytic, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Plasmacytoid_lyctic, Marked_21_to_50pc) 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Marked_21_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (Small_cleaved_dif, Marked_21_to_50pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_FCC_dif, Marked_21_to_50pc) 0.00, 0.89, 0.10, 0.01;
  (Large_cell_dif, Marked_21_to_50pc) 0.00, 0.97, 0.02, 0.01;
  (B_immunoblastic, Marked_21_to_50pc) 0.00, 0.88, 0.10, 0.02;
  (T_immunob_mixed, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Marked_21_to_50pc) 0.00, 0.97, 0.02, 0.01;
  (True_histiocytic, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Marked_21_to_50pc) 0.00, 0.01, 0.95, 0.04;
  (Mycosis_fungoides, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AML, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Marked_21_to_50pc) 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Marked_21_to_50pc) 0.00, 0.35, 0.64, 0.01;
  (Nasopharyngeal_CA, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, Marked_21_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, Marked_21_to_50pc) 0.00, 0.98, 0.01, 0.01;
  (AIDS_early, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, Striking_51_to_90pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_fol, Striking_51_to_90pc) 0.00, 0.97, 0.02, 0.01;
  (Large_cell_fol, Striking_51_to_90pc) 0.00, 0.97, 0.02, 0.01;
  (Small_noncleaved_fol, Striking_51_to_90pc) 0.00, 0.97, 0.02, 0.01;
  (Small_lymphocytic, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Plasmacytoid_lyctic, Striking_51_to_90pc) 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Striking_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (Small_cleaved_dif, Striking_51_to_90pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_FCC_dif, Striking_51_to_90pc) 0.00, 0.89, 0.10, 0.01;
  (Large_cell_dif, Striking_51_to_90pc) 0.00, 0.97, 0.02, 0.01;
  (B_immunoblastic, Striking_51_to_90pc) 0.00, 0.88, 0.10, 0.02;
  (T_immunob_mixed, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Striking_51_to_90pc) 0.00, 0.97, 0.02, 0.01;
  (True_histiocytic, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Striking_51_to_90pc) 0.00, 0.01, 0.95, 0.04;
  (Mycosis_fungoides, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AML, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Striking_51_to_90pc) 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Striking_51_to_90pc) 0.00, 0.35, 0.64, 0.01;
  (Nasopharyngeal_CA, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, Striking_51_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, Striking_51_to_90pc) 0.00, 0.98, 0.01, 0.01;
  (AIDS_early, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, Sheets_GT_90pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_fol, Sheets_GT_90pc) 0.00, 0.97, 0.02, 0.01;
  (Large_cell_fol, Sheets_GT_90pc) 0.00, 0.97, 0.02, 0.01;
  (Small_noncleaved_fol, Sheets_GT_90pc) 0.00, 0.97, 0.02, 0.01;
  (Small_lymphocytic, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Plasmacytoid_lyctic, Sheets_GT_90pc) 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Sheets_GT_90pc) 0.00, 0.98, 0.01, 0.01;
  (Small_cleaved_dif, Sheets_GT_90pc) 0.00, 0.97, 0.02, 0.01;
  (Mixed_FCC_dif, Sheets_GT_90pc) 0.00, 0.94, 0.05, 0.01;
  (Large_cell_dif, Sheets_GT_90pc) 0.00, 0.97, 0.02, 0.01;
  (B_immunoblastic, Sheets_GT_90pc) 0.00, 0.88, 0.10, 0.02;
  (T_immunob_mixed, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Sheets_GT_90pc) 0.00, 0.97, 0.02, 0.01;
  (True_histiocytic, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Sheets_GT_90pc) 0.00, 0.01, 0.95, 0.04;
  (Mycosis_fungoides, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (AML, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Sheets_GT_90pc) 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Sheets_GT_90pc) 0.00, 0.35, 0.64, 0.01;
  (Nasopharyngeal_CA, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, Sheets_GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, Sheets_GT_90pc) 0.00, 0.98, 0.01, 0.01;
}
probability ( FCC_KL | Fault, FOLLICLE ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, 1_to_25pc) 0.00, 0.00, 0.98, 0.02;
  (Mixed_fol, 1_to_25pc) 0.00, 0.00, 0.98, 0.02;
  (Large_cell_fol, 1_to_25pc) 0.00, 0.00, 0.98, 0.02;
  (Small_noncleaved_fol, 1_to_25pc) 0.00, 0.00, 0.98, 0.02;
  (Small_lymphocytic, 1_to_25pc) 0.00, 0.95, 0.00, 0.05;
  (Plasmacytoid_lyctic, 1_to_25pc) 0.00, 0.95, 0.00, 0.05;
  (Mantle_zone_lymphoma, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_dif, 1_to_25pc) 0.00, 0.95, 0.00, 0.05;
  (Mixed_FCC_dif, 1_to_25pc) 0.00, 0.95, 0.00, 0.05;
  (Large_cell_dif, 1_to_25pc) 0.00, 0.95, 0.00, 0.05;
  (B_immunoblastic, 1_to_25pc) 0.00, 0.95, 0.00, 0.05;
  (T_immunob_mixed, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, 1_to_25pc) 0.00, 0.95, 0.00, 0.05;
  (True_histiocytic, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Mycosis_fungoides, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (AML, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, 1_to_25pc) 0.00, 0.65, 0.30, 0.05;
  (Nasopharyngeal_CA, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, 1_to_25pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_early, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, 25_to_75pc) 0.00, 0.00, 0.98, 0.02;
  (Mixed_fol, 25_to_75pc) 0.00, 0.00, 0.98, 0.02;
  (Large_cell_fol, 25_to_75pc) 0.00, 0.00, 0.98, 0.02;
  (Small_noncleaved_fol, 25_to_75pc) 0.00, 0.00, 0.98, 0.02;
  (Small_lymphocytic, 25_to_75pc) 0.00, 0.95, 0.00, 0.05;
  (Plasmacytoid_lyctic, 25_to_75pc) 0.00, 0.95, 0.00, 0.05;
  (Mantle_zone_lymphoma, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_dif, 25_to_75pc) 0.00, 0.95, 0.00, 0.05;
  (Mixed_FCC_dif, 25_to_75pc) 0.00, 0.95, 0.00, 0.05;
  (Large_cell_dif, 25_to_75pc) 0.00, 0.95, 0.00, 0.05;
  (B_immunoblastic, 25_to_75pc) 0.00, 0.95, 0.00, 0.05;
  (T_immunob_mixed, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, 25_to_75pc) 0.00, 0.95, 0.00, 0.05;
  (True_histiocytic, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Mycosis_fungoides, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (AML, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, 25_to_75pc) 0.00, 0.65, 0.30, 0.05;
  (Nasopharyngeal_CA, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, 25_to_75pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_early, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, 75_to_90pc) 0.00, 0.00, 0.98, 0.02;
  (Mixed_fol, 75_to_90pc) 0.00, 0.00, 0.98, 0.02;
  (Large_cell_fol, 75_to_90pc) 0.00, 0.00, 0.98, 0.02;
  (Small_noncleaved_fol, 75_to_90pc) 0.00, 0.00, 0.98, 0.02;
  (Small_lymphocytic, 75_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (Plasmacytoid_lyctic, 75_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (Mantle_zone_lymphoma, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_dif, 75_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (Mixed_FCC_dif, 75_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (Large_cell_dif, 75_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (B_immunoblastic, 75_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (T_immunob_mixed, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, 75_to_90pc) 0.00, 0.95, 0.00, 0.05;
  (True_histiocytic, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mycosis_fungoides, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AML, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, 75_to_90pc) 0.00, 0.65, 0.30, 0.05;
  (Nasopharyngeal_CA, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, 75_to_90pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_early, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Sinus_histiocytosis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Syphilis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, GT_90pc) 0.00, 0.00, 0.98, 0.02;
  (Mixed_fol, GT_90pc) 0.00, 0.00, 0.98, 0.02;
  (Large_cell_fol, GT_90pc) 0.00, 0.00, 0.98, 0.02;
  (Small_noncleaved_fol, GT_90pc) 0.00, 0.00, 0.98, 0.02;
  (Small_lymphocytic, GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (Plasmacytoid_lyctic, GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (Mantle_zone_lymphoma, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_dif, GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (Mixed_FCC_dif, GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (Large_cell_dif, GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (B_immunoblastic, GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (T_immunob_mixed, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, GT_90pc) 0.00, 0.95, 0.00, 0.05;
  (True_histiocytic, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mycosis_fungoides, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (AML, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, GT_90pc) 0.00, 0.65, 0.30, 0.05;
  (Nasopharyngeal_CA, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, GT_90pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, GT_90pc) 0.00, 0.99, 0.00, 0.01;
}
probability ( MZL_KL | Fault, F_MZ ) {
  (AIDS_early, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AILD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (ALIP, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (SHML, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AML, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (SLE, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (LGV, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (CMV, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Absent) 1.0, 0.0, 0.0, 0.0;
  (AILD, Absent) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Absent) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent) 1.0, 0.0, 0.0, 0.0;
  (SHML, Absent) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent) 1.0, 0.0, 0.0, 0.0;
  (AML, Absent) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent) 1.0, 0.0, 0.0, 0.0;
  (SLE, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent) 1.0, 0.0, 0.0, 0.0;
  (LGV, Absent) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent) 1.0, 0.0, 0.0, 0.0;
  (CMV, Absent) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Present) 0.0, 1.0, 0.0, 0.0;
  (AILD, Present) 0.0, 1.0, 0.0, 0.0;
  (ALIP, Present) 0.0, 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Present) 0.0, 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Present) 0.0, 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Present) 0.0, 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Present) 0.0, 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Present) 0.0, 1.0, 0.0, 0.0;
  (Granulomatous_laden, Present) 0.0, 1.0, 0.0, 0.0;
  (Histiocytosis_x, Present) 0.0, 1.0, 0.0, 0.0;
  (Infectious_mono, Present) 0.0, 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Present) 0.0, 1.0, 0.0, 0.0;
  (Lymphangiographic, Present) 0.0, 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Present) 0.0, 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Present) 0.0, 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Present) 0.0, 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Present) 0.0, 1.0, 0.0, 0.0;
  (Sarcoidosis, Present) 0.0, 1.0, 0.0, 0.0;
  (SHML, Present) 0.0, 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Present) 0.0, 1.0, 0.0, 0.0;
  (Syphilis, Present) 0.0, 1.0, 0.0, 0.0;
  (Toxoplasmosis, Present) 0.0, 1.0, 0.0, 0.0;
  (Tuberculosis, Present) 0.0, 1.0, 0.0, 0.0;
  (Viral_NOS, Present) 0.0, 1.0, 0.0, 0.0;
  (Whipple_s_disease, Present) 0.0, 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Present) 0.0, 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Present) 0.0, 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Present) 0.0, 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Present) 0.0, 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Present) 0.0, 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Present) 0.0, 1.0, 0.0, 0.0;
  (Interfollicular_HD, Present) 0.0, 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Present) 0.0, 1.0, 0.0, 0.0;
  (Reticular_type_HD, Present) 0.0, 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Present) 0.00, 0.98, 0.00, 0.02;
  (Mixed_fol, Present) 0.00, 0.98, 0.00, 0.02;
  (Large_cell_fol, Present) 0.00, 0.98, 0.00, 0.02;
  (Small_noncleaved_fol, Present) 0.00, 0.98, 0.00, 0.02;
  (Small_lymphocytic, Present) 0.00, 0.98, 0.00, 0.02;
  (Plasmacytoid_lyctic, Present) 0.00, 0.98, 0.00, 0.02;
  (Mantle_zone_lymphoma, Present) 0.00, 0.00, 0.98, 0.02;
  (Small_cleaved_dif, Present) 0.00, 0.98, 0.00, 0.02;
  (Mixed_FCC_dif, Present) 0.00, 0.98, 0.00, 0.02;
  (Large_cell_dif, Present) 0.00, 0.98, 0.00, 0.02;
  (B_immunoblastic, Present) 0.00, 0.98, 0.00, 0.02;
  (T_immunob_mixed, Present) 0.0, 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Present) 0.0, 1.0, 0.0, 0.0;
  (Japanese_ATL, Present) 0.0, 1.0, 0.0, 0.0;
  (Lymphoblastic, Present) 0.0, 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Present) 0.00, 0.98, 0.00, 0.02;
  (True_histiocytic, Present) 0.0, 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Present) 0.0, 1.0, 0.0, 0.0;
  (Multiple_myeloma, Present) 0.0, 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Present) 0.0, 1.0, 0.0, 0.0;
  (AML, Present) 0.0, 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Present) 0.0, 1.0, 0.0, 0.0;
  (Carcinoma, Present) 0.0, 1.0, 0.0, 0.0;
  (Melanoma, Present) 0.0, 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Present) 0.00, 0.98, 0.00, 0.02;
  (Kaposi_s_sarcoma, Present) 0.0, 1.0, 0.0, 0.0;
  (Mast_cell_disease, Present) 0.0, 1.0, 0.0, 0.0;
  (AIDS_involutionary, Present) 0.0, 1.0, 0.0, 0.0;
  (T_immunob_large, Present) 0.0, 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Present) 0.00, 0.75, 0.20, 0.05;
  (Nasopharyngeal_CA, Present) 0.0, 1.0, 0.0, 0.0;
  (Seminoma, Present) 0.0, 1.0, 0.0, 0.0;
  (SLE, Present) 0.0, 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Present) 0.0, 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Present) 0.0, 1.0, 0.0, 0.0;
  (LGV, Present) 0.0, 1.0, 0.0, 0.0;
  (Histoplasmosis, Present) 0.0, 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Present) 0.0, 1.0, 0.0, 0.0;
  (CMV, Present) 0.0, 1.0, 0.0, 0.0;
  (Brucellosis, Present) 0.0, 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Present) 0.0, 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Present) 0.00, 0.00, 0.98, 0.02;
}
probability ( SR_LEU | Fault, SR ) {
  (AIDS_early, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (ALIP, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Cat_scratch_disease, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Dermatopathic_laden, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Florid_follic_hyperp, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (GLH_hyaline_vascular, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (GLH_plasma_cell, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Granulomatous_laden, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Histiocytosis_x, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Infectious_mono, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphangiographic, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mantle_zone_hyperpla, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotizing_Kikuchi, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotiz_non_Kikuchi, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Rheumatoid_arthritis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Sarcoidosis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (SHML, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Sinus_histiocytosis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Syphilis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Toxoplasmosis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Tuberculosis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Viral_NOS, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (L_H_nodular_HD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (L_H_diffuse_HD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Nodular_sclerosis_HD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Rare_1_to_3) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mixed_fol, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Large_cell_fol, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_noncleaved_fol, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_lymphocytic, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Plasmacytoid_lyctic, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mantle_zone_lymphoma, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_cleaved_dif, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mixed_FCC_dif, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Large_cell_dif, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (B_immunoblastic, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (T_immunob_mixed, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AILD_like_T_cell_lym, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Japanese_ATL, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Lymphoblastic, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_noncleaved_dif, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (True_histiocytic, Rare_1_to_3) 0.00, 0.99, 0.00, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Multiple_myeloma, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycosis_fungoides, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AML, Rare_1_to_3) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Hairy_cell_leukemia, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Carcinoma, Rare_1_to_3) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Melanoma, Rare_1_to_3) 0.0, 0.8, 0.2, 0.0, 0.0;
  (EM_plasmacytoma, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Kaposi_s_sarcoma, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mast_cell_disease, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AIDS_involutionary, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_large, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Monocytoid_B_cell, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Nasopharyngeal_CA, Rare_1_to_3) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Seminoma, Rare_1_to_3) 0.0, 0.8, 0.2, 0.0, 0.0;
  (SLE, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mast_cell_hyperplas, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (LGV, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Histoplasmosis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Coccidioidomycosis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (CMV, Rare_1_to_3) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Brucellosis, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Ki_1_LC_anaplas_B, Rare_1_to_3) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Intermed_lymphocytic, Rare_1_to_3) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AIDS_early, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (ALIP, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Cat_scratch_disease, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Dermatopathic_laden, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Florid_follic_hyperp, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (GLH_hyaline_vascular, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (GLH_plasma_cell, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Granulomatous_laden, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Histiocytosis_x, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Infectious_mono, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphangiographic, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mantle_zone_hyperpla, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotizing_Kikuchi, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotiz_non_Kikuchi, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Rheumatoid_arthritis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Sarcoidosis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (SHML, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Sinus_histiocytosis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Syphilis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Toxoplasmosis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Tuberculosis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Viral_NOS, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (L_H_nodular_HD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (L_H_diffuse_HD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Nodular_sclerosis_HD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Present_4_to_15) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mixed_fol, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Large_cell_fol, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_noncleaved_fol, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_lymphocytic, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Plasmacytoid_lyctic, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mantle_zone_lymphoma, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_cleaved_dif, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mixed_FCC_dif, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Large_cell_dif, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (B_immunoblastic, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (T_immunob_mixed, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AILD_like_T_cell_lym, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Japanese_ATL, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Lymphoblastic, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_noncleaved_dif, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (True_histiocytic, Present_4_to_15) 0.00, 0.99, 0.00, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Multiple_myeloma, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycosis_fungoides, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AML, Present_4_to_15) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Hairy_cell_leukemia, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Carcinoma, Present_4_to_15) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Melanoma, Present_4_to_15) 0.0, 0.8, 0.2, 0.0, 0.0;
  (EM_plasmacytoma, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Kaposi_s_sarcoma, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mast_cell_disease, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AIDS_involutionary, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_large, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Monocytoid_B_cell, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Nasopharyngeal_CA, Present_4_to_15) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Seminoma, Present_4_to_15) 0.0, 0.8, 0.2, 0.0, 0.0;
  (SLE, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mast_cell_hyperplas, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (LGV, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Histoplasmosis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Coccidioidomycosis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (CMV, Present_4_to_15) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Brucellosis, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Ki_1_LC_anaplas_B, Present_4_to_15) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Intermed_lymphocytic, Present_4_to_15) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AIDS_early, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (ALIP, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Cat_scratch_disease, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Dermatopathic_laden, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Florid_follic_hyperp, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (GLH_hyaline_vascular, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (GLH_plasma_cell, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Granulomatous_laden, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Histiocytosis_x, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Infectious_mono, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphangiographic, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mantle_zone_hyperpla, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotizing_Kikuchi, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotiz_non_Kikuchi, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Rheumatoid_arthritis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Sarcoidosis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (SHML, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Sinus_histiocytosis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Syphilis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Toxoplasmosis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Tuberculosis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Viral_NOS, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (L_H_nodular_HD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (L_H_diffuse_HD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Nodular_sclerosis_HD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Many_16_to_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mixed_fol, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Large_cell_fol, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_noncleaved_fol, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_lymphocytic, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Plasmacytoid_lyctic, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mantle_zone_lymphoma, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_cleaved_dif, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mixed_FCC_dif, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Large_cell_dif, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (B_immunoblastic, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (T_immunob_mixed, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AILD_like_T_cell_lym, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Japanese_ATL, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Lymphoblastic, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_noncleaved_dif, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (True_histiocytic, Many_16_to_50) 0.00, 0.99, 0.00, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Multiple_myeloma, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycosis_fungoides, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AML, Many_16_to_50) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Hairy_cell_leukemia, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Carcinoma, Many_16_to_50) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Melanoma, Many_16_to_50) 0.0, 0.8, 0.2, 0.0, 0.0;
  (EM_plasmacytoma, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Kaposi_s_sarcoma, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mast_cell_disease, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AIDS_involutionary, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_large, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Monocytoid_B_cell, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Nasopharyngeal_CA, Many_16_to_50) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Seminoma, Many_16_to_50) 0.0, 0.8, 0.2, 0.0, 0.0;
  (SLE, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mast_cell_hyperplas, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (LGV, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Histoplasmosis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Coccidioidomycosis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (CMV, Many_16_to_50) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Brucellosis, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Ki_1_LC_anaplas_B, Many_16_to_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Intermed_lymphocytic, Many_16_to_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AIDS_early, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (ALIP, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Cat_scratch_disease, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Dermatopathic_laden, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Florid_follic_hyperp, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (GLH_hyaline_vascular, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (GLH_plasma_cell, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Granulomatous_laden, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Histiocytosis_x, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Infectious_mono, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphangiographic, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mantle_zone_hyperpla, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotizing_Kikuchi, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotiz_non_Kikuchi, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Rheumatoid_arthritis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Sarcoidosis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (SHML, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Sinus_histiocytosis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Syphilis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Toxoplasmosis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Tuberculosis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Viral_NOS, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (L_H_nodular_HD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (L_H_diffuse_HD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Nodular_sclerosis_HD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Striking_GT_50) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mixed_fol, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Large_cell_fol, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_noncleaved_fol, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_lymphocytic, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Plasmacytoid_lyctic, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mantle_zone_lymphoma, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_cleaved_dif, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mixed_FCC_dif, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Large_cell_dif, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (B_immunoblastic, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (T_immunob_mixed, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AILD_like_T_cell_lym, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Japanese_ATL, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Lymphoblastic, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Small_noncleaved_dif, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (True_histiocytic, Striking_GT_50) 0.00, 0.99, 0.00, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Multiple_myeloma, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycosis_fungoides, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AML, Striking_GT_50) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Hairy_cell_leukemia, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Carcinoma, Striking_GT_50) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Melanoma, Striking_GT_50) 0.0, 0.8, 0.2, 0.0, 0.0;
  (EM_plasmacytoma, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Kaposi_s_sarcoma, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mast_cell_disease, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AIDS_involutionary, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_large, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Monocytoid_B_cell, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Nasopharyngeal_CA, Striking_GT_50) 0.0, 0.8, 0.2, 0.0, 0.0;
  (Seminoma, Striking_GT_50) 0.0, 0.8, 0.2, 0.0, 0.0;
  (SLE, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mast_cell_hyperplas, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (LGV, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Histoplasmosis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Coccidioidomycosis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (CMV, Striking_GT_50) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Brucellosis, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Ki_1_LC_anaplas_B, Striking_GT_50) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Intermed_lymphocytic, Striking_GT_50) 0.00, 0.01, 0.00, 0.99, 0.00;
}
probability ( LAC_LEU | Fault, LACUN ) {
  (AIDS_early, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AILD, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (ALIP, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Cat_scratch_disease, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Dermatopathic_laden, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Florid_follic_hyperp, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_hyaline_vascular, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_plasma_cell, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Granulomatous_laden, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histiocytosis_x, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Infectious_mono, Rare_1_to_5) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Lymphangiographic, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_hyperpla, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Necrotizing_Kikuchi, Rare_1_to_5) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotiz_non_Kikuchi, Rare_1_to_5) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Rheumatoid_arthritis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sarcoidosis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (SHML, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sinus_histiocytosis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Syphilis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Toxoplasmosis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Tuberculosis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Viral_NOS, Rare_1_to_5) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (L_H_nodular_HD, Rare_1_to_5) 0.0, 0.1, 0.1, 0.8, 0.0;
  (L_H_diffuse_HD, Rare_1_to_5) 0.0, 0.1, 0.1, 0.8, 0.0;
  (Nodular_sclerosis_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_fol, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Large_cell_fol, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_fol, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_lymphocytic, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Plasmacytoid_lyctic, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_lymphoma, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_cleaved_dif, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_FCC_dif, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Large_cell_dif, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (B_immunoblastic, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (T_immunob_mixed, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AILD_like_T_cell_lym, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Japanese_ATL, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Lymphoblastic, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_dif, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (True_histiocytic, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Ki_1_LC_anaplas_T, Rare_1_to_5) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Multiple_myeloma, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Mycosis_fungoides, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AML, Rare_1_to_5) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Hairy_cell_leukemia, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Carcinoma, Rare_1_to_5) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Melanoma, Rare_1_to_5) 0.0, 0.9, 0.1, 0.0, 0.0;
  (EM_plasmacytoma, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Kaposi_s_sarcoma, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_disease, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_involutionary, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (T_immunob_large, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Monocytoid_B_cell, Rare_1_to_5) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Nasopharyngeal_CA, Rare_1_to_5) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Seminoma, Rare_1_to_5) 0.0, 0.9, 0.1, 0.0, 0.0;
  (SLE, Rare_1_to_5) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_hyperplas, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (LGV, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histoplasmosis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Coccidioidomycosis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (CMV, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Brucellosis, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Ki_1_LC_anaplas_B, Rare_1_to_5) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Intermed_lymphocytic, Rare_1_to_5) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_early, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AILD, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (ALIP, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Cat_scratch_disease, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Dermatopathic_laden, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Florid_follic_hyperp, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_hyaline_vascular, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_plasma_cell, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Granulomatous_laden, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histiocytosis_x, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Infectious_mono, Few_6_to_25) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Lymphangiographic, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_hyperpla, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Necrotizing_Kikuchi, Few_6_to_25) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotiz_non_Kikuchi, Few_6_to_25) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Rheumatoid_arthritis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sarcoidosis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (SHML, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sinus_histiocytosis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Syphilis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Toxoplasmosis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Tuberculosis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Viral_NOS, Few_6_to_25) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (L_H_nodular_HD, Few_6_to_25) 0.0, 0.1, 0.1, 0.8, 0.0;
  (L_H_diffuse_HD, Few_6_to_25) 0.0, 0.1, 0.1, 0.8, 0.0;
  (Nodular_sclerosis_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_fol, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Large_cell_fol, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_fol, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_lymphocytic, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Plasmacytoid_lyctic, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_lymphoma, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_cleaved_dif, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_FCC_dif, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Large_cell_dif, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (B_immunoblastic, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (T_immunob_mixed, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AILD_like_T_cell_lym, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Japanese_ATL, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Lymphoblastic, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_dif, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (True_histiocytic, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Ki_1_LC_anaplas_T, Few_6_to_25) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Multiple_myeloma, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Mycosis_fungoides, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AML, Few_6_to_25) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Hairy_cell_leukemia, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Carcinoma, Few_6_to_25) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Melanoma, Few_6_to_25) 0.0, 0.9, 0.1, 0.0, 0.0;
  (EM_plasmacytoma, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Kaposi_s_sarcoma, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_disease, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_involutionary, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (T_immunob_large, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Monocytoid_B_cell, Few_6_to_25) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Nasopharyngeal_CA, Few_6_to_25) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Seminoma, Few_6_to_25) 0.0, 0.9, 0.1, 0.0, 0.0;
  (SLE, Few_6_to_25) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_hyperplas, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (LGV, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histoplasmosis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Coccidioidomycosis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (CMV, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Brucellosis, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Ki_1_LC_anaplas_B, Few_6_to_25) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Intermed_lymphocytic, Few_6_to_25) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_early, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AILD, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (ALIP, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Cat_scratch_disease, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Dermatopathic_laden, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Florid_follic_hyperp, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_hyaline_vascular, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_plasma_cell, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Granulomatous_laden, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histiocytosis_x, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Infectious_mono, Many_26_to_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Lymphangiographic, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_hyperpla, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Necrotizing_Kikuchi, Many_26_to_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotiz_non_Kikuchi, Many_26_to_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Rheumatoid_arthritis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sarcoidosis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (SHML, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sinus_histiocytosis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Syphilis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Toxoplasmosis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Tuberculosis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Viral_NOS, Many_26_to_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (L_H_nodular_HD, Many_26_to_100) 0.0, 0.1, 0.1, 0.8, 0.0;
  (L_H_diffuse_HD, Many_26_to_100) 0.0, 0.1, 0.1, 0.8, 0.0;
  (Nodular_sclerosis_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_fol, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Large_cell_fol, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_fol, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_lymphocytic, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Plasmacytoid_lyctic, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_lymphoma, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_cleaved_dif, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_FCC_dif, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Large_cell_dif, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (B_immunoblastic, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (T_immunob_mixed, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AILD_like_T_cell_lym, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Japanese_ATL, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Lymphoblastic, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_dif, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (True_histiocytic, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Ki_1_LC_anaplas_T, Many_26_to_100) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Multiple_myeloma, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Mycosis_fungoides, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AML, Many_26_to_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Hairy_cell_leukemia, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Carcinoma, Many_26_to_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Melanoma, Many_26_to_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (EM_plasmacytoma, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Kaposi_s_sarcoma, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_disease, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_involutionary, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (T_immunob_large, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Monocytoid_B_cell, Many_26_to_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Nasopharyngeal_CA, Many_26_to_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Seminoma, Many_26_to_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (SLE, Many_26_to_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_hyperplas, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (LGV, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histoplasmosis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Coccidioidomycosis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (CMV, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Brucellosis, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Ki_1_LC_anaplas_B, Many_26_to_100) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Intermed_lymphocytic, Many_26_to_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_early, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AILD, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (ALIP, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Cat_scratch_disease, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Dermatopathic_laden, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Florid_follic_hyperp, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_hyaline_vascular, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_plasma_cell, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Granulomatous_laden, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histiocytosis_x, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Infectious_mono, Striking_GT_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Lymphangiographic, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_hyperpla, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Necrotizing_Kikuchi, Striking_GT_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotiz_non_Kikuchi, Striking_GT_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Rheumatoid_arthritis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sarcoidosis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (SHML, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sinus_histiocytosis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Syphilis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Toxoplasmosis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Tuberculosis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Viral_NOS, Striking_GT_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (L_H_nodular_HD, Striking_GT_100) 0.0, 0.1, 0.1, 0.8, 0.0;
  (L_H_diffuse_HD, Striking_GT_100) 0.0, 0.1, 0.1, 0.8, 0.0;
  (Nodular_sclerosis_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_fol, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Large_cell_fol, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_fol, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_lymphocytic, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Plasmacytoid_lyctic, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_lymphoma, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_cleaved_dif, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_FCC_dif, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Large_cell_dif, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (B_immunoblastic, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (T_immunob_mixed, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AILD_like_T_cell_lym, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Japanese_ATL, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Lymphoblastic, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_dif, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (True_histiocytic, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Ki_1_LC_anaplas_T, Striking_GT_100) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Multiple_myeloma, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Mycosis_fungoides, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AML, Striking_GT_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Hairy_cell_leukemia, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Carcinoma, Striking_GT_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Melanoma, Striking_GT_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (EM_plasmacytoma, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Kaposi_s_sarcoma, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_disease, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_involutionary, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (T_immunob_large, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Monocytoid_B_cell, Striking_GT_100) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Nasopharyngeal_CA, Striking_GT_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Seminoma, Striking_GT_100) 0.0, 0.9, 0.1, 0.0, 0.0;
  (SLE, Striking_GT_100) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_hyperplas, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (LGV, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histoplasmosis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Coccidioidomycosis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (CMV, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Brucellosis, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Ki_1_LC_anaplas_B, Striking_GT_100) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Intermed_lymphocytic, Striking_GT_100) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_early, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AILD, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (ALIP, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Cat_scratch_disease, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Dermatopathic_laden, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Florid_follic_hyperp, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_hyaline_vascular, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (GLH_plasma_cell, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Granulomatous_laden, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histiocytosis_x, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Infectious_mono, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Lymphangiographic, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_hyperpla, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Necrotizing_Kikuchi, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotiz_non_Kikuchi, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Rheumatoid_arthritis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sarcoidosis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (SHML, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Sinus_histiocytosis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Syphilis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Toxoplasmosis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Tuberculosis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Viral_NOS, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (L_H_nodular_HD, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.1, 0.8, 0.0;
  (L_H_diffuse_HD, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.1, 0.8, 0.0;
  (Nodular_sclerosis_HD, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_fol, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Large_cell_fol, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_fol, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_lymphocytic, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Plasmacytoid_lyctic, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mantle_zone_lymphoma, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_cleaved_dif, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mixed_FCC_dif, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Large_cell_dif, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (B_immunoblastic, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (T_immunob_mixed, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AILD_like_T_cell_lym, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Japanese_ATL, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Lymphoblastic, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Small_noncleaved_dif, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (True_histiocytic, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Ki_1_LC_anaplas_T, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Multiple_myeloma, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Mycosis_fungoides, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (AML, Sheets_GT_50pc_of_section) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Hairy_cell_leukemia, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Carcinoma, Sheets_GT_50pc_of_section) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Melanoma, Sheets_GT_50pc_of_section) 0.0, 0.9, 0.1, 0.0, 0.0;
  (EM_plasmacytoma, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Kaposi_s_sarcoma, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_disease, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (AIDS_involutionary, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (T_immunob_large, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Monocytoid_B_cell, Sheets_GT_50pc_of_section) 0.00, 0.05, 0.00, 0.95, 0.00;
  (Nasopharyngeal_CA, Sheets_GT_50pc_of_section) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Seminoma, Sheets_GT_50pc_of_section) 0.0, 0.9, 0.1, 0.0, 0.0;
  (SLE, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Mast_cell_hyperplas, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (LGV, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Histoplasmosis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Coccidioidomycosis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (CMV, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Brucellosis, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
  (Ki_1_LC_anaplas_B, Sheets_GT_50pc_of_section) 0.0, 0.1, 0.0, 0.8, 0.1;
  (Intermed_lymphocytic, Sheets_GT_50pc_of_section) 0.00, 0.01, 0.01, 0.98, 0.00;
}
probability ( PLEO_LEU | Fault, PLEO ) {
  (AIDS_early, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AILD, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (ALIP, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Cat_scratch_disease, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Dermatopathic_laden, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Florid_follic_hyperp, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_hyaline_vascular, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_plasma_cell, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Granulomatous_laden, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histiocytosis_x, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Infectious_mono, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Leprosy_lepromatous, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphangiographic, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_hyperpla, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotizing_Kikuchi, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotiz_non_Kikuchi, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Rheumatoid_arthritis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sarcoidosis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (SHML, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sinus_histiocytosis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Syphilis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Toxoplasmosis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Tuberculosis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Viral_NOS, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Whipple_s_disease, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_nodular_HD, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_diffuse_HD, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nodular_sclerosis_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Rare_1_to_5) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_fol, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_fol, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_fol, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_lymphocytic, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Plasmacytoid_lyctic, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_lymphoma, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_cleaved_dif, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_FCC_dif, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_dif, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (B_immunoblastic, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_mixed, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD_like_T_cell_lym, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Japanese_ATL, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphoblastic, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_dif, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (True_histiocytic, Rare_1_to_5) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Multiple_myeloma, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycosis_fungoides, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AML, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Hairy_cell_leukemia, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Carcinoma, Rare_1_to_5) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Rare_1_to_5) 0.0, 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Kaposi_s_sarcoma, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_disease, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_involutionary, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (T_immunob_large, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Monocytoid_B_cell, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nasopharyngeal_CA, Rare_1_to_5) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Rare_1_to_5) 0.0, 1.0, 0.0, 0.0, 0.0;
  (SLE, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mycobact_histiocytos, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_hyperplas, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (LGV, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histoplasmosis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Coccidioidomycosis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (CMV, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Brucellosis, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_B, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Intermed_lymphocytic, Rare_1_to_5) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_early, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AILD, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (ALIP, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Cat_scratch_disease, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Dermatopathic_laden, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Florid_follic_hyperp, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_hyaline_vascular, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_plasma_cell, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Granulomatous_laden, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histiocytosis_x, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Infectious_mono, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Leprosy_lepromatous, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphangiographic, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_hyperpla, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotizing_Kikuchi, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotiz_non_Kikuchi, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Rheumatoid_arthritis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sarcoidosis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (SHML, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sinus_histiocytosis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Syphilis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Toxoplasmosis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Tuberculosis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Viral_NOS, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Whipple_s_disease, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_nodular_HD, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_diffuse_HD, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nodular_sclerosis_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Few_6_to_25) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_fol, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_fol, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_fol, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_lymphocytic, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Plasmacytoid_lyctic, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_lymphoma, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_cleaved_dif, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_FCC_dif, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_dif, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (B_immunoblastic, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_mixed, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD_like_T_cell_lym, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Japanese_ATL, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphoblastic, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_dif, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (True_histiocytic, Few_6_to_25) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Multiple_myeloma, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycosis_fungoides, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AML, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Hairy_cell_leukemia, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Carcinoma, Few_6_to_25) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Few_6_to_25) 0.0, 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Kaposi_s_sarcoma, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_disease, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_involutionary, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (T_immunob_large, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Monocytoid_B_cell, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nasopharyngeal_CA, Few_6_to_25) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Few_6_to_25) 0.0, 1.0, 0.0, 0.0, 0.0;
  (SLE, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mycobact_histiocytos, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_hyperplas, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (LGV, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histoplasmosis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Coccidioidomycosis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (CMV, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Brucellosis, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_B, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Intermed_lymphocytic, Few_6_to_25) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_early, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AILD, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (ALIP, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Cat_scratch_disease, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Dermatopathic_laden, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Florid_follic_hyperp, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_hyaline_vascular, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_plasma_cell, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Granulomatous_laden, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histiocytosis_x, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Infectious_mono, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Leprosy_lepromatous, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphangiographic, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_hyperpla, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotizing_Kikuchi, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotiz_non_Kikuchi, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Rheumatoid_arthritis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sarcoidosis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (SHML, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sinus_histiocytosis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Syphilis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Toxoplasmosis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Tuberculosis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Viral_NOS, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Whipple_s_disease, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_nodular_HD, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_diffuse_HD, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nodular_sclerosis_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Many_26_to_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_fol, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_fol, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_fol, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_lymphocytic, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Plasmacytoid_lyctic, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_lymphoma, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_cleaved_dif, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_FCC_dif, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_dif, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (B_immunoblastic, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_mixed, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD_like_T_cell_lym, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Japanese_ATL, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphoblastic, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_dif, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (True_histiocytic, Many_26_to_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Multiple_myeloma, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycosis_fungoides, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AML, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Hairy_cell_leukemia, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Carcinoma, Many_26_to_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Many_26_to_100) 0.0, 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Kaposi_s_sarcoma, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_disease, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_involutionary, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (T_immunob_large, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Monocytoid_B_cell, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nasopharyngeal_CA, Many_26_to_100) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Many_26_to_100) 0.0, 1.0, 0.0, 0.0, 0.0;
  (SLE, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mycobact_histiocytos, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_hyperplas, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (LGV, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histoplasmosis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Coccidioidomycosis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (CMV, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Brucellosis, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_B, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Intermed_lymphocytic, Many_26_to_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_early, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AILD, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (ALIP, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Cat_scratch_disease, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Dermatopathic_laden, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Florid_follic_hyperp, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_hyaline_vascular, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (GLH_plasma_cell, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Granulomatous_laden, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histiocytosis_x, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Infectious_mono, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Leprosy_lepromatous, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Lymphangiographic, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_hyperpla, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotizing_Kikuchi, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Necrotiz_non_Kikuchi, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Rheumatoid_arthritis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sarcoidosis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (SHML, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Sinus_histiocytosis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Syphilis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Toxoplasmosis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Tuberculosis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Viral_NOS, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Whipple_s_disease, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_nodular_HD, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (L_H_diffuse_HD, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nodular_sclerosis_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Cellular_phase_NSHD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Syncytial_NSHD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Mixed_cellularity_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Interfollicular_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Reticular_type_HD, Striking_GT_100) 0.00, 0.05, 0.95, 0.00, 0.00;
  (Small_cleaved_fol, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_fol, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_fol, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_fol, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_lymphocytic, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Plasmacytoid_lyctic, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mantle_zone_lymphoma, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_cleaved_dif, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mixed_FCC_dif, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Large_cell_dif, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (B_immunoblastic, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_mixed, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD_like_T_cell_lym, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Japanese_ATL, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphoblastic, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Small_noncleaved_dif, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (True_histiocytic, Striking_GT_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Multiple_myeloma, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycosis_fungoides, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AML, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Hairy_cell_leukemia, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Carcinoma, Striking_GT_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Striking_GT_100) 0.0, 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Kaposi_s_sarcoma, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_disease, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (AIDS_involutionary, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (T_immunob_large, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Monocytoid_B_cell, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Nasopharyngeal_CA, Striking_GT_100) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Striking_GT_100) 0.0, 1.0, 0.0, 0.0, 0.0;
  (SLE, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mycobact_histiocytos, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Mast_cell_hyperplas, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (LGV, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Histoplasmosis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Coccidioidomycosis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (CMV, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Brucellosis, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
  (Ki_1_LC_anaplas_B, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Intermed_lymphocytic, Striking_GT_100) 0.2, 0.2, 0.2, 0.2, 0.2;
}
probability ( MONO_LEU | Fault, MONO ) {
  (AIDS_early, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AILD, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (ALIP, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Cat_scratch_disease, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Dermatopathic_laden, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Florid_follic_hyperp, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (GLH_hyaline_vascular, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (GLH_plasma_cell, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Granulomatous_laden, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Histiocytosis_x, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Infectious_mono, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Lymphangiographic, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mantle_zone_hyperpla, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotizing_Kikuchi, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotiz_non_Kikuchi, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Rheumatoid_arthritis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Sarcoidosis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (SHML, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Sinus_histiocytosis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Syphilis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Toxoplasmosis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Tuberculosis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Viral_NOS, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (L_H_nodular_HD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (L_H_diffuse_HD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Nodular_sclerosis_HD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Cellular_phase_NSHD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Syncytial_NSHD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Mixed_cellularity_HD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Interfollicular_HD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Reticular_type_HD, Rare_1_to_2) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Small_cleaved_fol, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mixed_fol, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Large_cell_fol, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_noncleaved_fol, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_lymphocytic, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Plasmacytoid_lyctic, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mantle_zone_lymphoma, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_cleaved_dif, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mixed_FCC_dif, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Large_cell_dif, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (B_immunoblastic, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (T_immunob_mixed, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (AILD_like_T_cell_lym, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Japanese_ATL, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Lymphoblastic, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_noncleaved_dif, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (True_histiocytic, Rare_1_to_2) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Multiple_myeloma, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Mycosis_fungoides, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (AML, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Hairy_cell_leukemia, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Carcinoma, Rare_1_to_2) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Melanoma, Rare_1_to_2) 0.0, 0.9, 0.1, 0.0, 0.0;
  (EM_plasmacytoma, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Kaposi_s_sarcoma, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mast_cell_disease, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AIDS_involutionary, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (T_immunob_large, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Monocytoid_B_cell, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Nasopharyngeal_CA, Rare_1_to_2) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Seminoma, Rare_1_to_2) 0.0, 0.9, 0.1, 0.0, 0.0;
  (SLE, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mast_cell_hyperplas, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (LGV, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Histoplasmosis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Coccidioidomycosis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (CMV, Rare_1_to_2) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Brucellosis, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Ki_1_LC_anaplas_B, Rare_1_to_2) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Intermed_lymphocytic, Rare_1_to_2) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AIDS_early, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AILD, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (ALIP, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Cat_scratch_disease, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Dermatopathic_laden, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Florid_follic_hyperp, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (GLH_hyaline_vascular, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (GLH_plasma_cell, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Granulomatous_laden, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Histiocytosis_x, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Infectious_mono, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Lymphangiographic, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mantle_zone_hyperpla, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotizing_Kikuchi, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotiz_non_Kikuchi, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Rheumatoid_arthritis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Sarcoidosis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (SHML, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Sinus_histiocytosis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Syphilis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Toxoplasmosis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Tuberculosis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Viral_NOS, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (L_H_nodular_HD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (L_H_diffuse_HD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Nodular_sclerosis_HD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Cellular_phase_NSHD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Syncytial_NSHD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Mixed_cellularity_HD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Interfollicular_HD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Reticular_type_HD, Present_3_to_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Small_cleaved_fol, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mixed_fol, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Large_cell_fol, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_noncleaved_fol, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_lymphocytic, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Plasmacytoid_lyctic, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mantle_zone_lymphoma, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_cleaved_dif, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mixed_FCC_dif, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Large_cell_dif, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (B_immunoblastic, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (T_immunob_mixed, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (AILD_like_T_cell_lym, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Japanese_ATL, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Lymphoblastic, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_noncleaved_dif, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (True_histiocytic, Present_3_to_20) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Multiple_myeloma, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Mycosis_fungoides, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (AML, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Hairy_cell_leukemia, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Carcinoma, Present_3_to_20) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Melanoma, Present_3_to_20) 0.0, 0.9, 0.1, 0.0, 0.0;
  (EM_plasmacytoma, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Kaposi_s_sarcoma, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mast_cell_disease, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AIDS_involutionary, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (T_immunob_large, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Monocytoid_B_cell, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Nasopharyngeal_CA, Present_3_to_20) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Seminoma, Present_3_to_20) 0.0, 0.9, 0.1, 0.0, 0.0;
  (SLE, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mast_cell_hyperplas, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (LGV, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Histoplasmosis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Coccidioidomycosis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (CMV, Present_3_to_20) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Brucellosis, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Ki_1_LC_anaplas_B, Present_3_to_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Intermed_lymphocytic, Present_3_to_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AIDS_early, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AILD, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (ALIP, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Cat_scratch_disease, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Dermatopathic_laden, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Florid_follic_hyperp, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (GLH_hyaline_vascular, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (GLH_plasma_cell, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Granulomatous_laden, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Histiocytosis_x, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Infectious_mono, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Leprosy_lepromatous, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Lymphangiographic, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mantle_zone_hyperpla, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotizing_Kikuchi, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Necrotiz_non_Kikuchi, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Rheumatoid_arthritis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Sarcoidosis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (SHML, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Sinus_histiocytosis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Syphilis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Toxoplasmosis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Tuberculosis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Viral_NOS, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Whipple_s_disease, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (L_H_nodular_HD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (L_H_diffuse_HD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Nodular_sclerosis_HD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Cellular_phase_NSHD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Syncytial_NSHD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Mixed_cellularity_HD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Interfollicular_HD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Reticular_type_HD, Many_GT_20) 0.0, 0.1, 0.9, 0.0, 0.0;
  (Small_cleaved_fol, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mixed_fol, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Large_cell_fol, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_noncleaved_fol, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_lymphocytic, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Plasmacytoid_lyctic, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mantle_zone_lymphoma, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_cleaved_dif, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mixed_FCC_dif, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Large_cell_dif, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (B_immunoblastic, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (T_immunob_mixed, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (AILD_like_T_cell_lym, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Japanese_ATL, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Lymphoblastic, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Small_noncleaved_dif, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (True_histiocytic, Many_GT_20) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Multiple_myeloma, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Mycosis_fungoides, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (AML, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Hairy_cell_leukemia, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Carcinoma, Many_GT_20) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Melanoma, Many_GT_20) 0.0, 0.9, 0.1, 0.0, 0.0;
  (EM_plasmacytoma, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Kaposi_s_sarcoma, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mast_cell_disease, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (AIDS_involutionary, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (T_immunob_large, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Monocytoid_B_cell, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Nasopharyngeal_CA, Many_GT_20) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Seminoma, Many_GT_20) 0.0, 0.9, 0.1, 0.0, 0.0;
  (SLE, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mycobact_histiocytos, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Mast_cell_hyperplas, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (LGV, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Histoplasmosis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Coccidioidomycosis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (CMV, Many_GT_20) 0.00, 0.95, 0.05, 0.00, 0.00;
  (Brucellosis, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
  (Ki_1_LC_anaplas_B, Many_GT_20) 0.0, 0.2, 0.0, 0.8, 0.0;
  (Intermed_lymphocytic, Many_GT_20) 0.0, 0.1, 0.0, 0.9, 0.0;
}
probability ( LH_LEU | Fault, L_and_H ) {
  (AIDS_early, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AILD, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (ALIP, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Granulomatous_laden, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Histiocytosis_x, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Infectious_mono, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Leprosy_lepromatous, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Lymphangiographic, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotiz_non_Kikuchi, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Rheumatoid_arthritis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Sarcoidosis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (SHML, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Syphilis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Toxoplasmosis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Tuberculosis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Viral_NOS, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Whipple_s_disease, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Rare_1_to_5) 0.00, 0.02, 0.01, 0.97, 0.00;
  (L_H_diffuse_HD, Rare_1_to_5) 0.00, 0.02, 0.01, 0.97, 0.00;
  (Nodular_sclerosis_HD, Rare_1_to_5) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Cellular_phase_NSHD, Rare_1_to_5) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Syncytial_NSHD, Rare_1_to_5) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Mixed_cellularity_HD, Rare_1_to_5) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Interfollicular_HD, Rare_1_to_5) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Diffuse_fibrosis_HD, Rare_1_to_5) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Reticular_type_HD, Rare_1_to_5) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Small_cleaved_fol, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mixed_fol, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Large_cell_fol, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_lymphocytic, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Large_cell_dif, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (B_immunoblastic, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_mixed, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD_like_T_cell_lym, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Japanese_ATL, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphoblastic, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_noncleaved_dif, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (True_histiocytic, Rare_1_to_5) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Multiple_myeloma, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycosis_fungoides, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AML, Rare_1_to_5) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Hairy_cell_leukemia, Rare_1_to_5) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Rare_1_to_5) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Rare_1_to_5) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mast_cell_disease, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AIDS_involutionary, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (T_immunob_large, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Monocytoid_B_cell, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Nasopharyngeal_CA, Rare_1_to_5) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Rare_1_to_5) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycobact_histiocytos, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (LGV, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Histoplasmosis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (CMV, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Brucellosis, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Rare_1_to_5) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Intermed_lymphocytic, Rare_1_to_5) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AIDS_early, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AILD, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (ALIP, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Granulomatous_laden, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Histiocytosis_x, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Infectious_mono, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Leprosy_lepromatous, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Lymphangiographic, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotiz_non_Kikuchi, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Rheumatoid_arthritis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Sarcoidosis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (SHML, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Syphilis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Toxoplasmosis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Tuberculosis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Viral_NOS, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Whipple_s_disease, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Few_6_to_25) 0.00, 0.02, 0.01, 0.97, 0.00;
  (L_H_diffuse_HD, Few_6_to_25) 0.00, 0.02, 0.01, 0.97, 0.00;
  (Nodular_sclerosis_HD, Few_6_to_25) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Cellular_phase_NSHD, Few_6_to_25) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Syncytial_NSHD, Few_6_to_25) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Mixed_cellularity_HD, Few_6_to_25) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Interfollicular_HD, Few_6_to_25) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Diffuse_fibrosis_HD, Few_6_to_25) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Reticular_type_HD, Few_6_to_25) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Small_cleaved_fol, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mixed_fol, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Large_cell_fol, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_lymphocytic, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Large_cell_dif, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (B_immunoblastic, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_mixed, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD_like_T_cell_lym, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Japanese_ATL, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphoblastic, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_noncleaved_dif, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (True_histiocytic, Few_6_to_25) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Multiple_myeloma, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycosis_fungoides, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AML, Few_6_to_25) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Hairy_cell_leukemia, Few_6_to_25) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Few_6_to_25) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Few_6_to_25) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mast_cell_disease, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AIDS_involutionary, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (T_immunob_large, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Monocytoid_B_cell, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Nasopharyngeal_CA, Few_6_to_25) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Few_6_to_25) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycobact_histiocytos, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (LGV, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Histoplasmosis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (CMV, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Brucellosis, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Few_6_to_25) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Intermed_lymphocytic, Few_6_to_25) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AIDS_early, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AILD, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (ALIP, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Granulomatous_laden, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Histiocytosis_x, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Infectious_mono, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Leprosy_lepromatous, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Lymphangiographic, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotiz_non_Kikuchi, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Rheumatoid_arthritis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Sarcoidosis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (SHML, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Syphilis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Toxoplasmosis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Tuberculosis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Viral_NOS, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Whipple_s_disease, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Many_26_to_100) 0.00, 0.02, 0.01, 0.97, 0.00;
  (L_H_diffuse_HD, Many_26_to_100) 0.00, 0.02, 0.01, 0.97, 0.00;
  (Nodular_sclerosis_HD, Many_26_to_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Cellular_phase_NSHD, Many_26_to_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Syncytial_NSHD, Many_26_to_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Mixed_cellularity_HD, Many_26_to_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Interfollicular_HD, Many_26_to_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Diffuse_fibrosis_HD, Many_26_to_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Reticular_type_HD, Many_26_to_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Small_cleaved_fol, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mixed_fol, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Large_cell_fol, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_lymphocytic, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Large_cell_dif, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (B_immunoblastic, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_mixed, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD_like_T_cell_lym, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Japanese_ATL, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphoblastic, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_noncleaved_dif, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (True_histiocytic, Many_26_to_100) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Multiple_myeloma, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycosis_fungoides, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AML, Many_26_to_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Hairy_cell_leukemia, Many_26_to_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Many_26_to_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Many_26_to_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mast_cell_disease, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AIDS_involutionary, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (T_immunob_large, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Monocytoid_B_cell, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Nasopharyngeal_CA, Many_26_to_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Many_26_to_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycobact_histiocytos, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (LGV, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Histoplasmosis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (CMV, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Brucellosis, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Many_26_to_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Intermed_lymphocytic, Many_26_to_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AIDS_early, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AILD, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (ALIP, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Granulomatous_laden, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Histiocytosis_x, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Infectious_mono, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Leprosy_lepromatous, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Lymphangiographic, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Necrotiz_non_Kikuchi, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Rheumatoid_arthritis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Sarcoidosis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (SHML, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Syphilis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Toxoplasmosis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Tuberculosis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Viral_NOS, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Whipple_s_disease, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Striking_GT_100) 0.00, 0.02, 0.01, 0.97, 0.00;
  (L_H_diffuse_HD, Striking_GT_100) 0.00, 0.02, 0.01, 0.97, 0.00;
  (Nodular_sclerosis_HD, Striking_GT_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Cellular_phase_NSHD, Striking_GT_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Syncytial_NSHD, Striking_GT_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Mixed_cellularity_HD, Striking_GT_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Interfollicular_HD, Striking_GT_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Diffuse_fibrosis_HD, Striking_GT_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Reticular_type_HD, Striking_GT_100) 0.0, 0.1, 0.8, 0.1, 0.0;
  (Small_cleaved_fol, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mixed_fol, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Large_cell_fol, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_lymphocytic, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Large_cell_dif, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (B_immunoblastic, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (T_immunob_mixed, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AILD_like_T_cell_lym, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Japanese_ATL, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Lymphoblastic, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Small_noncleaved_dif, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (True_histiocytic, Striking_GT_100) 0.0, 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Multiple_myeloma, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycosis_fungoides, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (AML, Striking_GT_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Hairy_cell_leukemia, Striking_GT_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Striking_GT_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Striking_GT_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mast_cell_disease, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (AIDS_involutionary, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (T_immunob_large, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Monocytoid_B_cell, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Nasopharyngeal_CA, Striking_GT_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Striking_GT_100) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Mycobact_histiocytos, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (LGV, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Histoplasmosis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (CMV, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Brucellosis, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Striking_GT_100) 0.00, 0.01, 0.00, 0.99, 0.00;
  (Intermed_lymphocytic, Striking_GT_100) 0.0, 0.0, 0.0, 1.0, 0.0;
}
probability ( CA_KER | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 0.05, 0.95;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 0.05, 0.95;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( MLC_LEU9 | Fault, MLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_early, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AILD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (ALIP, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Rheumatoid_arthritis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (SHML, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Syphilis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Sparse_LT_10pc) 0.00, 0.05, 0.95;
  (Small_noncleaved_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AML, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Hairy_cell_leukemia, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Carcinoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Melanoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Seminoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (SLE, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (LGV, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (CMV, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Brucellosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AIDS_early, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AILD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (ALIP, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (SHML, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Syphilis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Moderate_11_to_50pc) 0.00, 0.05, 0.95;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AML, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Carcinoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Melanoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Seminoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (SLE, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (LGV, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (CMV, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Brucellosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AIDS_early, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AILD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (ALIP, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (SHML, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Syphilis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Numerous_51_to_90pc) 0.00, 0.05, 0.95;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AML, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Carcinoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Melanoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Seminoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (SLE, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (LGV, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (CMV, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Brucellosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AIDS_early, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AILD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (ALIP, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (SHML, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Syphilis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Striking_GT_90pc) 0.00, 0.05, 0.95;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AML, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Carcinoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Melanoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Seminoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (SLE, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (LGV, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (CMV, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Brucellosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
}
probability ( MLC_TDT | Fault, MLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_early, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AILD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (ALIP, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Rheumatoid_arthritis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (SHML, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Syphilis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Sparse_LT_10pc) 0.00, 0.02, 0.98;
  (Small_noncleaved_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AML, Sparse_LT_10pc) 0.00, 0.95, 0.05;
  (Hairy_cell_leukemia, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Carcinoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Melanoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Seminoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (SLE, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (LGV, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (CMV, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Brucellosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AIDS_early, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AILD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (ALIP, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (SHML, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Syphilis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Moderate_11_to_50pc) 0.00, 0.02, 0.98;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AML, Moderate_11_to_50pc) 0.00, 0.95, 0.05;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Carcinoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Melanoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Seminoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (SLE, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (LGV, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (CMV, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Brucellosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AIDS_early, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AILD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (ALIP, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (SHML, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Syphilis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Numerous_51_to_90pc) 0.00, 0.02, 0.98;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AML, Numerous_51_to_90pc) 0.00, 0.95, 0.05;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Carcinoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Melanoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Seminoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (SLE, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (LGV, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (CMV, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Brucellosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AIDS_early, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AILD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (ALIP, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (SHML, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Syphilis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Striking_GT_90pc) 0.00, 0.02, 0.98;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AML, Striking_GT_90pc) 0.00, 0.95, 0.05;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Carcinoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Melanoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Seminoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (SLE, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (LGV, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (CMV, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Brucellosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
}
probability ( CA_CHROM | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 0.95, 0.05;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 0.95, 0.05;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( UCHL_1 | Fault ) {
  (AIDS_early) 0.1, 0.9;
  (AILD) 0.5, 0.5;
  (ALIP) 0.1, 0.9;
  (Cat_scratch_disease) 0.1, 0.9;
  (Dermatopathic_laden) 0.1, 0.9;
  (Florid_follic_hyperp) 0.1, 0.9;
  (GLH_hyaline_vascular) 0.1, 0.9;
  (GLH_plasma_cell) 0.1, 0.9;
  (Granulomatous_laden) 0.1, 0.9;
  (Histiocytosis_x) 0.1, 0.9;
  (Infectious_mono) 0.1, 0.9;
  (Leprosy_lepromatous) 0.1, 0.9;
  (Lymphangiographic) 0.1, 0.9;
  (Mantle_zone_hyperpla) 0.1, 0.9;
  (Necrotizing_Kikuchi) 0.1, 0.9;
  (Necrotiz_non_Kikuchi) 0.1, 0.9;
  (Rheumatoid_arthritis) 0.1, 0.9;
  (Sarcoidosis) 0.1, 0.9;
  (SHML) 0.1, 0.9;
  (Sinus_histiocytosis) 0.1, 0.9;
  (Syphilis) 0.1, 0.9;
  (Toxoplasmosis) 0.1, 0.9;
  (Tuberculosis) 0.1, 0.9;
  (Viral_NOS) 0.1, 0.9;
  (Whipple_s_disease) 0.1, 0.9;
  (L_H_nodular_HD) 0.9, 0.1;
  (L_H_diffuse_HD) 0.2, 0.8;
  (Nodular_sclerosis_HD) 0.2, 0.8;
  (Cellular_phase_NSHD) 0.2, 0.8;
  (Syncytial_NSHD) 0.2, 0.8;
  (Mixed_cellularity_HD) 0.2, 0.8;
  (Interfollicular_HD) 0.2, 0.8;
  (Diffuse_fibrosis_HD) 0.2, 0.8;
  (Reticular_type_HD) 0.2, 0.8;
  (Small_cleaved_fol) 0.999, 0.001;
  (Mixed_fol) 0.999, 0.001;
  (Large_cell_fol) 0.999, 0.001;
  (Small_noncleaved_fol) 0.999, 0.001;
  (Small_lymphocytic) 0.999, 0.001;
  (Plasmacytoid_lyctic) 0.999, 0.001;
  (Mantle_zone_lymphoma) 0.999, 0.001;
  (Small_cleaved_dif) 0.999, 0.001;
  (Mixed_FCC_dif) 0.999, 0.001;
  (Large_cell_dif) 0.999, 0.001;
  (B_immunoblastic) 0.999, 0.001;
  (T_immunob_mixed) 0.5, 0.5;
  (AILD_like_T_cell_lym) 0.5, 0.5;
  (Japanese_ATL) 0.5, 0.5;
  (Lymphoblastic) 0.5, 0.5;
  (Small_noncleaved_dif) 0.999, 0.001;
  (True_histiocytic) 0.5, 0.5;
  (Ki_1_LC_anaplas_T) 0.5, 0.5;
  (Multiple_myeloma) 0.1, 0.9;
  (Mycosis_fungoides) 0.5, 0.5;
  (AML) 0.1, 0.9;
  (Hairy_cell_leukemia) 0.1, 0.9;
  (Carcinoma) 0.1, 0.9;
  (Melanoma) 0.1, 0.9;
  (EM_plasmacytoma) 0.1, 0.9;
  (Kaposi_s_sarcoma) 0.1, 0.9;
  (Mast_cell_disease) 0.1, 0.9;
  (AIDS_involutionary) 0.1, 0.9;
  (T_immunob_large) 0.5, 0.5;
  (Monocytoid_B_cell) 0.999, 0.001;
  (Nasopharyngeal_CA) 0.1, 0.9;
  (Seminoma) 0.1, 0.9;
  (SLE) 0.1, 0.9;
  (Mycobact_histiocytos) 0.1, 0.9;
  (Mast_cell_hyperplas) 0.1, 0.9;
  (LGV) 0.1, 0.9;
  (Histoplasmosis) 0.1, 0.9;
  (Coccidioidomycosis) 0.1, 0.9;
  (CMV) 0.1, 0.9;
  (Brucellosis) 0.1, 0.9;
  (Ki_1_LC_anaplas_B) 0.999, 0.001;
  (Intermed_lymphocytic) 0.999, 0.001;
}
probability ( KI_AB | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 0.99, 0.01;
  (L_H_diffuse_HD) 0.99, 0.01;
  (Nodular_sclerosis_HD) 0.05, 0.95;
  (Cellular_phase_NSHD) 0.05, 0.95;
  (Syncytial_NSHD) 0.05, 0.95;
  (Mixed_cellularity_HD) 0.05, 0.95;
  (Interfollicular_HD) 0.05, 0.95;
  (Diffuse_fibrosis_HD) 0.05, 0.95;
  (Reticular_type_HD) 0.05, 0.95;
  (Small_cleaved_fol) 0.99, 0.01;
  (Mixed_fol) 0.99, 0.01;
  (Large_cell_fol) 0.99, 0.01;
  (Small_noncleaved_fol) 0.99, 0.01;
  (Small_lymphocytic) 0.99, 0.01;
  (Plasmacytoid_lyctic) 0.99, 0.01;
  (Mantle_zone_lymphoma) 0.99, 0.01;
  (Small_cleaved_dif) 0.99, 0.01;
  (Mixed_FCC_dif) 0.99, 0.01;
  (Large_cell_dif) 0.99, 0.01;
  (B_immunoblastic) 0.99, 0.01;
  (T_immunob_mixed) 0.99, 0.01;
  (AILD_like_T_cell_lym) 0.99, 0.01;
  (Japanese_ATL) 0.99, 0.01;
  (Lymphoblastic) 0.99, 0.01;
  (Small_noncleaved_dif) 0.99, 0.01;
  (True_histiocytic) 0.99, 0.01;
  (Ki_1_LC_anaplas_T) 0.0, 1.0;
  (Multiple_myeloma) 0.98, 0.02;
  (Mycosis_fungoides) 0.98, 0.02;
  (AML) 0.98, 0.02;
  (Hairy_cell_leukemia) 0.98, 0.02;
  (Carcinoma) 0.98, 0.02;
  (Melanoma) 0.98, 0.02;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 0.99, 0.01;
  (Monocytoid_B_cell) 0.99, 0.01;
  (Nasopharyngeal_CA) 0.98, 0.02;
  (Seminoma) 0.98, 0.02;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 0.0, 1.0;
  (Intermed_lymphocytic) 0.99, 0.01;
}
probability ( L_26 | Fault ) {
  (AIDS_early) 0.5, 0.5;
  (AILD) 0.8, 0.2;
  (ALIP) 0.8, 0.2;
  (Cat_scratch_disease) 0.8, 0.2;
  (Dermatopathic_laden) 0.8, 0.2;
  (Florid_follic_hyperp) 0.8, 0.2;
  (GLH_hyaline_vascular) 0.8, 0.2;
  (GLH_plasma_cell) 0.8, 0.2;
  (Granulomatous_laden) 0.8, 0.2;
  (Histiocytosis_x) 0.8, 0.2;
  (Infectious_mono) 0.8, 0.2;
  (Leprosy_lepromatous) 0.8, 0.2;
  (Lymphangiographic) 0.8, 0.2;
  (Mantle_zone_hyperpla) 0.8, 0.2;
  (Necrotizing_Kikuchi) 0.8, 0.2;
  (Necrotiz_non_Kikuchi) 0.8, 0.2;
  (Rheumatoid_arthritis) 0.8, 0.2;
  (Sarcoidosis) 0.8, 0.2;
  (SHML) 0.8, 0.2;
  (Sinus_histiocytosis) 0.8, 0.2;
  (Syphilis) 0.8, 0.2;
  (Toxoplasmosis) 0.8, 0.2;
  (Tuberculosis) 0.8, 0.2;
  (Viral_NOS) 0.8, 0.2;
  (Whipple_s_disease) 0.8, 0.2;
  (L_H_nodular_HD) 0.2, 0.8;
  (L_H_diffuse_HD) 0.5, 0.5;
  (Nodular_sclerosis_HD) 0.8, 0.2;
  (Cellular_phase_NSHD) 0.8, 0.2;
  (Syncytial_NSHD) 0.8, 0.2;
  (Mixed_cellularity_HD) 0.8, 0.2;
  (Interfollicular_HD) 0.8, 0.2;
  (Diffuse_fibrosis_HD) 0.8, 0.2;
  (Reticular_type_HD) 0.8, 0.2;
  (Small_cleaved_fol) 0.01, 0.99;
  (Mixed_fol) 0.01, 0.99;
  (Large_cell_fol) 0.01, 0.99;
  (Small_noncleaved_fol) 0.01, 0.99;
  (Small_lymphocytic) 0.01, 0.99;
  (Plasmacytoid_lyctic) 0.01, 0.99;
  (Mantle_zone_lymphoma) 0.01, 0.99;
  (Small_cleaved_dif) 0.01, 0.99;
  (Mixed_FCC_dif) 0.01, 0.99;
  (Large_cell_dif) 0.01, 0.99;
  (B_immunoblastic) 0.01, 0.99;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 0.01, 0.99;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 0.8, 0.2;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 0.8, 0.2;
  (Hairy_cell_leukemia) 0.8, 0.2;
  (Carcinoma) 0.8, 0.2;
  (Melanoma) 0.8, 0.2;
  (EM_plasmacytoma) 0.01, 0.99;
  (Kaposi_s_sarcoma) 0.8, 0.2;
  (Mast_cell_disease) 0.8, 0.2;
  (AIDS_involutionary) 0.5, 0.5;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 0.01, 0.99;
  (Nasopharyngeal_CA) 0.8, 0.2;
  (Seminoma) 0.8, 0.2;
  (SLE) 0.8, 0.2;
  (Mycobact_histiocytos) 0.8, 0.2;
  (Mast_cell_hyperplas) 0.8, 0.2;
  (LGV) 0.8, 0.2;
  (Histoplasmosis) 0.8, 0.2;
  (Coccidioidomycosis) 0.8, 0.2;
  (CMV) 0.8, 0.2;
  (Brucellosis) 0.8, 0.2;
  (Ki_1_LC_anaplas_B) 0.01, 0.99;
  (Intermed_lymphocytic) 0.01, 0.99;
}
probability ( BER_H2 | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 0.99, 0.01;
  (L_H_diffuse_HD) 0.99, 0.01;
  (Nodular_sclerosis_HD) 0.05, 0.95;
  (Cellular_phase_NSHD) 0.05, 0.95;
  (Syncytial_NSHD) 0.05, 0.95;
  (Mixed_cellularity_HD) 0.05, 0.95;
  (Interfollicular_HD) 0.05, 0.95;
  (Diffuse_fibrosis_HD) 0.05, 0.95;
  (Reticular_type_HD) 0.05, 0.95;
  (Small_cleaved_fol) 0.99, 0.01;
  (Mixed_fol) 0.99, 0.01;
  (Large_cell_fol) 0.99, 0.01;
  (Small_noncleaved_fol) 0.99, 0.01;
  (Small_lymphocytic) 0.99, 0.01;
  (Plasmacytoid_lyctic) 0.99, 0.01;
  (Mantle_zone_lymphoma) 0.99, 0.01;
  (Small_cleaved_dif) 0.99, 0.01;
  (Mixed_FCC_dif) 0.99, 0.01;
  (Large_cell_dif) 0.99, 0.01;
  (B_immunoblastic) 0.99, 0.01;
  (T_immunob_mixed) 0.99, 0.01;
  (AILD_like_T_cell_lym) 0.99, 0.01;
  (Japanese_ATL) 0.99, 0.01;
  (Lymphoblastic) 0.99, 0.01;
  (Small_noncleaved_dif) 0.99, 0.01;
  (True_histiocytic) 0.99, 0.01;
  (Ki_1_LC_anaplas_T) 0.0, 1.0;
  (Multiple_myeloma) 0.98, 0.02;
  (Mycosis_fungoides) 0.98, 0.02;
  (AML) 0.98, 0.02;
  (Hairy_cell_leukemia) 0.98, 0.02;
  (Carcinoma) 0.98, 0.02;
  (Melanoma) 0.98, 0.02;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 0.99, 0.01;
  (Monocytoid_B_cell) 0.99, 0.01;
  (Nasopharyngeal_CA) 0.98, 0.02;
  (Seminoma) 0.98, 0.02;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 0.0, 1.0;
  (Intermed_lymphocytic) 0.99, 0.01;
}
probability ( SEMINOMA | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 0.0, 1.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( AGE | Fault ) {
  (AIDS_early) 0.05, 0.40, 0.54, 0.01;
  (AILD) 0.00001, 0.01000, 0.58999, 0.40000;
  (ALIP) 0.00001, 0.20000, 0.39999, 0.40000;
  (Cat_scratch_disease) 0.30, 0.20, 0.49, 0.01;
  (Dermatopathic_laden) 0.01, 0.10, 0.69, 0.20;
  (Florid_follic_hyperp) 0.34, 0.40, 0.25, 0.01;
  (GLH_hyaline_vascular) 0.30, 0.30, 0.39, 0.01;
  (GLH_plasma_cell) 0.20, 0.20, 0.55, 0.05;
  (Granulomatous_laden) 0.10, 0.15, 0.70, 0.05;
  (Histiocytosis_x) 0.40, 0.20, 0.39, 0.01;
  (Infectious_mono) 0.25, 0.45, 0.29, 0.01;
  (Leprosy_lepromatous) 0.1, 0.1, 0.7, 0.1;
  (Lymphangiographic) 0.05, 0.10, 0.65, 0.20;
  (Mantle_zone_hyperpla) 0.20, 0.30, 0.45, 0.05;
  (Necrotizing_Kikuchi) 0.40, 0.40, 0.19, 0.01;
  (Necrotiz_non_Kikuchi) 0.20, 0.25, 0.54, 0.01;
  (Rheumatoid_arthritis) 0.01, 0.01, 0.35, 0.63;
  (Sarcoidosis) 0.10, 0.10, 0.65, 0.15;
  (SHML) 0.88, 0.10, 0.01, 0.01;
  (Sinus_histiocytosis) 0.1, 0.1, 0.7, 0.1;
  (Syphilis) 0.01, 0.14, 0.84, 0.01;
  (Toxoplasmosis) 0.10, 0.64, 0.25, 0.01;
  (Tuberculosis) 0.10, 0.25, 0.64, 0.01;
  (Viral_NOS) 0.10, 0.35, 0.54, 0.01;
  (Whipple_s_disease) 0.05, 0.10, 0.65, 0.20;
  (L_H_nodular_HD) 0.40, 0.39, 0.20, 0.01;
  (L_H_diffuse_HD) 0.40, 0.39, 0.20, 0.01;
  (Nodular_sclerosis_HD) 0.35, 0.40, 0.20, 0.05;
  (Cellular_phase_NSHD) 0.35, 0.40, 0.20, 0.05;
  (Syncytial_NSHD) 0.35, 0.40, 0.20, 0.05;
  (Mixed_cellularity_HD) 0.20, 0.15, 0.60, 0.05;
  (Interfollicular_HD) 0.20, 0.15, 0.60, 0.05;
  (Diffuse_fibrosis_HD) 0.01, 0.15, 0.54, 0.30;
  (Reticular_type_HD) 0.01, 0.15, 0.54, 0.30;
  (Small_cleaved_fol) 0.001, 0.049, 0.650, 0.300;
  (Mixed_fol) 0.001, 0.049, 0.650, 0.300;
  (Large_cell_fol) 0.01, 0.01, 0.60, 0.38;
  (Small_noncleaved_fol) 0.01, 0.01, 0.60, 0.38;
  (Small_lymphocytic) 0.000001, 0.010000, 0.499999, 0.490000;
  (Plasmacytoid_lyctic) 0.000001, 0.010000, 0.499999, 0.490000;
  (Mantle_zone_lymphoma) 0.000001, 0.010000, 0.499999, 0.490000;
  (Small_cleaved_dif) 0.001, 0.100, 0.500, 0.399;
  (Mixed_FCC_dif) 0.01, 0.05, 0.40, 0.54;
  (Large_cell_dif) 0.3, 0.1, 0.3, 0.3;
  (B_immunoblastic) 0.05, 0.10, 0.30, 0.55;
  (T_immunob_mixed) 0.15, 0.20, 0.30, 0.35;
  (AILD_like_T_cell_lym) 0.00001, 0.01000, 0.58999, 0.40000;
  (Japanese_ATL) 0.05, 0.10, 0.30, 0.55;
  (Lymphoblastic) 0.5, 0.2, 0.2, 0.1;
  (Small_noncleaved_dif) 0.5, 0.2, 0.2, 0.1;
  (True_histiocytic) 0.05, 0.05, 0.40, 0.50;
  (Ki_1_LC_anaplas_T) 0.30, 0.25, 0.30, 0.15;
  (Multiple_myeloma) 0.00, 0.01, 0.40, 0.59;
  (Mycosis_fungoides) 0.00, 0.01, 0.60, 0.39;
  (AML) 0.02, 0.08, 0.73, 0.17;
  (Hairy_cell_leukemia) 0.001, 0.009, 0.600, 0.390;
  (Carcinoma) 0.01, 0.02, 0.60, 0.37;
  (Melanoma) 0.01, 0.10, 0.60, 0.29;
  (EM_plasmacytoma) 9.999990e-07, 9.999990e-03, 4.999995e-01, 4.899995e-01;
  (Kaposi_s_sarcoma) 0.20, 0.25, 0.30, 0.25;
  (Mast_cell_disease) 0.00, 0.01, 0.70, 0.29;
  (AIDS_involutionary) 0.05, 0.40, 0.54, 0.01;
  (T_immunob_large) 0.15, 0.20, 0.30, 0.35;
  (Monocytoid_B_cell) 0.001, 0.049, 0.650, 0.300;
  (Nasopharyngeal_CA) 0.15, 0.20, 0.60, 0.05;
  (Seminoma) 0.2, 0.3, 0.4, 0.1;
  (SLE) 0.25, 0.50, 0.20, 0.05;
  (Mycobact_histiocytos) 0.10, 0.25, 0.64, 0.01;
  (Mast_cell_hyperplas) 0.01, 0.05, 0.54, 0.40;
  (LGV) 0.01, 0.14, 0.84, 0.01;
  (Histoplasmosis) 0.15, 0.25, 0.40, 0.20;
  (Coccidioidomycosis) 0.15, 0.25, 0.40, 0.20;
  (CMV) 0.15, 0.25, 0.40, 0.20;
  (Brucellosis) 0.10, 0.64, 0.25, 0.01;
  (Ki_1_LC_anaplas_B) 0.30, 0.25, 0.30, 0.15;
  (Intermed_lymphocytic) 0.000001, 0.010000, 0.499999, 0.490000;
}
probability ( LYMPHADE | Fault ) {
  (AIDS_early) 0.15, 0.85;
  (AILD) 0.05, 0.95;
  (ALIP) 0.15, 0.85;
  (Cat_scratch_disease) 0.99, 0.01;
  (Dermatopathic_laden) 0.99, 0.01;
  (Florid_follic_hyperp) 0.99, 0.01;
  (GLH_hyaline_vascular) 0.99, 0.01;
  (GLH_plasma_cell) 0.9, 0.1;
  (Granulomatous_laden) 0.99, 0.01;
  (Histiocytosis_x) 0.99, 0.01;
  (Infectious_mono) 0.95, 0.05;
  (Leprosy_lepromatous) 0.9, 0.1;
  (Lymphangiographic) 0.9, 0.1;
  (Mantle_zone_hyperpla) 0.99, 0.01;
  (Necrotizing_Kikuchi) 0.98, 0.02;
  (Necrotiz_non_Kikuchi) 0.98, 0.02;
  (Rheumatoid_arthritis) 0.95, 0.05;
  (Sarcoidosis) 0.95, 0.05;
  (SHML) 0.99, 0.01;
  (Sinus_histiocytosis) 0.99, 0.01;
  (Syphilis) 0.95, 0.05;
  (Toxoplasmosis) 0.98, 0.02;
  (Tuberculosis) 0.95, 0.05;
  (Viral_NOS) 0.95, 0.05;
  (Whipple_s_disease) 0.9, 0.1;
  (L_H_nodular_HD) 0.9, 0.1;
  (L_H_diffuse_HD) 0.9, 0.1;
  (Nodular_sclerosis_HD) 0.6, 0.4;
  (Cellular_phase_NSHD) 0.6, 0.4;
  (Syncytial_NSHD) 0.6, 0.4;
  (Mixed_cellularity_HD) 0.5, 0.5;
  (Interfollicular_HD) 0.5, 0.5;
  (Diffuse_fibrosis_HD) 0.15, 0.85;
  (Reticular_type_HD) 0.15, 0.85;
  (Small_cleaved_fol) 0.15, 0.85;
  (Mixed_fol) 0.15, 0.85;
  (Large_cell_fol) 0.4, 0.6;
  (Small_noncleaved_fol) 0.4, 0.6;
  (Small_lymphocytic) 0.15, 0.85;
  (Plasmacytoid_lyctic) 0.15, 0.85;
  (Mantle_zone_lymphoma) 0.4, 0.6;
  (Small_cleaved_dif) 0.4, 0.6;
  (Mixed_FCC_dif) 0.4, 0.6;
  (Large_cell_dif) 0.4, 0.6;
  (B_immunoblastic) 0.4, 0.6;
  (T_immunob_mixed) 0.4, 0.6;
  (AILD_like_T_cell_lym) 0.05, 0.95;
  (Japanese_ATL) 0.4, 0.6;
  (Lymphoblastic) 0.6, 0.4;
  (Small_noncleaved_dif) 0.4, 0.6;
  (True_histiocytic) 0.4, 0.6;
  (Ki_1_LC_anaplas_T) 0.4, 0.6;
  (Multiple_myeloma) 0.7, 0.3;
  (Mycosis_fungoides) 0.7, 0.3;
  (AML) 0.7, 0.3;
  (Hairy_cell_leukemia) 0.95, 0.05;
  (Carcinoma) 0.98, 0.02;
  (Melanoma) 0.99, 0.01;
  (EM_plasmacytoma) 0.98, 0.02;
  (Kaposi_s_sarcoma) 0.9, 0.1;
  (Mast_cell_disease) 0.7, 0.3;
  (AIDS_involutionary) 0.15, 0.85;
  (T_immunob_large) 0.4, 0.6;
  (Monocytoid_B_cell) 0.4, 0.6;
  (Nasopharyngeal_CA) 0.98, 0.02;
  (Seminoma) 0.95, 0.05;
  (SLE) 0.95, 0.05;
  (Mycobact_histiocytos) 0.95, 0.05;
  (Mast_cell_hyperplas) 0.99, 0.01;
  (LGV) 0.99, 0.01;
  (Histoplasmosis) 0.99, 0.01;
  (Coccidioidomycosis) 0.99, 0.01;
  (CMV) 0.99, 0.01;
  (Brucellosis) 0.99, 0.01;
  (Ki_1_LC_anaplas_B) 0.4, 0.6;
  (Intermed_lymphocytic) 0.4, 0.6;
}
probability ( MED_MASS | Fault ) {
  (AIDS_early) 0.99, 0.01;
  (AILD) 0.97, 0.03;
  (ALIP) 0.995, 0.005;
  (Cat_scratch_disease) 0.995, 0.005;
  (Dermatopathic_laden) 0.995, 0.005;
  (Florid_follic_hyperp) 0.995, 0.005;
  (GLH_hyaline_vascular) 0.1, 0.9;
  (GLH_plasma_cell) 0.9, 0.1;
  (Granulomatous_laden) 0.995, 0.005;
  (Histiocytosis_x) 0.995, 0.005;
  (Infectious_mono) 0.995, 0.005;
  (Leprosy_lepromatous) 0.995, 0.005;
  (Lymphangiographic) 0.995, 0.005;
  (Mantle_zone_hyperpla) 0.995, 0.005;
  (Necrotizing_Kikuchi) 0.995, 0.005;
  (Necrotiz_non_Kikuchi) 0.995, 0.005;
  (Rheumatoid_arthritis) 0.995, 0.005;
  (Sarcoidosis) 0.8, 0.2;
  (SHML) 0.97, 0.03;
  (Sinus_histiocytosis) 0.995, 0.005;
  (Syphilis) 0.995, 0.005;
  (Toxoplasmosis) 0.995, 0.005;
  (Tuberculosis) 0.9, 0.1;
  (Viral_NOS) 0.995, 0.005;
  (Whipple_s_disease) 0.995, 0.005;
  (L_H_nodular_HD) 0.99, 0.01;
  (L_H_diffuse_HD) 0.99, 0.01;
  (Nodular_sclerosis_HD) 0.4, 0.6;
  (Cellular_phase_NSHD) 0.4, 0.6;
  (Syncytial_NSHD) 0.4, 0.6;
  (Mixed_cellularity_HD) 0.9, 0.1;
  (Interfollicular_HD) 0.9, 0.1;
  (Diffuse_fibrosis_HD) 0.9, 0.1;
  (Reticular_type_HD) 0.9, 0.1;
  (Small_cleaved_fol) 0.95, 0.05;
  (Mixed_fol) 0.95, 0.05;
  (Large_cell_fol) 0.95, 0.05;
  (Small_noncleaved_fol) 0.95, 0.05;
  (Small_lymphocytic) 0.97, 0.03;
  (Plasmacytoid_lyctic) 0.97, 0.03;
  (Mantle_zone_lymphoma) 0.97, 0.03;
  (Small_cleaved_dif) 0.97, 0.03;
  (Mixed_FCC_dif) 0.97, 0.03;
  (Large_cell_dif) 0.85, 0.15;
  (B_immunoblastic) 0.9, 0.1;
  (T_immunob_mixed) 0.9, 0.1;
  (AILD_like_T_cell_lym) 0.97, 0.03;
  (Japanese_ATL) 0.9, 0.1;
  (Lymphoblastic) 0.6, 0.4;
  (Small_noncleaved_dif) 0.9, 0.1;
  (True_histiocytic) 0.9, 0.1;
  (Ki_1_LC_anaplas_T) 0.9, 0.1;
  (Multiple_myeloma) 0.993, 0.007;
  (Mycosis_fungoides) 0.993, 0.007;
  (AML) 0.97, 0.03;
  (Hairy_cell_leukemia) 0.995, 0.005;
  (Carcinoma) 0.95, 0.05;
  (Melanoma) 0.993, 0.007;
  (EM_plasmacytoma) 0.993, 0.007;
  (Kaposi_s_sarcoma) 0.993, 0.007;
  (Mast_cell_disease) 0.993, 0.007;
  (AIDS_involutionary) 0.99, 0.01;
  (T_immunob_large) 0.9, 0.1;
  (Monocytoid_B_cell) 0.97, 0.03;
  (Nasopharyngeal_CA) 0.97, 0.03;
  (Seminoma) 0.95, 0.05;
  (SLE) 0.995, 0.005;
  (Mycobact_histiocytos) 0.995, 0.005;
  (Mast_cell_hyperplas) 0.995, 0.005;
  (LGV) 0.995, 0.005;
  (Histoplasmosis) 0.995, 0.005;
  (Coccidioidomycosis) 0.995, 0.005;
  (CMV) 0.995, 0.005;
  (Brucellosis) 0.995, 0.005;
  (Ki_1_LC_anaplas_B) 0.9, 0.1;
  (Intermed_lymphocytic) 0.97, 0.03;
}
probability ( HMB45 | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 0.05, 0.95;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 1.0, 0.0;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( MLC_LYZ | Fault, MLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0;
  (AIDS_early, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AILD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (ALIP, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Sparse_LT_10pc) 0.00, 0.98, 0.02;
  (Florid_follic_hyperp, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Sparse_LT_10pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, Sparse_LT_10pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (SHML, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Syphilis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_dif, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AML, Sparse_LT_10pc) 0.0, 0.7, 0.3;
  (Hairy_cell_leukemia, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Carcinoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Melanoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Seminoma, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (SLE, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (LGV, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (CMV, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Brucellosis, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Sparse_LT_10pc) 0.0, 1.0, 0.0;
  (AIDS_early, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AILD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (ALIP, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.00, 0.98, 0.02;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (SHML, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Syphilis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AML, Moderate_11_to_50pc) 0.0, 0.7, 0.3;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Carcinoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Melanoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Seminoma, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (SLE, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (LGV, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (CMV, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Brucellosis, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.0, 1.0, 0.0;
  (AIDS_early, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AILD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (ALIP, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.00, 0.98, 0.02;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (SHML, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Syphilis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AML, Numerous_51_to_90pc) 0.0, 0.7, 0.3;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Carcinoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Melanoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Seminoma, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (SLE, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (LGV, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (CMV, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Brucellosis, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.0, 1.0, 0.0;
  (AIDS_early, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AILD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (ALIP, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Cat_scratch_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Dermatopathic_laden, Striking_GT_90pc) 0.00, 0.98, 0.02;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (GLH_plasma_cell, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Granulomatous_laden, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Histiocytosis_x, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Infectious_mono, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Lymphangiographic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.0, 0.9, 0.1;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.0, 0.9, 0.1;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Sarcoidosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (SHML, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Syphilis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Toxoplasmosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Tuberculosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Viral_NOS, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Whipple_s_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (L_H_nodular_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Syncytial_NSHD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Interfollicular_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Reticular_type_HD, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Large_cell_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_lymphocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_cleaved_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Large_cell_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (B_immunoblastic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (T_immunob_mixed, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Japanese_ATL, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Lymphoblastic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (True_histiocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Multiple_myeloma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mycosis_fungoides, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AML, Striking_GT_90pc) 0.0, 0.7, 0.3;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Carcinoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Melanoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (EM_plasmacytoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_disease, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (AIDS_involutionary, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (T_immunob_large, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Seminoma, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (SLE, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (LGV, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Histoplasmosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Coccidioidomycosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (CMV, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Brucellosis, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.0, 1.0, 0.0;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.0, 1.0, 0.0;
}
probability ( MLC_I | MLC ) {
  (Absent_0pc) 1.0, 0.0;
  (Sparse_LT_10pc) 0.0, 1.0;
  (Moderate_11_to_50pc) 0.0, 1.0;
  (Numerous_51_to_90pc) 0.0, 1.0;
  (Striking_GT_90pc) 0.0, 1.0;
}
probability ( LLC_I | LLC ) {
  (Absent_0pc) 1.0, 0.0;
  (Sparse_LT_10pc) 0.0, 1.0;
  (Moderate_11_to_50pc) 0.0, 1.0;
  (Numerous_51_to_90pc) 0.0, 1.0;
  (Striking_GT_90pc) 0.0, 1.0;
}
probability ( LIPID | Fault ) {
  (AIDS_early) 0.99, 0.01;
  (AILD) 0.99, 0.01;
  (ALIP) 0.99, 0.01;
  (Cat_scratch_disease) 0.99, 0.01;
  (Dermatopathic_laden) 0.9, 0.1;
  (Florid_follic_hyperp) 0.99, 0.01;
  (GLH_hyaline_vascular) 0.99, 0.01;
  (GLH_plasma_cell) 0.99, 0.01;
  (Granulomatous_laden) 0.99, 0.01;
  (Histiocytosis_x) 0.99, 0.01;
  (Infectious_mono) 0.99, 0.01;
  (Leprosy_lepromatous) 0.9, 0.1;
  (Lymphangiographic) 0.01, 0.99;
  (Mantle_zone_hyperpla) 0.99, 0.01;
  (Necrotizing_Kikuchi) 0.99, 0.01;
  (Necrotiz_non_Kikuchi) 0.99, 0.01;
  (Rheumatoid_arthritis) 0.99, 0.01;
  (Sarcoidosis) 0.99, 0.01;
  (SHML) 0.99, 0.01;
  (Sinus_histiocytosis) 0.99, 0.01;
  (Syphilis) 0.99, 0.01;
  (Toxoplasmosis) 0.99, 0.01;
  (Tuberculosis) 0.99, 0.01;
  (Viral_NOS) 0.99, 0.01;
  (Whipple_s_disease) 0.01, 0.99;
  (L_H_nodular_HD) 0.95, 0.05;
  (L_H_diffuse_HD) 0.95, 0.05;
  (Nodular_sclerosis_HD) 0.95, 0.05;
  (Cellular_phase_NSHD) 0.95, 0.05;
  (Syncytial_NSHD) 0.95, 0.05;
  (Mixed_cellularity_HD) 0.95, 0.05;
  (Interfollicular_HD) 0.95, 0.05;
  (Diffuse_fibrosis_HD) 0.95, 0.05;
  (Reticular_type_HD) 0.95, 0.05;
  (Small_cleaved_fol) 0.95, 0.05;
  (Mixed_fol) 0.95, 0.05;
  (Large_cell_fol) 0.95, 0.05;
  (Small_noncleaved_fol) 0.95, 0.05;
  (Small_lymphocytic) 0.95, 0.05;
  (Plasmacytoid_lyctic) 0.95, 0.05;
  (Mantle_zone_lymphoma) 0.95, 0.05;
  (Small_cleaved_dif) 0.95, 0.05;
  (Mixed_FCC_dif) 0.95, 0.05;
  (Large_cell_dif) 0.95, 0.05;
  (B_immunoblastic) 0.95, 0.05;
  (T_immunob_mixed) 0.95, 0.05;
  (AILD_like_T_cell_lym) 0.95, 0.05;
  (Japanese_ATL) 0.95, 0.05;
  (Lymphoblastic) 0.95, 0.05;
  (Small_noncleaved_dif) 0.95, 0.05;
  (True_histiocytic) 0.95, 0.05;
  (Ki_1_LC_anaplas_T) 0.95, 0.05;
  (Multiple_myeloma) 0.95, 0.05;
  (Mycosis_fungoides) 0.95, 0.05;
  (AML) 0.95, 0.05;
  (Hairy_cell_leukemia) 0.95, 0.05;
  (Carcinoma) 0.95, 0.05;
  (Melanoma) 0.95, 0.05;
  (EM_plasmacytoma) 0.99, 0.01;
  (Kaposi_s_sarcoma) 0.99, 0.01;
  (Mast_cell_disease) 0.99, 0.01;
  (AIDS_involutionary) 0.99, 0.01;
  (T_immunob_large) 0.95, 0.05;
  (Monocytoid_B_cell) 0.95, 0.05;
  (Nasopharyngeal_CA) 0.95, 0.05;
  (Seminoma) 0.95, 0.05;
  (SLE) 0.99, 0.01;
  (Mycobact_histiocytos) 0.9, 0.1;
  (Mast_cell_hyperplas) 0.99, 0.01;
  (LGV) 0.9, 0.1;
  (Histoplasmosis) 0.99, 0.01;
  (Coccidioidomycosis) 0.99, 0.01;
  (CMV) 0.99, 0.01;
  (Brucellosis) 0.99, 0.01;
  (Ki_1_LC_anaplas_B) 0.95, 0.05;
  (Intermed_lymphocytic) 0.95, 0.05;
}
probability ( HX_LA | Fault ) {
  (AIDS_early) 0.995, 0.005;
  (AILD) 0.9, 0.1;
  (ALIP) 0.995, 0.005;
  (Cat_scratch_disease) 0.995, 0.005;
  (Dermatopathic_laden) 0.995, 0.005;
  (Florid_follic_hyperp) 0.995, 0.005;
  (GLH_hyaline_vascular) 0.995, 0.005;
  (GLH_plasma_cell) 0.995, 0.005;
  (Granulomatous_laden) 0.995, 0.005;
  (Histiocytosis_x) 0.995, 0.005;
  (Infectious_mono) 0.995, 0.005;
  (Leprosy_lepromatous) 0.995, 0.005;
  (Lymphangiographic) 0.0, 1.0;
  (Mantle_zone_hyperpla) 0.995, 0.005;
  (Necrotizing_Kikuchi) 0.995, 0.005;
  (Necrotiz_non_Kikuchi) 0.995, 0.005;
  (Rheumatoid_arthritis) 0.995, 0.005;
  (Sarcoidosis) 0.995, 0.005;
  (SHML) 0.995, 0.005;
  (Sinus_histiocytosis) 0.995, 0.005;
  (Syphilis) 0.995, 0.005;
  (Toxoplasmosis) 0.995, 0.005;
  (Tuberculosis) 0.995, 0.005;
  (Viral_NOS) 0.995, 0.005;
  (Whipple_s_disease) 0.995, 0.005;
  (L_H_nodular_HD) 0.4, 0.6;
  (L_H_diffuse_HD) 0.4, 0.6;
  (Nodular_sclerosis_HD) 0.4, 0.6;
  (Cellular_phase_NSHD) 0.4, 0.6;
  (Syncytial_NSHD) 0.4, 0.6;
  (Mixed_cellularity_HD) 0.4, 0.6;
  (Interfollicular_HD) 0.4, 0.6;
  (Diffuse_fibrosis_HD) 0.4, 0.6;
  (Reticular_type_HD) 0.4, 0.6;
  (Small_cleaved_fol) 0.9, 0.1;
  (Mixed_fol) 0.9, 0.1;
  (Large_cell_fol) 0.9, 0.1;
  (Small_noncleaved_fol) 0.9, 0.1;
  (Small_lymphocytic) 0.9, 0.1;
  (Plasmacytoid_lyctic) 0.9, 0.1;
  (Mantle_zone_lymphoma) 0.9, 0.1;
  (Small_cleaved_dif) 0.9, 0.1;
  (Mixed_FCC_dif) 0.9, 0.1;
  (Large_cell_dif) 0.9, 0.1;
  (B_immunoblastic) 0.9, 0.1;
  (T_immunob_mixed) 0.9, 0.1;
  (AILD_like_T_cell_lym) 0.9, 0.1;
  (Japanese_ATL) 0.9, 0.1;
  (Lymphoblastic) 0.9, 0.1;
  (Small_noncleaved_dif) 0.9, 0.1;
  (True_histiocytic) 0.9, 0.1;
  (Ki_1_LC_anaplas_T) 0.9, 0.1;
  (Multiple_myeloma) 0.98, 0.02;
  (Mycosis_fungoides) 0.98, 0.02;
  (AML) 0.98, 0.02;
  (Hairy_cell_leukemia) 0.98, 0.02;
  (Carcinoma) 0.98, 0.02;
  (Melanoma) 0.98, 0.02;
  (EM_plasmacytoma) 0.9, 0.1;
  (Kaposi_s_sarcoma) 0.98, 0.02;
  (Mast_cell_disease) 0.9, 0.1;
  (AIDS_involutionary) 0.995, 0.005;
  (T_immunob_large) 0.9, 0.1;
  (Monocytoid_B_cell) 0.9, 0.1;
  (Nasopharyngeal_CA) 0.98, 0.02;
  (Seminoma) 0.98, 0.02;
  (SLE) 0.995, 0.005;
  (Mycobact_histiocytos) 0.995, 0.005;
  (Mast_cell_hyperplas) 0.995, 0.005;
  (LGV) 0.995, 0.005;
  (Histoplasmosis) 0.995, 0.005;
  (Coccidioidomycosis) 0.995, 0.005;
  (CMV) 0.995, 0.005;
  (Brucellosis) 0.995, 0.005;
  (Ki_1_LC_anaplas_B) 0.9, 0.1;
  (Intermed_lymphocytic) 0.9, 0.1;
}
probability ( HEMATOX | Fault ) {
  (AIDS_early) 1.0, 0.0;
  (AILD) 1.0, 0.0;
  (ALIP) 1.0, 0.0;
  (Cat_scratch_disease) 1.0, 0.0;
  (Dermatopathic_laden) 1.0, 0.0;
  (Florid_follic_hyperp) 1.0, 0.0;
  (GLH_hyaline_vascular) 1.0, 0.0;
  (GLH_plasma_cell) 1.0, 0.0;
  (Granulomatous_laden) 1.0, 0.0;
  (Histiocytosis_x) 1.0, 0.0;
  (Infectious_mono) 1.0, 0.0;
  (Leprosy_lepromatous) 1.0, 0.0;
  (Lymphangiographic) 1.0, 0.0;
  (Mantle_zone_hyperpla) 1.0, 0.0;
  (Necrotizing_Kikuchi) 1.0, 0.0;
  (Necrotiz_non_Kikuchi) 1.0, 0.0;
  (Rheumatoid_arthritis) 1.0, 0.0;
  (Sarcoidosis) 1.0, 0.0;
  (SHML) 1.0, 0.0;
  (Sinus_histiocytosis) 1.0, 0.0;
  (Syphilis) 1.0, 0.0;
  (Toxoplasmosis) 1.0, 0.0;
  (Tuberculosis) 1.0, 0.0;
  (Viral_NOS) 1.0, 0.0;
  (Whipple_s_disease) 1.0, 0.0;
  (L_H_nodular_HD) 1.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0;
  (Mixed_fol) 1.0, 0.0;
  (Large_cell_fol) 1.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0;
  (Large_cell_dif) 1.0, 0.0;
  (B_immunoblastic) 1.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0;
  (Japanese_ATL) 1.0, 0.0;
  (Lymphoblastic) 1.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0;
  (True_histiocytic) 1.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0;
  (AML) 1.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0;
  (Carcinoma) 1.0, 0.0;
  (Melanoma) 1.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0;
  (AIDS_involutionary) 1.0, 0.0;
  (T_immunob_large) 1.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0;
  (Seminoma) 1.0, 0.0;
  (SLE) 0.15, 0.85;
  (Mycobact_histiocytos) 1.0, 0.0;
  (Mast_cell_hyperplas) 1.0, 0.0;
  (LGV) 1.0, 0.0;
  (Histoplasmosis) 1.0, 0.0;
  (Coccidioidomycosis) 1.0, 0.0;
  (CMV) 1.0, 0.0;
  (Brucellosis) 1.0, 0.0;
  (Ki_1_LC_anaplas_B) 1.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0;
}
probability ( CMV | Fault ) {
  (AIDS_early) 0.98, 0.02;
  (AILD) 0.99, 0.01;
  (ALIP) 0.99999, 0.00001;
  (Cat_scratch_disease) 0.99999, 0.00001;
  (Dermatopathic_laden) 0.99999, 0.00001;
  (Florid_follic_hyperp) 0.99999, 0.00001;
  (GLH_hyaline_vascular) 0.99999, 0.00001;
  (GLH_plasma_cell) 0.99999, 0.00001;
  (Granulomatous_laden) 0.99999, 0.00001;
  (Histiocytosis_x) 0.99999, 0.00001;
  (Infectious_mono) 0.99999, 0.00001;
  (Leprosy_lepromatous) 0.99999, 0.00001;
  (Lymphangiographic) 0.99999, 0.00001;
  (Mantle_zone_hyperpla) 0.99999, 0.00001;
  (Necrotizing_Kikuchi) 0.99999, 0.00001;
  (Necrotiz_non_Kikuchi) 0.99999, 0.00001;
  (Rheumatoid_arthritis) 0.99999, 0.00001;
  (Sarcoidosis) 0.99999, 0.00001;
  (SHML) 0.99999, 0.00001;
  (Sinus_histiocytosis) 0.99999, 0.00001;
  (Syphilis) 0.99999, 0.00001;
  (Toxoplasmosis) 0.99999, 0.00001;
  (Tuberculosis) 0.99999, 0.00001;
  (Viral_NOS) 0.99999, 0.00001;
  (Whipple_s_disease) 0.99999, 0.00001;
  (L_H_nodular_HD) 0.99, 0.01;
  (L_H_diffuse_HD) 0.99, 0.01;
  (Nodular_sclerosis_HD) 0.99, 0.01;
  (Cellular_phase_NSHD) 0.99, 0.01;
  (Syncytial_NSHD) 0.99, 0.01;
  (Mixed_cellularity_HD) 0.99, 0.01;
  (Interfollicular_HD) 0.99, 0.01;
  (Diffuse_fibrosis_HD) 0.99, 0.01;
  (Reticular_type_HD) 0.99, 0.01;
  (Small_cleaved_fol) 0.99, 0.01;
  (Mixed_fol) 0.99, 0.01;
  (Large_cell_fol) 0.99, 0.01;
  (Small_noncleaved_fol) 0.99, 0.01;
  (Small_lymphocytic) 0.99, 0.01;
  (Plasmacytoid_lyctic) 0.99, 0.01;
  (Mantle_zone_lymphoma) 0.99, 0.01;
  (Small_cleaved_dif) 0.99, 0.01;
  (Mixed_FCC_dif) 0.99, 0.01;
  (Large_cell_dif) 0.99, 0.01;
  (B_immunoblastic) 0.99, 0.01;
  (T_immunob_mixed) 0.99, 0.01;
  (AILD_like_T_cell_lym) 0.99, 0.01;
  (Japanese_ATL) 0.99, 0.01;
  (Lymphoblastic) 0.99, 0.01;
  (Small_noncleaved_dif) 0.99, 0.01;
  (True_histiocytic) 0.99, 0.01;
  (Ki_1_LC_anaplas_T) 0.99, 0.01;
  (Multiple_myeloma) 0.99, 0.01;
  (Mycosis_fungoides) 0.99, 0.01;
  (AML) 0.99, 0.01;
  (Hairy_cell_leukemia) 0.99, 0.01;
  (Carcinoma) 0.99, 0.01;
  (Melanoma) 0.99, 0.01;
  (EM_plasmacytoma) 0.99, 0.01;
  (Kaposi_s_sarcoma) 0.99, 0.01;
  (Mast_cell_disease) 0.99, 0.01;
  (AIDS_involutionary) 0.98, 0.02;
  (T_immunob_large) 0.99, 0.01;
  (Monocytoid_B_cell) 0.99, 0.01;
  (Nasopharyngeal_CA) 0.99, 0.01;
  (Seminoma) 0.99, 0.01;
  (SLE) 0.99999, 0.00001;
  (Mycobact_histiocytos) 0.99999, 0.00001;
  (Mast_cell_hyperplas) 0.99999, 0.00001;
  (LGV) 0.99999, 0.00001;
  (Histoplasmosis) 0.99999, 0.00001;
  (Coccidioidomycosis) 0.99999, 0.00001;
  (CMV) 0.0, 1.0;
  (Brucellosis) 0.99999, 0.00001;
  (Ki_1_LC_anaplas_B) 0.99, 0.01;
  (Intermed_lymphocytic) 0.99, 0.01;
}
probability ( BRUCELLA | Fault ) {
  (AIDS_early) 0.999999, 0.000001;
  (AILD) 0.999999, 0.000001;
  (ALIP) 0.999999, 0.000001;
  (Cat_scratch_disease) 0.999999, 0.000001;
  (Dermatopathic_laden) 0.999999, 0.000001;
  (Florid_follic_hyperp) 0.999999, 0.000001;
  (GLH_hyaline_vascular) 0.999999, 0.000001;
  (GLH_plasma_cell) 0.999999, 0.000001;
  (Granulomatous_laden) 0.999999, 0.000001;
  (Histiocytosis_x) 0.999999, 0.000001;
  (Infectious_mono) 0.999999, 0.000001;
  (Leprosy_lepromatous) 0.999999, 0.000001;
  (Lymphangiographic) 0.999999, 0.000001;
  (Mantle_zone_hyperpla) 0.999999, 0.000001;
  (Necrotizing_Kikuchi) 0.999999, 0.000001;
  (Necrotiz_non_Kikuchi) 0.999999, 0.000001;
  (Rheumatoid_arthritis) 0.999999, 0.000001;
  (Sarcoidosis) 0.999999, 0.000001;
  (SHML) 0.999999, 0.000001;
  (Sinus_histiocytosis) 0.999999, 0.000001;
  (Syphilis) 0.999999, 0.000001;
  (Toxoplasmosis) 0.999999, 0.000001;
  (Tuberculosis) 0.999999, 0.000001;
  (Viral_NOS) 0.999999, 0.000001;
  (Whipple_s_disease) 0.999999, 0.000001;
  (L_H_nodular_HD) 0.999999, 0.000001;
  (L_H_diffuse_HD) 0.999999, 0.000001;
  (Nodular_sclerosis_HD) 0.999999, 0.000001;
  (Cellular_phase_NSHD) 0.999999, 0.000001;
  (Syncytial_NSHD) 0.999999, 0.000001;
  (Mixed_cellularity_HD) 0.999999, 0.000001;
  (Interfollicular_HD) 0.999999, 0.000001;
  (Diffuse_fibrosis_HD) 0.999999, 0.000001;
  (Reticular_type_HD) 0.999999, 0.000001;
  (Small_cleaved_fol) 0.999999, 0.000001;
  (Mixed_fol) 0.999999, 0.000001;
  (Large_cell_fol) 0.999999, 0.000001;
  (Small_noncleaved_fol) 0.999999, 0.000001;
  (Small_lymphocytic) 0.999999, 0.000001;
  (Plasmacytoid_lyctic) 0.999999, 0.000001;
  (Mantle_zone_lymphoma) 0.999999, 0.000001;
  (Small_cleaved_dif) 0.999999, 0.000001;
  (Mixed_FCC_dif) 0.999999, 0.000001;
  (Large_cell_dif) 0.999999, 0.000001;
  (B_immunoblastic) 0.999999, 0.000001;
  (T_immunob_mixed) 0.999999, 0.000001;
  (AILD_like_T_cell_lym) 0.999999, 0.000001;
  (Japanese_ATL) 0.999999, 0.000001;
  (Lymphoblastic) 0.999999, 0.000001;
  (Small_noncleaved_dif) 0.999999, 0.000001;
  (True_histiocytic) 0.999999, 0.000001;
  (Ki_1_LC_anaplas_T) 0.999999, 0.000001;
  (Multiple_myeloma) 0.999999, 0.000001;
  (Mycosis_fungoides) 0.999999, 0.000001;
  (AML) 0.999999, 0.000001;
  (Hairy_cell_leukemia) 0.999999, 0.000001;
  (Carcinoma) 0.999999, 0.000001;
  (Melanoma) 0.999999, 0.000001;
  (EM_plasmacytoma) 0.999999, 0.000001;
  (Kaposi_s_sarcoma) 0.999999, 0.000001;
  (Mast_cell_disease) 0.999999, 0.000001;
  (AIDS_involutionary) 0.999999, 0.000001;
  (T_immunob_large) 0.999999, 0.000001;
  (Monocytoid_B_cell) 0.999999, 0.000001;
  (Nasopharyngeal_CA) 0.999999, 0.000001;
  (Seminoma) 0.999999, 0.000001;
  (SLE) 0.999999, 0.000001;
  (Mycobact_histiocytos) 0.999999, 0.000001;
  (Mast_cell_hyperplas) 0.999999, 0.000001;
  (LGV) 0.999999, 0.000001;
  (Histoplasmosis) 0.999999, 0.000001;
  (Coccidioidomycosis) 0.999999, 0.000001;
  (CMV) 0.999999, 0.000001;
  (Brucellosis) 0.01, 0.99;
  (Ki_1_LC_anaplas_B) 0.999999, 0.000001;
  (Intermed_lymphocytic) 0.999999, 0.000001;
}
probability ( COCCIDIA | Fault ) {
  (AIDS_early) 0.95, 0.05;
  (AILD) 0.999, 0.001;
  (ALIP) 0.999999, 0.000001;
  (Cat_scratch_disease) 0.999999, 0.000001;
  (Dermatopathic_laden) 0.999999, 0.000001;
  (Florid_follic_hyperp) 0.999999, 0.000001;
  (GLH_hyaline_vascular) 0.999999, 0.000001;
  (GLH_plasma_cell) 0.999999, 0.000001;
  (Granulomatous_laden) 0.999999, 0.000001;
  (Histiocytosis_x) 0.999999, 0.000001;
  (Infectious_mono) 0.999999, 0.000001;
  (Leprosy_lepromatous) 0.999999, 0.000001;
  (Lymphangiographic) 0.999999, 0.000001;
  (Mantle_zone_hyperpla) 0.999999, 0.000001;
  (Necrotizing_Kikuchi) 0.999999, 0.000001;
  (Necrotiz_non_Kikuchi) 0.999999, 0.000001;
  (Rheumatoid_arthritis) 0.999999, 0.000001;
  (Sarcoidosis) 0.999999, 0.000001;
  (SHML) 0.999999, 0.000001;
  (Sinus_histiocytosis) 0.999999, 0.000001;
  (Syphilis) 0.999999, 0.000001;
  (Toxoplasmosis) 0.999999, 0.000001;
  (Tuberculosis) 0.999999, 0.000001;
  (Viral_NOS) 0.999999, 0.000001;
  (Whipple_s_disease) 0.999999, 0.000001;
  (L_H_nodular_HD) 0.999, 0.001;
  (L_H_diffuse_HD) 0.999, 0.001;
  (Nodular_sclerosis_HD) 0.999, 0.001;
  (Cellular_phase_NSHD) 0.999, 0.001;
  (Syncytial_NSHD) 0.999, 0.001;
  (Mixed_cellularity_HD) 0.999, 0.001;
  (Interfollicular_HD) 0.999, 0.001;
  (Diffuse_fibrosis_HD) 0.999, 0.001;
  (Reticular_type_HD) 0.999, 0.001;
  (Small_cleaved_fol) 0.999, 0.001;
  (Mixed_fol) 0.999, 0.001;
  (Large_cell_fol) 0.999, 0.001;
  (Small_noncleaved_fol) 0.999, 0.001;
  (Small_lymphocytic) 0.999, 0.001;
  (Plasmacytoid_lyctic) 0.999, 0.001;
  (Mantle_zone_lymphoma) 0.999, 0.001;
  (Small_cleaved_dif) 0.999, 0.001;
  (Mixed_FCC_dif) 0.999, 0.001;
  (Large_cell_dif) 0.999, 0.001;
  (B_immunoblastic) 0.999, 0.001;
  (T_immunob_mixed) 0.999, 0.001;
  (AILD_like_T_cell_lym) 0.999, 0.001;
  (Japanese_ATL) 0.999, 0.001;
  (Lymphoblastic) 0.999, 0.001;
  (Small_noncleaved_dif) 0.999, 0.001;
  (True_histiocytic) 0.999, 0.001;
  (Ki_1_LC_anaplas_T) 0.999, 0.001;
  (Multiple_myeloma) 0.999, 0.001;
  (Mycosis_fungoides) 0.999, 0.001;
  (AML) 0.999, 0.001;
  (Hairy_cell_leukemia) 0.999, 0.001;
  (Carcinoma) 0.999, 0.001;
  (Melanoma) 0.999, 0.001;
  (EM_plasmacytoma) 0.999, 0.001;
  (Kaposi_s_sarcoma) 0.999, 0.001;
  (Mast_cell_disease) 0.999, 0.001;
  (AIDS_involutionary) 0.95, 0.05;
  (T_immunob_large) 0.999, 0.001;
  (Monocytoid_B_cell) 0.999, 0.001;
  (Nasopharyngeal_CA) 0.999, 0.001;
  (Seminoma) 0.999, 0.001;
  (SLE) 0.999999, 0.000001;
  (Mycobact_histiocytos) 0.999999, 0.000001;
  (Mast_cell_hyperplas) 0.999999, 0.000001;
  (LGV) 0.999999, 0.000001;
  (Histoplasmosis) 0.999999, 0.000001;
  (Coccidioidomycosis) 0.0, 1.0;
  (CMV) 0.999999, 0.000001;
  (Brucellosis) 0.999999, 0.000001;
  (Ki_1_LC_anaplas_B) 0.999, 0.001;
  (Intermed_lymphocytic) 0.999, 0.001;
}
probability ( HISTOPLA | Fault ) {
  (AIDS_early) 0.95, 0.05;
  (AILD) 0.9999, 0.0001;
  (ALIP) 0.999999, 0.000001;
  (Cat_scratch_disease) 0.999999, 0.000001;
  (Dermatopathic_laden) 0.999999, 0.000001;
  (Florid_follic_hyperp) 0.999999, 0.000001;
  (GLH_hyaline_vascular) 0.999999, 0.000001;
  (GLH_plasma_cell) 0.999999, 0.000001;
  (Granulomatous_laden) 0.999999, 0.000001;
  (Histiocytosis_x) 0.999999, 0.000001;
  (Infectious_mono) 0.999999, 0.000001;
  (Leprosy_lepromatous) 0.999999, 0.000001;
  (Lymphangiographic) 0.999999, 0.000001;
  (Mantle_zone_hyperpla) 0.999999, 0.000001;
  (Necrotizing_Kikuchi) 0.999999, 0.000001;
  (Necrotiz_non_Kikuchi) 0.999999, 0.000001;
  (Rheumatoid_arthritis) 0.999999, 0.000001;
  (Sarcoidosis) 0.999999, 0.000001;
  (SHML) 0.999999, 0.000001;
  (Sinus_histiocytosis) 0.999999, 0.000001;
  (Syphilis) 0.999999, 0.000001;
  (Toxoplasmosis) 0.999999, 0.000001;
  (Tuberculosis) 0.999999, 0.000001;
  (Viral_NOS) 0.999999, 0.000001;
  (Whipple_s_disease) 0.999999, 0.000001;
  (L_H_nodular_HD) 0.9999, 0.0001;
  (L_H_diffuse_HD) 0.9999, 0.0001;
  (Nodular_sclerosis_HD) 0.9999, 0.0001;
  (Cellular_phase_NSHD) 0.9999, 0.0001;
  (Syncytial_NSHD) 0.9999, 0.0001;
  (Mixed_cellularity_HD) 0.9999, 0.0001;
  (Interfollicular_HD) 0.9999, 0.0001;
  (Diffuse_fibrosis_HD) 0.9999, 0.0001;
  (Reticular_type_HD) 0.9999, 0.0001;
  (Small_cleaved_fol) 0.9999, 0.0001;
  (Mixed_fol) 0.9999, 0.0001;
  (Large_cell_fol) 0.9999, 0.0001;
  (Small_noncleaved_fol) 0.9999, 0.0001;
  (Small_lymphocytic) 0.9999, 0.0001;
  (Plasmacytoid_lyctic) 0.9999, 0.0001;
  (Mantle_zone_lymphoma) 0.9999, 0.0001;
  (Small_cleaved_dif) 0.9999, 0.0001;
  (Mixed_FCC_dif) 0.9999, 0.0001;
  (Large_cell_dif) 0.9999, 0.0001;
  (B_immunoblastic) 0.9999, 0.0001;
  (T_immunob_mixed) 0.9999, 0.0001;
  (AILD_like_T_cell_lym) 0.9999, 0.0001;
  (Japanese_ATL) 0.9999, 0.0001;
  (Lymphoblastic) 0.9999, 0.0001;
  (Small_noncleaved_dif) 0.9999, 0.0001;
  (True_histiocytic) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_T) 0.9999, 0.0001;
  (Multiple_myeloma) 0.9999, 0.0001;
  (Mycosis_fungoides) 0.9999, 0.0001;
  (AML) 0.9999, 0.0001;
  (Hairy_cell_leukemia) 0.9999, 0.0001;
  (Carcinoma) 0.9999, 0.0001;
  (Melanoma) 0.9999, 0.0001;
  (EM_plasmacytoma) 0.9999, 0.0001;
  (Kaposi_s_sarcoma) 0.9999, 0.0001;
  (Mast_cell_disease) 0.9999, 0.0001;
  (AIDS_involutionary) 0.95, 0.05;
  (T_immunob_large) 0.9999, 0.0001;
  (Monocytoid_B_cell) 0.9999, 0.0001;
  (Nasopharyngeal_CA) 0.9999, 0.0001;
  (Seminoma) 0.9999, 0.0001;
  (SLE) 0.999999, 0.000001;
  (Mycobact_histiocytos) 0.999999, 0.000001;
  (Mast_cell_hyperplas) 0.999999, 0.000001;
  (LGV) 0.999999, 0.000001;
  (Histoplasmosis) 0.0, 1.0;
  (Coccidioidomycosis) 0.999999, 0.000001;
  (CMV) 0.999999, 0.000001;
  (Brucellosis) 0.999999, 0.000001;
  (Ki_1_LC_anaplas_B) 0.9999, 0.0001;
  (Intermed_lymphocytic) 0.9999, 0.0001;
}
probability ( LGV | Fault ) {
  (AIDS_early) 0.97, 0.03;
  (AILD) 0.999999, 0.000001;
  (ALIP) 0.999999, 0.000001;
  (Cat_scratch_disease) 0.999999, 0.000001;
  (Dermatopathic_laden) 0.999999, 0.000001;
  (Florid_follic_hyperp) 0.999999, 0.000001;
  (GLH_hyaline_vascular) 0.999999, 0.000001;
  (GLH_plasma_cell) 0.999999, 0.000001;
  (Granulomatous_laden) 0.999999, 0.000001;
  (Histiocytosis_x) 0.999999, 0.000001;
  (Infectious_mono) 0.999999, 0.000001;
  (Leprosy_lepromatous) 0.999999, 0.000001;
  (Lymphangiographic) 0.999999, 0.000001;
  (Mantle_zone_hyperpla) 0.999999, 0.000001;
  (Necrotizing_Kikuchi) 0.999999, 0.000001;
  (Necrotiz_non_Kikuchi) 0.999999, 0.000001;
  (Rheumatoid_arthritis) 0.999999, 0.000001;
  (Sarcoidosis) 0.999999, 0.000001;
  (SHML) 0.999999, 0.000001;
  (Sinus_histiocytosis) 0.999999, 0.000001;
  (Syphilis) 0.999999, 0.000001;
  (Toxoplasmosis) 0.999999, 0.000001;
  (Tuberculosis) 0.999999, 0.000001;
  (Viral_NOS) 0.999999, 0.000001;
  (Whipple_s_disease) 0.999999, 0.000001;
  (L_H_nodular_HD) 0.999999, 0.000001;
  (L_H_diffuse_HD) 0.999999, 0.000001;
  (Nodular_sclerosis_HD) 0.999999, 0.000001;
  (Cellular_phase_NSHD) 0.999999, 0.000001;
  (Syncytial_NSHD) 0.999999, 0.000001;
  (Mixed_cellularity_HD) 0.999999, 0.000001;
  (Interfollicular_HD) 0.999999, 0.000001;
  (Diffuse_fibrosis_HD) 0.999999, 0.000001;
  (Reticular_type_HD) 0.999999, 0.000001;
  (Small_cleaved_fol) 0.999999, 0.000001;
  (Mixed_fol) 0.999999, 0.000001;
  (Large_cell_fol) 0.999999, 0.000001;
  (Small_noncleaved_fol) 0.999999, 0.000001;
  (Small_lymphocytic) 0.999999, 0.000001;
  (Plasmacytoid_lyctic) 0.999999, 0.000001;
  (Mantle_zone_lymphoma) 0.999999, 0.000001;
  (Small_cleaved_dif) 0.999999, 0.000001;
  (Mixed_FCC_dif) 0.999999, 0.000001;
  (Large_cell_dif) 0.999999, 0.000001;
  (B_immunoblastic) 0.999999, 0.000001;
  (T_immunob_mixed) 0.999999, 0.000001;
  (AILD_like_T_cell_lym) 0.999999, 0.000001;
  (Japanese_ATL) 0.999999, 0.000001;
  (Lymphoblastic) 0.999999, 0.000001;
  (Small_noncleaved_dif) 0.999999, 0.000001;
  (True_histiocytic) 0.999999, 0.000001;
  (Ki_1_LC_anaplas_T) 0.999999, 0.000001;
  (Multiple_myeloma) 0.999999, 0.000001;
  (Mycosis_fungoides) 0.999999, 0.000001;
  (AML) 0.999999, 0.000001;
  (Hairy_cell_leukemia) 0.999999, 0.000001;
  (Carcinoma) 0.999999, 0.000001;
  (Melanoma) 0.999999, 0.000001;
  (EM_plasmacytoma) 0.999999, 0.000001;
  (Kaposi_s_sarcoma) 0.999999, 0.000001;
  (Mast_cell_disease) 0.999999, 0.000001;
  (AIDS_involutionary) 0.97, 0.03;
  (T_immunob_large) 0.999999, 0.000001;
  (Monocytoid_B_cell) 0.999999, 0.000001;
  (Nasopharyngeal_CA) 0.999999, 0.000001;
  (Seminoma) 0.999999, 0.000001;
  (SLE) 0.999999, 0.000001;
  (Mycobact_histiocytos) 0.999999, 0.000001;
  (Mast_cell_hyperplas) 0.999999, 0.000001;
  (LGV) 0.01, 0.99;
  (Histoplasmosis) 0.999999, 0.000001;
  (Coccidioidomycosis) 0.999999, 0.000001;
  (CMV) 0.999999, 0.000001;
  (Brucellosis) 0.999999, 0.000001;
  (Ki_1_LC_anaplas_B) 0.999999, 0.000001;
  (Intermed_lymphocytic) 0.999999, 0.000001;
}
probability ( VDRL | Fault ) {
  (AIDS_early) 0.97, 0.03;
  (AILD) 0.9999, 0.0001;
  (ALIP) 0.9999, 0.0001;
  (Cat_scratch_disease) 0.9999, 0.0001;
  (Dermatopathic_laden) 0.9999, 0.0001;
  (Florid_follic_hyperp) 0.9999, 0.0001;
  (GLH_hyaline_vascular) 0.9999, 0.0001;
  (GLH_plasma_cell) 0.9999, 0.0001;
  (Granulomatous_laden) 0.9999, 0.0001;
  (Histiocytosis_x) 0.9999, 0.0001;
  (Infectious_mono) 0.9999, 0.0001;
  (Leprosy_lepromatous) 0.9999, 0.0001;
  (Lymphangiographic) 0.9999, 0.0001;
  (Mantle_zone_hyperpla) 0.9999, 0.0001;
  (Necrotizing_Kikuchi) 0.9999, 0.0001;
  (Necrotiz_non_Kikuchi) 0.9999, 0.0001;
  (Rheumatoid_arthritis) 0.9999, 0.0001;
  (Sarcoidosis) 0.9999, 0.0001;
  (SHML) 0.9999, 0.0001;
  (Sinus_histiocytosis) 0.9999, 0.0001;
  (Syphilis) 0.02, 0.98;
  (Toxoplasmosis) 0.9999, 0.0001;
  (Tuberculosis) 0.9999, 0.0001;
  (Viral_NOS) 0.9999, 0.0001;
  (Whipple_s_disease) 0.9999, 0.0001;
  (L_H_nodular_HD) 0.9999, 0.0001;
  (L_H_diffuse_HD) 0.9999, 0.0001;
  (Nodular_sclerosis_HD) 0.9999, 0.0001;
  (Cellular_phase_NSHD) 0.9999, 0.0001;
  (Syncytial_NSHD) 0.9999, 0.0001;
  (Mixed_cellularity_HD) 0.9999, 0.0001;
  (Interfollicular_HD) 0.9999, 0.0001;
  (Diffuse_fibrosis_HD) 0.9999, 0.0001;
  (Reticular_type_HD) 0.9999, 0.0001;
  (Small_cleaved_fol) 0.9999, 0.0001;
  (Mixed_fol) 0.9999, 0.0001;
  (Large_cell_fol) 0.9999, 0.0001;
  (Small_noncleaved_fol) 0.9999, 0.0001;
  (Small_lymphocytic) 0.9999, 0.0001;
  (Plasmacytoid_lyctic) 0.9999, 0.0001;
  (Mantle_zone_lymphoma) 0.9999, 0.0001;
  (Small_cleaved_dif) 0.9999, 0.0001;
  (Mixed_FCC_dif) 0.9999, 0.0001;
  (Large_cell_dif) 0.9999, 0.0001;
  (B_immunoblastic) 0.9999, 0.0001;
  (T_immunob_mixed) 0.9999, 0.0001;
  (AILD_like_T_cell_lym) 0.9999, 0.0001;
  (Japanese_ATL) 0.9999, 0.0001;
  (Lymphoblastic) 0.9999, 0.0001;
  (Small_noncleaved_dif) 0.9999, 0.0001;
  (True_histiocytic) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_T) 0.9999, 0.0001;
  (Multiple_myeloma) 0.9999, 0.0001;
  (Mycosis_fungoides) 0.9999, 0.0001;
  (AML) 0.9999, 0.0001;
  (Hairy_cell_leukemia) 0.9999, 0.0001;
  (Carcinoma) 0.9999, 0.0001;
  (Melanoma) 0.9999, 0.0001;
  (EM_plasmacytoma) 0.9999, 0.0001;
  (Kaposi_s_sarcoma) 0.9999, 0.0001;
  (Mast_cell_disease) 0.9999, 0.0001;
  (AIDS_involutionary) 0.97, 0.03;
  (T_immunob_large) 0.9999, 0.0001;
  (Monocytoid_B_cell) 0.9999, 0.0001;
  (Nasopharyngeal_CA) 0.9999, 0.0001;
  (Seminoma) 0.9999, 0.0001;
  (SLE) 0.9999, 0.0001;
  (Mycobact_histiocytos) 0.9999, 0.0001;
  (Mast_cell_hyperplas) 0.9999, 0.0001;
  (LGV) 0.9999, 0.0001;
  (Histoplasmosis) 0.9999, 0.0001;
  (Coccidioidomycosis) 0.9999, 0.0001;
  (CMV) 0.9999, 0.0001;
  (Brucellosis) 0.9999, 0.0001;
  (Ki_1_LC_anaplas_B) 0.9999, 0.0001;
  (Intermed_lymphocytic) 0.9999, 0.0001;
}
probability ( PLASCY_T | Fault ) {
  (AIDS_early) 0.99999, 0.00001, 0.00000;
  (AILD) 1.0, 0.0, 0.0;
  (ALIP) 0.99999, 0.00001, 0.00000;
  (Cat_scratch_disease) 0.985, 0.010, 0.005;
  (Dermatopathic_laden) 0.99999, 0.00001, 0.00000;
  (Florid_follic_hyperp) 0.99999, 0.00001, 0.00000;
  (GLH_hyaline_vascular) 0.94, 0.05, 0.01;
  (GLH_plasma_cell) 0.94, 0.05, 0.01;
  (Granulomatous_laden) 0.99999, 0.00001, 0.00000;
  (Histiocytosis_x) 0.99999, 0.00001, 0.00000;
  (Infectious_mono) 0.985, 0.010, 0.005;
  (Leprosy_lepromatous) 0.99999, 0.00001, 0.00000;
  (Lymphangiographic) 0.99999, 0.00001, 0.00000;
  (Mantle_zone_hyperpla) 0.99999, 0.00001, 0.00000;
  (Necrotizing_Kikuchi) 0.05, 0.45, 0.50;
  (Necrotiz_non_Kikuchi) 0.94, 0.05, 0.01;
  (Rheumatoid_arthritis) 0.99999, 0.00001, 0.00000;
  (Sarcoidosis) 0.99999, 0.00001, 0.00000;
  (SHML) 0.99999, 0.00001, 0.00000;
  (Sinus_histiocytosis) 0.99999, 0.00001, 0.00000;
  (Syphilis) 0.99999, 0.00001, 0.00000;
  (Toxoplasmosis) 0.99999, 0.00001, 0.00000;
  (Tuberculosis) 0.99999, 0.00001, 0.00000;
  (Viral_NOS) 0.985, 0.010, 0.005;
  (Whipple_s_disease) 0.99999, 0.00001, 0.00000;
  (L_H_nodular_HD) 1.0, 0.0, 0.0;
  (L_H_diffuse_HD) 1.0, 0.0, 0.0;
  (Nodular_sclerosis_HD) 1.0, 0.0, 0.0;
  (Cellular_phase_NSHD) 1.0, 0.0, 0.0;
  (Syncytial_NSHD) 1.0, 0.0, 0.0;
  (Mixed_cellularity_HD) 1.0, 0.0, 0.0;
  (Interfollicular_HD) 1.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD) 1.0, 0.0, 0.0;
  (Reticular_type_HD) 1.0, 0.0, 0.0;
  (Small_cleaved_fol) 1.0, 0.0, 0.0;
  (Mixed_fol) 1.0, 0.0, 0.0;
  (Large_cell_fol) 1.0, 0.0, 0.0;
  (Small_noncleaved_fol) 1.0, 0.0, 0.0;
  (Small_lymphocytic) 1.0, 0.0, 0.0;
  (Plasmacytoid_lyctic) 1.0, 0.0, 0.0;
  (Mantle_zone_lymphoma) 1.0, 0.0, 0.0;
  (Small_cleaved_dif) 1.0, 0.0, 0.0;
  (Mixed_FCC_dif) 1.0, 0.0, 0.0;
  (Large_cell_dif) 1.0, 0.0, 0.0;
  (B_immunoblastic) 1.0, 0.0, 0.0;
  (T_immunob_mixed) 1.0, 0.0, 0.0;
  (AILD_like_T_cell_lym) 1.0, 0.0, 0.0;
  (Japanese_ATL) 1.0, 0.0, 0.0;
  (Lymphoblastic) 1.0, 0.0, 0.0;
  (Small_noncleaved_dif) 1.0, 0.0, 0.0;
  (True_histiocytic) 1.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T) 1.0, 0.0, 0.0;
  (Multiple_myeloma) 1.0, 0.0, 0.0;
  (Mycosis_fungoides) 1.0, 0.0, 0.0;
  (AML) 1.0, 0.0, 0.0;
  (Hairy_cell_leukemia) 1.0, 0.0, 0.0;
  (Carcinoma) 1.0, 0.0, 0.0;
  (Melanoma) 1.0, 0.0, 0.0;
  (EM_plasmacytoma) 1.0, 0.0, 0.0;
  (Kaposi_s_sarcoma) 1.0, 0.0, 0.0;
  (Mast_cell_disease) 1.0, 0.0, 0.0;
  (AIDS_involutionary) 0.99999, 0.00001, 0.00000;
  (T_immunob_large) 1.0, 0.0, 0.0;
  (Monocytoid_B_cell) 1.0, 0.0, 0.0;
  (Nasopharyngeal_CA) 1.0, 0.0, 0.0;
  (Seminoma) 1.0, 0.0, 0.0;
  (SLE) 0.985, 0.010, 0.005;
  (Mycobact_histiocytos) 0.99999, 0.00001, 0.00000;
  (Mast_cell_hyperplas) 0.99999, 0.00001, 0.00000;
  (LGV) 0.985, 0.010, 0.005;
  (Histoplasmosis) 0.99999, 0.00001, 0.00000;
  (Coccidioidomycosis) 0.99999, 0.00001, 0.00000;
  (CMV) 0.99999, 0.00001, 0.00000;
  (Brucellosis) 0.99999, 0.00001, 0.00000;
  (Ki_1_LC_anaplas_B) 1.0, 0.0, 0.0;
  (Intermed_lymphocytic) 1.0, 0.0, 0.0;
}
probability ( TB | Fault, HIV_ST ) {
  (AIDS_early, Negative) 0.999999, 0.000001, 0.000000;
  (AILD, Negative) 0.999999, 0.000001, 0.000000;
  (ALIP, Negative) 0.999999, 0.000001, 0.000000;
  (Cat_scratch_disease, Negative) 0.999999, 0.000001, 0.000000;
  (Dermatopathic_laden, Negative) 0.999999, 0.000001, 0.000000;
  (Florid_follic_hyperp, Negative) 0.999999, 0.000001, 0.000000;
  (GLH_hyaline_vascular, Negative) 0.999999, 0.000001, 0.000000;
  (GLH_plasma_cell, Negative) 0.999999, 0.000001, 0.000000;
  (Granulomatous_laden, Negative) 0.999999, 0.000001, 0.000000;
  (Histiocytosis_x, Negative) 0.999999, 0.000001, 0.000000;
  (Infectious_mono, Negative) 0.999999, 0.000001, 0.000000;
  (Leprosy_lepromatous, Negative) 0.999999, 0.000001, 0.000000;
  (Lymphangiographic, Negative) 0.999999, 0.000001, 0.000000;
  (Mantle_zone_hyperpla, Negative) 0.999999, 0.000001, 0.000000;
  (Necrotizing_Kikuchi, Negative) 0.999999, 0.000001, 0.000000;
  (Necrotiz_non_Kikuchi, Negative) 0.999999, 0.000001, 0.000000;
  (Rheumatoid_arthritis, Negative) 0.999999, 0.000001, 0.000000;
  (Sarcoidosis, Negative) 0.999999, 0.000001, 0.000000;
  (SHML, Negative) 0.999999, 0.000001, 0.000000;
  (Sinus_histiocytosis, Negative) 0.999999, 0.000001, 0.000000;
  (Syphilis, Negative) 0.999999, 0.000001, 0.000000;
  (Toxoplasmosis, Negative) 0.999999, 0.000001, 0.000000;
  (Tuberculosis, Negative) 0.00, 0.98, 0.02;
  (Viral_NOS, Negative) 0.999999, 0.000001, 0.000000;
  (Whipple_s_disease, Negative) 0.999999, 0.000001, 0.000000;
  (L_H_nodular_HD, Negative) 0.999999, 0.000001, 0.000000;
  (L_H_diffuse_HD, Negative) 0.999999, 0.000001, 0.000000;
  (Nodular_sclerosis_HD, Negative) 0.999999, 0.000001, 0.000000;
  (Cellular_phase_NSHD, Negative) 0.999999, 0.000001, 0.000000;
  (Syncytial_NSHD, Negative) 0.999999, 0.000001, 0.000000;
  (Mixed_cellularity_HD, Negative) 0.999999, 0.000001, 0.000000;
  (Interfollicular_HD, Negative) 0.999999, 0.000001, 0.000000;
  (Diffuse_fibrosis_HD, Negative) 0.999999, 0.000001, 0.000000;
  (Reticular_type_HD, Negative) 0.999999, 0.000001, 0.000000;
  (Small_cleaved_fol, Negative) 0.999999, 0.000001, 0.000000;
  (Mixed_fol, Negative) 0.999999, 0.000001, 0.000000;
  (Large_cell_fol, Negative) 0.999999, 0.000001, 0.000000;
  (Small_noncleaved_fol, Negative) 0.999999, 0.000001, 0.000000;
  (Small_lymphocytic, Negative) 0.999999, 0.000001, 0.000000;
  (Plasmacytoid_lyctic, Negative) 0.999999, 0.000001, 0.000000;
  (Mantle_zone_lymphoma, Negative) 0.999999, 0.000001, 0.000000;
  (Small_cleaved_dif, Negative) 0.999999, 0.000001, 0.000000;
  (Mixed_FCC_dif, Negative) 0.999999, 0.000001, 0.000000;
  (Large_cell_dif, Negative) 0.999999, 0.000001, 0.000000;
  (B_immunoblastic, Negative) 0.999999, 0.000001, 0.000000;
  (T_immunob_mixed, Negative) 0.999999, 0.000001, 0.000000;
  (AILD_like_T_cell_lym, Negative) 0.999999, 0.000001, 0.000000;
  (Japanese_ATL, Negative) 0.999999, 0.000001, 0.000000;
  (Lymphoblastic, Negative) 0.999999, 0.000001, 0.000000;
  (Small_noncleaved_dif, Negative) 0.999999, 0.000001, 0.000000;
  (True_histiocytic, Negative) 0.999999, 0.000001, 0.000000;
  (Ki_1_LC_anaplas_T, Negative) 0.999999, 0.000001, 0.000000;
  (Multiple_myeloma, Negative) 0.999999, 0.000001, 0.000000;
  (Mycosis_fungoides, Negative) 0.999999, 0.000001, 0.000000;
  (AML, Negative) 0.999999, 0.000001, 0.000000;
  (Hairy_cell_leukemia, Negative) 0.999999, 0.000001, 0.000000;
  (Carcinoma, Negative) 0.999999, 0.000001, 0.000000;
  (Melanoma, Negative) 0.999999, 0.000001, 0.000000;
  (EM_plasmacytoma, Negative) 0.999999, 0.000001, 0.000000;
  (Kaposi_s_sarcoma, Negative) 0.999999, 0.000001, 0.000000;
  (Mast_cell_disease, Negative) 0.999999, 0.000001, 0.000000;
  (AIDS_involutionary, Negative) 0.999999, 0.000001, 0.000000;
  (T_immunob_large, Negative) 0.999999, 0.000001, 0.000000;
  (Monocytoid_B_cell, Negative) 0.999999, 0.000001, 0.000000;
  (Nasopharyngeal_CA, Negative) 0.999999, 0.000001, 0.000000;
  (Seminoma, Negative) 0.999999, 0.000001, 0.000000;
  (SLE, Negative) 0.999999, 0.000001, 0.000000;
  (Mycobact_histiocytos, Negative) 0.0, 0.0, 1.0;
  (Mast_cell_hyperplas, Negative) 0.999999, 0.000001, 0.000000;
  (LGV, Negative) 0.999999, 0.000001, 0.000000;
  (Histoplasmosis, Negative) 0.999999, 0.000001, 0.000000;
  (Coccidioidomycosis, Negative) 0.999999, 0.000001, 0.000000;
  (CMV, Negative) 0.999999, 0.000001, 0.000000;
  (Brucellosis, Negative) 0.999999, 0.000001, 0.000000;
  (Ki_1_LC_anaplas_B, Negative) 0.999999, 0.000001, 0.000000;
  (Intermed_lymphocytic, Negative) 0.999999, 0.000001, 0.000000;
  (AIDS_early, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (AILD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (ALIP, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Cat_scratch_disease, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Dermatopathic_laden, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Florid_follic_hyperp, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (GLH_hyaline_vascular, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (GLH_plasma_cell, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Granulomatous_laden, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Histiocytosis_x, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Infectious_mono, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Leprosy_lepromatous, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Lymphangiographic, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Mantle_zone_hyperpla, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Necrotizing_Kikuchi, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Necrotiz_non_Kikuchi, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Rheumatoid_arthritis, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Sarcoidosis, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (SHML, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Sinus_histiocytosis, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Syphilis, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Toxoplasmosis, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Tuberculosis, Positive_Asymptomatic) 0.00, 0.98, 0.02;
  (Viral_NOS, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Whipple_s_disease, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (L_H_nodular_HD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (L_H_diffuse_HD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Nodular_sclerosis_HD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Cellular_phase_NSHD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Syncytial_NSHD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Mixed_cellularity_HD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Interfollicular_HD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Diffuse_fibrosis_HD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Reticular_type_HD, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Small_cleaved_fol, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Mixed_fol, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Large_cell_fol, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Small_noncleaved_fol, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Small_lymphocytic, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Plasmacytoid_lyctic, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Mantle_zone_lymphoma, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Small_cleaved_dif, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Mixed_FCC_dif, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Large_cell_dif, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (B_immunoblastic, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (T_immunob_mixed, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (AILD_like_T_cell_lym, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Japanese_ATL, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Lymphoblastic, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Small_noncleaved_dif, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (True_histiocytic, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Ki_1_LC_anaplas_T, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Multiple_myeloma, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Mycosis_fungoides, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (AML, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Hairy_cell_leukemia, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Carcinoma, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Melanoma, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (EM_plasmacytoma, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Kaposi_s_sarcoma, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Mast_cell_disease, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (AIDS_involutionary, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (T_immunob_large, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Monocytoid_B_cell, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Nasopharyngeal_CA, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Seminoma, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (SLE, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Mycobact_histiocytos, Positive_Asymptomatic) 0.0, 0.0, 1.0;
  (Mast_cell_hyperplas, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (LGV, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Histoplasmosis, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Coccidioidomycosis, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (CMV, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Brucellosis, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Ki_1_LC_anaplas_B, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (Intermed_lymphocytic, Positive_Asymptomatic) 0.98, 0.02, 0.00;
  (AIDS_early, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (AILD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (ALIP, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Cat_scratch_disease, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Dermatopathic_laden, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Florid_follic_hyperp, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (GLH_hyaline_vascular, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (GLH_plasma_cell, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Granulomatous_laden, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Histiocytosis_x, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Infectious_mono, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Leprosy_lepromatous, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Lymphangiographic, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Mantle_zone_hyperpla, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Necrotizing_Kikuchi, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Necrotiz_non_Kikuchi, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Rheumatoid_arthritis, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Sarcoidosis, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (SHML, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Sinus_histiocytosis, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Syphilis, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Toxoplasmosis, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Tuberculosis, Positive_Symptomatic) 0.00, 0.98, 0.02;
  (Viral_NOS, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Whipple_s_disease, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (L_H_nodular_HD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (L_H_diffuse_HD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Nodular_sclerosis_HD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Cellular_phase_NSHD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Syncytial_NSHD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Mixed_cellularity_HD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Interfollicular_HD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Diffuse_fibrosis_HD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Reticular_type_HD, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Small_cleaved_fol, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Mixed_fol, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Large_cell_fol, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Small_noncleaved_fol, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Small_lymphocytic, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Plasmacytoid_lyctic, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Mantle_zone_lymphoma, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Small_cleaved_dif, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Mixed_FCC_dif, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Large_cell_dif, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (B_immunoblastic, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (T_immunob_mixed, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (AILD_like_T_cell_lym, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Japanese_ATL, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Lymphoblastic, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Small_noncleaved_dif, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (True_histiocytic, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Ki_1_LC_anaplas_T, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Multiple_myeloma, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Mycosis_fungoides, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (AML, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Hairy_cell_leukemia, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Carcinoma, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Melanoma, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (EM_plasmacytoma, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Kaposi_s_sarcoma, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Mast_cell_disease, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (AIDS_involutionary, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (T_immunob_large, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Monocytoid_B_cell, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Nasopharyngeal_CA, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Seminoma, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (SLE, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Mycobact_histiocytos, Positive_Symptomatic) 0.0, 0.0, 1.0;
  (Mast_cell_hyperplas, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (LGV, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Histoplasmosis, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Coccidioidomycosis, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (CMV, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Brucellosis, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Ki_1_LC_anaplas_B, Positive_Symptomatic) 0.8, 0.2, 0.0;
  (Intermed_lymphocytic, Positive_Symptomatic) 0.8, 0.2, 0.0;
}
probability ( MELANIN | Fault ) {
  (AIDS_early) 0.30, 0.65, 0.05;
  (AILD) 0.90, 0.09, 0.01;
  (ALIP) 0.99, 0.01, 0.00;
  (Cat_scratch_disease) 0.65, 0.20, 0.15;
  (Dermatopathic_laden) 0.001, 0.600, 0.399;
  (Florid_follic_hyperp) 0.99, 0.01, 0.00;
  (GLH_hyaline_vascular) 0.99, 0.01, 0.00;
  (GLH_plasma_cell) 0.99, 0.01, 0.00;
  (Granulomatous_laden) 0.65, 0.20, 0.15;
  (Histiocytosis_x) 0.99, 0.01, 0.00;
  (Infectious_mono) 0.99, 0.01, 0.00;
  (Leprosy_lepromatous) 0.65, 0.20, 0.15;
  (Lymphangiographic) 0.99, 0.01, 0.00;
  (Mantle_zone_hyperpla) 0.99, 0.01, 0.00;
  (Necrotizing_Kikuchi) 0.99, 0.01, 0.00;
  (Necrotiz_non_Kikuchi) 0.99, 0.01, 0.00;
  (Rheumatoid_arthritis) 0.99, 0.01, 0.00;
  (Sarcoidosis) 0.99, 0.01, 0.00;
  (SHML) 0.99, 0.01, 0.00;
  (Sinus_histiocytosis) 0.99, 0.01, 0.00;
  (Syphilis) 0.65, 0.20, 0.15;
  (Toxoplasmosis) 0.99, 0.01, 0.00;
  (Tuberculosis) 0.99, 0.01, 0.00;
  (Viral_NOS) 0.99, 0.01, 0.00;
  (Whipple_s_disease) 0.99, 0.01, 0.00;
  (L_H_nodular_HD) 0.99, 0.01, 0.00;
  (L_H_diffuse_HD) 0.99, 0.01, 0.00;
  (Nodular_sclerosis_HD) 0.99, 0.01, 0.00;
  (Cellular_phase_NSHD) 0.99, 0.01, 0.00;
  (Syncytial_NSHD) 0.99, 0.01, 0.00;
  (Mixed_cellularity_HD) 0.99, 0.01, 0.00;
  (Interfollicular_HD) 0.99, 0.01, 0.00;
  (Diffuse_fibrosis_HD) 0.99, 0.01, 0.00;
  (Reticular_type_HD) 0.99, 0.01, 0.00;
  (Small_cleaved_fol) 0.99, 0.01, 0.00;
  (Mixed_fol) 0.99, 0.01, 0.00;
  (Large_cell_fol) 0.99, 0.01, 0.00;
  (Small_noncleaved_fol) 0.99, 0.01, 0.00;
  (Small_lymphocytic) 0.99, 0.01, 0.00;
  (Plasmacytoid_lyctic) 0.99, 0.01, 0.00;
  (Mantle_zone_lymphoma) 0.99, 0.01, 0.00;
  (Small_cleaved_dif) 0.99, 0.01, 0.00;
  (Mixed_FCC_dif) 0.99, 0.01, 0.00;
  (Large_cell_dif) 0.99, 0.01, 0.00;
  (B_immunoblastic) 0.99, 0.01, 0.00;
  (T_immunob_mixed) 0.99, 0.01, 0.00;
  (AILD_like_T_cell_lym) 0.90, 0.09, 0.01;
  (Japanese_ATL) 0.01, 0.10, 0.89;
  (Lymphoblastic) 0.99, 0.01, 0.00;
  (Small_noncleaved_dif) 0.99, 0.01, 0.00;
  (True_histiocytic) 0.99, 0.01, 0.00;
  (Ki_1_LC_anaplas_T) 0.99, 0.01, 0.00;
  (Multiple_myeloma) 0.99, 0.01, 0.00;
  (Mycosis_fungoides) 0.01, 0.10, 0.89;
  (AML) 0.99, 0.01, 0.00;
  (Hairy_cell_leukemia) 0.99, 0.01, 0.00;
  (Carcinoma) 0.99, 0.01, 0.00;
  (Melanoma) 0.99, 0.01, 0.00;
  (EM_plasmacytoma) 0.99, 0.01, 0.00;
  (Kaposi_s_sarcoma) 0.3, 0.6, 0.1;
  (Mast_cell_disease) 0.6, 0.3, 0.1;
  (AIDS_involutionary) 0.01, 0.50, 0.49;
  (T_immunob_large) 0.99, 0.01, 0.00;
  (Monocytoid_B_cell) 0.99, 0.01, 0.00;
  (Nasopharyngeal_CA) 0.99, 0.01, 0.00;
  (Seminoma) 0.99, 0.01, 0.00;
  (SLE) 0.99, 0.01, 0.00;
  (Mycobact_histiocytos) 0.99, 0.01, 0.00;
  (Mast_cell_hyperplas) 0.6, 0.3, 0.1;
  (LGV) 0.99, 0.01, 0.00;
  (Histoplasmosis) 0.99, 0.01, 0.00;
  (Coccidioidomycosis) 0.99, 0.01, 0.00;
  (CMV) 0.99, 0.01, 0.00;
  (Brucellosis) 0.99, 0.01, 0.00;
  (Ki_1_LC_anaplas_B) 0.99, 0.01, 0.00;
  (Intermed_lymphocytic) 0.99, 0.01, 0.00;
}
probability ( MC_SL_NS | Fault, F_MZ ) {
  (AIDS_early, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_follicles) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (ALIP, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cat_scratch_disease, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Dermatopathic_laden, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Florid_follic_hyperp, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_hyaline_vascular, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (GLH_plasma_cell, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Granulomatous_laden, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histiocytosis_x, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Infectious_mono, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Leprosy_lepromatous, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphangiographic, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_hyperpla, Present) 0.000, 0.949, 0.050, 0.001, 0.000;
  (Necrotizing_Kikuchi, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Necrotiz_non_Kikuchi, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Rheumatoid_arthritis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sarcoidosis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SHML, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Sinus_histiocytosis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syphilis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Toxoplasmosis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Tuberculosis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Viral_NOS, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Whipple_s_disease, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_nodular_HD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (L_H_diffuse_HD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Nodular_sclerosis_HD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Cellular_phase_NSHD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Syncytial_NSHD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_cellularity_HD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Interfollicular_HD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Diffuse_fibrosis_HD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Reticular_type_HD, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_cleaved_fol, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_fol, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Large_cell_fol, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_noncleaved_fol, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_lymphocytic, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Plasmacytoid_lyctic, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mantle_zone_lymphoma, Present) 0.000, 0.100, 0.499, 0.400, 0.001;
  (Small_cleaved_dif, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mixed_FCC_dif, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Large_cell_dif, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (B_immunoblastic, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (T_immunob_mixed, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AILD_like_T_cell_lym, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Japanese_ATL, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Lymphoblastic, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Small_noncleaved_dif, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (True_histiocytic, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_T, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Multiple_myeloma, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mycosis_fungoides, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AML, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Hairy_cell_leukemia, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Carcinoma, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Melanoma, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (EM_plasmacytoma, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Kaposi_s_sarcoma, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_disease, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (AIDS_involutionary, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (T_immunob_large, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Monocytoid_B_cell, Present) 0.00, 0.89, 0.10, 0.01, 0.00;
  (Nasopharyngeal_CA, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Seminoma, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (SLE, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mycobact_histiocytos, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Mast_cell_hyperplas, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (LGV, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Histoplasmosis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Coccidioidomycosis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (CMV, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Brucellosis, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Ki_1_LC_anaplas_B, Present) 0.00, 0.99, 0.01, 0.00, 0.00;
  (Intermed_lymphocytic, Present) 0.0, 0.0, 0.6, 0.4, 0.0;
}
probability ( FMZ_FUS | Fault, F_MZSTAT ) {
  (AIDS_early, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (AILD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (ALIP, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (SHML, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (AML, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (SLE, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (LGV, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (CMV, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, No_follicles_no_mantle_zones) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (AILD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (SHML, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (AML, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (SLE, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (LGV, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (CMV, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Mantle_zones_absent_in_most_follicles) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (AILD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (SHML, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (AML, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (SLE, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (LGV, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (CMV, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Most_incompletely_surround_follicles) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (AILD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (ALIP, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (SHML, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (AML, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Carcinoma, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Melanoma, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Seminoma, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (SLE, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (LGV, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (CMV, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Brucellosis, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Most_completely_surround_fol_not_thick) 1.0, 0.0, 0.0, 0.0;
  (AIDS_early, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (AILD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (ALIP, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Cat_scratch_disease, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Dermatopathic_laden, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Florid_follic_hyperp, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (GLH_hyaline_vascular, Most_thick_GT_10_lymphocytes) 0.0, 0.3, 0.6, 0.1;
  (GLH_plasma_cell, Most_thick_GT_10_lymphocytes) 0.00, 0.94, 0.05, 0.01;
  (Granulomatous_laden, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Histiocytosis_x, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Infectious_mono, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Leprosy_lepromatous, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Lymphangiographic, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Mantle_zone_hyperpla, Most_thick_GT_10_lymphocytes) 0.00, 0.60, 0.35, 0.05;
  (Necrotizing_Kikuchi, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Necrotiz_non_Kikuchi, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Rheumatoid_arthritis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Sarcoidosis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (SHML, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Sinus_histiocytosis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Syphilis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Toxoplasmosis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Tuberculosis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Viral_NOS, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Whipple_s_disease, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (L_H_nodular_HD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (L_H_diffuse_HD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Nodular_sclerosis_HD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Cellular_phase_NSHD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Syncytial_NSHD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Mixed_cellularity_HD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Interfollicular_HD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Diffuse_fibrosis_HD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Reticular_type_HD, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Small_cleaved_fol, Most_thick_GT_10_lymphocytes) 1.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Most_thick_GT_10_lymphocytes) 1.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Most_thick_GT_10_lymphocytes) 1.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Most_thick_GT_10_lymphocytes) 1.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Plasmacytoid_lyctic, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Mantle_zone_lymphoma, Most_thick_GT_10_lymphocytes) 0.00, 0.00, 0.01, 0.99;
  (Small_cleaved_dif, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Mixed_FCC_dif, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Large_cell_dif, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (B_immunoblastic, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (T_immunob_mixed, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (AILD_like_T_cell_lym, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Japanese_ATL, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Lymphoblastic, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Small_noncleaved_dif, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (True_histiocytic, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Ki_1_LC_anaplas_T, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Multiple_myeloma, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Mycosis_fungoides, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (AML, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Hairy_cell_leukemia, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Carcinoma, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Melanoma, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (EM_plasmacytoma, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Kaposi_s_sarcoma, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Mast_cell_disease, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (AIDS_involutionary, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (T_immunob_large, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Monocytoid_B_cell, Most_thick_GT_10_lymphocytes) 0.00, 0.85, 0.14, 0.01;
  (Nasopharyngeal_CA, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Seminoma, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (SLE, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Mycobact_histiocytos, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Mast_cell_hyperplas, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (LGV, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Histoplasmosis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Coccidioidomycosis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (CMV, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Brucellosis, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Ki_1_LC_anaplas_B, Most_thick_GT_10_lymphocytes) 0.0, 0.9, 0.1, 0.0;
  (Intermed_lymphocytic, Most_thick_GT_10_lymphocytes) 0.00, 0.00, 0.03, 0.97;
}
probability ( BH_NOS_L | Fault, BH_NOS ) {
  (AIDS_early, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_to_slight_LT_5pc) 1.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_fol, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Large_cell_fol, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_fol, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Small_lymphocytic, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Plasmacytoid_lyctic, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_lymphoma, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_dif, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_FCC_dif, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Large_cell_dif, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (B_immunoblastic, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_mixed, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (True_histiocytic, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mycosis_fungoides, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AML, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Nasopharyngeal_CA, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, Absent_to_slight_LT_5pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_early, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, Moderate_5_to_50pc) 0.0, 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Moderate_5_to_50pc) 0.0, 0.0, 1.0, 0.0;
  (Syphilis, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_fol, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Large_cell_fol, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_fol, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_lymphocytic, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Plasmacytoid_lyctic, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_lymphoma, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_dif, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_FCC_dif, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Large_cell_dif, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (B_immunoblastic, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_mixed, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (True_histiocytic, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mycosis_fungoides, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AML, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Nasopharyngeal_CA, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, Moderate_5_to_50pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_early, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (AILD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (ALIP, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Cat_scratch_disease, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Dermatopathic_laden, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Florid_follic_hyperp, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_hyaline_vascular, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (GLH_plasma_cell, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Granulomatous_laden, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Histiocytosis_x, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Infectious_mono, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Leprosy_lepromatous, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphangiographic, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_hyperpla, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotizing_Kikuchi, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Necrotiz_non_Kikuchi, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Rheumatoid_arthritis, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Sarcoidosis, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (SHML, Marked_GT_50pc) 0.0, 0.0, 1.0, 0.0;
  (Sinus_histiocytosis, Marked_GT_50pc) 0.0, 0.0, 1.0, 0.0;
  (Syphilis, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Toxoplasmosis, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Tuberculosis, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Viral_NOS, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Whipple_s_disease, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_nodular_HD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (L_H_diffuse_HD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Nodular_sclerosis_HD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Cellular_phase_NSHD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Syncytial_NSHD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_cellularity_HD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Interfollicular_HD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Diffuse_fibrosis_HD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Reticular_type_HD, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_fol, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_fol, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Large_cell_fol, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_fol, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_lymphocytic, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Plasmacytoid_lyctic, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mantle_zone_lymphoma, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_cleaved_dif, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mixed_FCC_dif, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Large_cell_dif, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (B_immunoblastic, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_mixed, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (AILD_like_T_cell_lym, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Japanese_ATL, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Lymphoblastic, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Small_noncleaved_dif, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (True_histiocytic, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_T, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Multiple_myeloma, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mycosis_fungoides, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (AML, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Hairy_cell_leukemia, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Carcinoma, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Melanoma, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (EM_plasmacytoma, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Kaposi_s_sarcoma, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_disease, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (AIDS_involutionary, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (T_immunob_large, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Monocytoid_B_cell, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Nasopharyngeal_CA, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Seminoma, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (SLE, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mycobact_histiocytos, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Mast_cell_hyperplas, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (LGV, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Histoplasmosis, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Coccidioidomycosis, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (CMV, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Brucellosis, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Ki_1_LC_anaplas_B, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
  (Intermed_lymphocytic, Marked_GT_50pc) 0.00, 0.99, 0.00, 0.01;
}
probability ( SLC_NI | Fault, SLC ) {
  (AIDS_early, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (ALIP, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cat_scratch_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Dermatopathic_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Florid_follic_hyperp, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_hyaline_vascular, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (GLH_plasma_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Granulomatous_laden, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histiocytosis_x, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Infectious_mono, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Leprosy_lepromatous, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphangiographic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_hyperpla, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotizing_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Necrotiz_non_Kikuchi, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Rheumatoid_arthritis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sarcoidosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SHML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Sinus_histiocytosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syphilis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Toxoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Tuberculosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Viral_NOS, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Whipple_s_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_nodular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (L_H_diffuse_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nodular_sclerosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Cellular_phase_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Syncytial_NSHD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_cellularity_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Interfollicular_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Diffuse_fibrosis_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Reticular_type_HD, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_fol, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Plasmacytoid_lyctic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mantle_zone_lymphoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_cleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mixed_FCC_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Large_cell_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (B_immunoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_mixed, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AILD_like_T_cell_lym, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Japanese_ATL, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Lymphoblastic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Small_noncleaved_dif, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (True_histiocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_T, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Multiple_myeloma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycosis_fungoides, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AML, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Hairy_cell_leukemia, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Carcinoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Melanoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (EM_plasmacytoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Kaposi_s_sarcoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_disease, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_involutionary, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (T_immunob_large, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Monocytoid_B_cell, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Nasopharyngeal_CA, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Seminoma, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (SLE, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mycobact_histiocytos, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Mast_cell_hyperplas, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (LGV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Histoplasmosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Coccidioidomycosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (CMV, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Brucellosis, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Ki_1_LC_anaplas_B, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (Intermed_lymphocytic, Absent_0pc) 1.0, 0.0, 0.0, 0.0, 0.0;
  (AIDS_early, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (AILD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (ALIP, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Cat_scratch_disease, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Dermatopathic_laden, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Florid_follic_hyperp, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (GLH_hyaline_vascular, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (GLH_plasma_cell, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Granulomatous_laden, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Histiocytosis_x, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Infectious_mono, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Leprosy_lepromatous, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Lymphangiographic, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Mantle_zone_hyperpla, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Necrotizing_Kikuchi, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Necrotiz_non_Kikuchi, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Rheumatoid_arthritis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Sarcoidosis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (SHML, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Sinus_histiocytosis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Syphilis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Toxoplasmosis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Tuberculosis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Viral_NOS, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Whipple_s_disease, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (L_H_nodular_HD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (L_H_diffuse_HD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Nodular_sclerosis_HD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Cellular_phase_NSHD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Syncytial_NSHD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Mixed_cellularity_HD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Interfollicular_HD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Diffuse_fibrosis_HD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Reticular_type_HD, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Small_cleaved_fol, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Mixed_fol, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Large_cell_fol, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Small_noncleaved_fol, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Small_lymphocytic, Sparse_1_to_10pc) 0.00, 0.83, 0.01, 0.15, 0.01;
  (Plasmacytoid_lyctic, Sparse_1_to_10pc) 0.00, 0.95, 0.01, 0.03, 0.01;
  (Mantle_zone_lymphoma, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Small_cleaved_dif, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Mixed_FCC_dif, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Large_cell_dif, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (B_immunoblastic, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (T_immunob_mixed, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (AILD_like_T_cell_lym, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Japanese_ATL, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Lymphoblastic, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Small_noncleaved_dif, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (True_histiocytic, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Ki_1_LC_anaplas_T, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Multiple_myeloma, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Mycosis_fungoides, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (AML, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Hairy_cell_leukemia, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Carcinoma, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Melanoma, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (EM_plasmacytoma, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Kaposi_s_sarcoma, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Mast_cell_disease, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (AIDS_involutionary, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (T_immunob_large, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Monocytoid_B_cell, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Nasopharyngeal_CA, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Seminoma, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (SLE, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Mycobact_histiocytos, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Mast_cell_hyperplas, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (LGV, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Histoplasmosis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Coccidioidomycosis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (CMV, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Brucellosis, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Ki_1_LC_anaplas_B, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (Intermed_lymphocytic, Sparse_1_to_10pc) 0.00, 0.97, 0.01, 0.01, 0.01;
  (AIDS_early, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AILD, Moderate_11_to_50pc) 0.00, 0.94, 0.03, 0.03, 0.00;
  (ALIP, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Cat_scratch_disease, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Dermatopathic_laden, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Florid_follic_hyperp, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (GLH_hyaline_vascular, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (GLH_plasma_cell, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Granulomatous_laden, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Histiocytosis_x, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Infectious_mono, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Leprosy_lepromatous, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Lymphangiographic, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mantle_zone_hyperpla, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Necrotizing_Kikuchi, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Necrotiz_non_Kikuchi, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Rheumatoid_arthritis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Sarcoidosis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (SHML, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Sinus_histiocytosis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Syphilis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Toxoplasmosis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Tuberculosis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Viral_NOS, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Whipple_s_disease, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (L_H_nodular_HD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (L_H_diffuse_HD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Nodular_sclerosis_HD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Cellular_phase_NSHD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Syncytial_NSHD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mixed_cellularity_HD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Interfollicular_HD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Diffuse_fibrosis_HD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Reticular_type_HD, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_cleaved_fol, Moderate_11_to_50pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Mixed_fol, Moderate_11_to_50pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Large_cell_fol, Moderate_11_to_50pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Small_noncleaved_fol, Moderate_11_to_50pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Small_lymphocytic, Moderate_11_to_50pc) 0.00, 0.84, 0.01, 0.15, 0.00;
  (Plasmacytoid_lyctic, Moderate_11_to_50pc) 0.00, 0.96, 0.01, 0.03, 0.00;
  (Mantle_zone_lymphoma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_cleaved_dif, Moderate_11_to_50pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Mixed_FCC_dif, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Large_cell_dif, Moderate_11_to_50pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (B_immunoblastic, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (T_immunob_mixed, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AILD_like_T_cell_lym, Moderate_11_to_50pc) 0.00, 0.94, 0.03, 0.03, 0.00;
  (Japanese_ATL, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Lymphoblastic, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_noncleaved_dif, Moderate_11_to_50pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (True_histiocytic, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Multiple_myeloma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mycosis_fungoides, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AML, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Hairy_cell_leukemia, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Carcinoma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Melanoma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (EM_plasmacytoma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Kaposi_s_sarcoma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mast_cell_disease, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AIDS_involutionary, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (T_immunob_large, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Monocytoid_B_cell, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Nasopharyngeal_CA, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Seminoma, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (SLE, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mycobact_histiocytos, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mast_cell_hyperplas, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (LGV, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Histoplasmosis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Coccidioidomycosis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (CMV, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Brucellosis, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Ki_1_LC_anaplas_B, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Intermed_lymphocytic, Moderate_11_to_50pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AIDS_early, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AILD, Numerous_51_to_90pc) 0.00, 0.94, 0.03, 0.03, 0.00;
  (ALIP, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Cat_scratch_disease, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Dermatopathic_laden, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Florid_follic_hyperp, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (GLH_hyaline_vascular, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (GLH_plasma_cell, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Granulomatous_laden, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Histiocytosis_x, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Infectious_mono, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Leprosy_lepromatous, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Lymphangiographic, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mantle_zone_hyperpla, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Necrotizing_Kikuchi, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Necrotiz_non_Kikuchi, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Rheumatoid_arthritis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Sarcoidosis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (SHML, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Sinus_histiocytosis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Syphilis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Toxoplasmosis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Tuberculosis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Viral_NOS, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Whipple_s_disease, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (L_H_nodular_HD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (L_H_diffuse_HD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Nodular_sclerosis_HD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Cellular_phase_NSHD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Syncytial_NSHD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mixed_cellularity_HD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Interfollicular_HD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Diffuse_fibrosis_HD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Reticular_type_HD, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_cleaved_fol, Numerous_51_to_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Mixed_fol, Numerous_51_to_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Large_cell_fol, Numerous_51_to_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Small_noncleaved_fol, Numerous_51_to_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Small_lymphocytic, Numerous_51_to_90pc) 0.00, 0.84, 0.01, 0.15, 0.00;
  (Plasmacytoid_lyctic, Numerous_51_to_90pc) 0.00, 0.96, 0.01, 0.03, 0.00;
  (Mantle_zone_lymphoma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_cleaved_dif, Numerous_51_to_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Mixed_FCC_dif, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Large_cell_dif, Numerous_51_to_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (B_immunoblastic, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (T_immunob_mixed, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AILD_like_T_cell_lym, Numerous_51_to_90pc) 0.00, 0.94, 0.03, 0.03, 0.00;
  (Japanese_ATL, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Lymphoblastic, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_noncleaved_dif, Numerous_51_to_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (True_histiocytic, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Multiple_myeloma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mycosis_fungoides, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AML, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Hairy_cell_leukemia, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Carcinoma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Melanoma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (EM_plasmacytoma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Kaposi_s_sarcoma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mast_cell_disease, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AIDS_involutionary, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (T_immunob_large, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Monocytoid_B_cell, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Nasopharyngeal_CA, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Seminoma, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (SLE, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mycobact_histiocytos, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mast_cell_hyperplas, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (LGV, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Histoplasmosis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Coccidioidomycosis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (CMV, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Brucellosis, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Ki_1_LC_anaplas_B, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Intermed_lymphocytic, Numerous_51_to_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AIDS_early, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AILD, Striking_GT_90pc) 0.00, 0.94, 0.03, 0.03, 0.00;
  (ALIP, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Cat_scratch_disease, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Dermatopathic_laden, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Florid_follic_hyperp, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (GLH_hyaline_vascular, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (GLH_plasma_cell, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Granulomatous_laden, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Histiocytosis_x, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Infectious_mono, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Leprosy_lepromatous, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Lymphangiographic, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mantle_zone_hyperpla, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Necrotizing_Kikuchi, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Necrotiz_non_Kikuchi, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Rheumatoid_arthritis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Sarcoidosis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (SHML, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Sinus_histiocytosis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Syphilis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Toxoplasmosis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Tuberculosis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Viral_NOS, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Whipple_s_disease, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (L_H_nodular_HD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (L_H_diffuse_HD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Nodular_sclerosis_HD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Cellular_phase_NSHD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Syncytial_NSHD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mixed_cellularity_HD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Interfollicular_HD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Diffuse_fibrosis_HD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Reticular_type_HD, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_cleaved_fol, Striking_GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Mixed_fol, Striking_GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Large_cell_fol, Striking_GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Small_noncleaved_fol, Striking_GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Small_lymphocytic, Striking_GT_90pc) 0.00, 0.84, 0.01, 0.15, 0.00;
  (Plasmacytoid_lyctic, Striking_GT_90pc) 0.00, 0.96, 0.01, 0.03, 0.00;
  (Mantle_zone_lymphoma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_cleaved_dif, Striking_GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (Mixed_FCC_dif, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Large_cell_dif, Striking_GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (B_immunoblastic, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (T_immunob_mixed, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AILD_like_T_cell_lym, Striking_GT_90pc) 0.00, 0.94, 0.03, 0.03, 0.00;
  (Japanese_ATL, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Lymphoblastic, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Small_noncleaved_dif, Striking_GT_90pc) 0.0, 0.9, 0.1, 0.0, 0.0;
  (True_histiocytic, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Ki_1_LC_anaplas_T, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Multiple_myeloma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mycosis_fungoides, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AML, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Hairy_cell_leukemia, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Carcinoma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Melanoma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (EM_plasmacytoma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Kaposi_s_sarcoma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mast_cell_disease, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (AIDS_involutionary, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (T_immunob_large, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Monocytoid_B_cell, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Nasopharyngeal_CA, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Seminoma, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (SLE, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mycobact_histiocytos, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Mast_cell_hyperplas, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (LGV, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Histoplasmosis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Coccidioidomycosis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (CMV, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Brucellosis, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Ki_1_LC_anaplas_B, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
  (Intermed_lymphocytic, Striking_GT_90pc) 0.00, 0.98, 0.01, 0.01, 0.00;
}
probability ( HYALIN | Fault ) {
  (AIDS_early) 0.94, 0.05, 0.01;
  (AILD) 0.75, 0.20, 0.05;
  (ALIP) 0.75, 0.20, 0.05;
  (Cat_scratch_disease) 0.94, 0.05, 0.01;
  (Dermatopathic_laden) 0.94, 0.05, 0.01;
  (Florid_follic_hyperp) 0.94, 0.05, 0.01;
  (GLH_hyaline_vascular) 0.00, 0.01, 0.99;
  (GLH_plasma_cell) 0.6, 0.3, 0.1;
  (Granulomatous_laden) 0.94, 0.05, 0.01;
  (Histiocytosis_x) 0.94, 0.05, 0.01;
  (Infectious_mono) 0.94, 0.05, 0.01;
  (Leprosy_lepromatous) 0.94, 0.05, 0.01;
  (Lymphangiographic) 0.94, 0.05, 0.01;
  (Mantle_zone_hyperpla) 0.94, 0.05, 0.01;
  (Necrotizing_Kikuchi) 0.94, 0.05, 0.01;
  (Necrotiz_non_Kikuchi) 0.94, 0.05, 0.01;
  (Rheumatoid_arthritis) 0.94, 0.05, 0.01;
  (Sarcoidosis) 0.94, 0.05, 0.01;
  (SHML) 0.94, 0.05, 0.01;
  (Sinus_histiocytosis) 0.94, 0.05, 0.01;
  (Syphilis) 0.94, 0.05, 0.01;
  (Toxoplasmosis) 0.94, 0.05, 0.01;
  (Tuberculosis) 0.94, 0.05, 0.01;
  (Viral_NOS) 0.94, 0.05, 0.01;
  (Whipple_s_disease) 0.94, 0.05, 0.01;
  (L_H_nodular_HD) 0.94, 0.05, 0.01;
  (L_H_diffuse_HD) 0.94, 0.05, 0.01;
  (Nodular_sclerosis_HD) 0.94, 0.05, 0.01;
  (Cellular_phase_NSHD) 0.94, 0.05, 0.01;
  (Syncytial_NSHD) 0.94, 0.05, 0.01;
  (Mixed_cellularity_HD) 0.94, 0.05, 0.01;
  (Interfollicular_HD) 0.94, 0.05, 0.01;
  (Diffuse_fibrosis_HD) 0.94, 0.05, 0.01;
  (Reticular_type_HD) 0.94, 0.05, 0.01;
  (Small_cleaved_fol) 0.94, 0.05, 0.01;
  (Mixed_fol) 0.94, 0.05, 0.01;
  (Large_cell_fol) 0.94, 0.05, 0.01;
  (Small_noncleaved_fol) 0.94, 0.05, 0.01;
  (Small_lymphocytic) 0.94, 0.05, 0.01;
  (Plasmacytoid_lyctic) 0.94, 0.05, 0.01;
  (Mantle_zone_lymphoma) 0.94, 0.05, 0.01;
  (Small_cleaved_dif) 0.94, 0.05, 0.01;
  (Mixed_FCC_dif) 0.94, 0.05, 0.01;
  (Large_cell_dif) 0.94, 0.05, 0.01;
  (B_immunoblastic) 0.94, 0.05, 0.01;
  (T_immunob_mixed) 0.94, 0.05, 0.01;
  (AILD_like_T_cell_lym) 0.75, 0.20, 0.05;
  (Japanese_ATL) 0.94, 0.05, 0.01;
  (Lymphoblastic) 0.94, 0.05, 0.01;
  (Small_noncleaved_dif) 0.94, 0.05, 0.01;
  (True_histiocytic) 0.94, 0.05, 0.01;
  (Ki_1_LC_anaplas_T) 0.94, 0.05, 0.01;
  (Multiple_myeloma) 0.94, 0.05, 0.01;
  (Mycosis_fungoides) 0.94, 0.05, 0.01;
  (AML) 0.94, 0.05, 0.01;
  (Hairy_cell_leukemia) 0.94, 0.05, 0.01;
  (Carcinoma) 0.94, 0.05, 0.01;
  (Melanoma) 0.94, 0.05, 0.01;
  (EM_plasmacytoma) 0.94, 0.05, 0.01;
  (Kaposi_s_sarcoma) 0.94, 0.05, 0.01;
  (Mast_cell_disease) 0.94, 0.05, 0.01;
  (AIDS_involutionary) 0.94, 0.05, 0.01;
  (T_immunob_large) 0.94, 0.05, 0.01;
  (Monocytoid_B_cell) 0.94, 0.05, 0.01;
  (Nasopharyngeal_CA) 0.94, 0.05, 0.01;
  (Seminoma) 0.94, 0.05, 0.01;
  (SLE) 0.94, 0.05, 0.01;
  (Mycobact_histiocytos) 0.94, 0.05, 0.01;
  (Mast_cell_hyperplas) 0.94, 0.05, 0.01;
  (LGV) 0.94, 0.05, 0.01;
  (Histoplasmosis) 0.94, 0.05, 0.01;
  (Coccidioidomycosis) 0.94, 0.05, 0.01;
  (CMV) 0.94, 0.05, 0.01;
  (Brucellosis) 0.94, 0.05, 0.01;
  (Ki_1_LC_anaplas_B) 0.94, 0.05, 0.01;
  (Intermed_lymphocytic) 0.94, 0.05, 0.01;
}
